Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.7670548982727443,2.7165470815998733,0.0,0.0,0.0,17/23,14.99%,CASQ2;GSTM2;HRC;CALM1;CASQ1;ATP1A2;CLIC2;CACNA1C;AKAP6;ANK2;PRKACA;CALM2;CAMK2D;SLC8A1;DMD;PDE4D;DHRS7C
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.7816311665622923,2.624316935183857,0.0,0.0,0.0,13/17,13.25%,CASQ2;GSTM2;HRC;CALM1;ATP1A2;CLIC2;CACNA1C;ANK2;PRKACA;CALM2;CAMK2D;SLC8A1;DMD
prerank,muscle organ development (GO:0007517),0.5967448298562668,2.5955618587278138,0.0,0.0,0.0,27/56,13.25%,SMTN;FHL1;SGCA;BVES;ITGA7;SPEG;POU6F1;CACNA1H;SGCE;FHL3;CTF1;MEF2B;MEF2D;MRAS;CHODL;MYH3;TCF21;SGCD;ITGB1BP2;MSTN;MEF2A;MKX;SGCG;CAPN3;LAMA2;MEF2C;DMD
prerank,regulation of heart contraction (GO:0008016),0.5091677594003013,2.5458019397776304,0.0,0.0,0.0,40/91,12.53%,FXYD6;DMPK;HSPB7;PLN;TPM1;ATP2B4;NPR1;FXYD1;CACNA1H;ATP1B2;CASQ2;STIM1;HRC;DES;TNNI3K;CALM1;CASQ1;ATP1A2;NPR2;NOS1;ANK2;PRKACA;NPPC;TRPC1;SMAD7;ADORA3;SLC8A2;CELF2;AHCYL1;CALM2;ATP2A2;FXYD7;RYR3;ASB3;ATP1A3;NPPA;CAMK2D;ITPR1;SLC8A1;ABCC9
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.6745523706960453,2.5317812669038644,0.0,0.0,0.0,14/21,13.25%,CASQ2;GSTM2;HRC;CALM1;ATP1A2;CLIC2;CACNA1C;ANK2;PRKACA;CALM2;ATP2A2;CAMK2D;SLC8A1;DMD
prerank,negative regulation of ion transport (GO:0043271),0.6548243641585372,2.473847719892583,0.0,0.0,0.0,9/25,5.95%,GPM6B;PLN;SYT11;CASQ2;VIP;SNCA;INPP5K;PACSIN3;NOS1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.5647537065567233,2.4246357950823167,0.0,0.0,0.0,24/46,18.48%,NR1D1;ATF4;TFE3;NOVA1;FLCN;ALDH1A1;MAP2K6;ARNTL;PLCL1;LNPEP;NR1H2;RBPJ;IP6K1;ABHD6;LAMA4;NPR3;ADAMTS5;IL15;RHEB;DDIT3;NOVA2;NR1H3;WNT10B;IL18R1
prerank,regulation of microtubule polymerization (GO:0031113),0.5880255405105175,2.3736025552516336,0.0,0.00251475374098815,0.01,17/38,10.50%,CLIP3;STMN2;GBA2;MAPT;SNCA;RAC1;MAPRE3;ARL2;FES;OCLN;CLIP1;MAP2;NUMA1;DCTN1;TUBB4A;CDH5;SLAIN2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.6400504539885936,2.370322433219078,0.0,0.0022353366586561336,0.01,15/24,13.39%,JPH2;CASQ2;GSTM2;HRC;CALM1;CLIC2;PKD2;AKAP6;NOS1;PRKACA;CALM2;JPH4;CAMK2D;DMD;PDE4D
prerank,myofibril assembly (GO:0030239),0.5954555352096408,2.3579969964081102,0.0,0.00603540897837156,0.03,25/42,15.89%,CSRP1;PGM5;LMOD1;TPM1;TMOD2;TMOD1;CASQ1;FLII;CSRP2;MYOZ2;MYH3;OBSL1;PDGFRA;ACTC1;KLHL41;MYOZ1;MYL2;TCAP;CAPN3;CFLAR;WDR1;TNNT3;KRT19;MYOM2;FHOD3
prerank,extracellular matrix assembly (GO:0085029),0.6067129700054975,2.355754814426198,0.0,0.005486735434883237,0.03,13/24,11.07%,FBLN5;GPM6B;MFAP4;LAMB2;EFEMP2;LTBP3;EMILIN1;RAMP2;LAMB1;NTN4;TNXB;NTNG1;PXDN
prerank,regulation of endocytosis (GO:0030100),0.48406300779946765,2.319403434497338,0.0,0.005029507481976301,0.03,22/60,18.03%,CLIP3;STON1;LGALS3;SYT11;RAB5B;SNCA;PACSIN3;PACSIN2;SMPD1;RAB4B;PRKD1;FLOT1;SNX33;LRSAM1;PACSIN1;GPC3;RUFY1;SNX17;EPHA3;RIT2;RAB5C;DLL1
prerank,regulation of focal adhesion assembly (GO:0051893),0.500126251353216,2.30610596615444,0.0,0.004642622291055046,0.03,22/53,13.80%,FAM107A;GPM6B;FERMT2;PTEN;VCL;DUSP22;APOD;ARHGAP6;MYOC;CORO1C;RAC1;DUSP3;COL16A1;DAPK3;RHOA;EFNA5;PHLDB2;DLC1;SFRP1;TSC1;ITGB1BP1;PPM1F
prerank,retrograde axonal transport (GO:0008090),0.7943012722072081,2.305863788710046,0.0,0.004311006413122543,0.03,13/16,12.21%,DST;KIF5A;KIF1C;MAP1A;NEFL;TMEM108;HAP1;KIF1A;SOD1;PAFAH1B1;ACTR10;MGARP;DLG2
prerank,muscle contraction (GO:0006936),0.46691681072272995,2.2997186470404567,0.0,0.00402360598558104,0.03,57/128,14.66%,MYL9;CRYAB;SMTN;TACR2;TPM2;SGCA;LMOD1;SORBS1;MYLK;TPM1;TLN1;GNAO1;FXYD1;ACTA2;CACNA1H;CALD1;CASQ2;TMOD2;VCL;GALR2;HRC;TMOD1;SNTA1;SORBS3;DES;SSPN;CALM1;PABPN1;MYL7;MYL6;MYOM1;DTNA;TPCN2;GJC1;MYOT;MYH3;SMPX;NOS1;ALDOA;PXN;ACTC1;KLHL41;P2RX6;MYL2;TCAP;MYL1;MYOF;GAMT;SLC8A1;MYL3;DYSF;DMD;VIM;ITGB5;SCN4A;TNNT3;SLC6A8
prerank,regulation of muscle cell differentiation (GO:0051147),0.5449955164403489,2.295366616922522,0.0,0.003772130611482225,0.03,16/35,14.61%,BOC;MYOCD;CDK9;SRF;MAPK14;CDON;MEGF10;CAMK1;RBM4;ID2;MAPK11;MEF2A;BNIP2;FGFR2;MEF2C;CDH2
prerank,regulation of cardiac conduction (GO:1903779),0.5765161642671685,2.2805134060156798,0.0,0.0071004811510253655,0.06,27/54,12.53%,FXYD6;DMPK;ATP2B4;NPR1;FXYD1;ATP1B2;CASQ2;STIM1;TNNI3K;CASQ1;ATP1A2;NPR2;NOS1;ANK2;PRKACA;NPPC;TRPC1;SLC8A2;AHCYL1;ATP2A2;FXYD7;RYR3;ATP1A3;NPPA;ITPR1;SLC8A1;ABCC9
prerank,substantia nigra development (GO:0021762),0.5685582178060813,2.2481603145567317,0.0,0.007823678305296468,0.07,14/39,11.16%,NDRG2;PLP1;SYPL2;MAOB;INA;CALM1;SIRT2;RHOA;SYNGR3;ACTB;MAPKAP1;CALM2;CKB;CNP
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5566133424072309,2.2376957555042973,0.0,0.007411905762912443,0.07,15/27,14.40%,PLN;JPH2;HRC;CALM1;NOS1;ANK2;PRKACA;SLN;CALM2;JPH4;CAMK2D;CACNB2;DMD;PDE4D;AHNAK
prerank,regulation of potassium ion transport (GO:0043266),0.583624891811919,2.2347603454723366,0.0,0.00804721197116208,0.08,12/31,11.35%,FHL1;KCNA5;DPP6;CASQ2;KCNH2;VIP;KCNIP3;CD63;NOS1;ANK2;KCNE2;KCNIP4
prerank,anterograde axonal transport (GO:0008089),0.5551553353477068,2.233325863153553,0.0,0.007664011401106743,0.08,16/37,12.49%,AP3S2;HSPB1;KIF5A;KIF1C;MAP1A;BLOC1S1;NEFL;HAP1;SNAPIN;KIF5C;KIF1A;SOD1;TRAK2;MGARP;DLG2;AP3B2
prerank,positive regulation of cation channel activity (GO:2001259),0.5820488120365219,2.233168954332268,0.0,0.007315647246510982,0.08,24/38,19.34%,PIRT;JPH2;GSTM2;GALR2;CALM1;CASQ1;PKD2;AKAP6;LRRC55;ANK2;CTSS;HAP1;CCL2;STAC;CALM2;NLGN3;STAC2;ARC;ADRB2;ANK3;LRRC38;ACTN2;KCNIP2;SHANK3
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.6668729318997584,-2.2271126503153167,0.0,0.0,0.0,16/34,11.73%,CENPN;CENPU;CENPH;CENPW;HJURP;CENPA;OIP5;CENPO;CENPK;RUVBL1;CENPL;MIS18A;CENPM;MIS18BP1;CENPP;HIRA
prerank,protein localization to cell surface (GO:0034394),0.5947590209539104,2.2181166811571806,0.0,0.006997575627097461,0.08,11/27,10.29%,PRRT1;FBLN5;JAM3;FLNA;VCL;RIC3;GPIHBP1;ANK2;FGF7;GGA3;ANGPT1
prerank,cellular response to nutrient levels (GO:0031669),0.49873851972420324,2.2037588359140514,0.0,0.0067060099759684005,0.08,25/60,15.72%,FAM107A;MAP1LC3C;WDR45;ULK1;ZFYVE1;KCNB1;FLCN;CARTPT;GAS2L1;MTOR;KLF10;RRAGA;PRKAA2;TFEB;RRAGD;MAP1LC3A;SFRP1;ATG14;LPL;RRAGB;TSC1;RRAGC;HSPA8;MAP1LC3B;SREBF1
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.7212771959227654,-2.201147408113359,0.0,0.002338762384496822,0.01,15/26,11.37%,CENPN;CENPU;CENPH;CENPW;HJURP;CENPA;OIP5;CENPO;CENPK;RUVBL1;CENPL;MIS18A;CENPM;MIS18BP1;CENPP
prerank,CENP-A containing chromatin organization (GO:0061641),-0.7212771959227654,-2.201147408113359,0.0,0.002338762384496822,0.01,15/26,11.37%,CENPN;CENPU;CENPH;CENPW;HJURP;CENPA;OIP5;CENPO;CENPK;RUVBL1;CENPL;MIS18A;CENPM;MIS18BP1;CENPP
prerank,actin polymerization or depolymerization (GO:0008154),0.4730778561496928,2.1911231229651253,0.0,0.007242490774045873,0.09,17/48,13.90%,FAM107A;DSTN;GSN;CFL2;WASF1;GAS7;ARHGAP6;RAC1;FLII;CORO7;WASF3;MICAL3;ENAH;EVL;WDR1;JAK2;MSRB2
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.5680394801754363,2.1874762409423028,0.0,0.007737703818425078,0.09,11/27,14.61%,BOC;MYOCD;MAPK14;CDON;CAMK1;RBM4;MAPK11;MEF2A;BNIP2;MEF2C;CDH2
prerank,DNA replication (GO:0006260),-0.5353634537704868,-2.1801696850859495,0.0,0.0017540717883726162,0.01,46/106,17.37%,EXO1;ORC6;DBF4;CHEK1;BLM;RFC3;MCM4;CDK1;POLE2;FAM111B;TICRR;TIPIN;TIMELESS;RMI1;RPA3;FEN1;RECQL4;POLB;DNA2;RFC5;TOP1MT;RMI2;POLA1;MCM7;MCM10;RAD9B;MCM3;TOPBP1;WDHD1;RBBP8;RPA4;TOP1;BAZ1A;CDC7;WRN;MCM2;MCM5;ATR;CLSPN;RNASEH2A;RFC2;SET;CDC6;MCM6;POLD2;CDC45
prerank,centromere complex assembly (GO:0034508),-0.677742093230462,-2.175723138644321,0.0,0.001403257430698093,0.01,18/33,12.06%,CENPN;CENPE;CENPU;CENPH;CENPW;HJURP;CENPA;DLGAP5;OIP5;CENPO;CENPK;RUVBL1;CENPL;MIS18A;CENPM;MIS18BP1;CENPP;CENPF
prerank,platelet aggregation (GO:0070527),0.5490876405765629,2.174737321896362,0.0,0.00819623441507249,0.09,12/33,8.51%,CSRP1;MYL9;FLNA;TLN1;ACTN1;VCL;ILK;HSPB1;ITGB3;PDGFRA;ACTB;P2RY12
prerank,autophagosome maturation (GO:0097352),0.5208180583022002,2.163227618951145,0.0,0.008622012826245086,0.1,17/33,18.59%,GABARAPL1;MAP1LC3C;CHMP3;LIX1L;CALM1;TSG101;GABARAPL2;VTI1B;LIX1;MAP1LC3A;ATP2A2;ATG14;GABARAP;MAP1LC3B;VIPAS39;VPS16;VPS33A
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.49870138577805984,2.1515687156000074,0.0,0.008324702039133188,0.1,11/37,8.26%,FAM107A;STMN2;MAP6;STMN4;MAPT;MAPRE3;GAS2L1;EFNA5;PHLDB2;PRKAA2;MAPRE2
prerank,lysosome localization (GO:0032418),0.5459308569123198,2.140274615844211,0.0,0.00871781296875892,0.11,18/34,18.59%,RAB34;MAP6;KIT;RAB3A;FLCN;S100A13;BLOC1S1;HDAC6;SNAPIN;KLC2;TFEB;DEF8;PLEKHM2;ARL8B;MRGPRX2;NR4A3;NDEL1;VPS33A
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.7453437159360755,-2.1162950024662535,0.0,0.001169381192248411,0.01,12/18,17.35%,GINS4;GINS1;RFC3;MCM4;GINS2;MCMDC2;LIG1;POLA1;MCM7;MCM3;LIG3;POLD2
prerank,regulation of striated muscle contraction (GO:0006942),0.5781511390777927,2.1160857487679974,0.0,0.009734530610276711,0.13,14/27,15.06%,TNNI3K;CALM1;ATP1A2;NOS1;ANK2;PRKACA;SMAD7;MYL2;CALM2;ASB3;MYL3;DMD;TNNT3;RNF207
prerank,positive regulation of myoblast differentiation (GO:0045663),0.6661266922985768,2.113623977299969,0.0,0.0100590149639526,0.14,11/17,18.06%,SMYD1;BOC;RBM24;MAPK14;BTG1;LRRC8A;AKIRIN1;MEF2C;XKR8;HIF1AN;RANBP3L
prerank,protein polymerization (GO:0051258),0.4487074773623197,2.1120930070590807,0.0,0.00975419632868131,0.14,16/52,8.72%,FAM107A;GSN;CASQ2;WASF1;GAS7;CHMP3;ARHGAP6;MAPT;CASQ1;TRIM6;RAC1;CORO7;MAP7D3;TPPP3;WASF3;CHMP4A
prerank,regulation of supramolecular fiber organization (GO:1902903),0.5945860271251887,2.1118439958532167,0.0,0.009467308201367155,0.14,9/21,15.21%,GBA2;EFEMP2;MAPT;MAPRE3;ARL2;MAP1A;MAP2;MAP1B;HSPA8
prerank,chromatin remodeling at centromere (GO:0031055),-0.6905326760090128,-2.1109618175387577,0.0,0.0010023267362129237,0.01,15/28,11.37%,CENPN;CENPU;CENPH;CENPW;HJURP;CENPA;OIP5;CENPO;CENPK;RUVBL1;CENPL;MIS18A;CENPM;MIS18BP1;CENPP
prerank,ruffle organization (GO:0031529),0.6184644948050451,2.106224996531513,0.0,0.009196813681328091,0.14,6/16,9.39%,LIMA1;TPM1;INPP5K;RAC1;CCL21;CORO1B
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5578270270031405,2.102025728352015,0.0,0.008941346634624535,0.14,10/22,11.31%,PRNP;CASQ2;HRC;CASQ1;ATP1A2;NOS1;ANK2;CACNA2D1;NPPA;CAMK2D
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.5705569744365825,2.101014149079716,0.0,0.00869968861747252,0.14,11/27,9.31%,PLN;CASQ2;GSTM2;CALM1;ATP1A2;CLIC2;GNB5;PKD2;SLN;TLR9;CALM2
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.5600413462172782,-2.0891807626455035,0.0,0.0008770358941863081,0.01,29/54,27.49%,CXCL1;CXCL3;CXCL8;CXCL2;CXCL5;CXCL9;CXCL11;PF4;DEFA6;CXCL6;RPL39;PGLYRP4;CXCL10;SEMG1;RPS19;ROMO1;RNASE7;GNLY;PF4V1;REG3A;DEFB4A;PGLYRP3;PGLYRP1;DEFA1;GAPDH;S100A7;LTF;ANG;CXCL13
prerank,positive regulation of cell projection organization (GO:0031346),0.4052332534643931,2.088652554780315,0.0,0.009529593123744571,0.16,47/111,19.82%,RAP1A;PTN;PLXNB3;STMN2;ATP1B2;DPYSL3;MAP6;NPTN;FZD4;ROR2;DVL3;CHODL;NGF;NGFR;TOX;FES;OBSL1;CAMK1;RHOA;DVL2;DLG4;DAB2IP;SCN1B;PRKD1;SNX3;NDRG4;ROR1;CX3CL1;TENM3;NTRK1;MAGI2;INS;SCARF1;NTRK3;EPHA3;RET;KIDINS220;LRRC7;PLXNB1;FUT9;RIT2;TIAM1;SCARB2;METRN;GRIP1;DVL1;TWF2
prerank,heart contraction (GO:0060047),0.49674139382947613,2.086250012063361,0.0,0.009285244582110094,0.16,17/40,13.25%,TPM1;CASQ2;KCNH2;ATP1A2;SCN3B;SGCD;SCN2B;ACTC1;SCN1B;SOD1;MYL2;TCAP;SGCG;SCN4B;SLC8A1;MYL3;DMD
prerank,regulation of neuron projection development (GO:0010975),0.38162857937245737,2.0807554806953856,0.0,0.009053113467557342,0.16,57/158,17.28%,CAMK2G;NCS1;RAP1A;PTN;PSEN1;PLXNB3;PTEN;LPAR1;STMN2;ATP1B2;DPYSL3;CRMP1;NPTN;ROR2;PTPRS;DBN1;STX1B;TOX;FES;SPOCK1;CAMK1;EPHA4;DAB2IP;EFHC2;SCN1B;ZDHHC15;MYLIP;KIF1A;DENND5A;PRKD1;MARK1;SNX3;BRSK1;LRRC4C;NTNG1;NDRG4;SEMA3A;ROR1;CX3CL1;TENM3;MT3;NTRK1;ARC;MAGI2;SCARF1;CDH2;NTRK3;ADCY6;EPHA3;RET;KIDINS220;LRRC7;FUT9;KANK1;NDEL1;RIT2;ITM2C
prerank,positive regulation of T cell differentiation (GO:0045582),-0.5813163395789328,-2.0688583473080326,0.0,0.0007795874614989405,0.01,26/42,25.66%,SHH;IL4I1;SOX4;LEF1;IL23A;SOCS1;IL23R;PNP;TNFSF9;IL12B;BCL6;ZAP70;VNN1;CR1;LILRB4;ADAM8;IL36B;HLA-G;CD46;TNFSF4;IL12RB1;MDK;GATA3;XBP1;RHOH;IHH
prerank,negative regulation of metabolic process (GO:0009892),0.49016973720464374,2.0632577062211426,0.0,0.009813673135563514,0.17,26/55,18.48%,NR1D1;ATF4;TFE3;NOVA1;FLCN;ALDH1A1;MAP2K6;ARNTL;PLCL1;LNPEP;NR1H2;ZDHHC7;RBPJ;IP6K1;ABHD6;LAMA4;NPR3;ADAMTS5;IL15;RHEB;DDIT3;CCDC3;NOVA2;NR1H3;WNT10B;IL18R1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.5593898687777406,2.0624009701247363,0.0,0.00958001425138343,0.17,8/23,6.79%,ATP2B4;ATF4;MAPK1;MAPK3;SNCA;GNG2;SIRT2;PRKACA
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.43193132904015635,2.0527469564064686,0.0,0.010760806705623712,0.19,30/87,12.65%,LMOD1;CFL2;PSEN1;CLU;NCK1;SYNPO2;STMN2;EFEMP2;MAPT;CDC42EP3;RAC1;ARL2;FES;OCLN;CLIP1;CCL21;SYNPO;NUMA1;DCTN1;NCKAP1L;F2RL1;CDC42EP4;BAIAP2;SLAIN2;APP;CX3CL1;TENM1;EVL;WDR1;CCL11
prerank,histone exchange (GO:0043486),-0.6211022461161342,-2.051771041616491,0.0,0.0021048861460471395,0.03,15/34,11.37%,CENPN;CENPU;CENPH;CENPW;HJURP;CENPA;OIP5;CENPO;CENPK;RUVBL1;CENPL;MIS18A;CENPM;MIS18BP1;CENPP
prerank,homotypic cell-cell adhesion (GO:0034109),0.4740655158156334,2.050227127482237,0.0,0.010973470869766473,0.19,13/40,8.51%,CSRP1;MYL9;FLNA;TLN1;ACTN1;VCL;ILK;HSPB1;ITGB3;MEGF10;PDGFRA;ACTB;P2RY12
prerank,presynaptic endocytosis (GO:0140238),0.5737335277392444,2.042347692924896,0.0,0.01072961596154944,0.19,14/26,12.27%,VAMP2;STON1;PIP5K1C;NLGN2;SNCG;SNCA;AMPH;NLGN4X;NLGN1;NLGN3;SYT5;SYT1;PACSIN1;SNCB
prerank,synaptic vesicle membrane organization (GO:0048499),0.5975453310844979,2.040427446248051,0.0,0.010496363440646191,0.19,6/17,5.81%,SYNGR1;PRRT2;STX1B;STX2;SNAP25;SYP
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.5179861740315718,2.0391830031320177,0.0,0.010273036558930316,0.19,12/30,15.57%,VAMP2;RAB34;OPTN;VAMP4;BBS1;RAB31;GGA3;GOLPH3;GOLGA7;BBS2;GGA2;ANK3
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.5948220313767064,2.0361223508963757,0.0,0.010059014963952602,0.19,8/17,15.29%,MAPK1;CHMP3;MAPK3;VPS11;RDX;SNX3;MAP2K2;PTPN23
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.5076126266878509,-2.033783860404799,0.0,0.003189221433404757,0.04,48/94,28.20%,RAD54B;GINS4;FANCB;BLM;RAD51AP1;XRCC2;MCM4;ERCC5;RFWD3;GINS2;MMS22L;MCMDC2;RMI1;RAD51B;RAD54L;RAD51AP2;RPA3;FEN1;RECQL4;PSMD14;PALB2;MCM7;MCM3;BRCA2;TONSL;FANCM;RBBP8;RPA4;CDC7;WRN;MCM2;SLX1A;MCM5;LIG3;MCM6;CDC45;BRCA1;HUS1;NABP1;MEIOB;SAMHD1;GEN1;SMC6;SFR1;NSMCE2;RAD21L1;MCM8;NIPBL
prerank,DNA strand elongation (GO:0022616),-0.7564536661751095,-2.033038683588299,0.0,0.002923452980621027,0.04,11/17,12.65%,GINS4;GINS1;RFC3;MCM4;GINS2;MCMDC2;POLA1;MCM7;MCM3;DCLRE1B;TERT
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.7448106310130997,-2.029702396421947,0.0,0.003238286378534061,0.05,9/16,16.24%,CENPE;TACC3;PTTG1;UBE2C;HECW2;ANAPC1;NEK6;PLK1;CDC6
prerank,cardiac muscle cell contraction (GO:0086003),0.589543896495695,2.024602754670294,0.0,0.010264300983625104,0.2,10/19,11.31%,GSN;CACNA1C;SCN3B;CACNA2D1;SCN2B;SCN1B;FGF12;KCNE2;SCN4B;CAMK2D
prerank,lamellipodium organization (GO:0097581),0.5430330492403173,2.0227464941204656,0.0,0.010059014963952602,0.2,11/28,11.76%,VCL;WASF1;KIT;S1PR1;SNX1;RAC1;ARHGEF6;ABLIM3;P2RY12;WHAMM;GOLPH3
prerank,negative chemotaxis (GO:0050919),0.5197236923647433,2.0221676325561866,0.0,0.010256250551481084,0.21,16/33,16.48%,EPHA7;NTN1;SEMA4C;ITGB3;SEMA3G;SLIT3;RHOA;SEMA3B;SEMA6C;SEMA3A;SEMA3C;SEMA3E;SEMA4B;SEMA6D;PDGFA;SEMA6A
prerank,negative regulation of protein modification process (GO:0031400),0.45221652859275874,2.0204811143523096,0.0,0.010445900154873856,0.21,25/74,13.89%,ATP2B4;FXYD1;PTEN;WWTR1;BEX4;PRNP;CRTAP;CADM4;SNTA1;MAPT;CORO1C;FBLN1;INPP5K;TERF2IP;TARDBP;OCLN;PID1;DAB2IP;FKBP8;PRKAA2;ATG14;MYADM;DMD;TINF2;ARPP19
prerank,synaptic vesicle endocytosis (GO:0048488),0.4767395588232899,2.018574876788468,0.0,0.010628393169459351,0.21,14/37,12.27%,VAMP2;STON1;PIP5K1C;NLGN2;SNCG;SNCA;AMPH;NLGN4X;NLGN1;NLGN3;SYT5;SYT1;PACSIN1;SNCB
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.5131148555059972,2.0182147506917927,0.0,0.010431571073728624,0.21,13/35,10.60%,FHL1;FAM107A;KANK2;PTEN;CDKN1A;PKD2;JADE1;CDKN2C;SUSD2;CCL2;ZNF655;PRMT2;GPNMB
prerank,mRNA splice site selection (GO:0006376),0.5576619991367464,2.0165584272578867,0.0,0.010241906145115377,0.21,13/29,16.33%,SRSF5;LUC7L2;CELF6;LUC7L3;ISY1;SF1;PRPF39;CELF2;CELF4;LUC7L;PSIP1;CELF1;NOL3
prerank,mitochondrion localization (GO:0051646),0.5990275413789473,2.012985050164386,0.0,0.01041826549837948,0.21,7/17,9.30%,MFN2;ATCAY;MUL1;HAP1;TRAK2;MEF2A;MARK1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6460420078268723,2.0084747393069904,0.0,0.010059014963952602,0.21,8/16,8.16%,FAM107A;PTEN;DUSP22;APOD;ARHGAP6;CORO1C;PHLDB2;DLC1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6460420078268723,2.0084747393069904,0.0,0.010059014963952602,0.21,8/16,8.16%,FAM107A;PTEN;DUSP22;APOD;ARHGAP6;CORO1C;PHLDB2;DLC1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.460766013633089,2.001668677058145,0.0,0.010911473859202821,0.22,22/49,15.28%,TPM1;FERMT2;LPAR1;SYNPO2;SORBS3;MYOC;RAC1;RAPGEF3;ARHGEF15;RHOA;SYNPO;PXN;TESK1;ARHGEF10;RHOC;SFRP1;CX3CL1;EVL;ITGB1BP1;PPM1F;PFN2;RGCC
prerank,positive regulation of potassium ion transport (GO:0043268),0.49287004238427823,1.9974919484634714,0.0,0.01140021695914628,0.24,10/38,6.15%,FHL1;KCNMB1;FLNA;KCNH2;KCNN3;GNG2;GABBR1;KCNMA1;AKAP6;ANK2
prerank,glycogen metabolic process (GO:0005977),0.5222596181019306,1.9967123222080443,0.0,0.011213328156537326,0.24,9/25,14.08%,GYG1;NR1D1;PYGM;PPP1R3C;CALM1;UGP2;PGM1;PYGL;PRKAG2
prerank,membrane depolarization during action potential (GO:0086010),0.5238372575869867,1.9945133560661088,0.0,0.011032468024980271,0.24,13/26,14.18%,CACNA1H;SCN7A;KCNH2;ATP1A2;CACNA1C;SCN3B;SCN2B;SCN1B;SCN11A;SCN9A;SCN4B;SLC8A1;SCN4A
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.4997543155832295,1.9929826975296805,0.0,0.011176683293280669,0.25,15/36,10.31%,CNN1;TPM1;PTEN;MFN2;EFEMP2;FOXJ2;CDKN1A;MEF2D;FGF2;ADAMTS1;BMPR1A;GPER1;PDGFB;IGFBP5;PRKG1
prerank,cellular response to hormone stimulus (GO:0032870),0.4157584233525195,1.989608704130881,0.0,0.011316391834446677,0.26,39/75,20.72%,KLF9;CACNA1H;RAMP1;ZFP36L1;ATP1A2;INPP5K;THRB;GAS2L1;WBP2;SLIT3;CTSS;GPER1;ARID5A;RAMP3;SOCS2;RAMP2;BRD8;RDX;SFRP1;TFPI;ATP1A3;MGARP;AKR1C2;NKX3-1;AKR1C1;MEF2C;NCOA1;NR4A3;NCOA4;NR3C1;RARA;AR;STAT3;CYP11A1;AKR1C3;CYP11B1;GHR;SRA1;UBE2L3
prerank,synaptic vesicle exocytosis (GO:0016079),0.4950358128771413,1.98893796364654,0.0,0.011451801651269116,0.27,15/40,10.79%,VAMP2;PIP5K1C;PRRT2;RAB3A;SNCA;CPLX3;SNPH;STX1B;STX2;SNAP25;RIMS3;SNAPIN;SYT10;SYT5;SYT1
prerank,embryonic organ morphogenesis (GO:0048562),0.457619468149797,1.9888420256758055,0.0,0.011278289505037765,0.27,19/43,14.67%,RBPMS2;FOXF1;MFAP5;HOXD3;TCF21;HOXD9;PDGFRA;ID2;EFEMP1;HOXC4;HOXA4;FGFR2;HOXD4;MEGF8;HOXB4;OSR2;DSCAML1;SOX17;RARG
prerank,blood vessel diameter maintenance (GO:0097746),0.512831034892719,1.9781543087350513,0.038461538461538464,0.012611302342865947,0.3,15/34,15.97%,NPR1;SCPEP1;AGTR1;ECE1;NOS1;GPER1;F2RL1;KLF2;KCNMB4;ITGB1BP1;NPPB;INS;EDNRB;KCNMB2;ADCY6
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.5807442660829384,1.976767625544353,0.0,0.01242584201429439,0.3,7/21,6.52%,GPM6B;VCL;CORO1C;DUSP3;DAPK3;RHOA;EFNA5
prerank,regulation of myoblast differentiation (GO:0045661),0.5250290299808336,1.9767301475757353,0.0,0.012245757347420559,0.3,19/33,18.06%,SMYD1;BOC;RBM24;EID2B;ZFP36L1;MAPK14;KLHL41;MSTN;BTG1;LRRC8A;AKIRIN1;MEF2C;FLOT2;XKR8;ANKRD2;TRIP4;HIF1AN;DLL1;RANBP3L
prerank,negative regulation of cell communication (GO:0010648),-0.6829966910770947,-1.9755720003102324,0.0,0.006515123785384004,0.09,10/20,17.29%,IL11;OSM;SRMS;IL1B;GLRA1;NLRP12;IGFBP3;FGF23;LIF;OPRM1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5651987887051892,1.9732970310828786,0.0,0.012645618811826126,0.3,11/22,16.22%,RAP1A;STMN2;WASF1;MAPT;NGF;TMEM108;NTRK1;NTF3;MAGI2;NTRK3;KIDINS220
prerank,fatty acid beta-oxidation (GO:0006635),0.4454536165429446,1.973014854685083,0.0,0.012467511504617307,0.3,27/51,25.72%,ETFDH;PPARD;ACAD11;ECI2;ACADVL;CROT;ACOX2;ACAT1;BDH2;ACADS;HADHB;ECHDC2;ACAA2;ABCD4;ACADM;IVD;SLC27A2;HADH;HADHA;CRAT;ECHDC1;ACAA1;ADIPOQ;SCP2;ACAD10;ECI1;ACADL
prerank,autophagy of mitochondrion (GO:0000422),0.4584662063621426,1.970628407914965,0.0,0.01257376870494075,0.3,16/39,16.96%,GABARAPL1;MAP1LC3C;WDR45;ULK1;ATG9A;ULK2;ATG12;GABARAPL2;BNIP3;MAP1LC3A;FUNDC2;ATG14;GABARAP;MAP1LC3B;SQSTM1;ATG13
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5836652450450712,1.9696719573689796,0.0,0.012952704200158142,0.32,12/18,17.78%,PTEN;NCK1;INPP5K;SMAD7;GPD1L;DMD;PDE4D;PPM1F;RASSF2;CNKSR3;DMTN;INPP5J
prerank,regulation of blood circulation (GO:1903522),0.4998265065548592,1.969425212754139,0.0,0.012777667656912763,0.32,11/34,8.66%,DMPK;HSPB7;PLN;TPM1;FXYD1;CACNA1H;AGTR1;DES;ECE1;ADORA3;CELF2
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.45073815664218064,1.9693841540521944,0.0,0.012607298754820593,0.32,15/34,14.58%,CAP2;PDE2A;AQP1;PDE9A;MAPK7;RAPGEF3;AKAP6;CD36;PDE3A;NPPA;PDE7B;PDE4D;ADCYAP1;NPPB;ADCY2
prerank,positive regulation of macroautophagy (GO:0016239),0.4525360145354621,1.9676650193643817,0.0,0.012970835085096777,0.32,17/50,15.52%,HSPB8;SLC25A4;EPM2A;DCN;OPTN;CALCOCO2;BAG3;FYCO1;GPSM1;PIP4K2B;PRKAA2;BNIP3;LRSAM1;BNIP3L;PIP4K2A;ADRB2;SH3GLB1
prerank,ameboidal-type cell migration (GO:0001667),0.43166181871563847,1.9650858787375705,0.0,0.01280238268139422,0.32,23/50,18.91%,PDLIM1;ANXA6;AMOTL1;RADIL;SEMA4C;CORO1C;SEMA3G;PKN1;SEMA3B;AMOTL2;SEMA6C;SEMA3A;SEMA3C;SEMA3E;SEMA4B;MEGF8;GPC3;GDNF;SEMA6D;SEMA6A;SRGAP2;ITGA4;NANOS1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.5232320003337212,1.9603788544447818,0.0,0.012896173030708464,0.33,12/26,13.87%,PTEN;TMEM25;NLGN2;STX1B;DLG4;NLGN4X;TMEM108;SLC8A2;NLGN1;NLGN3;APP;NRXN1
prerank,actin filament polymerization (GO:0030041),0.48573933273222275,1.9557052352846964,0.0,0.013751564760846595,0.36,8/27,7.95%,FAM107A;GSN;WASF1;GAS7;ARHGAP6;RAC1;CORO7;WASF3
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.502145377372281,1.9557029084991309,0.0,0.013579670201336012,0.36,13/37,10.60%,FHL1;FAM107A;KANK2;PTEN;NACC2;CDKN1A;PKD2;JADE1;CDKN2C;CCL2;ZNF655;PRMT2;GPNMB
prerank,synaptic vesicle recycling (GO:0036465),0.4893414049338205,1.9552546539498474,0.0,0.013412019951936801,0.36,15/33,12.27%,VAMP2;STON1;PIP5K1C;NLGN2;SNCG;RAB3A;SNCA;AMPH;NLGN4X;NLGN1;NLGN3;SYT5;SYT1;PACSIN1;SNCB
prerank,positive regulation of neuron projection development (GO:0010976),0.40628420295415135,1.9529622321064686,0.0,0.013493800561399831,0.36,34/84,17.10%,RAP1A;PTN;PLXNB3;STMN2;ATP1B2;DPYSL3;NPTN;ROR2;DBN1;TOX;FES;CAMK1;DAB2IP;SCN1B;ZDHHC15;PRKD1;SNX3;BHLHB9;NDRG4;PACSIN1;ROR1;CX3CL1;TENM3;NTRK1;MAGI2;SCARF1;NTRK3;EPHA3;RET;KIDINS220;LRRC7;FUT9;VLDLR;RIT2
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.5132579443689963,1.9512324244057822,0.0,0.01381599645651321,0.36,14/33,16.47%,VAMP2;RAB34;OPTN;VAMP4;BBS1;RAB31;GORASP1;GGA3;GOLPH3;GOLGA7;BBS2;GGA2;ANK3;RILPL2
prerank,striated muscle cell differentiation (GO:0051146),0.5851267582391687,1.9452254716830573,0.0,0.01460952173335973,0.39,9/18,13.65%,BVES;MYOCD;POPDC2;CBY1;MYEF2;POPDC3;MEF2C;PLD3;SKI
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.6580956248493764,-1.944697391159022,0.0,0.011693811922484108,0.2,12/23,17.58%,CCND1;CDK1;CDC25C;ATAD5;FBXO5;RCC2;RAD51B;CDK4;CDC7;DYRK3;CDC25A;STOX1
prerank,negative regulation of protein polymerization (GO:0032272),0.5174362392354206,1.944538474400073,0.0,0.014674327712119089,0.4,15/26,22.05%,CLIP3;STMN2;SNCA;KANK3;PRKCD;MAP2;TUBB4A;CDH5;MYADM;PFN2;KANK1;SSH3;TWF2;PFN1;SLIT2
prerank,regulation of sodium ion transport (GO:0002028),0.4812180263580254,1.9438883705871488,0.0,0.014503695994536306,0.4,15/36,15.57%,PER1;ATP2B4;SNTA1;SLMAP;SCN3B;NOS1;P2RX7;SCN1B;GPD1L;AHCYL1;FGF12;SCN4B;NKAIN4;CNKSR3;ANK3
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.6314211474773662,-1.940880746204465,0.0,0.011401466624422004,0.21,16/25,21.96%,FOXP3;IL4I1;SOCS1;RUNX1;CBFB;BCL6;IL2RA;FANCA;CTLA4;IFNG;CR1;LILRB4;HLA-G;CD46;TNFSF4;MDK
prerank,regulation of macroautophagy (GO:0016241),0.34682085669251245,1.9396762845735427,0.0,0.014799470291792332,0.4,45/109,22.44%,EPM2A;ATP6V1G2;UCHL1;NRBP2;DCN;PRKAB2;ULK1;MAPK8;CASP3;MTOR;HDAC6;ATP6V1E1;GPSM1;PRKACA;RRAGA;PRKAA2;BNIP3;TBC1D25;RRAGD;BNIP3L;RRAGB;VPS26B;TSC1;ATP6V0E2;PRKAG2;LAMTOR3;RRAGC;EXOC7;RHEB;SH3GLB1;ATP6V1H;ATG13;SUPT5H;ATP6V0A1;ATP6V1D;SESN1;LAMTOR1;SCOC;WAC;ATP6V0D1;PRKAG1;ATP6V0E1;TSC2;SIRT1;UBQLN2
prerank,sarcomere organization (GO:0045214),0.5500970222683463,1.9385254757001444,0.0,0.014631294493021965,0.4,14/27,15.89%,CSRP1;TPM1;CASQ1;CSRP2;MYOZ2;MYH3;MYOZ1;TCAP;CAPN3;WDR1;TNNT3;KRT19;MYOM2;FHOD3
prerank,DNA-dependent DNA replication (GO:0006261),-0.474080955767521,-1.9379589813852112,0.0,0.011968960438307266,0.23,60/128,30.66%,ORC6;GINS4;DBF4;GINS1;BLM;RFC3;MCM4;POLE2;HMGA1;GINS2;PRIM1;MCMDC2;PSMB9;PRIM2;RPA3;RECQL4;POLB;PSMD14;DNA2;DDX21;RFC5;POLA1;MCM7;MCM10;MCM3;CDT1;TOPBP1;WDHD1;RPA4;BAZ1A;CDC7;WRN;MCM2;MGME1;MCM5;RFC2;CDC6;MCM6;PSMA3;POLD2;CDC45;NOC3L;TEFM;PSMB3;SSBP1;ORC1;PSMC1;PSMB11;PSMA5;PSMB2;PSME2;PSMD12;PSMA7;ORC2;MCM8;ORC5;PSME4;PSME3;UBC;ORC3
prerank,mitochondrion disassembly (GO:0061726),0.4571746163549097,1.93637309921291,0.0,0.014466897925684638,0.4,11/35,9.51%,GABARAPL1;MAP1LC3C;WDR45;ULK1;ATG9A;ULK2;ATG12;GABARAPL2;BNIP3;MAP1LC3A;FUNDC2
prerank,positive regulation of heart rate (GO:0010460),0.5578359893443479,1.9361407229941396,0.0,0.014306154615399254,0.4,7/17,13.39%,TPM1;HRC;SCN3B;ATP2A2;NPPA;ADM;PDE4D
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.6673261398592495,-1.9358397974287538,0.0,0.011693811922484108,0.24,9/15,16.70%,BLM;MCM4;HMGA1;MCMDC2;RECQL4;MCM7;WRN;MCM2;MCM6
prerank,DNA replication initiation (GO:0006270),-0.5893337230409812,-1.9274589963634912,0.0,0.01255546122203557,0.25,20/38,17.37%,ORC6;DBF4;MCM4;POLE2;PRIM1;PRIM2;RPA3;POLA1;MCM7;MCM10;MCM3;CDT1;TOPBP1;RPA4;CDC7;MCM2;MCM5;CDC6;MCM6;CDC45
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5503134320851901,1.9233241381592077,0.0,0.016359716644670168,0.42,12/20,16.04%,TULP3;GLI3;GPR161;SUFU;KIF7;MEGF8;PTCH2;GPC3;BTRC;GLIS2;KCTD6;KCTD21
prerank,actomyosin structure organization (GO:0031032),0.43256993055697285,1.9232809229518377,0.0,0.01618189363766288,0.42,31/75,18.13%,CSRP1;PGM5;LMOD1;SORBS1;TPM1;TMOD2;PDLIM1;TMOD1;CASQ1;FLII;CSRP2;EPB41L3;MYOZ2;MYH3;RHOA;ACTC1;KLHL41;MYOZ1;TCAP;FRMD6;CAPN3;WDR1;FRMD3;ITGB5;TNNT3;KRT19;MYOM2;FHOD3;CDC42BPB;ACTN2;TNFAIP1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5402779560548111,1.9228555246195054,0.0,0.016224217683794517,0.43,10/27,8.26%,STMN2;STMN4;GBA2;MAPT;MAPRE3;GAS2L1;ARL2;MAP1A;MAP2;MAPRE2
prerank,cell-cell junction assembly (GO:0007043),0.3973759872508637,1.9217494225583296,0.0,0.01605161962332862,0.43,26/65,14.61%,JAM3;CDH19;TLN1;PIP5K1C;CLDN5;VCL;CNTNAP1;CLDN11;FLCN;EPB41L3;GJC1;GJA4;CDHR3;RHOA;RAMP2;DCHS1;SMAD7;ACTB;RHOC;CDH5;FBF1;WDR1;PRKCA;CTNND2;ARVCF;CDH2
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.47551110200286906,1.9210282766717053,0.0,0.016306192678407373,0.44,13/40,8.70%,KCNMB1;FLNA;PIRT;KCNH2;KCNN3;GNG2;GABBR1;KCNMA1;AKAP6;NOS1;ANK2;CTSS;STAC
prerank,cellular response to starvation (GO:0009267),0.3457209353924903,1.9207325563427942,0.0,0.01634589931642298,0.45,44/148,15.72%,ATP6V1G2;GABARAPL1;ATF4;MAPK1;MAP1LC3C;NIM1K;WDR45;ZFYVE1;MAPK3;CDKN1A;FLCN;FAS;MAPK8;CARTPT;GAS2L1;MTOR;KLF10;ATF2;GABARAPL2;ATP6V1E1;RRAGA;PRKAA2;PRKD1;TFEB;RRAGD;MAP1LC3A;SFRP1;KPTN;ATG14;BRSK1;RRAGB;TCIRG1;ASNS;GABARAP;ATP6V0E2;PRKAG2;LAMTOR3;RRAGC;HSPA8;MAP1LC3B;RHEB;SH3GLB1;RRP8;SREBF1
prerank,hippo signaling (GO:0035329),0.5085472038614787,1.919646917455041,0.0,0.016384787260871246,0.46,11/26,10.89%,TEAD3;WWTR1;AMOTL1;CASP3;TEAD2;TEAD1;DVL2;LATS2;DCHS1;SAV1;AMOTL2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.5360370090425782,1.9175095855209612,0.0,0.016217595554127662,0.46,15/30,12.66%,KCNA5;KCNH2;SNTA1;GJC1;CACNA1C;SCN3B;ANK2;CACNA2D1;SCN2B;SCN1B;GPD1L;FGF12;KCNE2;SCN4B;KCNE4
prerank,positive regulation of stress fiber assembly (GO:0051496),0.46600779343062626,1.914103029370754,0.0,0.016663418728163907,0.48,21/42,17.78%,TPM1;FERMT2;LPAR1;SORBS3;MYOC;RAC1;RAPGEF3;ARHGEF15;RHOA;PXN;TESK1;ARHGEF10;RHOC;SFRP1;EVL;ITGB1BP1;PPM1F;PFN2;RGCC;TGFB3;LIMCH1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.6697728391773737,-1.9078542039522783,0.0,0.016488274810702593,0.35,10/20,17.58%,CCND1;CDK1;CDC25C;FBXO5;RCC2;RAD51B;CDK4;CDC7;CDC25A;STOX1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.4398365357467338,1.903804523440248,0.0,0.019514489030068045,0.54,17/48,11.98%,BVES;FERMT2;LAMB2;LAMA5;ILK;PARVA;RADIL;RAC1;LAMC1;ITGB3;PIK3R1;RHOA;PXN;LAMB1;NTN4;NTNG1;TMEFF2
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4753723872717659,1.8991149874724156,0.0,0.01952046468252188,0.54,18/32,17.33%,CNN1;TPM1;PTEN;VIP;APOD;MFN2;EFEMP2;CDKN1A;OGN;GPER1;HMOX1;IGFBP5;PRKG1;NDRG4;MEF2C;IL12A;TGFB3;PDCD4
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.7130421257087856,-1.8986579176821403,0.0,0.017373663427690676,0.38,11/15,23.36%,TNFSF11;POU4F1;IL23A;IL23R;IL17A;IL12B;IFNG;POU4F2;TYROBP;OCSTAMP;TNF
prerank,myelination (GO:0042552),0.469055513622794,1.8970899488536859,0.0,0.019329087577791275,0.54,20/46,14.78%,LGI4;MAL;PLP1;PMP22;MPZ;CNTNAP1;MYOC;SIRT2;MARVELD1;EPB41L3;NFASC;DEGS1;GPC1;ARHGEF10;TNFRSF21;PARD3;SKI;FAM126A;EIF2B4;ZNF24
prerank,DNA replication checkpoint signaling (GO:0000076),-0.6947116457498698,-1.8946064123480397,0.0,0.018816406457088066,0.4,12/17,22.88%,TICRR;TIPIN;TIMELESS;DNA2;RAD9B;CDT1;TOPBP1;CLSPN;CDC6;CDC45;HUS1;ORC1
prerank,response to nutrient levels (GO:0031667),0.5383955129794484,1.8933552933183089,0.0,0.020313350606816903,0.56,8/21,9.11%,FAM107A;ATF4;ULK1;KCNB1;PRL;MTOR;PRKAA2;GH1
prerank,regulation of stress fiber assembly (GO:0051492),0.419783187522662,1.8913839102376973,0.0,0.020118029927905203,0.56,30/72,15.28%,TPM1;FERMT2;LPAR1;SORBS3;ARHGAP6;ASAP3;MYOC;INPP5K;RAC1;RAPGEF3;ARHGEF15;ARHGEF18;PIK3R1;RHOA;PHLDB2;PXN;DLC1;TESK1;ARHGEF10;RHOC;SFRP1;WASF2;EVL;TMEFF2;TSC1;PTGER4;ITGB1BP1;PPM1F;PFN2;RGCC
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.5641373380175588,-1.8902514279191376,0.0,0.019523581644495205,0.42,16/34,22.30%,IL1B;AZGP1;CD1A;IL23A;ZP3;IL23R;HSPD1;IL12B;CD55;CD1B;HLA-F;HLA-G;TRAF2;TNFSF4;IL12RB1;XCL1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.6184393309876678,-1.8869844654080201,0.0,0.021048861460471396,0.44,10/26,16.24%,CENPE;DLGAP5;UBE2C;FBXO5;DUSP1;HECW2;NEK6;PLK1;ESPL1;CDC6
prerank,axonal transport (GO:0098930),0.49750786540763126,1.8868258345455062,0.0,0.019926429642877535,0.56,14/36,12.49%,AP3S2;DST;MAPT;BLOC1S1;NEFL;DCTN1;TMEM108;HAP1;SNAPIN;KIF1A;SOD1;PAFAH1B1;MGARP;AP3B2
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.609440417814057,-1.8833484187449985,0.013157894736842105,0.02161016443275063,0.47,9/19,19.94%,SHH;IL23A;IL23R;PNP;SYK;IL12B;CD55;HSPH1;TNFSF4
prerank,negative regulation of endocytosis (GO:0045806),0.48505831436520236,1.8817918389277786,0.0,0.020118029927905203,0.57,10/24,16.81%,LGALS3;SYT11;RAC1;PACSIN3;NR1H2;PRKD1;SNX33;LRSAM1;EPHA3;NR1H3
prerank,cellular response to chemokine (GO:1990869),-0.5137889711570877,-1.8783991206297315,0.0,0.021318718658682567,0.47,24/54,18.24%,CXCL1;CXCL3;CXCL8;CXCL2;SLC12A2;CXCL5;CXCL9;CCL24;CXCL11;CCL20;DUSP1;CCL22;PF4;CCL4;CCL3;CXCL6;CXCL10;CCL17;GPR35;STK39;DOCK8;PF4V1;CCL26;CCL1
prerank,chemokine-mediated signaling pathway (GO:0070098),-0.5144894108043302,-1.8732267733681875,0.0,0.02156858643480402,0.49,22/51,18.24%,CXCL1;CXCL3;CXCL8;CXCL2;CXCL5;CXCL9;CCL24;CXCL11;CCL20;RBM15;CCL22;PF4;CCL4;CCL3;CXCL6;CXCL10;CCL17;GPR35;STK39;PF4V1;CCL26;CCL1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5497368996170693,1.872910311300448,0.0,0.02143416272692704,0.59,8/19,13.11%,CLU;PRNP;RTN1;HAP1;RTN4;GGA3;PIN1;FLOT2
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.5419835371213405,1.8712743461703596,0.0,0.021421976312121283,0.59,9/24,13.94%,OR51E2;RASD2;PDE2A;PRKAR2B;PDE3B;PDE3A;GNAI1;PDE4D;UBE2B
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.5456492149943288,1.870491775618926,0.0,0.021410013501256913,0.59,14/28,11.31%,FXYD6;ATP2B4;FXYD1;SNTA1;SLMAP;SCN3B;NOS1;SCN2B;SCN1B;GPD1L;FXYD7;FGF12;SCN4B;CAMK2D
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.5101930058361489,1.8677021163872385,0.0,0.021946941739532946,0.6,20/30,26.92%,VPS11;ABLIM3;LEPROT;SAE1;RHOU;BAP1;CSNK2A2;HSPA1L;TOMM7;SH3GLB1;RNF31;UBE2D3;ATG13;UBE2L3;UBL4B;ARIH2;UBE2J2;PINK1;NPEPPS;GSK3A
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.4500301947349355,1.864738839195099,0.0,0.021749221543681297,0.6,14/33,10.38%,KIT;FGF2;TNFAIP8L3;WDR91;PIK3R1;PDGFRA;CCL21;DAB2IP;PDGFB;PIK3IP1;P2RY12;PIK3R3;PRKD1;ATG14
prerank,DNA metabolic process (GO:0006259),-0.42985076378127157,-1.864179060603392,0.0,0.022552351564790785,0.53,91/267,20.33%,EXO1;ORC6;DBF4;CHEK1;BLM;RFC3;RAD51AP1;XRCC2;MCM4;UBE2T;CDK1;ERCC5;POLE2;NEIL3;TICRR;TDP1;PRIM1;MSH3;TIMELESS;ZRANB3;DNMT1;PRIM2;RAD51B;RAD54L;PRKDC;POLH;RNASEH1;RPA3;FEN1;TOP3B;UHRF1;RECQL4;POLB;DNA2;LIG1;DDX21;RFC5;TOP1MT;HMGB3;RMI2;POLA1;AXIN2;FANCL;MCM7;MCM10;RAD9B;RAG1;MCM3;PARP4;RAD18;PARP2;CDT1;TOPBP1;DCLRE1B;WDHD1;RBBP8;RPA4;TOP1;NUDT1;CDC7;MSH6;WRN;TERT;MCM2;SLX1A;FANCA;DCTPP1;MCM5;ATR;FANCC;NUDT15;RNASEH2A;RFC2;ENDOG;LIG3;CDC6;TOP2A;MCM6;PARG;POLD2;CDC45;TRRAP;BRCA1;UNG;HUS1;SMC1A;RAN;NOC3L;RIF1;BARD1;NTHL1
prerank,neurotrophin signaling pathway (GO:0038179),0.5276174743777692,1.8638647885774449,0.0,0.021734657332826157,0.6,10/21,19.00%,RAP1A;CASP3;NGF;NGFR;HAP1;NTRK1;NTF3;MAGI2;KIDINS220;GRB2
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.5639527071474479,-1.8623297277348778,0.0,0.022258566142107684,0.53,22/41,24.35%,CST1;CST4;CST2;LPO;AZGP1;PKD1L3;TAS2R38;TAS2R3;TAS2R13;TAS2R31;TAS2R46;TAS2R50;TAS2R43;TAS2R19;CA6;TAS2R39;TAS2R42;PKD2L1;TAS2R41;TAS2R60;TAS2R40;TAS1R3
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.5871145296184849,-1.8599358211819594,0.0,0.022218242652719808,0.54,15/24,26.88%,DARS2;NARS2;YARS2;AIMP2;MARS2;LARS2;FARSB;EARS2;WARS2;FARS2;RARS2;FARSA;AARS2;PPA1;TARS2
prerank,eye photoreceptor cell development (GO:0042462),-0.6940250757050955,-1.858795928769871,0.0,0.021727856991454342,0.54,8/15,15.12%,THY1;RP1;CRB2;TH;RPGRIP1L;TULP1;NRL;USH1C
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.5574163955986828,1.85682552528006,0.0,0.021720350895614467,0.61,11/22,10.91%,JPH2;GSTM2;CALM1;CASQ1;PKD2;AKAP6;ANK2;HAP1;STAC;CALM2;STAC2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.5293641630152743,-1.8558446687708936,0.0,0.02214515632820428,0.54,22/41,29.43%,AZGP1;CD1A;IL23A;IL23R;IL21;RASGRP1;IL12B;RAET1E;NOS2;CD1B;HLA-F;HLA-G;SPI1;CRTAM;IL12RB1;XCL1;KLRC2;TYROBP;CD160;NCR3;SLAMF6;CD1E
prerank,regulation of interleukin-4 production (GO:0032673),-0.5996240194084834,-1.8536794886397683,0.0136986301369863,0.021686705747152348,0.54,13/23,22.54%,CEBPB;FOXP3;LEF1;ZP3;SLC7A5;SYK;ZFPM1;PRKCZ;NLRP3;CD86;PRKCQ;TNFSF4;GATA3
prerank,Golgi to plasma membrane transport (GO:0006893),0.44545843164587945,1.8521581797872766,0.0,0.022059243342001315,0.63,18/46,15.81%,VAMP2;RAB34;OPTN;VAMP4;ARL3;BBS1;OSBPL5;RAB31;GGA3;GOLPH3;GOLGA7;BBS2;EXOC6B;STEAP2;GGA2;ANK3;GOPC;RABEP1
prerank,intracellular lipid transport (GO:0032365),0.5357285410382157,1.8512784636644495,0.0,0.02186742383467957,0.63,11/20,23.20%,PRKAB2;ACACB;PRKAA2;CPT1B;SLC25A20;PRKAG2;ABCD4;SGPP1;MID1IP1;CPT1A;ARV1
prerank,DNA recombination (GO:0006310),-0.541097745665803,-1.8482001104756558,0.0,0.023937920876614532,0.59,11/37,8.54%,RAD54B;EXO1;BLM;XRCC2;HDAC10;MSH3;RAD51B;RAD54L;RECQL4;HMGB3;RAG1
prerank,recombinational repair (GO:0000725),-0.4618317428695778,-1.848108894998591,0.0,0.02325398028013983,0.59,33/76,27.51%,RAD54B;BLM;RAD51AP1;XRCC2;ERCC5;RFWD3;MMS22L;RMI1;RAD51B;RAD51AP2;RPA3;FEN1;RECQL4;PSMD14;PALB2;BRCA2;TONSL;RBBP8;RPA4;WRN;SLX1A;LIG3;BRCA1;HUS1;NABP1;MEIOB;RHNO1;SAMHD1;GEN1;SMC6;SFR1;NSMCE2;MCM8
prerank,plasma membrane organization (GO:0007009),0.400409129192465,1.8478681596171818,0.0,0.022372636730170443,0.66,21/60,11.63%,EHD2;PLSCR4;SYT11;ANXA6;RAB3A;MICALL1;EPB41L3;STX2;DEGS1;PACSIN3;PACSIN2;P2RX7;ANK2;A4GALT;SMPD1;CHMP4A;WHAMM;SNX33;PACSIN1;MYOF;ARL8B
prerank,regulation of cation transmembrane transport (GO:1904062),0.5003825390023438,1.8438619781986396,0.0,0.022869213507789674,0.67,11/30,11.35%,ATP2B4;DPP6;KCNH2;KCNIP3;HRC;SNTA1;SLMAP;CD63;FGF12;KCNE2;KCNIP4
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.5725320043086712,-1.8419698200010146,0.0,0.024946798767966096,0.62,15/30,16.02%,MGAT2;FUT8;ALG8;UGGT1;MGAT5;RPN2;STT3A;ASGR1;STT3B;RPN1;ALG5;ST6GAL1;DPM1;MAGT1;NUDT14
prerank,cardiac muscle contraction (GO:0060048),0.4924639416606722,1.8409472950505898,0.0,0.02301639017175595,0.67,14/33,13.25%,GSN;TPM1;CASQ2;KCNH2;ATP1A2;SCN3B;SCN2B;SCN1B;TCAP;SCN4B;CAMK2D;SLC8A1;MYL3;DMD
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5593693724537055,1.8390057123424002,0.0,0.02333015235336906,0.69,7/17,10.92%,CLU;PRNP;RTN1;HAP1;RTN4;GGA3;PIN1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.37610650902443726,1.8365726146006078,0.0,0.02380633541468782,0.7,33/124,11.17%,LIMA1;PLP1;GPM6B;TPM1;STMN2;ATP1B2;GPM6A;STMN4;ULK1;L1CAM;MAPT;MYOC;FRYL;MICALL1;RAC1;PKD2;LGI1;BLOC1S1;CCL21;MAP2;ATCAY;NCDN;BTG2;TMEM108;SNAPIN;PTPRM;NPY;VAPA;CORO1B;NLGN1;LAMB1;MARK4;APP
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.46613928092751944,1.8331018984212626,0.0,0.023942118261308674,0.71,22/36,25.90%,VPS11;ABLIM3;LEPROT;SAE1;RHOU;BAP1;CSNK2A2;HSPA1L;TOMM7;SH3GLB1;RNF31;SREBF1;UBE2D3;ATG13;PARL;UBE2L3;UBL4B;ARIH2;LRRK2;UBE2J2;PINK1;NPEPPS
prerank,positive regulation of cytokinesis (GO:0032467),-0.5644411607729776,-1.8325072328550858,0.0,0.028823666144068935,0.71,16/37,16.24%,KIF14;KIF20B;KIF23;SSTR5;RACGAP1;AURKB;TAS2R13;CXCR5;OR2A4;DRD2;ECT2;CDC14C;CSPP1;SPAST;RXFP3;CDC6
prerank,peptidyl-asparagine modification (GO:0018196),-0.5591812849538538,-1.8302713347067756,0.0,0.028803705156434545,0.73,15/31,16.02%,MGAT2;FUT8;ALG8;UGGT1;MGAT5;RPN2;STT3A;ASGR1;STT3B;RPN1;ALG5;ST6GAL1;DPM1;MAGT1;NUDT14
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.5830113708146945,1.8238459468429478,0.0,0.025229988352208986,0.74,10/16,17.33%,CNN1;TPM1;PTEN;EFEMP2;CDKN1A;GPER1;PRKG1;MEF2C;TGFB3;PDCD4
prerank,neutrophil migration (GO:1990266),-0.4709242508587526,-1.8220326835392155,0.0,0.03238286378534061,0.76,31/69,20.92%,CXCL1;CXCL3;CXCL8;CXCL2;CXCL5;TGFB2;CXCL9;CCL24;CXCL11;CCL20;CCL22;PF4;CCL4;SYK;CXCR2;CXADR;PIK3CG;CCL3;PECAM1;CXCL6;UMODL1;CXCL10;PPIB;CCL17;CXCR1;PF4V1;CCL26;CCL1;ITGB2;PIK3CD;XCL2
prerank,neutrophil chemotaxis (GO:0030593),-0.47129209400174665,-1.818484064263013,0.0,0.032976549621405185,0.77,29/64,20.92%,CXCL1;CXCL3;CXCL8;CXCL2;CXCL5;TGFB2;CXCL9;CCL24;CXCL11;CCL20;CCL22;PF4;CCL4;SYK;CXCR2;CXADR;PIK3CG;CCL3;CXCL6;CXCL10;PPIB;CCL17;CXCR1;PF4V1;CCL26;CCL1;ITGB2;PIK3CD;XCL2
prerank,establishment of skin barrier (GO:0061436),-0.6137907209528585,-1.817736327750123,0.0,0.031907401102778066,0.77,12/18,31.33%,CLDN1;MET;ABCA12;ALOX12B;ALOX12;ALOXE3;LSR;STMN1;SFN;CLDN4;KDF1;FA2H
prerank,regulation of water loss via skin (GO:0033561),-0.6137907209528585,-1.817736327750123,0.0,0.031907401102778066,0.77,12/18,31.33%,CLDN1;MET;ABCA12;ALOX12B;ALOX12;ALOXE3;LSR;STMN1;SFN;CLDN4;KDF1;FA2H
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.579896562572488,1.8163550336875183,0.0,0.027478284779577835,0.78,8/17,16.16%,CADM4;CALM1;INPP5K;SIRT2;SMAD7;CALM2;PARD3;DMTN
prerank,regulation of smoothened signaling pathway (GO:0008589),0.40658735063693685,1.8145258201099828,0.0,0.028392380946640407,0.79,20/46,16.04%,RAB34;TTC23;TULP3;IFT81;INTU;GLI3;TXNDC15;SFRP1;FGFR2;SUFU;KIF7;SMO;MEGF8;PTCH2;GPC3;STK36;BTRC;GLIS2;KCTD6;KCTD21
prerank,synaptic vesicle cycle (GO:0099504),0.429497098447549,1.8141904104015363,0.0,0.028648074617337007,0.79,11/30,10.40%,VAMP2;PIP5K1C;RAB3A;SNCA;CPLX3;SNAP25;SNAPIN;SYT10;SLC17A7;NLGN1;BRSK1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.46563046596261903,-1.810849969709867,0.0,0.03442875789270903,0.83,43/122,13.74%,ERCC6L;CENPN;KIF18A;CENPE;NUF2;CENPU;INCENP;MAD2L1;CENPH;TACC3;WDR62;NDC80;CENPA;KIF2A;DLGAP5;SKA1;CENPO;CENPK;SPDL1;RCC2;SPC24;DSN1;NUP37;CENPL;AURKB;KIF4B;GPSM2;ZWINT;KNTC1;AURKA;BUB1;NEK6;KIF2C;CENPM;NUP107;RCC1;PLK1;RANBP2;CENPP;EML4;CENPF;ESPL1;SEH1L
prerank,macroautophagy (GO:0016236),0.35713441409285845,1.8107964478988623,0.0,0.02889970965834001,0.79,40/115,17.73%,GABARAPL1;MAP1LC3C;PRKAB2;ULK1;ZFYVE1;CHMP3;MFN2;VPS39;LIX1L;TSG101;ATG12;GABARAPL2;PIP4K2B;VTI1B;TMEM74;PRKAA2;UBXN6;CHMP4A;LIX1;MAP1LC3A;CSNK2B;ATG14;ATG4B;CSNK2A2;ARL8B;TCIRG1;GABARAP;VPS4A;PRKAG2;PIP4K2A;VPS28;MAP1LC3B;TOMM7;VPS37D;VPS37A;SQSTM1;ATG13;KLHL3;VIPAS39;VPS16
prerank,glutathione derivative metabolic process (GO:1901685),0.49195213486612543,1.8090219159652143,0.0,0.029234012238987247,0.79,7/20,12.75%,GSTM3;GSTM2;GSTM5;GSTA4;GSTM4;HPGDS;GSTT2B
prerank,glutathione derivative biosynthetic process (GO:1901687),0.49195213486612543,1.8090219159652143,0.0,0.029234012238987247,0.79,7/20,12.75%,GSTM3;GSTM2;GSTM5;GSTA4;GSTM4;HPGDS;GSTT2B
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5372552521511825,1.8083907074923602,0.0,0.02963120687055805,0.8,6/18,6.03%,FAM107A;KLF9;AQP1;ZFP36L1;BCL2L11;ZFP36
prerank,regulation of protein localization (GO:0032880),0.4004324261459412,1.805938838119875,0.0,0.029712782662752298,0.8,23/64,16.16%,VIP;MAPK8;DVL3;TRIM6;ITGB3;CAMK1;ZDHHC7;MAP2;ATCAY;TESK1;CSNK1E;TRIM21;PLEKHM2;MMD;TRIM34;NKX3-1;DNAJB6;ADCYAP1;PPM1F;VPS4A;INS;MMD2;TRIM68
prerank,regulation of cardiac muscle contraction (GO:0055117),0.44949175148448495,1.8049702992174874,0.0,0.02963954027546339,0.8,15/36,15.06%,PLN;RGS2;TNNI3K;CALM1;NOS1;ANK2;PRKACA;SMAD7;CALM2;ATP2A2;ASB3;NPPA;SLC8A1;PDE4D;RNF207
prerank,interstrand cross-link repair (GO:0036297),-0.531918209803996,-1.8036484578766092,0.0,0.036994968627495184,0.87,19/52,14.48%,FANCB;EME1;RAD51AP1;UBE2T;NEIL3;FANCF;RFWD3;DCLRE1C;RAD51AP2;RPA3;FANCL;DCLRE1B;FANCM;MSH6;SLX1A;FANCA;FAAP24;ATR;FANCC
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.5985464862598571,-1.8019279552974214,0.0,0.03664061069045021,0.87,12/23,19.38%,OSM;IL23A;SLC7A5;IL23R;IL21;IL12B;TGFB1;CARD9;PHB;CCL1;NOD2;PRKCQ
prerank,cellular protein localization (GO:0034613),0.3109850292361946,1.801793303508277,0.0,0.030177044891857803,0.8,92/304,16.48%,TBC1D1;PRRT1;FBLN5;JAM3;FLNA;FERMT2;ARL4D;REEP1;RAB6B;SNX15;COPZ2;VCL;RIC3;SEC31B;WDR45;CNTNAP1;RAB5B;WLS;MFN2;SNX1;ATG9A;GPIHBP1;DNAJC27;STX1B;VPS45;SGSM2;EPB41L3;STX2;NGFR;CD63;EVI5L;RAB23;STX12;TBC1D17;ESAM;OCLN;HDAC6;RABL2B;STX16;ANK2;FGF7;RRAGA;ZDHHC15;RAB28;HHEX;RABGAP1;CROCC;TRIM23;RAB31;TBC1D25;ADPRH;RRAGD;TICAM2;CORO1B;EGFR;USP6;GGA3;NAPB;OXA1L;ANGPT1;SGSM1;TBC1D10A;PACSIN1;CAPN3;RRAGB;RAB24;VPS26B;CPE;TBC1D26;HEY2;SGSM3;DMD;FGF10;TM9SF1;BBS2;LAMTOR3;NPHP1;RRAGC;SNX27;SNX9;GGA2;STX7;SNX17;RABL2A;STX8;CEP68;STXBP1;ARMCX3;ARL6;RTP5;AP2A1;ARF1
prerank,regulation of metal ion transport (GO:0010959),0.5622337220051464,1.799235043219254,0.0,0.031008993497899,0.83,7/17,12.90%,CAMK2G;PLN;STIM1;ANK2;CACNA2D1;SLN;BCL2
prerank,lamellipodium assembly (GO:0030032),0.49565004671541546,1.799188977311377,0.0,0.030777583098660945,0.83,11/25,17.09%,VCL;KIT;S1PR1;RAC1;ARHGEF6;ABLIM3;P2RY12;WHAMM;GOLPH3;DMTN;SRGAP2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.3795877158657306,1.7979867717927382,0.0,0.030698623445544235,0.83,31/70,17.60%,ATP2B4;NPR1;YJEFN3;CLDN5;DCN;FOXJ2;EMILIN1;THBS4;FOXO4;PRL;ATF2;SERPINF1;ECSCR;ADAMTS1;HOXA5;STAB1;DAB2IP;COL4A2;HHEX;PTPRM;PDE3B;MECP2;SEMA3E;ANGPT4;SPINK5;NPPB;SYNJ2BP;RGCC;SEMA6A;HSPG2;KLF4
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5237037352460759,1.7975034782642383,0.0,0.030768751654443253,0.83,11/21,12.66%,FLNA;KCNA5;KCNH2;SNTA1;ANK2;CACNA2D1;SCN1B;NPPA;KCNE2;SCN4B;KCNE4
prerank,response to unfolded protein (GO:0006986),0.4315454608965647,1.7970969882106813,0.0,0.030837856093869288,0.83,12/48,8.25%,HSPB8;DNAJB5;HSPB7;HSPA2;OPTN;HSPB1;BAG3;DNAJB4;DNAJC4;DNAJB2;DAB2IP;HSPB2
prerank,calcium-ion regulated exocytosis (GO:0017156),0.4666951552899537,1.7954434914296151,0.0,0.03076017619411593,0.83,11/26,15.29%,VAMP2;SYT11;PPP3CB;RIMS3;SYT10;SYT4;SYT5;SYT1;ARL8B;SYT6;DOC2B
prerank,detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),-0.562986989708785,-1.7948336422447446,0.0,0.03843705136259994,0.88,19/37,23.93%,CST1;CST4;CST2;LPO;AZGP1;TAS2R38;TAS2R3;TAS2R13;TAS2R31;TAS2R46;TAS2R50;TAS2R43;TAS2R19;CA6;TAS2R39;TAS2R42;TAS2R41;TAS2R60;TAS2R40
prerank,granulocyte chemotaxis (GO:0071621),-0.4619823248878007,-1.7937148074610672,0.0,0.03791780716992719,0.88,30/67,20.92%,CXCL1;CXCL3;CXCL8;CXCL2;CXCL5;TGFB2;CXCL9;CCL24;CXCL11;CCL20;ADGRE2;CCL22;PF4;CCL4;SYK;CXCR2;CXADR;PIK3CG;CCL3;CXCL6;CXCL10;PPIB;CCL17;CXCR1;PF4V1;CCL26;CCL1;ITGB2;PIK3CD;XCL2
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.5944294990421319,-1.7904641010222235,0.0,0.0375663708009802,0.88,8/19,17.39%,MTHFD1L;DHFR;MTHFD1;GGH;SHMT2;MTHFD2;SLC46A1;SLC19A1
prerank,protein N-linked glycosylation (GO:0006487),-0.4753480293777752,-1.7902922414970077,0.0,0.03679971017238877,0.88,25/67,16.17%,PMM2;ALG11;ALG10;ALG1;MGAT2;FUT8;ALG8;UGGT1;MGAT5;RPN2;GFPT1;STT3A;SRD5A3;ASGR1;STT3B;RPN1;ALG5;ST6GAL1;DPM1;SLC39A8;MAGT1;PGM3;ALG2;NUDT14;ALG14
prerank,regulation of cation channel activity (GO:2001257),0.381856955100331,1.7901996532319515,0.0,0.03198622024508669,0.83,40/87,19.16%,PRRT1;VAMP2;PIRT;JPH2;NLGN2;HRC;CALM1;SLMAP;DAPK1;NEFL;NOS1;ANK2;CTSS;DLG4;PRKACA;STAC;CALM2;JPH4;FGF12;NLGN1;KCNE2;APP;CAMK2D;CACNB2;DLG2;MEF2C;GRIA4;DMD;PDE4D;GRIA1;AHNAK;SHISA7;ANK3;LRRC7;GRIA2;SHISA9;ACTN2;CAMK2A;JPH3;KCNG1
prerank,regulation of cytoskeleton organization (GO:0051493),0.33604695368283655,1.78992295810694,0.0,0.03190144745710682,0.83,27/110,9.88%,FAM107A;GPM6B;CORO2B;CLIC4;MAPK1;SYDE1;RHOB;MAP6;NEXN;SORBS3;MAPK3;MAPT;RND2;RAC1;MTOR;PRKCD;P2RX7;RHOA;EFNA5;PHLDB2;RHOQ;PRKAA2;DLC1;TESK1;RHOC;BAIAP2;SPATA4
prerank,synapse organization (GO:0050808),0.3456562672396233,1.789838818593098,0.0,0.031675196056701806,0.83,52/124,21.07%,PSEN1;PDZRN3;PTEN;NLGN2;SNCG;GPM6A;L1CAM;MAPT;SNCA;DNER;PTPRS;MYOT;OBSL1;ZC4H2;SLITRK2;KIRREL3;NLGN4X;DCTN1;CBLN2;SLITRK3;SLC8A2;NLGN1;NLGN3;PCDHB4;LRRC4C;NTNG1;PIN1;APP;CX3CL1;CACNB2;SNCB;SEMA3E;GPC4;CTNND2;NRXN1;LRFN5;CDH2;PPFIBP1;ANK3;NRXN2;CNTN2;GPC6;RAB39B;SHANK3;SDK1;DVL1;CDH1;CACNB3;RAB29;ADGRL3;PCDHB5;APBB2
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.5400036657047022,-1.7889461607900323,0.0,0.03648469319815042,0.88,18/37,24.97%,CHEK1;TIPIN;E2F1;INTS7;CHEK2;TIMELESS;DNA2;RAD9B;CDT1;RPA4;ATR;CLSPN;CDC6;CDC45;HUS1;ERCC6;BRIP1;RHNO1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.44887286118291914,1.7887090229725884,0.0,0.03173548382993496,0.83,21/43,20.14%,CALCOCO1;EGLN2;WBP2;DDX17;RHOXF1;PGR;GPER1;RNF14;RBFOX2;ZMIZ1;NKX3-1;KDM3A;UBE3A;PPARGC1B;TRIP4;NCOA4;NR3C1;TADA3;AR;TRERF1;DAXX
prerank,regulated exocytosis (GO:0045055),0.3395075539185281,1.788674576826517,0.0,0.03151355736958577,0.83,61/163,17.41%,VAMP2;FLNA;TLN1;SYNGR1;CLU;PIP5K1C;ACTN1;CFD;SYT11;F8;VCL;PPP3CB;MMRN1;VEGFB;CYB5R1;RAB3A;SNCA;TIMP3;CPLX3;CALM1;ITGB3;CD63;RARRES2;SNAP25;ALDOA;RIMS3;CLEC3B;CD36;VTI1B;PDGFB;SYNGR3;F13A1;SNAPIN;SOD1;RAB31;SYT10;SYT4;CDC37L1;ISLR;ENDOD1;PCDH7;SYT5;SYT1;APP;SCG3;TMX3;RAB11B;WDR1;SELP;MAGED2;SYT6;VEGFC;STEAP2;RAB11FIP2;STXBP1;PDGFA;A1BG;TGFB3;GAS6;PROS1;CD109
prerank,positive regulation of macrophage activation (GO:0043032),-0.6701776558138615,-1.7883791757512497,0.0,0.03618202983074495,0.88,9/15,23.08%,WNT5A;HSPD1;CEBPA;CCL3;SPACA3;THBS1;TTBK1;MMP8;LBP
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.4296027848068069,1.7873435311114745,0.0,0.03143442176235188,0.83,12/54,5.12%,FHL1;KCNMB1;FLNA;DPP6;KCNH2;KCNN3;KCNIP3;GNG2;GABBR1;KCNMA1;CD63;AKAP6
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.47437680075265765,1.7821026888693352,0.0,0.03316006312254719,0.84,15/35,16.58%,FLNA;PLXNB3;NRP2;SEMA4C;RAC1;SEMA3G;SEMA3B;SEMA6C;SEMA3A;SEMA3C;SEMA3E;SEMA4B;SEMA6D;SEMA6A;PLXNB1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.4044605316949948,1.778501734767691,0.0,0.03472427083446652,0.86,21/66,12.22%,NCK1;NRP2;VEGFB;HSPB1;SHC2;CLEC14A;RAC1;ITGB3;MAPK14;PIK3R1;RHOA;PXN;DAB2IP;NCKAP1L;MAPK11;PRKD1;BAIAP2;FLT4;BRK1;WASF2;ELMO2
prerank,striated muscle contraction (GO:0006941),0.40248786614896864,1.7758507632989984,0.0,0.03503548069077368,0.87,21/51,14.26%,TPM1;CASQ2;KCNH2;ATP1A2;DTNA;MYH3;SMPX;SCN3B;NOS1;ALDOA;SCN2B;SCN1B;KLHL41;STAC;TCAP;STAC2;SCN4B;SLC8A1;MYL3;DMD;TNNT3
prerank,central nervous system neuron development (GO:0021954),0.583147298082257,1.7749248500106747,0.0,0.03479875446989008,0.87,6/15,8.97%,PTEN;GBA2;MAPT;MAP2;LHX6;NPY
prerank,sensory perception of bitter taste (GO:0050913),-0.5611496869081075,-1.772330242705846,0.0,0.041423079925414864,0.92,19/38,23.93%,CST1;CST4;CST2;LPO;AZGP1;TAS2R38;TAS2R3;TAS2R13;TAS2R31;TAS2R46;TAS2R50;TAS2R43;TAS2R19;CA6;TAS2R39;TAS2R42;TAS2R41;TAS2R60;TAS2R40
prerank,circulatory system development (GO:0072359),0.34849621787245094,1.7719752477381316,0.0,0.035105287122519147,0.87,36/122,9.83%,PDLIM7;BVES;PDLIM4;FOXF1;POU6F1;PTEN;CITED2;LDB3;OSR1;HEY1;RBM20;PDLIM1;NXN;HAND1;CDKN1A;POPDC2;ECE1;SRF;HAND2;KAT2B;CACNA1C;PKD2;KAT2A;PDLIM2;TCF21;DVL2;PKD1;ID2;PDGFB;RAMP2;SOX18;MYL2;MEF2A;CDH5;FGF12;FLT4
prerank,positive regulation of signaling (GO:0023056),0.40437575044574114,1.7688582553146053,0.0,0.03581009327167126,0.87,17/38,17.38%,BVES;WLS;ILK;SNCA;ECE1;CARTPT;LGI1;DLG4;RIMS3;RAMP3;SYT1;GRIK2;VAMP3;ANXA2;PTPN23;INPP5F;CLSTN2
prerank,regulation of fat cell differentiation (GO:0045598),0.33912468669269386,1.767024499021994,0.0,0.03610586828120735,0.89,26/80,12.92%,PPARD;FERMT2;NR1D1;WWTR1;LMO3;ZFP36L1;SIRT2;ARNTL;RARRES2;ZADH2;ZFP36;GPER1;ID2;TRIB2;MEDAG;ZNF385A;SFRP1;GNB3;CREB1;GPS2;BBS12;SMAD3;LPL;GATA2;RUNX1T1;TMEM64
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.39163941131708235,1.7668516706950157,0.0,0.03613304059419816,0.89,17/69,11.01%,CRYAB;CLIP3;LIMA1;CLU;STMN2;CHADL;SNCA;EMILIN1;KANK3;PRKCD;MAP2;PLEKHH2;TUBB4A;CDH5;SMAD4;PFDN5;MYADM
prerank,mismatch repair (GO:0006298),-0.5215914363002881,-1.7664144150651977,0.0,0.04487776122704279,0.94,9/29,17.35%,EXO1;TP73;MSH3;RPA3;LIG1;PMS2;MSH6;RNASEH2A;POLD2
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.36830220582085066,1.7597645299854683,0.0,0.03721178084704034,0.89,24/80,13.33%,CLU;ZER1;BAG2;SIRT2;ECSCR;DNAJB2;DAB2IP;RNF217;RNF185;TRIB2;PSMC5;SMAD7;RNF144B;CSNK1E;RNF14;NUPR1;PIAS1;KCNE2;TMEM259;CSNK1A1;RNF180;ZYG11B;OSBPL7;GABARAP
prerank,tRNA aminoacylation (GO:0043039),-0.5897250834201475,-1.7581081028407717,0.0,0.04924394131801641,0.96,12/20,28.09%,DARS2;YARS2;AIMP2;MARS2;LARS2;FARSB;WARS2;FARS2;RARS2;FARSA;PPA1;QRSL1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.6021581854830708,1.7536903864995612,0.0,0.0389296942760763,0.91,10/17,12.10%,ATP1A2;CACNA1C;SCN3B;ANK2;CACNA2D1;SCN2B;SCN1B;SCN4B;CACNB2;SLC8A1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.5156662228256552,-1.7525891640623332,0.0,0.05268593807984658,0.97,29/47,32.58%,NUP155;NUP37;NUP210;NUP107;RANBP2;NOS2;KHK;NUP35;PNPT1;NUP50;SEH1L;NUP205;NUP88;NUP93;GCKR;POM121;RAE1;EIF6;NUP43;NUP160;NUP153;JMJD8;NDC1;TIGAR;NUP62;NUP98;HIF1A;NOA1;SEC13
prerank,cellular respiration (GO:0045333),0.4218224647919568,1.7518131300225908,0.0,0.03945729740698827,0.92,15/39,19.57%,ETFDH;MTFR1L;SDHA;COQ10A;BLOC1S1;COX4I2;OXA1L;NDUFA5;SIRT3;SURF1;ME3;NR4A3;UQCRFS1;NDUFS4;COQ10B
prerank,regulation of T cell proliferation (GO:0042129),-0.4651334620921709,-1.7512646571906116,0.0,0.05237157196712526,0.97,41/75,30.46%,CEBPB;FOXP3;CD80;IL4I1;IL1B;CD276;IL23A;ZP3;JAK3;IL23R;IL21;PNP;IDO1;TNFSF9;IL12B;CD70;VTCN1;PLA2G2F;SLC7A1;ARG1;IL10;TNFRSF1B;TNFSF18;CR1;LILRB4;TNFSF8;HLA-G;CD86;CD46;TNFSF4;IL27;CD6;GLMN;ANXA1;CCL5;CD28;PLA2G2D;CLC;LILRB2;PDCD1LG2;CD3E
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5860609643541962,1.7502332854850213,0.0,0.03959125120427498,0.92,7/16,18.79%,WASF1;WASF3;CORO1B;BRK1;WASF2;ARF1;ABI2
prerank,positive regulation of dephosphorylation (GO:0035306),0.46189023537724455,1.7491319201804976,0.023809523809523808,0.03972349858376187,0.92,9/28,14.14%,CALM1;PRKCD;MTMR9;SMPD1;DLC1;CDH5;CALM2;PIN1;CHP2
prerank,autophagosome assembly (GO:0000045),0.4118138673938152,1.7490564127578507,0.0,0.039472084035763376,0.92,16/56,10.38%,GABARAPL1;MAP1LC3C;WDR45;ULK1;MFN2;ATG9A;ULK2;ATG12;TP53INP2;RAB23;STX12;GABARAPL2;EMC6;MAP1LC3A;ATP2A2;ATG14
prerank,positive regulation of cell cycle process (GO:0090068),-0.4431947030698053,-1.74871855090892,0.0,0.05317607105803301,0.97,35/100,16.43%,IL1A;KIF14;DBF4;KIF20B;KIF23;PDGFRB;MAD2L1;SSTR5;IL1B;EREG;NDC80;RCC2;SPAG5;RACGAP1;AURKB;FEN1;TAS2R13;CXCR5;GPSM2;EPGN;AURKA;DMRT1;OR2A4;DRD2;ECT2;CDC14C;E2F8;CDC7;RANBP1;CSPP1;SPAST;CEP295;RXFP3;CDC6;PLK4
prerank,positive regulation of immune response (GO:0050778),-0.4600378157099382,-1.7462547148374437,0.0,0.05371088786465114,0.97,43/72,37.31%,TGFB2;EREG;IL23A;GBP5;SKAP1;ZP3;IL23R;IFNK;CD81;POLR3B;FPR2;IL12B;MYB;IL10;NLRP3;IFNG;POLR3C;ADAM8;CYBA;CD46;NOD2;TNFSF4;ITGB2;GPR151;IL12RB1;POLR3G;NMI;IFNB1;XBP1;CCL5;NLRP10;TLR8;IFNL1;PLSCR1;DHX9;IFI35;CD226;EIF2AK4;CD74;SLC15A4;ZP4;AKIRIN2;IL2
prerank,mitotic sister chromatid segregation (GO:0000070),-0.45215302237488947,-1.7455174575012515,0.0,0.0531572941967837,0.97,49/96,29.58%,KIF18A;KIF14;CENPE;CEP55;KIF23;NCAPG;CDK1;NCAPD3;NDC80;CDCA5;DLGAP5;SMC4;SMC2;CENPK;SPDL1;KNSTRN;DSN1;SPAG5;ZWINT;NCAPD2;CHMP4C;KIF2C;KIF22;PLK1;KIF18B;EML4;ESPL1;SEH1L;RRS1;NCAPH;SET;PSRC1;TTN;CSNK2A1;SMC1A;RAN;PRC1;NCAPG2;PIBF1;PDS5A;ZW10;KIFC1;CDCA8;RAD21L1;CUL3;NIPBL;KPNB1;NUP62;PDS5B
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5298199477296641,1.744451964595092,0.0,0.04061564532614824,0.93,10/17,18.88%,DCN;CADM4;CCBE1;MYO1C;CD63;DAB2IP;IL12A;SEMA6A;DLL1;SMOC2
prerank,negative regulation of calcium ion transport (GO:0051926),0.553886096069499,1.7427145926175356,0.037037037037037035,0.04111622366515626,0.94,6/18,8.67%,PLN;ATP1A2;INPP5K;PACSIN3;NOS1;SLN
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.4795065539306535,-1.7426723777551796,0.0,0.05461010167800079,0.97,22/54,27.11%,WDR12;WDR74;NOP16;BRIX1;NIP7;BOP1;MRTO4;PAK1IP1;NLE1;RRS1;GTF3A;MAK16;RPL26L1;EBNA1BP2;PES1;NPM1;HEATR3;MDN1;RPF2;RPL23A;EIF6;RSL1D1
prerank,negative regulation of signaling (GO:0023057),-0.5773437997908775,-1.7419305740532296,0.0,0.05417493851301654,0.97,11/24,17.29%,IL11;OSM;SRMS;IL1B;GLRA1;PCSK9;NLRP12;IGFBP3;FGF23;LIF;OPRM1
prerank,nucleotide biosynthetic process (GO:0009165),-0.5933918039665926,-1.7413382710796907,0.014492753623188406,0.053640646947652915,0.97,5/18,6.89%,PPAT;HPRT1;MTHFD1;GART;PNP
prerank,protein deacetylation (GO:0006476),0.433583084347711,1.7408020296704898,0.0,0.04161058363970455,0.94,23/44,23.56%,FLNA;MORF4L1;SIN3B;SIRT2;HDAC7;HDAC4;HDAC6;HDAC5;BRMS1L;TBL1X;SIRT3;SIN3A;HDAC11;MSL3;RCOR3;TRERF1;RBM14;HDAC9;MTA3;PRDM5;SIRT1;MIER2;ZNF541
prerank,positive regulation of immune effector process (GO:0002699),-0.5298513409169116,-1.7390817835953933,0.0,0.05390290448078389,0.97,17/31,24.62%,IL1B;IL23A;IL23R;CD81;IL12B;MYB;IL10;RPS19;IFNG;ANKRD17;PHB;CD46;TNFSF4;PTPRJ;IL12RB1;LBP;XBP1
prerank,neuron projection morphogenesis (GO:0048812),0.32531790519774967,1.7370020203811012,0.0,0.042223025774615855,0.94,53/138,18.20%,APBB1;S100B;PTEN;GPM6A;SDC2;MAP6;GAS7;CNTNAP1;RAB3A;DBN1;NGF;EPB41L3;MAP1A;SLITRK2;DLG4;MAP2;ZDHHC17;UBB;DAB2IP;DCLK1;NCKAP1L;ACTB;SLITRK3;BAIAP2;MEF2A;ISL2;NLGN1;NBL1;FGFR2;BRSK1;NYAP1;NTNG1;APP;PACSIN1;PARD3;ATL1;CCK;MAP1B;CTNND2;ARC;NTF3;DSCAML1;SGK1;ANK3;TAOK2;NRK;PLXNB1;BTBD3;SRGAP2;KLF7;LLGL1;ZNF335;SLITRK4
prerank,autophagosome organization (GO:1905037),0.3992753909905539,1.7368578967436366,0.04,0.04196398880667343,0.94,15/53,10.38%,GABARAPL1;MAP1LC3C;WDR45;ULK1;ATG9A;ULK2;ATG12;TP53INP2;RAB23;STX12;GABARAPL2;EMC6;MAP1LC3A;ATP2A2;ATG14
prerank,positive regulation of protein polymerization (GO:0032273),0.40958838682043375,1.7364214610020703,0.0,0.041830781740339475,0.94,23/65,15.94%,LMOD1;NCK1;MAPT;CDC42EP3;RAC1;ARL2;FES;OCLN;CLIP1;CCL21;NUMA1;DCTN1;TPPP3;NCKAP1L;CDC42EP4;BAIAP2;SLAIN2;TENM1;EVL;CCL11;PFN2;SNX9;FCHSD1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.45208657625422244,1.7353375907741042,0.0,0.04206497166743815,0.94,10/23,13.80%,FERMT2;MYOC;RAC1;DUSP3;COL16A1;PIK3R1;MAPRE2;SFRP1;TSC1;PPM1F
prerank,neuron projection organization (GO:0106027),0.5910377932008302,1.7341489616229488,0.0,0.04241753298052301,0.95,8/16,16.48%,PSEN1;PRNP;MAP1A;DCTN1;ATP1A3;APP;INS;ARF1
prerank,negative regulation of catalytic activity (GO:0043086),0.469713184206895,1.7341376306387295,0.030303030303030304,0.042284003022124116,0.95,9/24,12.10%,PLN;TMBIM1;NOS1;HDAC6;SERPINA5;PPP1R12A;SLN;OXA1L;MT3
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.46452290555905995,-1.7335287901930314,0.0,0.05667844466179016,0.98,29/85,17.70%,MYC;CCND1;DBF4;CDKN3;INHBA;E2F1;TRIM71;FBXO5;USP37;SPDYA;CDKN2A;DHFR;CCNE1;POLA1;E2F3;CDK4;CDK7;RCC1;CDT1;USP26;TFDP1;CDC7;NPAT;CDC25A;EIF4E;CDC6;CDC45;CRLF3;CDK5
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.4131213733141786,1.7325011810230142,0.0,0.042511313240513965,0.95,10/44,6.15%,KCNMB1;FLNA;ATP1B2;KCNH2;KCNN3;GNG2;GABBR1;KCNMA1;AKAP6;ANK2
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.36030062538323926,1.7323222553520428,0.0,0.04237880860552812,0.95,38/74,22.98%,APBB1;S100B;SDC2;MAP6;RAB3A;MAP1A;SLITRK2;MAP2;ZDHHC17;ACTB;SLITRK3;BAIAP2;MEF2A;ISL2;FGFR2;BRSK1;NTNG1;APP;PARD3;ATL1;CCK;MEF2C;MAP1B;DSCAML1;ANK3;TAOK2;BTBD3;KLF7;LLGL1;SLITRK4;CNTN4;DVL1;UNK;SPTBN4;CELSR2;NEFH;MINK1;SLITRK5
prerank,selective autophagy (GO:0061912),0.3715334660659356,1.7322181957747167,0.0,0.04212952149608384,0.95,26/54,27.04%,DYNC1I1;MAP1LC3C;ULK1;ULK2;CALCOCO2;HDAC6;UBB;ATG14;VIM;MAP1LC3B;SQSTM1;UBE2V1;ATG13;KLHL3;DYNC1LI2;ATG2B;WDR81;DYNC1I2;DYNLL2;NBR1;PHB2;RAB7A;ATG2A;LGALS8;PEX5;RPS27A
prerank,regulation of muscle contraction (GO:0006937),0.5076496578332537,1.7319752861592432,0.03225806451612903,0.041883150025346504,0.95,10/27,8.88%,MYL9;CNN1;TPM1;PPP1R12B;CHRNA3;ANXA6;ATP1A2;DAPK3;CHRM2;MYL2
prerank,positive regulation of T cell activation (GO:0050870),-0.45895656897967047,-1.7319435227858875,0.0,0.05699384026219947,0.98,34/73,26.62%,THY1;TNFSF11;CD80;IL1B;CD276;IL23A;ZP3;JAK3;IL23R;IL21;CD81;PNP;HSPD1;IL12B;CD70;SLC7A1;ZAP70;DOCK8;IL36B;CD86;CD46;NOD2;SIRPB1;PRKCQ;TNFSF4;CD6;MDK;LCK;GATA3;ANXA1;XBP1;RHOH;CCL5;CD28
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.4818850483884886,1.731209856572567,0.0,0.04199053920998818,0.95,10/25,10.50%,STMN2;MAPT;RAC1;ARL2;FES;OCLN;CLIP1;NUMA1;DCTN1;SLAIN2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.4773198131948407,1.7288451724244742,0.0,0.042910711233508786,0.95,11/27,16.43%,PER1;CRY2;FBXL22;USP2;PER3;RBM4;ID2;PPP1CB;CRY1;FBXL12;CRTC1
prerank,sister chromatid segregation (GO:0000819),-0.5577827562018851,-1.7282947011004466,0.0,0.059744748185782445,0.98,23/32,32.77%,KIF18A;NDC80;SMC4;CENPK;KNSTRN;DSN1;SPAG5;ZWINT;PLK1;KIF18B;ESPL1;TOP2A;SMC1A;RAN;NCAPG2;CHAMP1;ZW10;KIFC1;CDCA8;TUBG1;NSL1;NUSAP1;KIF25
prerank,tRNA transport (GO:0051031),-0.5510000385064465,-1.727420751579726,0.0,0.05990024256412755,0.98,23/35,30.26%,NUP155;TOMM20L;NUP37;NUP210;NUP107;RANBP2;NUP35;XPOT;NUP50;SEH1L;NUP205;NUP88;NUP93;POM121;RAN;RAE1;NUP43;NUP160;NUP153;NDC1;NUP62;NUP98;SSB
prerank,positive regulation of apoptotic process (GO:0043065),0.2786129680743024,1.7271247948379191,0.0,0.043126581397176095,0.95,89/299,17.98%,APBB1;CLIP3;ARHGEF26;EPHA7;PSEN1;CLU;PNMA1;MOAP1;PRNP;TNFSF10;ATF4;TRIM39;RHOB;BCL10;ING4;CALHM2;PHLDA3;SNCA;ARHGEF17;APAF1;FLCN;FAS;MAPK8;GADD45B;CASP3;SIRT2;NGF;KCNMA1;DAPK1;RPS6KA2;NGFR;MLLT11;RNF122;KLF11;DAPK3;PTGIS;BCL2L11;PRDM11;HOXA5;JMY;ARHGEF18;GPER1;ADAMTSL4;ARHGEF6;UBB;DAB2IP;LATS2;SOD1;SMPD1;DLC1;PRMT2;BNIP3;APH1B;MTCH1;NUPR1;SFRP1;PIDD1;ERCC3;RBM5;ARHGEF9;BTG1;BNIP3L;BOK;ARL6IP5;NKX3-1;OLFM1;QRICH1;GADD45G;BAD;RIPK1;RYBP;RARG;PLEKHG2;ARHGEF3;RASSF2;FAM162A;FRZB;ING3;DDIT3;BACE1;SQSTM1;TGFB3;SFRP2;STPG1;WNT10B;MAP3K10;FGD1;TIAM1;PSEN2
prerank,cellular response to amino acid starvation (GO:0034198),0.398260133935113,1.7260365473267778,0.0,0.04345494464427524,0.95,31/70,21.40%,ATP6V1G2;ATF4;MAPK1;MAPK3;CDKN1A;FLCN;FAS;MAPK8;MTOR;ATF2;ATP6V1E1;RRAGA;PRKD1;TFEB;RRAGD;KPTN;RRAGB;TCIRG1;ATP6V0E2;LAMTOR3;RRAGC;RHEB;SH3GLB1;ATP6V1H;WDR59;RNF152;ATP6V1D;SESN1;LAMTOR1;ATP6V0D1;NPRL2
prerank,signal release from synapse (GO:0099643),0.40777653449206464,1.725219076960383,0.0,0.0435509625143857,0.95,23/43,19.90%,VAMP2;PIP5K1C;RAB3A;SNCA;CPLX3;SNPH;SYN2;SNAP25;SNAPIN;SYT10;SYN1;BRSK1;SYT1;NRXN1;HSPA8;STXBP1;LIN7A;NRXN2;LIN7B;NAAA;STXBP3;DVL1;CPLX2
prerank,basement membrane organization (GO:0071711),0.5718818724676621,1.7247422382467694,0.0,0.04375955662284465,0.96,8/16,11.07%,LAMB2;NID1;CTSS;RAMP2;LAMB1;NTN4;NTNG1;PXDN
prerank,Ras protein signal transduction (GO:0007265),0.2972433511619095,1.723596523020224,0.0,0.04430487489740921,0.97,29/138,9.34%,RAP1A;RERG;NTN1;AGTR1;RHOB;WASF1;ARHGAP6;CDKN1A;SHC2;RRAS;FGF2;MRAS;CDC42EP3;RAC1;RASGRP2;RAPGEF3;MAPK14;NGFR;ERAS;RGL2;RHOA;CTNNAL1;MAPK11;GNA12;CDC42EP4;TAX1BP3;PRKD1;GDI1;ARHGAP1
prerank,supramolecular fiber organization (GO:0097435),0.295502979249823,1.7220337841711495,0.0,0.04473170900171101,0.97,79/339,11.29%,DPT;TPM2;PGM5;CLIP3;CORO6;LMOD1;FBLN5;COL6A1;GSN;TPM1;MFAP4;ACTN1;COL6A2;STMN2;COL21A1;CRTAP;TMOD2;RHOB;DDR2;DST;STMN4;TMOD1;INPPL1;DES;CLIP4;EFEMP2;MAPT;LOXL4;COL28A1;SNCA;LTBP3;EMILIN1;KRT20;RND2;CORO1C;P3H2;MFGE8;PRL;DBN1;FIGN;RAC1;FLII;MYO1C;COL16A1;CORO7;NEFL;KATNAL1;RHOA;CLIP1;MAP7D3;ALDOA;COL24A1;UBB;CD36;ACTC1;KLHL41;COL4A2;DCTN1;TPPP3;BMP1;MYOZ1;COLGALT2;B2M;TUBGCP6;APH1B;RHOC;COL5A3;NCKAP5L;CORO1B;GGA3;WHAMM;NPPA;SLAIN2;TNXB;PIN1;PXDN;APP;CAPN3;MYO5C
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5339490947042167,1.7193422297973364,0.0,0.04571263466951793,0.97,11/21,12.10%,CADM4;EMILIN1;TMEM204;ITGB3;DAB2IP;HHEX;MMRN2;GRB10;EPN2;ARNT;MT3
prerank,negative regulation of cell projection organization (GO:0031345),0.4011012239981976,1.7191195804924833,0.0,0.04557122801348692,0.97,15/46,12.10%,PTEN;LPAR1;STMN2;PRNP;DPYSL3;CRMP1;PTPRS;STX1B;SPOCK1;EPHA4;MYLIP;DENND5A;GORASP1;SEMA3A;MT3
prerank,negative regulation of cellular component organization (GO:0051129),0.352539147476417,1.718484005674224,0.0,0.04554191390273046,0.97,18/71,12.72%,CRYAB;HSPA2;CLU;LGALS3;SYT11;ULK1;RAPGEF3;PACSIN3;HDAC6;DNAJB2;SLN;PRKD1;RDX;SNX33;LRSAM1;RAF1;TMEFF2;DNAJB6
prerank,vesicle transport along microtubule (GO:0047496),0.5399464218838977,1.7168479034511728,0.0,0.046282462293158966,0.97,12/21,20.87%,DYNC1I1;KIF5A;KIF1C;FYCO1;HAP1;KIF1A;PAFAH1B1;TRAK2;KIFAP3;NDEL1;FBXW11;KIF13A
prerank,base-excision repair (GO:0006284),-0.4556940245382568,-1.7163152951237735,0.0,0.06758335419906257,0.99,17/47,20.33%,RFC3;ERCC5;NEIL3;HMGA2;RPA3;FEN1;POLB;DNA2;LIG1;RFC5;WRN;RFC2;LIG3;PARG;POLD2;UNG;NTHL1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.43245957738623464,1.7157621869615516,0.0,0.047014961244561074,0.97,15/32,20.85%,SYT11;CHRNA3;CPLX3;STX1B;CHRNB4;RIMS3;GPER1;SNAPIN;SYN1;MEF2C;KCNMB4;VPS18;CAMK2A;CPLX2;RIMS4
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.5425274899742423,-1.710396836741482,0.01282051282051282,0.07168815135088084,1.0,13/26,26.62%,IL1A;CD80;CARD11;IL1B;PNP;RUNX1;CD86;TRAF2;CLEC7A;GLMN;ANXA1;PDE4B;CD28
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.48147921917440295,-1.7101593915943283,0.0,0.07096473292387499,1.0,12/34,20.33%,RFC3;RPA3;FEN1;POLB;LIG1;RFC5;RFC2;LIG3;PARG;POLD2;UNG;NTHL1
prerank,cell junction assembly (GO:0034329),0.34491975856320517,1.710024285836212,0.0,0.048827002365564524,0.97,25/102,10.44%,LIMS2;FLNA;FERMT2;CDH19;TLN1;PTEN;CLDN5;FLNC;NLGN2;GPM6A;ILK;FLCN;DNER;GJC1;OBSL1;GJA4;CDHR3;RHOA;KIRREL3;DCHS1;ACTB;CDH5;NLGN1;NLGN3;PCDHB4
prerank,protein stabilization (GO:0050821),0.3133853099230073,1.70975534633068,0.0,0.04856449160015826,0.97,47/167,14.71%,CRYAB;FLNA;CLU;PTEN;ATP1B2;TRIM39;CRTAP;BAG2;PARVA;TMEM88;CDKN1A;GPIHBP1;DVL3;BAG3;STX12;USP2;PRKCD;ANK2;PIK3R1;CAMLG;PER3;EPHA4;WFS1;USP19;MTMR9;MUL1;SMAD7;RTN4;PEX19;CDC37L1;ZSWIM7;FLOT1;CREB1;PIN1;WIZ;IFT46;MT3;PRKRA;TSC1;FLOT2;GNAQ;GOLGA7;UBE2B;TBL1X;SOX17;PFN2;RASSF2
prerank,DNA repair (GO:0006281),-0.3908440733959714,-1.7075496624323963,0.0,0.07243575328885227,1.0,71/278,14.93%,EXO1;FANCB;CHEK1;TP73;BLM;EME1;RFC3;RAD51AP1;XRCC2;UBE2T;CDK1;ERCC5;POLE2;NEIL3;TICRR;FANCF;CDCA5;RFWD3;TDP1;DCLRE1C;CHEK2;MSH3;TIMELESS;ZRANB3;RAD51B;RAD54L;PRKDC;POLH;ASCC3;RAD51AP2;HMGA2;RPA3;FEN1;TRAIP;RECQL4;POLB;DNA2;LIG1;RFC5;GTF2H2C;EYA1;RMI2;POLA1;FANCL;RAD9B;BRCC3;ERCC8;PMS2;PARP4;RAD18;PARP2;BRCA2;TOPBP1;DCLRE1B;TRIP13;XRCC4;FANCM;WDHD1;RBBP8;RPA4;GTF2H2;NUDT1;MSH6;WRN;SLX1A;MGME1;FANCA;FAAP24;ATR;FANCC;RNASEH2A
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.48928848916274786,1.7072395745544355,0.0625,0.048519954532006665,0.97,8/17,12.66%,KCNH2;SNTA1;ANK2;CACNA2D1;SCN1B;KCNE2;SCN4B;KCNE4
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.6678681220711883,-1.7055015976623469,0.0,0.07289142765015094,1.0,7/15,8.97%,CD80;IL1B;IL23A;IL23R;IL17F;RASGRP1;IL12B
prerank,cell cycle G1/S phase transition (GO:0044843),-0.46281722544735504,-1.7051419076386556,0.0,0.07208514198791574,1.0,20/63,17.47%,MYC;CCND1;DBF4;CDKN3;INHBA;E2F1;TRIM71;USP37;SPDYA;CDKN2A;CCNE1;E2F3;CDK4;CDK7;RCC1;USP26;CDC7;CDC25A;EIF4E;CRLF3
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.4386737346318447,1.7050001124140517,0.0,0.049224966844874436,0.97,21/56,14.61%,PALLD;PLXNB3;CADM3;IGSF11;TRO;ROBO3;NEXN;L1CAM;NPTN;MYOT;AMIGO2;OBSL1;KIRREL3;PKD1;PTPRM;ROBO4;CEACAM1;TENM3;CADM1;DSCAML1;CDH2
prerank,regulation of T cell differentiation (GO:0045580),-0.4862970831686035,-1.7046468184781718,0.0,0.07186953597764557,1.0,21/39,24.72%,TCF7;FOXP3;RUNX1;CBFB;PRDM1;ZAP70;IL2RA;FANCA;PRELID1;CTLA4;IFNG;CR1;IL36B;ZNF683;CRTAM;MDK;CD2;GATA3;IFNB1;XBP1;RHOH
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5243187989035527,1.7029293904123777,0.0,0.04960318490160753,0.98,8/17,12.66%,KCNH2;SNTA1;KCNJ8;SCN3B;ANK2;GPD1L;KCNE2;KCNE4
prerank,photoperiodism (GO:0009648),0.46139500485359497,1.701649829213334,0.0,0.04997742171563818,0.98,11/28,16.43%,PER1;CRY2;FBXL22;USP2;PER3;RBM4;ID2;PPP1CB;CRY1;FBXL12;CRTC1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.4540178858500494,1.70052898903444,0.0,0.04992641982108411,0.98,15/31,17.60%,MAP3K3;RHOJ;FGF2;STARD13;HDAC7;MEOX2;RHOA;HDAC5;HMOX1;MMRN2;TBXA2R;GATA2;ITGB1BP1;MAP2K5;KLF4
prerank,positive regulation of organelle organization (GO:0010638),0.43396086339615714,1.6989480401686965,0.0,0.050399856225637515,0.98,10/31,15.29%,PLA2G5;SORBS3;CALCOCO2;FYCO1;P2RX7;ATL3;MGARP;ANXA2;ADRB2;DOC2B
prerank,positive regulation of microtubule polymerization (GO:0031116),0.4624856983880778,1.6968038319966983,0.0,0.05107686354753135,0.99,10/27,11.40%,MAPT;RAC1;ARL2;FES;OCLN;CLIP1;NUMA1;DCTN1;SLAIN2;MECP2
prerank,negative regulation of transport (GO:0051051),0.4251901377096414,1.6960441769847512,0.0,0.05081358074573994,0.99,19/46,16.81%,CRYAB;PTEN;LGALS3;SYT11;SNCA;ITGB3;PACSIN3;NR1H2;PRKD1;SNX3;SNX33;LRSAM1;ARL6IP5;DYSF;PPM1F;PXK;PRTN3;EPHA3;NR1H3
prerank,tRNA export from nucleus (GO:0006409),-0.5551829390918751,-1.694891775078375,0.0,0.07773307609524963,1.0,23/32,32.58%,NUP155;NUP37;NUP210;NUP107;RANBP2;NUP35;XPOT;NUP50;SEH1L;NUP205;NUP88;NUP93;POM121;RAN;RAE1;NUP43;NUP160;NUP153;NDC1;NUP62;NUP98;SSB;SEC13
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.5551829390918751,-1.694891775078375,0.0,0.07773307609524963,1.0,23/32,32.58%,NUP155;NUP37;NUP210;NUP107;RANBP2;NUP35;XPOT;NUP50;SEH1L;NUP205;NUP88;NUP93;POM121;RAN;RAE1;NUP43;NUP160;NUP153;NDC1;NUP62;NUP98;SSB;SEC13
prerank,response to ethanol (GO:0045471),-0.6080901576297052,-1.6948106713679756,0.0,0.07681467623886315,1.0,6/15,11.86%,GRIN2B;TH;ADCY7;GLRA1;CHRNB2;GLRA2
prerank,neurotransmitter secretion (GO:0007269),0.39897698451141894,1.6947937055871953,0.0,0.05117201458585118,0.99,23/44,19.90%,VAMP2;PIP5K1C;RAB3A;SNCA;CPLX3;SNPH;SYN2;SNAP25;SNAPIN;SYT10;SYN1;BRSK1;SYT1;NRXN1;HSPA8;STXBP1;LIN7A;NRXN2;LIN7B;NAAA;STXBP3;DVL1;CPLX2
prerank,positive regulation of cell differentiation (GO:0045597),0.3042237464309032,1.6932228699026415,0.0,0.051526790937798016,0.99,80/250,15.49%,TGFB1I1;IL6R;TMEM100;RAP1A;PPARD;PTN;GLIPR2;FERMT2;CD34;WWTR1;FGFR1;SMYD1;PLA2G5;AGTR1;BOC;DDR2;LMO3;RBM24;KITLG;RRAS;ZFP36L1;SMAD2;SRF;NGF;MAPK14;MTOR;ARNTL;FES;RARRES2;CDON;ZHX3;ZC4H2;HOXD3;CAMK1;HOXA5;ZFP36;RHOA;BMPR1A;GPC1;RBM4;PCP4;ID2;CD36;GPRC5B;MAPK11;GCNT2;PRKD1;MEF2A;CEACAM1;MEDAG;BNIP2;ZNF385A;SMAD4;SFRP1;NBL1;CREB1;HOXA11;MMD;BTG1;SMAD3;LPL;LRRC8A;PKDCC;ADRA2B;AKIRIN1;MEF2C;TMEM64;HOXB4;OLFM1;NFKB1;GDF5;GDNF;INS;CDH2;KCTD11;FRZB;GDF6;RGCC;MMD2;XKR8
prerank,regulation of actin filament polymerization (GO:0030833),0.394417590187405,1.692580358989753,0.0,0.051469477582051885,0.99,34/67,24.05%,LMOD1;NCK1;GBA2;DBN1;CDC42EP3;KANK3;PRKCD;ESAM;CCL21;NCKAP1L;CDC42EP4;BAIAP2;MYADM;TENM1;EVL;CCL11;PFN2;PLEKHG2;SNX9;FCHSD1;KANK1;CDC42EP2;HCLS1;SSH3;FER;TWF2;PRKCE;PFN1;VASP;SLIT2;NCK2;ALOX15;NCKAP1;KANK4
prerank,response to amino acid starvation (GO:1990928),0.3899481815112861,1.6916956488351163,0.0,0.05161595557260527,0.99,31/71,21.40%,ATP6V1G2;ATF4;MAPK1;MAPK3;CDKN1A;FLCN;FAS;MAPK8;MTOR;ATF2;ATP6V1E1;RRAGA;PRKD1;TFEB;RRAGD;KPTN;RRAGB;TCIRG1;ATP6V0E2;LAMTOR3;RRAGC;RHEB;SH3GLB1;ATP6V1H;WDR59;RNF152;ATP6V1D;SESN1;LAMTOR1;ATP6V0D1;NPRL2
prerank,negative regulation of phosphorylation (GO:0042326),0.37362103463897695,1.690164866855733,0.0,0.0519631526781069,0.99,23/81,11.01%,PTEN;WWTR1;PRNP;CADM4;MAPT;CDKN1A;CDKN1C;CORO1C;FBLN1;INPP5K;TERF2IP;TARDBP;HDAC4;OCLN;CDKN2C;PRKRIP1;PID1;DAB2IP;FKBP8;TESK1;NUPR1;ATG14;MYADM
prerank,positive regulation of programmed cell death (GO:0043068),0.2742235911091824,1.6898974489562921,0.0,0.05170333691471637,0.99,70/276,15.11%,APBB1;CLIP3;ARHGEF26;PSEN1;CLU;PNMA1;MOAP1;TNFSF10;ATF4;RHOB;BCL10;ING4;CALHM2;PHLDA3;SNCA;ARHGEF17;APAF1;FLCN;FAS;MAPK8;GADD45B;CASP3;NGF;KCNMA1;DAPK1;RPS6KA2;NGFR;MLLT11;RNF122;KLF11;DAPK3;BCL2L11;HDAC6;HOXA5;JMY;ARHGEF18;GPER1;ADAMTSL4;ARHGEF6;UBB;DAB2IP;LATS2;SOD1;SMPD1;PRMT2;BNIP3;APH1B;MTCH1;SFRP1;PIDD1;ERCC3;RBM5;MARK4;ARHGEF9;BNIP3L;BOK;ARL6IP5;OLFM1;NTRK1;QRICH1;GADD45G;BAD;RIPK1;RYBP;RARG;PLEKHG2;ARHGEF3;RASSF2;FAM162A;FRZB
prerank,cellular response to ATP (GO:0071318),0.5217189522771085,1.6884044351610583,0.0,0.051746375486203935,0.99,7/15,12.73%,P2RY1;P2RX7;HSP90B1;P2RY12;TRPV1;RYR3;P2RY11
prerank,positive regulation of cell division (GO:0051781),-0.493816152757256,-1.6874135920189295,0.0,0.08185668345738877,1.0,17/44,16.24%,KIF14;SHH;KIF20B;KIF23;SSTR5;RACGAP1;AURKB;TAS2R13;CXCR5;OR2A4;DRD2;ECT2;CDC14C;CSPP1;SPAST;RXFP3;CDC6
prerank,neuron development (GO:0048666),0.33761133817912165,1.687101910295222,0.0,0.0518885821407852,0.99,37/141,13.57%,LGI4;PLP1;GPM6B;PBX3;STMN2;GPM6A;STMN4;ULK1;L1CAM;GBA2;MAPT;MYOC;FRYL;MICALL1;SRF;ARL3;LGI1;BLOC1S1;PBX2;MAP2;ATCAY;NCDN;BTG2;TMEM108;SNAPIN;PTPRM;NPY;VAPA;ISL2;NLGN1;LAMB1;APP;TENM1;TENM3;MEF2C;ADCYAP1;GDNF
prerank,folic acid metabolic process (GO:0046655),-0.5822401007250735,-1.6857905276235283,0.0,0.08233035685171722,1.0,7/18,17.39%,MTHFD1L;DHFR;MTHFD1;SHMT2;MTHFD2;SLC46A1;SLC19A1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.4198925204404955,1.6851393822741272,0.0,0.05262400931880621,1.0,18/41,13.80%,CORO2B;FZD7;FZD4;CORO1C;RAC1;ARL2;SPOCK1;RHOA;RSU1;PDGFB;GCNT2;FBLN2;MYADM;VIT;CX3CL1;TSC1;JAK2;PPM1F
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.5516115042333234,-1.6848741077802474,0.013513513513513514,0.08191515251700118,1.0,11/24,22.30%,AZGP1;CD1A;IL23A;IL23R;IL12B;CD1B;HLA-F;SLC22A13;HLA-G;IL12RB1;XCL1
prerank,mitotic spindle organization (GO:0007052),-0.41796599150133873,-1.6847751014336625,0.0,0.08099047516683439,1.0,67/147,26.43%,ERCC6L;CENPN;KIF18A;CENPE;NUF2;CENPU;KIF23;INCENP;MAD2L1;CENPH;WDR62;NDC80;CENPA;KIF2A;DLGAP5;SKA1;CENPO;CENPK;SPDL1;CHEK2;RCC2;SPC24;DSN1;NUP37;CENPL;AURKB;KIF4B;GPSM2;TPX2;ZWINT;KNTC1;AURKA;BUB1;NEK6;KIF2C;CENPM;NUP107;RCC1;PLK1;RANBP2;CENPP;EML4;CENPF;SPAST;SEH1L;NDE1;BIRC5;MZT1;CDC20;CKAP5;KIF3B;SMC1A;CENPQ;RAN;BUB1B;PRC1;PIBF1;STMN1;STAG1;MAP4;TTK;SPC25;ZW10;KIFC1;NUP43;NUP160;CDCA8
prerank,neuron cell-cell adhesion (GO:0007158),0.5629743599475312,1.6837632661860398,0.0,0.05305637304516177,1.0,11/15,18.87%,NLGN2;NRXN3;NLGN4X;NLGN1;NLGN3;NCAM2;NRXN1;RET;ASTN1;NRXN2;CNTN4
prerank,epidermis development (GO:0008544),-0.4369475650463046,-1.6834556252586848,0.0,0.08179964047240103,1.0,32/77,25.95%,GRHL3;LAMC2;CDSN;RBP2;KLK7;GJB5;EDAR;ZNF750;OVOL3;GRHL2;KRT32;DSP;GATA6;LAMA3;SCEL;LAMB3;NTF4;COL7A1;ATP2C1;KRT15;OVOL1;SPRR2D;EVPL;KRT83;HDAC2;HOXB13;KRT9;FOXN1;S100A7;GRHL1;KRT31;OVOL2
prerank,negative regulation of neuron projection development (GO:0010977),0.3785650896922053,1.6832082771490924,0.0,0.05289569820068734,1.0,18/55,12.10%,PTEN;LPAR1;STMN2;DPYSL3;CRMP1;PTPRS;STX1B;NGFR;SPOCK1;RHOA;EPHA4;MYLIP;RTN4;DENND5A;GDI1;NLGN1;SEMA3A;MT3
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5340756409651676,-1.6806097506062558,0.02702702702702703,0.08235784682549521,1.0,8/23,12.65%,IL1A;IFI6;CSF2;IL1B;PF4;EYA1;BCL2L1;TERT
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5340756409651676,-1.6806097506062558,0.02702702702702703,0.08235784682549521,1.0,8/23,12.65%,IL1A;IFI6;CSF2;IL1B;PF4;EYA1;BCL2L1;TERT
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.4997707772133309,-1.6798730742133556,0.0,0.081013641202512,1.0,25/49,29.67%,POLR2F;TRIM71;NUP155;NUP37;NUP210;NUP107;RANBP2;NUP35;NUP50;SEH1L;POLR2J;NUP205;NUP88;POLR2D;NUP93;POM121;RAE1;POLR2I;FMR1;NUP43;NUP160;NUP153;NDC1;NUP62;NUP98
prerank,regulation of gene silencing by RNA (GO:0060966),-0.4997707772133309,-1.6798730742133556,0.0,0.081013641202512,1.0,25/49,29.67%,POLR2F;TRIM71;NUP155;NUP37;NUP210;NUP107;RANBP2;NUP35;NUP50;SEH1L;POLR2J;NUP205;NUP88;POLR2D;NUP93;POM121;RAE1;POLR2I;FMR1;NUP43;NUP160;NUP153;NDC1;NUP62;NUP98
prerank,regulation of protein autophosphorylation (GO:0031952),0.44334805847012704,1.6786349297682255,0.0,0.05420148839799702,1.0,14/36,16.28%,EPHA7;PPP2R5B;CALM1;PPP2R5D;PDGFB;TESK1;CALM2;PDGFD;GPNMB;INS;RASSF2;TAOK2;PDGFA;ERRFI1
prerank,visual perception (GO:0007601),-0.4448114915433278,-1.6783183132936699,0.0,0.08137280158473424,1.0,34/92,25.07%,COL1A1;ZIC2;GRM8;COL11A1;GPR143;PAX6;CEP250;PAX2;POU6F2;EYS;TH;FSCN2;BEST1;REEP6;TULP1;CRYBA1;SIX3;SLC24A1;CHRNB2;ADGRV1;TRPM1;ARR3;COL2A1;CRYBB3;RP2;TYR;RPE65;RDH12;RBP3;POU4F3;RPGR;EML2;RAX;CRYBA4
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.46552951599448156,1.6780475054034063,0.0,0.054134022559628986,1.0,9/29,12.77%,CLU;PTEN;BAG2;ECSCR;DAB2IP;PSMC5;NUPR1;KCNE2;OSBPL7
prerank,cellular response to topologically incorrect protein (GO:0035967),0.4589326604534381,1.6777478995136734,0.0,0.05406720543124523,1.0,7/31,7.09%,HSPB8;HSPA2;OPTN;DNAJC18;BAG3;HDAC6;DAB2IP
prerank,action potential (GO:0001508),0.43230454562816817,1.6777115354008232,0.0,0.053808510668416305,1.0,20/44,17.74%,CACNA1H;SCN7A;KCNH2;KCNB1;AKAP6;SCN3B;KCNA2;GPER1;SCN11A;SCN9A;KCNE2;KCNE4;DMD;KCNMB4;GNAQ;SCN4A;KCNMB2;ANK3;KCNA1;GNA14
prerank,sulfation (GO:0051923),-0.5790518413364432,-1.6773872527279228,0.016129032258064516,0.08124541601598619,1.0,4/17,1.92%,SULT2B1;SULT1C3;SULT1C2;CHST4
prerank,nuclear membrane organization (GO:0071763),0.5181861214018211,1.6771298528407643,0.0,0.05383968009277488,1.0,11/19,21.26%,TOR1AIP1;TMEM43;TARDBP;GPER1;DCTN1;AKAP8L;CHMP7;VPS4A;EMD;NSFL1C;NEMP1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.41728584207904545,1.676291507369217,0.0,0.053775207958950404,1.0,17/33,18.08%,ATP2B4;FGF2;STARD13;MEOX2;RHOA;HDAC5;MMRN2;CSNK2B;TBXA2R;MECP2;ANGPT4;MEF2C;ITGB1BP1;RGCC;MAP2K5;KLF4;AGTR2
prerank,axonogenesis (GO:0007409),0.29831195267091754,1.6759082571490547,0.0,0.05380624042038797,1.0,70/237,14.10%,APBB1;S100B;PALLD;PDLIM7;GFRA1;EPHA7;GFRA3;PTEN;MAPK1;NRP2;PPP3CB;ROBO3;NEXN;ULK1;LAMA5;MAPK3;NCAM1;L1CAM;RAB3A;NPTN;KIF5A;SEMA4C;ULK2;MAPK7;SEMA3G;NRXN3;MAP1A;SLIT3;LGI1;SLITRK2;PIK3R1;GFRA2;GPC1;EFNA5;EPHA4;ZDHHC17;SCN1B;KIF5C;ACTB;SEMA3B;SLITRK3;ROBO4;BAIAP2;ISL2;GRB10;FEZ2;NLGN3;FGFR2;NTN4;BRSK1;EPHB6;ENAH;NTNG1;APP;SEMA6C;LAMA2;SEMA3A;EVL;SEMA3C;SEMA3E;PARD3;ATL1;CCK;SEMA4B;MAP1B;PRKCA;GDNF;SEMA6D;NRXN1;DSCAML1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.31655808052638135,1.6742851806014638,0.0,0.0545925882550667,1.0,37/95,22.86%,CLU;ZER1;TRIM39;BAG2;SIRT2;MAP1A;CAMLG;DNAJB2;RNF217;TRIB2;SMAD7;GNA12;RNF144B;CSNK1E;RNF14;PIAS1;UBXN1;CSNK1A1;RNF180;ZYG11B;GABARAP;RYBP;ARAF;RNF19A;BBS7;FOXF2;CBFA2T3;BAG6;KLHL40;DVL1;WAC;HFE;SDCBP;HERPUD1;RNF144A;DDA1;UBQLN4
prerank,regulation of calcium ion transport (GO:0051924),0.39242732055199164,1.6735741530141128,0.0,0.054525501673761766,1.0,17/56,12.99%,CAMK2G;PLN;MYLK;STIM1;HRC;CASQ1;INPP5K;PKD2;PACSIN3;NOS1;ANK2;WFS1;CACNA2D1;SLN;CACNB2;BCL2;TRPC6
prerank,positive regulation of endocytosis (GO:0045807),0.37444116359558904,1.673550889512181,0.0,0.05427189468923264,1.0,12/45,9.89%,CLIP3;CLU;SNCA;ANKFY1;CCL21;NCKAP1L;F2RL1;SMPD1;B2M;RAB31;FLOT1;NLGN1
prerank,neuronal action potential (GO:0019228),0.4962215637830112,1.6723347828497892,0.0,0.05457947008218727,1.0,11/22,16.48%,CACNA1H;SCN7A;KCNA2;GPER1;SCN11A;SCN9A;KCNMB4;SCN4A;KCNMB2;ANK3;KCNA1
prerank,regulation of membrane depolarization (GO:0003254),0.5193065022645675,1.6705486248195756,0.038461538461538464,0.054513371417549576,1.0,7/18,11.31%,FHL1;SCN3B;SCN2B;SCN1B;SMAD7;GPD1L;CAMK2D
prerank,anion transport (GO:0006820),-0.5046292651321574,-1.6688223608415513,0.0,0.08679699051677531,1.0,21/41,27.56%,LRRC8E;SLC22A11;ABCC11;SLCO1B3;SLC26A8;SLC13A4;SLC26A9;SLC13A5;LRRC8B;SLCO1A2;LRRC8D;SLC22A25;SLC22A9;SLC19A1;SLC13A3;VDAC1;SLC22A10;SLC22A24;SLC17A3;SLC17A1;SLC22A12
prerank,regulation of blood coagulation (GO:0030193),-0.5567693603485742,-1.6688031642643062,0.0,0.08583257951103336,1.0,9/24,7.42%,FAP;F12;THBD;EPHB2;SERPINE1;KNG1;CAV1;FOXA2;PROC
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.49222008476222817,-1.6669428084812612,0.0,0.08635430342757495,1.0,13/40,14.21%,BLM;EME1;RFWD3;TIPIN;MSH3;MMS22L;TIMELESS;ZRANB3;TRAIP;TONSL;FANCM;WRN;ATR
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.37488014893785876,1.666941449730448,0.0,0.055278440031262456,1.0,24/77,13.39%,PALM;DPYSL3;GPM6A;CDC42EP3;RAC1;ARPC2;OCLN;P2RX7;PIK3R1;CCL21;RHOQ;F2RL1;CROCC;MSTN;CDC42EP4;P2RY12;DEF8;NLGN1;MARK4;BRK1;WASF2;TENM1;AKIRIN1;TAPT1
prerank,cellular response to copper ion (GO:0071280),0.4955418490223395,1.6658653083956128,0.0,0.05530161651415038,1.0,9/19,20.14%,PRNP;AQP1;SNCA;MT1X;MT1M;MT3;MT1A;MT1E;DAXX
prerank,regulation of protein dephosphorylation (GO:0035304),0.42118440801377094,1.665825037011742,0.0,0.05505024552999515,1.0,16/38,22.72%,CALM1;PRKCD;HSP90B1;SMPD1;DLC1;CDH5;CALM2;PIN1;TSC1;ARPP19;PPP6R2;PPP1R15A;CNEP1R1;CALM3;ENSA;PPP1R2
prerank,oxoacid metabolic process (GO:0043436),-0.4778679871116522,-1.66316887738986,0.014084507042253521,0.08907634125300938,1.0,7/32,13.68%,SULT2B1;SULT1C3;SULT1C2;MIF;LIPT2;SULT1A3;AGXT
prerank,dendrite self-avoidance (GO:0070593),0.5856280872623113,1.6621444759432984,0.027777777777777776,0.056075594731174676,1.0,9/16,20.98%,PALLD;ROBO3;NEXN;NPTN;ROBO4;DSCAML1;CNTN2;CNTN4;BSG
prerank,protein localization to cell periphery (GO:1990778),0.3148544363842447,1.6614925209594908,0.0,0.05618548898784336,1.0,57/137,21.66%,RAP1A;FLNA;EHD2;RAB34;RAMP1;DPP6;KCNIP3;P2RY1;RAB3A;TMEM88;KCNB1;INPP5K;SLMAP;EPB41L3;WDR19;SCN3B;ARL3;ANK2;TMEM150A;RAMP3;RAMP2;ZDHHC22;PLEKHF1;RDX;FLOT1;TNFRSF1A;RAB3C;MYADM;PACSIN1;KCNIP4;RAB8B;CACNB2;FLOT2;PACS1;ITGB1BP1;FAM126A;SLC9A3R2;ANK3;RABEP1;STXBP1;RAB13;LIN7A;GAS6;TTC7B;ACTN2;LIN7B;EHD1;CDH1;CACNB3;PDZD3;RAB29;FCHO2;BSG;RAB12;MYO5A;FGF13;SPTBN4
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.4922187975430196,-1.6609955490506854,0.0,0.09023096167284511,1.0,21/38,29.76%,CEBPB;FOXP3;CD80;IL4I1;VTCN1;PLA2G2F;ARG1;LST1;IL10;CTLA4;CR1;LILRB4;HLA-G;CD86;MNDA;TYROBP;LYN;GLMN;PLA2G2D;LILRB2;PDCD1LG2
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.4257075195386663,-1.6608905106462317,0.0,0.08927105782526165,1.0,28/84,17.05%,CEMIP;COL1A1;COL11A1;CACNA1D;KCNQ1;LHFPL5;MYO3B;CEACAM16;EYA1;LRP2;ATP6V0A4;DCDC2;GRAP;MARVELD2;CHRNB2;GRM7;ADGRV1;COL2A1;TSPEAR;SLC52A3;MYH14;SLC26A5;USH1C;USH2A;LOXHD1;BIRC5;CLRN1;PAX3
prerank,cellular response to mechanical stimulus (GO:0071260),0.39809531215587574,1.6606592659790524,0.0,0.05638461302664014,1.0,24/48,19.85%,TLR3;PDE2A;BCL10;AQP1;MAPK3;MAP2K4;FAS;MAPK8;MAP3K14;TMEM150C;BNIP3;TNFRSF1A;PTGER4;NFKB1;BAD;PIEZO1;MAP3K1;PIEZO2;KCNK4;TNFSF14;CD40;CRADD;CASP1;SLC9A1
prerank,negative regulation of intracellular protein transport (GO:0090317),0.44784980640628913,1.660222694006155,0.03333333333333333,0.05613289600419978,1.0,8/22,16.16%,APOD;INPP5K;RAB23;GDI1;SUFU;MDFIC;ITGB1BP1;DMTN
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.45743967337206215,-1.6600091414568523,0.0,0.08929148598494707,1.0,16/54,10.82%,CCND1;CHEK1;BLM;EME1;CDK1;TICRR;RFWD3;TIPIN;CHEK2;PRKDC;HMGA2;RAD9B;BRCC3;CDC14C;PLK1;TOPBP1
prerank,axoneme assembly (GO:0035082),-0.5319376263624482,-1.6575345640969246,0.0,0.09070012872376737,1.0,15/28,22.33%,RP1;SPAG17;CFAP74;CCDC103;RP1L1;RSPH9;SPAG1;DNAAF3;DNAAF2;DNAAF1;LRGUK;TTC26;DNAJB13;RSPH6A;CFAP46
prerank,cAMP-mediated signaling (GO:0019933),0.4117579241530667,1.6568914654833882,0.0,0.05713520499525077,1.0,10/25,14.58%,CAP2;PDE2A;MAPK7;RAPGEF3;AKAP6;PDE3A;PDE7B;PDE4D;ADCYAP1;ADCY2
prerank,positive regulation of DNA recombination (GO:0045911),-0.5200287317443781,-1.6566099392822604,0.0,0.09077773585186116,1.0,12/24,26.08%,FANCB;RAD51AP1;TIMELESS;PAXIP1;PRDM7;ACTR2;FUS;RIF1;PRDM9;ERCC6;ARID2;WRAP53
prerank,positive regulation of signal transduction (GO:0009967),0.28072233970375987,1.6564947690165022,0.0,0.057060430016757674,1.0,73/238,14.32%,LIMS2;SLC2A4;SORBS1;FLNA;RAB34;PTEN;AGPAT1;CITED2;NLGN2;TRIM39;CAV2;LMO3;TTC23;WLS;ILK;GKAP1;NPTN;FAS;CCBE1;RSPO2;KAT2B;ITGB3;STX1B;MYO1C;SASH1;CD63;RWDD3;PKD2;RSPO1;PTGIS;PIK3R1;DLG4;GPER1;RBPJ;DAB2IP;HHEX;TMEM108;HAP1;FGF1;MN1;GH1;GRB10;TXNDC15;EPN2;SFRP1;NLGN1;RSPO3;NLGN3;FGFR2;NECAB2;KLF2;GPS2;ARNT;TSLP;TM2D3;SPIN1;ZMIZ1;MAML1;KIF7;MT3;ENHO;NKX3-1;SMO;PRKCA;JAK2;SKI;STK36;ITGB1BP1;NOTCH4;NRXN1;IL7;NTF3;INS
prerank,positive regulation of phospholipase activity (GO:0010518),0.4440190220578185,1.6551319907937914,0.0,0.0574294422611567,1.0,9/24,15.43%,FGFR1;PLA2G5;AGTR1;KIT;FGF2;PDGFRA;FGFR2;NTF3;NTRK3
prerank,negative regulation of nervous system development (GO:0051961),-0.5712453622443108,-1.6547049484992518,0.031746031746031744,0.09149811206286546,1.0,9/18,24.86%,IL1B;PAX6;ROBO2;SORL1;WNT7A;WNT3A;TNF;REST;NOTCH1
prerank,regulation of protein sumoylation (GO:0033233),0.46139593272891993,1.6544355891140956,0.0,0.057442269662571425,1.0,10/17,13.24%,RASD2;PIAS3;RWDD3;HDAC4;MUL1;SAE1;PIAS1;CAPN3;ZMIZ1;PIAS4
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.5171243768070761,1.6537360703873674,0.034482758620689655,0.05755505953287662,1.0,7/15,22.61%,AP3S2;BLOC1S1;SNAPIN;AP3B2;BLOC1S6;BLOC1S5;AP3S1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.5171243768070761,1.6537360703873674,0.034482758620689655,0.05755505953287662,1.0,7/15,22.61%,AP3S2;BLOC1S1;SNAPIN;AP3B2;BLOC1S6;BLOC1S5;AP3S1
prerank,cytoskeleton organization (GO:0007010),0.33184162278766693,1.6535510690311093,0.0,0.057480085508300575,1.0,44/114,17.64%,PALLD;TPM1;RHOB;ARHGAP10;DST;CNTNAP1;DES;RND2;RAC1;EPB41L3;ZNF135;PACSIN3;OBSL1;CAPZB;PACSIN2;RHOA;MAST1;MAST2;WASF3;ZMYM3;CCL2;DPYSL2;RHOC;FGD6;MARK1;KLHL20;SIPA1;MICAL3;RHOU;PACSIN1;RANBP10;CCL11;ZMYM6;CCL13;ARC;PPP2R3C;SPRYD3;WTIP;DMTN;KRT25;SEMA6A;RHOBTB1;CDC42BPB;FGD1
prerank,regulation of protein polymerization (GO:0032271),0.4040388446372512,1.653148843934925,0.0,0.05740575781152261,1.0,8/33,7.41%,GBA2;MAPT;DBN1;MAPRE3;ARL2;ESAM;MAP2;TPPP3
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.37878047048620317,1.6521188664399,0.0,0.05759109854898184,1.0,14/45,13.05%,FGFR1;MAP3K3;RHOJ;HSPB1;FGF2;MAPK14;HDAC7;HMOX1;PDGFB;PRKD1;ANGPT1;GATA2;ANGPT4;PRKCA
prerank,ribosome biogenesis (GO:0042254),-0.4040217842058986,-1.6514621831527954,0.0,0.09362136696728185,1.0,116/184,44.88%,DDX47;WDR43;DKC1;DCAF13;WDR3;WDR12;WDR74;UTP14A;NOB1;NOP16;NIP7;BOP1;URB2;UTP18;DDX31;HEATR1;ABCE1;NAF1;RPL39;LYAR;EMG1;UTP20;RRP12;MRTO4;RCL1;BYSL;RRP9;PAK1IP1;EXOSC3;DDX10;PDCD11;DDX27;PIH1D2;EXOSC8;NOP58;DIS3;RRP1;RPS19;EXOSC4;RRS1;NOP14;VCX;PWP2;FBL;NOLC1;WDR36;EXOSC5;ESF1;GTF3A;RRP1B;DHX37;UTP15;RPL36;RAN;IMP4;DDX52;RPL26L1;EBNA1BP2;PES1;NPM1;HEATR3;MDN1;RPF2;XRN2;RPL23A;RPL37;EIF6;EXOSC7;RRP7A;UTP6;RPL8;ZNF658;NOP56;NOM1;BMS1;NOL11;EXOSC2;XPO1;IMP3;RIOK1;NOC2L;KRR1;NOC4L;DDX54;RPS7;EXOSC1;RPS2;WDR75;RPL41;WDR46;RPS24;CUL4A;RPL32;LSG1;RPL27A;RPL35;RPL4;RPL30;POP5;WDR18;MPHOSPH6;NVL;RPL37A;MALSU1;MRPL36;RPL18;NOL6;MRPL22;ZNF622;RPL19;RPL38;UTP3;RPLP2;RPL12;NOL8;RPS14
prerank,protein localization to plasma membrane (GO:0072659),0.31535494642903705,1.6503558469812136,0.0,0.05829070209880225,1.0,37/131,14.35%,RAP1A;FLNA;EHD2;RAB34;RAMP1;DPP6;KCNIP3;P2RY1;RAB3A;TMEM88;KCNB1;INPP5K;SLMAP;EPB41L3;SCN3B;ANK2;TMEM150A;RAMP3;RAMP2;ZDHHC22;PLEKHF1;GORASP1;RDX;FLOT1;ASB3;TNFRSF1A;RAB3C;MYADM;PACSIN1;KCNIP4;RAB8B;CACNB2;FLOT2;PACS1;ITGB1BP1;FAM126A;SLC9A3R2
prerank,negative regulation of organelle assembly (GO:1902116),0.3910955524970568,1.6502071543491863,0.0,0.05804265655795629,1.0,9/34,9.91%,MDM1;KAT2B;EVI5L;KAT2A;TESK1;CHMP4A;SMAD4;NUPR1;FEZ2
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.44011831687360164,1.6500256318050528,0.0,0.05779671309796495,1.0,18/28,24.38%,LIMA1;KANK3;PRKCD;PLEKHH2;SMAD4;MYADM;IQCJ-SCHIP1;PFN2;ARPIN;KANK1;SSH3;SHANK3;TWF2;PFN1;SLIT2;KANK4;TJP1;CLASP1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.6161190543696522,-1.6486337261743649,0.0,0.09542150528747032,1.0,9/16,26.80%,IL23A;CD81;SYK;IL12B;CD55;TGFBR2;TNFSF4;XCL1;PTPN22
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.4323647048937424,1.6468652415170828,0.0,0.05882613814362154,1.0,13/23,27.04%,UBB;COPS7B;COPS7A;COPS4;COPS8;XPA;CETN2;DDB2;COPS2;COPS3;COPS6;GPS1;RPS27A
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.6235938164487352,-1.646436002073046,0.0,0.09628291083898798,1.0,5/15,5.20%,CDK1;CENPA;MTBP;SPDL1;AURKB
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.45700850422126804,-1.6463485426726783,0.0,0.09533896073272338,1.0,25/58,23.96%,WDR12;WDR74;NOP16;NIP7;BOP1;URB2;TGS1;DDX31;NAF1;EMG1;MRTO4;BYSL;PAK1IP1;RPS19;RRS1;NOP14;SHQ1;GTF3A;DHX37;RPL26L1;EBNA1BP2;PES1;NPM1;HEATR3;RPF2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.5133493095913062,-1.6457312230828498,0.02631578947368421,0.09509453268225913,1.0,10/28,12.65%,IL1A;INHBA;IFI6;CSF2;IL1B;PF4;EYA1;BCL2L1;PPP2R1B;TERT
prerank,tube closure (GO:0060606),-0.5185726651163898,-1.6455768644531104,0.027777777777777776,0.09431509077480452,1.0,9/31,7.82%,GRHL3;CELSR1;MTHFD1L;TGFB2;FOLR1;PAX2;MTHFD1;LRP2;GRHL2
prerank,regulation of immune response (GO:0050776),-0.4007691097127224,-1.6451585593900768,0.0,0.09415189142160062,1.0,78/170,32.09%,ULBP3;COL1A1;IFITM1;FOXP3;LRP8;COL1A2;IL4I1;TGFB2;TREM1;LAIR2;CD1A;CD276;SELL;ICAM1;C3;FCGR3B;ULBP1;NCR3LG1;CD81;SYK;CXADR;ADCY7;CD300LD;XIAP;FCGR1A;RAET1E;COL3A1;BCL6;CD1B;TREML4;HLA-F;TREML2;COL2A1;FCGR3A;NCR1;CD3D;KIR2DL3;KIR3DL1;CD3G;MICB;ICAM5;HLA-G;TREML1;SLA2;TNFSF4;ITGB2;ERAP1;GPR151;CRTAM;TKFC;TYROBP;SH2D1A;LYN;KIR3DL2;HCST;CD8B;SAMHD1;DENND1B;CD160;CD300LF;PTPN22;NCR3;CXCL13;SLAMF6;LILRB2;ITGAL;ICAM2;PDCD1;IRF7;IFNL1;CD300E;PLSCR1;CD3E;SIGLEC7;ICAM3;CD300LB;CD226;CD96
prerank,mammary gland development (GO:0030879),-0.528241993157325,-1.6447295845834136,0.0,0.09346224019555223,1.0,8/23,10.00%,WNT2;TDGF1;WNT7B;FOXB1;CAV1;OXTR;PRLR;APLN
prerank,amino acid transmembrane transport (GO:0003333),-0.4841793765367419,-1.6443411910194352,0.02531645569620253,0.09285105242376168,1.0,23/45,27.64%,LRRC8E;SLC6A14;SLC7A11;SLC6A20;TSPO2;SLC7A5;SLC38A5;SLC6A6;SLC7A1;LRRC8D;SLC7A6;MFSD12;SFXN2;SLC25A13;SLC36A3;SLC38A3;SLC22A4;SLC7A7;SLC38A8;SLC38A9;SLC3A2;SLC7A10;SLC25A22
prerank,actin filament organization (GO:0007015),0.3108561038077444,1.643819539383655,0.0,0.059339735333569135,1.0,34/147,12.22%,TPM2;CORO6;LMOD1;DSTN;FLNA;GSN;TPM1;EFS;ACTN1;DPYSL3;TMOD2;RHOB;TMOD1;INPPL1;RND2;CORO1C;DBN1;RAC1;FLII;MYO1C;GAS2L1;CORO7;RHOA;ALDOA;ACTC1;RHOC;BAIAP2;TCAP;CORO1B;WHAMM;ENAH;MYO5C;EVL;ELMO2
prerank,inner ear morphogenesis (GO:0042472),-0.5254757668518896,-1.6387972787990706,0.0,0.09647394836049389,1.0,14/24,24.58%,EPHB2;PAX2;SOX9;CHD7;MYO3B;SIX1;MYO6;PAX8;USH1C;DCANP1;MYO3A;HPN;TIFAB;ZIC1
prerank,regulation of dendritic spine development (GO:0060998),0.4585539379120864,1.6367345550840025,0.03125,0.061616727645299615,1.0,10/21,21.16%,PSEN1;PTPRS;CAMK1;KIF1A;NLGN1;MEF2C;CPEB3;SHANK3;FOXO6;SRGAP2C
prerank,actin filament bundle assembly (GO:0051017),0.41699984053535316,1.6366612871663884,0.0,0.06135999128011087,1.0,8/33,9.39%,FAM107A;LIMA1;ADD1;CALD1;DPYSL3;HSP90B1;BAIAP2;CORO1B
prerank,cilium movement (GO:0003341),-0.4950214027458549,-1.6364466145908951,0.012987012987012988,0.09777743290047722,1.0,17/39,20.64%,SPAG17;CCDC103;DNAH9;DNAH11;RSPH9;DNAH7;DNAAF2;DNAAF1;DNAH5;TTC29;TEKT5;DNAI1;SPA17;ADCY10;DNAAF5;DNAI2;RSPH6A
prerank,actin filament bundle organization (GO:0061572),0.42232379407815207,1.6354199443844164,0.0,0.06177320392800768,1.0,5/31,1.58%,FAM107A;LIMA1;ADD1;CALD1;DPYSL3
prerank,ncRNA export from nucleus (GO:0097064),-0.5202405025755191,-1.6339278041042984,0.0,0.09943992429356031,1.0,23/36,30.26%,NUP155;NUP37;NUP210;NUP107;RANBP2;NUP35;XPOT;NUP50;SEH1L;NUP205;NUP88;NUP93;POM121;RAN;RAE1;NPM1;NUP43;NUP160;NUP153;NDC1;NUP62;NUP98;SSB
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.42298637022403307,1.6331886344770996,0.0,0.06218300159534335,1.0,11/24,16.48%,SEMA4C;SEMA3G;SEMA3B;SEMA6C;SEMA3A;SEMA3C;SEMA3E;SEMA4B;MEGF8;SEMA6D;SEMA6A
prerank,mitotic metaphase plate congression (GO:0007080),-0.4718499759639314,-1.6326361537661371,0.0,0.10025073356248539,1.0,24/51,28.97%,KIF18A;KIF14;CENPE;NUF2;CEP55;NDC80;CDCA5;SPDL1;CHMP4C;KIF2C;KIF22;CDT1;EML4;SEH1L;RRS1;PSRC1;PIBF1;CHAMP1;ZW10;KIFC1;CDCA8;CUL3;KPNB1;NUP62
prerank,histone H4-K16 acetylation (GO:0043984),0.44798734743708674,1.6324049178797235,0.0,0.062092684962670376,1.0,9/19,21.17%,ING4;JADE1;MSL1;KANSL3;KAT8;JADE2;MSL3;MEAF6;KAT7
prerank,autophagy of nucleus (GO:0044804),0.511326717961991,1.632010272851542,0.06666666666666667,0.06183820674561026,1.0,5/16,4.10%,WDR45;ULK1;ATG9A;ULK2;ATG12
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.5093476007775147,-1.6311371880754233,0.0,0.10110970951547868,1.0,15/30,23.36%,THY1;TNFSF11;SKAP1;CD44;HSPD1;FUT7;RELA;IRAK1;NFAT5;SIRPB1;PRKCQ;ITGB2;MDK;LCK;TNF
prerank,response to ATP (GO:0033198),0.48909824734428947,1.6303672167848324,0.0,0.06232483557257163,1.0,8/19,12.73%,P2RY1;P2RX7;HSP90B1;P2RY12;TRPV1;RYR3;ABCC9;P2RY11
prerank,myotube differentiation (GO:0014902),0.47480945986710027,1.6303039408053732,0.0,0.06215326319190225,1.0,9/18,13.98%,CACNA1H;JAM2;NOS1;ADGRB3;MYEF2;MEF2C;PLD3;SKI;ADAMTS5
prerank,positive regulation of autophagy (GO:0010508),0.32643326212284646,1.6284775767915063,0.0,0.06296047422781668,1.0,33/87,22.30%,EPM2A;DCN;OPTN;ULK1;FLCN;TRIM6;DAPK1;GPSM1;PRKAA2;BNIP3;PLEKHF1;PRKD1;TFEB;TRIM21;TRIM34;BNIP3L;BAD;TPCN1;TP53INP1;SH3GLB1;TRIM68;CAMKK2;TRIM8;RNF152;SUPT5H;SESN1;SCOC;WAC;KAT5;FBXO7;NPRL2;TSC2;SIRT1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.42357849538438797,1.627624813367026,0.0,0.0633555700552176,1.0,10/32,14.87%,NR1D1;TLR3;PTPRS;DAB2IP;F2RL1;TLR9;TICAM2;GPS2;NFKBIL1;GPR108
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5142503135505787,1.6255574285762282,0.041666666666666664,0.06382828772307272,1.0,8/16,16.56%,CACNA1H;RAB3A;KCNB1;SYT10;SYT4;NLGN1;DOC2B;RAB27A
prerank,striated muscle tissue development (GO:0014706),0.41073644797102254,1.6245896129375033,0.05555555555555555,0.06405580729045016,1.0,11/34,12.78%,PGM5;BVES;POPDC2;MYL6;MYOZ2;SGCD;MYOZ1;SGCG;CFLAR;POPDC3;MEF2C
prerank,regulation of RNA splicing (GO:0043484),0.35461220816074546,1.6228308096339892,0.0,0.06476242303485022,1.0,27/74,20.00%,RBM20;RBM38;PTBP2;CLK1;SNRNP70;JMJD6;HNRNPH3;CLK4;PIK3R1;MBNL1;SF1;QKI;CLK2;PRX;HNRNPH2;AKAP17A;CLK3;SLC38A2;AHNAK;TIA1;CELF1;MBNL2;POLR2A;RBM23;FASTK;AHNAK2;FAM50A
prerank,negative regulation of cell junction assembly (GO:1901889),0.450336202682613,1.622096173902498,0.03571428571428571,0.06522393036150219,1.0,8/25,8.16%,FAM107A;PTEN;DUSP22;APOD;ARHGAP6;CORO1C;PHLDB2;DLC1
prerank,neuron projection development (GO:0031175),0.30626942091365206,1.6216441477970132,0.0,0.06528419988462518,1.0,52/168,16.58%,PLP1;GPM6B;PTEN;STMN2;GPM6A;STMN4;GAS7;CNTNAP1;ULK1;L1CAM;MAPT;MYOC;FRYL;MICALL1;DBN1;NGF;EPB41L3;LGI1;BLOC1S1;DLG4;EPHA4;MAP2;ATCAY;UBB;DAB2IP;NCDN;BTG2;DCLK1;NCKAP1L;TMEM108;SNAPIN;PTPRM;NPY;VAPA;NLGN1;NBL1;LAMB1;NYAP1;APP;PACSIN1;CTNND2;ADCYAP1;ARC;GDNF;SVBP;NTF3;SGK1;TAOK2;MAPK8IP3;RAB13;NRK;PLXNB1
prerank,mitotic chromosome condensation (GO:0007076),-0.5657425007224328,-1.6210761486359404,0.0,0.11070831853693362,1.0,13/24,20.69%,NCAPG;CDK1;NCAPD3;CDCA5;SMC4;SMC2;NCAPD2;PLK1;NCAPH;SET;TTN;CSNK2A1;NCAPG2
prerank,chloride transmembrane transport (GO:1902476),-0.4455940192156258,-1.6209618602860052,0.024096385542168676,0.10986028569281124,1.0,22/50,24.93%,SLC12A2;GABRP;SLC12A8;CLCN1;GABRB1;GLRA1;GABRD;GLRA2;CFTR;CLCN3;GABRR1;GABRE;SLC12A3;SLC4A8;SLC12A5;SLC12A1;GABRB2;GABRA1;SLC5A1;GABRA3;GABRG3;ANO9
prerank,heart development (GO:0007507),0.31833460795059737,1.620879860745871,0.0,0.06526479000233813,1.0,41/159,9.98%,PDLIM7;BVES;PDLIM4;FOXF1;POU6F1;PTEN;CITED2;LDB3;DAND5;OSR1;RBM20;PDLIM1;HAND1;CDKN1A;MYOCD;POPDC2;MEF2D;ECE1;CRELD1;SRF;HAND2;KAT2B;CACNA1C;PKD2;KAT2A;PDLIM2;TGFBR3;DVL2;SGCD;PKD1;ID2;TBX19;PDGFB;RAMP2;DLC1;SOX18;MYL2;MEF2A;TCAP;FGF12;SGCG
prerank,rRNA processing (GO:0006364),-0.39944413504307014,-1.620873947303981,0.0,0.10902700124597792,1.0,101/167,44.88%,DDX47;WDR43;DKC1;DCAF13;WDR3;WDR12;PRKDC;WDR74;UTP14A;NOB1;BOP1;UTP18;TFB1M;SRFBP1;HEATR1;RPL39;LYAR;EMG1;UTP20;RRP12;MRTO4;RCL1;NAT10;BYSL;RRP9;EXOSC3;DDX10;PDCD11;DDX27;PIH1D2;EXOSC8;NOP58;DIS3;RRP1;RPS19;EXOSC4;NOP14;PWP2;FBL;NOLC1;WDR36;EXOSC5;ESF1;RRP1B;MAK16;DHX37;UTP15;RPL36;IMP4;DDX52;EBNA1BP2;PES1;MDN1;XRN2;RPL23A;RPL37;EIF6;EXOSC7;RRP7A;RSL1D1;UTP6;RPL8;NOP56;BMS1;NOL11;EXOSC2;IMP3;RIOK1;KRR1;NOC4L;DDX54;RPS7;ERI1;NHP2;EXOSC1;RPS2;WDR75;RPL41;WDR46;RPS24;RPL32;RPL27A;RPL35;LSM6;RPL4;RPL30;POP5;WDR18;MPHOSPH6;NVL;RPL37A;RPL18;NOL6;RPL19;RRP15;RPL38;UTP3;RPLP2;RPL12;NOL8;RPS14
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.3435752244206751,1.618807480620773,0.0,0.0659555804695245,1.0,20/65,13.80%,LIMS2;FLNA;FERMT2;ILK;MYOC;RAC1;ARL2;CCL28;CCL21;CD36;RSU1;PDGFB;TESK1;FBLN2;SFRP1;MYADM;VIT;CX3CL1;JAK2;PPM1F
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.6130171106611793,-1.6186025064668457,0.0,0.11080894883788389,1.0,8/15,20.72%,TACSTD2;PAX2;SOX9;SIX1;PAX8;AGT;LHX1;BMP4
prerank,positive regulation of lamellipodium organization (GO:1902745),0.443810149181288,1.617877257313646,0.0,0.06609087175534482,1.0,11/30,12.57%,CORO1C;RAC1;ENPP2;ARPC2;OCLN;PIK3R1;MSTN;CORO1B;BRK1;WASF2;AKIRIN1
prerank,regulation of protein import into nucleus (GO:0042306),0.4008754698339541,1.6175118269370832,0.03333333333333333,0.06599026937441278,1.0,11/36,11.48%,FLNA;PSEN1;APOD;BAG3;DMAP1;RAB23;PRKCD;PIK3R1;SUFU;SMAD3;MDFIC
prerank,regulation of interleukin-17 production (GO:0032660),-0.5061725883903616,-1.6156712549740722,0.027777777777777776,0.11381976937884532,1.0,16/32,21.38%,OSM;FOXP3;IL23A;SLC7A5;IL23R;IL21;IL12B;TGFB1;IFNG;CARD9;PHB;CCL1;NOD2;PRKCQ;TNFSF4;IL36RN
prerank,cell-matrix adhesion (GO:0007160),0.3222000331834517,1.615551693998139,0.0,0.06667021545875561,1.0,23/95,8.16%,LYVE1;FBLN5;SORBS1;ITGA7;FERMT2;ACTN1;CD34;SGCE;VCL;ILK;L1CAM;EMILIN1;ITGA10;RAC1;ITGB3;CD63;HOXD3;BCAM;SIGLEC1;CCL21;PKD1;THBS3;DLC1
prerank,regulation of amyloid fibril formation (GO:1905906),0.49342659697021213,1.614608262267046,0.058823529411764705,0.06703420782927487,1.0,5/15,11.17%,CRYAB;PSEN1;CLU;PFDN5;APP
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.39040405829422953,1.613716758735766,0.0,0.06700851506756118,1.0,16/51,11.82%,TSPYL2;TLN1;ADD1;PPP2R5B;PLA2G4B;PARP16;CXXC1;CTDSP2;EXTL2;ACADVL;ZBTB17;WFS1;DCTN1;TPP1;EXTL1;KLHDC3
prerank,cell junction organization (GO:0034330),0.37512495820141245,1.6121383100161653,0.0,0.06790798607848461,1.0,27/71,13.75%,LIMS2;FLNA;FERMT2;PSEN1;FLNC;NLGN2;SNCG;ILK;L1CAM;MAPT;SNCA;MYOT;OCLN;RHOA;NLGN4X;CBLN2;ACTB;SLC8A2;NLGN3;PIN1;APP;SMAD3;RAB8B;SNCB;SEMA3E;CTNND2;FBLIM1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.46808202716842107,1.611972283039167,0.06896551724137931,0.0676210587690806,1.0,10/20,19.43%,DLD;ACAT1;ACADSB;ACAD8;BCKDK;BCKDHA;BCAT2;IVD;DBT;ALDH6A1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.46808202716842107,1.611972283039167,0.06896551724137931,0.0676210587690806,1.0,10/20,19.43%,DLD;ACAT1;ACADSB;ACAD8;BCKDK;BCKDHA;BCAT2;IVD;DBT;ALDH6A1
prerank,chromosome condensation (GO:0030261),-0.5212652891269308,-1.611856105399584,0.0,0.1177903800937679,1.0,15/32,20.69%,INCENP;NCAPG;CDK1;NCAPD3;CDCA5;SMC4;SMC2;NCAPD2;PLK1;NCAPH;SET;TOP2A;TTN;CSNK2A1;NCAPG2
prerank,negative regulation of synaptic transmission (GO:0050805),0.43212451968422816,1.6116219514555024,0.0,0.06759353237140876,1.0,6/24,6.65%,PRRT1;PTEN;TMEM25;SYT11;GRIK3;NLGN4X
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.33902409659163885,1.6113867570657465,0.0,0.06749029662606688,1.0,39/94,17.12%,ATP2B4;PTEN;NCK1;HRC;SNCA;INPP5K;TRIM6;TERF2IP;NGF;RAPGEF3;CAMK1;NOS1;HDAC6;RAMP3;MTCP1;SMAD7;GPD1L;PRKD1;EGFR;APP;TENM1;RAF1;DMD;PDE4D;PPM1F;NTF3;BCAR3;PFN2;RASSF2;TFRC;NTRK3;CNKSR3;SH2D3C;TXN;ARAF;DMTN;CREBL2;GAS6;SFRP2
prerank,error-prone translesion synthesis (GO:0042276),-0.5201847697121845,-1.6109625297036032,0.03896103896103896,0.11756703011815116,1.0,5/21,6.80%,RFC3;POLE2;POLH;RPA3;RFC5
prerank,cell projection organization (GO:0030030),0.48221433366441313,1.6105330473386832,0.0,0.06791725892954463,1.0,10/30,10.02%,GSN;ATP1B2;RHOJ;PARVA;RAC1;PACSIN2;RHOQ;NCKAP1L;P2RY12;RHOU
prerank,negative regulation of reproductive process (GO:2000242),-0.5526257313916958,-1.6103095192332397,0.028169014084507043,0.11699658828445351,1.0,9/20,13.90%,TIMP1;DUSP1;ZP3;CALR;ARHGDIB;WDR77;SEMG1;HYAL3;ASTL
prerank,amino acid transport (GO:0006865),-0.48347284487352105,-1.609746818480764,0.011494252873563218,0.11684147615110155,1.0,24/50,27.84%,SLC6A14;SLC7A11;SLC6A20;SLC7A5;SLC38A5;SLC6A6;SLC16A10;SLC25A47;SLC1A5;SLC7A1;SH3BP4;SLC1A4;SLC7A6;SLC6A18;SLC36A3;SLC38A3;SLC25A48;SLC7A7;SLC38A8;SLC38A9;SLC7A4;SLC3A2;SLC7A10;SLC6A12
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.47736246399722293,1.6078096736547083,0.0,0.0696972946940536,1.0,10/16,20.94%,FAM107A;ZFP36L1;BCL2L11;ZFP36;GPER1;NR3C1;ZFP36L2;AKR1C3;UBE2L3;SSTR2
prerank,negative regulation of angiogenesis (GO:0016525),0.34031012815421036,1.607113260232936,0.0,0.06981256654086507,1.0,30/79,15.28%,ATP2B4;NPR1;YJEFN3;CLDN5;DCN;FOXJ2;EMILIN1;THBS4;FOXO4;PRL;ATF2;SERPINF1;ECSCR;ADAMTS1;HOXA5;STAB1;DAB2IP;COL4A2;HHEX;PTPRM;PDE3B;EPN2;KLF2;MECP2;SEMA3E;ANGPT4;SPINK5;NPPB;SYNJ2BP;RGCC
prerank,fatty acid transmembrane transport (GO:1902001),0.5064270883978987,1.6047782306740523,0.0,0.07060007528603164,1.0,11/19,21.07%,PRKAB2;ACACB;CD36;PRKAA2;CPT1B;SLC27A1;SLC25A20;PRKAG2;ABCD4;MID1IP1;CPT1A
prerank,detection of visible light (GO:0009584),-0.6064001730547424,-1.6042231451556914,0.0,0.12151979307643732,1.0,5/16,7.45%,RP1;CEP250;EYS;REEP6;TULP1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.42784883235261345,1.603757839216185,0.034482758620689655,0.07093468330135465,1.0,8/21,9.37%,MFN2;FOXJ2;MEF2D;FGF2;ADAMTS1;BMPR1A;PDGFB;IGFBP5
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.36666303189646077,1.6032284539211956,0.04,0.07096987679364344,1.0,16/54,17.12%,RBFOX3;CELF6;RBM24;NOVA1;DDX17;MBNL1;RBM4;CELF2;CELF4;RBFOX2;RBM5;ZC3H10;CELF1;NOVA2;MBNL2;NSRP1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.4440728203749531,-1.602189789500958,0.0,0.1236121484684052,1.0,16/58,17.58%,CCND1;CDK1;CDCA5;DLGAP5;CDC25C;UBE2C;FBXO5;RCC2;RAD51B;CDK4;TFDP1;CDC7;ESPL1;CDC25A;ANKRD17;STOX1
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.44961822729048523,-1.6012192743431375,0.0,0.12369035256072707,1.0,29/60,30.74%,POLR2F;TRIM71;NUP155;NUP37;AJUBA;NUP210;NUP107;RANBP2;NUP35;TGFB1;NUP50;SEH1L;POLR2J;NUP205;NUP88;POLR2D;NUP93;POM121;RAE1;PPARG;POLR2I;FMR1;NUP43;NUP160;NUP153;NDC1;NUP62;NUP98;DHX9
prerank,cardiac atrium morphogenesis (GO:0003209),-0.5607087781273181,-1.6005084704931705,0.014285714285714285,0.12371117509034389,1.0,5/19,8.66%,TBX20;TGFB2;ENG;PROX1;ZFPM1
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.579121709857096,-1.6001059822952097,0.015151515151515152,0.12339755819154659,1.0,11/18,26.62%,CEBPB;ZP3;SLC7A5;SYK;PRKCZ;NLRP3;CD86;PRKCQ;TNFSF4;GATA3;CD28
prerank,positive regulation of axonogenesis (GO:0050772),0.41219816723435576,1.5996410074731593,0.038461538461538464,0.07196633499945501,1.0,10/43,6.27%,PLXNB3;NTN1;MAP6;L1CAM;MAPT;CHODL;DBN1;NGF;NGFR;RHOA
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.5260579597886523,-1.5994362348161075,0.04477611940298507,0.12297838743047067,1.0,3/18,1.18%,SULT2B1;SULT1C3;SULT1C2
prerank,cellular defense response (GO:0006968),-0.45363082260706333,-1.5992471472270322,0.0,0.1222368777522167,1.0,28/48,34.49%,CXCL9;CLEC5A;PRF1;CXCR2;DCDC2;RELA;IL1RL2;CCR3;ITK;ADORA2B;NCR1;NCF2;GNLY;HLA-G;MNDA;KLRC2;TYROBP;LBP;KIR3DL2;TRAT1;LILRB2;CCR6;FOSL1;CX3CR1;CCR9;NCF1;CD5L;KLRC3
prerank,sensory perception of sound (GO:0007605),-0.4103412344223837,-1.5973586933460338,0.0,0.12302977938911189,1.0,42/87,30.62%,CEMIP;COL1A1;COL11A1;CACNA1D;KCNQ1;LHFPL5;MYO3B;CEACAM16;EYA1;LRP2;ATP6V0A4;DCDC2;GRAP;MARVELD2;TMC1;CHRNB2;GRM7;ADGRV1;COL2A1;TSPEAR;SLC52A3;MYH14;SLC26A5;USH1C;USH2A;LOXHD1;BIRC5;CLRN1;PAX3;PDZD7;MYO3A;HPN;EML2;TIMM10;ALDH7A1;TIMM13;TMC2;TPRN;NIPBL;GRXCR2;TFAP2A;USH1G
prerank,platelet degranulation (GO:0002576),0.3067737330007879,1.596773657475976,0.0,0.07295549314515073,1.0,40/109,17.41%,FLNA;TLN1;CLU;ACTN1;CFD;F8;VCL;MMRN1;VEGFB;CYB5R1;TIMP3;CALM1;ITGB3;CD63;RARRES2;ALDOA;CLEC3B;CD36;VTI1B;PDGFB;F13A1;SOD1;CDC37L1;ISLR;ENDOD1;PCDH7;APP;SCG3;TMX3;WDR1;SELP;MAGED2;VEGFC;STXBP1;PDGFA;A1BG;TGFB3;GAS6;PROS1;CD109
prerank,double-strand break repair (GO:0006302),-0.38423625975652764,-1.5966376060727896,0.0,0.12294693950500982,1.0,60/150,28.87%,RAD54B;BLM;EME1;RAD51AP1;XRCC2;ERCC5;CDCA5;RFWD3;TDP1;DCLRE1C;CHEK2;MMS22L;RMI1;RAD51B;PRKDC;RAD51AP2;RPA3;FEN1;RECQL4;POLB;PSMD14;DNA2;EYA1;POLA1;PALB2;BRCC3;PARP2;BRCA2;TONSL;DCLRE1B;TRIP13;XRCC4;RBBP8;RPA4;WRN;SLX1A;PAXIP1;LIG3;ACTR8;BRCA1;HUS1;RIF1;BARD1;APTX;NABP1;MEIOB;DTX3L;KPNA2;HMGB1;BRIP1;SAMHD1;GEN1;SMC6;SFR1;SMARCAD1;NSMCE2;MCM8;SETX;PRPF19;XRCC5
prerank,muscle cell differentiation (GO:0042692),0.43072237053427065,1.5960057593579857,0.0,0.07305634955571415,1.0,13/31,13.93%,BVES;SPEG;MYOCD;POPDC2;SEMA4C;TMEM204;WNT5B;MEGF10;POPDC3;MEF2C;HEY2;DMD;NINJ1
prerank,blood circulation (GO:0008015),0.38511202287741914,1.5958550661929056,0.0,0.07279069010278427,1.0,17/49,13.93%,PLN;HOXB2;NPR1;SCPEP1;AGTR1;CYB5R3;MEOX2;SGCD;ACTC1;SOD1;MYL2;SGCG;AVPR1A;MYOF;ELN;ITGB1BP1;NPPB
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.41763852237225035,1.5947403853044713,0.0,0.07289141278226523,1.0,8/32,11.01%,LIMS2;FLNA;FERMT2;ILK;MYOC;RAC1;TESK1;MYADM
prerank,positive regulation of filopodium assembly (GO:0051491),0.4515572837734654,1.5940248108826927,0.0,0.07320929302284637,1.0,8/24,11.60%,PALM;DPYSL3;GPM6A;PIK3R1;CCL21;RHOQ;NLGN1;TENM1
prerank,protein localization to membrane (GO:0072657),0.3045825386110766,1.5932705225276227,0.0,0.07316305128457612,1.0,80/192,21.66%,RAP1A;PTN;FLNA;EHD2;FERMT2;RAB34;NLGN2;RAMP1;DPP6;KCNIP3;P2RY1;RAB3A;TMEM88;KCNB1;INPP5K;SLMAP;EPB41L3;WDR19;SCN3B;ARL3;ANK2;DLG4;TMEM150A;RAMP3;ZDHHC15;RAMP2;ZDHHC22;PLEKHF1;RDX;FLOT1;NLGN1;SAV1;TNFRSF1A;RAB3C;MYADM;PACSIN1;CAPN3;KCNIP4;RAB11B;RAB8B;CACNB2;DLG2;CPE;FLOT2;PACS1;ITGB1BP1;NRXN1;FAM126A;CYP46A1;TM9SF1;MAGI2;SLC9A3R2;SYNJ2BP;SH3GLB1;ANK3;RABEP1;STXBP1;RAB13;LIN7A;LRRC7;NRXN2;GAS6;TTC7B;ITGA4;ACTN2;SHANK3;LIN7B;EHD1;DVL1;SYNE3;CDH1;CACNB3;PDZD3;RAB29;FCHO2;BSG;RAB12;MYO5A;FGF13;SPTBN4
prerank,positive regulation of protein modification process (GO:0031401),0.285178285938838,1.5927526485655608,0.0,0.07297292576000022,1.0,62/208,17.17%,CLIP3;RAMP1;FAXDC2;VEGFB;P2RY1;MAPK3;ILK;NPTN;FLCN;FAS;FGF2;CALM1;DVL3;TERF2IP;RAC1;ITGB3;RAPGEF3;TRABD2B;ARNTL;RARRES2;RSPO1;CAMK1;PRKCD;DVL2;EFNA5;AKTIP;GPER1;FGF7;SMPD1;DLC1;FGF1;TESK1;PIK3R3;CDH5;CALM2;NNMT;EGFR;FLOT1;FLT4;ANGPT1;ATG14;GPNMB;SLC51B;PIN1;APP;MT3;NKX3-1;NTRK1;FGF5;RALBP1;FGF10;RIPK1;TFRC;VEGFC;NTRK3;TXN;CAMKK2;LEPR;GOLGA2;FGF17;GAS6;FGF16
prerank,regulation of filopodium assembly (GO:0051489),0.38323320842658043,1.5926201415152932,0.0,0.07292785848865635,1.0,11/38,11.60%,PALM;DPYSL3;GPM6A;GAP43;CAPZB;PRKCD;PIK3R1;CCL21;RHOQ;NLGN1;TENM1
prerank,regulation of cytokinesis (GO:0032465),-0.4152853889072929,-1.5925090794322214,0.0,0.127096560421625,1.0,27/83,16.43%,KIF14;KIF20B;KIF23;SSTR5;KIF20A;RACGAP1;AURKB;TAS2R13;CXCR5;AURKA;CHMP4C;BCL2L1;OR2A4;DRD2;ECT2;CDC14C;PLK1;RAB11FIP4;E2F8;CSPP1;PDXP;SPAST;BIRC6;PRPF40A;RXFP3;CDC6;PLK4
prerank,negative regulation of cellular protein localization (GO:1903828),0.40588155591756536,1.5921561674323679,0.0,0.07295470639336442,1.0,16/33,23.04%,GPM6B;MAPT;FLCN;MAP1A;LATS2;TAX1BP3;LEPROT;SNX33;ANKRD13A;GOPC;SIN3A;ACTN2;NSFL1C;CTNNA1;TTBK2;OTUD7B
prerank,positive regulation of macrophage migration (GO:1905523),0.4627618469096207,1.590091856027157,0.041666666666666664,0.07455085558390404,1.0,7/18,12.57%,MAPK1;MAPK3;RARRES2;MSTN;P2RY12;CX3CL1;AKIRIN1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.32273460802038667,1.5896425191955892,0.0,0.07457177877870162,1.0,47/140,16.28%,PTEN;WWTR1;NCK1;PRNP;CADM4;DBNDD2;SNCA;HSPB1;EMILIN1;CALM1;CORO1C;FBLN1;INPP5K;SIRT2;TERF2IP;TARDBP;PRKCD;OCLN;PRKRIP1;PID1;DAB2IP;TRIB2;FKBP8;SMAD7;TESK1;GPD1L;CEACAM1;CALM2;DUSP19;SFRP1;TAB1;ATG14;DEPTOR;MYADM;PARD3;DMD;PDE4D;GNAQ;ITGB1BP1;PPM1F;PRKAG2;NTF3;RASSF2;NTRK3;CNKSR3;DMTN;ERRFI1
prerank,regulation of ion transport (GO:0043269),0.32720736872379175,1.5880269233480095,0.0,0.07530093596254658,1.0,24/77,15.57%,PER1;VAMP2;KCNA5;SYT11;CHRNA3;KCNJ8;SNCA;ITGB3;NOS1;KCNA2;P2RX7;B2M;SYT10;SYT4;SYT5;SYT1;RAB11B;CA2;GDNF;PXK;VAMP3;SYT6;NKAIN4;ANK3
prerank,regulation of receptor recycling (GO:0001919),0.4693132774513746,1.5873123483836116,0.03333333333333333,0.07531908046692931,1.0,10/17,20.45%,BVES;OPTN;SNCA;ECE1;RAMP3;VAMP3;ANXA2;INPP5F;LAMTOR1;RAB29
prerank,positive regulation of actin filament polymerization (GO:0030838),0.44973774039131803,1.5869781902187798,0.0,0.07512606980070893,1.0,23/44,23.86%,LMOD1;GSN;NCK1;CDC42EP3;CCL21;NCKAP1L;CDC42EP4;BAIAP2;WHAMM;TENM1;EVL;CCL11;PFN2;SNX9;FCHSD1;CDC42EP2;FER;PRKCE;PFN1;VASP;NCK2;ALOX15;NCKAP1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.5055295283287115,-1.5867536435791552,0.0,0.1331499948446486,1.0,17/28,34.09%,DCAF13;RPP40;HEATR1;NOL10;UTP20;RPS19;RRS1;NOP14;PWP2;RPS21;DHX37;NOP9;UTP6;BMS1;TSR1;HELB;MRPS11
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.4842684761839605,-1.5866487822716608,0.02702702702702703,0.13230712918010593,1.0,8/24,17.35%,RFC3;RPA3;POLB;LIG1;RFC5;RFC2;LIG3;POLD2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3083219273813487,1.5860595770831256,0.0,0.07521479481756893,1.0,35/103,16.58%,PTEN;PIP5K1C;FGFR1;PPP2R5B;DCN;MAPK1;KIT;MAPK3;MYOC;FGF2;ROR2;PIK3R1;PDGFRA;GPER1;PIP4K2B;DAB2IP;PDGFB;F2RL1;PIK3IP1;GH1;CEACAM1;EGFR;PDGFD;ROR1;NKX3-1;SELP;JAK2;NTRK1;NTF3;PIP4K2A;INS;NTRK3;PDGFA;WNT16;PLXNB1
prerank,sensory perception of light stimulus (GO:0050953),-0.42356147207289485,-1.5850525641528483,0.011627906976744186,0.13351889732388572,1.0,34/93,25.07%,COL1A1;ZIC2;GRM8;COL11A1;GPR143;PAX6;PAX2;POU6F2;TH;FSCN2;BEST1;TULP1;CRYBA1;SIX3;SLC24A1;CHRNB2;ADGRV1;TRPM1;ARR3;COL2A1;CRYBB3;USH1C;USH2A;RP2;CLRN1;TYR;RPE65;RDH12;RBP3;POU4F3;RPGR;EML2;RAX;CRYBA4
prerank,amino acid import (GO:0043090),-0.526175540237033,-1.5845454231186453,0.02857142857142857,0.1330495934291525,1.0,8/22,14.34%,SLC6A14;SLC6A20;TSPO2;SLC7A5;SLC6A6;SLC7A1;SH3BP4;SFXN2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.3357565692553052,1.5844441121290336,0.0,0.07642057201780657,1.0,29/68,23.84%,DNAJC18;FBXO17;FBXO44;WFS1;USP19;DNAJB2;HSP90B1;RNF185;TMUB2;FAM8A1;UBE2G2;FBXO27;ANKZF1;TMEM129;UBE4B;DNAJB12;RNF175;SGTA;BAG6;DERL3;SEL1L;MAN1A1;SYVN1;HERPUD1;RNF5;UBQLN2;SGTB;DNAJB14;DERL2
prerank,fatty acid oxidation (GO:0019395),0.3608146407892875,1.5834103913102573,0.0,0.07671304145519563,1.0,28/58,25.72%,PPARD;ACAD11;ADH5;ECI2;ACADVL;CROT;ACAT1;BDH2;ACADS;HADHB;ECHDC2;ACAA2;PHYH;ABCD4;ACADM;SLC27A2;ALDH3A2;CYP4V2;HADH;HADHA;ALOX15;ECHDC1;ACAA1;ADIPOQ;SCP2;ACAD10;ECI1;ACADL
prerank,neural crest cell development (GO:0014032),0.3649955433692859,1.5831699915841717,0.045454545454545456,0.07651788624303253,1.0,16/44,14.61%,ANXA6;RADIL;SEMA4C;CORO1C;SEMA3G;SEMA3B;SEMA6C;SEMA3A;SEMA3C;SEMA3E;SEMA4B;PEF1;TAPT1;GDNF;SEMA6D;CDH2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.46633172015635793,1.583148441826211,0.034482758620689655,0.07625493818034171,1.0,8/26,14.87%,TLR3;CD36;TLR9;FLOT1;GPS2;FLOT2;NFKBIL1;GPR108
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.34505963572765463,1.582880163394809,0.0,0.0760626884945457,1.0,21/72,12.98%,BVES;FERMT2;ACTN1;LAMB2;ATF4;LAMA5;ILK;PARVA;RADIL;RAC1;LAMC1;ITGB3;PIK3R1;RHOA;PXN;LAMB1;NTN4;NTNG1;TMEFF2;MEF2C;METTL3
prerank,axonemal dynein complex assembly (GO:0070286),-0.5369139544105993,-1.5826757062313752,0.02702702702702703,0.134238082157222,1.0,11/22,20.55%,DNAH8;CCDC103;DNAH7;SPAG1;DNAAF3;DNAAF2;DNAAF1;DNAH5;DNAI1;DNAAF5;DNAI2
prerank,skeletal muscle tissue development (GO:0007519),0.376039591651821,1.5826503098776428,0.0,0.07594041331147833,1.0,12/35,13.65%,BVES;CAV2;POPDC2;MYL6;MYOZ2;TCF21;KLHL41;MYOZ1;CFLAR;POPDC3;MEF2C;SKI
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.4363804769439054,1.5826283088283923,0.0,0.07568211258592909,1.0,8/28,10.90%,CAMK2G;NCS1;PSEN1;PTEN;EFHC2;MARK1;BRSK1;NTNG1
prerank,regulation of mitochondrion organization (GO:0010821),0.3801758987662714,1.5822523021125157,0.0,0.07563015318659955,1.0,16/43,17.88%,PDE2A;MAPT;FLCN;HDAC6;PID1;MUL1;RHOT2;CSNK2A2;MGARP;GOLPH3;MIEF2;SREBF1;MFF;SQSTM1;PISD;PARL
prerank,negative regulation of protein kinase activity (GO:0006469),0.3296200454581387,1.5821465143944766,0.0,0.0753746459123205,1.0,25/83,14.08%,WWTR1;ADARB1;DUSP26;DBNDD2;SNCA;HSPB1;CDKN1A;CDKN1C;CORO1C;INPP5K;DUSP3;PRKRIP1;DAB2IP;TRIB2;TESK1;CEACAM1;DUSP19;TAB1;SH3BP5L;DEPTOR;SLC8A1;GNAQ;ITGB1BP1;PPM1F;PRKAG2
prerank,inositol phosphate-mediated signaling (GO:0048016),0.47650513433674213,1.5812610450777496,0.0,0.0754595465982707,1.0,9/20,21.24%,NFATC4;INPP5A;PPP3CB;NFATC1;PPP3CC;NFATC3;NMUR1;HRH1;EDN3
prerank,adherens junction organization (GO:0034332),0.39271123574963024,1.5803635791847692,0.0,0.07547636731341616,1.0,13/43,9.16%,JAM3;FERMT2;CDH19;PIP5K1C;CADM3;VCL;CADM2;CDHR3;RAMP2;DCHS1;SMAD7;ACTB;CDH5
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.5395493306161361,-1.5803448577140564,0.013157894736842105,0.1363310686320556,1.0,13/22,26.13%,WDR12;RPP40;UTP20;EXOSC3;EXOSC8;RRS1;NOP14;RPS21;URB1;ERI2;PES1;NOP9;EXOSC7
prerank,rRNA metabolic process (GO:0016072),-0.38864135699960367,-1.57745673882893,0.0,0.1395631031618212,1.0,59/154,28.85%,DDX47;WDR43;DKC1;DCAF13;WDR3;WDR12;WDR74;UTP14A;NOB1;BOP1;UTP18;HEATR1;NIFK;RPL39;LYAR;EMG1;UTP20;RRP12;MRTO4;RCL1;BYSL;RRP9;EXOSC3;DDX10;PDCD11;DDX27;PIH1D2;EXOSC8;NOP58;DIS3;RRP1;RPS19;EXOSC4;NOP14;PWP2;FBL;NOLC1;WDR36;EXOSC5;ESF1;RRP1B;DHX37;UTP15;RPL36;IMP4;DDX52;EBNA1BP2;PES1;MDN1;XRN2;RPL23A;RPL37;EXOSC7;RRP7A;XRN1;SLFN14;UTP6;RPL8;NOP56
prerank,lytic vacuole organization (GO:0080171),0.3933315578811914,1.5754314352799843,0.0,0.07798259761351882,1.0,13/31,20.10%,TPCN2;MTOR;AKTIP;SNAPIN;TFEB;TPP1;HPS1;CLVS2;VPS18;ZKSCAN3;GAA;ACP2;LAMTOR1
prerank,maturation of SSU-rRNA (GO:0030490),-0.4890180242407094,-1.5750591075986893,0.013157894736842105,0.14173909587770664,1.0,19/32,34.09%,DCAF13;WDR3;NOB1;SRFBP1;HEATR1;NOL10;NAT10;RPS19;NOP14;PWP2;DHX37;DDX52;UTP6;BMS1;NOL11;RIOK1;TSR1;HELB;MRPS11
prerank,cardiac muscle cell action potential (GO:0086001),0.4529963301908679,1.5748118930652446,0.0,0.07799089602051251,1.0,14/30,13.25%,KCNH2;ATP1A2;CACNA1C;SCN3B;ANK2;CACNA2D1;SCN2B;SCN1B;FGF12;KCNE2;SCN4B;KCND3;SLC8A1;DMD
prerank,membrane assembly (GO:0071709),0.3831916524707249,1.573403450193126,0.08333333333333333,0.07846700044970335,1.0,17/35,20.48%,PTEN;NLGN2;STX2;NLGN4X;FLOT1;NLGN1;NLGN3;CHMP7;FLOT2;NRXN1;VPS4A;ANXA2;ANK3;NRXN2;UGCG;NSFL1C;STX4
prerank,regulation of protein localization to membrane (GO:1905475),0.4043172001703896,1.5732785312106294,0.0,0.078207175944903,1.0,14/29,18.90%,GSN;GPC1;ZDHHC7;VTI1B;ACTB;NECAB2;GPC4;GPC3;VPS4A;INS;STX7;STX8;AR;GPC6
prerank,negative regulation of TOR signaling (GO:0032007),0.38883442706232024,1.5719491217775523,0.037037037037037035,0.07874582011384677,1.0,13/33,22.30%,EPM2A;FLCN;ARNTL;PRKAA2;TNFAIP8L1;KPTN;DEPTOR;TSC1;RNF152;SESN1;NPRL2;TSC2;SIRT1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.46981683610097397,1.5707548727771945,0.0,0.07928092057115274,1.0,13/26,21.17%,MAPK1;MAPK3;MAPK8;SKP1;UBB;MAPK11;NFKB1;BTRC;TAOK2;TNIP2;CUL1;FBXW11;KAT7
prerank,negative regulation of cell growth (GO:0030308),0.30987985121360456,1.56913575380967,0.0,0.079680590665277,1.0,35/122,15.23%,FHL1;APBB1;TSPYL2;RERG;NPR1;DACT3;ULK1;CGRRF1;CDKN1A;WFDC1;FLCN;ULK2;PTPRS;SEMA3G;SLIT3;PRDM11;JADE1;MAP2;CDKN2C;DNAJB2;MUL1;RTN4;MYL2;SIPA1;SMAD4;SFRP1;SERTAD3;BTG1;SMAD3;MT3;NPPB;SOX17;TCHP;FRZB;OSGIN1
prerank,chemical synaptic transmission (GO:0007268),0.2595217280238761,1.5675938717399032,0.0,0.08001190334072102,1.0,87/303,17.13%,KCNMB1;PLP1;PMP22;VAMP2;MPZ;PDLIM4;NPTX1;PTEN;NLGN2;MAPK1;CHRNA3;RIC3;SNCG;NTSR1;GRIK5;RAB3A;SNCA;NOVA1;PENK;KIF5A;PTCHD1;CALM1;SNPH;SLC5A7;SYN2;DTNA;RPS6KA2;GLRB;SLC12A4;GRIK3;PRKAR2B;CAMK1;SNAP25;CHRNB4;AMPH;HTR3A;DLG4;NLGN4X;PRKACA;SCN2B;CHRM2;NPFF;CBLN2;HAP1;SNAPIN;CORT;PAFAH1B1;SYT10;NPY;SST;SYN1;SLC17A7;NAPB;NLGN1;NLGN3;BRSK1;PCDHB4;SYT5;SYT1;CNP;PDE7B;GRIK2;CACNB2;DLG2;SNCB;GRIA4;CAMKK1;KCNMB4;GABARAP;NPTX2;NRXN1;GRIA1;SYNJ2BP;HSPA8;SLC18A3;FCHSD1;STXBP1;LIN7A;CAMKK2;KCNA1;NRXN2;NSG1;GRIA2;KCNK3;CHRM3;RIT2;GRID1
prerank,T cell migration (GO:0072678),-0.5882971756000913,-1.5667149438848427,0.043478260869565216,0.15175226786263663,1.0,12/18,21.29%,SLC12A2;CXCL11;CCL20;PIK3CG;CCL3;ZAP70;CXCL10;CXCL16;MSN;CCL26;PIK3CD;DEFA1
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.500120989956382,-1.566557578255987,0.013157894736842105,0.15092481515274173,1.0,17/28,32.06%,GRIN2B;EFNA3;USP50;SEMG1;PRELID1;FYN;TTBK1;CR1;MEFV;LYN;ROCK2;PSME2;EFNA1;SEMG2;AIM2;PSME3;AGER
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.4622929566824338,1.5665252740535927,0.0,0.0801444645010686,1.0,6/16,11.00%,DPYSL3;CRMP1;NT5E;NT5M;DPYSL2;DPYSL4
prerank,regulation of neuron projection arborization (GO:0150011),0.42926786894320845,1.56564746706904,0.03125,0.08034148315364739,1.0,5/15,10.90%,FZD4;DVL3;DVL2;DLG4;NTNG1
prerank,regulation of autophagy (GO:0010506),0.28083206256202026,1.5649220601938347,0.0,0.08047211971162081,1.0,65/224,17.10%,ATP6V1G2;UCHL1;DCN;OPTN;PRKAB2;WDR6;ULK1;MAPT;HSPB1;FLCN;MAPK8;CASP3;TRIM6;SIRT2;DAPK1;TPCN2;MTOR;DAPK3;HDAC6;ATP6V1E1;PRKACA;RRAGA;PIP4K2B;MTMR9;PRKAA2;BNIP3;PLEKHF1;EEF1A2;PRKD1;TFEB;RRAGD;TRIM21;NUPR1;KLHL22;CSNK2A2;TRIM34;BOK;RRAGB;ITPR1;MT3;VPS26B;OSBPL7;RASIP1;BCL2;KAT8;BAD;ATP6V0E2;PRKAG2;LAMTOR3;PIP4K2A;RRAGC;TPCN1;EXOC7;RHEB;TP53INP1;SH3GLB1;DDIT3;SREBF1;SOGA1;TRIM68;ATP6V1H;LEPR;GOLGA2;ATG13;TRIM8
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.4147811990274022,1.5623876904120708,0.0,0.08079556070724629,1.0,4/23,3.39%,TGFB1I1;CITED2;CDKN1C;FLCN
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.4147811990274022,1.5623876904120708,0.0,0.08079556070724629,1.0,4/23,3.39%,TGFB1I1;CITED2;CDKN1C;FLCN
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.5556778537406022,-1.5623584222890539,0.0,0.15579122109123547,1.0,10/16,23.36%,FOXP3;TGFB2;JAK3;HLA-F;TGFB1;IL10;LILRB4;IRAK3;XCL1;TNF
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.4523792670426344,1.5618251677155022,0.06060606060606061,0.0810524474980027,1.0,6/18,13.87%,NLGN2;TSHZ3;CCL2;NLGN1;NLGN3;NRXN1
prerank,response to interferon-gamma (GO:0034341),-0.41682314298347733,-1.561144552479147,0.011904761904761904,0.15612465540144518,1.0,31/74,22.30%,IFITM3;IFITM1;TDGF1;IFITM2;UBD;CCL24;CCL20;CYP27B1;GBP5;WNT5A;KYNU;CCL22;IL23R;BST2;CCL4;GBP7;CCL3;STAT1;IRF8;CITED1;CXCL16;CCL17;GBP1;CCL26;CCL1;MEFV;GCH1;XCL2;GAPDH;IL12RB1;XCL1
prerank,O-glycan processing (GO:0016266),-0.4178578289794304,-1.5559721190068572,0.0,0.1637620911311212,1.0,30/57,34.01%,GALNT6;B3GNT4;MUC5AC;CHST4;MUC12;C1GALT1;GALNT5;GCNT1;GALNT3;MUC17;MUC19;MUC4;ST6GAL1;MUC5B;POFUT1;B3GNT5;MUC20;B3GNT2;B3GNT3;MUC3A;GALNT7;C1GALT1C1;MUCL1;GXYLT1;MUC15;GALNT14;MUC2;GXYLT2;MUC13;ST3GAL2
prerank,negative regulation of chemokine production (GO:0032682),0.4476076226288804,1.555949280343265,0.038461538461538464,0.08452143563960174,1.0,9/17,17.60%,APOD;OAS1;C1QTNF3;F2RL1;MUL1;ELANE;LGALS9;MAP2K5;KLF4
prerank,placenta development (GO:0001890),-0.5621650046664075,-1.5534782397197129,0.0,0.1666005287549495,1.0,10/15,27.49%,ASCL2;PLAC1;PHLDA2;E2F8;CITED1;TEX19;PPARG;NODAL;E2F7;ANG
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.41475727897633496,-1.5523298000972305,0.03296703296703297,0.16723752941196451,1.0,27/56,30.40%,IL1B;CD276;IL23A;ZP3;SLC7A5;IL12RB2;IL23R;ISG15;IL21;RASGRP1;HSPD1;ZFPM1;IL12B;TNFSF4;IL27;CRTAM;IL12RB1;CD2;CLEC7A;PDE4B;TLR7;PTPN22;SLAMF6;CD244;TLR8;IFNL1;TXK
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.5536144184473137,-1.5520436802819382,0.029411764705882353,0.16633850836676375,1.0,11/17,29.96%,ETV4;SULT2B1;CYP27B1;ZBED2;MED1;IL20;SFRP4;BMP4;SFN;FOXC1;KDF1
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.4862372558527739,-1.5509538198629218,0.012195121951219513,0.16706348600608376,1.0,24/41,32.58%,NUP155;NUP37;NUP210;NUP107;RANBP2;NUP35;NUP50;SEH1L;NUP205;NUP88;NUP93;GCKR;POM121;RAE1;EIF6;NUP43;NUP160;NUP153;JMJD8;NDC1;NUP62;NUP98;HIF1A;SEC13
prerank,negative regulation of JNK cascade (GO:0046329),0.3780242757663906,1.5507946792267517,0.0,0.08687913561222756,1.0,8/30,10.57%,PER1;ZMYND11;DUSP3;F2RL1;DUSP19;MAPK8IP1;NPPA;GPS2
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.45553329625001915,1.5506585728838973,0.0,0.08673106235585798,1.0,12/20,20.72%,OR51E2;ATP1A2;GPER1;TFPI;ATP1A3;MGARP;NKX3-1;NR3C1;AR;TRERF1;AKR1C3;UBE2L3
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3481304170780153,1.5487003849277896,0.047619047619047616,0.08779355465373821,1.0,21/51,13.39%,JPH2;CASQ2;GSTM2;HRC;SNCA;CALM1;CASQ1;CLIC2;AKAP6;NOS1;ANK2;GPER1;PRKACA;TRPC1;CALM2;JPH4;CAPN3;CAMK2D;CX3CL1;DMD;PDE4D
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3818625326771985,1.5486207350150973,0.0,0.087516603377228,1.0,23/52,17.94%,GPM6A;WASF1;GAS7;CNTNAP1;SNX1;DBN1;NGF;EPB41L3;UBB;DAB2IP;DCLK1;NCKAP1L;NBL1;NYAP1;PACSIN1;NTF3;SGK1;TAOK2;NRK;PLXNB1;SRGAP2;SNX2;ZNF335
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.37277368507457165,1.5476382562299311,0.043478260869565216,0.08800056487332118,1.0,6/31,5.64%,KANK2;PER1;CRY2;VPS11;ARNTL;TCF21
prerank,negative regulation of protein metabolic process (GO:0051248),0.3505165938549691,1.5471236097067356,0.0,0.08791389880720957,1.0,18/51,15.26%,CRYAB;FLNA;CLU;PRNP;PTX3;SIRT2;ITGB3;EGFR;SNX3;PFDN5;PIN1;FMN2;FLOT2;NFKB1;AZIN2;INS;EDNRB;RILP
prerank,regulation of protein localization to cell surface (GO:2000008),0.38614393079208553,1.5455920172954694,0.0,0.0885822005263076,1.0,14/32,21.31%,GPM6B;RIC3;MAP1A;TAX1BP3;GPD1L;LEPROT;SNX33;RAB11B;GBF1;GOPC;ACTN2;RAB11FIP5;STX4;HFE
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.47057573335119285,1.5455739405281057,0.043478260869565216,0.08830624351532221,1.0,10/20,16.48%,SEMA4C;SEMA3G;SEMA3B;SEMA6C;SEMA3A;SEMA3C;SEMA3E;SEMA4B;SEMA6D;SEMA6A
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.47654177835686734,1.545398787582321,0.02857142857142857,0.08809447887685197,1.0,8/17,12.78%,FGF2;AKAP6;TGFBR3;BMPR1A;RBPJ;FGFR2;PIM1;MEF2C
prerank,primary neural tube formation (GO:0014020),-0.4920730656759176,-1.5449583960360573,0.027777777777777776,0.17517173295962774,1.0,8/30,7.82%,GRHL3;CELSR1;MTHFD1L;TGFB2;PAX2;MTHFD1;LRP2;GRHL2
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.5384458134023739,-1.544279927782314,0.02564102564102564,0.1753604035895717,1.0,12/22,25.85%,MAD2L1;FBXO5;ZWINT;KNTC1;BUB1;PLK1;TRIP13;CENPF;CDC20;BUB1B;TTK;ZW10
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.40945224051472184,1.5430594482280933,0.0,0.0892542937668364,1.0,23/39,30.07%,NDUFA11;NDUFC2;NDUFA5;NDUFS2;NDUFB8;NDUFB10;NDUFS4;NDUFV2;NDUFAF1;NDUFA8;NDUFS8;NDUFV1;NDUFA13;NDUFC1;NDUFS5;NDUFA6;NDUFA10;NDUFB6;NDUFV3;NDUFA9;NDUFB4;NDUFB5;NDUFA7
prerank,negative regulation of endothelial cell migration (GO:0010596),0.3844615874408081,1.5427357557468866,0.0,0.08928928097632,1.0,13/36,15.28%,ATP2B4;DCN;FGF2;NR2F2;DAB2IP;PTPRM;CSNK2B;MECP2;ANGPT4;MEF2C;SVBP;SYNJ2BP;RGCC
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.49833736323593575,-1.5422166712818233,0.04285714285714286,0.17721933247293134,1.0,11/36,8.97%,TNFSF11;TESC;POU4F1;LEF1;IL23A;DCSTAMP;IL23R;PF4;IL17A;RUNX1;IL12B
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.5500808885889751,-1.5414505942463392,0.015384615384615385,0.17776132781639328,1.0,6/19,12.24%,RGPD4;RGPD3;RGPD8;KPNA7;RANBP2;NUP35
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.4990255970502372,-1.5402975532744816,0.012658227848101266,0.17884653528505107,1.0,8/24,10.22%,MAD2L1;NDC80;CENPA;SAPCD2;SPDL1;PKHD1;GPSM2;PLK1
prerank,inositol phosphate metabolic process (GO:0043647),0.3658714112488797,1.5401865763657372,0.0,0.0901906757075627,1.0,21/47,20.69%,INPP5A;PTEN;PLCD4;ITPKB;NUDT10;INPPL1;FGF2;CALM1;NUDT11;IP6K1;PLCD1;INPP5B;IP6K3;ISYNA1;INPP5J;INPP1;OCRL;INPP4A;ITPK1;PLCD3;IP6K2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.4342913345399668,1.5401548609322095,0.03225806451612903,0.08991401719312231,1.0,7/18,13.87%,PTEN;NLGN2;STX1B;DLG4;NLGN1;NLGN3;NRXN1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.4876499070015729,-1.539785299669021,0.024691358024691357,0.1785508399644749,1.0,24/41,32.58%,NUP155;NUP37;NUP210;NUP107;RANBP2;NUP35;NUP50;SEH1L;NUP205;NUP88;NUP93;GCKR;POM121;RAE1;EIF6;NUP43;NUP160;NUP153;JMJD8;NDC1;NUP62;NUP98;HIF1A;SEC13
prerank,positive regulation of innate immune response (GO:0045089),-0.4688756921974792,-1.5381347746707283,0.05063291139240506,0.18043174576653545,1.0,21/35,31.48%,EREG;GBP5;WNT5A;IFNK;NLRC5;POLR3B;FPR2;RPS19;ZBP1;POLR3C;ADAM8;SPI1;POLR3G;NMI;LBP;IFNB1;CCL5;TLR8;PLSCR1;DHX9;IFI35
prerank,lymphocyte chemotaxis (GO:0048247),-0.4500867465075745,-1.5376089110691382,0.0375,0.18012967980595715,1.0,19/40,22.30%,SLC12A2;CCL24;CXCL11;CCL20;CCL22;CCL4;CYP7B1;PIK3CG;CCL3;CXCL10;CXCL16;CCL17;ADAM8;CCL26;CCL1;PIK3CD;XCL2;DEFA1;XCL1
prerank,regulation of cellular catabolic process (GO:0031329),0.33122405306650765,1.5360663406833783,0.0,0.09209997187178622,1.0,20/61,15.79%,MAPT;HSPB1;DAPK1;TPCN2;DAPK3;WDR91;HDAC6;RRAGA;PIP4K2B;RRAGD;NUPR1;BOK;RRAGB;ITPR1;OSBPL7;KAT8;PIP4K2A;RRAGC;DDIT3;SOGA1
prerank,negative regulation of growth (GO:0045926),0.30464798294476864,1.5357082287776305,0.0,0.09200318564590794,1.0,40/122,18.08%,FHL1;APBB1;TSPYL2;RERG;NPR1;DACT3;ING4;CGRRF1;CDKN1A;WFDC1;FLCN;SLIT3;PRDM11;MT1X;JADE1;CDKN2C;DNAJB2;MUL1;RTN4;MYL2;MT1M;SIPA1;SMAD4;SFRP1;SERTAD3;BTG1;SMAD3;MT3;NPPB;SOX17;TCHP;FRZB;MT1A;OSGIN1;CDKN2D;NDRG3;SFRP2;MT1E;SERTAD2;AGTR2
prerank,negative regulation of cell aging (GO:0090344),-0.5544464409233602,-1.5356827773254154,0.01639344262295082,0.1823787762636598,1.0,7/16,12.65%,MIF;RBL1;FBXO5;HMGA2;AKT3;FOXM1;TERT
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.45781463661888905,-1.5347477220584957,0.0,0.18291194167865332,1.0,9/30,11.39%,ETV4;CYP27B1;CTSV;ZBED2;RUNX1;GRHL2;CBFB;ABCA12;MED1
prerank,skin development (GO:0043588),-0.3999268859226091,-1.5340511594724289,0.011627906976744186,0.18304125228099655,1.0,33/74,29.96%,CLDN1;COL1A1;COL1A2;EREG;CDSN;WNT5A;EPHA2;MET;DSP;COL3A1;GATA6;ABCA12;MED1;SCEL;ALOX12B;ALOX12;ABCB6;ALOXE3;ADAM9;LSR;EVPL;OPN3;STMN1;KRT9;S100A7;ANXA1;ST14;BCR;CSTA;DHCR24;SFN;CLDN4;KDF1
prerank,regulation of viral genome replication (GO:0045069),-0.4067385835146939,-1.5338144990974447,0.013157894736842105,0.18224805881191483,1.0,34/66,35.58%,IFITM3;CXCL8;IFITM1;IFITM2;OAS2;SRPK1;BST2;PROX1;ISG15;MX1;PPIH;APOBEC3F;PABPC1;HACD3;FKBP6;OAS3;SLPI;IFI16;TMEM39A;TNF;IFNB1;LTF;CCL5;PDE12;CD28;STAU1;PLSCR1;LARP1;OASL;IFNL3;BTBD17;APOBEC3A;SRPK2;EIF2AK2
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.46062861294902535,1.5334480993000277,0.06666666666666667,0.09294652124746476,1.0,7/18,16.11%,PDE9A;HAND2;AKAP6;MEF2A;CAMK2D;PRKCA;NR4A3
prerank,neural tube closure (GO:0001843),-0.47327270199156163,-1.5334314653059686,0.027777777777777776,0.18181335406436164,1.0,9/34,7.82%,GRHL3;CELSR1;MTHFD1L;TGFB2;FOLR1;PAX2;MTHFD1;LRP2;GRHL2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.33846667042417783,1.5318300611961049,0.0,0.0937622122094491,1.0,26/89,17.12%,CIRBP;RBFOX3;CELF6;RBM24;NOVA1;JMJD6;DDX17;SRSF4;MBNL1;RBM4;SF1;QKI;PCBP4;CELF2;CELF4;RBFOX2;PRDX6;RBM5;ZC3H10;SRSF7;TIA1;CELF1;SF3B4;NOVA2;MBNL2;NSRP1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.4688381705626082,1.5308547410288178,0.04878048780487805,0.09414751769886755,1.0,5/15,9.71%,EHD2;RAPGEF3;MAPK14;CAMK1;FLOT1
prerank,stress-activated MAPK cascade (GO:0051403),0.34586081950651426,1.5307105320211225,0.0,0.09386394083832879,1.0,27/61,19.77%,MAPK1;MAPK3;MAP2K4;ZFP36L1;MAPK8;MAPK14;SKP1;ZFP36;ARHGEF6;UBB;MAPK11;MAP4K2;TAB1;GPS2;PTGER4;NFKB1;MAPK10;LGALS9;BTRC;SH2D3C;TAOK2;UBE2V1;MAP3K10;TNIP2;MAP3K12;CUL1;FBXW11
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.40718157345619843,1.5299333749149842,0.0,0.09412579768070964,1.0,9/27,16.28%,ATP2B4;PRNP;MYOZ2;AKAP6;MYOZ1;RCAN1;CHP2;HOMER3;HOMER2
prerank,endoplasmic reticulum organization (GO:0007029),0.3384900860308644,1.528783759848158,0.0,0.0947474882532781,1.0,25/69,20.00%,RNF112;REEP2;VAMP2;REEP1;PRNP;CAV2;SEC31B;ATL2;HMOX1;ATL3;RTN4;TRAM1L1;VAPA;LMAN2L;APP;ATL1;LMAN1L;REEP5;EMD;SGTA;REEP3;CYB5A;ALDH3A2;SEC16B;WDR83OS
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.5110049643510662,-1.52869390397261,0.04225352112676056,0.18805381987935554,1.0,13/23,21.96%,PAX2;SOX9;SIX1;LBX2;PAX8;ITGAX;AGT;LIF;LHX1;PIK3CD;BMP4;EGF;MDK
prerank,pre-replicative complex assembly (GO:0036388),-0.4233898824614611,-1.5285162842038513,0.012048192771084338,0.1871583837016966,1.0,28/64,30.66%,ORC6;MCM4;PSMB9;PSMD14;MCM7;MCM3;CDT1;MCM2;MCM5;CDC6;MCM6;PSMA3;PSMB3;ORC1;PSMC1;PSMB11;PSMA5;PSMB2;PSME2;PSMD12;PSMA7;ORC2;MCM8;ORC5;PSME4;PSME3;UBC;ORC3
prerank,endoderm formation (GO:0001706),-0.47239711105554244,-1.5274605069555791,0.024096385542168676,0.18760011687838835,1.0,17/35,20.13%,COL11A1;DUSP4;INHBA;TBX20;ITGA5;FN1;DUSP1;HMGA2;MMP2;MMP9;LAMA3;LAMB3;COL7A1;DUSP2;LHX1;MMP8;ITGB2
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.386866793362004,-1.5272794982895601,0.011904761904761904,0.18663323828284636,1.0,55/113,30.84%,IL1A;CXCL1;CXCL3;CXCL8;CXCL2;CXCL5;CD80;IL1B;CXCL9;CXCL11;SERPINE1;TNFAIP3;CARD17;WNT5A;TNIP3;PF4;DEFA6;CCL3;CXCL6;RELA;IRAK1;CXCL10;TGFB1;IL10;TNFRSF1B;NLRP3;ADAM9;PF4V1;IL36B;PLAA;CD86;NOD2;TNFSF4;DEFA1;IL36RN;CD6;CARD16;AXL;LBP;LYN;TNF;HMGB1;XBP1;IL37;PDE4B;CCL5;PTPN22;CXCL13;NLRP7;CDC73;ZC3H12A;LILRB2;PDCD1LG2;MYD88;IL36G
prerank,regulation of fibroblast migration (GO:0010762),0.46543007647454165,1.5270208650313768,0.058823529411764705,0.09590595162646152,1.0,7/20,16.16%,DDR2;FGF2;CORO1C;RAC1;GNA12;ITGB1BP1;DMTN
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.5569322654778648,-1.526132628848441,0.0,0.18762228117074803,1.0,6/15,14.83%,LIPG;CETP;APOC1;SCARB1;PLA2G3;APOM
prerank,embryonic digestive tract development (GO:0048566),0.42930926018875354,1.5252237635141155,0.04,0.0972371446515418,1.0,10/20,11.68%,RBPMS2;FOXF1;RARRES2;TCF21;RARB;PDGFRA;ID2;GLI3;FGFR2;PKDCC
prerank,endothelial cell development (GO:0001885),0.41552895470966555,1.5241011552611925,0.041666666666666664,0.09784406840307604,1.0,11/25,15.00%,RAP1A;GSTM3;PDE2A;RAPGEF3;F2RL1;SOX18;ROBO4;RDX;MYADM;PDE4D;COL15A1
prerank,dendritic cell differentiation (GO:0097028),-0.5160809274273357,-1.5239174610650699,0.0379746835443038,0.1900699585771908,1.0,11/24,23.86%,UBD;CSF2;DHRS2;DCSTAMP;TRPM2;IRF8;BATF;TGFBR2;AXL;LYN;BATF2
prerank,positive regulation of synaptic transmission (GO:0050806),0.30678332977426737,1.523499767958659,0.0,0.09814979689679194,1.0,23/72,14.32%,NFATC4;VAMP2;MPP2;NLGN2;TSHZ3;NPTN;STX1B;LGI1;DLG4;RIMS3;GPER1;HAP1;CCL2;SLC8A2;FLOT1;NLGN1;NLGN3;SYT1;APP;GRIK2;ARC;NRXN1;INS
prerank,axon guidance (GO:0007411),0.2725472905621885,1.5219333794555974,0.0,0.0985130669036066,1.0,54/202,14.24%,PALLD;PDLIM7;GFRA1;EPHA7;PLXNB3;GFRA3;NTN1;MAPK1;NRP2;ROBO3;NEXN;LAMA5;MAPK3;NCAM1;L1CAM;NPTN;KIF5A;SEMA4C;GAP43;MAPK7;RAC1;SEMA3G;NRXN3;SLIT3;LGI1;PIK3R1;GFRA2;GPC1;EFNA5;EPHA4;SCN1B;KIF5C;PTPRM;SEMA3B;ROBO4;GRB10;FEZ2;NTN4;EPHB6;ENAH;SEMA6C;LAMA2;SEMA3A;EVL;SEMA3C;SEMA3E;SEMA4B;SMO;PRKCA;GDNF;SEMA6D;NRXN1;DSCAML1;NTN5
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.39723034386473927,1.5203389679633823,0.041666666666666664,0.09922922408557948,1.0,9/33,8.63%,ATP2B4;PTEN;TRIM39;CDKN1A;FAM83D;PKD1;ID2;SUSD2;MN1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.42568126033305587,1.5191502386042655,0.0,0.09970519231131904,1.0,13/28,18.12%,SYNGR1;RAB3A;DBN1;SYP;DLG4;NCDN;SLC8A2;APP;GRIK2;ARC;SHISA7;SHISA9;CAMK2A
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.40005268104493075,1.51828327178318,0.07692307692307693,0.10000190315040597,1.0,8/27,13.05%,MEIS2;DUSP3;USP2;TAL1;APP;NKX3-1;ASNS;PRKCA
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.35031984283724954,1.5181419654434427,0.0,0.099769005560836,1.0,19/71,11.46%,FHL1;FAM107A;KANK2;PTEN;CDKN1A;PKD2;LSM11;ADAMTS1;JADE1;CDKN2C;PKD1;ID2;CCL2;ZNF655;PRMT2;RDX;EGFR;GPNMB;LSM10
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.5764530270337713,-1.5171433734860276,0.07352941176470588,0.20038182001456695,1.0,7/15,22.89%,IL23A;IL23R;IL12B;HLA-F;KLRC2;AXL;TYROBP
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.45914942640087075,-1.5158840270477787,0.012987012987012988,0.20114740389740415,1.0,14/33,23.37%,THY1;TNFSF11;IL23A;PRKDC;HSPD1;IL12B;SH3KBP1;NOD2;SIRPB1;PRKCQ;TNFSF4;LCK;TYROBP;CLEC7A
prerank,regulation of endothelial cell migration (GO:0010594),0.2990486964984347,1.5156758617609227,0.0,0.10129194138119713,1.0,26/87,14.51%,PTN;DCN;NRP2;RHOB;RHOJ;RRAS;FGF2;RAC1;ITGB3;SASH1;GLUL;ATOH8;NR2F2;DAB2IP;ZNF580;FGF1;PTPRM;PRKD1;CEACAM1;FLT4;ANGPT1;ANGPT4;PRKCA;ITGB1BP1;SVBP;SYNJ2BP
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3085787833721883,1.5146543104345473,0.0,0.10158147285336483,1.0,18/77,9.90%,RBPMS2;ATP2B4;DAND5;FSTL3;CADM4;EMILIN1;FGF2;SPRY1;CHRD;BMPR1A;GPC1;DAB2IP;HHEX;SMAD7;MMRN2;EPN2;SMAD4;NBL1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.44461761680893686,1.5144641107187045,0.058823529411764705,0.10146231856703636,1.0,4/18,8.22%,IL6R;PTN;F2RL1;ZNF580
prerank,positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141),-0.5339413461891444,-1.513973802933569,0.030303030303030304,0.2031421492322357,1.0,14/18,41.66%,IFNK;IFNG;LIF;IFNE;IFNB1;IFNA1;IFNA21;IFNA4;IFNA7;IFNA14;IFNA10;IFNA17;IFNA2;IFNA16
prerank,regulation of vesicle-mediated transport (GO:0060627),0.3019534399730683,1.513957430349626,0.0,0.10145980511191384,1.0,28/90,17.36%,VAMP2;STON1;MAPK1;CHMP3;RAB5B;MAPK3;RAB3A;FES;PACSIN3;PACSIN2;HAP1;RAB4B;USP6;SYT1;RAB3C;MAP2K2;PACSIN1;RAB11B;RAB8B;LGI3;RUFY1;SNX17;RAB13;RAB33B;INPP5F;SLC30A8;RIT2;RAB5C
prerank,regulation of wound healing (GO:0061041),-0.43229417418166755,-1.5139398866459253,0.024390243902439025,0.20199521436627813,1.0,19/44,24.05%,CLDN1;PLAU;EPPK1;CASK;EPHB2;SERPINE1;TNFAIP3;DUOX2;CAV1;FOXA2;INSL3;DUOX1;F2R;REG3A;ARFGEF1;TNFRSF12A;GP1BA;CLEC7A;ANXA1
prerank,regulation of TORC1 signaling (GO:1903432),0.42323586918917594,1.513877107145004,0.0,0.10122606437862647,1.0,10/28,19.49%,FLCN;RRAGA;SIK3;RRAGD;KPTN;KLHL22;RRAGB;RRAGC;RNF152;SESN1
prerank,DNA geometric change (GO:0032392),-0.48037073637508987,-1.5113032499359573,0.039473684210526314,0.20591986948151086,1.0,7/25,12.63%,BLM;ZRANB3;ASCC3;RECQL4;DNA2;HMGB3;WRN
prerank,carboxylic acid metabolic process (GO:0019752),-0.4357221335675528,-1.5105104589851717,0.0,0.20627073099799137,1.0,11/39,14.26%,MIF;CYP2S1;TBXAS1;CYP4F8;LIPT2;GSTO2;PON1;CYP4F3;ST6GAL1;AGXT;PON3
prerank,barbed-end actin filament capping (GO:0051016),0.43183644813169303,1.5104901155573385,0.0,0.10283187297434973,1.0,4/19,5.44%,GSN;ADD1;FLII;CAPZB
prerank,actin filament capping (GO:0051693),0.43183644813169303,1.5104901155573385,0.0,0.10283187297434973,1.0,4/19,5.44%,GSN;ADD1;FLII;CAPZB
prerank,ncRNA processing (GO:0034470),-0.3650583104386836,-1.5103360442842702,0.0,0.2053272079630658,1.0,71/189,31.01%,DDX47;WDR43;POP1;DKC1;DCAF13;WDR3;INTS7;WDR12;WDR74;UTP14A;PUS10;NOB1;BOP1;SMAD1;ADAT1;UTP18;HEATR1;RPL39;LYAR;EMG1;UTP20;RRP12;MRTO4;RCL1;BYSL;RRP9;EXOSC3;DDX10;PDCD11;DDX27;PIH1D2;EXOSC8;NOP58;DIS3;RRP1;RPS19;EXOSC4;NOP14;PWP2;FBL;NOLC1;WDR36;EXOSC5;ESF1;LIN28A;RRP1B;DHX37;UTP15;RPL36;IMP4;DDX52;FARS2;EBNA1BP2;INTS2;PES1;MDN1;XRN2;RPL23A;RPL37;INTS6;EXOSC7;RRP7A;UTP6;LIN28B;RPL8;NOP56;DROSHA;SSB;BMS1;NOL11;EXOSC2
prerank,response to interferon-alpha (GO:0035455),-0.5450193372852692,-1.5101992726091242,0.014925373134328358,0.20435437497909084,1.0,5/17,5.16%,IFITM3;IFITM1;IFITM2;LAMP3;BST2
prerank,response to organophosphorus (GO:0046683),-0.5365322904004763,-1.5095780869303121,0.013333333333333334,0.20434936334540982,1.0,6/16,13.28%,RFC3;DUOX2;STAT1;VGF;CITED1;DUOX1
prerank,amino acid import across plasma membrane (GO:0089718),-0.5008641822560531,-1.5094582565017705,0.036585365853658534,0.20331376728956269,1.0,8/24,11.44%,SLC6A14;SLC6A20;TSPO2;SLC7A5;SLC6A6;SLC1A5;SLC7A1;SLC1A4
prerank,aerobic electron transport chain (GO:0019646),0.35239632370333335,1.5085468524187986,0.0,0.10379986381605791,1.0,32/69,28.15%,SDHA;COX4I2;NDUFA11;COX6A2;NDUFC2;NDUFA5;NDUFS2;NDUFB8;NDUFB10;UQCRFS1;NDUFS4;SDHAF2;SDHD;UQCRC2;NDUFV2;COX7C;NDUFAF1;NDUFA8;UQCR11;NDUFS8;NDUFV1;NDUFA13;NDUFC1;UQCR10;UQCRB;NDUFS5;NDUFA6;COX6C;COX8A;NDUFA10;NDUFB6;NDUFV3
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.33981544522980256,1.5076273747798887,0.0,0.1045908942274617,1.0,15/46,14.96%,AGPAT1;PLA2G5;PLA2G4B;ABHD4;PLD6;DGKG;GPD1L;DDHD2;SLC27A1;DGKE;AGPAT4;PLA2G1B;DGKB;ABHD8;PLA2G4A
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.430260348691258,1.507071042398174,0.038461538461538464,0.10446557750099217,1.0,9/22,16.23%,CALM1;PDGFB;CALM2;PDGFD;GPNMB;INS;RASSF2;TAOK2;PDGFA
prerank,protein transport (GO:0015031),0.26005629225929633,1.5070327196159639,0.0,0.10422730759259362,1.0,95/354,16.85%,TBC1D1;ATP6V1G2;VAMP2;ARL4D;RAB34;CLU;RAB6B;ARRDC4;RAMP1;SNX15;OPTN;COPZ2;SEC31B;CHMP3;RAB5B;WLS;RAB3A;VAMP4;SNX1;GPIHBP1;DNAJC27;STX1B;VPS45;SGSM2;STX2;NGFR;EVI5L;RAB23;STX12;TBC1D17;HDAC6;RABL2B;STX16;ATP6V1E1;BBS1;ZDHHC17;CD36;MCOLN1;RAMP3;HSP90B1;RAB28;RABGAP1;RAMP2;SCG2;TRIM23;NEURL1B;RAB31;TBC1D25;ADPRH;TXNIP;ARRDC2;ARHGAP1;TICAM2;USP6;GGA3;NAPB;SNX33;LMAN2L;SGSM1;LRSAM1;RAB3C;TBC1D10A;RAB11B;GOLPH3;RAB8B;ARL6IP5;RAB24;TCIRG1;VPS26B;TBC1D26;SGSM3;GOLGA7;SVBP;ATP6V0E2;BBS2;TFRC;SNX27;SNX9;RILP;GGA2;RUFY1;ANK3;STX7;SNX17;RABL2A;STX8;STXBP1;RAB13;ARL6;AP2A1;ATP6V1H;ZG16;ARF1;PRKCB;VLDLR
prerank,replication fork processing (GO:0031297),-0.4642943018632086,-1.5052255328815125,0.0,0.20981851976421206,1.0,12/35,14.21%,BLM;EME1;RFWD3;MMS22L;ZRANB3;TRAIP;DNA2;BRCA2;TONSL;FANCM;WRN;ATR
prerank,positive regulation of TOR signaling (GO:0032008),0.3585745989167175,1.5041426490411032,0.058823529411764705,0.10625720032344298,1.0,13/39,17.11%,FLCN;RRAGA;SIK3;NCKAP1L;RRAGD;KLHL22;GOLPH3;RRAGB;LAMTOR3;RRAGC;RHEB;WDR59;GAS6
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.41483938590696934,-1.5026456872783047,0.02531645569620253,0.21362438539957002,1.0,17/53,18.31%,CCND1;CDKN3;BLM;CCNK;CDC25C;CCNO;CCNI2;CCNE1;PKMYT1;CCNF;CDK7;GTPBP4;TTBK1;CDC25A;CDC6;STOX1;CCNJ
prerank,regulation of angiogenesis (GO:0045765),0.2772995927517363,1.5024496232979885,0.0,0.10686290616199083,1.0,57/191,13.93%,ATP2B4;NPR1;YJEFN3;CD34;CLDN5;DCN;RHOB;STIM1;AQP1;VEGFB;RHOJ;HSPB1;FOXJ2;HSPB6;EMILIN1;RRAS;FGF2;THBS4;FOXO4;PRL;RAPGEF3;SASH1;GLUL;TIE1;ATF2;PTGIS;SERPINF1;ECSCR;ADAMTS1;HOXA5;STAB1;DAB2IP;HMOX1;COL4A2;HHEX;RAMP2;FGF1;PTPRM;PDE3B;ANGPTL4;PRKD1;CDH5;CEACAM1;EGLN1;SFRP1;GPNMB;HK2;BTG1;MECP2;GATA2;SEMA3E;ANGPT4;SPINK5;PRKCA;RNH1;NINJ1;NPPB
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4455215454431425,1.5016122845819626,0.030303030303030304,0.10723980659048626,1.0,7/17,12.10%,ATP1B2;ATP1A2;GJC1;CACNA1C;PRKACA;ATP1A3;SLC8A1
prerank,cell projection assembly (GO:0030031),0.48054161500351616,1.5011779768070521,0.034482758620689655,0.10705264528675813,1.0,7/22,10.02%,GSN;RHOJ;PARVA;RAC1;RHOQ;NCKAP1L;RHOU
prerank,amide biosynthetic process (GO:0043604),-0.42525024311849946,-1.5007325061537604,0.012345679012345678,0.21614062370058126,1.0,26/51,26.83%,SLC25A15;CERS6;PCSK1;SPTLC1;ASAH2;RHCE;PNPLA1;NMRAL1;ALOX12B;ASS1;SLC25A2;ARG1;RHD;AANAT;NAGS;ALOXE3;ASMT;SPTLC2;SMPD2;SPTSSB;NANP;PM20D1;DEGS2;CERS2;GBA;CYP4F22
prerank,energy reserve metabolic process (GO:0006112),0.42544662339732825,1.4997525416100181,0.05263157894736842,0.10821146459828676,1.0,10/19,16.67%,PYGM;PPP1R3C;ADRB3;UGP2;GFPT2;PID1;MT3;PYGL;PRKAG2;LEPR
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.4596936500799681,1.499428967254024,0.03571428571428571,0.10824617769542326,1.0,6/19,12.57%,JAM3;MAPK1;MAPK3;RARRES2;MSTN;AKIRIN1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.4377496143382228,1.499343735189646,0.08,0.10800205540243846,1.0,8/24,15.26%,CHMP3;TMEM50B;UBXN6;CHMP4A;LEPROT;CHMP7;TMEM50A;RILP
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.4175394000594116,-1.499014781837328,0.011363636363636364,0.2185902942460372,1.0,26/73,20.16%,MTHFD1L;TCN1;PNPO;MMACHC;DHFR;MTHFD1;GSTO2;SHMT2;HLCS;VNN3;SLC5A6;VNN1;SLC52A3;MTHFD2;THTPA;PDXK;SLC46A1;SLC19A1;MCCC2;SLC2A1;PANK2;PCCA;SLC25A19;MMAA;PCCB;PRSS3
prerank,protein insertion into membrane (GO:0051205),0.40034083388018155,1.4982708503008946,0.0,0.10853732720773165,1.0,18/32,22.71%,VAMP2;REEP1;PRNP;HMOX1;TRAM1L1;VAPA;EGFR;OXA1L;APP;RTP5;EMD;SGTA;CYB5A;ALDH3A2;WDR83OS;STX1A;RTP1;TRAM2
prerank,negative regulation of developmental growth (GO:0048640),0.3725862804168615,1.4977485830140076,0.0,0.10862627729667822,1.0,13/32,14.15%,PTEN;ULK1;CDKN1A;ULK2;PTPRS;SEMA3G;MAP2;RTN4;MSTN;MYOZ1;WWC3;MT3;BBS2
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.54706226710239,-1.4973032539940243,0.0547945205479452,0.2198565144854732,1.0,11/15,35.02%,DKC1;RUVBL1;NAF1;SHQ1;CCT6A;CCT2;RUVBL2;NOP10;CCT3;CCT8;NHP2
prerank,modulation of chemical synaptic transmission (GO:0050804),0.28301025751720327,1.4969416013822296,0.0,0.1091016238397936,1.0,35/107,14.61%,NPTX1;PTEN;NLGN2;GRIK5;NPTXR;CPLX3;ATP1A2;NGF;STX1B;NPAS4;GRIK3;LGI1;CHRNB4;DLG4;NLGN4X;RIMS3;TMEM108;PSMC5;SLC8A2;SYN1;NLGN1;NLGN3;LRRC4C;SYT1;APP;GRIK2;MEF2C;TPRG1L;KCNMB4;NPTX2;ARC;NTF3;PXK;IQSEC2;CDH2
prerank,actin-myosin filament sliding (GO:0033275),0.3757831877796174,1.4969401789713312,0.0,0.10850544010296413,1.0,17/38,18.04%,TPM2;TPM1;TMOD1;DES;MYL6;MYH3;ACTC1;MYL2;TCAP;MYL1;MYL3;DMD;VIM;TNNT3;MYL4;MYBPC1;ACTN2
prerank,muscle filament sliding (GO:0030049),0.3757831877796174,1.4969401789713312,0.0,0.10850544010296413,1.0,17/38,18.04%,TPM2;TPM1;TMOD1;DES;MYL6;MYH3;ACTC1;MYL2;TCAP;MYL1;MYL3;DMD;VIM;TNNT3;MYL4;MYBPC1;ACTN2
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.3501624262437663,1.4966626557793785,0.0,0.10859350759449647,1.0,21/56,18.12%,PRRT1;NPTX1;LYNX1;NLGN2;NPTXR;DAPK1;NEFL;DLG4;NLGN1;APP;DLG2;MEF2C;GRIA4;NPTX2;GRIA1;SHISA7;LRRC7;GRIA2;SHISA9;ACTN2;CAMK2A
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3050863168776389,1.4964378061235022,0.0,0.10857175933918405,1.0,16/76,8.37%,RGS2;UCHL1;PTEN;PKIG;MYOCD;CDKN1C;SPRY1;INPP5K;PRKAR2B;NR2F2;PRKCD;DAB2IP;HHEX;LATS2;SMPD1;TESK1
prerank,negative regulation of stress fiber assembly (GO:0051497),0.39656971563333876,1.495920745569543,0.029411764705882353,0.10871369017952025,1.0,9/24,11.98%,ARHGAP6;MYOC;INPP5K;ARHGEF18;PIK3R1;PHLDB2;DLC1;WASF2;TMEFF2
prerank,positive regulation of T cell proliferation (GO:0042102),-0.4008255120253384,-1.4957947389059822,0.025,0.22164566138977257,1.0,30/65,32.06%,CD80;IL1B;CD276;IL23A;ZP3;JAK3;IL23R;IL21;PNP;SYK;TNFSF9;IL12B;CD70;SLC7A1;CD86;CD46;TNFSF4;IL12RB1;CD6;IL27RA;ANXA1;HMGB1;IGFBP2;CCL5;CD28;LILRB2;PDCD1LG2;CD3E;IGF1;AGER
prerank,in utero embryonic development (GO:0001701),0.4283826438529164,1.4918435861693256,0.0,0.11102977598049303,1.0,12/25,17.01%,EGFL8;FOXF1;FLCN;MBNL1;PKD1;ARNT2;FOXD3;FGFR2;HINFP;LMX1B;ZNF568;TGFB3
prerank,maintenance of blood-brain barrier (GO:0035633),0.3719684176491933,1.4910053937961272,0.043478260869565216,0.11105586332169771,1.0,11/30,13.25%,JAM3;JAM2;CLDN5;VCL;LAMC1;ESAM;OCLN;ACTB;CDH5;LAMA2;DMD
prerank,DNA alkylation (GO:0006305),-0.5153482230762946,-1.4909651245963347,0.014925373134328358,0.22778281429115532,1.0,11/19,30.78%,FOS;DNMT1;DNMT3B;DNMT3L;SPOCD1;BEND3;ATRX;ATF7IP;GATAD2A;TEX15;HELLS
prerank,DNA methylation or demethylation (GO:0044728),-0.5153482230762946,-1.4909651245963347,0.014925373134328358,0.22778281429115532,1.0,11/19,30.78%,FOS;DNMT1;DNMT3B;DNMT3L;SPOCD1;BEND3;ATRX;ATF7IP;GATAD2A;TEX15;HELLS
prerank,regulation of cell cycle process (GO:0010564),-0.394293489558534,-1.4908613176932424,0.0,0.2268599512961917,1.0,30/104,13.68%,DBF4;CHEK1;KIF20B;KIF20A;NEK2;CEP250;CDC25C;TIPIN;FBXO5;KNSTRN;SOX9;SPAG5;RACGAP1;HMGA2;SND1;AURKB;PKMYT1;RMI2;AURKA;SIX3;BUB1;BCL2L1;RCC1;HORMAD1;ECT2;PLK1;RAB11FIP4;PDXP;BIRC6;PRPF40A
prerank,regulation of microtubule-based process (GO:0032886),0.38075389035803064,1.4899791043341815,0.0,0.11129813331083041,1.0,11/36,16.01%,FAM107A;MAP6;MAPT;KLHL42;HDAC6;EFNA5;PHLDB2;PRKAA2;MARK4;PHLDB1;EPHA3
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3352677191252371,1.489943487228277,0.0,0.11099974689444748,1.0,26/79,15.94%,LMOD1;CFL2;NCK1;SYNPO2;SORBS3;CDC42EP3;FES;CCL27;P2RX7;CCL21;SYNPO;NUMA1;NCKAP1L;F2RL1;CDC42EP4;BAIAP2;CX3CL1;TENM1;EVL;WDR1;CCL11;NTF3;PFN2;SNX9;NTRK3;FCHSD1
prerank,phosphatidic acid metabolic process (GO:0046473),0.3356483907380647,1.4890951029729276,0.0,0.11129466288993546,1.0,16/48,14.96%,AGPAT1;PLA2G5;PLA2G4B;ABHD4;PLD6;DGKG;GPD1L;DDHD2;SLC27A1;DGKE;AGPAT4;PLA2G6;PLA2G1B;DGKB;ABHD8;PLA2G4A
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.44193319529157776,1.4890467665298488,0.1,0.11110517328184445,1.0,6/17,11.93%,MAP3K3;RHOJ;FGF2;HDAC7;HMOX1;GATA2
prerank,positive regulation of hydrolase activity (GO:0051345),0.2804043394061142,1.4883242189347732,0.0,0.11123772398966734,1.0,50/141,17.09%,RAP1A;FERMT2;CCL14;RGS10;CAV2;ASAP3;FLCN;CALM1;MAPK8;DVL3;PLIN5;RASGRP2;RAPGEF3;SGSM2;TBC1D20;GNB5;EVI5L;MTCL1;RHOA;CCL21;MTMR9;RSU1;F2RL1;CCL2;MAPRE2;RHOC;CALM2;SFRP1;SNX18;PIN1;CX3CL1;CCL11;CCL13;SGSM3;RGS1;NTRK1;ADCYAP1;CCL8;RALBP1;CHP2;BCAR3;SNX9;FNTA;PRTN3;RAB11FIP2;GBA3;CCL23;PLXNB1;NDEL1;SRGAP2
prerank,regulation of signal transduction (GO:0009966),0.26755320765544705,1.488287886314489,0.0,0.11094266371383267,1.0,81/191,23.11%,TSPYL2;RGS2;IGFBP6;YJEFN3;CLU;WWTR1;NCK1;PRNP;NCAM1;ILK;LIFR;RGS11;GNG7;USP20;TMEM204;IGFBP4;RGS5;TULP3;CD63;IFT81;ZDHHC7;ZDHHC17;PXN;CD36;SOCS2;FRRS1L;GRK5;TMEM108;INTU;SLC8A2;ZFAND2B;PRKD1;ANKRD54;RFNG;IGFBP5;MTCH1;SNX3;RSPO3;FGFR2;APP;MDFIC;CX3CL1;CD24;TCF7L1;GDF5;ADCYAP1;GDNF;ITGB1BP1;SYNJ2BP;MGLL;ITGA3;GIT2;IGFBP7;KCTD8;RGS4;LLGL1;DLL1;RORA;ERBB3;RIC8B;SNW1;UGCG;GRK4;DHRS3;AKR1C3;RGS8;DOK5;MFNG;SENP2;GAS1;CRK;CDKN2AIP;TSC2;SIRT1;WDR11;NCK2;ACVR1;ALOX15;FUZ;CD177;BST1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.36529220009864133,1.4878703222250131,0.0,0.11107494301465122,1.0,17/48,16.48%,PTEN;LMO3;DUSP26;EMILIN1;TIMP3;FLCN;SPRY1;FBLN1;DUSP3;GPER1;DAB2IP;SMAD4;PIN1;ITGB1BP1;SYNJ2BP;CNKSR3;SEMA6A
prerank,negative regulation of phosphatase activity (GO:0010923),-0.4800044142177625,-1.4866533888602846,0.0136986301369863,0.2335260494295436,1.0,16/27,32.41%,TGFB2;MASTL;SEMA4D;SH2D4A;STYXL1;PPP1R1B;GSK3B;PPP1R35;BOD1L2;PPP4R4;TMEM225;GPATCH2;FKBP1B;URI1;PPP1R27;SH3RF2
prerank,protein localization to cell junction (GO:1902414),0.4463417087798793,1.486187973821697,0.0,0.11200275236907646,1.0,7/21,10.09%,JAM3;FERMT2;NLGN2;ARHGEF18;DLG4;NLGN1;JAK1
prerank,embryonic organ development (GO:0048568),0.3668114657392291,1.4844725257979725,0.0,0.11329627380451877,1.0,27/66,14.30%,RNF112;TEAD3;PBX3;ATF4;HEY1;KIT;HAND1;KITLG;TPO;RARRES2;TEAD2;RARB;PBX2;TEAD1;BMPR1A;FLT3LG;RBPJ;SOX18;GLI3;FGFR2;TAL1;ERCC3;NDRG4;PKDCC;HEY2;GDNF;SOX17
prerank,metal ion export (GO:0070839),0.370291022248801,1.4833133815711899,0.0,0.11379095667883388,1.0,9/31,12.66%,ATP2B4;KCNA5;ATP1B2;KCNH2;ATP1A2;ATP1A3;KCNE2;KCND3;KCNE4
prerank,cellular glucuronidation (GO:0052695),-0.5072115702536204,-1.482853625653256,0.0547945205479452,0.2385537632186758,1.0,14/18,41.92%,UGT1A6;UGT2B7;UGT1A7;UGT2B28;UGT1A4;UGT1A5;UGT2A1;UGT1A3;UGT2B11;UGT1A9;UGT1A10;UGT2A2;UGT1A8;UGT1A1
prerank,regulation of interferon-gamma production (GO:0032649),-0.3841806582613841,-1.4828298900979766,0.011235955056179775,0.23736582042020124,1.0,38/84,30.40%,INHBA;FOXP3;IL1B;CD276;IL23A;ZP3;SLC7A5;IL12RB2;IL23R;ISG15;IL21;RASGRP1;HSPD1;ZFPM1;IL12B;CR1;LILRB4;TNFSF4;IL27;IL36RN;CRTAM;IL12RB1;CD2;XCL1;AXL;CLEC7A;HMGB1;PDE4B;TLR7;PTPN22;SLAMF6;ZC3H12A;CD244;C1QBP;PDCD1LG2;TLR8;IFNL1;TXK
prerank,membrane depolarization (GO:0051899),0.39467310414382245,1.482650567193084,0.0,0.11396705959158861,1.0,9/31,10.16%,CACNA1H;SCN7A;KCNH2;SCN3B;P2RX7;SCN1B;BEST2;SCN11A;SCN9A
prerank,response to lipopolysaccharide (GO:0032496),-0.3594961365028242,-1.4819612296507567,0.01098901098901099,0.23763056754058495,1.0,66/150,29.16%,IL1A;CXCL1;CXCL3;CXCL8;CXCL2;CXCL5;CD80;IL1B;CXCL9;CXCL11;SERPINE1;CYP27B1;TNFAIP3;CARD17;WNT5A;TNIP3;IL23R;PF4;DEFA6;NOCT;MAPKAPK2;SCARB1;CXCL6;PALM3;RELA;NOS2;IRAK1;CXCL10;CITED1;IL10;TNFRSF1B;TRIB1;NLRP3;F2R;ADAM9;SRR;PF4V1;SLPI;IL36B;PLAA;CD86;IRAK3;NOD2;TNFSF4;GCH1;DEFA1;IL36RN;RPS6KA3;CD6;CARD16;SMAD6;AXL;LBP;S100A7;MAPKAPK3;HMGB1;XBP1;IL37;PDE4B;PTPN22;CXCL13;NLRP7;CDC73;ZC3H12A;TNFRSF11A;LILRB2
prerank,regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139),-0.5191508403776705,-1.481671901493667,0.045454545454545456,0.23693744575923298,1.0,14/19,41.66%,IFNK;IFNG;LIF;IFNE;IFNB1;IFNA1;IFNA21;IFNA4;IFNA7;IFNA14;IFNA10;IFNA17;IFNA2;IFNA16
prerank,multivesicular body organization (GO:0036257),0.3989220316599789,1.4812044523891381,0.043478260869565216,0.11472004533301557,1.0,10/31,16.56%,CHMP3;TSG101;CHMP4A;CHMP7;VPS4A;VPS28;IST1;VPS37D;VPS37A;RAB27A
prerank,organelle transport along microtubule (GO:0072384),0.41869219552387443,1.4810768137350558,0.037037037037037035,0.11442129521496085,1.0,7/28,8.90%,DYNC1I1;MAPT;UBB;HAP1;RHOT2;PAFAH1B1;TRAK2
prerank,ribosomal large subunit assembly (GO:0000027),-0.514323387570056,-1.4809342066950992,0.07792207792207792,0.23709203672836532,1.0,9/24,24.17%,BRIX1;BOP1;NLE1;RRS1;FASTKD2;DDX28;MDN1;RPF2;RPL23A
prerank,negative regulation of axon extension (GO:0030517),0.3935602042658691,1.4803981776621056,0.058823529411764705,0.11480340714703306,1.0,13/31,13.82%,SEMA4C;PTPRS;SEMA3G;MAP2;RTN4;SEMA3B;SEMA6C;SEMA3A;SEMA3C;MT3;SEMA3E;SEMA4B;SEMA6D
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.3939738125944207,1.4803342670297654,0.0,0.11455810824232031,1.0,6/22,11.81%,UROD;FECH;NFE2L1;RSAD1;ALAD;ABCG2
prerank,response to progesterone (GO:0032570),-0.48721527744793763,-1.4802177952221547,0.05970149253731343,0.23749950245467985,1.0,11/20,26.78%,TGFB2;CAV1;CATSPERB;CATSPER1;THBS1;TGFB1;CATSPER3;ABHD2;CATSPER2;CATSPER4;CATSPERG
prerank,regulation of DNA recombination (GO:0000018),-0.4519857562836041,-1.4802067283744962,0.024096385542168676,0.23631144464384893,1.0,12/31,23.69%,CHEK1;BLM;RAD51AP1;MSH3;ZRANB3;FIGNL1;IL7R;MSH6;IL10;ALYREF;PPP4C;KPNA2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.5071851647294591,-1.478278167373164,0.04,0.2381939536210609,1.0,11/19,31.84%,IL21;RASGRP1;IL12B;RAET1E;HLA-F;CRTAM;KLRC2;CD160;NCR3;SLAMF6;CD226
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.5179501989590257,-1.4765722475909728,0.05128205128205128,0.2382348410753353,1.0,11/21,25.85%,MAD2L1;ZWINT;KNTC1;BUB1;PLK1;TRIP13;CENPF;CDC20;BUB1B;TTK;ZW10
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.5179501989590257,-1.4765722475909728,0.05128205128205128,0.2382348410753353,1.0,11/21,25.85%,MAD2L1;ZWINT;KNTC1;BUB1;PLK1;TRIP13;CENPF;CDC20;BUB1B;TTK;ZW10
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.5179501989590257,-1.4765722475909728,0.05128205128205128,0.2382348410753353,1.0,11/21,25.85%,MAD2L1;ZWINT;KNTC1;BUB1;PLK1;TRIP13;CENPF;CDC20;BUB1B;TTK;ZW10
prerank,dendritic cell chemotaxis (GO:0002407),-0.5149162353536656,-1.476501111158274,0.058823529411764705,0.23714345424309982,1.0,8/16,29.75%,CXCR4;TRPM2;CXCR2;PIK3CG;CXCR1;HMGB1;CCL5;CCR6
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.521457077573262,-1.475645668638137,0.058823529411764705,0.2376767273244895,1.0,9/17,31.90%,GBP5;IL17A;CARD9;NOD2;CD6;TNF;CLEC7A;MYD88;HIF1A
prerank,regulation of chromosome segregation (GO:0051983),-0.5483326140558915,-1.474904931178485,0.041666666666666664,0.23799525279849745,1.0,9/17,18.71%,AURKB;RMI2;BUB1;KIF2C;HORMAD1;RAD18;CDC6;MKI67;CSNK2A1
prerank,negative regulation of double-strand break repair (GO:2000780),-0.49130420977278777,-1.4748082537932385,0.014285714285714285,0.23699072895180917,1.0,12/25,33.63%,PARPBP;FANCB;OTUB2;HMGA2;RMI2;RNF169;RIF1;ERCC6;TWIST1;POLQ;TFIP11;HELB
prerank,peripheral nervous system development (GO:0007422),0.4343044456663116,1.4739057638411799,0.038461538461538464,0.11857681205568932,1.0,6/24,6.50%,PMP22;GFRA3;GSTM3;NGF;NFASC;GPC1
prerank,protein insertion into ER membrane (GO:0045048),0.37986944249976723,1.4737296987725412,0.06451612903225806,0.1182712017153396,1.0,20/35,25.24%,VAMP2;PRNP;CAMLG;HMOX1;TRAM1L1;EMC6;VAPA;APP;EMC4;EMD;SGTA;CYB5A;ALDH3A2;BAG6;WDR83OS;STX1A;TRAM2;EMC9;EMC7;UBE2J2
prerank,response to axon injury (GO:0048678),0.45262854218968746,1.473365387329062,0.047619047619047616,0.11807059723755162,1.0,6/18,9.05%,DPYSL3;APOD;GAP43;SOD1;P2RY12;MORN4
prerank,regulation of calcium ion import (GO:0090279),0.40587579159610426,1.4728703550478202,0.07142857142857142,0.1179226061927982,1.0,7/24,8.67%,PLN;PRNP;LGALS3;PKD2;PDGFB;CCL2;SLN
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.4787230862536714,-1.4726934964139884,0.028169014084507043,0.2396252159366965,1.0,15/28,33.25%,CDH3;IL1B;CYP27B1;DHFR;SCARB1;TERT;IFNG;FGF23;PIK3CB;GCH1;TNF;NOS1AP;NUS1;HIF1A;ATP7A
prerank,axon development (GO:0061564),0.31401952878984773,1.4722854586614371,0.0,0.11787827765941386,1.0,32/78,18.87%,APBB1;S100B;PLP1;L1CAM;RAB3A;MAPT;GAP43;MAP1A;SLITRK2;ZDHHC17;RTN4;ACTB;SLITRK3;BAIAP2;ISL2;FGFR2;BRSK1;NTNG1;APP;PARD3;ATL1;CCK;MAP1B;SVBP;DSCAML1;ANK3;TAOK2;MAPK8IP3;KLF7;LLGL1;SLITRK4;CNTN4
prerank,metanephros development (GO:0001656),-0.4880590576329167,-1.4721952633695687,0.08571428571428572,0.23958557015301266,1.0,12/26,14.26%,SHH;WNT7B;FOXD1;PAX2;CTSH;ROBO2;SIX1;PAX8;BMP7;CITED1;PTCH1;NF1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.5279294221118664,-1.4712172773802155,0.0684931506849315,0.24047040751426346,1.0,6/15,16.53%,DPEP1;GGACT;ABHD12B;CHAC1;CHAC2;ABHD12
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.36514870886148687,1.4710998694642192,0.0,0.11865531937070618,1.0,15/38,12.66%,KCNA5;KCNH2;CACNA1C;CTNNA3;SCN3B;ANK2;CACNA2D1;SCN2B;SCN1B;KCNE2;SCN4B;CAMK2D;KCND3;CACNB2;KCNE4
prerank,regulation of lamellipodium assembly (GO:0010591),0.38126793790573454,1.4702929190772651,0.037037037037037035,0.11907007026032443,1.0,14/32,19.82%,PLXNB3;RAC1;CAPZB;ARPC2;OCLN;PIK3R1;MSTN;BRK1;WASF2;AKIRIN1;DMTN;ABI2;FER;TWF2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.24287087238731986,1.470245052488661,0.0,0.11881892294983605,1.0,70/261,18.04%,RAP1A;PMP22;FLNA;GSN;MYLK;EHD2;RFX2;NTN1;VCL;TTLL3;KIT;S1PR1;PARVA;INPP5K;DZIP1;BBS5;RAC1;EMP1;EMP3;WDR19;RAB23;ARL3;CYS1;HDAC6;RABL2B;P2RX7;BBS1;CCL21;IFT81;PKD1;ARHGEF6;ABLIM3;NPHP3;INTU;P2RY12;FGD6;TXNDC15;FBF1;UBXN10;WHAMM;CLUAP1;INPP5E;RAB11FIP3;IFT46;CC2D2A;GOLPH3;RAB8B;CEP126;TMEM138;STK36;CEP89;BBS2;S1PR2;GBF1;IFT80;EXOC7;AIF1L;RILP;PTPN23;DMTN;ARL6;RILPL2;CEP19;SRGAP2;BBS7;IFT43;FGD1;BBS4;IFT172;ACTN2
prerank,regulation of protein targeting to membrane (GO:0090313),0.3917969669200665,1.469900421558107,0.08333333333333333,0.11872184243530894,1.0,12/28,16.33%,PRNP;KCNB1;INPP5K;MYO1C;MTCL1;GDI1;SLC51B;MIEF2;ITGB1BP1;ANK3;DMTN;MFF
prerank,cellular amide metabolic process (GO:0043603),-0.37989878590943826,-1.4663427734163708,0.023255813953488372,0.25006592369382036,1.0,38/105,23.46%,CPZ;MTHFD1L;MME;BAAT;NLN;CPN1;DHFR;MTHFD1;ACSL6;PLA2G4E;THEM5;MIPEP;ASAH2;FUT7;SHMT2;HLCS;VNN3;ABCA12;CPD;SLC5A6;ST6GAL1;ACOT12;VNN1;ACOT6;ACSM6;ACSM4;MTHFD2;SMPD2;SLC46A1;SLC19A1;MCCC2;PANK2;PCCA;PCCB;FUT6;ACOT13;PM20D1;FUT5
prerank,endocrine system development (GO:0035270),-0.4889245321522423,-1.4659867477403161,0.013157894736842105,0.24960356810774775,1.0,14/24,31.23%,STRA6;SIX1;SIX3;PAX8;GCM2;NF1;WNT11;TG;MDK;WNT4;SALL1;WT1;TGFBR1;FOXE1
prerank,cellular calcium ion homeostasis (GO:0006874),0.29102895953642177,1.4656959792077526,0.0,0.12157183236736653,1.0,34/130,13.11%,DMPK;PLN;ATP2B4;PSEN1;SCGN;CCL14;CAV2;STIM1;HRC;ANXA6;NPTN;TMEM178A;TPCN2;SLC24A3;ANK2;WFS1;GPER1;PRKACA;TRPC1;PTH1R;CALB2;ELANE;SLC8A2;TRPC4;CDH5;RGN;ATP2A2;CAMK2D;SLC8A1;CCL11;BCL2;TRPC6;SMDT1;CCL13
prerank,regulation of mitotic nuclear division (GO:0007088),-0.42474424016801265,-1.4654189172681509,0.013888888888888888,0.24982030124399224,1.0,17/57,10.93%,IL1A;CHEK1;KIF20B;PDGFRB;IL1B;EREG;NEK2;CDC25C;FBXO5;DUSP1;TOM1L1;PKMYT1;EPGN;AURKA;DMRT1;RCC1;BMP7
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.42872667561444905,1.4654045569991057,0.029411764705882353,0.1216203320578652,1.0,15/26,25.32%,PSEN1;RAC1;ITGB3;RIN3;DLG4;APP;ANKRD13A;UNC119;ANKRD13D;SDCBP;UBQLN2;LRPAP1;ADIPOQ;ANKRD13B;ABCA2
prerank,sulfur compound biosynthetic process (GO:0044272),0.2876681713179114,1.4652316363225635,0.0,0.12141584896188014,1.0,31/107,15.50%,PRELP;CSPG4;DCN;GSTM3;GSTM2;UST;GSTM5;GSTA4;OGN;CHST3;B4GAT1;ST3GAL3;CDO1;MAT2A;CHST15;GSTM4;HPGDS;CHST9;ANGPT1;CHST14;CHST7;HAGH;GSTT2B;LIAS;KERA;ST3GAL6;GGT5;OMD;GGT7;FMOD;CSGALNACT2
prerank,cellular response to cAMP (GO:0071320),0.39154663925533717,1.4652011619118406,0.04,0.12111154858854209,1.0,8/31,5.12%,RAP1A;PDE2A;AQP1;ZFP36L1;INPP5K;RAPGEF3;PKD2;AKAP6
prerank,cellular component disassembly (GO:0022411),-0.3991672769934093,-1.4649268575305885,0.056818181818181816,0.2493635453403214,1.0,20/63,17.22%,MMP7;MMP13;TIMP1;KLK7;MMP10;MMP1;MMP11;CTSV;CD44;KIF9;MMP3;MMP2;CAPG;NOXO1;MMP9;TMPRSS6;DYRK3;ADAM10;MMP12;ADAM8
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.3522720109243444,1.4635810048173938,0.0,0.12191526136310551,1.0,8/26,17.43%,DNAJB5;HSPA2;DNAJC18;DNAJB4;ST13;HSPA1L;HSPA8;DNAJB12
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2727604671945309,1.463502948808149,0.0,0.12171157258129184,1.0,64/223,14.51%,RAP1A;GLIPR2;FERMT2;EPHA7;PTEN;CCL14;PLA2G5;LMO3;DUSP26;P2RY1;MAPK3;EMILIN1;RRAS;TIMP3;FLCN;ACKR3;FGF2;SPRY1;FBLN1;ROR2;MTURN;HAND2;DUSP3;FAM83D;TNFAIP8L3;TIRAP;TGFBR3;PDGFRA;CCL21;ZDHHC17;GPER1;CD36;DAB2IP;RAMP3;PDGFB;GCNT2;F2RL1;CCL2;CEACAM1;EGFR;PDGFD;YWHAZ;SMAD4;FLT4;FGFR2;NECAB2;ANGPT1;GPNMB;PIN1;NDRG4;APP;ROR1;CX3CL1;MT3;CCL11;PRKCA;CCL13;NTRK1;ADCYAP1;ITGB1BP1;CCL8;FGF10;LGALS9;SYNJ2BP
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.4953935357217114,-1.4619523453435186,0.05263157894736842,0.2541900603035974,1.0,8/18,18.16%,PPAT;PAICS;HPRT1;GART;ATIC;NT5C2;GMPS;AMPD3
prerank,cellular response to unfolded protein (GO:0034620),0.4047859514063957,1.461743520406505,0.03333333333333333,0.12250979418784064,1.0,5/26,7.09%,HSPB8;HSPA2;OPTN;BAG3;DAB2IP
prerank,histone H4-K8 acetylation (GO:0043982),0.4383318995877843,1.4610462809636502,0.0,0.12230168688845341,1.0,7/15,21.17%,ING4;JADE1;KANSL3;KAT8;JADE2;MEAF6;KAT7
prerank,histone H4-K5 acetylation (GO:0043981),0.4383318995877843,1.4610462809636502,0.0,0.12230168688845341,1.0,7/15,21.17%,ING4;JADE1;KANSL3;KAT8;JADE2;MEAF6;KAT7
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.33030577253963145,1.4598095560463942,0.0,0.12279449378217694,1.0,26/79,16.59%,CLIP3;SORBS1;ATP2B4;LGALS3;TMBIM1;CNPY4;AP2M1;PIK3R1;ZDHHC7;GPER1;PID1;VTI1B;RAMP3;RHOQ;ACTB;STAC;EGFR;STAC2;NUMB;VPS4A;INS;ITGA3;STX7;EPHA3;STX8;SQSTM1
prerank,polyol metabolic process (GO:0019751),0.3430830809598566,1.458801631600563,0.0,0.12303711406647441,1.0,20/47,20.69%,INPP5A;PTEN;PLCD4;ITPKB;NUDT10;INPPL1;CALM1;NUDT11;IP6K1;PLCD1;INPP5B;IP6K3;ISYNA1;INPP5J;INPP1;OCRL;INPP4A;ITPK1;PLCD3;IP6K2
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.387697491385652,1.4581384084559776,0.0,0.12298196181972518,1.0,13/26,22.05%,PLXNB3;EVI5L;CAPZB;PRKCD;CCL21;TESK1;EVL;PFN2;TCHP;KANK1;ARHGAP24;SRGAP2C;SLIT2
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.4910007042383224,1.457342463121781,0.03333333333333333,0.12307500661777301,1.0,8/16,19.70%,GABARAPL2;ANK2;BCAP29;VAPA;TAPT1;GBF1;PPP1R15A;SEC16B
prerank,regulation of cell growth (GO:0001558),0.2686264645429718,1.456539728275425,0.0,0.1232659731034974,1.0,58/204,17.12%,FHL1;FAM107A;APBB1;TSPYL2;RERG;NPR1;DACT3;AGTR1;LTBP4;CGRRF1;CDKN1A;EGLN2;WFDC1;FLCN;RASGRP2;MTOR;AKAP6;SPOCK1;SLIT3;LGI1;PRDM11;JADE1;CDKN2C;DNAJB2;SOCS2;MUL1;RTN4;MYL2;CEACAM1;SIPA1;EGFR;SMAD4;SFRP1;BAP1;SERTAD3;KLHL22;BTG1;SMAD3;CAMK2D;MT3;N6AMT1;BCL2;PTCH2;USP47;NPPB;SOX17;INS;TCHP;TFRC;SGK1;FRZB;OSGIN1;TAF9B;TAOK2;RAB33B;CDKN2D;NDRG3;SFRP2
prerank,organic anion transport (GO:0015711),-0.3602137236494084,-1.4563064406882367,0.0,0.2641582234470533,1.0,39/97,28.00%,LRRC8E;SLC4A11;SLC22A11;CA9;ABCC11;SLCO1B3;SLCO5A1;AQP9;SLC26A9;SLC2A14;SLCO1A2;HBA1;LRRC8D;CA5A;SLC4A9;SLC52A3;SLC22A13;SLC35A2;CFTR;SLC39A8;CYB5R2;CA6;SLC22A25;SLCO4A1;SLC22A9;SLCO3A1;SLC19A1;SLC25A19;SLC4A8;SLC22A10;SLC52A2;SLCO1C1;CYB5RL;SLC22A24;SLC17A3;SLC17A1;SLC22A12;SLC17A9;CA13
prerank,chloride transport (GO:0006821),-0.3815495795371203,-1.4557936141000196,0.024096385542168676,0.26420292616186025,1.0,30/75,25.11%,SLC12A2;GABRP;SLC12A8;CLCN1;GABRB1;SLC26A8;BEST1;TTYH3;CLIC3;SLC26A9;GLRA1;GABRD;CLCN4;GLRA2;CFTR;CLCN3;GABRR1;CLIC1;GABRE;SLC12A3;SLC4A8;SLC12A5;SLC12A1;GABRB2;GABRA1;SLC5A1;GABRA3;GABRG3;ANO9;SLC26A1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.5611765183338484,-1.4557351623991168,0.027777777777777776,0.2629625368371567,1.0,10/17,23.37%,WNT5A;HSPD1;CEBPA;HAVCR1;SPACA3;THBS1;CRLF2;CD2;LBP;CLEC7A
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.4534188681360045,-1.455552641673704,0.012195121951219513,0.2619960310445902,1.0,14/29,28.54%,MYC;TCF7;LEF1;RUVBL1;BCL9L;AXIN2;SMARCA4;TERT;TRRAP;RBBP5;CREBBP;KMT2D;LEO1;CDC73
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.27184053758734356,1.4548942956697553,0.0,0.12414296516487844,1.0,51/162,15.97%,GLP2R;GNAO1;LPAR1;RAMP1;CNR1;ADCY5;PDE2A;VIP;GALR2;S1PR1;AKAP12;ADCYAP1R1;GNAZ;PTGER3;GABBR1;ADRB3;ADCY4;GNAI2;VIPR2;ADGRD1;GPER1;ADGRB3;RAMP3;CHRM2;GRK5;RAMP2;PTH1R;GNA12;P2RY12;CORT;ADGRL4;GPR161;TBXA2R;WASF2;ADM;AVPR2;ADGRL2;GNAI1;PTGER4;GPR4;GNAQ;RGS1;ADCYAP1;ADCY9;S1PR2;ADCY2;ADRB2;NPY1R;ADGRL1;PTGFR;ADCY6
prerank,establishment of endothelial barrier (GO:0061028),0.3691442558276699,1.4548780193765445,0.043478260869565216,0.12384091415474492,1.0,9/28,13.39%,RAP1A;PDE2A;RAPGEF3;F2RL1;SOX18;ROBO4;RDX;MYADM;PDE4D
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.45325217327822626,-1.4537901977965921,0.014705882352941176,0.2648240476770936,1.0,3/24,1.18%,SULT2B1;SULT1C3;SULT1C2
prerank,skeletal muscle organ development (GO:0060538),0.3487382676373457,1.4536299781044248,0.05263157894736842,0.12471225348512108,1.0,10/30,12.78%,BVES;POPDC2;MYL6;DISP1;MYOZ2;TCF21;MYOZ1;CFLAR;POPDC3;MEF2C
prerank,T cell activation involved in immune response (GO:0002286),-0.4762898186316038,-1.4528262138871169,0.05714285714285714,0.2656769103166598,1.0,22/28,42.98%,ICAM1;IFNK;TNFSF18;IFNE;MDK;IFNB1;LCP1;ITGAL;IFNA1;FCER1G;EIF2AK4;CD74;IFNA21;IFNA4;IFNA7;IFNA14;IFNA10;IFNA17;CD1C;IFNA2;IFNA16;LILRB1
prerank,negative regulation of DNA recombination (GO:0045910),-0.44533825743426464,-1.4525684637409382,0.041666666666666664,0.2651962545296258,1.0,13/40,22.72%,PARPBP;FANCB;BLM;POLR2F;MSH3;ZRANB3;RMI2;MSH6;POLR2J;POLR2D;RIF1;POLR2I;ATRX
prerank,regulation of centrosome duplication (GO:0010824),-0.4596288184232883,-1.4517186810806597,0.06756756756756757,0.265878661353141,1.0,12/30,25.19%,PKHD1;CEP295NL;CHMP4C;CCNF;NAT10;CEP76;CEP295;CENPJ;ALMS1;NPM1;RAB6C;GEN1
prerank,positive regulation of double-strand break repair (GO:2000781),-0.44158993385659606,-1.4510729765085817,0.04938271604938271,0.26585000365143324,1.0,13/32,26.08%,FANCB;RAD51AP1;TIMELESS;PRKDC;FOXM1;ACTR2;FUS;RIF1;DTX3L;ERCC6;SPIRE2;ARID2;WRAP53
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3239231504125199,1.4508754001907755,0.0,0.1263587642445184,1.0,13/39,18.20%,PER1;NR1D1;TRIM39;ZMYND11;NLRX1;DAB2IP;TLE1;PPM1A;RIPK1;MAPKBP1;PPM1B;RIOK3;RORA
prerank,Wnt signaling pathway (GO:0016055),0.2961882627986005,1.4506919556866116,0.0,0.1261993326636952,1.0,31/91,17.31%,WNT9A;FERMT2;PTEN;DIXDC1;FZD7;WLS;NXN;WNT6;FZD4;DVL3;SKP1;WNT5B;DVL2;UBB;CSNK1E;SFRP1;SNX3;SFRP5;CSNK1A1;CD24;CPE;TCF7L1;GPC4;BTRC;RARG;FRZB;PORCN;ARL6;WNT16;SFRP2;WNT10B
prerank,regulation of myotube differentiation (GO:0010830),0.4035138437704256,1.4500018351750616,0.0,0.1265254412333315,1.0,6/24,6.41%,DMPK;SMYD1;RBM24;MAPK14;HDAC4;HDAC5
prerank,cellular response to insulin stimulus (GO:0032869),0.2918030688220288,1.449940255097613,0.0,0.12622129353805908,1.0,54/125,22.85%,SLC2A4;ATP6V1G2;VAMP2;SORBS1;CAV2;ZFP36L1;INPP5K;FOXO4;KAT2B;CPEB1;RARRES2;ATP6V1E1;PIK3R1;HDAC5;ZDHHC7;RHOQ;GRB14;PDE3B;RAB31;PIK3R3;BAIAP2;SLC27A1;CEACAM1;GRB10;USF1;RAB8B;TCIRG1;LPIN1;PLA2G1B;ZNF106;ATP6V0E2;INS;BCAR3;SOGA1;RAB13;ATP6V1H;PDK2;ATP6V0A1;GRB2;ATP6V1D;FER;LPIN3;CPEB2;SHC1;ATP6V0D1;RAB12;MYO5A;HDAC9;ATP6V0E1;IGF2;PCK1;INSIG2;AP3S1;GAB1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.3623886977612258,1.4498446526233575,0.0,0.1259668492608165,1.0,9/31,8.16%,FAM107A;PTEN;DUSP22;APOD;ARHGAP6;MYOC;CORO1C;PHLDB2;DLC1
prerank,histone H4 acetylation (GO:0043967),0.3416275451409829,1.449541577586706,0.0,0.12585801019490933,1.0,19/48,18.98%,APBB1;PER1;ING4;MORF4L1;DMAP1;ATF2;JADE1;BRD8;MSL1;KANSL3;KAT8;ING3;CHD5;NAA60;JADE2;ACTL6B;TADA3;MSL3;MEAF6
prerank,cytoplasmic microtubule organization (GO:0031122),0.3404118348156221,1.4490229937055783,0.04,0.12594174821216073,1.0,15/54,13.60%,CLIP3;DST;CLIP4;MAPT;FIGN;KATNAL1;RHOA;CLIP1;NUMA1;DCTN1;TUBGCP6;SLAIN2;CEP126;CCDC13;KATNA1
prerank,multivesicular body assembly (GO:0036258),0.389730585923054,1.4477385983245767,0.08,0.12669568847454585,1.0,9/30,15.83%,CHMP3;TSG101;CHMP4A;CHMP7;VPS4A;VPS28;IST1;VPS37D;VPS37A
prerank,regulation of ATP metabolic process (GO:1903578),-0.4235118394423303,-1.4476242435159647,0.046511627906976744,0.2717535583404193,1.0,28/53,33.25%,NUP155;NUP37;NUP210;SHMT2;NUP107;BEND3;RANBP2;NUP35;NUP50;SEH1L;NUP205;NUP88;NUP93;GCKR;POM121;RAE1;UQCC2;EIF6;NUP43;NUP160;NUP153;JMJD8;NDC1;NUP62;NUP98;HIF1A;SEC13;ATP7A
prerank,protein import into nucleus (GO:0006606),-0.3907738633915967,-1.4472961076558266,0.045454545454545456,0.2711271144380478,1.0,29/75,28.98%,RGPD4;NUP62CL;RGPD3;RGPD8;NUP155;KPNA7;CSE1L;SYK;E2F3;NUP107;RANBP2;RANBP17;NUP35;NXT2;NUP50;MMP12;NUP88;NUP93;GCKR;POM121;RAN;TNPO3;HEATR3;KPNA2;NUP153;NXT1;KPNB1;NUP62;IPO11
prerank,regulation of DNA replication (GO:0006275),-0.4252693713520266,-1.4467190142120876,0.041666666666666664,0.27113841211619233,1.0,27/50,36.05%,BLM;MCIDAS;EREG;DSCC1;ESCO2;ATAD5;FBXO5;USP37;DNA2;CDT1;S100A11;GTPBP4;ATR;CDC6;ANKRD17;EGF;PDS5A;GDF2;ORC5;ORC3;DHX9;NPM2;ESCO1;SMC3;ENPP7;FAF1;GMNN
prerank,regulation of epithelial cell migration (GO:0010632),0.3304439057239664,1.4466679871250885,0.0,0.1272071156011488,1.0,16/51,15.29%,PTN;GLIPR2;RHOJ;CORO1C;ENPP2;SASH1;GLUL;HDAC6;DAB2IP;RTN4;CEACAM1;EVL;PPM1F;FGF10;PFN2;PTPN23
prerank,regulation of brown fat cell differentiation (GO:0090335),0.42367658027753974,1.446531677281749,0.0,0.12700102305198924,1.0,7/18,17.62%,TFE3;SOX13;FLCN;FNDC5;PIM1;INS;ZBTB7B
prerank,regulation of protein phosphorylation (GO:0001932),0.27887541124958665,1.4451629482662427,0.0,0.12769955167003658,1.0,56/255,11.17%,CLIP3;TSPYL2;EPHA7;PTEN;WWTR1;PRNP;PPP2R5B;ATF4;FAXDC2;CADM4;VEGFB;HRC;P2RY1;MAPK3;ILK;NPTN;HSPB1;FLCN;FAS;FGF2;CORO1C;FBLN1;INPP5K;DVL3;TERF2IP;RAC1;ITGB3;TARDBP;RARRES2;RSPO1;OCLN;PPP2R5D;DVL2;EFNA5;AKTIP;GPER1;FGF7;PID1;DAB2IP;FKBP8;SOD1;FGF1;AKAP8L;TESK1;PIK3R3;ANKRD54;CDH5;EGFR;FLOT1;FLT4;ANGPT1;ATG14;GPNMB;PIN1;MYADM;APP
prerank,regulation of organelle organization (GO:0033043),0.3045475182641101,1.4447619159191132,0.058823529411764705,0.12796775168764227,1.0,25/76,18.17%,CLIC4;MAPK1;SYT11;SYDE1;PDE2A;NEXN;MAPK3;MAPT;VPS11;MUL1;RHOT2;TBC1D25;RDX;RBSN;SPATA4;GOLPH3;MIEF2;CAPN2;MFF;RAB33B;PLXNB1;SQSTM1;PISD;PARL;SCARB2
prerank,epithelial cell development (GO:0002064),-0.4695177577111182,-1.4446380048813279,0.07246376811594203,0.2744217782634253,1.0,10/21,19.05%,WNT7B;PKHD1;GRHL2;SIX3;POF1B;SIPA1L3;WNT7A;ROS1;EXPH5;PDZD7
prerank,negative regulation of cell development (GO:0010721),-0.46856975199531825,-1.4444368756965476,0.0958904109589041,0.2735412308546082,1.0,12/24,31.94%,IL1B;PAX6;SORL1;WNT7A;WNT3A;GSK3B;TNF;REST;NOTCH1;LTF;FBXW7;IGF1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.3734322461381389,-1.4444333121151858,0.02247191011235955,0.2723566755492699,1.0,30/83,30.59%,MAD2L1;CDK1;PTTG1;SKP2;UBE2C;FBXO5;PSMB9;AURKB;PSMD14;UBE2S;AURKA;ANAPC1;PLK1;CDC20B;PSMA3;CDC20;BUB1B;PSMB3;CDC26;PSMC1;PSMB11;PSMA5;PSMB2;PSME2;PSMD12;PSMA7;CUL3;PSME4;PSME3;UBC
prerank,negative regulation of macroautophagy (GO:0016242),0.39812077208205976,1.444044636539967,0.05555555555555555,0.12795067034147706,1.0,6/24,12.81%,NRBP2;MTOR;CHMP4A;NUPR1;FEZ2;TSC1
prerank,response to interferon-beta (GO:0035456),-0.4771260828812485,-1.4436089999068622,0.025974025974025976,0.2732316072472105,1.0,8/25,12.90%,IFITM3;IFITM1;IFITM2;BST2;IKBKE;STAT1;XAF1;PNPT1
prerank,epithelial structure maintenance (GO:0010669),-0.5156733413602717,-1.443557193768083,0.03389830508474576,0.2720897612871214,1.0,11/15,36.88%,CXADR;TFF1;VSIG1;MUC4;RBP4;SERPINA3;NOD2;MUC2;MUC13;TFF3;PIWIL4
prerank,diol biosynthetic process (GO:0034312),-0.533226418848423,-1.4435314930501182,0.06944444444444445,0.270927158330395,1.0,8/17,25.34%,DHFR;SPTLC1;ASAH2;ASAH2B;SPTLC2;ACER2;GCH1;GBA
prerank,regulation of glucose import (GO:0046324),0.34042594980637164,1.4424375790820967,0.09090909090909091,0.1287837267920129,1.0,12/34,16.65%,SORBS1;OCLN;PIK3R1;PID1;RHOQ;PEA15;GRB10;PLA2G1B;ARPP19;PRKAG2;INS;CREBL2
prerank,chemical homeostasis (GO:0048878),-0.3927856118192033,-1.4422697718933626,0.0625,0.27237900783637653,1.0,20/59,23.17%,SLC4A11;ACOXL;TLCD1;PNPLA3;ANGPTL3;ZBTB20;CETP;AQP9;CEBPA;PNPLA1;VGF;SLC4A9;WNK4;SLC4A8;PPARG;ATP13A2;THADA;ABCB4;ABHD5;HNF4A
prerank,extracellular matrix disassembly (GO:0022617),-0.3911271366467085,-1.4421911760503792,0.056818181818181816,0.27131677366584434,1.0,16/63,11.02%,MMP7;MMP13;TIMP1;KLK7;MMP10;MMP1;MMP11;CTSV;CD44;KIF9;MMP3;MMP2;CAPG;NOXO1;MMP9;TMPRSS6
prerank,regulation of innate immune response (GO:0045088),-0.41022964187336586,-1.4414512264152035,0.037037037037037035,0.27184316027592925,1.0,28/62,31.48%,LRP8;EREG;TNFAIP3;GBP5;IFNK;POLR3B;ABCE1;FPR2;XIAP;USP18;LYAR;POLR3C;ADAM8;IRAK3;ERAP1;IFI16;POLR3G;NMI;TKFC;IFNB1;SAMHD1;CCL5;PTPN22;TLR8;PLSCR1;PTPN11;DHX9;IFI35
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4964879455686142,-1.440986400724922,0.07462686567164178,0.27148797317622375,1.0,4/17,4.88%,STRA6;TBX20;TGFB2;ROBO2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.36826768724973397,1.4388978166097743,0.05263157894736842,0.13149747430628436,1.0,10/29,16.14%,CACNA1H;SYT11;KCNB1;SYT10;SYT4;SYT5;SYT1;SYT6;DOC2B;STXBP1
prerank,regulation of amyloid-beta formation (GO:1902003),0.42346859054847397,1.438764488013502,0.0,0.1312842467024281,1.0,10/34,10.92%,CLU;PRNP;RTN1;CASP3;IFNGR1;EPHA4;HAP1;RTN4;GGA3;PIN1
prerank,response to calcium ion (GO:0051592),0.2978829699174853,1.4384920973425392,0.0,0.13111890834131223,1.0,34/104,15.27%,KCNMB1;ADD1;CLIC4;SYT11;CASQ2;ITPKB;SLC25A12;STIM1;CALM1;KCNMA1;RASGRP2;PKD2;MCOLN1;TRPC1;PRKAA2;SMPD1;AHCYL1;SYT10;MEF2A;SYT4;CALM2;RYR3;NLGN1;SYT5;SYT1;CAPN3;CAMK2D;MEF2C;PEF1;KCNMB4;CHP2;SYT6;CPNE8;KCNMB2
prerank,mitotic nuclear division (GO:0140014),-0.3831397697648947,-1.4372693392286782,0.04938271604938271,0.27899528101755006,1.0,37/68,33.77%,KIF18A;NDC80;KIF2A;SMC4;CENPK;UBE2C;CHEK2;KNSTRN;DSN1;SPAG5;TPX2;ZWINT;UBE2S;PLK1;KIF18B;SPAST;ESPL1;NDE1;MZT1;KIF3B;SMC1A;RAN;NCAPG2;PIBF1;STAG1;ZW10;KIFC1;CDCA8;KPNB1;NUP62;STAG2;TUBG1;NSL1;NUSAP1;KIF25;MISP;SMC3
prerank,neural crest cell migration (GO:0001755),0.3410935270874513,1.4372240772883544,0.0,0.13165613073750054,1.0,13/36,13.82%,ANXA6;RADIL;SEMA4C;CORO1C;SEMA3G;SEMA3B;SEMA6C;SEMA3A;SEMA3C;SEMA3E;SEMA4B;GDNF;SEMA6D
prerank,organic hydroxy compound transport (GO:0015850),-0.4273582577578545,-1.4356012110388814,0.0641025641025641,0.28191081973127075,1.0,11/38,13.07%,STRA6;ABCC11;SLCO1B3;SLC10A1;ABCG5;AQP9;AKR1C4;ABCC2;ABCG8;SLCO1A2;RBP4
prerank,negative regulation of chemotaxis (GO:0050922),0.36228888762916894,1.4344670140602185,0.0625,0.13415131789512655,1.0,12/31,13.82%,SEMA4C;DUSP3;SEMA3G;SEMA3B;ELANE;CORO1B;SEMA6C;SEMA3A;SEMA3C;SEMA3E;SEMA4B;SEMA6D
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.4979982651742215,-1.4343773159002786,0.06578947368421052,0.28321914867238535,1.0,12/17,37.87%,ALG1;ALG8;SRD5A3;ALG2;ALG14;ALG6;DOLK;ALG3;NUS1;MPDU1;ALG12;DPAGT1
prerank,long-term memory (GO:0007616),0.43953681274072015,1.4339845704534415,0.03333333333333333,0.13425990806053403,1.0,6/19,5.34%,SLC2A4;NFATC4;PRNP;PJA2;NPAS4;KAT2A
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3440119343249772,1.4331402196923697,0.0,0.13441445861762066,1.0,10/45,8.37%,LIMS2;FLNA;FERMT2;ILK;MYOC;CORO1C;FBLN1;RAC1;EFNA5;TESK1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.42934910177663693,1.4321745365006282,0.07692307692307693,0.13521726566751033,1.0,8/24,16.11%,RGS2;PDE9A;HAND2;MEF2A;SMAD4;CAMK2D;PRKCA;NR4A3
prerank,regulation of cell killing (GO:0031341),-0.5301471883815712,-1.4321132570457196,0.09090909090909091,0.28760831323248626,1.0,10/17,17.28%,IL11;TGFB2;WNT5A;ICAM1;CR1L;NOXO1;CD55;NOX1;IL10;CYBA
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.29263279789191493,1.4310107967354617,0.0,0.13643261675246057,1.0,25/105,14.18%,TGFB1I1;RBPMS2;CILP;DAND5;FSTL3;EMILIN1;SPRY1;SMAD2;CHRD;FST;BMPR1A;UBB;SMAD7;IL17RD;WFIKKN2;SMAD4;NBL1;PEG10;PIN1;SMAD3;SMAD9;PPM1A;VASN;SKI;MAGI2
prerank,epidermal cell differentiation (GO:0009913),-0.41167665115200075,-1.4307205473678908,0.04878048780487805,0.2895920714575685,1.0,22/47,27.34%,EREG;CDSN;WNT5A;EPHA2;OVOL3;DSP;GATA6;MED1;SCEL;USH2A;ADAM9;PITX2;OVOL1;EVPL;HDAC2;OPN3;S100A7;ANXA1;ST14;OVOL2;BCR;CSTA
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.45496631265423326,1.43049108424962,0.05555555555555555,0.13644269380003596,1.0,5/16,15.28%,DDR2;EFEMP2;EMILIN1;SMAD3;RGCC
prerank,positive regulation by host of viral transcription (GO:0043923),-0.5347738903842756,-1.4303781416959396,0.10144927536231885,0.28928918418992405,1.0,7/16,22.49%,LEF1;TFAP4;SMARCA4;RRP1B;CHD1;HPN;SMARCB1
prerank,antibacterial humoral response (GO:0019731),-0.42224385438380974,-1.4294571007462211,0.012345679012345678,0.2899576075942482,1.0,19/35,33.74%,DEFA6;RPL39;WFDC13;WFDC10A;SEMG1;RNASE7;SLPI;PI3;DMBT1;DEFA1;WFDC3;WFDC12;LTF;ANG;SEMG2;WFDC9;WFDC10B;BPIFA1;WFDC5
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.46435422203853804,1.4287070588191213,0.14285714285714285,0.13783382518111711,1.0,5/15,13.42%,CASP3;NGF;NGFR;HAP1;NTRK1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.4706876152316892,-1.4285820091610455,0.08450704225352113,0.29100050969101704,1.0,6/22,4.05%,THY1;IL1B;IL1RN;SKAP1;CEACAM6;CD44
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.40696355787335253,1.4282929265903646,0.038461538461538464,0.1380243834094866,1.0,8/22,13.49%,RBPMS;WWTR1;CILP;BMPR1A;SH2B1;SMAD4;JAK2;GDF5
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.3658338123823995,1.4281150750963894,0.08823529411764706,0.13793911180636598,1.0,14/33,20.57%,DUSP26;CALM1;MTOR;PRKCD;SMPD1;DLC1;CDH5;CALM2;PIN1;MAGI2;PPP1R15A;AGTR2;CNEP1R1;CALM3
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.4517166234591188,-1.4279741592219395,0.02666666666666667,0.2912778131563158,1.0,8/26,13.88%,POLR2F;POLR1C;TAF1A;POLR1B;CDK7;TAF1B;GTF2H2;POLR1A
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.5344200359038607,-1.427468607641626,0.08108108108108109,0.2912049097919762,1.0,4/16,0.67%,IFITM3;LY6E;IFITM1;IFITM2
prerank,regulation of smooth muscle contraction (GO:0006940),0.4483610372619291,1.4272187578898825,0.04,0.13854006973080174,1.0,7/20,7.40%,CNN1;CHRNA3;MYOCD;SRF;DAPK3;SETD3;CHRM2
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.4441226608115661,-1.4270126047361726,0.02666666666666667,0.2911037328456414,1.0,7/28,3.64%,MYC;WNT2;MIF;EREG;E2F1;FN1;WNT5A
prerank,cytosolic calcium ion transport (GO:0060401),0.4094729255334397,1.426893227224935,0.0,0.13845401549023195,1.0,15/26,20.19%,JPH2;CACNA1C;CACNA2D1;SLC8A2;JPH4;ATP2A2;SLC25A23;SLC8A1;SMDT1;MICU3;MICU1;ADRA1A;JPH3;ATP2B3;CACNB3
prerank,regulation of cell junction assembly (GO:1901888),0.3607768931488564,1.4268507395650658,0.0,0.13818628701610905,1.0,7/27,12.78%,RAP1A;CLDN5;MYO1C;OCLN;PRKACA;FLOT1;MEF2C
prerank,negative regulation of viral life cycle (GO:1903901),-0.5055732225459515,-1.4261255548139076,0.08,0.29183728819989646,1.0,5/19,5.16%,IFITM3;LY6E;IFITM1;IFITM2;BST2
prerank,cellular response to metal ion (GO:0071248),0.27315689136931687,1.4256642196000135,0.0,0.13923674889155158,1.0,43/129,16.56%,CACNA1H;ADD1;PRNP;CLIC4;MAPK1;SYT11;ITPKB;AQP1;MAPK3;SNCA;MAPK8;RASGRP2;PKD2;MT1X;DLG4;SLC41A1;MCOLN1;PRKAA2;SMPD1;BNIP3;B2M;SYT10;MEF2A;SYT4;MT1M;EGFR;RYR3;NLGN1;SYT5;SYT1;CAPN3;CAMK2D;MT3;DLG2;MEF2C;CHP2;SYT6;CPNE8;MT1A;ANK3;DMTN;KCNA1;CARF
prerank,fatty acid transport (GO:0015908),0.41350746250017517,1.425652843600723,0.038461538461538464,0.13892315261026428,1.0,6/20,9.07%,PPARD;CD36;CPT1B;SLC27A3;FABP4;SLC27A1
prerank,DNA biosynthetic process (GO:0071897),-0.5144095370794601,-1.4249647438647224,0.08450704225352113,0.2930516997619099,1.0,6/16,17.35%,RFC3;POLH;POLA1;WRN;TERT;POLD2
prerank,mitotic cell cycle phase transition (GO:0044772),-0.3397513932377707,-1.424686196613567,0.010526315789473684,0.292288255077115,1.0,57/207,19.38%,MYC;CCND1;DBF4;CDKN3;INHBA;CEP72;CDK1;TACC3;SKP2;NEK2;PHLDA1;CEP250;CDC25C;E2F1;TRIM71;UBE2C;CCNO;CHEK2;MASTL;USP37;CCNI2;SPDYA;CDKN2A;CCNE1;PKMYT1;HAUS7;UBE2S;AJUBA;AURKA;E2F3;CCNF;ANAPC1;CDK4;CDK7;RCC1;PLK1;FOXM1;USP26;CDC7;SPAST;HAUS6;CEP76;USH1C;CEP152;CDC25A;EIF4E;NDE1;PLK4;TAF2;CRLF3;SDCCAG8;CENPJ;CKAP5;CCNJ;ALMS1;CEP78;CEP41
prerank,regulation of chemokine production (GO:0032642),0.3084766370726678,1.42428165926565,0.0,0.1394699378148035,1.0,12/42,14.49%,IL6R;ACKR1;TLR3;HMOX1;F2RL1;ELANE;TLR9;TSLP;APP;LPL;IL7;LGALS9
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.45753239001651513,-1.4234296090417156,0.02631578947368421,0.2939455039041268,1.0,10/27,21.65%,ALG11;ST8SIA6;GK;ALG8;GCNT1;GAL3ST2;ALG2;B3GNT5;G6PD;ALG6
prerank,long-chain fatty acid transport (GO:0015909),0.38265322895546783,1.422698610346189,0.041666666666666664,0.14051045566238723,1.0,14/32,21.89%,PRKAB2;ACACB;CD36;PRKAA2;CPT1B;FABP4;SLC27A1;SLC25A20;PRKAG2;ABCD4;SLC27A2;MID1IP1;CPT1A;SLC27A6
prerank,neuron apoptotic process (GO:0051402),0.4159451823576019,1.4224928993769412,0.09375,0.14028612815498998,1.0,9/20,14.93%,ATN1;FAS;NGFR;BNIP3;NLRP1;APP;TNFRSF21;BCL2;FAM162A
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.4108085890880562,-1.4217631749141466,0.10666666666666667,0.29677763000046364,1.0,9/36,13.22%,IL1A;PDGFRB;IL1B;EREG;DLGAP5;EPGN;AURKA;DMRT1;ESPL1
prerank,embryonic limb morphogenesis (GO:0030326),0.35356947878783085,1.4214210156804248,0.0,0.14087111581213976,1.0,16/35,14.67%,OSR1;ECE1;ZNF358;CACNA1C;MYH3;MBNL1;AFF3;INTU;GLI3;HOXA11;FBXW4;MEGF8;OSR2;CYP26B1;SKI;RARG
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.2676516943600542,1.4212415826487759,0.0,0.14091582210080592,1.0,49/219,11.59%,S100B;PER1;FLNA;NR1D1;LPAR1;MAP3K3;TNFSF10;OPTN;TRIM39;BCL10;LITAF;WLS;ZMYND11;HSPB1;TRIM6;TERF2IP;MAP3K14;S100A13;TIRAP;NLRX1;RHOA;APOL3;CCL21;ZDHHC17;GPRC5B;DAB2IP;HMOX1;F2RL1;CASP10;MUL1;TRAF1;LURAP1;RHOC;PRKD1;VAPA;TLR9;TLE1;TICAM2;TRIM21;PIDD1;TNFRSF1A;SLC44A2;CAPN3;TRIM34;CFLAR;TRIM52;PPM1A;ROR1;CX3CL1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.4861688850313793,-1.4202943135580206,0.06493506493506493,0.2994742966558099,1.0,11/18,30.03%,WNT5A;CCL4;CCL3;ADAM10;STK39;XCL2;XCL1;S100A7;CCL5;CXCL13;CCL7
prerank,regulation of GTPase activity (GO:0043087),0.24872545030710555,1.4197819180795554,0.0,0.14189917109149136,1.0,55/181,17.09%,RAP1A;BVES;FERMT2;PLXNB3;CCL14;RGS10;CAV2;ASAP3;FLCN;DVL3;RASGRP2;RAPGEF3;SGSM2;TBC1D20;GNB5;EVI5L;ARL2;FICD;CCL21;EFNA5;EPHA4;GPSM1;DAB2IP;RSU1;RABGAP1;F2RL1;SOD1;CCL2;MAPRE2;FGD6;RDX;SFRP1;SNX18;PRKG1;PIN1;CX3CL1;CCL11;RASIP1;CCL13;SGSM3;RGS1;NTRK1;ADCYAP1;ITGB1BP1;CCL8;RALBP1;BCAR3;SNX9;PRTN3;RAB11FIP2;EPHA3;CCL23;PLXNB1;NDEL1;SRGAP2
prerank,negative regulation of viral genome replication (GO:0045071),-0.38871081427084486,-1.4189213725537642,0.04285714285714286,0.3022335854237553,1.0,27/51,35.85%,IFITM3;IFITM1;IFITM2;OAS2;SRPK1;HMGA2;BST2;PROX1;ISG15;MX1;APOBEC3F;OAS3;SLPI;IFI16;TNF;IFNB1;LTF;CCL5;PLSCR1;APOBEC3B;OASL;IFNL3;BTBD17;APOBEC3A;SRPK2;EIF2AK2;AICDA
prerank,inflammatory response (GO:0006954),-0.32228553472901167,-1.4188983557335322,0.0,0.3010853742240868,1.0,75/220,24.18%,IL1A;CEBPB;CXCL1;CXCL3;CXCL8;CXCL2;CXCL5;ADCY1;IL1B;CXCL9;OLR1;IL1RN;CXCR4;CCL24;CXCL11;RIPK2;CCL20;NAIP;FOS;CCL22;CD44;PF4;TAC4;CCL4;CXCR2;MMP25;MAPKAPK2;PIK3CG;CCL3;FUT7;CXCL6;FPR2;RELA;PARP4;NOS2;CXCL10;NOX1;CCR3;HYAL3;THBS1;TGFB1;VNN1;IL2RA;PROK2;CCL17;CHI3L1;NLRP3;CCRL2;F2R;IFNG;PF4V1;ADAM8;CYBA;CYBB;IL36B;SERPINA3;CCL26;CCL1;LY75;MEFV;FPR3;PRDX5;TNFSF4;ITGB2;PIK3CD;XCL2;IKBKG;IL36RN;XCL1;ABCF1;NFAM1;XCR1;TNF;ANXA1;HMGB1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.24889159666560726,1.4184890668346692,0.0,0.1427889441224491,1.0,59/242,14.51%,KCNMB1;PLP1;PMP22;MPZ;NPTX1;NLGN2;MAPK1;CHRNA3;SNCG;NTSR1;SNCA;NOVA1;PENK;KIF5A;PTCHD1;CALM1;SYN2;DTNA;RPS6KA2;GLRB;SLC12A4;PRKAR2B;CAMK1;SNAP25;CHRNB4;AMPH;HTR3A;DLG4;NLGN4X;PRKACA;SCN2B;CHRM2;NPFF;HAP1;CORT;PAFAH1B1;SYT10;NPY;SST;SYN1;NLGN1;NLGN3;PCDHB4;SYT5;SYT1;CNP;PDE7B;GRIK2;CACNB2;DLG2;SNCB;GRIA4;CAMKK1;KCNMB4;GABARAP;NPTX2;NRXN1;GRIA1;SYNJ2BP
prerank,negative regulation of blood coagulation (GO:0030195),-0.43965104664283483,-1.4159522230179675,0.075,0.3068233509185116,1.0,10/32,12.27%,PLAU;F12;THBD;SERPINE1;SERPING1;F7;KNG1;PROC;PLAUR;F11
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.49222988463006356,-1.4158188253840955,0.07462686567164178,0.30583246928337093,1.0,9/22,29.86%,ENC1;PSMB9;PSMA3;PSMB3;PSMB11;PSMA5;PSMB2;PSMA7;PSME4
prerank,DNA damage checkpoint signaling (GO:0000077),-0.4568071147788377,-1.4156900689044922,0.047619047619047616,0.3048493898658298,1.0,13/30,30.45%,CHEK1;E2F1;INTS7;CHEK2;RPA4;ATR;CLSPN;HUS1;ERCC6;BRIP1;RHNO1;PRPF19;CDC5L
prerank,establishment of mitotic spindle localization (GO:0040001),-0.45566945429962225,-1.4152523020713912,0.08571428571428572,0.3047269812741447,1.0,10/29,16.18%,MAD2L1;NDC80;CENPA;SAPCD2;SPDL1;PKHD1;GPSM2;PLK1;ESPL1;NDE1
prerank,GPI anchor metabolic process (GO:0006505),-0.47019993318026254,-1.4149737802766875,0.038461538461538464,0.30411219630910236,1.0,13/26,31.62%,PIGM;PIGU;PIGW;PYURF;PIGF;DPM1;PGAP1;PIGN;PIGA;PIGB;DPM2;GPLD1;PGAP2
prerank,nuclear envelope organization (GO:0006998),0.415781044777716,1.4138243542361895,0.05555555555555555,0.14710196661886438,1.0,11/21,21.26%,DMPK;TOR1AIP1;TMEM43;SUN2;SUN1;VPS4A;CTDNEP1;EMD;REEP3;LEMD2;NEMP1
prerank,T cell differentiation (GO:0030217),-0.4036734991603081,-1.4134747199582276,0.06666666666666667,0.3058500582900921,1.0,20/41,26.80%,TCF7;SHH;SOX4;CHD7;GPR89A;GPR89B;RAG1;LFNG;ZAP70;RAG2;PTPN2;PIK3CD;SPI1;LCK;GATA3;JAG2;ANXA1;RHOH;CD28;PTPN22
prerank,negative regulation of cell migration (GO:0030336),0.283079648953158,1.4134136964265551,0.0,0.14708811285037976,1.0,36/137,11.98%,TPM1;PLXNB3;PTEN;CITED2;CLDN5;ADARB1;ATP1B2;CLIC4;DPYSL3;VCL;RHOB;DUSP22;MITF;PODN;RECK;FLCN;FGF2;CORO1C;RAC1;DUSP3;NGFR;CHRD;BMPR1A;EPHA4;PHLDB2;DAB2IP;HMOX1;SMAD7;ADORA3;DLC1;IGFBP5;SFRP1;NDRG4;CX3CL1;EVL;TMEFF2
prerank,response to molecule of bacterial origin (GO:0002237),-0.3771909487858555,-1.4119554019187865,0.03488372093023256,0.3075744484727797,1.0,26/68,24.38%,CXCL8;CXCL2;IL1B;CYP27B1;TNFAIP3;IL23R;NOCT;MAPKAPK2;PALM3;NOS2;IRAK1;CITED1;IL10;TRIB1;F2R;SRR;SLPI;IRAK3;GCH1;RPS6KA3;CD6;SMAD6;LBP;S100A7;MAPKAPK3;GPR31
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.4041692969757905,-1.4114862361032126,0.025,0.3071725097815768,1.0,16/64,13.58%,CCND1;CDK1;SOX4;GTSE1;RFWD3;CDC25C;E2F1;PML;CHEK2;PRKDC;ARID3A;AURKA;E2F8;TFDP1;CNOT1;CASP2
prerank,glucose transmembrane transport (GO:1904659),0.423938869251762,1.410963215652414,0.125,0.1492013364917551,1.0,6/18,12.25%,SLC2A4;PPARD;SLC45A1;RAB4B;SLC2A11;SLC2A5
prerank,transepithelial transport (GO:0070633),-0.504989192159121,-1.4104664255655783,0.07246376811594203,0.3087975919130438,1.0,5/16,10.51%,SLC12A2;BEST1;ABCC2;CXADR;RHBG
prerank,protein glycosylation (GO:0006486),-0.3354817765004528,-1.4097411164569684,0.01098901098901099,0.3091198696474592,1.0,45/126,27.35%,POMK;PMM2;GALNT6;B3GNT4;ALG11;ALG10;ST8SIA6;ALG1;ALG1L2;MGAT2;FUT8;ALG8;MGAT5;RPN2;FUT1;B3GALNT2;GFPT1;FUT7;STT3A;STT3B;RPN1;TET3;ALG5;DPM1;SLC39A8;MAGT1;PGM3;FUT10;POFUT1;ALG2;B3GNT5;FUT2;PLOD3;B3GNT2;FUT6;B3GNT3;ALG6;GALNT7;FUT5;ALG3;TET2;B4GALT7;C1GALT1C1;DDOST;TET1
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.47016767036814533,-1.4096828302483384,0.012987012987012988,0.308127480870463,1.0,8/26,8.75%,PPAT;PAICS;HPRT1;MTHFD1;ADK;GART;PNP;SHMT2
prerank,negative regulation of axonogenesis (GO:0050771),0.3977443480908046,1.4095448783393203,0.09090909090909091,0.15024410042861952,1.0,10/28,8.99%,PTEN;ULK1;ULK2;PTPRS;SEMA3G;NGFR;RHOA;MAP2;RTN4;GDI1
prerank,protein K48-linked deubiquitination (GO:0071108),-0.4804169496889261,-1.409210365509808,0.09333333333333334,0.3078362641221539,1.0,4/21,3.86%,OTUB2;USP50;TNFAIP3;USP37
prerank,nucleocytoplasmic transport (GO:0006913),-0.42949992536524983,-1.4082818599985947,0.09090909090909091,0.3087697884441372,1.0,26/40,41.92%,SMN1;SNRPD1;SNRPG;SNRPF;RSRC1;NXT2;CITED1;NCBP1;NUP205;ANP32A;NPM1;SNRPB;NEMF;SNRPE;SNRPD3;NXT1;NUP98;GEMIN5;XPO1;SNRPD2;HTATIP2;LSG1;MALT1;RITA1;NUTF2;GEMIN6
prerank,dendritic cell migration (GO:0036336),-0.4888096817024366,-1.4078775662456628,0.07936507936507936,0.30842539264532237,1.0,8/18,29.75%,CXCR4;TRPM2;CXCR2;PIK3CG;CXCR1;HMGB1;CCL5;CCR6
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.4580889657639301,-1.407814549757683,0.08108108108108109,0.30739778378487925,1.0,7/19,12.78%,MYC;SHH;FOXD1;PAX2;SIX1;PAX8;CITED1
prerank,cellular response to inorganic substance (GO:0071241),-0.48861889490029814,-1.4078136399133234,0.08974358974358974,0.3062464812238872,1.0,9/18,23.04%,DPEP1;BLM;TIMELESS;MMP3;ADCY10;DDI1;KCNC2;ATRX;FMR1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5249022160386327,-1.407106415583498,0.047619047619047616,0.3063080585665614,1.0,6/18,11.24%,CLDN1;CLDN2;CLDN16;CLDN14;CLDN20;CLDN6
prerank,innate immune response (GO:0045087),-0.3210396132262764,-1.4068782696998234,0.0,0.3056910239364619,1.0,97/278,26.02%,IFITM3;IFITM1;SIGLEC15;IFITM2;RNF39;UBD;IFI6;CLPB;SRMS;F12;TREM1;SKP2;RIPK2;CLEC5A;CYP27B1;PML;COLEC10;SRPK1;KYNU;C3;CLEC6A;IL23R;BST2;SERINC5;ISG15;LCN2;MX1;DEFA6;SYK;NLRC5;PIK3CG;SHMT2;RPL39;RELA;WFDC13;NOS2;WFDC10A;APOBEC3F;CORO1A;IRAK1;ZAP70;PGLYRP4;CXCL10;FRK;CITED1;CXCL16;VNN1;ATAD3A;FYN;TRIM17;NCF2;RNASE7;PPP1R14B;KIR2DS4;CR1;CARD9;ANKRD17;SLPI;CYBA;CYBB;PHB;PI3;NOD2;PGLYRP3;SIRPB1;PGLYRP1;TREML1;MEFV;TRIM14;DMBT1;GCH1;TRIM22;PIK3CD;PGLYRP2;POLR3A;PPARG;OTULIN;DEFA1;IKBKG;LCK;KLRC2;TKFC;TYROBP;LBP;LYN;CLEC7A;S100A7;HMGB1;CAPZA1;ADAM15;WFDC3;WFDC12;LTF;YES1;TRIM31;IFNL2;RNASE8
prerank,negative regulation of macrophage activation (GO:0043031),0.4147983539158406,1.4056904932107446,0.08333333333333333,0.15366468912038117,1.0,5/15,16.81%,NR1D1;SYT11;CX3CL1;LRFN5;NR1H3
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.3674199924122402,1.4055159053801354,0.1,0.15363659616715353,1.0,14/33,20.29%,SORBS1;PLIN5;MTOR;NR1H2;SLC27A1;CREB1;INS;SREBF1;CTDNEP1;CREBL2;NR1H3;ELOVL5;CNEP1R1;MID1IP1
prerank,negative regulation of cell motility (GO:2000146),0.28019212632042934,1.4049138360842945,0.10526315789473684,0.15369647754965132,1.0,28/109,11.98%,TPM1;PLXNB3;PTEN;CITED2;CLDN5;ADARB1;CLIC4;DPYSL3;VCL;RHOB;DUSP22;MITF;PODN;RECK;FLCN;FBLN1;DUSP3;NGFR;CHRD;EPHA4;SMAD7;ADORA3;DLC1;IGFBP5;SFRP1;PIN1;CX3CL1;TMEFF2
prerank,negative regulation of wound healing (GO:0061045),-0.44382349169869495,-1.4048119481165338,0.046875,0.3094962222150794,1.0,7/26,7.42%,SLC12A2;EPPK1;CASK;THBD;SERPINE1;KNG1;PROC
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.4724622754217919,-1.4034796377250434,0.08108108108108109,0.3114869031130767,1.0,12/22,31.84%,IL21;RASGRP1;RAET1E;HLA-F;HLA-G;CRTAM;KLRC2;CD160;NCR3;RAET1G;SLAMF6;CD226
prerank,regulation of amyloid-beta clearance (GO:1900221),0.4470278739937149,1.403356909811074,0.0967741935483871,0.1548956814057015,1.0,4/16,5.59%,CLU;MYOCD;SRF;IFNGR1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.333715974789197,1.4022381162070163,0.0,0.15587099709359595,1.0,32/70,28.15%,SDHA;COX4I2;NDUFA11;COX6A2;NDUFC2;NDUFA5;NDUFS2;NDUFB8;NDUFB10;UQCRFS1;NDUFS4;SDHAF2;SDHD;UQCRC2;NDUFV2;COX7C;NDUFAF1;NDUFA8;UQCR11;NDUFS8;NDUFV1;NDUFA13;NDUFC1;UQCR10;UQCRB;NDUFS5;NDUFA6;COX6C;COX8A;NDUFA10;NDUFB6;NDUFV3
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.4233232738320769,-1.400333502520622,0.04054054054054054,0.31759017438887727,1.0,18/39,33.63%,PARPBP;FANCB;CHEK1;RAD51AP1;TIMELESS;RMI2;FIGNL1;ACTR2;FUS;RIF1;PPP4C;ERCC6;ARID2;WRAP53;POLQ;KDM1A;ZNF365;HELB
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.36650829801950824,1.3982058312005559,0.08695652173913043,0.1601587198165121,1.0,14/39,14.06%,FHL1;FXYD6;FXYD1;SCN3B;ANK2;SCN2B;SCN1B;GPD1L;AHCYL1;FXYD7;FGF12;SCN4B;TRPC6;RIPK1
prerank,regulation of peptidase activity (GO:0052547),-0.4906799322733147,-1.3981202799778634,0.1267605633802817,0.32159267821108495,1.0,9/20,27.34%,PRSS22;CTSH;CAV1;PSMA3;CSTB;ATP13A2;CST7;A2ML1;CSTA
prerank,cellular response to reactive oxygen species (GO:0034614),0.31612401345319824,1.3980996027988775,0.058823529411764705,0.1598991469594543,1.0,15/62,9.53%,TPM1;MAPK1;RHOB;AQP1;MAPK3;MAPT;MAPK8;MAPK7;PKD2;PRKCD;HDAC6;PDGFRA;PXN;ZNF580;EGFR
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.43569457148771706,-1.3979428879376299,0.05263157894736842,0.32064944429199854,1.0,7/25,12.59%,BLM;MSH3;ZRANB3;ZNF91;DNMT3L;ZNF93;MSH6
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.43217683065739154,1.3975030083979447,0.08695652173913043,0.16003175858417898,1.0,6/15,15.03%,PRKCD;ORMDL1;PLA2G6;TNFRSF1A;SIRT3;SAMD8
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.3308189076914568,-1.3973692331445393,0.0,0.3208101624290513,1.0,84/307,25.65%,EXO1;ORC6;DBF4;CHEK1;INHBA;BLM;RFC3;MCM4;CDK1;POLE2;FAM111B;IGF2BP3;TICRR;POLR2F;TIPIN;E2F1;TIMELESS;RMI1;RPA3;FEN1;RECQL4;DNA2;RFC5;TOP1MT;RMI2;POLA1;MCM7;MCM10;RAD9B;YARS2;RPL39;GCNT1;PAX8;MCM3;MRPL3;TOPBP1;RRBP1;MRPS18C;TAF1B;RBBP8;SRBD1;RPA4;TOP1;CDC7;WRN;TERT;MCM2;MCM5;ATR;CLSPN;NKX2-8;RNASEH2A;RPS19;POLR2J;RFC2;GAL3ST2;FARSB;SET;CDC6;ASMT;MCM6;POLD2;CDC45;RPS21;POLR2D;BRCA1;HUS1;MRPS16;MRPL13;RPL36;BARD1;POLR3A;ZAR1L;ABCF1;POLR2I;ORC1;EXT1;PTMA;RPL23A;BRIP1;RPL37;RHNO1;TUFM;MRPL9
prerank,response to peptide (GO:1901652),-0.4301249552348418,-1.3967052130601518,0.05194805194805195,0.32102055860245504,1.0,14/36,18.57%,MMP13;IRS1;CALCR;MMP3;MMP2;STAT1;MMP9;FYN;MMP12;REG3A;CHRNA7;STAT5A;STAT5B;NOD2
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3192874075221356,1.3964904124593953,0.03571428571428571,0.1604673033689163,1.0,7/46,5.36%,LIMS2;FLNA;FERMT2;ILK;MYOC;RAC1;OBSL1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.3606123417961884,1.3964401263579391,0.038461538461538464,0.16029527071588984,1.0,5/22,10.34%,CLU;NR1H2;WFS1;CREB3;UBXN1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.33706062160154837,1.395879310018484,0.05,0.1605988655188999,1.0,11/34,15.29%,PTEN;DCN;CORO1C;NR2F2;DAB2IP;PTPRM;EVL;SVBP;SYNJ2BP;PFN2;PTPN23
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.3705595659999692,-1.3947127609457568,0.04597701149425287,0.32434497112074157,1.0,29/66,28.94%,POLR2F;CSTF2;MAZ;POLR1C;TAF1A;SMN1;CPSF3;POLR1B;CDK7;SNRPG;TTF2;SNRPF;POLR3K;TAF1B;GTF2H2;POLR1A;CSTF1;NCBP1;ZNF473;GTF2H3;CPSF2;CCNH;SNRPB;SETX;SNRPE;SNRPD3;CPSF4;TAF1D;CSTF3
prerank,membrane repolarization (GO:0086009),0.4194187005558168,1.3946895137469553,0.034482758620689655,0.16115963588927915,1.0,6/15,12.66%,ATP1B2;KCNH2;ATP1A2;KCNE2;KCND3;KCNE4
prerank,positive regulation of hormone secretion (GO:0046887),-0.49353748043168455,-1.3946616824763316,0.10666666666666667,0.3233549316925174,1.0,5/17,12.63%,TFR2;SPP1;HCAR2;CYP19A1;PLA2G3
prerank,bicellular tight junction assembly (GO:0070830),-0.3947133838606766,-1.3931639684290245,0.06097560975609756,0.32554063513238013,1.0,13/49,11.24%,CLDN1;CLDN2;CLDN16;PARD6B;CLDN14;CLDN20;FRMPD2;GRHL2;PECAM1;MARVELD2;ECT2;POF1B;CLDN6
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.26037448841289385,1.393151303355963,0.1,0.16236281845661954,1.0,49/167,17.10%,S100B;FLNA;LPAR1;MAP3K3;TNFSF10;BCL10;LITAF;WLS;TRIM6;TERF2IP;MAP3K14;S100A13;TIRAP;RHOA;APOL3;CCL21;ZDHHC17;GPRC5B;HMOX1;F2RL1;CASP10;MUL1;LURAP1;RHOC;PRKD1;VAPA;TLR9;TICAM2;TRIM21;TNFRSF1A;SLC44A2;TRIM34;CFLAR;TRIM52;PPM1A;ROR1;CX3CL1;MIB2;RIPK1;LGALS9;TFRC;SECTM1;IFIT5;RNF31;EDA2R;TRIM68;UBE2V1;PRKCB;TRIM8
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.3867702805183129,-1.393144053148963,0.05333333333333334,0.32440304817531274,1.0,14/64,15.05%,CEBPB;CCND1;CDK1;LEF1;SOX9;CDKN2A;HNF1A;CBFB;CDK4;RELA;MED1;MED14;PAXIP1;MED13
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.3854529700418208,-1.392762232285462,0.0125,0.32414747269257377,1.0,26/73,24.10%,CDK1;SOX4;GTSE1;CDC25C;E2F1;PML;CHEK2;ARID3A;TFAP4;AURKA;MYO6;FOXM1;E2F8;BATF;TFDP1;CNOT1;CASP2;PAXIP1;ACER2;MDM2;CARM1;CNOT10;CNOT11;ATRX;HIPK2;E2F7
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.3901287832260548,1.3927619523366157,0.0,0.16240268935404928,1.0,12/31,12.52%,FSTL3;LTBP4;SMAD2;FSTL1;FST;TGFBR3;TWSG1;LATS2;SMAD7;SMAD4;SMAD3;DKK3
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3076776710814952,1.391936999090371,0.07692307692307693,0.16295604241603215,1.0,17/73,13.33%,CLU;PTEN;ZER1;BAG2;SIRT2;DNAJB2;RNF217;TRIB2;SMAD7;RNF144B;CSNK1E;RNF14;PIAS1;CSNK1A1;RNF180;ZYG11B;GABARAP
prerank,negative regulation of cation channel activity (GO:2001258),0.34467103609161376,1.3909041109535347,0.038461538461538464,0.16389146673752072,1.0,6/26,5.08%,CASQ2;GSTM2;CALM1;CLIC2;GNB5;PKD2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3406151391608951,1.3907556547352502,0.1,0.16379997672232985,1.0,17/34,22.40%,MFN2;MYOC;FLCN;SPRY1;KCTD10;LZTR1;DAB2IP;DLC1;MAPKAP1;RASIP1;ITGA3;KANK1;TNFAIP1;SYNGAP1;ARHGAP24;HEG1;SPRY3
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.446585122662858,1.3903981173297966,0.10344827586206896,0.16366634072426897,1.0,8/15,16.09%,ST6GALNAC3;A4GALT;ST8SIA1;B3GALT4;ST3GAL5;ST6GALNAC5;ST8SIA3;ST6GALNAC6
prerank,regulation of adenylate cyclase activity (GO:0045761),0.38010100834647365,1.390284505944383,0.030303030303030304,0.16344838238895132,1.0,5/22,5.62%,CAP2;PALM;STIM1;CACNA1C;GNAI2
prerank,negative regulation of fat cell differentiation (GO:0045599),0.36793059874557416,1.3884962680033102,0.07142857142857142,0.1647137229255228,1.0,13/36,12.25%,FERMT2;WWTR1;FLCN;SIRT2;ARNTL;ZADH2;GPER1;TRIB2;GPS2;BBS12;SMAD3;GATA2;RUNX1T1
prerank,cytosolic transport (GO:0016482),0.2935432837099207,1.3880096216399875,0.0,0.16483259814880313,1.0,44/108,26.16%,RAB9B;RAB6B;SNX1;CORO7;WDR91;TBC1D17;ANKFY1;STX16;DENND2A;AKTIP;VTI1B;DCTN1;DENND5A;KLHL20;RBSN;TBC1D10A;VPS26B;VAMP3;GBF1;RILP;PTPN23;STX8;AP2A1;SNX2;RAB14;MAGEL2;GGA1;RAB29;VPS52;WDR81;SYS1;SORT1;GOSR2;EHD3;STX10;BET1L;SNX16;RHOBTB3;CCDC91;PIK3C3;RAB7A;PREPL;BAIAP3;CLN3
prerank,positive regulation of fat cell differentiation (GO:0045600),0.33310412926264726,1.3878945263470106,0.09090909090909091,0.16461356563650736,1.0,21/51,17.62%,PPARD;LMO3;TFE3;SOX13;ZFP36L1;RARRES2;ZFP36;ID2;FNDC5;MEDAG;ZNF385A;SFRP1;PIM1;CREB1;LPL;TMEM64;INS;FRZB;CREBL2;SFRP2;ZBTB7B
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.5100697236695807,-1.387823652073591,0.04918032786885246,0.3344927818848433,1.0,8/15,34.10%,MIF;CD44;MDM2;ARMC10;TWIST1;RNF34;KDM1A;CD74
prerank,regulation of biomineral tissue development (GO:0070167),-0.46278989940435394,-1.3876634303373112,0.10606060606060606,0.33370750913774433,1.0,8/24,12.70%,NOTUM;CEBPB;BMP2K;CYP27B1;FBXO5;SOX9;ANKH;TGFB1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.37492560068153064,1.3876186318511448,0.038461538461538464,0.16456380129311576,1.0,7/23,9.79%,PDE2A;NUDT10;NT5E;PDE9A;NUDT11;NUDT16;ACAT1
prerank,membrane organization (GO:0061024),0.2427315576292752,1.387415585162366,0.0,0.16443024460907904,1.0,60/238,16.44%,DMPK;BTC;VAMP2;FNBP1;REEP1;SYNGR1;PIP5K1C;TOR1AIP1;CHMP3;MFN2;VAMP4;TMEM43;FZD4;CORO1C;TRIP10;SUN2;AP2M1;ARPC2;SYP;PACSIN2;ANK2;AMPH;DVL2;SUN1;UBB;VTI1B;CHRM2;A4GALT;ACTB;GLTP;CHMP4A;VAPA;IGF2R;EGFR;EPN2;MTCH1;OXA1L;SNX3;CHMP7;AP2A2;SYT1;MYADM;MYOF;AVPR2;DYSF;AZIN2;VPS4A;VAMP3;TFRC;SNX9;NECAP1;HSPA8;ADRB2;SH3GLB1;ANK3;SLC18A3;RABEP1;CTDNEP1;RTP5;AP2A1
prerank,negative regulation of transposition (GO:0010529),-0.462198267598725,-1.3851666156986233,0.08108108108108109,0.33794292948097204,1.0,8/24,17.55%,PIWIL1;BTBD18;ZNF91;ZNF93;SPOCD1;APOBEC3F;TEX19;MYBL1
prerank,import into nucleus (GO:0051170),-0.3751547785044375,-1.3851334849937367,0.0449438202247191,0.3368064019189581,1.0,44/76,42.64%,NUP62CL;NUP155;CSE1L;SYK;SMN1;SNRPD1;E2F3;SNRPG;NUP107;SNRPF;RANBP17;NXT2;NUP50;MMP12;NUP88;NUP93;GCKR;POM121;RAN;TNPO3;HEATR3;NUP153;SNRPB;SNRPE;SNRPD3;NXT1;KPNB1;NUP62;IPO11;GEMIN5;SEC13;SNRPD2;NUP214;IPO7;HTATIP2;POM121L2;RPAIN;TPR;IPO5;POM121C;AKT1;NUTF2;GEMIN6;FAM53A
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.524205458870968,-1.3844276422774255,0.0684931506849315,0.3375177575444819,1.0,4/15,7.51%,C2CD4A;OSM;IL1B;FFAR2
prerank,diterpenoid metabolic process (GO:0016101),0.2879641737961255,1.3836536322621786,0.0,0.16781789964860921,1.0,23/59,19.93%,RDH5;ADH1B;SDC2;LRAT;GPIHBP1;ALDH1A1;SDC3;RARRES2;GPC1;AKR1B1;CLPS;RLBP1;LPL;GPC4;AKR1C1;GPC3;AKR1B10;HSPG2;GPC6;ALDH3A2;CYP4V2;DHRS3;AKR1C3
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.2730690053987879,1.3826309013958804,0.0,0.16843099068539344,1.0,33/112,13.69%,FERMT2;CLDN5;CILP;PDE2A;DUSP22;ZFP36L1;SMAD2;MAPK7;TGFBR3;ARHGEF18;RHOA;BMPR1A;CLEC3B;HPGD;PXN;UBB;TWSG1;GCNT2;LRRC32;SMAD7;PDE3A;CDH5;WFIKKN2;SMAD4;SFRP1;SMAD3;ZMIZ1;SMAD9;PARD3;MEF2C;GDF5;SKI;ITGB5
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3436511069071587,1.3823423441671336,0.1,0.16829024205251822,1.0,6/31,9.16%,CLIP3;STMN2;SNCA;MAP2;TUBB4A;CDH5
prerank,response to cytokine (GO:0034097),-0.33825125582518656,-1.3806587156731236,0.02127659574468085,0.3452159961478706,1.0,39/145,14.87%,IFITM3;IFITM1;IFITM2;UBD;TIMP1;LAMP3;IRAK2;POU4F1;IL1B;MME;LEF1;CXCR4;CYP27B1;PML;KYNU;JAK3;IL23R;BST2;IKBKE;ISG15;MX1;FOXA2;MAPKAPK2;ASAH2;STAT1;XAF1;SHMT2;RELA;BCL2L1;COL3A1;IL1RL2;IRAK1;CITED1;FOXH1;NLRP12;CXCL16;CHI3L1;PTPN7;ADAM10
prerank,protein K63-linked deubiquitination (GO:0070536),-0.4427720834168237,-1.3803548856751031,0.0641025641025641,0.34479691695607834,1.0,6/28,8.75%,OTUB2;USP50;TNFAIP3;PSMD14;BRCC3;SHMT2
prerank,negative regulation of kinase activity (GO:0033673),0.3097448463279032,1.3798206783331342,0.058823529411764705,0.17035764473112275,1.0,17/58,14.08%,WWTR1;DBNDD2;MAPT;SNCA;HSPB1;CDKN1C;INPP5K;PRKRIP1;TRIB2;CEACAM1;DUSP19;TAB1;DEPTOR;GNAQ;ITGB1BP1;PPM1F;PRKAG2
prerank,post-translational protein modification (GO:0043687),0.22036252338599804,1.3788533318728275,0.0,0.1712110852748792,1.0,85/330,16.17%,ASB2;SPARCL1;FBXO32;HIF3A;LAMB2;KCTD7;CHRDL1;SDC2;FBXO10;FSTL3;HRC;RAB3A;DCAF8;FBXL22;DCAF5;FBXO9;PENK;WSB1;KLHL21;MFGE8;FBXO17;LAMC1;IGFBP4;FBXO44;SKP1;FSTL1;FBXO31;OBSL1;FBXL7;ASB5;WDTC1;KLHL42;ASB8;FBXL5;UBE2F;TNC;ASB1;MXRA8;WFS1;FBXO30;SOCS2;HSP90B1;NEDD8;KLHL41;SCG2;PSMC5;FAM20C;IGFBP5;FBXO27;SPSB1;KLHL20;ASB3;LAMB1;COPS7B;BTBD6;NUCB1;COPS7A;KLHL22;COPS4;APP;SCG3;FBXW4;RAB11B;LRRC41;KLHL5;FBXW5;RNF7;FEM1B;EPAS1;GPC3;DCAF6;PSMD9;COPS8;CDH2;BTRC;FBXL15;VWA1;PNPLA2;PSMB6;KLHL13;FBXL12;KCTD6;PRSS23;RAB13;IGFBP7
prerank,regulation of TOR signaling (GO:0032006),0.3002793234093113,1.3774824536010555,0.0,0.17214396742434349,1.0,20/67,17.11%,EPM2A;FBXO9;FLCN;FAM83D;ARNTL;RRAGA;PRKAA2;GNA12;TNFAIP8L1;RRAGD;DEPTOR;GOLPH3;RRAGB;TSC1;LAMTOR3;RRAGC;RHEB;ARAF;WDR59;GAS6
prerank,regulation of small molecule metabolic process (GO:0062012),0.3761235906615589,1.3772531496429226,0.06896551724137931,0.17199673734659693,1.0,15/27,26.61%,FMO5;ACADVL;GNB3;BCKDK;PDK2;EPHX2;RORA;NR1H4;PDK3;SIRT1;ARV1;PDK4;ADIPOQ;ACADL;APOE
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.3899100676315258,1.37676797697435,0.06896551724137931,0.17185011190982677,1.0,7/23,7.94%,DYNC1I1;MAP6;KIF5A;TUBA1A;KIF1C;KIF5C;KIF1A
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.3126242463162227,1.376100513338916,0.0,0.17236369493559767,1.0,10/48,13.26%,CRYAB;JAM3;CLU;PRRT2;ULK1;HDAC6;THRA;PPM1A;RAF1;PTGER4
prerank,cellular response to type I interferon (GO:0071357),-0.37792585050967165,-1.3760573177198494,0.024691358024691357,0.3535240961613886,1.0,15/65,12.01%,IFITM3;IFITM1;IFITM2;IFI6;EGR1;OAS2;BST2;ISG15;MX1;IFIT3;STAT1;XAF1;IRAK1;HLA-F;IRF8
prerank,type I interferon signaling pathway (GO:0060337),-0.37792585050967165,-1.3760573177198494,0.024691358024691357,0.3535240961613886,1.0,15/65,12.01%,IFITM3;IFITM1;IFITM2;IFI6;EGR1;OAS2;BST2;ISG15;MX1;IFIT3;STAT1;XAF1;IRAK1;HLA-F;IRF8
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.45923190117197005,1.3759624069503464,0.041666666666666664,0.1720934952728578,1.0,6/16,14.18%,FSTL3;FST;SMAD7;CSNK2B;SKI;MAGI2
prerank,nervous system development (GO:0007399),0.236210279824165,1.3756415921923346,0.0,0.17198862728162223,1.0,84/439,10.44%,S100B;MAL;MAB21L2;PMP22;PTN;GPM6B;MPZ;GFRA1;GSN;NPTX1;ATN1;RBFOX3;GFRA3;PTEN;WWTR1;LPAR1;NLGN2;TAGLN3;TMOD2;CHRNA3;NUMBL;GPM6A;SDHA;CRMP1;L1CAM;GBA2;APAF1;NAB2;FGF2;PTPRZ1;ZNF358;DNER;NGF;NRSN2;NFASC;LY6H;GLRB;TRIM3;LRCH4;PKD2;SPOCK1;OBSL1;IRF2BPL;ZC4H2;HDAC4;LGI1;PPP2R5D;ROGDI;GFRA2;SCRG1;TEAD1;KIRREL3;MBNL1;EFNA5;DLG4;PKD1;ARNT2;LDB2;ADAM23;DPF2;DCTN1;CHRM2;DCLK1;LSAMP;DCHS1;MYLIP;HAP1;SCD5;INTU;SMPD1;DPYSL2;NRSN1;PRX;TRAK2;TPP1;FGF12;NLGN1;NBL1;FEZ2;PCDHB15;NLGN3;RBFOX2;BTBD6;PCDHB4
prerank,mesenchyme morphogenesis (GO:0072132),-0.4702500961285129,-1.375278368157205,0.09230769230769231,0.3540693362508848,1.0,4/17,5.28%,TBX20;TGFB2;SOX9;ENG
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.413130299799947,1.3749261607166294,0.125,0.17217100154186896,1.0,7/17,14.38%,ADD1;CLDN5;VCL;PPP1R12A;CDH5;TNFRSF1A;S1PR2
prerank,myeloid cell development (GO:0061515),0.42898639155665363,1.3748069452511023,0.10714285714285714,0.17190284109128753,1.0,7/19,17.24%,KIT;NCKAP1L;ZNF385A;APP;ANXA2;DMTN;NRROS
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.3603631669391098,1.3747815729123989,0.15625,0.17155415378684272,1.0,9/26,11.98%,ARHGAP6;MYOC;INPP5K;ARHGEF18;PIK3R1;PHLDB2;DLC1;WASF2;TMEFF2
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3714945468377578,-1.3746517823633997,0.03571428571428571,0.3542023593479553,1.0,25/71,23.86%,TNFSF11;UBD;CSF2;DHRS2;LEF1;E2F1;PML;DCSTAMP;EPHA2;CEBPA;SNX10;RUNX1;CDK4;MMP9;BATF;EFNA2;TGFBR2;IFNG;PIK3CD;PPARG;BMP4;SPI1;IFI16;TYROBP;BATF2
prerank,regulation of trans-synaptic signaling (GO:0099177),0.3596080913956485,1.374601844722043,0.0,0.1712883276857678,1.0,16/34,17.13%,NLGN2;GRIK5;NGF;GRIK3;NLGN4X;PSMC5;NLGN1;NLGN3;LRRC4C;GRIK2;ARC;NTF3;PXK;IQSEC2;EIF4EBP2;GRID1
prerank,positive regulation of cytokine production (GO:0001819),-0.31560504050039984,-1.3745818482620644,0.0,0.35313715581066174,1.0,130/325,30.74%,IL1A;CEBPB;OSM;CSF2;CD80;CARD11;IL1B;MIF;POLR2F;EREG;RIPK2;SERPINE1;CD276;IL23A;EGR1;POLR1C;GBP5;WNT5A;C3;ZP3;CLEC6A;PRKDC;SLC7A5;IL12RB2;IL23R;IL17A;ISG15;IL17F;IL21;RASGRP1;PNP;HSPD1;SYK;FFAR2;RUNX1;SORL1;POLR3B;PIK3CG;ZFPM1;NFKB2;IL12B;RELA;DRD2;POLR3K;NOS2;PRKCZ;IRAK1;NOX1;BATF;AGT;G3BP1;TGFB1;ITK;IL10;CHI3L1;NLRP3;F2R;IFNG;LTB;CARD9;ZBP1;POLR3C;CYBA;PHB;HLA-G;CD86;EIF2AK3;CCL1;TRAF2;CD46;BRCA1;NOD2;IL26;CRLF2;PRKCQ;MMP8;TNFSF4;PIK3CD;IL27;POLR3A;TIGIT;PIBF1;IFI16;GAPDH;CRTAM;IL12RB1;CD6;MDK;CD2;POLR3G;XCL1;GATA3;NFAM1;TYROBP;LBP;NODAL;TNF;CLEC7A;GDF2;GLMN;SCIMP;ANXA1;HMGB1;CREBBP;XBP1;ROCK2;PDE4B;IL13;TLR7;CD28;TWIST1;HPSE;PTPN22;NLRP10;TMEM106A;SLAMF6;XRCC5;LILRB2;CD58;CD244;AIRE;TLR8;SULF2;IRF7;MAPK13;IFNL1;TXK;MYD88;PTPN11;DHX9
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.4496789923502651,-1.3745761865234967,0.0547945205479452,0.35198373886677164,1.0,10/28,14.23%,CHEK1;BLM;CDK1;TICRR;HMGA2;BRCC3;CDC14C;PLK1;TOPBP1;CLSPN
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.3072780192117338,-1.3736811761571748,0.0,0.35283599973569846,1.0,97/328,23.48%,MYC;CCND1;EXO1;CHEK1;TP73;BLM;RFC3;RAD51AP1;XRCC2;UBE2T;CDK1;POLE2;TICRR;FANCF;RFWD3;TDP1;CCNK;E2F1;PML;CHEK2;MSH3;MASTL;TIMELESS;ZRANB3;SPDYA;RAD51B;RAD54L;PRKDC;POLH;IKBKE;FEN1;DCUN1D5;TRAIP;MAPK15;BCL2A1;RECQL4;POLB;LIG1;RFC5;EPHA2;RMI2;POLA1;FANCL;MAPKAPK2;MCM7;MCM10;RAD9B;ERCC8;XIAP;NEK4;BCL2L1;PARP4;RAD18;PARP2;BCL6;TOPBP1;WDHD1;RBBP8;BATF;NUDT1;MSH6;WRN;SLX1A;CASP2;FANCA;SUV39H1;ATR;FANCC;TNFRSF1B;RFC2;CTLA4;CBX3;TOP2A;ACER2;TRRAP;RNF169;MNDA;BRCA1;UNG;RBBP5;HUS1;SMC1A;SHPRH;RIF1;BARD1;APTX;FBXO45;VCPIP1;IKBKG;NABP1;NPM1;CHCHD6;DTX3L;FMR1;PDS5A;LYN;GTF2H3
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.39852126060900994,-1.3728363370807772,0.06329113924050633,0.3533743543386346,1.0,11/49,12.61%,GNL3L;PRR7;SOX4;TNFAIP3;FBXO5;PRMT3;CAV1;ISG15;PRKCG;GTPBP4;LIMK1
prerank,regulation of axon extension (GO:0030516),0.341460556152087,1.3724640125459906,0.09523809523809523,0.17386854955874437,1.0,11/38,13.02%,NTN1;L1CAM;MAPT;PTPRS;DBN1;SEMA3G;MAP2;RTN4;SEMA3A;MT3;OLFM1
prerank,digestive tract morphogenesis (GO:0048546),0.4489746039463104,1.3721515080903788,0.06666666666666667,0.17392361357027725,1.0,6/15,10.07%,RBPMS2;FOXF1;TCF21;PDGFRA;ID2;FGFR2
prerank,protein-containing complex disassembly (GO:0032984),0.30915297988654916,1.3718341880199534,0.1111111111111111,0.1738165402624244,1.0,19/54,18.59%,GABARAPL1;MAP1LC3C;CHMP3;LIX1L;DVL3;TSG101;GABARAPL2;DVL2;VTI1B;LIX1;MAP1LC3A;CSNK1A1;GABARAP;VPS4A;HSPA8;MAP1LC3B;VIPAS39;VPS16;VPS33A
prerank,negative regulation of execution phase of apoptosis (GO:1900118),-0.5052985762792829,-1.3717416777958193,0.13636363636363635,0.35544463471857757,1.0,7/16,36.82%,MTRNR2L3;BCL2L1;MTRNR2L5;RNF34;MTRNR2L4;PAK2;MTRNR2L7
prerank,regulation of interleukin-10 production (GO:0032653),-0.3962459368725871,-1.3714447138373087,0.08,0.35495820512088005,1.0,22/46,26.62%,FOXP3;IL23A;JAK3;IL23R;ISG15;HSPD1;SYK;IL12B;PRKCZ;LILRB4;CD46;NOD2;MMP8;TNFSF4;TIGIT;PIBF1;XCL1;TYROBP;CLEC7A;HMGB1;IL13;CD28
prerank,positive regulation of lipid kinase activity (GO:0090218),0.3416645433493095,1.371248669998681,0.0967741935483871,0.17415427112289023,1.0,10/30,10.38%,KIT;FGF2;TNFAIP8L3;PDGFRA;CCL21;PDGFB;P2RY12;EEF1A2;PRKD1;ATG14
prerank,regulation of endopeptidase activity (GO:0052548),-0.391452558857131,-1.3710173486204582,0.08536585365853659,0.35503820947261117,1.0,21/61,21.72%,SERPINB5;SERPIND1;TIMP1;SERPINE1;SERPINA10;PSMB9;SERPINA4;SERPING1;SERPINE3;CRB2;KNG1;SERPINA7;SERPINB7;AGT;PRELID1;PSMA3;SERPINA3;SERPINB1;FETUB;ATP13A2;GAPDH
prerank,regulation of interleukin-12 production (GO:0032655),-0.39338839470571907,-1.370996282217282,0.0625,0.3538781363982141,1.0,22/51,24.18%,RIPK2;IL23A;JAK3;IL23R;IL17A;HSPD1;SYK;IL12B;THBS1;IL10;IFNG;LTB;HLA-G;IRAK3;MEFV;TNFSF4;TIGIT;PIBF1;MDK;CLEC7A;SCIMP;HMGB1
prerank,protein destabilization (GO:0031648),0.3398050775755632,1.3702476054581154,0.08,0.17521634883101403,1.0,10/33,14.67%,GSN;NR1D1;PRNP;SNCA;MUL1;TRIM21;GGA3;CAPN3;SOX17;BTRC
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.4395853326492421,1.369946052010551,0.08333333333333333,0.17514756855234268,1.0,6/18,11.48%,APOD;FLCN;RAB23;LATS2;SUFU;MDFIC
prerank,establishment of spindle orientation (GO:0051294),-0.4319722175216444,-1.3699184515687626,0.06666666666666667,0.3551500035567466,1.0,8/30,10.22%,MAD2L1;NDC80;CENPA;SAPCD2;SPDL1;PKHD1;GPSM2;PLK1
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.4255352694387015,1.3698826839239389,0.08823529411764706,0.17487828410384662,1.0,7/16,19.85%,PDE9A;HAND2;MEF2A;CAMK2D;PRKCA;NR4A3;SLC9A1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.4474932682500431,-1.3679441807276007,0.06666666666666667,0.3593640055966573,1.0,10/28,22.30%,AZGP1;CD1A;IL23A;IL23R;IL12B;CD1B;HLA-F;HLA-G;IL12RB1;XCL1
prerank,mitotic recombination (GO:0006312),-0.48235197092155674,-1.3677567403989983,0.10666666666666667,0.35866426310367594,1.0,8/15,38.39%,RAD54B;MSH3;GEN1;SMC6;NSMCE2;DMC1;RAD51D;SMC5
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.3947068281719501,-1.3676238178791296,0.025,0.35789988450387056,1.0,20/61,20.53%,MYC;RFC3;PDGFRB;DSCC1;NEK2;DKC1;AURKB;MAPK15;RFC5;GRHL2;NAF1;ATR;FBXO4;RFC2;CCT6A;CCT2;FGFR4;PRKCQ;HMBOX1;CHTF18
prerank,receptor signaling pathway via STAT (GO:0097696),0.37766415138294,1.3672738836874103,0.047619047619047616,0.17737529972292515,1.0,9/25,13.37%,IFNAR1;PKD2;PKD1;SOCS2;CCL2;STAT6;PIAS1;CLCF1;JAK2
prerank,regulation of osteoblast proliferation (GO:0033688),0.4692564299552733,1.3666803940786572,0.038461538461538464,0.17770259834927002,1.0,6/16,16.58%,RHOA;MN1;SFRP1;FGFR2;NPR3;PLXNB1
prerank,keratinocyte differentiation (GO:0030216),-0.41227096217468057,-1.36655730967783,0.08536585365853659,0.3592108980385364,1.0,16/35,27.34%,EREG;CDSN;WNT5A;EPHA2;DSP;MED1;SCEL;ADAM9;EXPH5;EVPL;OPN3;S100A7;ANXA1;ST14;BCR;CSTA
prerank,aorta morphogenesis (GO:0035909),0.4216085849103951,1.3659985082014579,0.10526315789473684,0.17814834834968435,1.0,5/17,6.99%,MYLK;HEY1;EFEMP2;BMPR1A;RBPJ
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.26755656690167756,1.3655487021916515,0.0,0.17827363153935796,1.0,23/99,13.65%,TGFB1I1;CITED2;DAND5;LTBP4;CDKN1C;EMILIN1;FLCN;SPRY1;SMAD2;TGFBR3;UBB;LATS2;SMAD7;IL17RD;WFIKKN2;SMAD4;PEG10;PIN1;SMAD3;PPM1A;DKK3;VASN;SKI
prerank,spliceosomal snRNP assembly (GO:0000387),-0.40757096243154917,-1.365369385332799,0.08433734939759036,0.36127000127580317,1.0,16/38,33.78%,TGS1;SMN1;SNRPD1;SNRPG;SNRPF;WDR77;CLNS1A;PRPF6;LSM4;SNRPB;SNRPE;SNRPD3;PRPF19;GEMIN5;PRMT5;SNRPD2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.2934234035093522,1.3649209221648417,0.07142857142857142,0.1786369732531187,1.0,20/75,13.05%,PLXNB3;FGFR1;NRP2;AGTR1;VIP;VEGFB;FGF2;THBS4;ITGB3;EGFL7;HMOX1;PDGFB;SCG2;ZNF580;PRKD1;FLT4;ARNT;GATA2;CCL11;PRKCA
prerank,signal transduction in response to DNA damage (GO:0042770),-0.3793285397654232,-1.3643304433048635,0.09090909090909091,0.36297287482650026,1.0,19/50,28.40%,CHEK1;E2F1;INTS7;CHEK2;MYO6;RPA4;BATF;ATR;CLSPN;PAXIP1;ACER2;HUS1;ATRX;E2F7;ERCC6;BRIP1;RHNO1;USP10;PRPF19
prerank,lymphocyte activation involved in immune response (GO:0002285),-0.4615406484098608,-1.3641677916466148,0.09230769230769231,0.3621588739162059,1.0,18/24,41.66%,IFNK;IFNE;MDK;IFNB1;LCP1;CD244;IFNA1;EIF2AK4;CD74;IFNA21;IFNA4;IFNA7;IFNA14;IFNA10;IFNA17;CD1C;IFNA2;IFNA16
prerank,protein palmitoylation (GO:0018345),0.3720211438617018,1.363085857993946,0.17647058823529413,0.18026865870310324,1.0,13/29,20.83%,CLIP3;GLUL;ZDHHC7;ZDHHC17;ZDHHC15;ZDHHC22;ZDHHC18;GOLGA7;PORCN;ZDHHC1;ZDHHC20;ZDHHC11;ZDHHC8
prerank,cilium-dependent cell motility (GO:0060285),-0.4544548426471573,-1.3628593031769525,0.08108108108108109,0.3640067940375587,1.0,7/22,16.69%,DNAH2;DNAH8;RSPH9;DNAH7;DNAH3;DNAAF2;TEKT5
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.3380047509966148,1.3627543165252287,0.1111111111111111,0.1805078354554959,1.0,13/45,9.37%,RBPMS2;IL6R;MFN2;FOXJ2;MEF2D;FGF2;ADAMTS1;BMPR1A;ID2;HMOX1;PDGFB;ELANE;IGFBP5
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.4636204992252681,-1.3625129956674817,0.06666666666666667,0.36398687097559246,1.0,16/25,38.67%,TNFAIP3;CARD17;NLRP3;LILRB4;MEFV;SERPINB1;CARD16;GHSR;NLRP7;ZC3H12A;IGF1;CX3CR1;GHRL;PYDC1;PYDC2;FFAR4
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3929661719317439,1.3623704395583716,0.05714285714285714,0.1803508262495706,1.0,7/22,7.54%,PTEN;CDKN1A;MYOCD;CDKN1C;NR2F2;HHEX;LATS2
prerank,regulation of cellular component organization (GO:0051128),0.2519619971844608,1.3607054159561554,0.0,0.18169342323123797,1.0,37/136,17.40%,FAM107A;RAP1A;STON1;AGTR1;LTBP4;RAB5B;EGLN2;WFDC1;RASGRP2;MTOR;PIFO;SPOCK1;PACSIN3;SLITRK2;PACSIN2;CD36;DAB2IP;ANGPTL7;SOCS2;RAB4B;CEACAM1;BAP1;MARK4;PACSIN1;CAMK2D;PTCH2;TFRC;SGK1;HSPA8;RUFY1;TAOK2;SNX17;SETD1A;RAB33B;RIT2;RAB5C;STK38L
prerank,glycosaminoglycan catabolic process (GO:0006027),0.31343326396302706,1.3606664414188827,0.0,0.18137722872379505,1.0,18/55,14.84%,PRELP;LYVE1;CSPG4;DCN;SDC2;FGF2;OGN;SDC3;GPC1;IDS;HGSNAT;HPSE2;GUSB;GPC4;KERA;GPC3;OMD;FMOD
prerank,establishment of vesicle localization (GO:0051650),0.40611619715608327,1.3600106032975023,0.2,0.1815337856775821,1.0,5/18,8.37%,SYT11;KIF5A;SNAPIN;KIF5C;TESK1
prerank,regulation of JNK cascade (GO:0046328),0.2817226320076217,1.3598500056187097,0.0,0.18149365010983487,1.0,31/102,16.49%,PER1;FZD7;DUSP22;ZMYND11;GADD45B;PJA2;MTURN;DUSP3;TIRAP;TGFBR3;CCL21;DAB2IP;F2RL1;TRAF1;TLR9;MAP4K2;EGFR;DUSP19;FLT4;MAPK8IP1;GPS2;APP;SEMA3A;ANKRD6;GADD45G;RIPK1;RASSF2;TAOK2;EDA2R;MAPK8IP3;WNT16
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.27245402981439465,1.3595548377929405,0.0,0.1814536707116119,1.0,56/172,20.02%,PTEN;PIP5K1C;AGPAT1;PLA2G5;PLA2G4B;ABHD4;INPPL1;PI4KB;FGF2;LCAT;INPP5K;PITPNM2;PLD6;PIK3R1;PIP4K2B;MTMR9;CDIPT;DGKG;CHKB;GPD1L;PIK3R3;DDHD2;SLC27A1;PLA2G4C;PI4K2A;DGKE;CSNK2B;AGPAT4;INPP5E;BMX;CSNK2A2;SLC44A2;LPIN1;PLEKHA4;PLA2G1B;DGKB;ABHD8;PIP4K2A;CDS2;ETNK2;PLA2G4A;RUFY1;PCYT1A;ARF1;INPP5F;PISD;INPP5J;RAB14;MTMR12;FAR1;LPCAT4;OCRL;INPP4A;ABHD3;PTDSS2;LPIN3
prerank,inorganic anion transmembrane transport (GO:0098661),-0.36241782542569795,-1.358850321988209,0.047619047619047616,0.37244978976519,1.0,28/65,31.30%,SLC12A2;GABRP;SLC12A8;CLCN1;GABRB1;GLRA1;GABRD;SLC5A6;GLRA2;CFTR;CLCN3;GABRR1;GABRE;SLC12A3;SLC4A8;SLC12A5;SLC12A1;GABRB2;GABRA1;SLC5A1;GABRA3;GABRG3;ANO9;SLC37A1;SLC5A5;GABRR3;GABRQ;GABRA4
prerank,wound healing (GO:0042060),0.2721769116472096,1.3587259845112294,0.037037037037037035,0.1818044879310113,1.0,23/66,14.32%,TPM1;SYT11;FZD7;DST;ANXA6;RAB3A;FGF2;SRF;ITGB3;PDGFRA;HMOX1;SMPD1;FGF1;MYOZ1;CORO1B;SMAD3;CFLAR;MYOF;ARL8B;RAF1;DYSF;FGF10;INS
prerank,microtubule depolymerization (GO:0007019),-0.48457367891916575,-1.3585487968031944,0.10666666666666667,0.3722455168324605,1.0,8/18,18.28%,KIF18A;KIF14;KIF24;KIF2A;KIF2C;KIF18B;NCKAP5;CKAP5
prerank,regulation of glycolytic process (GO:0006110),-0.3737509656563473,-1.3583193151145467,0.04395604395604396,0.3715718078474695,1.0,35/68,32.95%,PFKFB3;NUP155;GAPDHS;PFKFB4;NUP37;ZBTB20;NUP210;NUP107;RANBP2;NUP35;NUP50;SEH1L;NUP205;IFNG;NUP88;MLXIPL;PFKFB1;NUP93;GCKR;POM121;RAE1;EIF6;NUP43;NUP160;NUP153;JMJD8;NDC1;FBP1;TIGAR;NUP62;NUP98;HIF1A;IGF1;SEC13;NCOR1
prerank,neurotransmitter transport (GO:0006836),0.28566516538297054,1.3582486969887602,0.0,0.1818420379530036,1.0,27/72,19.79%,VAMP2;RAB3A;ATP1A2;SNPH;SLC5A7;SLC29A1;SYN2;GLUL;SNAP25;SNAPIN;SYN1;SLC17A7;SLC6A16;BRSK1;SYT1;SLC38A2;NRXN1;HSPA8;SLC6A15;SLC18A3;STXBP1;LIN7A;NRXN2;LIN7B;NAAA;STXBP3;DVL1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.3207496231739212,1.3576455497488198,0.125,0.18211292081740105,1.0,13/40,13.25%,FXYD6;FXYD1;OSR1;SLMAP;SCN3B;SCN2B;SCN1B;GPD1L;FXYD7;FGF12;SCN4B;CAMK2D;DMD
prerank,inorganic anion transport (GO:0015698),-0.37435747748719245,-1.3575852726677617,0.08235294117647059,0.37204197804336386,1.0,13/53,10.98%,SLC4A11;CLCN1;RACGAP1;SLC26A8;BEST1;SLC34A3;SLC13A4;TTYH3;SLC34A1;CLIC3;SLC26A9;GLRA1;CLCN4
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.27698315179162936,1.3572981797158465,0.0,0.1821885683239446,1.0,22/71,15.90%,IL6R;BCL2L2;MOAP1;TLR3;FAS;CASP3;NGF;BAG3;MLLT11;P2RX7;DAB2IP;TNFRSF1A;SMAD3;BOK;DEDD;BCL2;GABARAP;JAK2;BAD;RIPK1;RNF41;IL12A
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.3455157420650975,-1.3563898044738774,0.05952380952380952,0.374402446866734,1.0,48/107,30.84%,IL1A;CXCL1;CXCL3;CXCL8;CXCL2;CXCL5;CD80;IL1B;CXCL9;CXCL11;SERPINE1;TNFAIP3;CARD17;WNT5A;TNIP3;PF4;DEFA6;CXCL6;RELA;IRAK1;CXCL10;IL10;TNFRSF1B;NLRP3;ADAM9;PF4V1;IL36B;PLAA;CD86;NOD2;TNFSF4;DEFA1;IL36RN;CARD16;AXL;LBP;HMGB1;XBP1;IL37;PDE4B;CXCL13;NLRP7;CDC73;ZC3H12A;LILRB2;PDCD1LG2;MYD88;IL36G
prerank,ERAD pathway (GO:0036503),0.2866686894043608,1.3561133625286472,0.0,0.18334929009439616,1.0,36/81,25.24%,DNAJC18;FBXO17;FBXO44;WFS1;USP19;DNAJB2;HSP90B1;RNF185;TMUB2;FAM8A1;UBE2G2;UBXN6;FBXO27;POMT2;ANKZF1;TMEM129;UBE4B;DNAJB12;RNF175;SGTA;BAG6;DERL3;SEL1L;MAN1A1;SYVN1;ATXN3;RCN3;HERPUD1;RNF5;UBQLN2;SGTB;DNAJB14;DERL2;DNAJB9;USP13;UBE2J2
prerank,positive regulation of kinase activity (GO:0033674),0.27242501098426153,1.3550961236876535,0.0,0.18407997384033262,1.0,33/111,16.05%,RAP1A;EPHA7;FGFR1;DDR2;KIT;MAPT;CDKN1A;ROR2;MAPRE3;TIE1;PIFO;PDGFRA;CCL21;EPHA4;LMO4;EEF1A2;EGFR;DUSP19;FLT4;FGFR2;EPHB6;MMD;ROR1;CAMKK1;NTRK1;ADCYAP1;PRKAG2;RASSF2;SNX9;NTRK3;MMD2;EPHA3;RET
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.40649514794186625,-1.354677307974225,0.10714285714285714,0.37728085858262655,1.0,15/34,24.18%,RIPK2;IL23A;IL23R;IL17A;HSPD1;SYK;IL12B;IFNG;LTB;HLA-G;TNFSF4;MDK;CLEC7A;SCIMP;HMGB1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.4670548172008455,-1.3543385439458067,0.1282051282051282,0.37748510221697124,1.0,9/22,25.85%,CHEK1;AURKB;ZWINT;CHMP4C;BUB1;BUB1B;WEE2;NABP1;ZW10
prerank,androgen metabolic process (GO:0008209),-0.4792383988972848,-1.3543300598328922,0.04,0.3762980421471065,1.0,13/20,33.21%,SHH;SPP1;AKR1C4;SRD5A3;CYP19A1;MED1;SRD5A1;UGT2B7;AKR1D1;HSD3B1;SRD5A2;HSD17B4;HSD17B10
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.36409564934454663,-1.3541967673773585,0.023529411764705882,0.3754703385493283,1.0,16/74,9.64%,CD80;IL1B;MIF;EPHB2;CD276;IL23A;ZP3;JAK3;IL23R;IL21;CD81;PNP;IL12B;CD70;SLC7A1;CHRNB2
prerank,regulation of intracellular pH (GO:0051453),-0.3926954725021719,-1.3541084943385677,0.11538461538461539,0.3744724009201989,1.0,10/35,19.16%,SLC9C1;GPR89A;GPR89B;SLC9A7;SLC9B1;NOX1;SLC4A9;CFTR;SLC4A8;TM9SF4
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.4653190131580984,1.3541002481103588,0.08,0.18492369544095588,1.0,7/15,17.07%,CSPG4;DCN;UST;CHST14;CSGALNACT2;DSEL;B3GAT3
prerank,camera-type eye development (GO:0043010),-0.41859751672633144,-1.352193635376652,0.13513513513513514,0.3775024779686412,1.0,9/25,20.78%,STRA6;FOXE3;PAX2;FBN2;NF1;SHROOM2;FOXL2;PITX2;LAMA1
prerank,regulation of ossification (GO:0030278),-0.40922832364903605,-1.352190689763669,0.0945945945945946,0.37633011002463923,1.0,8/34,5.25%,NOTUM;TGFB2;KREMEN2;BMP2K;CYP27B1;WNT5A;SOX9;LRP4
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.4998222535655351,-1.3520925956327978,0.1111111111111111,0.374266947141283,1.0,8/17,18.82%,IRS1;SOCS1;JAK3;IL7R;SMARCA4;STAT5A;STAT5B;CRLF2
prerank,cellular response to interleukin-7 (GO:0098761),-0.4998222535655351,-1.3520925956327978,0.1111111111111111,0.374266947141283,1.0,8/17,18.82%,IRS1;SOCS1;JAK3;IL7R;SMARCA4;STAT5A;STAT5B;CRLF2
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.3484206949743371,1.351836253771021,0.04,0.18734433616771493,1.0,11/33,16.48%,VEGFB;HSPB1;MAPK14;DAB2IP;RAMP2;PRKD1;FLT4;ITGB1BP1;VEGFC;NR4A1;SEMA6A
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.2831282886184558,1.3518079451071796,0.05555555555555555,0.18698612519989902,1.0,23/79,15.61%,TNFSF10;MAPT;SNCA;APAF1;FAS;CASP12;NGF;NGFR;CASP10;MUL1;DLC1;NLRP1;MTCH1;PIDD1;SMAD3;CFLAR;BOK;NKX3-1;JAK2;BAD;RIPK1;FAM162A;BCL2L13
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.327905873392348,1.3510004234377722,0.0,0.18747393156099446,1.0,12/51,11.38%,RBPMS2;CHRDL1;DAND5;FSTL3;GREM2;CHRD;FSTL1;BMPR1A;SMAD7;SMAD4;NBL1;SMAD9
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.4346193689964649,-1.3503139263438113,0.05714285714285714,0.3775410145853577,1.0,10/23,27.36%,SLC39A10;CD81;RUNX1;CBFB;GCSAM;NFAM1;LYN;PAX5;PTPN22;ELF1
prerank,protein acylation (GO:0043543),0.3429487985865797,1.34970388347062,0.0,0.18861132058123697,1.0,9/37,10.13%,ING4;KAT2B;GLUL;KAT2A;ZDHHC7;ZDHHC17;ZDHHC15;ZDHHC22;ZDHHC18
prerank,regulation of mRNA processing (GO:0050684),0.3427775024956337,1.3492931117647884,0.03333333333333333,0.18886469920911766,1.0,7/35,8.78%,ZFP36L1;PABPN1;JMJD6;SRPK3;SF1;QKI;AHCYL1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.39992497983250724,1.3491994889894945,0.10344827586206896,0.1886590206901471,1.0,9/18,24.86%,HSPB1;MAPK7;SOD1;INS;NME5;NOL3;SIRT1;NFE2L2;SOD2
prerank,purine nucleotide metabolic process (GO:0006163),-0.4497287935566308,-1.348775023887129,0.08450704225352113,0.38004171336298964,1.0,8/24,15.10%,PPAT;HPRT1;MTHFD1;GART;PNP;ITPA;NUDT15;NT5C2
prerank,regulation of NMDA receptor activity (GO:2000310),0.3503941686284,1.3483048113424692,0.11538461538461539,0.1890637585270182,1.0,15/32,18.12%,DAPK1;NEFL;DLG4;CCL2;NLGN1;APP;DLG2;MEF2C;GRIA4;SLC6A9;GRIA1;LRRC7;GRIA2;ACTN2;CAMK2A
prerank,cholesterol biosynthetic process (GO:0006695),-0.39709577029858983,-1.3474116754274874,0.11940298507462686,0.3820550735628478,1.0,13/32,27.50%,CYP51A1;IDI2;SQLE;MVK;DHCR7;SC5D;FDPS;NSDHL;G6PD;TM7SF2;ACAT2;HMGCS1;DHCR24
prerank,regulation of T cell activation (GO:0050863),-0.4111933482740413,-1.3463847908653197,0.07894736842105263,0.3833074679981574,1.0,19/45,22.32%,THY1;TNFSF11;IL4I1;JAK3;HSPD1;TNFSF9;VTCN1;PRELID1;TNFRSF1B;TNFSF18;SIT1;TNFSF8;SIRPB1;PRKCQ;IL27;TIGIT;CRTAM;CD2;LCK
prerank,cellular response to cytokine stimulus (GO:0071345),-0.3040667920603268,-1.3459741596124428,0.02040816326530612,0.38337931355105803,1.0,163/468,25.99%,MYC;IL1A;CCND1;CXCL1;IL11;TNFSF11;CXCL8;CXCL2;TCF7;OSM;TDGF1;SLC12A2;IFITM2;CSF2;LRP8;COL1A2;TIMP1;IRAK2;CD80;POU4F1;IL1B;MME;LEF1;IL20RA;EREG;IL1RN;CXCR4;CCL24;SOCS3;CCL20;MMP1;FN1;IL23A;EGR1;GBP5;FOS;JUNB;WNT5A;DUSP1;SOCS1;ICAM1;CCL22;SOX9;DCSTAMP;DUOX2;JAK3;ABL2;IL12RB2;IL23R;IL19;PF4;IL17A;IL13RA2;MMP3;ADAMTS12;CCL4;LCN2;IL17F;IFNK;MMP2;CEBPA;SYK;IL5;GBP7;CCL3;ASAH2;STAT1;ZEB1;PRLR;IL12B;ZNF675;RELA;BCL2L1;IL22RA2;NOS2;ITGAX;BCL6;IL1RL2;MMP9;IRAK1;CXCL10;IRF8;HYAL3;BATF;TGFB1;FOXH1;INPP5D;PNPT1;NLRP12;CSF2RA;DUOX1;IL2RA;CCL17;FYN;GBP1;IL10;TNFRSF1B;CHI3L1;PTPN7;IFNGR2;BIRC5;STK39;DOCK8;LIF;TEC;OPRM1;PHB;IL36B;CD86;CCL26;FASLG;STAT5A;NFAT5;STAT5B;IRAK3;CCL1;NANOG;MNDA;IL24;BRCA1;IL26;PTPN2;CRLF2;PIK3CB;IL20;SLA2;IL31;IFNE;ITGB2;PIK3CD;PTPRJ;XCL2;IL36RN;IFI16;GAPDH;SDC1;IL20RB;GSK3B;IL12RB1;IL27RA;XCL1;LCK;POU4F2;GATA3;AXL;OCSTAMP;LBP;TNF;BAG4;IL10RA;ANXA1;IFNB1;GBP3;XBP1;CSF3R;PTPN4;IL37;GBA;IL13;IL2RB;SELPLG;CCL5;IFNL2
prerank,regulation of necroptotic process (GO:0060544),0.3941788673384946,1.345529272527349,0.041666666666666664,0.19144454188482946,1.0,6/23,14.06%,SLC25A4;YBX3;FLOT1;CFLAR;FLOT2;RIPK1
prerank,negative regulation of T cell proliferation (GO:0042130),-0.3999875640363489,-1.345206955058758,0.10526315789473684,0.384386228630164,1.0,12/34,17.66%,CEBPB;FOXP3;CD80;IL4I1;VTCN1;PLA2G2F;ARG1;IL10;CR1;LILRB4;HLA-G;CD86
prerank,organic acid transport (GO:0015849),-0.3566907304282358,-1.3451437444005165,0.06818181818181818,0.383415716109775,1.0,38/98,27.84%,SLC6A14;SLC7A11;SLC6A20;ABCC11;SLCO1B3;FOLR1;SLC10A1;SLC26A8;AKR1C4;SLC38A5;ABCC2;SLC6A6;SLC16A10;SLC25A47;SLC1A5;SLC7A1;SLC13A5;SLC5A6;SLC1A4;SLCO1A2;LRRC8D;SLC7A6;SLC22A13;SLC6A18;SLC46A1;SLC19A1;SLC13A3;SLC38A3;SLC25A48;SLC7A7;SLC10A5;SLCO1C1;SLC27A5;SLC26A1;SLC7A4;SLC3A2;SLC7A10;SLC6A12
prerank,small GTPase mediated signal transduction (GO:0007264),0.29318982794366477,1.3429517040249312,0.0,0.1943857193600048,1.0,22/105,10.48%,RERG;NTN1;DIRAS3;CDKN1A;SHC2;ARHGAP33;RRAS;FGF2;MRAS;RAC1;RASGRP2;MAPK14;ERAS;RGL2;RRAD;ARL3;ARHGEF18;MAPK11;RGL1;PRKD1;ARHGAP1;NUCB1
prerank,protein-DNA complex assembly (GO:0065004),-0.3379343477261461,-1.3413667661125563,0.06666666666666667,0.3920878781888813,1.0,47/115,34.32%,ORC6;MCM4;CHAF1B;ERCC5;CHAF1A;PSMB9;SOX9;RPA3;PSMD14;MCM7;CDK7;MCM3;CDT1;GTF2H2;MCM2;MCM5;CDC6;MCM6;PSMA3;SPTY2D1;PSMB3;NPM1;ATRX;ORC1;PSMC1;GTF2H3;PSMB11;PSMA5;CCNH;PSMB2;PSME2;PSMD12;PSMA7;ORC2;MCM8;DMC1;ORC5;PSME4;GRWD1;PSME3;UBC;ORC3;ERCC2;ANP32B;PSMD1;CENPV;PADI4
prerank,sensory perception of smell (GO:0007608),-0.33544596079829475,-1.3410961226020588,0.06451612903225806,0.39158467491777865,1.0,96/103,59.35%,OR2A7;OBP2B;OR6A2;OR10A5;OR2A4;OR2D2;DRD2;OR51B5;GFY;OMP;OR5B21;OR5M11;OR1K1;OR8D4;OR51I2;OR51M1;OR8B12;OR52D1;OR4D1;OR51I1;OR51B6;OR2A25;OR1Q1;ADCY3;OR2S2;OR1D2;OR13G1;OR8B2;OR52A1;OR8B3;OR1D5;OR8A1;OR9Q2;OR6K3;OR10K1;OR8B8;OR8G1;OR4E2;OR5AK2;GPR148;OR10A3;OR9I1;OR8D2;OR10J1;OR12D2;OR10Z1;OR2M4;OR5M1;OR5M10;OR8B4;OR10K2;OR1C1;OR9Q1;OR6K2;OR10J3;OR9G4;OR6C2;OR12D3;OR51B4;OR5B12;OR6N2;OR6C3;OR8D1;OR52A5;UBR3;OR5L1;OR8H2;OR6K6;OR5B3;OR10T2;OR5B17;OR51V1;OR5D18;OR8H3;OR5AP2;OR5D16;OR8K3;OR10R2;OR8H1;OR5M8;OR5D14;OR5M9;OR8U1;OR5I1;OR8K1;OR5AC2;OR5L2;OR5D13;OR8J3;OR8I2;OR8G5;OR5M3;OR5F1;OR8K5;OR5B2;OR8J1
prerank,mitotic cytokinesis (GO:0000281),-0.39060870353383403,-1.3405631184570856,0.09876543209876543,0.3919247587505138,1.0,16/48,18.08%,CEP55;KIF23;INCENP;KIF20A;CENPA;RACGAP1;MYH10;KIF4B;ECT2;PLK1;SPAST;ESPL1;ANLN;TTC19;RTKN;CKAP2
prerank,T cell activation (GO:0042110),-0.33451317921271917,-1.3405578295444849,0.07407407407407407,0.3907548340975272,1.0,38/91,27.08%,FOXP3;SOX4;CD276;CD44;CHD7;GPR89A;GPR89B;IFNK;RASGRP1;HSPD1;CXADR;PIK3CG;LFNG;ZAP70;TREML2;ITK;MSN;CD3G;MICB;PTPN2;SLA2;IFNE;TNFSF4;PIK3CD;CRTAM;MDK;CD2;LCK;GATA3;JAG2;CLEC7A;CD8B;IFNB1;RHOH;CD28;DDOST;PTPN22;LCP1
prerank,negative regulation of ATPase activity (GO:0032780),0.42568071939847657,1.3396235546070543,0.19047619047619047,0.19822510844218458,1.0,10/16,22.30%,PLN;SLN;TLR9;OXA1L;TSC1;VCPKMT;PXK;PAM16;IFIT1;SIRT1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.40411872083408007,1.3387195023120932,0.14285714285714285,0.19917605945540734,1.0,7/15,13.49%,WNT5B;NPHP3;CSNK1E;DAAM2;SFRP1;RSPO3;GPC3
prerank,vitamin transport (GO:0051180),-0.43645070285552834,-1.337714396457816,0.05333333333333334,0.3974643145224331,1.0,9/28,22.12%,TCN1;FOLR1;SLC2A14;SLC5A6;TTPA;SLC52A3;SLC46A1;SLC19A1;SLC52A2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.32545428861445275,1.337674440900998,0.05555555555555555,0.20012344217214517,1.0,15/50,13.17%,BAG2;GABARAPL2;ECSCR;PKD1;USP19;PRKACA;UBB;DAB2IP;PSMC5;GNA12;ALAD;NUPR1;KCNE2;OSBPL7;RHBDF1
prerank,negative regulation of autophagy (GO:0010507),0.32734566205136534,1.3359232012017708,0.0,0.20163238983922968,1.0,18/56,18.34%,NRBP2;WDR6;SNCA;SIRT2;SNRNP70;MTOR;RRAGA;MTMR9;NUPR1;KLHL22;MT3;TSC1;RASIP1;BCL2;LEPR;GOLGA2;ZKSCAN3;STAT3
prerank,protein sumoylation (GO:0016925),-0.3945952046561283,-1.3355949580326052,0.06097560975609756,0.401302477399195,1.0,28/53,35.05%,NUP155;RNF212B;NUP37;EYA1;NUP210;NUP107;RANBP2;NUP35;NUP50;SEH1L;NUP205;NUP88;NUP93;POM121;RAE1;NUP43;NUP160;NUP153;NSMCE2;NDC1;NUP62;SUMO4;NUP98;EGR2;RANGAP1;UBA2;ZNF451;NUP214
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.3988693063700358,-1.3351067810956356,0.06666666666666667,0.4010493130338337,1.0,15/39,22.88%,CHEK1;BLM;CDK1;TICRR;HMGA2;BRCC3;CDC14C;PLK1;TOPBP1;CLSPN;CDC6;BRCA1;HUS1;NABP1;ORC1
prerank,positive regulation of chemotaxis (GO:0050921),0.3386216340960197,1.333703064809773,0.09523809523809523,0.20362454590580686,1.0,11/44,8.82%,IL6R;PTN;HSPB1;FGF2;RARRES2;CCL21;PDGFB;F2RL1;ZNF580;P2RY12;PRKD1
prerank,triglyceride metabolic process (GO:0006641),-0.3997628976999969,-1.3336060275225021,0.04878048780487805,0.40468868056695895,1.0,9/47,8.14%,DGAT2;FABP6;GK;PNPLA3;LIPG;CAV1;CETP;APOC1;PNPLA1
prerank,regulation of protein kinase activity (GO:0045859),0.2719624446666461,1.3325868919421326,0.1,0.20414545667514253,1.0,29/104,15.47%,RAP1A;TSPYL2;WWTR1;DDR2;DBNDD2;SNCA;HSPB1;CDKN1A;INPP5K;MAPRE3;CCL21;PRKRIP1;TRIB2;SOD1;ANKRD54;CEACAM1;DUSP19;TAB1;DEPTOR;MMD;CAMKK1;GNAQ;ADCYAP1;ITGB1BP1;PPM1F;PRKAG2;RASSF2;SNX9;MMD2
prerank,protein-DNA complex disassembly (GO:0032986),-0.49376054124711777,-1.3325038487466572,0.136986301369863,0.4062223900484112,1.0,10/18,30.06%,MYC;HMGA1;SMARCA4;SET;SMARCC1;SMARCB1;NFE2;ARID2;ARID1A;GRWD1
prerank,regulation of RNA metabolic process (GO:0051252),0.2960759738304869,1.332433056365087,0.1111111111111111,0.2038027612808274,1.0,16/63,9.05%,RBM20;RBM38;MITF;PTBP2;NOVA1;CLK1;SNRNP70;PCBP3;HNRNPH3;CLK4;MBNL1;OAS1;PCBP4;CLK2;PRX;HNRNPH2
prerank,epithelial cell morphogenesis (GO:0003382),-0.4929969641552538,-1.3308572450683667,0.14084507042253522,0.4094548808048688,1.0,9/16,34.25%,PKHD1;GRHL2;MET;POF1B;SIPA1L3;CCDC88C;RAB25;TNMD;DACT2
prerank,axon extension (GO:0048675),0.40312420836367424,1.3304471126730457,0.16,0.20600413916882857,1.0,8/23,13.04%,NRP2;PPP3CB;ULK1;ULK2;SLIT3;NLGN3;SEMA3A;MAP1B
prerank,cellular response to decreased oxygen levels (GO:0036294),0.29993062575402235,1.3298873430763347,0.0,0.2065177357905371,1.0,25/66,15.42%,AQP1;EGLN2;ZFP36L1;SIRT2;CPEB1;MTOR;PTGIS;HP1BP3;HMOX1;BNIP3;EGLN1;SFRP1;MGARP;BNIP3L;MT3;NKX3-1;ANGPT4;TSC1;FMN2;EPAS1;BAD;ACAA2;FAM162A;RGCC;AK4
prerank,negative regulation of ossification (GO:0030279),-0.46704543405547677,-1.3296455668502036,0.10144927536231885,0.410904138588481,1.0,10/22,24.86%,KREMEN2;SOX9;LRP4;CCL3;FGF23;SRGN;MDK;SMAD6;CHSY1;NOTCH1
prerank,actin cytoskeleton reorganization (GO:0031532),0.3075229624107113,1.3292449465084306,0.1,0.20695491898058038,1.0,10/63,6.87%,FLNA;GSN;PDLIM4;EFS;SYDE1;KIT;S1PR1;PARVA;RHOA;FGF7
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.4705034481490298,-1.3285090950312648,0.16,0.4131222605011471,1.0,15/18,45.41%,DKC1;RUVBL1;NAF1;SHQ1;CCT6A;CCT2;RUVBL2;NOP10;CCT3;CCT8;NHP2;CCT7;DCP2;PARN;CCT4
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.38666006499090283,-1.3277085065405498,0.0963855421686747,0.41379777258725164,1.0,13/55,7.70%,SERPINB5;SERPIND1;TIMP1;SERPINE1;SERPINA10;SERPINA4;SERPING1;SERPINE3;CRB2;KNG1;SERPINA7;SERPINB7;SORL1
prerank,amyloid fibril formation (GO:1990000),0.2995048094362457,1.327143521414515,0.037037037037037035,0.20939857028472122,1.0,18/54,17.11%,GSN;MAPT;SNCA;MFGE8;PRL;UBB;CD36;B2M;APH1B;GGA3;NPPA;APP;RIPK1;INS;GGA2;BACE1;ITM2B;HSPG2
prerank,hemopoiesis (GO:0030097),0.2918929991947391,1.3261292960246738,0.0,0.21034847896944422,1.0,25/94,10.84%,YJEFN3;CD34;MEIS1;ATF4;FSTL3;KIT;KITLG;RRAS;FLCN;MFAP5;TOX;TPO;FST;TIRAP;TGFBR3;KIRREL3;FLT3LG;PDGFB;SBDS;SNRK;SFRP1;FLT4;FGFR2;TAL1;MKNK2
prerank,error-free translesion synthesis (GO:0070987),-0.4340146451968003,-1.3260213409767667,0.10810810810810811,0.41721487233001997,1.0,4/21,6.80%,RFC3;POLH;RPA3;RFC5
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.27905822139814745,1.324669164648057,0.06666666666666667,0.21170243647891404,1.0,15/92,8.42%,FHL1;FAM107A;KANK2;PTEN;CDKN1A;ZFP36L1;SKP1;PKD2;FBXL7;JADE1;CDKN2C;PSMC5;CCL2;ZNF655;PRMT2
prerank,regulation of neurotransmitter transport (GO:0051588),0.4002316755932748,1.3245990807287766,0.07692307692307693,0.2113502592609894,1.0,8/16,19.90%,CPLX3;CHRNB4;SYN1;FLOT1;MEF2C;KCNMB4;CAMK2A;CPLX2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.41269818681604253,1.324322620548574,0.07407407407407407,0.21133159878395832,1.0,6/17,7.23%,FSTL3;TMEM204;FSTL1;FST;ZDHHC17;TWSG1
prerank,liver development (GO:0001889),-0.39307122488175894,-1.3239739084612485,0.13580246913580246,0.4213016817945604,1.0,15/32,25.09%,CEBPB;PROX1;CEBPA;AURKA;MET;PCSK9;E2F8;DNAAF1;NF1;NKX2-8;LSR;ANXA1;E2F7;XBP1;WNT4
prerank,epithelial cell differentiation (GO:0030855),-0.32755860318411467,-1.3234326621478931,0.05555555555555555,0.4217051437267929,1.0,35/98,25.95%,MCIDAS;CDK1;PAX2;CCNO;UPK3A;ACTL8;PROX1;TAGLN;SIX1;OVOL3;GRHL2;SIX3;UPK2;GATA6;EHF;ANXA4;E2F8;SETSIP;CITED1;KDR;KRT3;PTER;DLX3;OVOL1;VDAC1;DMBT1;PPARG;BMP4;HDAC2;GATA3;UPK1B;ANXA1;E2F7;IRF6;OVOL2
prerank,natural killer cell activation (GO:0030101),-0.3911405638123472,-1.3231819643871163,0.08860759493670886,0.42093690572004006,1.0,27/42,41.66%,ULBP3;ULBP2;ULBP1;IL21R;IFNK;RASGRP1;IL12B;NCR1;IFNE;PIK3CD;ELF4;CD2;AXL;IFNB1;NCR3;CD244;IFNA1;IFNA21;PBX1;IL2;IFNA4;IFNA7;IFNA14;IFNA10;IFNA17;IFNA2;IFNA16
prerank,positive regulation of immune system process (GO:0002684),-0.4544238802366289,-1.3221642234865623,0.11392405063291139,0.4225252352576192,1.0,12/21,30.22%,TGFB2;HCAR2;ZP3;TNFSF18;HLA-G;PIK3CB;PIK3CD;GPR151;AQP3;ANXA1;LILRB2;IFNL1
prerank,regulation of endothelial cell proliferation (GO:0001936),0.2812192799396484,1.3221089641316524,0.0625,0.21333954813657716,1.0,27/87,15.78%,PLXNB3;NRP2;VIP;CAV2;VEGFB;FGF2;THBS4;PRL;ITGB3;TIE1;ATOH8;NR2F2;EGFL7;PDGFB;SCG2;ZNF580;PTPRM;PRKD1;FLT4;ANGPT1;ARNT;CCL11;PRKCA;SYNJ2BP;RGCC;VEGFC;NR4A1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.4759301375811445,-1.3216822529440966,0.1044776119402985,0.4228616034735082,1.0,7/16,27.06%,SOCS3;SOCS1;CAV1;VHL;PTPN2;PIBF1;PARP14
prerank,endocardial cushion morphogenesis (GO:0003203),-0.4498090764426599,-1.3213089985142417,0.13846153846153847,0.42273629835332294,1.0,4/19,5.28%,TBX20;TGFB2;SOX9;ENG
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.45723804501232235,-1.3212479361605745,0.15789473684210525,0.4216748713979852,1.0,7/18,14.72%,PLAU;PDGFRB;SERPINE1;SORL1;S100A11;TRIB1;IGFBP3
prerank,positive regulation of type I interferon production (GO:0032481),-0.35662679345414533,-1.3211528131306836,0.10843373493975904,0.4207784675336917,1.0,30/73,30.74%,POLR2F;RIPK2;POLR1C;OAS2;PRKDC;ISG15;HSPD1;POLR3B;STAT1;NFKB2;RELA;POLR3K;IRAK1;G3BP1;OAS3;ZBP1;POLR3C;POLR3A;IFI16;GAPDH;POLR3G;CREBBP;TLR7;PTPN22;XRCC5;TLR8;IRF7;MYD88;PTPN11;DHX9
prerank,tight junction assembly (GO:0120192),-0.37676005378193683,-1.3204634143313623,0.10975609756097561,0.4215123697550331,1.0,21/52,25.32%,CLDN1;CLDN2;CLDN16;PARD6B;CLDN14;CLDN20;FRMPD2;GRHL2;PECAM1;MARVELD2;ECT2;POF1B;CLDN6;CLDN24;CLDN12;STRN;LSR;CLDN10;PRKCI;CLDN34;CRB3
prerank,regulation of mRNA polyadenylation (GO:1900363),0.38560712192543917,1.3204408003214774,0.1724137931034483,0.21519304041713588,1.0,3/17,4.78%,CDK9;CPEB1;CPSF7
prerank,cellular response to amino acid stimulus (GO:0071230),0.2980509926814198,1.3203027708120147,0.125,0.21491048758751286,1.0,12/30,20.10%,CPEB1;MTOR;RRAGA;RRAGD;KLHL22;RRAGB;CAPN2;LAMTOR3;RRAGC;CPEB3;SESN1;LAMTOR1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.47656962478926107,-1.3199367872545176,0.13157894736842105,0.4217085042085241,1.0,7/16,30.14%,PIGM;PIGW;PIGF;PIGN;PIGA;PIGB;DPM2
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3013612646433377,1.3193366221762863,0.1111111111111111,0.2158382445817152,1.0,17/55,16.35%,MOAP1;TNFSF10;DCN;PLD6;MLLT11;BCL2L11;GPER1;MUL1;BNIP3;MGARP;BOK;MIEF2;RALBP1;BAD;FAM162A;MFF;CAMKK2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.27891915854690186,1.3191728177053572,0.09090909090909091,0.21566528082714378,1.0,27/85,17.55%,KANK2;CADM4;MFN2;FLCN;SPRY1;NGF;STARD8;STARD13;LZTR1;ARHGEF18;DAB2IP;DENND3;DLC1;MAPKAP1;RDX;DENND4B;RAF1;SGSM3;GABARAP;JAK2;NTRK1;FGF10;STK19;MMD2;SQSTM1;KANK1;EPOR
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.4029821844548123,1.319019310781115,0.19047619047619047,0.2153834093370468,1.0,5/18,9.89%,RAP1A;RIMS3;SNAPIN;SYN1;NLGN1
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.41224620669450185,-1.3189705538542984,0.11940298507462686,0.4231254744333899,1.0,16/31,26.62%,IL23A;ISG15;HSPD1;SYK;IL12B;PRKCZ;CD46;NOD2;TNFSF4;TIGIT;PIBF1;XCL1;CLEC7A;HMGB1;IL13;CD28
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3402344200691314,1.3186401412319304,0.1,0.21539412477159373,1.0,5/35,3.56%,GNAO1;PPP3CB;GNG2;CALM1;FZD4
prerank,negative regulation of peptidase activity (GO:0010466),-0.3833991670302367,-1.3183647557395182,0.10112359550561797,0.4236304470405798,1.0,12/55,7.49%,SERPINB5;SERPIND1;TIMP1;SERPINE1;SERPINA10;SERPINA4;SERPING1;SERPINE3;CRB2;KNG1;SERPINA7;SERPINB7
prerank,regulation of T cell chemotaxis (GO:0010819),-0.4729974677381479,-1.3180476147517284,0.07042253521126761,0.423446648710377,1.0,9/15,27.49%,WNT5A;CXCL10;ADAM10;STK39;XCL2;XCL1;S100A7;CCL5;CXCL13
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.3508256849942356,1.3178287829060853,0.06896551724137931,0.21587773886471875,1.0,12/30,14.10%,OSR1;HOXD3;HOXD9;PDGFRA;HOXC4;HOXA4;FGFR2;HOXD4;MEGF8;HOXB4;OSR2;DSCAML1
prerank,regulation of complement activation (GO:0030449),-0.39258236140415403,-1.317821661626516,0.08333333333333333,0.4230098026466508,1.0,13/40,18.34%,IL1B;C3;SERPING1;CPN1;C4BPA;CR1L;CD81;C4BPB;CD55;C2;CR1;PHB;CD46
prerank,regulation of chemotaxis (GO:0050920),0.32964526281864676,1.3174248268816295,0.0625,0.21592383745726412,1.0,9/31,8.51%,ZSWIM8;DUSP3;RARRES2;PDGFRA;CCL21;PDGFB;F2RL1;ELANE;P2RY12
prerank,embryonic skeletal system development (GO:0048706),0.331725227625594,1.3173188723726068,0.2,0.21564353160560007,1.0,12/34,14.10%,WNT9A;OSR1;HOXD3;HOXD9;PDGFRA;HOXC4;HOXA4;HOXD4;MEGF8;HOXB4;OSR2;DSCAML1
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.477243483613622,-1.315951039960699,0.15384615384615385,0.4265512795591453,1.0,7/16,20.58%,GLS2;GAD1;NOS2;ARG1;GLUD2;DDAH1;ARHGAP11B
prerank,histone H3 deacetylation (GO:0070932),0.4515719681071443,1.3156988291171043,0.12903225806451613,0.21735432693691825,1.0,3/15,5.60%,PER1;SIRT2;HDAC4
prerank,histone deacetylation (GO:0016575),0.3532112402480516,1.3156761016414311,0.125,0.21700022227442453,1.0,21/46,23.56%,PER1;MORF4L1;SIN3B;SIRT2;HDAC4;HDAC6;HDAC5;BRMS1L;TBL1X;SIN3A;HDAC11;MSL3;RCOR3;TRERF1;RBM14;HDAC9;MTA3;PRDM5;SIRT1;MIER2;ZNF541
prerank,regulation of cytoplasmic translation (GO:2000765),0.4337621788963036,1.3154979763107517,0.15151515151515152,0.21689976352379514,1.0,8/15,21.64%,RBM24;YBX3;CPEB1;ZNF385A;CNBP;CPEB3;CPEB2;UNK
prerank,organelle assembly (GO:0070925),0.22582483060948996,1.3153127529054192,0.0,0.21661971759581647,1.0,97/404,15.86%,PGM5;LMOD1;FLNA;GABARAPL1;GSN;EHD2;CIRBP;CD34;RFX2;TMOD2;MAP1LC3C;TTLL3;WDR45;TMOD1;ULK1;ZFYVE1;CHMP3;PARVA;MAPT;CENPT;ATG9A;ULK2;DZIP1;TSG101;BBS5;ATG12;MAPRE3;FLII;TP53INP2;CSDE1;STARD9;WDR19;RAB23;STX12;GABARAPL2;ARL3;CYS1;HDAC6;RABL2B;BBS1;IFT81;SYNPO;PKD1;NEK7;ABLIM3;HAUS4;POGZ;NPHP3;KLHL41;INTU;MAPRE2;MYOZ1;TUBGCP6;CHMP4A;EMC6;PLA2G4C;MAP1LC3A;ATP2A2;TXNDC15;FBF1;UBXN10;BSCL2;ATG14;CLUAP1;HPS1;CHMP7;EIF4ENIF1;INPP5E;RAB11FIP3;CAPN3;IFT46;CC2D2A;RAB8B;CEP126;FITM1;TMEM138;GABARAP;GOLGA8A;STK36;CEP89;VPS4A;BBS2;ATXN2L;VPS28;CDS2;MIS12;GBF1;IFT80;EXOC7;IST1;RILP;PTPN23;MAP1LC3B;TP53INP1;VPS37D;VPS37A;STX7
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.40202935070088625,-1.3152869071243367,0.18309859154929578,0.42680793875526485,1.0,11/27,19.08%,CYP2W1;NUDT19;CEL;ACBD5;CYP4F3;CYP26C1;AGXT;AGXT2;CYP26A1;HAO2;CYP4F11
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.331900042276023,1.3149293537151505,0.05,0.2165562221525224,1.0,17/52,16.59%,CLIP3;SORBS1;ATP2B4;LGALS3;CNPY4;PIK3R1;GPER1;NUMA1;RAMP3;STAC;EGFR;STAC2;GNAI1;ITGA3;EPHA3;EFCAB7;SQSTM1
prerank,kidney development (GO:0001822),-0.3502083417896682,-1.314706545552999,0.058823529411764705,0.4273151460580229,1.0,20/68,14.26%,STRA6;SHH;TGFB2;SOX4;MME;PAX2;CTSH;ROBO2;LRP4;PROX1;REN;SIX1;C1GALT1;PAX8;PCSK9;BMP7;CENPF;AGT;CITED1;NF1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.4945875825846151,-1.3146528681586054,0.10144927536231885,0.4262539410356067,1.0,12/15,36.43%,MTHFD1L;IRX5;MTHFD1;SIX1;TGFBR2;LHX1;TWIST1;NIPBL;TFAP2A;TGFBR1;EIF4A3;HOXA1
prerank,Rho protein signal transduction (GO:0007266),0.32033799068481206,1.3138516218908272,0.09523809523809523,0.21781981066327305,1.0,14/54,10.02%,NTN1;AGTR1;RHOB;RHOJ;ARHGAP6;CDC42EP3;NGFR;RHOA;CTNNAL1;GNA12;CDC42EP4;TAX1BP3;ARHGAP1;RHOU
prerank,serine family amino acid metabolic process (GO:0009069),-0.503749815244857,-1.3135614373211595,0.15714285714285714,0.427781485707181,1.0,6/15,16.84%,BAAT;MTHFD1;PSPH;SHMT2;CTH;SRR
prerank,neuromuscular synaptic transmission (GO:0007274),0.35007694931309863,1.313509148751437,0.1,0.2178260001980483,1.0,4/19,5.97%,CHRNA3;SLC5A7;DTNA;CHRNB4
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.43411866116559167,-1.31334373418174,0.12857142857142856,0.4271669400681236,1.0,13/24,39.80%,FPR2;CR1;MICB;SLA2;FPR3;LYN;NCR3;LAX1;GPLD1;FCER1G;GPR33;FPR1;CD19
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3939763543261999,1.3128155818474132,0.125,0.21840390571821777,1.0,8/23,12.57%,RAC1;ARPC2;OCLN;PIK3R1;MSTN;BRK1;WASF2;AKIRIN1
prerank,snRNA 3'-end processing (GO:0034472),-0.4296139379104727,-1.312686204210967,0.0945945945945946,0.42780181452812355,1.0,17/25,44.28%,INTS7;EXOSC3;EXOSC8;EXOSC4;EXOSC5;INTS2;SAGE1;INTS6;EXOSC7;EXOSC2;CT45A1;CT45A5;CT45A3;INTS12;CT45A6;CT45A7;CT45A2
prerank,positive regulation of neurogenesis (GO:0050769),0.2828324062463292,1.3122733643758444,0.0,0.21894409166220236,1.0,12/72,6.78%,PLXNB3;NUMBL;MAP6;NPTN;CHODL;NGF;SMARCD3;NGFR;OBSL1;SERPINF1;RHOA;GPER1
prerank,zinc ion transmembrane transport (GO:0071577),-0.44938616729851893,-1.3122362037919648,0.10810810810810811,0.42793616251697697,1.0,8/22,22.29%,SLC30A2;TRPM2;SLC39A10;SLC39A11;SLC39A8;SLC30A6;SLC39A2;SLC30A5
prerank,regulation of acute inflammatory response (GO:0002673),-0.48005829385240895,-1.3122349284761028,0.10126582278481013,0.4267732925101374,1.0,9/19,28.30%,C2CD4A;OSM;F12;FFAR2;NLRP3;ADAM8;DNASE1;PLA2G2D;C2CD4B
prerank,artery morphogenesis (GO:0048844),-0.40686306821814305,-1.3120071132515287,0.1323529411764706,0.4263772984549328,1.0,7/30,7.41%,STRA6;PDGFRB;TGFB2;FOLR1;ANGPTL3;ENG;LRP2
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.42199515079169236,-1.3118310019601458,0.10144927536231885,0.42568003789609177,1.0,4/23,1.88%,CDH3;AREG;EPPK1;CASK
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.4955677671514716,-1.3115667953457337,0.19117647058823528,0.42521347805681836,1.0,6/15,13.80%,GRM8;HOMER1;GRM7;TRPM1;GRM1;GRM5
prerank,ncRNA 3'-end processing (GO:0043628),-0.45663968851626957,-1.311526538257123,0.15714285714285714,0.4242401799555404,1.0,14/19,44.28%,INTS7;TRNT1;INTS2;SAGE1;INTS6;SSB;CT45A1;ERI1;CT45A5;CT45A3;INTS12;CT45A6;CT45A7;CT45A2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.266286083819808,1.3115251878638137,0.0,0.21926872264785882,1.0,30/88,17.24%,FERMT2;CLDN5;DUSP22;SMAD2;TGFBR3;ARHGEF18;RHOA;BMPR1A;HPGD;PXN;UBB;TWSG1;GCNT2;LRRC32;SMAD7;CDH5;WFIKKN2;SMAD4;SMAD3;ZMIZ1;SMAD9;PARD3;GDF5;SKI;ITGB5;FMOD;FNTA;GDF10;TGFB3;NRROS
prerank,regulation of lipid catabolic process (GO:0050994),-0.45657107073283576,-1.3114375555004902,0.17567567567567569,0.4233285318748068,1.0,5/19,10.88%,IL1B;HCAR2;ANGPTL3;APOC1;SCT
prerank,mesenchymal cell differentiation (GO:0048762),-0.37087849447982785,-1.3113635757821844,0.09210526315789473,0.4224217589174995,1.0,9/51,5.28%,TBX20;LOXL2;AMELX;TGFB2;LEF1;WNT5A;SOX9;HMGA2;ENG
prerank,positive regulation of heart contraction (GO:0045823),0.37033728302781477,1.3110391778331498,0.03125,0.21952111808258398,1.0,7/20,12.35%,RGS2;HRC;ATP1A2;SCN3B;ATP2A2;NPPA;ADM
prerank,regulation of kinase activity (GO:0043549),0.27734288238124905,1.3108443538343906,0.0,0.2194532894252093,1.0,21/93,11.58%,TSPYL2;EPHA7;FGFR1;DDR2;KIT;MAPT;CDKN1C;ROR2;TIE1;PIFO;PDGFRA;EPHA4;LDB2;LMO4;SOD1;ANKRD54;EGFR;FLT4;FGFR2;EPHB6;ROR1
prerank,amide transport (GO:0042886),-0.4497476304864213,-1.3103613351436496,0.12857142857142856,0.4243263369440274,1.0,10/27,17.39%,ABCA13;FOLR1;UPK3A;SLC38A5;ABCA12;SLC5A6;GLTPD2;TAP1;SLC46A1;SLC19A1
prerank,ear morphogenesis (GO:0042471),-0.411863845056172,-1.310224364000793,0.1506849315068493,0.42368297824468354,1.0,13/23,30.55%,EPHB2;PAX2;CHD7;SIX1;MYO6;PAX8;USH1C;DCANP1;TIFAB;ZIC1;TWIST1;NIPBL;TFAP2A
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.3658981081811204,1.3097673575292106,0.14285714285714285,0.22069620507179102,1.0,11/26,16.81%,TLR3;PJA2;TIRAP;F2RL1;RTN4;TLR9;TICAM2;FLOT1;NINJ1;TLR1;NR1H3
prerank,negative regulation of signal transduction (GO:0009968),0.25456421906365284,1.3086631166065383,0.0,0.22165189739549687,1.0,79/254,17.12%,KANK2;TNS2;RGS2;PALM;PTEN;TMEM25;NCK1;DACT3;CILP;NTN1;DCN;HEY1;FSTL3;CADM4;NXN;APOD;TMBIM1;SNCA;EMILIN1;FGF2;SPRY1;INPP5K;PLIN5;TULP3;TRABD2B;PRKCD;GPC1;NLGN4X;PIP4K2B;PID1;DAB2IP;EGFL7;HHEX;SMPD1;GRB14;CBY1;MMRN2;TAX1BP3;GLI3;TLR9;TLE1;IGFBP5;LEPROT;GRB10;EGFR;EPN2;SFRP1;GPS2;CSNK2A2;NDRG4;SUFU;SFRP5;CX3CL1;GATA2;KIF7;DKK3;NKX3-1;MEGF8;BCL2;PTCH2;CRY1;METTL3;GPC3;CYP26B1;NFATC1;PIP4K2A;NFKBIL1;BTRC;GPR108;GLIS2;FRZB;KCTD6;IL12A;KCTD21;SEMA6A;PRKCB;KANK1;HIF1AN;SFRP2
prerank,cellular response to cadmium ion (GO:0071276),0.3773541148761205,1.308271036195714,0.14285714285714285,0.22154539273238766,1.0,12/27,20.43%,MAPK1;MAPK3;MAPK8;MT1X;MT1M;EGFR;MT3;MT1A;MT1E;AKR1C3;DAXX;JUN
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2814665305739401,1.3065537543153192,0.06666666666666667,0.22270764829122378,1.0,18/72,13.43%,FAM107A;RASD2;TSPYL5;BCL10;PIAS3;RWDD3;DCUN1D4;HDAC4;WFS1;UBB;MUL1;SMAD7;SAE1;ANGPT1;PIAS1;CRY1;PIAS4;UBE3A
prerank,regulation of MAPK cascade (GO:0043408),0.24131936129914644,1.305365368036904,0.0,0.2239361827814203,1.0,45/162,16.55%,EPHA7;FGFR1;LPAR1;MAPK1;CAV2;KIT;MAPK3;MYOC;RRAS;FAS;FGF2;ROR2;DUSP3;FAM83D;ADRB3;TGFBR3;PRDM11;P2RX7;ZDHHC17;GPER1;DAB2IP;PDGFB;CEACAM1;TLR9;EGFR;DUSP19;YWHAZ;FLT4;FGFR2;MAP2K2;ROR1;CX3CL1;ADRA2B;CD24;NTRK1;FGF10;INS;BCAR3;RNF41;ADRB2;NTRK3;TAOK2;RET;PDGFA;NRK
prerank,positive regulation of phosphorylation (GO:0042327),0.22954584903438716,1.3046332945434669,0.0,0.22438800919588506,1.0,69/246,17.17%,CLIP3;EPHA7;PSEN1;FGFR1;FZD7;BCL10;DDR2;FAXDC2;VEGFB;KIT;P2RY1;MAPK3;ILK;NPTN;FLCN;FAS;FGF2;ROR2;DVL3;RAC1;ITGB3;TIE1;PIFO;RARRES2;RSPO1;P2RX7;PDGFRA;DVL2;EFNA5;AKTIP;EPHA4;GPER1;FGF7;NCKAP1L;LMO4;PRKAA2;FGF1;TESK1;PIK3R3;EGFR;FLOT1;FLT4;FGFR2;ANGPT1;ATG14;EPHB6;GPNMB;ARNT;PIN1;APP;ROR1;MT3;NKX3-1;NTRK1;FGF5;RALBP1;FGF10;RIPK1;INS;TFRC;VEGFC;NTRK3;EPHA3;RET;CAMKK2;LEPR;FGF17;GAS6;FGF16
prerank,neural tube development (GO:0021915),-0.49444479121016716,-1.3046084013254644,0.1076923076923077,0.4386947500850855,1.0,6/16,13.67%,SOX4;TRIM71;PROX1;GRHL2;TGFB1;PTCH1
prerank,telomere organization (GO:0032200),-0.37674404223710883,-1.304408730724882,0.14864864864864866,0.4379610989063691,1.0,12/41,20.19%,BLM;PRKDC;RPA3;RECQL4;DNA2;DCLRE1B;WRN;TERT;ATR;POLD2;HUS1;RIF1
prerank,microglial cell activation (GO:0001774),0.38022330317415887,1.3038107916728527,0.13793103448275862,0.22511865196330158,1.0,7/22,13.37%,CLU;MAPT;SNCA;IFNGR1;APP;CX3CL1;JAK2
prerank,DNA methylation (GO:0006306),-0.4396572526556364,-1.3024602266593535,0.05714285714285714,0.4423408053971007,1.0,10/23,26.86%,FOS;DNMT1;DNMT3B;DNMT3L;SPOCD1;BEND3;ATRX;ATF7IP;GATAD2A;TEX15
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.2485820272928035,1.302404108576569,0.0,0.22647653517100935,1.0,33/139,14.09%,PTN;EPHA7;EFS;NPR1;FGFR1;DDR2;ANGPTL1;KIT;LIFR;SHC2;SHC4;ROR2;NGF;PILRB;TIE1;FES;NPR2;GFRA2;PDGFRA;EPHA4;NPPC;EGFR;FLT4;FGFR2;NPPA;EPHB6;ROR1;SH2D6;BLNK;JAK2;NTRK1;NPPB;NTF3
prerank,negative regulation of DNA binding (GO:0043392),-0.41423474694689627,-1.3022196883493344,0.136986301369863,0.4418414515342811,1.0,7/30,9.09%,LEF1;MSX2;E2F1;MDFI;HMGA2;TFAP4;ZNF675
prerank,dopaminergic neuron differentiation (GO:0071542),-0.4319612130655542,-1.3017909303348316,0.17391304347826086,0.441841936151435,1.0,8/20,31.36%,WNT2;SHH;FOXA2;EN1;MANF;FGF8;OTX2;WNT9B
prerank,negative regulation of response to wounding (GO:1903035),-0.42662378969251025,-1.3014570923084379,0.125,0.4416403785488959,1.0,5/20,8.39%,EPPK1;CASK;KLK8;SERPINE1;RTN4R
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.3484784575264937,-1.3012666517881064,0.0963855421686747,0.4409269334134778,1.0,37/79,33.58%,RIPK2;USP50;TNFAIP3;CARD17;EGR1;GBP5;WNT5A;IL17A;CCL3;NLRP12;NLRP3;F2R;IFNG;LILRB4;MNDA;NOD2;MEFV;SERPINB1;IFI16;CARD16;TYROBP;GHSR;TNF;CLEC7A;TMEM106A;NLRP7;ZC3H12A;AIM2;NLRP2;TLR8;MYD88;NLRC4;IGF1;AGER;CX3CR1;LILRA5;GHRL
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.4091176612257741,1.3009579067984955,0.14285714285714285,0.22807419345350863,1.0,9/15,24.39%,GNB3;BCKDK;PDK2;SCARB2;RORA;PDK3;SIRT1;PDK4;ADIPOQ
prerank,neutral amino acid transport (GO:0015804),-0.42368006912486345,-1.300724663923172,0.09876543209876543,0.44103942528893975,1.0,16/28,38.52%,SLC6A14;SLC6A20;SLC7A5;SLC38A5;SLC6A6;SLC1A5;SLC1A4;SLC36A3;SLC38A3;SLC3A2;SLC7A10;SLC43A2;SLC36A2;SLC1A1;LLGL2;SLC7A8
prerank,import into cell (GO:0098657),-0.389493420838511,-1.3006408081666114,0.12195121951219512,0.4402036784222394,1.0,14/41,17.39%,LRRC8E;SLC6A14;SLC6A20;TSPO2;SLC7A5;SLC6A6;LRP2;SLC7A1;SLC5A6;LRRC8D;SLC11A2;SLC29A2;SLC46A1;SLC19A1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3664088735292494,1.3006114491677219,0.0,0.22820191659989522,1.0,11/29,21.68%,TRIM39;MAP1A;CAMLG;UBXN1;RYBP;SGTA;BAG6;KLHL40;WAC;HFE;SDCBP
prerank,spliceosomal complex assembly (GO:0000245),0.3166150783736318,1.3004974921844703,0.09375,0.22784190987554923,1.0,12/45,12.20%,SRSF5;LUC7L2;CELF6;SRPK3;DDX39B;LUC7L3;SF1;CELF2;CELF4;LUC7L;RBM5;SF3B1
prerank,positive regulation of catabolic process (GO:0009896),-0.3521389834985867,-1.3004630676892808,0.1111111111111111,0.4398812153224593,1.0,25/63,31.03%,IL1B;CSNK2A3;TNFAIP3;ASB9;WNT5A;ANGPTL3;C4BPA;HECW1;HECW2;OAZ3;SORL1;C4BPB;SCT;CSNK2A1;BARD1;GSK3B;TNF;AXIN1;IDE;ITCH;APC2;DTL;HUWE1;NSF;NKD1
prerank,regulation of cell size (GO:0008361),0.38584908860088823,1.2995608212473007,0.1724137931034483,0.22883824715921186,1.0,6/23,10.55%,PTEN;RAC1;MTOR;RHOA;RDX;DEPTOR
prerank,pyroptosis (GO:0070269),-0.48328138179750874,-1.299154077438023,0.14634146341463414,0.44260624878078225,1.0,10/18,30.77%,GZMB;NAIP;GSDMA;GSDMC;ZBP1;GZMA;GSDMB;AIM2;DHX9;NLRC4
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.40742426611065136,1.2988943777730872,0.1794871794871795,0.2290333648516518,1.0,8/17,22.49%,HEY1;BMPR1A;RBPJ;HEY2;HEYL;SNAI2;NOG;ACVR1
prerank,regulation of DNA metabolic process (GO:0051052),-0.3849395419621945,-1.2988206424730915,0.1125,0.4422611724559698,1.0,22/44,33.63%,MYC;TICRR;POLH;TOM1L1;KDM1B;GRHL2;IL7R;CDT1;PARG;STOX1;ALYREF;KPNA2;SMARCAD1;SMG1;XRCC5;PIF1;USP1;MPV17;HDAC8;UBE2N;ZNF365;HELB
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.36884747467048734,1.2984766069972442,0.15384615384615385,0.22852284510890258,1.0,10/22,20.83%,CLIP3;ZDHHC7;ZDHHC15;ZDHHC22;ZDHHC18;GOLGA7;ZDHHC1;ZDHHC20;ZDHHC11;ZDHHC8
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.36884747467048734,1.2984766069972442,0.15384615384615385,0.22852284510890258,1.0,10/22,20.83%,CLIP3;ZDHHC7;ZDHHC15;ZDHHC22;ZDHHC18;GOLGA7;ZDHHC1;ZDHHC20;ZDHHC11;ZDHHC8
prerank,oligodendrocyte development (GO:0014003),0.3833850291219779,1.2974731207731511,0.12121212121212122,0.22926962408405174,1.0,4/15,14.22%,PLP1;CNTNAP1;EIF2B1;EIF2B4
prerank,nuclear transport (GO:0051169),-0.49868472341417547,-1.2974049373212204,0.07894736842105263,0.44498411404566396,1.0,10/16,31.43%,HMGA1;RSRC1;NXT2;CITED1;NUP205;ANP32A;NPM1;NXT1;NUP98;XPO1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.4229231235018785,1.297379324647404,0.21212121212121213,0.22901483383683865,1.0,5/17,6.03%,YBX3;TARDBP;MAPK14;TIRAP;ZFP36
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.4532073274131714,-1.2973567021830599,0.13043478260869565,0.4428515362173687,1.0,9/16,26.67%,AMELX;RUNX1;TGFB1;SUCO;F2R;BMP4;HDAC2;WNT4;CREB3L1
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.4532073274131714,-1.2973567021830599,0.13043478260869565,0.4428515362173687,1.0,9/16,26.67%,AMELX;RUNX1;TGFB1;SUCO;F2R;BMP4;HDAC2;WNT4;CREB3L1
prerank,tRNA processing (GO:0008033),-0.3645094555167944,-1.2962838751953987,0.09411764705882353,0.44428132582637836,1.0,34/56,46.04%,POP1;CSTF2;WDR4;RPP40;ADAT1;DTWD2;METTL1;CDKAL1;TRMT6;TRNT1;TSEN2;FARS2;ANKRD16;TRUB1;AARS2;FTSJ1;TRMT10C;CPSF4;NSUN2;SSB;TSEN54;ADAT3;TYW5;NSUN6;POP7;CTU2;POP5;CTU1;TRMT10A;ZBTB8OS;FAM98B;TRDMT1;CLP1;ADAT2
prerank,heme biosynthetic process (GO:0006783),0.35681328117612715,1.2959724234036,0.10714285714285714,0.23051479419957022,1.0,5/20,11.81%,UROD;FECH;NFE2L1;ALAD;ABCG2
prerank,ceramide catabolic process (GO:0046514),-0.4913176459922593,-1.2959316420304725,0.15789473684210525,0.4439720837989844,1.0,6/16,19.31%,ASAH2;ASAH2B;HEXB;ACER2;NEU1;GLA
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.4060271524215044,-1.29581908338421,0.1506849315068493,0.4431123686302113,1.0,7/34,5.95%,CEMIP;THY1;NPSR1;CXCL9;CXCL11;CALCR;CAV1
prerank,bicarbonate transport (GO:0015701),-0.3774742362923413,-1.295767605457333,0.15942028985507245,0.44207937892676125,1.0,10/35,14.81%,SLC4A11;CA9;SLC26A9;HBA1;CA5A;SLC4A9;CFTR;SLC39A8;CYB5R2;CA6
prerank,negative regulation of cell death (GO:0060548),0.2656764730514355,1.2956954040865498,0.0,0.23060205977088608,1.0,19/85,12.10%,KANK2;INPP5A;FERMT2;CLU;CD34;NCK1;SNCA;PARP16;FGF2;AMIGO2;WFS1;TMEM109;PSMC5;BNIP3;CHMP4A;PRKD1;GPNMB;BNIP3L;MT3
prerank,negative regulation of protein catabolic process (GO:0042177),0.32936325477012435,1.2953054704272744,0.05263157894736842,0.2308261185084183,1.0,15/42,15.26%,FLNA;TIMP4;SNCA;TIMP3;TIMP2;SIRT2;SNRNP70;DAB2IP;EGFR;SNX3;PIN1;FMN2;AZIN2;INS;RILP
prerank,negative regulation of MAPK cascade (GO:0043409),0.265736990067891,1.2952390752409706,0.0,0.23060462876544402,1.0,17/91,8.16%,RGS2;UCHL1;PTEN;LMO3;DUSP26;EMILIN1;TIMP3;FLCN;SPRY1;FBLN1;INPP5K;DUSP3;PRKCD;P2RX7;GPER1;DAB2IP;SMPD1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.346290296685861,-1.2951996097370906,0.08433734939759036,0.44234501281323974,1.0,23/71,30.10%,OSM;TP73;PUS7;PSMB9;PRKDC;PSMD14;RUNX1;CBFB;MYB;PSMA3;PSMB3;GATA3;PSMC1;PSMB11;PSMA5;PSMB2;PSME2;ITCH;PSMD12;PSMA7;FOXC1;PSME4;PSME3
prerank,cortical cytoskeleton organization (GO:0030865),0.3244523559521291,1.2950950351553707,0.2,0.23038389110988217,1.0,16/41,20.15%,RHOB;RND2;RAC1;EPB41L3;RHOA;RHOQ;NCKAP1L;RHOC;NLGN1;PPP2R3C;FHOD3;RAB13;RHOBTB1;LLGL1;RHOG;FHOD1
prerank,exogenous drug catabolic process (GO:0042738),-0.45500264990122985,-1.2947886932605663,0.1267605633802817,0.4422558431459582,1.0,9/20,22.25%,CYP2W1;CYP2S1;CYP2F1;CYP2A7;CYP2B6;CYP2D6;NUDT15;CYP2A13;CYP2C19
prerank,regulation of cellular localization (GO:0060341),0.3113110180958659,1.2945831349452002,0.125,0.23057308198727963,1.0,14/47,13.80%,GSN;NR1D1;ADCY5;DVL3;FES;EFNA5;MAP2;NUMA1;CSNK1E;PARD6G;BRSK1;CAMK2D;KIAA1614;PPM1F
prerank,ncRNA catabolic process (GO:0034661),-0.4350876525054938,-1.2931407693415655,0.1125,0.44537557448689225,1.0,13/25,31.01%,POP1;SND1;EXOSC3;EXOSC8;DIS3;EXOSC4;EXOSC5;LIN28A;EXOSC7;XRN1;SLFN14;LIN28B;EXOSC2
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.36663368532813334,1.2928536576547027,0.11538461538461539,0.23219134033543382,1.0,5/21,6.03%,MEIS1;MEIS2;ZFP36L1;HOXA5;ZFP36
prerank,DNA duplex unwinding (GO:0032508),-0.36263820451667744,-1.2927630133603576,0.0975609756097561,0.44541993382935713,1.0,10/49,12.81%,BLM;MCM4;HMGA1;MCMDC2;ASCC3;RECQL4;MCM7;GTF2H2;WRN;MCM2
prerank,response to glucagon (GO:0033762),0.38007100755303463,1.292751859733337,0.11764705882352941,0.23190107470950183,1.0,9/21,15.97%,ADCY5;ADCY4;PRKAR2B;PRKACA;CREB1;CRY1;ADCY9;ADCY2;ADCY6
prerank,insulin receptor signaling pathway (GO:0008286),0.2971159064493346,1.2927430663099495,0.08333333333333333,0.2315100105025718,1.0,30/73,22.85%,ATP6V1G2;SORBS1;CAV2;FOXO4;RARRES2;ATP6V1E1;PIK3R1;RHOQ;GRB14;PIK3R3;BAIAP2;GRB10;TCIRG1;ZNF106;ATP6V0E2;INS;BCAR3;SOGA1;ATP6V1H;PDK2;ATP6V0A1;GRB2;ATP6V1D;FER;SHC1;ATP6V0D1;ATP6V0E1;IGF2;AP3S1;GAB1
prerank,sphingosine metabolic process (GO:0006670),-0.474287641714094,-1.2924211993689967,0.18421052631578946,0.44513079773531883,1.0,6/16,17.24%,SPTLC1;ASAH2;SGPP2;ASAH2B;SPTLC2;ACER2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.36640929959997115,1.291846965232983,0.09090909090909091,0.23233953755122844,1.0,9/27,18.57%,GBA2;DBN1;ESAM;BRK1;WDR1;PFN2;PLEKHG2;FCHSD1;HCLS1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.4813793449653903,-1.2913545361556331,0.1282051282051282,0.44687275286819567,1.0,8/16,22.89%,FOXP3;IL23A;JAK3;IL23R;IL12B;LILRB4;MMP8;TYROBP
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.42089142890573955,-1.2900721057317077,0.16666666666666666,0.44954852789167643,1.0,6/27,4.80%,CEMIP;THY1;NPSR1;CXCL9;CXCL11;CALCR
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.3783576464864615,1.2897193987412048,0.23809523809523808,0.23465399613388588,1.0,10/19,15.97%,NPR1;ADCY5;ADCY4;NPR2;NPPC;NPPA;ADCY9;NPPB;ADCY2;ADCY6
prerank,response to fatty acid (GO:0070542),-0.44946558637658646,-1.2894418806373735,0.1891891891891892,0.45033072831807536,1.0,6/19,11.63%,IRS1;SOX9;FFAR2;SCD;GLDC;UCP1
prerank,male meiosis I (GO:0007141),-0.48302959202913076,-1.2890043574315306,0.19718309859154928,0.4507269814221239,1.0,4/15,7.65%,SYCP3;BTBD18;HSF2BP;DNMT3L
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.398801981918908,-1.2889472901141197,0.16883116883116883,0.44971802029002217,1.0,11/29,24.62%,EPHB2;IL21;RBP4;PAXIP1;IL10;PHB;CD86;TNFSF4;RIF1;XCL1;XBP1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.4308847917609825,-1.2888189832235377,0.12307692307692308,0.448973251841582,1.0,9/22,22.49%,WDR43;IPPK;NCL;HEATR1;SMARCA4;LYAR;EIF2AK3;UTP15;SMARCB1
prerank,negative regulation of T cell activation (GO:0050868),-0.39040061008686616,-1.2888046922348748,0.1518987341772152,0.4478701234586789,1.0,22/42,30.22%,CEBPB;FOXP3;CD80;IL4I1;JAK3;VTCN1;PLA2G2F;ARG1;IL10;CR1;LILRB4;HLA-G;CD86;TIGIT;GLMN;IFNB1;PTPN22;PLA2G2D;LAX1;LILRB2;PDCD1LG2;IFNL1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.2590996961095343,1.2886633615823717,0.0,0.23594803556385463,1.0,27/139,11.30%,ARHGEF26;SYDE1;RHOB;ARHGAP10;RHOJ;ARHGAP6;ARHGEF17;ARHGAP33;FLCN;TRIP10;RAC1;STARD8;STARD13;ARHGEF18;RHOA;ARHGEF6;RHOQ;DLC1;RHOT2;ARHGAP20;RHOC;ARHGAP23;ARHGAP1;RHOU;ARHGAP19;ARHGEF9;INPP5B
prerank,carboxylic acid transport (GO:0046942),-0.36760021961471007,-1.288254893825965,0.12345679012345678,0.44818253871144237,1.0,29/55,38.52%,SLC6A14;SLC6A20;SLC7A5;SLC16A13;AQP9;SLC38A5;SLC6A6;SLC1A5;SLC7A1;SLC1A4;SLC7A6;SLC16A3;SLC16A6;SLC36A3;SLC13A3;SLC38A3;SLC16A11;SLC3A2;SLC17A3;SLC17A1;SLC6A12;SLC6A13;SLC36A2;SLC1A1;SLC15A4;LLGL2;SLC16A4;SLC6A11;SLC7A8
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.25838591499954233,1.2873762418030428,0.0,0.2373725340237257,1.0,32/120,14.87%,FERMT2;CHRNA3;SDC2;MAPT;FGF2;ZNF135;CAPZB;EFNA5;EPHA4;PHLDB2;PID1;ADGRB3;HMOX1;ZDHHC15;KIF1A;ZMYM3;CEACAM1;EGLN1;SFRP1;FLT4;FGFR2;BRSK1;GPNMB;LRRC4C;MEF2C;ZMYM6;ARC;GDNF;RNH1;PHLDB1;CDH2;WTIP
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.3341263602785137,1.2871438532737478,0.16,0.2370765165584414,1.0,9/25,17.45%,SORBS1;PPP1R3C;INPP5K;PPP1R3B;EPM2AIP1;PPP1R3E;INS;PPP1R3F;PPP1R3G
prerank,regulation of lipid biosynthetic process (GO:0046890),0.3328346316493833,1.286448715577971,0.125,0.23795699839600726,1.0,10/33,16.65%,SORBS1;PRKAB2;MTOR;GPER1;PRKAA2;CEACAM1;CREB1;PRKAG2;INS;CREBL2
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.3888828538976252,-1.2861485449177064,0.13513513513513514,0.45324528822095733,1.0,27/42,41.52%,EREG;GBP5;IFNK;POLR3B;FPR2;POLR3C;ANKRD17;ADAM8;CYBA;POLR3G;NMI;SCIMP;IFNB1;CCL5;NLRP10;TLR8;PLSCR1;DHX9;IFI35;TRIM15;OASL;BMP6;SLC15A4;AKIRIN2;CD180;DDX60;LY86
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.39823029117941244,1.2860890632781543,0.14705882352941177,0.23792923394735888,1.0,6/15,15.90%,AGTR1;FGF2;NGFR;HMOX1;GATA2;IL12A
prerank,positive chemotaxis (GO:0050918),0.39606506010911247,1.2858012761638915,0.15625,0.23820283022790917,1.0,8/17,13.94%,PLXNB3;LGALS3;FGF7;SCG2;ANGPT1;GPNMB;CX3CL1;FGF10
prerank,cellular response to organonitrogen compound (GO:0071417),0.2677835567911056,1.2852747733035526,0.0,0.23850893620508212,1.0,31/101,15.34%,RAP1A;DEFB124;PDE2A;AQP1;P2RY1;ZFP36L1;INPP5K;CPEB1;RAPGEF3;MTOR;PKD2;AKAP6;P2RX7;RRAGA;HSP90B1;ACTB;P2RY12;PDE3A;RRAGD;TRPV1;IGFBP5;RYR3;SFRP1;GOLPH3;RRAGB;P2RY11;MEF2C;CAPN2;LAMTOR3;RRAGC;HCN3
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.3144863672920169,-1.2852361407312498,0.03296703296703297,0.45474097202366376,1.0,48/152,24.97%,EXO1;CHEK1;TP73;BLM;RFC3;CDK1;POU4F1;PML;CHEK2;RMI1;RPA3;AURKB;DNA2;BOP1;TPX2;RFC5;RMI2;AURKA;TAF4B;RAD9B;TAF1L;PRDM1;TOPBP1;RBBP8;PAK1IP1;WRN;ATR;TP53RK;RRS1;RFC2;SMYD2;TAF2;CDK5;MDM2;BRCA1;CSNK2A1;HUS1;BARD1;HDAC2;POU4F2;TAF4;MAPKAPK5;CHD4;HIPK2;RPF2;BRIP1;RPL37;RHNO1
prerank,negative regulation of protein secretion (GO:0050709),-0.38845717863709656,-1.2852097858226004,0.12987012987012986,0.4536857600758214,1.0,8/37,10.07%,IRS1;BMP8A;IL1B;CYP51A1;RAB11FIP1;IL12B;RHBDF2;DRD2
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.364073648008605,-1.2833567208103354,0.14666666666666667,0.45754025959424355,1.0,18/48,22.28%,CHEK1;MAD2L1;TOM1L1;ZWINT;BUB1;BCL6;PTPN3;BMP7;RFPL1;TGFB1;IL10;BRINP2;BUB1B;NME6;BMP4;WEE2;NABP1;BTG4
prerank,regulation of cellular component size (GO:0032535),0.33058115218017897,1.2831433601246864,0.12,0.24048218859094644,1.0,9/30,14.67%,PTEN;RAC1;MTOR;AP2M1;HP1BP3;RIN3;RDX;PEX11A;RARG
prerank,vasculature development (GO:0001944),0.37475248630515223,1.28310294240988,0.08571428571428572,0.24011734726865663,1.0,8/17,16.28%,FOXF1;TCF21;PDGFRA;SOX18;CDH5;FLT4;NOTCH4;ERRFI1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.40340457542499064,-1.2830495484971485,0.13924050632911392,0.45711195747934125,1.0,12/29,25.34%,SPTLC1;ASAH2;GCHFR;NOS2;CYB5B;NQO1;ASAH2B;SPTLC2;ACER2;GCH1;PM20D1;GBA
prerank,regulation of axonogenesis (GO:0050770),0.303855124190702,1.282660457261307,0.125,0.24041877087397456,1.0,12/51,10.69%,PLXNB3;PTEN;MAP6;CHODL;NGF;NGFR;RHOA;EPHA4;RTN4;GDI1;BRSK1;LRRC4C
prerank,regulation of secretion by cell (GO:1903530),0.30390330148230404,1.2816711259997147,0.0,0.24121717071973467,1.0,23/54,21.17%,VAMP2;RAB3A;CPLX3;DISP1;CHRNB4;HAP1;SYN1;SYT1;RAB3C;RAB8B;LGI3;MEF2C;RHBDF1;KCNMB4;INS;VAMP3;RAB13;LLGL1;CAMK2A;STXBP5L;CPLX2;STX4;RAB12
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.3193256892117583,-1.2812560316619719,0.0449438202247191,0.46104124570906907,1.0,49/114,33.99%,CARD11;MUC5AC;PSMB9;CLEC6A;MUC12;PSMD14;SYK;FFAR2;RELA;MUC17;CLEC4C;MUC19;MUC4;MUC5B;FYN;CARD9;MUC20;PSMA3;NRAS;TAB3;IKBKG;PSMB3;MUC3A;KLRC2;TYROBP;PSMC1;LYN;CLEC7A;PSMB11;PSMA5;PRKACG;CREBBP;PSMB2;PSME2;MUCL1;PSMD12;PSMA7;MUC15;ICAM2;PSME4;PSME3;ICAM3;CLEC4D;MUC2;PSMD1;TRAF6;PAK1;FCER1G;MUC13
prerank,response to lipid (GO:0033993),-0.3174105152617334,-1.2811603830185165,0.03260869565217391,0.4601162768246819,1.0,38/108,24.05%,IL1B;SPP1;CYP27B1;CTSH;SOX9;IL23R;CYP24A1;NOCT;SCD;MAPKAPK2;CYP19A1;PALM3;GATA6;NOS2;IRAK1;TGFB1;CITED1;WNT8B;RBP4;TRIB1;F2R;SRR;SLPI;MICB;ACER2;FGFR4;STAT5B;IRAK3;GCH1;PPARG;RPS6KA3;CD6;SMAD6;AQP3;LBP;S100A7;MAPKAPK3;ANXA1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.3022727539587824,1.2808824460986021,0.06666666666666667,0.24204608330064528,1.0,9/30,17.43%,DNAJB5;HSPA2;DNAJC18;DNAJB4;ST13;HSPA1L;CHCHD4;HSPA8;DNAJB12
prerank,protein O-linked glycosylation (GO:0006493),-0.325166476618326,-1.2807647761095833,0.11904761904761904,0.46017398724960057,1.0,43/91,34.01%,POMK;GALNT6;B3GNT4;MUC5AC;CHST4;ST8SIA6;MUC12;TMTC4;B3GALNT2;C1GALT1;GALNT5;GCNT1;GALNT3;MUC17;MUC19;TET3;MUC4;ST6GAL1;DPM1;MUC5B;PGM3;POFUT1;B3GNT5;MUC20;PLOD3;B3GNT2;B3GNT3;GALNTL6;MUC3A;GALNT7;TET2;C1GALT1C1;MUCL1;TET1;GXYLT1;MUC15;GALNT14;DPM2;SLC35C1;MUC2;GXYLT2;MUC13;ST3GAL2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.44206700093485857,1.2806806770369552,0.18518518518518517,0.24174724778499243,1.0,5/15,11.61%,KCNA5;KCNH2;KCNJ8;KCNE2;KCND3
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.3192571746642772,-1.280099684561465,0.03409090909090909,0.45993608682486176,1.0,48/111,33.99%,CARD11;MUC5AC;PSMB9;CLEC6A;MUC12;PSMD14;SYK;RELA;MUC17;CLEC4C;MUC19;MUC4;MUC5B;FYN;CARD9;MUC20;PSMA3;NRAS;TAB3;IKBKG;PSMB3;MUC3A;KLRC2;TYROBP;PSMC1;LYN;CLEC7A;PSMB11;PSMA5;PRKACG;CREBBP;PSMB2;PSME2;MUCL1;PSMD12;PSMA7;MUC15;ICAM2;PSME4;PSME3;ICAM3;CLEC4D;MUC2;PSMD1;TRAF6;PAK1;FCER1G;MUC13
prerank,cellular response to lectin (GO:1990858),-0.3192571746642772,-1.280099684561465,0.03409090909090909,0.45993608682486176,1.0,48/111,33.99%,CARD11;MUC5AC;PSMB9;CLEC6A;MUC12;PSMD14;SYK;RELA;MUC17;CLEC4C;MUC19;MUC4;MUC5B;FYN;CARD9;MUC20;PSMA3;NRAS;TAB3;IKBKG;PSMB3;MUC3A;KLRC2;TYROBP;PSMC1;LYN;CLEC7A;PSMB11;PSMA5;PRKACG;CREBBP;PSMB2;PSME2;MUCL1;PSMD12;PSMA7;MUC15;ICAM2;PSME4;PSME3;ICAM3;CLEC4D;MUC2;PSMD1;TRAF6;PAK1;FCER1G;MUC13
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3290198704697537,1.2799485489625557,0.1,0.24207704977288885,1.0,12/51,10.91%,CLIP3;SORBS1;ATP2B4;LGALS3;CNPY4;PIK3R1;GPER1;RAMP3;CNST;STAC;EGFR;STAC2
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.3794881606235135,-1.2797591000677557,0.16417910447761194,0.4599435781501732,1.0,12/31,27.50%,CYP51A1;IDI2;SQLE;MVK;DHCR7;FDPS;NSDHL;G6PD;TM7SF2;ACAT2;HMGCS1;DHCR24
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.3589510898307933,1.2797245779586275,0.2727272727272727,0.2419440451657583,1.0,5/26,6.15%,FHL1;VAMP2;ATP1B2;CASQ2;ANK2
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.3239072337790909,-1.279304738842605,0.0898876404494382,0.46003456103052487,1.0,15/89,7.73%,ENC1;CST4;IGF2BP1;GZMB;IGF2BP3;PUS7;TRIM71;CALR;DHFR;GRB7;NANOS3;KNG1;NCL;IGF2BP2;CAPRIN1
prerank,lysosome organization (GO:0007040),0.31841103884638056,1.279164521829364,0.17391304347826086,0.24227244551477328,1.0,14/35,20.10%,TPCN2;MTOR;AKTIP;SNAPIN;TFEB;TPP1;HPS1;CLVS2;VPS18;ZKSCAN3;GAA;ACP2;VPS33A;LAMTOR1
prerank,GPI anchor biosynthetic process (GO:0006506),-0.4088169163229078,-1.2790217461514855,0.12987012987012986,0.4599417882708547,1.0,12/30,31.62%,PIGM;PIGU;PIGW;PYURF;PIGF;DPM1;PGAP1;PIGN;PIGA;PIGB;DPM2;PGAP2
prerank,protein localization to organelle (GO:0033365),0.24313975704621107,1.2782288118422875,0.0,0.2432572246184616,1.0,48/136,20.03%,VAMP2;TUB;PRNP;OPTN;TOR1AIP1;MICALL1;GBP2;TULP3;OBSL1;GABARAPL2;ARL3;PACSIN2;ANK2;BBS1;HMOX1;HHEX;CROCC;TRAM1L1;VAPA;APP;SCG3;TMEM30A;RPA1;PAF1;XPA;BBS2;LAMP5;GBF1;TIA1;CTDNEP1;CEP68;ARL6;RAB33B;PPP1R15A;BBS4;EMD;SGTA;IFT20;CYB5A;ALDH3A2;CNEP1R1;ATP6V1D;CNTLN;TTC21A;EHD1;DVL1;WDR83OS;TOLLIP
prerank,positive regulation of nuclear division (GO:0051785),-0.40188157182815076,-1.2777947085725985,0.19117647058823528,0.46212725457646314,1.0,7/27,9.47%,IL1A;PDGFRB;IL1B;EREG;EPGN;AURKA;DMRT1
prerank,positive regulation of response to stimulus (GO:0048584),-0.37746651636966794,-1.2766724227940105,0.12345679012345678,0.4640867571335927,1.0,8/44,7.41%,MYC;CD80;TGFB2;HMGA1;WNT5A;CDKN2A;HMGA2;HOMER1
prerank,protein maturation (GO:0051604),-0.3261182556781128,-1.2760903967410722,0.060240963855421686,0.464646997601082,1.0,23/94,16.15%,TESC;CPZ;F12;MME;DUOXA2;CIAO1;CPN1;LIPT2;PCSK1;F7;MMEL1;HSPD1;SORL1;CPD;NAA15;PRSS37;CASP2;PTCH1;PCSK6;NAA35;ADAM10;AANAT;PCSK7
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.3616061492413301,-1.2756349069521975,0.14285714285714285,0.4646763164924615,1.0,23/52,32.18%,DCLRE1C;PRKDC;POLB;PSMD14;POLA1;BRCC3;ERCC8;DCLRE1B;XRCC4;PAXIP1;LIG3;BRCA1;RIF1;BARD1;HMGB1;ERCC6;NSMCE2;PRPF19;XRCC5;DNTT;POLQ;SMARCAL1;UBE2N
prerank,regulation of cell cycle (GO:0051726),-0.2926975515193696,-1.2756189730811862,0.021052631578947368,0.4636678778053136,1.0,71/288,17.75%,FAP;MYC;DDIAS;CCND1;CXCL8;CDKN3;CHEK1;INHBA;ZBED6;TP73;KIF20B;MCIDAS;TGFB2;POU4F1;MIF;SKP2;DLGAP5;MYBL2;FOXE3;CKS2;CSNK2A3;PML;FBXO5;JUNB;DUSP1;WDR12;MASTL;LIN9;SOX9;CDKN2A;CALR;HMGA2;SND1;NANOS3;PROX1;BOP1;TFAP4;CKS1B;ASAH2;FIGNL1;NEK6;CDK4;IL12B;XIAP;CDK7;PRR11;GATA6;CDC14C;PLK1;FOXM1;BMP7;LIN54;CENPF;ZBED9;THBS1;TGFB1;PNPT1;PTPRK;ADAM10;CDC25A;GADD45GIP1;IFNG;BIRC7;BIRC5;RNF40;MLXIPL;SMIM22;ANKRD17;CRLF3;CDK5;MDM2
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.28267396886017976,1.2753962555934386,0.0,0.24670021365100067,1.0,31/102,16.15%,SLC2A4;VAMP2;SORBS1;ADCY5;ZFP36L1;INPP5K;KAT2B;CPEB1;ADCY4;PRKAR2B;PRKCD;PIK3R1;HDAC5;GPER1;PRKACA;RHOQ;PDE3B;RAB31;CEACAM1;USF1;MGARP;RAB8B;LPIN1;PLA2G1B;NFKB1;ADCY9;ADCY2;NR4A1;ADCY6;NR4A3;RAB13
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.42790416461899483,-1.2750046529840244,0.12987012987012986,0.4641758683816209,1.0,14/32,25.27%,E2F1;FBXO5;DHFR;CCNE1;POLA1;CDT1;TFDP1;NPAT;CDC6;CDC45;CDK5;ORC1;E2F7;ZPR1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3143736121072567,1.2748854990714515,0.15,0.24744521500902295,1.0,11/51,8.35%,IL6R;PTN;MAPK1;DEFB124;VEGFB;MAPK3;RARRES2;F2RL1;MSTN;ZNF580;CREB3
prerank,positive regulation of calcium ion transport (GO:0051928),0.303534229627823,1.273914973555715,0.07407407407407407,0.24838406706111252,1.0,11/37,13.24%,MYLK;LGALS3;P2RX7;ANK2;WFS1;PDGFB;CCL2;P2RX2;CACNB2;TRPC6;PLA2G1B
prerank,activation of protein kinase B activity (GO:0032148),0.3506628690465111,1.273771862141957,0.14814814814814814,0.2481768010099864,1.0,12/31,17.11%,MTOR;PDGFB;FGF1;MAPKAP1;MT3;ADRA2B;ITGB1BP1;NTF3;INS;NTRK3;TXN;GAS6
prerank,inositol lipid-mediated signaling (GO:0048017),0.2894847330647959,1.2728170546070636,0.05263157894736842,0.24901360544475207,1.0,12/51,7.70%,PIRT;FGFR1;PLCD4;PI4KB;PITPNM2;NGF;TNFAIP8L3;PLCL1;PIK3R1;RHOA;PDGFRA;PLCD1
prerank,positive regulation of GTPase activity (GO:0043547),0.23911108869637374,1.2728087743356258,0.0,0.24861067080811006,1.0,60/199,17.09%,TBC1D1;RAP1A;ARHGEF26;FERMT2;CCL14;RGS10;SYDE1;CAV2;ASAP3;FLCN;CORO1C;DVL3;RASGRP2;RAPGEF3;SGSM2;TBC1D20;GNB5;ARHGEF15;EVI5L;TBC1D17;CCL21;RSU1;RABGAP1;F2RL1;CCL2;MAPRE2;ARHGEF10;TAX1BP3;TBC1D25;ADPRH;SIPA1;USP6;SFRP1;SNX18;SGSM1;PIN1;TBC1D10A;CX3CL1;CCL11;TSC1;TBC1D26;CCL13;SIPA1L2;SGSM3;RGS1;NTRK1;ADCYAP1;CCL8;RALBP1;NTF3;BCAR3;SNX9;NTRK3;PRTN3;RAB11FIP2;CCL23;PLXNB1;NDEL1;ARHGAP29;SRGAP2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3143288287546369,1.272311168200859,0.08695652173913043,0.24892405689471075,1.0,12/41,14.32%,ITPKB;PI4KB;PIK3R1;TMEM150A;PIP4K2B;IP6K1;SOCS2;PIK3R3;PI4K2A;IP6K3;FAM126A;PIP4K2A
prerank,granulocyte differentiation (GO:0030851),-0.4348588902550819,-1.272173406051687,0.16216216216216217,0.47128794246658273,1.0,5/20,8.95%,LEF1;E2F1;PML;CEBPA;CDK4
prerank,positive regulation of intracellular protein transport (GO:0090316),0.2355439343084194,1.2721357156777995,0.0625,0.2489443961401431,1.0,43/146,17.11%,VAMP2;FLNA;PSEN1;PRNP;KCNB1;MAPK8;MYO1C;RAPGEF3;BAG3;DMAP1;VPS11;MTCL1;CAMK1;PRKCD;PIK3R1;ABLIM3;LEPROT;YWHAZ;SAE1;RHOU;BAP1;SLC51B;CSNK2A2;SMAD3;TENM1;HSPA1L;BCL2;MIEF2;TMEM30A;ITGB1BP1;BAD;CHP2;TOMM7;SH3GLB1;ANK3;RNF31;MFF;UBE2D3;EFCAB7;PPP3CC;ATG13;B3GAT3;GAS6
prerank,regulation of histone acetylation (GO:0035065),0.3147341575364425,1.2712778250173975,0.17391304347826086,0.24954780118301734,1.0,8/33,6.41%,MAPK3;SNCA;MYOCD;FLCN;RAPGEF3;CAMK1;NOS1;HDAC5
prerank,negative regulation of cell cycle process (GO:0010948),-0.35691883482496906,-1.2709009658012012,0.13580246913580246,0.4738201751136883,1.0,21/62,20.72%,CHEK1;NEK2;E2F1;FBXO5;AURKB;TOM1L1;CHMP4C;DMRT1;BMP7;E2F8;RBBP8;TFDP1;CDC7;ESPL1;CBX3;HLA-G;BRCA1;FBXO43;RNF2;NME6;BMP4
prerank,piRNA metabolic process (GO:0034587),-0.43883085873164585,-1.2708046163426971,0.17142857142857143,0.4730609236139432,1.0,9/19,28.89%,PIWIL1;HENMT1;BTBD18;FKBP6;TDRD1;MYBL1;EXD1;TEX15;ASZ1
prerank,ureteric bud morphogenesis (GO:0060675),-0.4285285052463767,-1.26997771902627,0.14925373134328357,0.47422612776874884,1.0,9/19,22.54%,MYC;SHH;PAX2;SIX1;PAX8;CITED1;WNT11;BMP4;GATA3
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.35382555512795405,-1.2698572318057073,0.11538461538461539,0.4733720031843358,1.0,12/61,15.05%,CEBPB;CCND1;CDK1;LEF1;SOX9;CDKN2A;CBFB;CDK4;RELA;MED1;MED14;MED13
prerank,regulation of DNA binding (GO:0051101),-0.3627059332547897,-1.2697655044362515,0.15584415584415584,0.47248941595526206,1.0,18/45,24.18%,LEF1;HJURP;E2F1;MDFI;HMGA2;TFAP4;CDT1;MMP9;PLAUR;TGFB1;NFKBIA;NME1;MMP8;PPARG;EGF;IFI16;GZMA;HMGB1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.3966773694662778,1.2697547104787565,0.09375,0.25121662130231465,1.0,6/16,14.41%,TMEM50B;CHMP4A;LEPROT;CHMP7;TMEM50A;VPS28
prerank,regulation of cell death (GO:0010941),0.2571025664136501,1.2686156748457411,0.1111111111111111,0.2522665325791259,1.0,20/90,12.81%,CRYAB;FERMT2;CLU;NCK1;SNCG;SNCA;PARP16;FGF2;TMEM109;UBB;CD36;RAMP3;BNIP3;PRKD1;ACOX2;BNIP3L;MT3;SNCB;NKX3-1;TSC1
prerank,negative regulation of anoikis (GO:2000811),-0.47182191500401244,-1.2685676540562327,0.19718309859154928,0.4744562105544658,1.0,5/15,15.09%,ITGA5;CEACAM6;CAV1;CEACAM5;PTRH2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.375791007732713,-1.2683098885796122,0.10256410256410256,0.4742042352014245,1.0,18/55,24.10%,CDK1;SOX4;GTSE1;CDC25C;E2F1;PML;CHEK2;ARID3A;AURKA;E2F8;TFDP1;CNOT1;CASP2;MDM2;CARM1;CNOT10;CNOT11;E2F7
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.41629945575826915,1.2678829659063644,0.14285714285714285,0.25276499140188585,1.0,7/18,17.13%,GRIK5;GRIK3;SLC17A7;NAPB;GRIK2;GRIA2;GRID1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.42428657751659465,-1.2678570365400121,0.14666666666666667,0.47413043211763667,1.0,9/20,24.72%,PRKDC;SYK;ZAP70;IL36B;MDK;GATA3;AXL;XBP1;RHOH
prerank,negative regulation of mitochondrion organization (GO:0010823),0.3250314542038686,1.2672491435471813,0.1724137931034483,0.2533262328521823,1.0,9/33,16.33%,CLU;MAPT;FLCN;VAT1;MUL1;BNIP3;ACAA2;TFRC;NOL3
prerank,clathrin-dependent endocytosis (GO:0072583),0.3180354626835901,1.2667921011195242,0.14814814814814814,0.2536285817748049,1.0,9/26,20.51%,PIP5K1C;AP2M1;SIGLEC1;AP2A2;AP2A1;INPP5F;DLL1;ITSN1;FCHO2
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.3219523874924913,-1.2662974098591548,0.10227272727272728,0.47744469355456737,1.0,28/80,24.18%,IL1A;MIF;EPHB2;IL23A;OAS2;WNT5A;PF4;IL17A;IL17F;RASGRP1;SYK;CCL3;IL12B;ARFGEF2;THBS1;OAS3;IFNG;ADAM8;CYBA;CD86;NOD2;MMP8;PTPRJ;CD2;TYROBP;LBP;CLEC7A;HMGB1
prerank,regulation of T cell cytokine production (GO:0002724),-0.44943590903472297,-1.2661973280022694,0.21428571428571427,0.47657890206277365,1.0,8/19,22.30%,FOXP3;CD55;HLA-F;TNFRSF1B;LILRB4;TRAF2;TNFSF4;XCL1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.3682826589991598,1.2656591661097236,0.10344827586206896,0.2549567237753345,1.0,4/18,7.49%,NXF1;PABPN1;POLDIP3;HHEX
prerank,neuron maturation (GO:0042551),0.39481474227927393,1.2645490444334764,0.16129032258064516,0.25644081142178526,1.0,7/18,17.64%,LGI4;ADGRB3;MTCH1;APP;CX3CL1;SCARF1;ACTL6B
prerank,maturation of LSU-rRNA (GO:0000470),-0.441727401737853,-1.2644458447047024,0.1388888888888889,0.48028803018118893,1.0,11/25,30.12%,WDR12;BOP1;NIFK;MAK16;URB1;PES1;DDX18;RPF2;EIF6;RSL1D1;RPL7L1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.37418150248726956,1.2640427373225127,0.225,0.25667279836476825,1.0,3/15,3.42%,CLU;NACC2;ACKR3
prerank,alpha-amino acid catabolic process (GO:1901606),-0.3978590166902827,-1.2637433079730562,0.1875,0.4812216220864437,1.0,6/27,10.40%,IL4I1;ACMSD;KYNU;TDO2;IDO1;KMO
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.42769694124418345,-1.2630854623579573,0.22666666666666666,0.4818327810509268,1.0,9/21,25.54%,IL1B;CD81;PRKCZ;CD55;NLRP3;TRAF2;TNFSF4;XCL1;DENND1B
prerank,aggrephagy (GO:0035973),0.34401641238368147,1.2626182489666666,0.1111111111111111,0.25821331745562137,1.0,11/28,22.15%,DYNC1I1;MAP1LC3C;HDAC6;UBB;VIM;SQSTM1;UBE2V1;DYNC1LI2;WDR81;DYNC1I2;DYNLL2
prerank,positive regulation of cell cycle (GO:0045787),0.27878825656633505,1.2625461058556242,0.13636363636363635,0.25789975291097494,1.0,20/65,13.05%,CITED2;MEIS2;DUSP3;MAPRE3;PKD2;CCPG1;USP2;PKD1;USP19;PDGFB;NUDT16;EGFR;TRIM21;NUPR1;FGFR2;TAL1;APP;NKX3-1;ASNS;PRKCA
prerank,steroid metabolic process (GO:0008202),-0.3201967875968603,-1.2623779348546427,0.12941176470588237,0.48325074618486474,1.0,41/100,33.21%,SULT2B1;SHH;DHRS2;BAAT;CYP51A1;CYP27B1;CYP3A7;AKR1C4;CYP24A1;LRP2;CYP7B1;PRLR;CYP19A1;CYP2B6;CYP2D6;CYP26C1;SRD5A1;UGT2B7;CYP26A1;CYP39A1;RDH8;UGT1A7;AKR1D1;SULT1E1;UGT2B28;CYP2C19;SLC22A24;CYP3A43;HSD3B1;DHCR24;UGT2A1;SULT2A1;UGT1A3;UGT2B11;NPC1;SRD5A2;MSMO1;CYP3A5;FDXR;HSD17B4;HSD17B10
prerank,regulation of nuclear division (GO:0051783),-0.4553071753918102,-1.2623192434374597,0.2054794520547945,0.48223907731259075,1.0,9/20,18.85%,KIF20B;NEK2;CDC25C;FBXO5;PKMYT1;RCC1;PDXP;MKI67;FBXO43
prerank,glial cell differentiation (GO:0010001),-0.40976098690787977,-1.2620492553486156,0.14473684210526316,0.48202208793450374,1.0,5/27,4.08%,SHH;SOX4;PAX2;MMP24;SOX9
prerank,regulation of cellular senescence (GO:2000772),-0.4145819824392247,-1.2618451196929896,0.24285714285714285,0.4816957052276117,1.0,10/30,12.90%,HMGA1;RBL1;FBXO5;CDKN2A;HMGA2;NEK6;NEK4;AKT3;TERT;PNPT1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.3171563163432923,-1.261743339803643,0.1728395061728395,0.4809303017250157,1.0,21/90,12.70%,IL11;OSM;TDGF1;LRP8;CD80;MIF;RIPK2;ITGA5;IL23A;CD44;CLEC6A;IL23R;CD81;IL5;PECAM1;IL12B;SEMA4D;IL22RA2;PRKCZ;AGT;TGFB1
prerank,positive regulation of neuron differentiation (GO:0045666),0.32356960758845316,1.2614450404537658,0.15384615384615385,0.25870131206342656,1.0,14/43,16.29%,FGFR1;NGF;ZC4H2;HOXD3;RHOA;PCP4;GPRC5B;NBL1;MMD;ADRA2B;MEF2C;KCTD11;MMD2;SIN3A
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.43764005473196504,-1.2614212211241622,0.22857142857142856,0.4807961785202829,1.0,11/18,35.28%,SYK;FER1L5;IFNG;NMI;TYROBP;LBP;DNASE1;DOCK2;IFI35;FCER1G;ENPP3
prerank,regulation of cellular component movement (GO:0051270),0.28667219258018656,1.2610210429966466,0.05555555555555555,0.259277864378911,1.0,13/49,11.74%,BTC;ACTN1;CADM4;ZSWIM8;FES;DAPK3;TGFBR3;HDAC6;RHOA;PKN1;EGFR;NRG2;RAF1
prerank,external encapsulating structure organization (GO:0045229),-0.29821854529484926,-1.2608923082109211,0.10309278350515463,0.4810698493164434,1.0,51/208,16.01%,COL10A1;MMP7;MMP13;ACAN;COL1A1;COL11A1;ADAM12;COL1A2;VWF;LAMC2;TGFBI;ITGA5;SPP1;MMP10;SERPINE1;MMP1;FN1;MMP24;MMP11;IBSP;MMP20;ICAM1;CD44;BCAN;MMP3;ADAMTS12;MMP2;ADAMTS18;MMP25;PECAM1;FBN2;COL3A1;SMOC1;ITGAX;DMP1;MMP9;AGRN;LAMA3;THBS1;COL2A1;ITGAD;ITGA11;LAMB3;VCAN;KDR;SLC39A8;NF1;COL7A1;MMP12;ADAMTS20;ITGB6
prerank,positive regulation of protein import into nucleus (GO:0042307),0.35240548802936567,1.2606259771040205,0.11764705882352941,0.25947181501653127,1.0,6/28,6.20%,FLNA;PSEN1;BAG3;DMAP1;PRKCD;PIK3R1
prerank,rRNA modification (GO:0000154),-0.47313718205520294,-1.260523873029942,0.2,0.48098289217023726,1.0,7/19,16.53%,DKC1;TFB1M;NAT10;NSUN3;GAR1;FBL;TFB2M
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.4105873067108825,-1.260231881330236,0.18309859154929578,0.48072481225870667,1.0,10/24,34.10%,MIF;CD44;PMAIP1;ATR;SMYD2;MDM2;SPRED1;TWIST1;KDM1A;CD74
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.3947951811563867,1.2599438490090686,0.23076923076923078,0.25976020059668464,1.0,12/23,19.93%,GSN;ECSCR;GPER1;CCL2;PLA2G1B;PIAS4;RGCC;PDCD4;ITGA4;ANO6;CD40;AKR1C3
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.3182374575554568,1.2592084696431647,0.13043478260869565,0.2603323684066978,1.0,12/33,15.90%,CAV2;PRL;NGFR;ATOH8;NR2F2;SCG2;CCL2;PTPRM;MEF2C;SYNJ2BP;RGCC;IL12A
prerank,vasculogenesis (GO:0001570),-0.4080866638022177,-1.2591668406933711,0.13043478260869565,0.48250586710755383,1.0,11/33,15.30%,TBX20;SHH;PDGFRB;WNT7B;ENG;CAV1;APELA;TNNI3;TGFB1;KDR;TGFBR2
prerank,collagen fibril organization (GO:0030199),0.25119528542665165,1.2590532073838585,0.0,0.26020792555103767,1.0,16/89,8.78%,DPT;COL6A1;COL6A2;COL21A1;CRTAP;DDR2;DST;LOXL4;COL28A1;P3H2;COL16A1;COL24A1;COL4A2;BMP1;COLGALT2;COL5A3
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.35906582680653043,1.2586030799152974,0.15789473684210525,0.26046226834560654,1.0,6/20,7.54%,PTEN;MYOCD;CDKN1C;NR2F2;HHEX;LATS2
prerank,regulation of exit from mitosis (GO:0007096),-0.3774616634801636,-1.2573613923363718,0.09722222222222222,0.4865764095427259,1.0,12/39,22.13%,MAD2L1;CDCA5;NEK2;UBE2C;UBE2S;KNTC1;ANAPC1;CDC14C;ANLN;CDC20;BUB1B;CDC26
prerank,cellular response to growth factor stimulus (GO:0071363),0.25304106553062344,1.2571699311277778,0.0,0.26238444666535515,1.0,30/152,9.83%,TMEM100;RAP1A;CILP;STMN2;PDE2A;DUSP22;MAPT;HSPB1;ZFP36L1;INPP5K;SIRT2;MAPK7;DUSP3;MAPK14;NOS1;ZFP36;BMPR1A;CLEC3B;DAB2IP;PDGFB;RAMP2;SMAD7;CCL2;PRKD1;PDE3A;CORO1B;EGFR;SMAD4;SFRP1;FLT4
prerank,receptor-mediated endocytosis (GO:0006898),0.24031957335502824,1.2569038587484855,0.0,0.26257172498092524,1.0,26/136,10.77%,PDLIM7;PIP5K1C;RAMP1;CAV2;MASP1;WASF1;SNCA;SNX1;PI4KB;ACKR3;MICALL1;LMBR1L;ADRB3;TPCN2;AP2M1;COLEC12;STAB1;CD36;RAMP3;HSP90B1;RAMP2;TMEM108;RAB31;IGF2R;NLGN3;AP2A2
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.4478173481342462,-1.2566031459026192,0.17142857142857143,0.48754677045821826,1.0,10/22,29.91%,DUSP4;DUSP1;DUSP18;DUSP9;PDP1;DUSP16;DUSP2;DUSP6;PPM1G;PPP1CA
prerank,protein catabolic process (GO:0030163),0.28569468214939603,1.255664157072497,0.125,0.26407660501309577,1.0,17/60,15.21%,NR1D1;FBXO17;UBE2G1;FBXO44;MTOR;DAB2IP;DENND3;UBE2G2;ELANE;TPP1;CEACAM1;FBXO27;LRSAM1;CAPN3;RIPK1;RNF41;HSPA8
prerank,sodium ion import across plasma membrane (GO:0098719),-0.46513173987658996,-1.2552156670734955,0.18840579710144928,0.49024374687890865,1.0,4/18,6.58%,SLC12A2;SLC5A2;SLC9C1;SLC9A7
prerank,regulation of hydrolase activity (GO:0051336),0.29028367258354687,1.2551412793216152,0.15384615384615385,0.26441734662252975,1.0,25/70,19.90%,BVES;PLXNB3;NOS1;EFNA5;EPHA4;DAB2IP;SERPINA5;RABGAP1;SOD1;PAFAH1B1;FGD6;RDX;PRKG1;RASIP1;ITGB1BP1;RALBP1;EPHA3;PLXNB1;FGD1;CAMK2A;SCARB2;CHN1;CDK5RAP3;FBXW11;OCRL
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.3766860952802739,1.2550188184400608,0.16666666666666666,0.26413127317476787,1.0,8/18,18.10%,EGLN2;DDX17;RBFOX2;PPARGC1B;TRIP4;NCOA4;TADA3;AR
prerank,positive regulation of ion transport (GO:0043270),0.30404466881620174,1.2549451540861998,0.1111111111111111,0.2638460881538623,1.0,18/50,18.47%,FHL1;MYLK;SCN3B;P2RX7;ANK2;WFS1;SCN1B;GPD1L;AHCYL1;SCN4B;CACNB2;TRPC6;GDNF;CNKSR3;ANK3;ACTN2;CAMK2A;ANO6
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.3507848385352723,1.254069746078614,0.15151515151515152,0.2647158449583433,1.0,9/30,11.17%,PSEN1;FZD7;BCL10;ILK;SNCA;NCKAP1L;PTH1R;EGFR;APP
prerank,protein mannosylation (GO:0035268),0.37164954946582157,1.2536352299144753,0.19230769230769232,0.26514691456065775,1.0,7/18,11.68%,TMTC1;B4GAT1;POMT1;TMTC2;FKRP;DPY19L2;POMT2
prerank,regulation of AMPA receptor activity (GO:2000311),0.33966232674930114,1.253457941425288,0.19230769230769232,0.26486148211112287,1.0,10/24,19.34%,PRRT1;NLGN2;NLGN1;NLGN3;MEF2C;ARC;ADRB2;SHISA7;SHISA9;SHANK3
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.36348228316137693,1.2534470485045057,0.14814814814814814,0.2644527452560131,1.0,6/21,11.02%,CSPG4;DCN;CHST3;CHST15;CHST9;CHST7
prerank,B cell activation involved in immune response (GO:0002312),-0.45026201116630643,-1.2532336833498705,0.2,0.49511856686653155,1.0,9/15,41.04%,BATF;EXOSC3;MSH6;IFNB1;MSH2;CD19;CD180;CD40LG;RNF168
prerank,response to insulin (GO:0032868),0.26905324173858386,1.2529075492520614,0.07692307692307693,0.26494422464376854,1.0,20/79,13.24%,SLC2A4;VAMP2;SORBS1;ZFP36L1;INPP5K;KAT2B;CPEB1;PIK3R1;HDAC5;RHOQ;PDE3B;RAB31;SLC27A1;CEACAM1;USF1;RAB8B;EPM2AIP1;LPIN1;TSC1;PLA2G1B
prerank,regulation of actin filament bundle assembly (GO:0032231),0.36833609400468337,1.252092084346236,0.11764705882352941,0.26540324097198015,1.0,13/25,21.30%,SYNPO2;ASAP3;RAC1;SYNPO;RDX;CX3CL1;TSC1;PTGER4;PFN2;SHANK3;SLC9A1;FHOD1;PFN1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.35307191679567745,1.2520780871822443,0.11538461538461539,0.2650573620455344,1.0,14/27,25.33%,ATF4;HSPB1;MAPK7;INS;NME5;TXN;NOL3;FBXO7;PDE8A;SIRT1;NFE2L2;SOD2;LRRK2;PINK1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.42275962774567083,-1.2510937684125951,0.18666666666666668,0.5001258720110835,1.0,10/20,26.80%,IL1B;CCL3;IRAK1;TGFB1;CD6;LBP;LYN;TNF;CCL5;PTPN22
prerank,extracellular structure organization (GO:0043062),-0.2964235528788169,-1.250803426678886,0.10416666666666667,0.4998298568250232,1.0,51/207,16.01%,COL10A1;MMP7;MMP13;ACAN;COL1A1;COL11A1;ADAM12;COL1A2;VWF;LAMC2;TGFBI;ITGA5;SPP1;MMP10;SERPINE1;MMP1;FN1;MMP24;MMP11;IBSP;MMP20;ICAM1;CD44;BCAN;MMP3;ADAMTS12;MMP2;ADAMTS18;MMP25;PECAM1;FBN2;COL3A1;SMOC1;ITGAX;DMP1;MMP9;AGRN;LAMA3;THBS1;COL2A1;ITGAD;ITGA11;LAMB3;VCAN;KDR;SLC39A8;NF1;COL7A1;MMP12;ADAMTS20;ITGB6
prerank,MAPK cascade (GO:0000165),0.20697331715246683,1.2500345160232897,0.0,0.2676129962649107,1.0,95/300,19.92%,BTC;GFRA1;GFRA3;FGFR1;MAP3K3;MAPK1;FNTB;KIT;MAPK3;NCAM1;SHC2;KITLG;ZFP36L1;FGF2;CALM1;MRAS;MAPK8;PABPN1;FRS3;SKP1;RGL2;ARL2;NEFL;ZFP36;PIK3R1;GFRA2;PDGFRA;DLG4;KL;FGF7;UBB;FLT3LG;DAB2IP;PDGFB;MAPK11;SCG2;PPP1CB;PSMC5;RGL1;CCL2;FGF1;PRKG2;PEA15;IL17RD;MEF2A;EGFR;FGFR2;JAK1;ANGPT1;NRG2;PLVAP;MAP2K2;RAF1;MT3;DLG2;MEF2C;PTGER4;JAK2;NFKB1;GDNF;GOLGA7;FGF5;PSMD9;FGF10;LAMTOR3;RALGDS;RASA3;LGALS9;BTRC;FNTA;PSMB6;TAOK2;ARAF;RET;PDGFA;CAMKK2;LRRC7;NRK;FGF17;RIT2;FGF16;ACTN2;CAMK2A;TNIP2;SHC3;ERBB3;FGF9;GRB2;CUL1;ZFP36L2;SHANK3;FGFR3;FBXW11;IL3RA;SYNGAP1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.48638322354371555,-1.2500153273990402,0.18055555555555555,0.5012355881551408,1.0,11/18,34.91%,DNMT1;DNMT3B;MYB;PAXIP1;AUTS2;CTCFL;BRCA1;BCOR;KDM1A;CTR9;WDR5
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.29270898568924936,1.2492654869696722,0.16666666666666666,0.2677789763339676,1.0,29/55,30.07%,TIMM21;NDUFA11;OXA1L;ECSIT;NDUFC2;NDUFA5;NDUFS2;NDUFB8;NDUFB10;NDUFS4;NDUFV2;BCS1L;TIMMDC1;NDUFAF1;NDUFA8;NDUFS8;NDUFV1;NDUFA13;NDUFC1;NDUFS5;TMEM126B;NDUFA6;NDUFA10;NDUFB6;NDUFV3;NDUFA9;NDUFB4;NDUFB5;NDUFA7
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.29270898568924936,1.2492654869696722,0.16666666666666666,0.2677789763339676,1.0,29/55,30.07%,TIMM21;NDUFA11;OXA1L;ECSIT;NDUFC2;NDUFA5;NDUFS2;NDUFB8;NDUFB10;NDUFS4;NDUFV2;BCS1L;TIMMDC1;NDUFAF1;NDUFA8;NDUFS8;NDUFV1;NDUFA13;NDUFC1;NDUFS5;TMEM126B;NDUFA6;NDUFA10;NDUFB6;NDUFV3;NDUFA9;NDUFB4;NDUFB5;NDUFA7
prerank,positive regulation of JNK cascade (GO:0046330),0.28267682941155264,1.2491771889446912,0.05555555555555555,0.2675237262168768,1.0,25/72,17.37%,FZD7;DUSP22;GADD45B;PJA2;MTURN;TIRAP;CCL21;DAB2IP;F2RL1;TRAF1;TLR9;MAP4K2;DUSP19;FLT4;MAPK8IP1;APP;SEMA3A;ANKRD6;GADD45G;RIPK1;RASSF2;TAOK2;EDA2R;WNT16;MAP3K10
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.24702586608518937,1.2490936591947108,0.0,0.2672079188442653,1.0,44/192,14.18%,EPM2A;PER1;BCL2L2;ATP2B4;NR1D1;PTEN;PPP2R5B;TRIM39;PDE2A;ZMYND11;PHLDA3;FLCN;INPP5K;DUSP3;MAPK14;ARNTL;HDAC7;P2RX7;NLRX1;GPER1;DAB2IP;C1QTNF3;DGKG;PIK3IP1;MUL1;PRKAA2;MSTN;TNFAIP8L1;PDE3B;GPD1L;PDE3A;TLE1;DEPTOR;MYADM;SFRP5;PPM1A;WWC3;ITPR1;TSC1;BCL2;PDE4D;UBE2B;RIPK1;MAGI2
prerank,cellular response to lipid (GO:0071396),-0.29102435266256765,-1.2487112063116526,0.10416666666666667,0.5037357883575704,1.0,84/209,30.84%,IL1A;CXCL1;CXCL3;CXCL8;CXCL2;IRS1;WNT2;TESC;CXCL5;CD80;ADCY1;WNT7B;POU4F1;IL1B;CXCL9;PTK7;CXCL11;SPP1;SERPINE1;TNFAIP3;CARD17;PAX2;WNT5A;SOX9;TNIP3;ABL2;PF4;DEFA6;FFAR2;CXCL6;RELA;IRAK1;MED1;CXCL10;FZD10;UCP1;WNT8B;CFTR;IL10;TNFRSF1B;NLRP3;MSN;ADAM9;WNT11;PF4V1;IL36B;PLAA;CD86;NOD2;BRINP2;WNT3A;TNFSF4;WNT3;DEFA1;IL36RN;CARD16;POU4F2;AXL;RUVBL2;ABCB4;LBP;LYN;LCOR;HMGB1;ADAM15;XBP1;IL37;ROCK2;PDE4B;CCDC62;CXCL13;NLRP7;SETX;CDC73;NRIP1;ZC3H12A;ADCY8;LILRB2;URI1;STRA8;PDCD1LG2;MYD88;GPLD1;IL36G
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.4093783043691938,-1.2486188566592535,0.21052631578947367,0.5030067777126273,1.0,13/20,40.61%,IL23A;IL23R;TNFSF9;IL12B;IL12RB1;IL27RA;HMGB1;IGFBP2;IGF1;AGER;IL2;RPS3;IL18
prerank,regulation of interleukin-2 production (GO:0032663),-0.363761026313244,-1.2484705007087409,0.13333333333333333,0.5024026874983085,1.0,21/48,28.05%,IL1A;FOXP3;CD80;CARD11;IL1B;TNFAIP3;IL17F;PNP;RUNX1;GBP1;CR1;LILRB4;CD86;TRAF2;XCL1;CLEC7A;GLMN;ANXA1;PDE4B;CD28;EZR
prerank,synapse assembly (GO:0007416),0.2791647587840664,1.247020833476619,0.043478260869565216,0.2701389041460878,1.0,28/68,23.00%,PTEN;NLGN2;GPM6A;DNER;NPAS4;OBSL1;KIRREL3;NLGN4X;LGI2;NLGN1;NLGN3;PCDHB4;NRXN1;CDH2;PLXNB1;NRXN2;SHANK3;SDK1;DVL1;CDH1;RAB29;ADGRL3;PCDHB5;FGF13;ACHE;PCDHB6;SPOCK2;FZD1
prerank,membrane protein proteolysis (GO:0033619),-0.3711516033306556,-1.2468044253054724,0.21794871794871795,0.505552344269576,1.0,12/39,20.21%,MMP7;CTSH;HM13;BACE2;RELA;TMPRSS6;TGFB1;ADAM10;ADAM9;PRKCQ;ERAP1;MBTPS2
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.35964079134980864,-1.246721529189968,0.1411764705882353,0.5046574401415539,1.0,24/58,28.46%,CEP55;KIF23;INCENP;KIF20A;CENPA;RACGAP1;MYH10;AURKB;KIF4B;ECT2;PLK1;SPAST;ESPL1;ANLN;TTC19;RTKN;CKAP2;STMN1;BIN3;SPIRE2;ROCK2;RASA1;CIT;KIF4A
prerank,positive regulation of cell adhesion (GO:0045785),0.2836037850002845,1.246197894229879,0.05555555555555555,0.2707678921603776,1.0,18/78,8.60%,TPM1;CITED2;FSTL3;DUSP26;TFE3;FLCN;RAC1;CHRD;ARL2;MEGF10;CCL21;EPHA4;RSU1;PDGFB;NCKAP1L;SMAD7;P2RY12;FBLN2
prerank,meiosis I (GO:0007127),-0.4248726630224763,-1.245889338064024,0.22058823529411764,0.5058077700091725,1.0,5/22,7.65%,SYCP3;PTTG1;BTBD18;HSF2BP;DNMT3L
prerank,maturation of 5.8S rRNA (GO:0000460),-0.43359777570422586,-1.245729289099459,0.18055555555555555,0.5050066983659621,1.0,7/16,25.91%,WDR12;PRKDC;EXOSC4;MAK16;URB1;PES1;EIF6
prerank,mucosal immune response (GO:0002385),-0.42822213055206954,-1.2457178037631638,0.1388888888888889,0.5039380494148624,1.0,10/20,36.40%,DEFA6;FFAR2;RPL39;NOS2;DEFA1;LTF;IFNL2;PIGR;RAB17;RNASE3
prerank,regulation of humoral immune response (GO:0002920),-0.36143992176039397,-1.2453943586098828,0.14285714285714285,0.5038054756273999,1.0,11/44,12.11%,C3;ZP3;SERPING1;CPN1;C4BPA;CR1L;CD81;GATA6;C4BPB;CD55;C2
prerank,positive regulation of defense response (GO:0031349),-0.3273903295126522,-1.2448100874485672,0.08536585365853659,0.5045280161889201,1.0,43/96,31.48%,OSM;IL1B;EREG;SERPINE1;IL23A;GBP5;WNT5A;ZP3;PLA2G7;IFNK;IL21;CEBPA;POLR3B;CCL3;FEM1A;FPR2;IL12B;AGT;NLRP12;NFKBIA;IFNG;ZBP1;POLR3C;ADAM8;CYBA;CCL1;MGST2;TNFSF4;MDK;POLR3G;NMI;TNF;NPAS2;IFNB1;TLR7;CCL5;NLRP10;TLR8;MAPK13;PLSCR1;ETS1;DHX9;IFI35
prerank,neuron projection extension (GO:1990138),0.3389202055124638,1.2444170144369915,0.2,0.2724939835151469,1.0,8/32,13.04%,NRP2;PPP3CB;ULK1;ULK2;TMEM108;NLGN3;SEMA3A;MAP1B
prerank,regulation of mononuclear cell migration (GO:0071675),0.35427995550074276,1.2442585431617246,0.12,0.2722944868878442,1.0,5/22,8.18%,LGALS3;MAPK1;MAPK3;RARRES2;MSTN
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.35121086139743113,1.2440504032225674,0.1388888888888889,0.27230864412249295,1.0,9/24,16.33%,MOAP1;TNFSF10;MLLT11;BCL2L11;GPER1;BNIP3;BAD;FAM162A;MFF
prerank,drug catabolic process (GO:0042737),-0.43281213102413757,-1.2437341645676931,0.14285714285714285,0.5062647623907695,1.0,9/21,22.25%,CYP2W1;CYP2S1;CYP2F1;CYP2A7;CYP2B6;CYP2D6;NUDT15;CYP2A13;CYP2C19
prerank,maintenance of protein location in nucleus (GO:0051457),0.37699893324144845,1.2436845671250878,0.1724137931034483,0.272353148359345,1.0,5/20,6.38%,SUPT7L;SKP1;ARL2;SUN2;SUN1
prerank,ethanol metabolic process (GO:0006067),0.40530915166054493,1.2433968615182787,0.08823529411764706,0.2722761425989342,1.0,3/19,3.76%,ADH1B;ADH5;ALDH1A1
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.42034420470059874,-1.2433847778183016,0.17333333333333334,0.5060235864720559,1.0,18/29,38.67%,TNFAIP3;CARD17;NLRP12;IL10;NLRP3;LILRB4;MEFV;SERPINB1;CARD16;GHSR;NLRP7;ZC3H12A;IGF1;CX3CR1;GHRL;PYDC1;PYDC2;FFAR4
prerank,negative regulation of hydrolase activity (GO:0051346),0.30829936509515515,1.2432661964636933,0.09523809523809523,0.2719872811186822,1.0,13/52,9.74%,PLXNB3;PTX3;MAPK7;PLIN5;ARL2;FICD;NOS1;GPSM1;MAP2;DAB2IP;SERPINA5;RDX;EGLN1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.3846669206750853,1.2428823460607241,0.21428571428571427,0.2719715624840117,1.0,7/18,13.80%,FERMT2;MYOC;RAC1;COL16A1;SFRP1;TSC1;PPM1F
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.31481249758902047,-1.241955276617457,0.14457831325301204,0.5088968189756715,1.0,18/81,11.88%,CCND1;CDKN3;BLM;CCNK;CDC25C;CCNO;CCNI2;SPDYA;CDKN2A;CCNE1;PROX1;TFAP4;PKMYT1;CEBPA;CCNF;CDK7;PLK1;GTPBP4
prerank,regulation of osteoclast differentiation (GO:0045670),-0.3719914571407279,-1.2417766376202386,0.14473684210526316,0.508175408112765,1.0,15/35,23.36%,CEBPB;TNFSF11;POU4F1;IL23A;IL23R;IL17A;CCL3;IL12B;ZNF675;IFNG;LILRB4;GPR55;POU4F2;OCSTAMP;TNF
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.31430299416879165,1.2408373198265932,0.15,0.2746745437454084,1.0,10/30,16.65%,CLIP3;SORBS1;OCLN;PIK3R1;RHOQ;GH1;ARPP19;INS;NR4A3;CREBL2
prerank,response to organic cyclic compound (GO:0014070),-0.3456249683105869,-1.2407698263061717,0.10344827586206896,0.5101715942283246,1.0,16/57,13.01%,IL1B;SPP1;CYP27B1;KYNU;DHFR;TRPM2;CYP24A1;PMAIP1;CCL3;CYP19A1;HLCS;CHRNB2;DRD2;GLDC;TGFB1;WNT8B
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.34925638841777207,-1.2407046164679099,0.1643835616438356,0.5092729103709693,1.0,9/45,12.70%,TDGF1;AREG;EREG;FAM83A;SOX9;GRB7;EPGN;REPS2;TGFB1
prerank,cellular component assembly (GO:0022607),0.24424797863562944,1.2405250807036996,0.0,0.2747453292553051,1.0,46/251,10.05%,LIMS2;FAM107A;SH3BGR;LIMA1;VAMP2;GPM6B;FLNA;GSN;FERMT2;ADD1;CALD1;FLNC;NLGN2;DPYSL3;TTLL3;WASF1;RHOJ;MITF;ILK;PARVA;FAS;RAC1;LAMC1;SKAP2;WDR19;OCLN;TEAD2;TSPAN4;RHOA;TEAD1;DLG4;NLGN4X;RHOQ;NCKAP1L;WASF3;RTN4;TRAF1;ACTB;ST13;BAIAP2;TCAP;CORO1B;YWHAZ;NLGN1;RHOU;NLGN3
prerank,cellular response to ketone (GO:1901655),0.3131722168714359,1.2404002335099735,0.10714285714285714,0.27442438428603627,1.0,17/37,19.93%,KLF9;ADCY5;AQP1;GNG2;SFRP1;GOLPH3;AKR1C2;GNAI1;PTGER4;ADCY2;PTGFR;ADCY6;NCOA4;NR3C1;AR;TRERF1;AKR1C3
prerank,cellular response to acid chemical (GO:0071229),0.33156336805782555,1.2403167609557868,0.1935483870967742,0.2740743269998924,1.0,9/26,14.69%,CPEB1;MTOR;RRAGA;RRAGD;KLF2;RRAGB;CAPN2;LAMTOR3;RRAGC
prerank,regulation of protein binding (GO:0043393),0.25115925824626933,1.2397353371324922,0.0,0.2747462296124367,1.0,23/108,11.17%,PSEN1;ADD1;CLDN5;BAG2;CDKN1A;MAPK8;HDAC4;CAMK1;PRKCD;HDAC5;AKTIP;PKD1;PRKACA;DNAJB2;PDGFB;SNAPIN;ACTB;B2M;CSNK1E;TRIM21;FLOT1;PIN1;APP
prerank,modified amino acid transport (GO:0072337),-0.4615159415488099,-1.2394126994267791,0.25,0.5118935395878149,1.0,6/17,17.39%,SLC6A20;FOLR1;SLC5A6;SLC1A4;SLC46A1;SLC19A1
prerank,positive regulation of bone mineralization (GO:0030501),0.3278895988023548,1.2394068373296194,0.21739130434782608,0.2749663971219353,1.0,10/35,13.13%,PTN;GPM6B;OSR1;P2RX7;BMPR1A;KL;PKDCC;SLC8A1;MEF2C;OSR2
prerank,regulation of regulated secretory pathway (GO:1903305),0.30099189902365875,1.2391680708800341,0.14285714285714285,0.274766783747491,1.0,12/34,16.73%,SYT11;RAB3A;RIMS3;SNAPIN;SYT10;SYT4;SYN1;SYT5;SYT1;SYT6;RAB27A;VPS18
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.3501355500965054,-1.2384918445617357,0.09876543209876543,0.513161808742893,1.0,17/45,25.96%,SOCS3;SOCS1;JAK3;CAV1;OCIAD2;PIGU;VHL;IL10;F2R;CRLF3;CENPJ;IL26;EGF;TNF;IL10RA;NOTCH1;CCL5
prerank,positive regulation of cell death (GO:0010942),-0.32641570730524216,-1.237214661966953,0.1282051282051282,0.5161016087096855,1.0,21/62,23.36%,GRIN2B;PRR7;RIPK2;EGR1;FOS;WNT5A;CALCR;MMP3;SLC6A6;AXIN2;HBA1;FYN;IFNG;ACER2;PHB;ITGB2;BMP4;GSK3B;POU4F2;TYROBP;TNF
prerank,response to purine-containing compound (GO:0014074),-0.4356021417394515,-1.2367525340072374,0.2028985507246377,0.516372313331885,1.0,6/17,13.28%,DUOX2;TRPM2;STAT1;VGF;CITED1;DUOX1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.31434828838693496,1.2363586853424227,0.12121212121212122,0.2779157863889074,1.0,8/32,13.52%,PTEN;DBN1;EPHA4;ZDHHC15;KIF1A;NLGN1;BHLHB9;ARC
prerank,establishment of protein localization to membrane (GO:0090150),0.26060295745160966,1.2361133314222157,0.0,0.2778019355178245,1.0,20/67,16.66%,REEP1;NACAD;MICALL1;MYO1C;ZDHHC7;ZDHHC15;ZDHHC22;GORASP1;EGFR;OXA1L;ZDHHC18;RAB11B;PARD3;GOLGA7;VPS37D;TAOK2;VPS37A;ARL6;RTP5;ZDHHC1
prerank,translesion synthesis (GO:0019985),-0.355346195484039,-1.2356646780468508,0.16883116883116883,0.518384973615924,1.0,6/40,6.80%,RFC3;POLE2;POLH;RPA3;ISG15;RFC5
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.3516491036262234,-1.2351102215449594,0.15,0.5187228796164919,1.0,11/44,13.88%,ATAD2;CHEK1;HMGA1;POLR2F;POLR1C;DDX21;TAF1A;POLR1B;CDCA4;TAF1B;POLR1A
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.42070046752773266,-1.2347175382183297,0.19402985074626866,0.518680121837451,1.0,8/20,22.88%,CARD11;SLC39A10;CD81;RELA;KCNN4;IKBKG;LCK;NFAM1
prerank,response to retinoic acid (GO:0032526),-0.3293350894688391,-1.2345398238961742,0.16455696202531644,0.5180989468195698,1.0,21/60,23.29%,WNT2;TESC;WNT7B;PTK7;PAX2;WNT5A;CTSH;SOX9;ABL2;GATA6;FZD10;WNT8B;RBP4;WNT11;MICB;ACER2;BRINP2;WNT3A;WNT3;AQP3;LYN
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.3136753499042723,-1.2339787225993752,0.14814814814814814,0.5184789256364011,1.0,15/72,15.10%,SULT2B1;ENTPD7;SULT1C3;SULT1C2;BAAT;HPRT1;ACSL6;THEM5;EPHA2;SULT1A3;ACOT12;ACOT6;ACSM6;ACSM4;NT5C2
prerank,glutamate metabolic process (GO:0006536),-0.43493352430939713,-1.2338708048542941,0.11764705882352941,0.517639631563714,1.0,6/20,17.54%,GLS2;GAD1;ALDH5A1;ALDH18A1;NAGS;GLUD2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.3328600428146844,-1.2336759587674118,0.09195402298850575,0.5173101284982794,1.0,28/82,24.26%,KIF14;CEP72;CDK1;GTSE1;NEK2;CEP250;ATAD5;TPX2;HAUS7;AURKA;PLK1;CENPF;HAUS6;DYRK3;CEP76;CEP152;NDE1;PLK4;SDCCAG8;CENPJ;CKAP5;ALMS1;CEP78;CEP41;AKAP9;NPM1;HAUS8;HAUS2
prerank,epithelial to mesenchymal transition (GO:0001837),-0.33999578846983763,-1.23336509449368,0.20253164556962025,0.5170541654367511,1.0,8/46,5.28%,LOXL2;AMELX;TGFB2;LEF1;WNT5A;SOX9;HMGA2;ENG
prerank,calcium ion transport (GO:0006816),0.25348034988522994,1.2331883994687094,0.05555555555555555,0.2815033965467624,1.0,27/113,12.10%,ATP2B4;PSEN1;CACNA1H;RAMP1;STIM1;ORAI3;CACNA1C;PKD2;SLC24A3;P2RX7;ANK2;PKD1;CACNA2D1;MCOLN1;RAMP3;TRPC1;RAMP2;SLC8A2;SLN;TRPC4;TRPV1;ATP2A2;RYR3;MCOLN3;CACNB2;ITPR1;SLC8A1
prerank,cellular response to hydrogen peroxide (GO:0070301),0.3024700769819441,1.2331401096818948,0.17857142857142858,0.28111673180324337,1.0,7/35,8.22%,RNF112;RHOB;AQP1;MAPK7;PRKCD;HDAC6;ZNF580
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.33405045021387075,1.2327886905733885,0.12,0.2813552545899652,1.0,11/24,19.57%,COQ10A;ADRB3;ACADVL;COX4I2;GFPT2;PID1;MT3;NR4A3;LEPR;NDUFS4;COQ10B
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.3947175596587605,-1.2326256465805268,0.15714285714285714,0.5181823409642538,1.0,10/26,18.28%,KIF18A;KIF14;KIF24;KIF2A;TRPV4;KIF2C;KIF18B;NCKAP5;CENPJ;CKAP5
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.3366783861277578,1.2317185121692165,0.14285714285714285,0.2828393234111982,1.0,8/25,12.99%,TPM1;HAND1;TGFBR3;ID2;SMAD7;MYL2;FGFR2;MYL3
prerank,cellular protein-containing complex assembly (GO:0034622),0.2269179209312025,1.2315885258156194,0.0,0.2825116573822918,1.0,44/158,17.91%,VAMP2;COX7A1;CLU;NCK1;VAMP1;CASQ2;CHRNA3;CHMP3;MAPT;VAMP4;SNCA;CENPT;PTGES3L;CASQ1;SMAD2;PILRB;ARL2;AP2M1;PXN;POGZ;RTN4;CHMP4A;SMAD4;CSNK2B;ANGPT1;TBCEL;BBS12;SMAD3;DMD;VAMP3;MIS12;HIGD1B;FMOD;SNX9;CHCHD4;ADRB2;EIF4H;HIGD1A;STXBP1;ARL6;NSG1;DNAJB12;TIAM1;CCDC40
prerank,chondroitin sulfate metabolic process (GO:0030204),0.32341107136108654,1.2313810386018234,0.2,0.28239205244390464,1.0,9/30,16.39%,CSPG4;DCN;CHST3;IDS;CHST15;CHST9;CHST7;CSGALNACT2;DSEL
prerank,regulation of cell adhesion (GO:0030155),-0.2981835655688326,-1.231334216972832,0.1,0.521146230435592,1.0,50/129,29.10%,C2CD4A;CXCL8;KIF14;TESC;PLAU;TGFBI;CXCR4;EPHB2;DUSP1;IBSP;ABL2;ADGRG1;PKHD1;KNG1;ARHGDIB;FUT1;EPHB3;EPHA2;PIK3CG;FUT7;IL12B;SEMA4D;SEMA5A;P4HB;PLXNC1;TNFSF18;ADAM10;CXCR3;EPHA8;ADAM8;FUT2;PTPRJ;MDK;ZFHX3;PRKX;LYN;TNF;PKP4;TMEM102;ROCK2;RASA1;FRMD5;CCL5;CYTIP;EFNA1;STX3;C2CD4B;DSCAM;MIP;RAC2
prerank,myeloid cell differentiation (GO:0030099),-0.3491301906048988,-1.2307820540472285,0.1643835616438356,0.5216587976266929,1.0,18/49,25.28%,IL11;INHBA;CSF2;JAK3;CEBPA;RUNX1;ZFPM1;DYRK3;RPS19;KLF1;PTPN2;SPI1;IFI16;PRKX;LYN;HIPK2;TET2;HSPA9
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.23900556385526683,1.2303352243990573,0.0,0.2836908096882139,1.0,30/130,13.69%,TGFB1I1;TMEM100;RGMA;FERMT2;CLDN5;DUSP22;MAPK3;SMAD2;TGFBR3;ARHGEF18;RHOA;BMPR1A;HPGD;PXN;UBB;TWSG1;GCNT2;LRRC32;SMAD7;CDH5;WFIKKN2;SMAD4;SMAD3;ZMIZ1;SMAD9;PARD3;MEGF8;GDF5;SKI;ITGB5
prerank,B cell proliferation (GO:0042100),-0.386599356651654,-1.229680578904255,0.1643835616438356,0.5239161850184951,1.0,20/32,41.66%,IFNK;RASGRP1;HSPD1;CD70;IL10;IFNE;IFNB1;CR2;IFNA1;IFNA21;IFNA4;IFNA7;IFNA14;IFNA10;CD19;CD180;IFNA17;CD40LG;IFNA2;IFNA16
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.32358085273130854,-1.2292941035625282,0.14457831325301204,0.5238780108637758,1.0,35/74,32.59%,IL1A;IL1B;EREG;WNT5A;IL17A;IL17F;HSPD1;SYK;NOS2;F2R;IFNG;CARD9;CYBA;NOD2;MMP8;TNFSF4;TYROBP;LBP;TNF;CLEC7A;SCIMP;HMGB1;XBP1;TLR7;TWIST1;NLRP10;TMEM106A;LILRB2;TLR8;MAPK13;MYD88;PTPN11;DHX9;AGER;LILRA5
prerank,glycoprotein biosynthetic process (GO:0009101),-0.3062019198327241,-1.2292765425489312,0.15555555555555556,0.522841739651262,1.0,36/81,34.99%,PMM2;B3GNT4;ST8SIA6;ALG1;ALG1L2;FUT1;B3GALNT2;FUT7;GCNT1;ALG5;FUT10;GAL3ST2;B3GNT5;FUT2;B3GNT2;FUT6;B3GNT3;CANT1;FUT5;ALG3;FOXL1;B4GALT7;DDOST;TMEM106A;COG3;NPC1;CHST13;B3GALT6;GALNTL5;NUS1;ST8SIA5;IGF1;ATP7A;B3GALT2;ST3GAL2;ST8SIA4
prerank,second-messenger-mediated signaling (GO:0019932),-0.3166681333149245,-1.2290295616269504,0.14102564102564102,0.5225212633679562,1.0,23/87,18.36%,PDX1;TNFSF11;CXCL8;CCR8;CXCR4;CXCR5;CXCR2;CCR4;CCL3;FPR2;NOS2;NUDT4;CXCR6;CCR3;AGT;MAFA;CXCR1;CCRL2;CXCR3;EIF2AK3;DDAH1;NMUR2;KSR2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.2340707103868589,1.2289297826017325,0.1111111111111111,0.28557572981239043,1.0,35/136,16.16%,PSEN1;DCN;OPTN;ULK1;SNCA;FLCN;ZSWIM8;TRIM6;PLIN5;DAPK1;VPS11;PACSIN3;PRKCD;P2RX7;PRKAA2;BNIP3;PLEKHF1;PRKD1;TFEB;RDX;TRIM21;DXO;SNX33;ARNT;APP;TRIM34;BAD;INS;SNX9;TPCN1;TP53INP1;PNPLA2;SH3GLB1;PTTG1IP;TRIM68
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.34056688055557943,1.228906477960485,0.2,0.2852459763130805,1.0,10/25,18.04%,PIRT;ATP1B2;ANK2;CTSS;STAC;TRPC6;DMD;SLC6A9;ANK3;ACTN2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3480111863119325,1.2284207159845124,0.20689655172413793,0.28553484581886507,1.0,4/21,3.95%,BCL2L2;MOAP1;FAS;CASP3
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.4319618703826861,-1.2283037397361916,0.26153846153846155,0.5237218066757235,1.0,9/16,33.53%,FUT7;RELA;IRAK1;NFAT5;ITGB2;MDK;TNF;ETS1;TRAF6
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.2355063469361268,1.2281629624557884,0.1111111111111111,0.28558791681598567,1.0,42/160,13.94%,RAP1A;GLIPR2;FERMT2;CCL14;PLA2G5;P2RY1;MAPK3;ACKR3;FGF2;ROR2;MTURN;HAND2;TNFAIP8L3;TIRAP;PDGFRA;CCL21;GPER1;CD36;RAMP3;PDGFB;GCNT2;F2RL1;CCL2;EGFR;PDGFD;FLT4;FGFR2;NECAB2;ANGPT1;GPNMB;NDRG4;APP;ROR1;CX3CL1;MT3;CCL11;PRKCA;CCL13;NTRK1;ADCYAP1;CCL8;FGF10
prerank,regulation of stem cell population maintenance (GO:2000036),-0.42481615229855674,-1.228058105817247,0.19736842105263158,0.5232874527930526,1.0,4/19,4.90%,MYC;LOXL2;WDR43;HMGA2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.23137117540572769,1.2279988976553886,0.0,0.2855821799386893,1.0,30/117,14.93%,GSN;TNFSF10;BCL10;MAPT;SNCA;APAF1;FAS;CASP12;NGF;SOX7;DAPK1;NGFR;GPER1;CASP10;MUL1;DLC1;NLRP1;MTCH1;PIDD1;SMAD3;CFLAR;BOK;ARL6IP5;NKX3-1;JAK2;PPM1F;BAD;RIPK1;LGALS9;FAM162A
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.32740603208080177,1.226807899756646,0.15384615384615385,0.28706993796689184,1.0,9/27,17.07%,CSPG4;DCN;CHST3;CHST15;CHST9;CHST7;B3GAT1;CSGALNACT2;B3GAT3
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.3912830587049668,-1.2267867895910054,0.21333333333333335,0.5262639737324712,1.0,8/28,13.88%,POLR2F;POLR1C;TAF1A;POLR1B;CDK7;TAF1B;GTF2H2;POLR1A
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3740771362723417,-1.2266831470133275,0.17647058823529413,0.5254309689451945,1.0,22/33,47.58%,CALR;HLA-F;PDIA3;TAP1;CANX;HLA-G;ERAP1;SEC24A;IDE;SEC13;SEC24D;FCER1G;SEC24C;TAP2;TAPBP;MFSD6;BCAP31;ERAP2;ACE;ABCB9;CLEC4A;IFI30
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.38135782821028746,1.226463089446987,0.21621621621621623,0.28712054631119355,1.0,9/18,20.97%,NCK1;BCL2L11;PIK3R1;RNF185;TMEM259;BOK;DDIT3;BAG6;ATXN3
prerank,regulation of sprouting angiogenesis (GO:1903670),0.3078791262943485,1.225881158019961,0.1,0.287375399928074,1.0,13/32,18.03%,RHOJ;FGF2;GLUL;FGF1;CEACAM1;EPN2;JAK1;KLF2;SYNJ2BP;SEMA6A;FGF16;KLF4;DLL1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.3341216943475433,-1.2256672110145697,0.16049382716049382,0.5275599848643584,1.0,22/61,24.64%,MYC;GRIN2B;RIPK2;USP50;SYK;PMAIP1;FYN;FOXL2;NLRP3;TTBK1;PERP;F2R;CARD9;MEFV;BLID;IFI16;ASPH;NODAL;TNF;CLEC7A;HMGB1;REST
prerank,negative regulation of protein localization to membrane (GO:1905476),0.3417984781305656,1.2255025944240283,0.20833333333333334,0.28742541888302825,1.0,9/24,16.16%,TMBIM1;INPP5K;AP2M1;PID1;RHOQ;GDI1;NUMB;ITGB1BP1;DMTN
prerank,positive regulation of inflammatory response (GO:0050729),-0.33433545518944235,-1.2254586051042493,0.12345679012345678,0.5268683285139102,1.0,30/87,23.36%,C2CD4A;OSM;IL1B;SERPINE1;IL23A;WNT5A;ZP3;PLA2G7;IL21;CD81;CEBPA;CCL3;FEM1A;IL12B;AGT;PLA2G3;NLRP12;NFKBIA;RPS19;IFNG;ZBP1;ADAM8;CCL1;MGST2;MMP8;TNFSF4;MDK;NMI;LBP;TNF
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.3459785800118015,-1.2254003386745707,0.13157894736842105,0.5259689501742593,1.0,17/41,34.70%,RFC3;POLH;RPA3;ISG15;RFC5;POLA1;WRN;RFC2;POLD2;USP43;SYCP1;USP10;DTL;UBC;RFC4;SPRTN;POLD1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.2565575760262295,1.2249553274389702,0.05263157894736842,0.2876790936579325,1.0,24/104,9.60%,FERMT2;ATP2B4;FGFR1;KIT;SNCA;PARP16;FGF2;CALM1;MAPRE3;PKD2;CAMK1;RHOA;PKD1;DAB2IP;MTCP1;PDGFB;FGF1;ELANE;SLC8A2;SLC27A1;GH1;CALM2;EGFR;PDGFD
prerank,positive regulation of cell communication (GO:0010647),0.3229823762581916,1.224441333979952,0.1,0.2879901798639147,1.0,11/28,17.38%,WLS;ILK;CARTPT;LGI1;DLG4;RIMS3;SYT1;GRIK2;PTPN23;ANK3;CLSTN2
prerank,regulation of transposition (GO:0010528),-0.4176030730907917,-1.2241203957619682,0.22666666666666666,0.5287283536784012,1.0,11/21,36.88%,PIWIL1;BTBD18;SPOCD1;APOBEC3F;TEX19;MYBL1;TEX15;APOBEC3B;APOBEC3A;AICDA;PIWIL4
prerank,positive regulation of axon extension (GO:0045773),0.33600004937573996,1.2240562502356063,0.10344827586206896,0.28832939862042495,1.0,4/22,4.01%,NTN1;L1CAM;MAPT;DBN1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.316631551437582,-1.2239466833379522,0.13829787234042554,0.5281363399779765,1.0,42/115,30.69%,TNFSF11;TNFRSF11B;CARD14;EDAR;PSMB9;PSMD14;TNFRSF9;STAT1;TNFSF9;TNFSF15;CD70;RELA;NFKBIA;TNFRSF1B;TNFSF18;TXNDC17;LTB;PSMA3;TNFSF8;LTA;EIF5A;TRAF2;ST18;TNFSF4;TNFRSF12A;TNFSF13B;PSMB3;PSMC1;TNF;BAG4;PSMB11;PSMA5;PSMB2;PSME2;PSMD12;ACTN4;PSMA7;AIM2;TNFRSF11A;PSME4;PSME3;TNFRSF4
prerank,sprouting angiogenesis (GO:0002040),0.27703427817592224,1.223611819612594,0.09523809523809523,0.2886096627697755,1.0,17/50,15.78%,YJEFN3;VEGFB;PARVA;RECK;FGF2;CCBE1;SRF;JMJD6;RAMP2;PIK3R3;FLT4;RSPO3;ANGPT1;SEMA3E;ITGB1BP1;VEGFC;NR4A1
prerank,apical junction assembly (GO:0043297),-0.33717787144943645,-1.2231747495842766,0.25301204819277107,0.5295274213137278,1.0,13/56,11.24%,CLDN1;CLDN2;CLDN16;PARD6B;CLDN14;CLDN20;FRMPD2;GRHL2;PECAM1;MARVELD2;ECT2;POF1B;CLDN6
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.26064266300266786,1.2231544067375304,0.058823529411764705,0.28903385443184665,1.0,19/88,9.07%,FAM107A;GPM6B;CORO2B;RHOB;RND2;RAC1;RAPGEF3;MTOR;DAPK3;PRKCD;ESAM;RHOA;PDGFRA;EFNA5;RHOQ;DLC1;TESK1;RHOC;BAIAP2
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.4017847350185192,-1.2230423766730198,0.20253164556962025,0.528810880580335,1.0,11/24,31.05%,RNF212B;HORMAD1;TRIP13;MEIOB;ANKRD31;SYCE3;PRDM9;SYCP1;RAD21L1;SYCE2;P3H4
prerank,detection of chemical stimulus involved in sensory perception of smell (GO:0050911),-0.4299260974089574,-1.2229142731263591,0.18666666666666668,0.5281249649078804,1.0,20/20,57.05%,OR2A7;OR2A4;OR1K1;OR2A25;OR13G1;OR6K3;OR10K1;OR4E2;GPR148;OR10J1;OR12D2;OR10Z1;OR10K2;OR6K2;OR10J3;OR12D3;OR6N2;OR6K6;OR10T2;OR10R2
prerank,natural killer cell mediated immunity (GO:0002228),-0.42323637860812374,-1.2221289169846654,0.22727272727272727,0.529313694684173,1.0,5/20,9.43%,ULBP3;GZMB;ULBP2;ULBP1;RAET1E
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.36928243054862764,1.2220701250474981,0.34615384615384615,0.2905263201226655,1.0,6/15,18.66%,NLGN2;NPAS4;HAP1;NLGN1;STXBP1;ADRA1A
prerank,positive regulation of T cell migration (GO:2000406),-0.386822046158212,-1.2216097186313932,0.1388888888888889,0.5297781159959013,1.0,12/25,27.49%,CCL20;WNT5A;CXCL10;ADAM10;STK39;DOCK8;XCL2;XCL1;S100A7;TMEM102;CCL5;CXCL13
prerank,central nervous system neuron differentiation (GO:0021953),0.31079681453484376,1.221584251787938,0.04,0.2910908634475236,1.0,13/34,17.51%,GBA2;MAPT;TOX;SPOCK1;ZC4H2;MAP2;NPY;CEND1;CHD5;SIN3A;FOXN4;MDGA1;FAIM2
prerank,nucleotide-excision repair (GO:0006289),-0.2957556325546903,-1.221039523265445,0.12087912087912088,0.5301440277550749,1.0,40/105,35.72%,RFC3;ERCC5;POLR2F;RPA3;POLB;LIG1;RFC5;GTF2H2C;POLA1;ERCC8;CDK7;BRCA2;RPA4;GTF2H2;HMGN1;FANCC;POLR2J;RFC2;LIG3;POLD2;POLR2D;HUS1;POLR2I;GTF2H3;ERCC6;BRIP1;CCNH;PRPF19;COMMD1;UBC;SLX4;COPS5;USP7;AQR;RFC4;ERCC2;SLC30A9;POLD1;PNKP;RNF111
prerank,ribosome assembly (GO:0042255),-0.3498678386751632,-1.220638170283232,0.15853658536585366,0.5300398303065135,1.0,15/47,29.74%,BRIX1;BOP1;NLE1;RPS19;RRS1;VCX;PWP2;DHX37;NPM1;MDN1;RPF2;RPL23A;EIF6;RRP7A;C1QBP
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.27489073841781897,1.2198268563646626,0.1,0.29312373118452134,1.0,14/48,12.93%,RBPMS2;IL6R;VIP;APOD;MFN2;OGN;ID2;HMOX1;PDGFB;ELANE;IGFBP5;NDRG4;CX3CL1;ELN
prerank,regulation of immune effector process (GO:0002697),-0.3510425947224059,-1.2196629505089571,0.13953488372093023,0.5318620810861596,1.0,12/43,18.79%,C3;SERPING1;CPN1;C4BPA;CR1L;CD81;C4BPB;CD55;C2;CR1;CD46;ZNF683
prerank,cardiac myofibril assembly (GO:0055003),-0.45105711111417746,-1.2192121266489881,0.17567567567567569,0.5317823903222813,1.0,4/15,5.96%,NEBL;PDGFRB;NEB;PROX1
prerank,positive regulation of RNA splicing (GO:0033120),0.3225748841779578,1.218705309762206,0.12,0.29431612881653585,1.0,11/31,21.78%,CIRBP;RBM20;PIK3R1;CELF4;PRDX6;SLC38A2;SF3B4;POLR2A;SNW1;TRA2A;THRAP3
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.29489681683349156,1.2183936830535944,0.125,0.2944704780590239,1.0,16/47,16.00%,PER1;MAPK1;MAPK3;SEMA4C;FAS;TGFBR3;DAB2IP;F2RL1;EGFR;MID1;MAPK8IP1;MAP2K2;ARL6IP5;LGALS9;TAOK2;MAPK8IP3
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.3707774004866045,-1.2178529963399538,0.20238095238095238,0.5345122664490147,1.0,15/41,27.50%,SLC6A14;SLC7A11;SLC7A5;SLC38A5;SLC5A6;SLC7A6;SLC19A1;SLC36A3;SLC13A3;SLC38A3;SLC7A7;SLC38A8;SLC38A9;ABCB1;SLC7A10
prerank,regulation of fibroblast proliferation (GO:0048145),-0.3351608214082281,-1.2174037375180558,0.17721518987341772,0.534755967669247,1.0,7/46,3.64%,MYC;WNT2;MIF;EREG;E2F1;FN1;WNT5A
prerank,regulation of double-strand break repair (GO:2000779),-0.38043706159466656,-1.2173174096987496,0.22077922077922077,0.533988593691427,1.0,17/38,34.45%,OTUB2;CHEK1;RAD51AP1;PML;TIMELESS;FIGNL1;FOXM1;ACTR2;RNF169;PPP4C;SPIRE2;WRAP53;TWIST1;DEK;KDM1A;ZNF365;DDX11
prerank,regulation of cell motility (GO:2000145),0.2498198996661912,1.2173060017467072,0.09090909090909091,0.295772348697562,1.0,30/128,10.96%,BTC;FLNA;PLXNB3;BEX4;NTN1;RHOB;CADM4;NEXN;AMOTL1;FGF2;FBLN1;RAC1;ENPP2;FES;DAPK3;RHOA;CCL21;LDB2;FGF7;PKN1;LMO4;FGF1;ROBO4;SST;CEACAM1;EGFR;CCDC25;AMOTL2;PIN1;NRG2
prerank,detection of chemical stimulus involved in sensory perception (GO:0050907),-0.4299643811219947,-1.2172958592622067,0.21333333333333335,0.533019841928468,1.0,22/22,57.05%,OR2A7;OR2A4;PKD2L1;OR1K1;OR2A25;OR13G1;OR6K3;OR10K1;OR4E2;GPR148;OR10J1;OR12D2;OR10Z1;OR5AN1;OR10K2;OR6K2;OR10J3;OR12D3;OR6N2;OR6K6;OR10T2;OR10R2
prerank,renal system development (GO:0072001),-0.33074109875983765,-1.2170481485063074,0.11904761904761904,0.5327619127149417,1.0,15/55,13.07%,STRA6;TGFB2;MME;PAX2;LRP4;PROX1;REN;SIX1;C1GALT1;STAT1;PAX8;PCSK9;CENPF;AGT;RBP4
prerank,midbody abscission (GO:0061952),-0.4401707268356184,-1.2162874813382543,0.2054794520547945,0.533943523727135,1.0,3/17,8.16%,CEP55;KIF20A;CHMP4C
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.31213015505276953,-1.2160233027655392,0.10714285714285714,0.5335358126949603,1.0,25/76,24.18%,IL1A;MIF;EPHB2;IL23A;OAS2;WNT5A;PF4;IL17A;RASGRP1;SYK;CCL3;IL12B;ARFGEF2;THBS1;OAS3;IFNG;CYBA;NOD2;MMP8;PTPRJ;CD2;TYROBP;LBP;CLEC7A;HMGB1
prerank,response to ionizing radiation (GO:0010212),-0.339804031880495,-1.215944577420286,0.13924050632911392,0.5327917013607181,1.0,19/67,21.47%,MYC;BLM;RAD51AP1;TICRR;RFWD3;INTS7;EYA1;FIGNL1;RAD9B;BRCC3;ECT2;TOPBP1;XRCC4;PAXIP1;XRRA1;BRCA1;HUS1;NABP1;IFI16
prerank,cellular response to organic cyclic compound (GO:0071407),0.24106386485878803,1.215675276379093,0.0,0.2983314694437225,1.0,45/148,16.29%,RAP1A;ADCY5;PDE2A;AQP1;P2RY1;ZFP36L1;GNG2;ATP1A2;INPP5K;CASP3;RAPGEF3;PKD2;AKAP6;FES;P2RX7;GPER1;CYP1A1;RAMP3;HSP90B1;PDGFB;CCL2;ACTB;P2RY12;PDE3A;TRPV1;IGFBP5;EGFR;RYR3;SFRP1;TFPI;ATP1A3;MGARP;GOLPH3;ARL6IP5;NKX3-1;P2RY11;MEF2C;GNAI1;GPBAR1;ADCY2;HCN3;ADCY6;NR4A3;DMTN;NCOA4
prerank,gliogenesis (GO:0042063),-0.42962189066016915,-1.215503414713462,0.23376623376623376,0.5330489236265276,1.0,5/17,16.40%,TGFB2;PAX2;MMP24;GCM2;GCM1
prerank,histone acetylation (GO:0016573),0.2694956465356962,1.215205813535628,0.125,0.2987370048611699,1.0,26/69,22.08%,APBB1;PER1;ING4;MORF4L1;KAT2B;SUPT7L;DMAP1;KAT2A;ATF2;JADE1;BRD8;KAT8;ING3;CHD5;NAA60;JADE2;ACTL6B;TADA3;BRD1;MSL3;MEAF6;KAT5;KAT7;EP300;NAA40;BRPF3
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3498884058679089,1.2145889190511645,0.17391304347826086,0.29937000216581666,1.0,8/26,14.55%,SMYD1;RBM24;MYOCD;MAPK14;AKAP6;MAML1;MEF2C;PIEZO1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.33705619036485956,-1.2131541839023134,0.1891891891891892,0.538988216399518,1.0,12/44,15.30%,MYC;SHH;PAX2;ENG;PKHD1;SIX1;EPHA2;MET;PAX8;CITED1;KDR;TGFBR2
prerank,retina homeostasis (GO:0001895),-0.38549619284618486,-1.2112671568581357,0.1643835616438356,0.5432380490334686,1.0,10/30,19.66%,CDH3;CST4;AZGP1;CRB2;TULP1;POC1B;ZG16B;LCN1;POTEI;RPE65
prerank,osteoclast differentiation (GO:0030316),-0.4181973308734306,-1.2110400587075063,0.25,0.5429103724944658,1.0,11/22,33.07%,TNFSF11;DCSTAMP;EPHA2;SNX10;EFNA2;TYROBP;OCSTAMP;TNFRSF11A;FARP2;GLO1;OSCAR
prerank,histone methylation (GO:0016571),-0.4022974755850932,-1.2109055501790802,0.17105263157894737,0.5421822507998777,1.0,15/25,34.04%,SUV39H2;SMYD3;NTMT1;SETD6;SUV39H1;FBL;SMYD2;CTCFL;CARM1;EZH2;CREBBP;NSD1;PRMT6;PRMT5;PRMT8
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.2856005551177093,1.2102975804181522,0.2,0.30530893928887626,1.0,17/80,14.75%,RAB9B;RAB6B;SNX1;SGSM2;TBC1D17;ANKFY1;STX16;DENND2A;VTI1B;DCTN1;DENND5A;RBSN;SNX3;TBC1D10A;VPS26B;VAMP3;GBF1
prerank,response to cAMP (GO:0051591),0.2999812016674905,1.209147482858983,0.2,0.3072701369866881,1.0,8/38,5.12%,RAP1A;PDE2A;AQP1;ZFP36L1;INPP5K;RAPGEF3;PKD2;AKAP6
prerank,regulation of actin filament-based process (GO:0032970),0.2601933866462515,1.2081073713934671,0.1111111111111111,0.3085713105207978,1.0,15/71,9.07%,FAM107A;GPM6B;CORO2B;RHOB;RND2;RAC1;MTOR;PRKCD;RHOA;EFNA5;RHOQ;DLC1;TESK1;RHOC;BAIAP2
prerank,regulation of interleukin-6 production (GO:0032675),-0.3045090699276726,-1.2079136664031422,0.19101123595505617,0.5497561682780643,1.0,45/105,30.74%,IL1A;IL1B;EREG;TNFAIP3;WNT5A;IL17A;IL17F;HSPD1;SYK;MAPKAPK2;NOS2;NLRP12;IL10;F2R;IFNG;CARD9;LILRB4;CYBA;IRAK3;NOD2;MMP8;TNFSF4;TYROBP;LBP;GHSR;TNF;CLEC7A;SCIMP;HMGB1;XBP1;IL37;GBA;TLR7;FOXJ1;TWIST1;PTPN22;NLRP10;TMEM106A;ZC3H12A;LILRB2;TLR8;MAPK13;MYD88;PTPN11;DHX9
prerank,positive regulation of cell killing (GO:0031343),-0.43852797359378604,-1.207885716737728,0.2638888888888889,0.5488177160517332,1.0,8/15,17.28%,WNT5A;PRF1;SYK;NOXO1;NOS2;NOX1;IFNG;CYBA
prerank,nucleosome disassembly (GO:0006337),-0.4540294282264986,-1.2077590247136438,0.2328767123287671,0.5471906674364212,1.0,9/16,30.06%,HMGA1;SMARCA4;SET;SMARCC1;SMARCB1;NFE2;ARID2;ARID1A;GRWD1
prerank,chromatin disassembly (GO:0031498),-0.4540294282264986,-1.2077590247136438,0.2328767123287671,0.5471906674364212,1.0,9/16,30.06%,HMGA1;SMARCA4;SET;SMARCC1;SMARCB1;NFE2;ARID2;ARID1A;GRWD1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.2527843056205616,1.2068481624827119,0.058823529411764705,0.3099824696094885,1.0,30/97,16.49%,FZD7;DUSP22;SEMA4C;GADD45B;PJA2;MTURN;HAND2;SASH1;TIRAP;CCL21;DAB2IP;F2RL1;TRAF1;TLR9;MAP4K2;DUSP19;MID1;FLT4;MAPK8IP1;APP;SEMA3A;ARL6IP5;ANKRD6;GADD45G;RIPK1;RASSF2;GDF6;TAOK2;EDA2R;WNT16
prerank,regulation of cellular respiration (GO:0043457),-0.43050005285381104,-1.2065913412337728,0.21875,0.5493527365036325,1.0,6/16,16.22%,SHMT2;NOS2;PNPT1;TRAP1;PRELID1;IFNG
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.3765702933452469,-1.2056326784110978,0.18421052631578946,0.5514272171537582,1.0,19/34,28.05%,THY1;CARD11;CD81;RELA;KCNN4;GBP1;LILRB4;PTPN2;PVRIG;SLA2;PTPRJ;IKBKG;LCK;SH2D1A;CD160;UBASH3A;PTPN22;TRAT1;EZR
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3215864764763823,1.2047055339877029,0.1111111111111111,0.31272328326578736,1.0,9/28,10.38%,KIT;FGF2;TNFAIP8L3;PDGFRA;CCL21;PDGFB;P2RY12;PRKD1;ATG14
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.3702095941284015,-1.2045322857974972,0.25316455696202533,0.5537581512535441,1.0,17/37,30.69%,EPHB2;WNT5A;SLC7A5;IL21;FFAR2;RBP4;IL10;PHB;CD86;NOD2;TNFSF4;XCL1;SCIMP;XBP1;PTPN22;CD244;TNFRSF4
prerank,glycosphingolipid metabolic process (GO:0006687),0.27390506496446615,1.2044304525127458,0.23809523809523808,0.3128211977522161,1.0,17/46,19.58%,GBA2;ST6GALNAC3;A4GALT;SMPD1;GLTP;ST8SIA1;ESYT3;ST3GAL5;ST6GALNAC5;ST8SIA3;ESYT1;ST6GALNAC6;GBA3;ARSA;CERK;ESYT2;UGCG
prerank,cellular response to retinoic acid (GO:0071300),-0.34062922388862815,-1.2037176118422106,0.18072289156626506,0.5553417659007077,1.0,8/42,4.66%,WNT2;TESC;WNT7B;PTK7;PAX2;WNT5A;SOX9;ABL2
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.3689996081966438,-1.2033374742260472,0.24358974358974358,0.5554056052158907,1.0,9/32,18.02%,GLYATL1;GLS2;ALDH5A1;ALDH18A1;SLC39A8;NAGS;CAD;GLUD2;DDAH1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.3504328387346727,1.2016997180087428,0.1724137931034483,0.3169367837165487,1.0,3/16,9.79%,PPT2;SCD5;ACAT1
prerank,negative regulation of insulin secretion (GO:0046676),-0.4226923251168833,-1.201481065897322,0.23728813559322035,0.5598970870256352,1.0,2/15,0.80%,IRS1;BMP8A
prerank,calcium ion transport into cytosol (GO:0060402),-0.420461752798336,-1.2013034793408177,0.18181818181818182,0.5593882471868828,1.0,6/21,12.19%,GRIN2D;GRIN2B;JPH1;TRPM2;TRPV4;TRPM1
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.36044563027059645,-1.200837807438967,0.18292682926829268,0.5596274410187022,1.0,16/34,28.94%,CSTF2;MAZ;CPSF3;SNRPG;TTF2;SNRPF;CSTF1;NCBP1;ZNF473;CPSF2;SNRPB;SETX;SNRPE;SNRPD3;CPSF4;CSTF3
prerank,tRNA metabolic process (GO:0006399),-0.4572355948357114,-1.200327472488585,0.26153846153846155,0.560231583924328,1.0,4/15,8.42%,POP1;DARS2;ADAT1;YARS2
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.3753220596968122,1.2002481772064522,0.25925925925925924,0.3190064015253507,1.0,7/24,11.09%,JAM3;THBS4;RAC1;TIRAP;CCL21;NCKAP1L;DPP4
prerank,phosphatidylinositol metabolic process (GO:0046488),0.24075100619545522,1.1998651975639436,0.0,0.31946190020160264,1.0,29/109,16.70%,PTEN;PIP5K1C;PLA2G5;INPPL1;PI4KB;FGF2;INPP5K;PITPNM2;PIK3R1;PIP4K2B;MTMR9;CDIPT;PLCD1;PIK3R3;SLC27A1;PLA2G4C;PI4K2A;INPP5E;BMX;INPP5B;IP6K3;PLEKHA4;PLA2G1B;PIP4K2A;PLA2G4A;MTMR10;RUFY1;ARF1;INPP5F
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.2016884228629533,1.1991773370666892,0.0,0.32033877065875943,1.0,58/248,14.30%,IGFBP6;PSEN1;WWTR1;DACT3;FZD7;WLS;ILK;SOX13;TMEM88;LZTS2;FZD4;DVL3;IGFBP4;LMBR1L;SOX7;ARNTL;DAPK3;RSPO1;JADE1;DVL2;GPRC5B;DAB2IP;NPHP3;HHEX;LATS2;PSMC5;TLE2;RNF146;CSNK1E;GLI3;DAAM2;TLE1;EGFR;SFRP1;FGFR2;PFDN5;PIN1;RBMS3;SFRP5;PPM1A;RNF220;CSNK1A1;DKK3;ANKRD6;TMEM64;PLEKHA4;CTNND2;GNAQ;NFKB1;GPC3;USP47;PSMD9;UBE2B;FGF10;TBL1X;TLE4;TMEM170B;SOX17
prerank,negative regulation of viral process (GO:0048525),-0.3238120846991218,-1.1988250547421337,0.17073170731707318,0.5636765117995629,1.0,31/68,35.58%,IFITM3;IFITM1;IFITM2;PML;OAS2;SRPK1;BST2;PROX1;ISG15;MX1;STAT1;APOBEC3F;OAS3;SLPI;TRIM14;IFI16;TNF;IFNB1;LTF;TRIM31;CCL5;PLSCR1;TRIM15;OASL;IFNL3;BTBD17;APOBEC3A;SRPK2;TRIM11;MBL2;EIF2AK2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.4621918623251453,-1.198695574826272,0.25396825396825395,0.5629561605324716,1.0,4/15,8.60%,POP1;RNASEH1;RPP40;LACTB2
prerank,positive regulation of cell motility (GO:2000147),-0.2845204130358608,-1.1979073220538685,0.0851063829787234,0.5644473083739496,1.0,40/210,13.93%,MMP7;CLDN1;CEMIP;COL1A1;TDGF1;PLAU;PDGFRB;LAMC2;IL1B;GTSE1;LEF1;CCL24;DUOXA2;EPHB2;MAZ;CTSH;CEACAM6;DUOX2;EPHA1;FAM83H;ANGPTL3;GRB7;MGAT5;F7;CAV1;LGR6;IGF1R;C1QTNF8;PLET1;CCL3;PECAM1;SEMA4D;SEMA5A;ITGAX;MMP9;THBS1;TGFB1;CXCL16;DUOX1;KDR
prerank,positive regulation of cell migration (GO:0030335),-0.27988267150276025,-1.1978214829451688,0.0425531914893617,0.5636244425204106,1.0,56/257,17.73%,MMP7;CLDN1;CEMIP;COL1A1;TDGF1;KIF20B;PLAU;PDGFRB;TGFB2;FERMT1;LAMC2;IL1B;GTSE1;LEF1;CCL24;EPHB2;FN1;MAZ;FBXO5;CTSH;CEACAM6;ZP3;SOX9;EPHA1;FAM83H;ANGPTL3;GRB7;MGAT5;F7;CAV1;LGR6;IGF1R;PLET1;CCL3;PECAM1;SEMA4D;SEMA5A;APELA;ITGAX;INSL3;MMP9;S100A11;THBS1;TGFB1;CXCL16;KDR;TNFSF18;ADAM10;F2R;IFNG;ADAM9;SHTN1;WNT11;SMIM22;PLAA;CCL26
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.4330288127975579,-1.1964058640842221,0.2535211267605634,0.5671541933002293,1.0,6/18,18.70%,SPAG17;CCDC103;DNAAF2;DNAAF1;SPA17;ADCY10
prerank,regulation of cytokine production (GO:0001817),-0.29171998466354954,-1.1962218484916252,0.1411764705882353,0.5666653280226968,1.0,46/146,24.05%,IL1A;FOXP3;IGF2BP1;IGF2BP3;MIF;EREG;CD276;CLEC6A;IGF2BP2;ISG15;IL17F;IL21;BTN1A1;POLA1;MAPKAPK2;PIK3CG;IL12B;VTCN1;NOS2;BCL6;IRF8;PLD4;BATF;AGT;NLRP12;ITK;IL10;TNFRSF1B;BTNL10;IFNG;CARD9;ZBP1;IL26;SRGN;TNFSF4;PIK3CD;ACE2;IFI16;GAPDH;CRTAM;GATA3;NFAM1;LYN;TNF;GLMN;ANXA1
prerank,macrophage differentiation (GO:0030225),-0.44907320350816127,-1.1958040026319965,0.19402985074626866,0.5669392176580521,1.0,4/15,20.72%,CSF2;MMP9;IFNG;BMP4
prerank,regulation of BMP signaling pathway (GO:0030510),0.2557176590636603,1.1956785121771458,0.08,0.32563071378412156,1.0,22/73,16.40%,RBPMS2;DAND5;FSTL3;SMAD2;CHRD;FSTL1;FST;BMPR1A;RBPJ;NUMA1;TWSG1;SMAD7;CDH5;SMAD4;NBL1;SMAD9;GDF5;SKI;FBXL15;ITGA3;HTRA3;UBE2D3
prerank,proteolysis (GO:0006508),-0.27752798654851507,-1.1954846049506556,0.08080808080808081,0.5667486410240564,1.0,39/279,8.26%,MMP7;FAP;ACAN;PRSS22;TMPRSS3;PRSS33;CPZ;UBD;PLAU;CAPN12;LRP8;GZMB;F12;MME;OLR1;MMP1;MMP24;CTSV;KLK12;CTSH;CPA5;NLN;HABP2;CPN1;PCSK1;F7;REN;MMP3;ADAMTS12;MMEL1;MMP2;PRSS54;ERMP1;PROC;MMP25;MIPEP;HM13;TMPRSS7;BACE2
prerank,negative regulation of transferase activity (GO:0051348),0.34920382748829043,1.1948912607641187,0.2,0.32641222579954576,1.0,7/29,11.80%,MAPT;CDKN1C;INPP5K;ZFP36;SMAD7;CERS1;EIF4A2
prerank,receptor clustering (GO:0043113),0.3320717345839222,1.194238065136805,0.2413793103448276,0.3269951475311119,1.0,13/28,17.72%,PTN;FLNA;DLG4;NLGN1;SAV1;DLG2;ITGB1BP1;NRXN1;MAGI2;SYNJ2BP;LRRC7;NRXN2;ITGA4
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.2677298069347327,1.193902798652244,0.17391304347826086,0.3272962501223686,1.0,16/70,12.85%,NCK1;MAPK1;MAPK3;RAC1;MYO1C;ARPC2;PRKCD;PIK3R1;NCKAP1L;ACTB;BAIAP2;PLA2G6;BRK1;WASF2;ELMO2;WIPF1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.2990047041051364,-1.1934194109052705,0.11956521739130435,0.5723542670631233,1.0,48/148,27.48%,CCND1;KIF14;CEP72;CDK1;NEK2;CEP250;CDC25C;FBXO5;RCC2;PSMB9;RAD51B;PSMD14;TPX2;HAUS7;AURKA;CDK4;PLK1;CENPF;RFPL1;CDC7;HAUS6;CEP76;CEP152;CDC25A;NDE1;PLK4;PSMA3;STOX1;SDCCAG8;CENPJ;CKAP5;ALMS1;CEP78;CEP41;PSMB3;AKAP9;PSMC1;GPR132;PSMB11;PSMA5;HAUS8;HAUS2;PSMB2;CEP135;PSME2;PSMD12;PSMA7;TUBB4B
prerank,negative regulation of cell cycle (GO:0045786),0.2501222103330948,1.1933014315013906,0.0,0.3280162237063042,1.0,21/78,13.14%,TSPYL2;PTEN;RHOB;MYOCD;CDKN1C;RPS6KA2;NR2F2;ZBTB17;HPGD;GPER1;NPPC;BTG2;HHEX;LATS2;RNF167;SIPA1;NUPR1;BTG1;SMAD3;NKX3-1;BTG3
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.4053282136125965,-1.1926331687151197,0.24615384615384617,0.5735654412348805,1.0,12/24,29.96%,SULT2B1;CTSV;RUNX1;CBFB;ABCA12;IL20;SFRP4;BMP4;AQP3;ROCK2;SFN;KDF1
prerank,regulation of adaptive immune response (GO:0002819),-0.4208613372194332,-1.1923945634372504,0.2535211267605634,0.5731589611553908,1.0,9/18,41.14%,IL4I1;SKAP1;ADCY7;TNFSF4;IRF7;SAMSN1;EIF2AK4;TRIM27;AHR
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.3260821539410549,1.192201444442078,0.20689655172413793,0.3292371481118153,1.0,12/30,16.94%,FAM107A;PTN;SCGN;EPHA4;CALB2;APP;ARC;CYP46A1;INS;SHISA7;SQSTM1;NSG1
prerank,regulation of myelination (GO:0031641),0.31442315582208946,1.1921800316083084,0.16129032258064516,0.3288084114707835,1.0,6/26,7.00%,LGI4;PTN;JAM2;PTPRZ1;SIRT2;RNF10
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.2839079165343202,-1.1920721948852875,0.18181818181818182,0.5731501456695572,1.0,23/133,9.27%,IL11;OSM;TDGF1;CSF2;LRP8;CD80;MIF;SOCS3;RIPK2;ITGA5;IL23A;CD44;CLEC6A;DOK7;IL23R;ARL2BP;IL21;CD81;IL5;PECAM1;IL12B;SEMA4D;FCGR1A
prerank,actin nucleation (GO:0045010),0.36388423396573355,1.191597751950142,0.20833333333333334,0.3290774701503607,1.0,4/20,10.20%,LMOD1;ARPC2;JMY;WHAMM
prerank,icosanoid metabolic process (GO:0006690),-0.3398277370905235,-1.1909046293623045,0.21621621621621623,0.5756034411866241,1.0,14/52,15.39%,DPEP1;CYP2S1;FAAH2;TBXAS1;CYP4F8;MAPKAPK2;PON1;CYP4F3;CYP2D6;ALOX12B;ALOX12;PON3;AWAT1;ALOXE3
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.35434095955770656,-1.19027191007552,0.21794871794871795,0.5753736785816175,1.0,22/51,32.92%,CDK1;VRK1;NUP155;NUP37;CHMP4C;NUP107;RCC1;NUP35;SPAST;SEH1L;NUP205;NUP93;POM121;RAN;NUP43;NUP160;NDC1;CCNB2;KPNB1;NUP98;SEC13;RANGAP1
prerank,mitotic nuclear membrane organization (GO:0101024),-0.35434095955770656,-1.19027191007552,0.21794871794871795,0.5753736785816175,1.0,22/51,32.92%,CDK1;VRK1;NUP155;NUP37;CHMP4C;NUP107;RCC1;NUP35;SPAST;SEH1L;NUP205;NUP93;POM121;RAN;NUP43;NUP160;NDC1;CCNB2;KPNB1;NUP98;SEC13;RANGAP1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.3301125953631057,1.1902048834825318,0.17857142857142858,0.33137706557596547,1.0,9/24,16.33%,PRNP;KCNB1;MYO1C;MTCL1;SLC51B;MIEF2;ITGB1BP1;ANK3;MFF
prerank,regulation of cell division (GO:0051302),-0.3175097889121825,-1.189976755711374,0.18292682926829268,0.5751325437029345,1.0,18/74,16.43%,MYC;ORC6;SHH;BLM;KIF20A;AURKB;AURKA;BCL2L1;PLK1;KIF18B;RAB11FIP4;RFPL1;CSPP1;PDXP;BIRC6;PRPF40A;MLLT3;PLK4
prerank,focal adhesion assembly (GO:0048041),0.3562277347939481,1.1897542791207427,0.2,0.33169740780304474,1.0,8/21,18.04%,SORBS1;FERMT2;ACTN1;DLC1;WHAMM;THSD1;TAOK2;ACTN2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.32916344633429406,-1.1897078327922224,0.2125,0.5747529667864698,1.0,24/53,32.59%,RIPK2;USP50;EGR1;GBP5;WNT5A;IL17A;CCL3;NLRP12;NLRP3;IFNG;MNDA;NOD2;IFI16;TYROBP;TNF;CLEC7A;TMEM106A;AIM2;NLRP2;TLR8;MYD88;NLRC4;AGER;LILRA5
prerank,defense response to bacterium (GO:0042742),-0.2810759277849853,-1.189460758954966,0.17647058823529413,0.574564387097276,1.0,61/160,32.31%,CEBPB;PRB3;LPO;SERPINE1;IL23A;NAIP;OAS2;IL23R;ISG15;LCN2;GSDMA;DEFA6;GSDMC;SYK;GBP7;FPR2;RPL39;IL12B;WFDC13;LYG2;NOS2;WFDC10A;PGLYRP4;SEMG1;HAMP;ANXA3;RPS19;OAS3;ROMO1;RNASE7;GNLY;ANKRD17;SLPI;PI3;DEFB4A;NOD2;PGLYRP3;PGLYRP1;DMBT1;IFNE;PGLYRP2;DEFA1;LBP;S100A7;WFDC3;WFDC12;LTF;RNASE8;NLRP10;GSDMB;ANG;CXCL13;SEMG2;WFDC9;DROSHA;GBP6;MYD88;NLRC4;WFDC10B;BPIFA1;SLAMF8
prerank,response to reactive oxygen species (GO:0000302),0.2777576068002878,1.1894212241640236,0.2,0.33160063122547195,1.0,12/56,9.53%,TPM1;MAPK1;MAPK3;APOD;MAPT;MAPK8;PKD2;PDGFRA;PXN;HMOX1;SOD1;EGFR
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.3797996558366007,1.1886073204644887,0.20833333333333334,0.3322800232307318,1.0,8/20,16.81%,NR1D1;TIRAP;DAB2IP;F2RL1;TICAM2;FLOT1;NINJ1;NR1H3
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.4114223752823759,-1.1885401730898468,0.2222222222222222,0.5764334188566383,1.0,7/23,20.19%,MMP7;HM13;BACE2;ADAM10;ADAM9;PRKCQ;ERAP1
prerank,cellular response to radiation (GO:0071478),-0.3497925088332251,-1.1882940667671116,0.2077922077922078,0.5760157611396983,1.0,10/43,12.85%,BLM;RAD51AP1;INTS7;GPR52;FIGNL1;RAD9B;ECT2;RRH;TRPM1;ADIRF
prerank,regulation of hormone secretion (GO:0046883),-0.43716628737612656,-1.1874233839030184,0.273972602739726,0.5772216452833929,1.0,5/16,17.18%,IL11;OSM;FFAR2;FGF23;LIF
prerank,epoxygenase P450 pathway (GO:0019373),-0.42251865948080425,-1.187054667090336,0.24,0.5773814406935867,1.0,7/17,25.64%,CYP2S1;CYP2F1;CYP2A7;CYP2B6;CYP2A13;CYP2C19;CYP4F2
prerank,transcription by RNA polymerase I (GO:0006360),-0.37038453934639537,-1.186495491114553,0.2631578947368421,0.5780543578581957,1.0,8/30,13.88%,POLR2F;POLR1C;TAF1A;POLR1B;CDK7;TAF1B;GTF2H2;POLR1A
prerank,DNA double-strand break processing (GO:0000729),-0.42973851348404957,-1.1864577848500397,0.19718309859154928,0.5771615321912263,1.0,9/18,32.18%,BLM;DNA2;RBBP8;SLX1A;BRCA1;BARD1;SMARCAD1;SLX4;UBE2N
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.3540393109994566,-1.1864427497339969,0.19480519480519481,0.5761720078660827,1.0,15/37,34.09%,WDR3;NOB1;SRFBP1;EMG1;RPS19;NOP14;PWP2;DDX52;NPM1;RRP7A;NOM1;NOL11;RIOK1;RPS7;MRPS11
prerank,negative regulation of response to stimulus (GO:0048585),-0.3297732560817581,-1.186185623307685,0.20253164556962025,0.5760832858920963,1.0,15/58,18.02%,THY1;FOXP3;SRMS;CASK;RBL1;FBXO5;HMGA2;FOXA2;COL3A1;AKT3;TERT;NLRP12;IGFBP3;HLA-G;DDAH1
prerank,mitochondrial translation (GO:0032543),-0.2952599156859089,-1.1861584791287851,0.21428571428571427,0.5751116225281281,1.0,41/103,34.81%,MRPL19;MRPL3;LARS2;MTIF2;MRPS18C;GADD45GIP1;FASTKD2;GFM2;EARS2;MRPL17;MRPS16;MRPL13;MRPL48;GFM1;RARS2;MRPL30;MRPS35;MRPL53;MRPS31;TUFM;MRPL47;MRPL9;MRPS23;MRPL50;QRSL1;MRPL14;MRPL37;MRPL42;DAP3;MRPS12;MRPS22;MRPL15;MRPL57;MRPS30;MRPS18A;NOA1;MRPL4;MRPS11;MRPL52;MRPS33;MRPL44
prerank,negative regulation of protein depolymerization (GO:1901880),0.3112777430857512,1.1856860326828897,0.20833333333333334,0.3369977557937133,1.0,3/23,6.83%,LIMA1;STMN2;PLEKHH2
prerank,peptide cross-linking (GO:0018149),-0.4025438660854896,-1.185502155856511,0.19753086419753085,0.575770183843514,1.0,11/27,27.34%,FN1;DSP;COL3A1;THBS1;FCGR3A;TGM6;CD3G;PI3;EVPL;ANXA1;CSTA
prerank,positive regulation of lyase activity (GO:0051349),0.39644644862051515,1.1854214355190176,0.2894736842105263,0.33700463594890656,1.0,4/15,5.95%,ISCU;STIM1;CACNA1C;NOS1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.24498774473595977,1.1852429932623927,0.15,0.33681831998639644,1.0,19/68,17.98%,TGFB1I1;DAND5;EMILIN1;SPRY1;SMAD2;UBB;SMAD7;IL17RD;WFIKKN2;PEG10;PIN1;SMAD3;PPM1A;VASN;SKI;HTRA3;NRROS;CD109;ASPN
prerank,negative regulation of cell differentiation (GO:0045596),0.2290520677266401,1.184847246997366,0.0,0.3369907807649655,1.0,44/184,13.86%,WNT9A;FERMT2;PTEN;WWTR1;MEIS1;CHADL;OSR1;HEY1;TWIST2;MEIS2;MYOCD;EID2B;SPRY1;SIRT2;ITGB3;CHRD;ARNTL;HDAC7;NKX3-2;ZADH2;NR1H2;GPER1;ID2;DAB2IP;NPHP3;TRIB2;EFEMP1;SMAD7;MSTN;IL17RD;EGFR;SFRP1;GPS2;BBS12;SUFU;SMAD3;GATA2;RUNX1T1;TMEM64;VASN;GDF5;SKI;PAF1;NOTCH4
prerank,tRNA modification (GO:0006400),-0.3342367135944013,-1.1843136942208579,0.24390243902439024,0.5783478394807379,1.0,29/60,36.50%,PUS7;WDR4;PUS10;METTL2A;PUS1;MOCS3;DTWD2;METTL1;CDKAL1;TRMT6;METTL6;TYW1;THUMPD3;THADA;ANKRD16;TRUB1;METTL2B;AARS2;FTSJ1;TRMT61B;NSUN2;TARBP1;SSB;TYW1B;ADAT3;DUS2;TYW5;NSUN6;TRMT12
prerank,defense response to virus (GO:0051607),-0.2971775065892073,-1.1841658474597536,0.2,0.577723806587318,1.0,31/128,17.33%,IFITM3;IFITM1;IFITM2;IFI6;CLPB;IFI44L;SKP2;OAS2;BST2;SERINC5;ISG15;MX1;IFIT3;IL21;PRF1;NLRC5;PMAIP1;STAT1;ABCE1;RELA;BCL2L1;APOBEC3F;CXCL10;NT5C3A;G3BP1;ATAD3A;EXOSC4;OAS3;EXOSC5;ZBP1;PHB
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.28805452038405677,1.1841613757617508,0.16666666666666666,0.33779575832436176,1.0,10/33,15.28%,FAM83D;LSM11;ADAMTS1;RDX;EGFR;LSM10;PAGR1;PAF1;FGF10;RGCC
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.321922483629128,-1.1841160511014777,0.1951219512195122,0.576916681719399,1.0,29/75,36.00%,OSM;TP73;PUS7;PSMB9;PRKDC;PSMD14;RUNX1;CBFB;MYB;PSMA3;SPI1;PSMB3;GATA3;PSMC1;PSMB11;PSMA5;PSMB2;PSME2;ITCH;PSMD12;PSMA7;FOXC1;PSME4;PSME3;PDCD2;PSMD1;LDB1;EIF2AK2;TCF3
prerank,regulation of chondrocyte differentiation (GO:0032330),0.325799558968989,1.1838065595229033,0.2962962962962963,0.3381587981324394,1.0,15/26,25.16%,WNT9A;CHADL;NKX3-2;EFEMP1;HOXA11;PKDCC;GDF5;GDF6;ADAMTS7;ZBTB16;PTHLH;SNAI2;BMPR1B;ACVRL1;SOX5
prerank,renal water homeostasis (GO:0003091),0.31699618950838176,1.1835941832749548,0.2,0.3381091550912199,1.0,12/30,16.84%,ADCY5;AQP1;ADCY4;PRKAR2B;WFS1;PRKACA;AVPR2;ADCY9;ADCY2;ADCY6;RAB11FIP2;CYP4F12
prerank,visual system development (GO:0150063),0.3021696976883687,1.1835690283106641,0.2631578947368421,0.33764851591534634,1.0,8/41,6.22%,MAB21L2;PBX3;MEIS1;CHRDL1;SALL2;MEIS2;MAB21L1;PBX2
prerank,regulation of phagocytosis (GO:0050764),-0.32261532750588773,-1.1829374204665666,0.275,0.5797623428746242,1.0,19/54,25.76%,IL1B;IL15RA;SYT7;CALR;SYK;TULP1;FER1L5;SCARB1;SPACA3;FPR2;LYAR;IFNG;CYBA;SIRPB1;OLFM4;TNF;CLEC7A;LMAN2;IL2RB
prerank,acylglycerol metabolic process (GO:0006639),-0.3411497581931469,-1.1828153513689044,0.21621621621621623,0.5791391127799524,1.0,10/36,22.35%,DGAT2;GK;PNPLA3;CAV1;CETP;APOC1;ABHD12;DGKK;DGAT2L6;ABHD2
prerank,protein autoprocessing (GO:0016540),-0.45162065713724775,-1.182684271571673,0.2638888888888889,0.5785180656278188,1.0,10/16,39.28%,KLK6;F12;PCSK9;MYRFL;MYRF;FXN;SPRTN;CASP4;AFG3L2;OMA1
prerank,dorsal/ventral pattern formation (GO:0009953),-0.3706653172876816,-1.1822470273339891,0.23076923076923078,0.5788068914541165,1.0,6/24,13.67%,TBX20;SHH;MDFI;SIX3;WNT8B;PTCH1
prerank,nuclear membrane reassembly (GO:0031468),-0.34254187218281007,-1.1820026304795563,0.2222222222222222,0.5784702228711982,1.0,22/54,32.92%,CDK1;VRK1;NUP155;NUP37;CHMP4C;NUP107;RCC1;NUP35;SPAST;SEH1L;NUP205;NUP93;POM121;RAN;NUP43;NUP160;NDC1;CCNB2;KPNB1;NUP98;SEC13;RANGAP1
prerank,histone mRNA metabolic process (GO:0008334),-0.388056339173606,-1.181869345981506,0.26582278481012656,0.5777802459428351,1.0,15/24,34.14%,CPSF3;SNRPG;SNRPF;EXOSC4;NCBP1;MTPAP;ZNF473;CPSF2;SNRPB;XRN1;SNRPE;SNRPD3;SSB;SLBP;ERI1
prerank,neuron migration (GO:0001764),0.27052553076630725,1.1815470168661155,0.16666666666666666,0.3406926782484844,1.0,21/49,22.00%,FGFR1;GPM6A;DNER;RAC1;SPOCK1;PAFAH1B1;MARK1;SEMA3A;CCK;MEF2C;MAP1B;ASTN1;MDGA1;TUBGCP2;POMGNT2;TUBB2B;ADGRL3;CEP85L;FGF13;NAV1;ASTN2
prerank,regulation of receptor internalization (GO:0002090),0.3108954973793819,1.1811731358629134,0.1891891891891892,0.34085846902306777,1.0,11/35,16.48%,CD63;RSPO1;RIN3;DLG4;GH1;FLOT1;ANGPT1;NTF3;MAGI2;ANKRD13A;ARF1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.30862733091749994,1.1806252844872926,0.09523809523809523,0.341214890229057,1.0,8/38,8.18%,PTEN;PPP2R5B;PHLDA3;FLCN;INPP5K;GPER1;MUL1;MSTN
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.33925058939967806,-1.1767771222016106,0.20987654320987653,0.5923332648554568,1.0,17/51,30.10%,PSMB9;PSMD14;OAZ3;NQO1;ODC1;PSMA3;PSMB3;PSMC1;PSMB11;AZIN1;PSMA5;PSMB2;PSME2;PSMD12;PSMA7;PSME4;PSME3
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.4157588025302145,-1.1767450995889417,0.29508196721311475,0.5914510811418915,1.0,2/16,0.80%,IRS1;BMP8A
prerank,cellular response to calcium ion (GO:0071277),0.2677506780975436,1.1766734446582465,0.0,0.34743128920210264,1.0,24/69,16.56%,ADD1;CLIC4;SYT11;ITPKB;RASGRP2;PKD2;MCOLN1;PRKAA2;SMPD1;SYT10;MEF2A;SYT4;RYR3;NLGN1;SYT5;SYT1;CAPN3;CAMK2D;MEF2C;CHP2;SYT6;CPNE8;DMTN;CARF
prerank,endodermal cell differentiation (GO:0035987),-0.3751525994654913,-1.1763253432240244,0.2345679012345679,0.5917879495648535,1.0,12/31,20.13%,COL11A1;INHBA;ITGA5;FN1;HMGA2;MMP2;MMP9;LAMA3;LAMB3;COL7A1;MMP8;ITGB2
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.34079273690135486,-1.1761302295949612,0.2702702702702703,0.5912375122801152,1.0,14/44,20.84%,CTAGE4;CTAGE9;CTAGE8;CTAGE15;CTAGE6;PDIA4;RAB15;MTTP;RAB8A;RAB3D;CANX;TVP23C;CTAGE1;MIA2
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.3870800977285187,-1.1751001402637844,0.23943661971830985,0.5930762104769091,1.0,10/24,25.96%,SERPINE1;DUSP1;PLA2G7;FPR2;CXCL10;CCL1;LYN;S100A7;HMGB1;CCL5
prerank,histone H3 acetylation (GO:0043966),0.2825028799510472,1.1746950860628123,0.23076923076923078,0.3500918333868212,1.0,6/40,6.04%,PER1;ING4;KAT2B;SUPT7L;KAT2A;JADE1
prerank,positive regulation of protein kinase activity (GO:0045860),0.2196805710259114,1.1743674033884497,0.125,0.35035277254177616,1.0,28/150,9.58%,IL6R;RAP1A;CLU;PRNP;DDR2;SNCA;CDKN1A;PARP16;NAB2;CALM1;MAPRE3;ITGB3;CAMK1;PRKCD;RHOA;STRADA;CCL21;DLG4;EPHA4;GPRC5B;DAB2IP;MTCP1;PDGFB;SLC8A2;SLC27A1;GH1;CALM2;DUSP19
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.2626611751477723,1.1743286690239387,0.21739130434782608,0.349988561134448,1.0,16/71,12.85%,NCK1;MAPK1;MAPK3;RAC1;MYO1C;ARPC2;PRKCD;PIK3R1;NCKAP1L;ACTB;BAIAP2;PLA2G6;BRK1;WASF2;ELMO2;WIPF1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.2980553044142346,1.1741723497718002,0.1,0.3498693506599579,1.0,13/41,13.80%,FERMT2;EFEMP2;MYOC;RRAS;RAC1;COL16A1;CCL28;CCL21;CD36;SFRP1;CX3CL1;TSC1;PPM1F
prerank,regulation of epithelial cell proliferation (GO:0050678),0.24674045357381508,1.174125045728684,0.07142857142857142,0.3493984632431881,1.0,32/91,17.17%,NR1D1;OSR1;CDKN1C;ZFP36L1;FGF2;LAMC1;TIE1;TGFBR3;ZFP36;FGF7;DAB2IP;FGF1;B2M;PRKD1;EGFR;NUPR1;SFRP1;LAMB1;FGFR2;ANGPT1;NKX3-1;OSR2;GDF5;TINF2;BAD;FGF10;NR4A1;NR4A3;NME2;RAB33B;SFRP2;FGF16
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.21967942901605936,1.173962192268011,0.0,0.349307406732096,1.0,41/190,13.47%,TCEAL1;ATP2B4;PSEN1;CD34;CITED2;CLDN5;CILP;OPTN;MAPT;EMILIN1;FLCN;FGF2;TRIM6;HAND2;TARDBP;ATOH8;SLC24A3;OCLN;PGR;BMPR1A;RIN3;DLG4;GPER1;ID2;PDGFB;PRKAA2;SFRP1;RBMS3;MYADM;APP;MAP2K2;HINFP;MECP2;GATA2;NKX3-1;SMO;MEF2C;OLFM1;HEY2;FLOT2;NFKB1
prerank,regulation of protein kinase A signaling (GO:0010738),0.32969769432865165,1.1739365049341162,0.17142857142857143,0.34886554179678836,1.0,5/19,7.21%,AKAP12;PJA2;PRKAR2B;AKAP6;RAMP3
prerank,homologous chromosome segregation (GO:0045143),-0.4325539797342223,-1.173684092898108,0.2608695652173913,0.5962150493912605,1.0,6/15,24.77%,PTTG1;RNF212B;MEIOB;ANKRD31;PRDM9;SYCP1
prerank,protein dephosphorylation (GO:0006470),0.2313903113695941,1.1727305766065854,0.09090909090909091,0.35047441949471314,1.0,36/138,17.48%,TNS2;PTEN;NCK1;PPP2R5B;PPP3CB;DUSP22;DUSP26;PPM1M;PPP2R2B;PTPRZ1;PTPRS;DUSP3;CTDSP2;PPP2R5D;RPRD1A;PTPN21;PPP1CB;PPP1R12A;PTPRM;PPM1L;TAB1;PPP4R1;PPP2R3A;PPP2CB;PPM1A;PPM1F;PTPN5;BTRC;PTPN14;CTDSP1;LHPP;CTDNEP1;PPM1B;PPP3CC;PPP1R15A;ILKAP
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.27469107710099094,1.1727064001403043,0.16666666666666666,0.35000524356500134,1.0,10/37,15.43%,RAPGEF3;FES;DAPK3;CCL27;ESAM;PDGFRA;BAIAP2;SEMA3E;NTF3;NTRK3
prerank,rRNA transcription (GO:0009303),-0.4294166733098365,-1.172542325050398,0.25,0.5986788909368155,1.0,7/15,33.39%,NIFK;GTF3C4;TAF1B;GTF3A;ANG;GTF3C3;TCOF1
prerank,skeletal system development (GO:0001501),-0.28742298338731126,-1.1724576244287614,0.16483516483516483,0.5979154535252004,1.0,34/147,19.32%,COL10A1;NOTUM;ACAN;COL1A1;TNFRSF11B;COL1A2;TGFB2;SOX4;WNT5A;CD44;SOX9;CHD7;BCAN;TEAD4;IL17F;ETS2;EN1;BMP7;TBX4;PPIB;ANKH;HYAL3;COL2A1;RBP4;DLL3;VCAN;ALX4;CHI3L1;WNT11;PITX1;EIF2AK3;CDH11;COMP;WWOX
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.4823494342807165,-1.1724390962328313,0.273972602739726,0.5969620783440609,1.0,7/15,24.04%,DNMT1;DNMT3B;MYB;PAXIP1;AUTS2;BRCA1;PRDM9
prerank,response to dsRNA (GO:0043331),-0.37833899046616837,-1.1719453399606243,0.25,0.5972614439408758,1.0,16/25,41.66%,IFNK;PMAIP1;IRAK3;IFNE;IFNB1;PDE12;SLC3A2;IFNA1;IFNA21;IFNA4;IFNA7;IFNA14;IFNA10;IFNA17;IFNA2;IFNA16
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.2903426661016202,-1.1718979166897379,0.23529411764705882,0.5963364334336743,1.0,22/108,16.24%,THY1;CCND1;CDKN3;BLM;INCENP;TRIB3;CCNK;CDC25C;CCNO;CCNI2;HMGA2;CCNE1;PKMYT1;CCNF;SYAP1;CDK7;CDK12;GTPBP4;TRIB1;CDC25A;IFNG;CDC6
prerank,long-term synaptic potentiation (GO:0060291),0.37965535007872425,1.1717506682215533,0.23333333333333334,0.35142002545188417,1.0,5/20,2.80%,NFATC4;VAMP2;MPP2;TSHZ3;NPTN
prerank,regulation of cholesterol storage (GO:0010885),0.37504353951377095,1.1715839349337895,0.34285714285714286,0.35143431719187135,1.0,6/15,19.55%,PPARD;NR1H2;LPL;CES1;NR1H3;EHD1
prerank,cellular response to alkaloid (GO:0071312),0.39715931980383323,1.1704708911124235,0.26666666666666666,0.3536213180527657,1.0,6/18,12.10%,CASQ2;GSTM2;CASP3;TRPV1;RYR3;SLC8A1
prerank,histone H2A monoubiquitination (GO:0035518),0.38031619933234423,1.170428420270518,0.12903225806451613,0.3532040274293343,1.0,8/17,20.83%,RING1;SKP1;PCGF6;RYBP;PCGF3;PCGF2;DDB2;PCGF5
prerank,positive regulation of telomerase activity (GO:0051973),-0.37422873714491023,-1.170359272467386,0.19480519480519481,0.5997009806431347,1.0,7/34,8.75%,MYC;NEK2;DKC1;AURKB;MAPK15;GRHL2;NAF1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3291794333557498,1.1700457986286967,0.18181818181818182,0.35340315870695177,1.0,5/27,10.63%,NR1D1;ADCY5;PPP3CB;EFNA5;PLA2G6
prerank,regulation of activated T cell proliferation (GO:0046006),-0.353737263668624,-1.1699458107806633,0.23684210526315788,0.599970244752051,1.0,16/34,32.06%,FOXP3;IL23A;IL23R;IDO1;TNFSF9;IL12B;LILRB4;CRTAM;IL12RB1;IL27RA;HMGB1;IGFBP2;CLC;PDCD1LG2;IGF1;AGER
prerank,response to amino acid (GO:0043200),0.29280205206738796,1.1698960079527883,0.24242424242424243,0.35336130654246245,1.0,9/29,14.69%,CPEB1;GLRB;MTOR;RRAGA;RRAGD;RRAGB;CAPN2;LAMTOR3;RRAGC
prerank,retinoid metabolic process (GO:0001523),0.23787215768595968,1.1690985556291293,0.1875,0.3539866088242949,1.0,21/85,13.63%,RDH5;SCPEP1;ADH1B;SDC2;LRAT;GPIHBP1;ALDH1A1;SDC3;RARRES2;GPC1;CYP1A1;AKR1B1;CLPS;CYP27C1;RLBP1;ALDH8A1;LPL;GPC4;AKR1C1;GPC3;CYP26B1
prerank,stem cell development (GO:0048864),-0.4430371043425365,-1.168999442060389,0.2878787878787879,0.6018852726347153,1.0,6/17,20.77%,SHH;CYP26C1;WNT7A;NOLC1;KBTBD8;NRG1
prerank,calcium ion homeostasis (GO:0055074),0.2505105712561123,1.1686639564427226,0.09090909090909091,0.35455696188173064,1.0,18/94,9.46%,DMPK;ATP2B4;JPH2;CCL14;STIM1;NPTN;SNCA;TPCN2;SLC24A3;ANK2;WFS1;PTH1R;TMTC2;ELANE;SLC8A2;CDH5;RGN;ATP2A2
prerank,positive regulation of viral genome replication (GO:0045070),-0.3714153764254614,-1.1685681645211963,0.1917808219178082,0.6020784407451079,1.0,15/29,39.12%,SRPK1;PPIH;PABPC1;HACD3;FKBP6;TOP2A;TMEM39A;CCL5;PDE12;CD28;STAU1;LARP1;SRPK2;VAPB;TARBP2
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.3709227746996666,-1.1668892083943752,0.2753623188405797,0.6058504496978394,1.0,11/32,17.24%,TESC;PLAU;TGFB2;SERPINE1;EPHA2;SYK;PIK3CG;ADAM9;EPHA8;LIF;ACER2
prerank,retinol metabolic process (GO:0042572),0.3538100470390191,1.1663197365765865,0.2777777777777778,0.358638477960818,1.0,9/20,22.44%,ADH1B;LRAT;CYP1A1;CYP27C1;RETSAT;DHRS3;ADH1C;DHRS9;CYP1B1
prerank,aerobic respiration (GO:0009060),0.3414863747679071,1.1657125066822462,0.17857142857142858,0.3594403629787554,1.0,6/20,16.03%,MTFR1L;BLOC1S1;OXA1L;SIRT3;SURF1;ME3
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.41608099067841353,-1.1652797621085713,0.234375,0.6095978219245828,1.0,9/18,31.90%,DHFR;SCARB1;TERT;PIK3CB;GCH1;TNF;NOS1AP;NUS1;HIF1A
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.3870984711829783,-1.165150244499155,0.22077922077922077,0.60893550280268,1.0,15/24,39.01%,HSD17B12;DGAT2;ACSL6;THEM5;ACSF3;ACSL5;ELOVL7;TECR;ACSL3;FAR2;HACD2;ACSL4;ACOT7;ACSBG2;ACSBG1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.2345125899000908,1.1647395160457479,0.23529411764705882,0.36058516438063337,1.0,25/93,13.94%,GLIPR2;NRP2;RHOB;RRAS;FGF2;RAC1;ITGB3;ENPP2;SASH1;MTOR;ATOH8;HDAC6;FGF7;RTN4;ZNF580;FGF1;MAPRE2;PRKD1;FLT4;ANGPT1;ANGPT4;PRKCA;ITGB1BP1;PPM1F;FGF10
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.24836529504065274,1.1642695034163124,0.1875,0.36124984174890645,1.0,24/73,17.79%,TGFB1I1;GLIPR2;FERMT2;PTEN;WWTR1;SPRY1;SMAD2;MTOR;PHLDB2;DAB2IP;GCNT2;SMAD7;IL17RD;SMAD4;SFRP1;SMAD3;OLFM1;VASN;PHLDB1;RGCC;EPHA3;TGFB3;SFRP2;TIAM1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.33948458488857647,1.1638989853254273,0.16666666666666666,0.36148923249404397,1.0,8/24,12.52%,LTBP4;SMAD2;TGFBR3;LATS2;SMAD7;SMAD4;SMAD3;DKK3
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.28007386601848044,1.1638434589803925,0.21052631578947367,0.3610935227138727,1.0,14/52,13.05%,ATP2B4;FGFR1;HSPB1;FGF2;MAPK14;PDGFB;PRKD1;CSNK2B;ANGPT1;MECP2;GATA2;ANGPT4;MEF2C;PRKCA
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.3289713458339719,1.1634058402321694,0.2222222222222222,0.3613060886658565,1.0,8/27,9.43%,TNS2;NCK1;INPP5K;PRKCD;PIP4K2B;PID1;GRB14;GRB10
prerank,positive regulation of protein import (GO:1904591),0.3230206576599774,1.1633749235046988,0.12903225806451613,0.36085892214064297,1.0,6/30,6.20%,FLNA;PSEN1;BAG3;DMAP1;PRKCD;PIK3R1
prerank,regulation of gluconeogenesis (GO:0006111),0.3483728234689722,1.162899762760508,0.35294117647058826,0.3612818987053133,1.0,9/26,17.03%,ZNF692;C1QTNF3;CLK2;NNMT;CRY1;ARPP19;INS;SOGA1;PDK2
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.4008290302140216,-1.1624718567349566,0.28378378378378377,0.6158004741830772,1.0,10/24,25.00%,SUV39H2;EEF2KMT;BEND3;TET3;METTL21C;SUV39H1;PRDM7;PRDM9;KMT2D;TET2
prerank,sulfur compound transport (GO:0072348),-0.3596637820149425,-1.1622442293028263,0.2876712328767123,0.6154016173347697,1.0,6/28,11.94%,RACGAP1;SLC26A8;SLC13A4;SLC6A6;SLC5A6;LRRC8D
prerank,regulation of macrophage chemotaxis (GO:0010758),0.3234180096920274,1.1622324321031068,0.26666666666666666,0.3622560290939793,1.0,5/21,12.57%,MAPK1;MAPK3;RARRES2;MSTN;AKIRIN1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.39931947046931515,-1.1621657658892373,0.25675675675675674,0.6146857150420126,1.0,4/17,7.94%,NOTCH3;DLGAP5;WWC1;STAT1
prerank,cellular response to gamma radiation (GO:0071480),0.3753765127893175,1.161585649009127,0.25806451612903225,0.36322761606126497,1.0,3/16,6.87%,CRYAB;TSPYL5;TMEM109
prerank,regulation of nervous system process (GO:0031644),0.3618605208917159,1.1615040841450932,0.24,0.36288519433190153,1.0,6/18,13.50%,NPTX1;NPTXR;TMEM108;SLC8A2;APP;NPTX2
prerank,positive regulation of wound healing (GO:0090303),-0.3487703141754731,-1.1610498784266297,0.2361111111111111,0.6173861803316342,1.0,17/37,30.60%,CLDN1;FERMT1;F12;SERPINE1;DUOX2;INSL3;THBS1;DUOX1;F2R;REG3A;ARFGEF1;CLEC7A;ANXA1;XBP1;HPSE;CLDN4;RREB1
prerank,activation of adenylate cyclase activity (GO:0007190),0.287088197182846,1.16071760324471,0.13043478260869565,0.36369625979041126,1.0,15/35,18.01%,CAP2;ADCY5;ADRB3;ADCY4;ADORA3;RAF1;AVPR2;P2RY11;ADCYAP1;ADCY9;ADCY2;ADRB2;ADCY6;ACR;CAP1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.36862877219159573,1.1601006087061305,0.23076923076923078,0.364452893271323,1.0,6/16,20.29%,PPARD;NR1H2;NR4A3;NR1H3;ELOVL5;MID1IP1
prerank,triglyceride biosynthetic process (GO:0019432),-0.44675713437106834,-1.159923893209646,0.26865671641791045,0.6197485267420647,1.0,5/16,19.48%,DGAT2;GK;PNPLA3;MOGAT1;AGMO
prerank,regulation of Rho protein signal transduction (GO:0035023),0.24906086811715397,1.1596002360556368,0.19047619047619047,0.36502467028930335,1.0,24/71,18.85%,KANK2;LPAR1;MYOC;FLCN;RAC1;STARD8;KCTD10;STARD13;ARHGEF18;GPR17;F2RL1;DLC1;RAF1;RASIP1;GPR4;RALBP1;ARHGEF3;ITGA3;GPR20;KANK1;RIT2;F2RL3;TNFAIP1;LPAR4
prerank,positive regulation of DNA replication (GO:0045740),-0.4144892738738379,-1.1577590152836819,0.2608695652173913,0.6254703208451893,1.0,4/16,10.68%,EREG;ATAD5;DNA2;CDT1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.41794283399631005,-1.1575558830075303,0.3055555555555556,0.6250117966996623,1.0,3/18,4.54%,KLK6;C3;MRAP
prerank,negative regulation of platelet activation (GO:0010544),0.38472659179771346,1.1574540716001196,0.3142857142857143,0.368673988134076,1.0,6/16,10.31%,PRKCD;PDGFRA;PDGFB;CEACAM1;C1QTNF1;PRKG1
prerank,establishment of spindle localization (GO:0051293),-0.42161606296846854,-1.1573826202820399,0.31343283582089554,0.6244612504725738,1.0,8/15,36.91%,ESPL1;MAP4;NLRP5;KPNB1;DYNC1H1;NUSAP1;KIF25;LLGL2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.25753334949654594,1.1573130656679833,0.22727272727272727,0.36850914664573503,1.0,16/73,12.85%,NCK1;MAPK1;MAPK3;RAC1;MYO1C;ARPC2;PRKCD;PIK3R1;NCKAP1L;ACTB;BAIAP2;PLA2G6;BRK1;WASF2;ELMO2;WIPF1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.3263346497264954,1.1567646388992079,0.35714285714285715,0.36896935354193017,1.0,8/20,18.10%,ZDHHC7;VTI1B;ACTB;VPS4A;INS;STX7;STX8;AR
prerank,telomere maintenance (GO:0000723),-0.3264480116845658,-1.1559563052894375,0.26666666666666666,0.627601632420123,1.0,13/51,20.19%,BLM;PRKDC;RPA3;RECQL4;DNA2;DCLRE1B;WRN;TERT;SLX1A;ATR;POLD2;HUS1;RIF1
prerank,regulation of cell morphogenesis (GO:0022604),0.2979580996603413,1.1555144184644417,0.2857142857142857,0.37085794704308966,1.0,9/32,14.87%,FERMT2;ZNF135;CAPZB;EFNA5;ZMYM3;NTNG1;ZMYM6;ARC;WTIP
prerank,positive regulation of endothelial cell migration (GO:0010595),0.23148028021026723,1.1554201524524625,0.16666666666666666,0.37048325565298457,1.0,21/82,13.77%,FGFR1;NRP2;RHOB;HSPB1;RRAS;FGF2;RAC1;ITGB3;MAPK14;SASH1;ATOH8;PDGFB;ZNF580;FGF1;PRKD1;FLT4;ANGPT1;GATA2;ANGPT4;PRKCA;ITGB1BP1
prerank,pulmonary valve development (GO:0003177),-0.3968367641909862,-1.1553701973946444,0.3088235294117647,0.6284005887952582,1.0,7/18,24.86%,STRA6;TGFB2;ROBO2;TNFRSF1B;BMP4;SMAD6;NOTCH1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.3316167343311034,-1.1553104052512897,0.25925925925925924,0.6275446352391398,1.0,8/52,8.26%,GNL3L;PRR7;SOX4;TNFAIP3;PRMT3;CAV1;ISG15;PRKCG
prerank,sterol biosynthetic process (GO:0016126),-0.3337083922499433,-1.1551389554928748,0.3088235294117647,0.6272026362225342,1.0,13/35,27.50%,CYP51A1;IDI2;SQLE;MVK;DHCR7;SC5D;FDPS;NSDHL;G6PD;TM7SF2;ACAT2;HMGCS1;DHCR24
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.3315018781726798,1.1549357647987684,0.24,0.3709650647402004,1.0,5/19,13.84%,SLC25A4;MUL1;BNIP3;BCL2;BAD
prerank,peptidyl-lysine methylation (GO:0018022),-0.3984378305152376,-1.1543927225820423,0.28169014084507044,0.6286825232904432,1.0,7/19,16.29%,SUV39H2;EEF2KMT;SMYD3;SETD6;METTL21C;SUV39H1;SMYD2
prerank,pharyngeal system development (GO:0060037),-0.41808294987905653,-1.153895931752573,0.3150684931506849,0.6290344571767937,1.0,11/17,41.87%,TGFB2;FOLR1;BMP7;PTCH1;BMP4;GATA3;TGFBR1;NKX2-6;SIX4;HES1;NKX2-5
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.2875056323356352,-1.1536289464635003,0.1797752808988764,0.6287957246502929,1.0,58/187,27.72%,KIF14;CENPE;UBD;CEP72;MAD2L1;CDK1;NEK2;CEP250;E2F1;UBE2C;FBXO5;PSMB9;PSMD14;HECW2;TPX2;TFAP4;HAUS7;UBE2S;KNTC1;AURKA;ANAPC1;NEK6;CDC14C;PLK1;CENPF;HAUS6;CEP76;CEP152;NDE1;CDC6;PLK4;ANLN;PSMA3;CDC20;SDCCAG8;CENPJ;CKAP5;ALMS1;CEP78;CEP41;BUB1B;PSMB3;AKAP9;CDC26;PSMC1;TM4SF5;PSMB11;PSMA5;HAUS8;HAUS2;ZW10;PSMB2;CEP135;PSME2;PSMD12;PSMA7;TUBB4B;CUL3
prerank,regulation of cellular protein localization (GO:1903827),0.2783373435828963,1.1535879063203953,0.19047619047619047,0.37255898665717885,1.0,17/46,19.79%,MAPT;DVL3;MAP1A;GPC1;MAP2;PRKAA2;CSNK1E;PIN1;RAB11B;GPC4;GPC3;PPM1F;GBF1;NDEL1;GPC6;RAB11FIP5;DVL1
prerank,myoblast differentiation (GO:0045445),0.4041681127022462,1.1533191103361933,0.24242424242424243,0.3725455747703474,1.0,5/15,13.30%,SOX15;DDX17;MBNL1;HINFP;EPAS1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.32948019675617274,1.1526774614853943,0.32142857142857145,0.37310035734075286,1.0,10/23,22.06%,PTEN;INPP5K;MTMR9;INPP5B;MTMR10;INPP5F;INPP5J;MTMR12;OCRL;MTMR11
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.30440034342289884,-1.1522309813969354,0.24096385542168675,0.6318697419233066,1.0,36/73,43.59%,PSMB9;CALR;PSMD14;FCGR1A;HLA-F;PDIA3;TAP1;NCF2;PSMA3;CYBA;CYBB;HLA-G;IKBKG;PSMB3;PSMC1;PSMB11;PSMA5;PSMB2;PSME2;PSMD12;PSMA7;VAMP8;PSME4;PSME3;NCF1;PSMD1;TAP2;TAPBP;PSMC4;CHUK;IKBKB;PSMD13;PSMC2;ITGAV;PSMD3;CD207
prerank,postsynaptic membrane organization (GO:0001941),0.34436703058891344,1.1518862111736432,0.23076923076923078,0.37398901789054545,1.0,9/18,19.34%,NLGN2;DLG4;NLGN4X;NLGN1;NLGN3;NRXN1;SHISA7;NRXN2;SHANK3
prerank,positive regulation of leukocyte migration (GO:0002687),0.336579794431332,1.1515647520924912,0.23333333333333334,0.3741283824236814,1.0,8/28,11.06%,IL6R;JAM3;PTN;LGALS3;NCKAP1L;F2RL1;ZNF580;PLVAP
prerank,positive regulation of protein secretion (GO:0050714),0.25336094444170504,1.151464539270355,0.16666666666666666,0.3739072211920387,1.0,20/68,17.01%,APBB1;OR51E2;APBB3;NLGN2;WLS;MYOM1;NNAT;GPER1;C1QTNF3;F2RL1;LRRC8A;GOLPH3;PLA2G1B;BAD;PSMD9;DOC2B;PTPN23;SLC30A8;FRMD4A;TGFB3
prerank,leukotriene biosynthetic process (GO:0019370),0.35691430802920454,1.1514044586825805,0.2916666666666667,0.37353246371888355,1.0,5/15,14.96%,PLA2G5;PLA2G1B;GGT5;GGT7;PLA2G4A
prerank,sensory organ development (GO:0007423),-0.3238057152774518,-1.1513420390047957,0.21428571428571427,0.633666354235023,1.0,15/56,14.43%,STRA6;ASCL2;TGFB2;PAX6;FOXE3;CHD7;SCO2;ADAMTS18;SIX3;PAX8;SMOC1;SIPA1L3;RBP4;NTF4;SHROOM2
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.40914737514601396,-1.1513042820727144,0.2692307692307692,0.6327655822540507,1.0,7/18,26.73%,IRS1;IL1B;ANGPTL3;SCT;AADAC;ABHD5;TWIST1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.28981898412594437,1.1510745625887358,0.19444444444444445,0.37372319881379,1.0,10/37,7.61%,CORO2B;FZD7;MYOC;FZD4;CORO1C;FBLN1;SPOCK1;RHOA;EFNA5;GCNT2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3872806236614895,-1.1502998495431538,0.2535211267605634,0.6348074797579484,1.0,6/20,19.37%,IL12B;CD70;CD55;PHB;CD46;SLA2
prerank,negative regulation of MAP kinase activity (GO:0043407),0.2620730731113389,1.1499189462406243,0.2631578947368421,0.37560490015717024,1.0,10/47,10.32%,RGS2;UCHL1;SPRY1;INPP5K;PRKCD;DAB2IP;SMPD1;DUSP19;MAPK8IP1;NPPA
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.41118260560551834,-1.1494015035988427,0.2898550724637681,0.6364758397064219,1.0,4/17,7.70%,IL1B;HCAR2;APOC1;SORL1
prerank,regulation of phospholipase C activity (GO:1900274),0.36286096685446795,1.1490627207728679,0.3103448275862069,0.37638120876570735,1.0,4/15,6.32%,FGFR1;KIT;FGF2;PDGFRA
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.3827471657306949,1.1486650426198324,0.3333333333333333,0.3766442858421286,1.0,7/18,13.66%,RAB34;TTC23;TXNDC15;SFRP1;KIF7;SMO;STK36
prerank,sensory perception of pain (GO:0019233),-0.4091995377307062,-1.1485378001702573,0.35526315789473684,0.6382303229458105,1.0,7/20,17.29%,MME;PRDM12;CHRNB2;PROK2;NIPSNAP1;ALOXE3;OPRM1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.3296780714350092,1.1478114547922487,0.23529411764705882,0.377596018570708,1.0,8/26,9.43%,TNS2;NCK1;INPP5K;PRKCD;PIP4K2B;PID1;GRB14;GRB10
prerank,estrogen metabolic process (GO:0008210),-0.3626662329152634,-1.147697669816667,0.273972602739726,0.6397619748783668,1.0,12/27,33.21%,CYP3A7;CYP19A1;CYP2D6;UGT2B7;UGT1A7;SULT1E1;HSD3B1;UGT1A3;UGT2B11;CYP3A5;HSD17B4;HSD17B10
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.2808528571371364,-1.147203969779733,0.19148936170212766,0.6400793345472887,1.0,70/186,30.74%,TNFSF11;CXCL8;TDGF1;TNFRSF11B;CARD14;CCL24;CCL20;EDAR;CCL22;PSMB9;DCSTAMP;PSMD14;ADAMTS12;CCL4;TNFRSF9;CCL3;STAT1;TNFSF9;TNFSF15;CD70;RELA;HYAL3;CCL17;NFKBIA;GBP1;TNFRSF1B;TNFSF18;CHI3L1;TXNDC17;LTB;PSMA3;TNFSF8;CCL26;LTA;EIF5A;CCL1;TRAF2;ST18;BRCA1;TNFSF4;TNFRSF12A;XCL2;TNFSF13B;PSMB3;XCL1;GATA3;OCSTAMP;PSMC1;TNF;BAG4;PSMB11;PSMA5;GBP3;GBA;PSMB2;CCL5;PSME2;PSMD12;ACTN4;PSMA7;HAS2;ZC3H12A;AIM2;TNFRSF11A;CD58;PSME4;CCL7;PSME3;TNFRSF4;DHX9
prerank,"phototransduction, visible light (GO:0007603)",-0.4392528912944258,-1.1471315753694233,0.25,0.6392224859432442,1.0,7/15,33.09%,RP1;GRK1;GNGT1;GNAT1;SAG;CNGA1;PDE6G
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.2850384014262479,1.1470415267732537,0.18181818181818182,0.37844334624837644,1.0,12/34,21.68%,TRIM39;MAP1A;GABARAPL2;CAMLG;ALAD;UBXN1;RYBP;BAG6;KLHL40;WAC;HFE;SDCBP
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.27145168795567143,1.1465337265666053,0.11764705882352941,0.3789065408826601,1.0,14/71,7.70%,PIRT;PTEN;FGFR1;PLCD4;ZFP36L1;PI4KB;PITPNM2;SIRT2;NGF;PLCL1;PIK3R1;RHOA;PDGFRA;PLCD1
prerank,regulation of mitochondrial fission (GO:0090140),0.3280545533357445,1.1458099045324457,0.28,0.3799026713440203,1.0,7/22,16.33%,DCN;MAPT;MUL1;BNIP3;MIEF2;RALBP1;MFF
prerank,apoptotic process (GO:0006915),0.20054525543042478,1.145699561149595,0.125,0.3795754055715751,1.0,73/221,19.58%,MAL;DMPK;PPARD;ATN1;RHOB;ING4;MAGEH1;APAF1;FAS;CASP3;CASP12;DAPK1;PRUNE2;CDIP1;NGFR;MTOR;DAPK3;BCL2L11;PRKCD;JADE1;EFNA5;ATCAY;ARHGEF6;PDE1B;DPF2;CASP10;RTN4;DLC1;BNIP3;AHCYL1;NLRP1;BNIP2;ZNF385A;PIDD1;ERCC3;HK2;APP;CAPN3;CFLAR;CSRNP1;SFRP5;BOK;RAF1;TNFRSF21;CIDEC;BCL2;PLAGL1;FEM1B;JAK2;BAD;RIPK1;TCHP;RRAGC;FAM162A;GDF6;BCL2L13;TAOK2;SEMA6A;NSG1;AKAP1;PPP1R15A;PDCD4;MAP3K10;TNFAIP1;RNF152;TNFSF14;ADRA1A;ERBB3;CASP9;NUDT2;BAG6;KREMEN1;CASP1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.4070138467920895,-1.1456677468328613,0.34328358208955223,0.6423484804525379,1.0,7/22,15.34%,ULBP3;GZMB;ULBP2;ULBP1;RAET1E;CORO1A;KIR3DL1
prerank,aminoglycan catabolic process (GO:0006026),0.3137775986639038,1.1456405080809893,0.2,0.37914748710282886,1.0,12/31,18.90%,SDC2;SDC3;GPC1;IDS;HGSNAT;HPSE2;GUSB;GPC4;GPC3;HSPG2;SGSH;GPC6
prerank,glycosaminoglycan metabolic process (GO:0030203),0.24634893072231118,1.145042124264106,0.25,0.37983549955822027,1.0,21/54,21.04%,SDC2;SDC3;GPC1;IDS;GCNT2;CHST9;NDST2;HGSNAT;HPSE2;GUSB;GPC4;GPC3;NDST1;B3GAT1;B3GAT3;HSPG2;SGSH;GPC6;HS6ST1;HS3ST5;UGDH
prerank,calcium ion import (GO:0070509),0.30544489279916787,1.144560761335076,0.22580645161290322,0.38034464127850964,1.0,10/26,16.12%,CACNA1H;CACNA1C;TRPC4;ATP2A2;SLC25A23;CACNB2;SLC8A1;SMDT1;MICU3;MICU1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.3021659766395856,-1.1443325896541456,0.2840909090909091,0.6454530052592878,1.0,24/73,23.36%,IRAK2;SOCS3;VRK2;TNFAIP3;SOCS1;SYK;RUNX1;STAT1;CBFB;ABCE1;USP18;PALM3;IRAK1;IFNGR2;IFNG;ZBP1;IRAK3;TRAF2;PTPN2;OTULIN;IKBKG;IL36RN;AXL;TNF
prerank,regulation of anoikis (GO:2000209),-0.4009657577914409,-1.144208391201211,0.2777777777777778,0.644716311798682,1.0,5/19,15.09%,ITGA5;CEACAM6;CAV1;CEACAM5;PTRH2
prerank,regulation of programmed necrotic cell death (GO:0062098),0.3356324377932191,1.1438739280461212,0.2,0.381079968910747,1.0,11/20,28.37%,FLOT1;NUPR1;CFLAR;FLOT2;RIPK1;SDCBP;CYLD;OGT;BIRC2;PDCD6IP;CDC37
prerank,cellular lipid catabolic process (GO:0044242),-0.3767566406255841,-1.1437084564758864,0.32857142857142857,0.6450570710259839,1.0,10/26,19.52%,AOAH;ANGPTL3;LIPG;NUDT19;CEL;PLBD1;ACBD5;ABHD12;HAO2;MGST2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.3662223059275161,-1.143587719958718,0.2328767123287671,0.6442781942683419,1.0,7/24,14.58%,IL11;SERPINE1;TNFAIP3;ICAM1;SEMA5A;KDR;IL10
prerank,regulation of dopamine secretion (GO:0014059),0.3156379101435076,1.1434121677284412,0.17391304347826086,0.38130860739138767,1.0,9/24,14.50%,SYT11;SNCA;KCNA2;SYT10;SYT4;SYT5;SYT1;GDNF;SYT6
prerank,glutathione metabolic process (GO:0006749),0.26450712236565566,1.1432152711497459,0.13043478260869565,0.38110809325832445,1.0,11/39,14.82%,GSTM3;GSTM2;GSTM5;GSTA4;GSTM4;SOD1;HPGDS;HAGH;GSTT2B;GGT5;GGT7
prerank,negative regulation of DNA replication (GO:0008156),-0.4245311134582989,-1.1431816716138354,0.30303030303030304,0.6444831997227077,1.0,7/15,23.47%,MCIDAS;S100A11;GTPBP4;ATR;CDC6;PDS5A;GDF2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.2403325552821171,1.1427281621424725,0.25,0.3816634513732003,1.0,24/86,18.40%,VAMP2;AP1S2;SORCS1;CORO7;ARL3;BLOC1S1;AP1M1;OSBPL5;KLHL20;APP;TXNDC5;GOLGA7;CLVS2;GBF1;EXOC6B;HSPA8;STEAP2;GOPC;RABEP1;AP2A1;ARF1;LLGL1;BLOC1S6;RAB14
prerank,chromosome organization (GO:0051276),-0.28704538560446474,-1.1423137251185747,0.25,0.64597142624383,1.0,21/100,16.28%,MYC;NUF2;CENPH;CENPW;NDC80;RFWD3;PADI1;HDAC10;MSH3;NUP155;PADI3;HMGA2;SOX1;AXIN2;SMARCA4;CDT1;MSH6;HMGN1;SUV39H1;VCX;TOP2A
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.3738550669377596,-1.1421327728953987,0.27941176470588236,0.6454871740711974,1.0,5/20,7.99%,RASSF10;TRIM71;PROX1;SHCBP1;SIX3
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.33823106507351297,1.1419815890499252,0.2727272727272727,0.3829215521402656,1.0,4/20,4.63%,TLR3;FSTL3;TMEM178A;CARTPT
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.3239064003384702,1.1414394904906129,0.32142857142857145,0.3833476788884108,1.0,6/22,8.37%,CDKN1A;CDKN1C;INPP5K;CDKN2C;PRKRIP1;TESK1
prerank,dendrite morphogenesis (GO:0048813),0.2958900642940214,1.14076126093304,0.23809523809523808,0.38447511808603874,1.0,14/35,19.79%,PTN;PTEN;SDC2;MAP6;DLG4;MAP2;MEF2A;CTNND2;ARC;TAOK2;BTBD3;KLF7;SHANK3;DVL1
prerank,cellular response to organic substance (GO:0071310),0.22223763631490479,1.1407260895301161,0.0,0.38402137326890534,1.0,24/120,10.21%,CACNA1H;RAMP1;DPYSL3;CDK9;MAPK8;INPP5K;MAPK7;AKAP6;SLIT3;NOS1;HDAC6;RHOA;BMPR1A;CLEC3B;CYP1A1;PID1;RAMP3;SOCS2;PDGFB;RAMP2;CCL2;IGFBP5;SFRP1;CERS1
prerank,regulation of catecholamine secretion (GO:0050433),0.30817762456000375,1.1399400600428338,0.2727272727272727,0.38514516996308074,1.0,8/28,10.79%,SYT11;SNCA;KCNB1;KCNA2;SYT10;SYT4;SYT5;SYT1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.3061137658797943,1.1398201106918304,0.25925925925925924,0.38491664217341115,1.0,4/20,6.50%,NPTN;FGF2;SPRY1;GPC1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.41055260332991433,-1.1397832151039244,0.2714285714285714,0.6515941684000752,1.0,8/18,25.96%,SERPINE1;PLA2G7;FPR2;CXCL10;CCL1;S100A7;HMGB1;CCL5
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.39309817526422186,1.1390988941107356,0.23333333333333334,0.3859366981951244,1.0,4/15,8.82%,FGFR1;HSPB1;FGF2;PRKD1
prerank,defense response to symbiont (GO:0140546),-0.28782341477369855,-1.1387226567706024,0.21176470588235294,0.6536579341718274,1.0,55/119,36.51%,IFITM3;IFITM1;IFITM2;IFI6;IFI44L;SKP2;OAS2;BST2;SERINC5;ISG15;MX1;IFIT3;IL21;PRF1;NLRC5;PMAIP1;STAT1;ABCE1;RELA;BCL2L1;APOBEC3F;NT5C3A;G3BP1;EXOSC4;OAS3;EXOSC5;ZBP1;IFNE;AGBL4;IFI16;IFNB1;IFIT1B;SAMHD1;TLR7;IFNL2;PDE12;TLR8;IRF7;IFNL1;MYD88;PLSCR1;PLA2G10;APOBEC3B;IFNL4;BPIFA1;OASL;IFNL3;STAT2;APOBEC3A;IRF3;IFIT2;EIF2AK2;AICDA;MLKL;DDIT4
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.23592249250805125,1.1374299163135355,0.07692307692307693,0.38859956693455555,1.0,30/97,17.11%,PRELP;CSPG4;DCN;SDC2;UST;OGN;CHST3;SDC3;B4GAT1;GPC1;ST3GAL3;CHST15;GCNT2;CHST9;NDST2;ABCC5;ANGPT1;CHST14;CHST7;GPC4;KERA;GPC3;ST3GAL6;NDST1;OMD;FMOD;CSGALNACT2;DSEL;B3GAT3;HSPG2
prerank,gland development (GO:0048732),-0.3207655059624601,-1.1373816348072108,0.3125,0.6567222395165788,1.0,26/71,25.09%,STRA6;TDGF1;SHH;SOX9;CAV1;PROX1;EPHB3;SIX1;CEBPA;SIX3;MET;PAX8;PCSK9;GCM2;NF1;NKX2-8;MSN;WNT11;PTF1A;TG;LSR;NRG1;MDK;ANXA1;XBP1;WNT4
prerank,acylglycerol biosynthetic process (GO:0046463),-0.4060024099084242,-1.1367605275380275,0.2753623188405797,0.6574194028229926,1.0,8/21,27.49%,DGAT2;GK;PNPLA3;MOGAT1;AGMO;DGAT2L6;LPGAT1;ANG
prerank,mononuclear cell differentiation (GO:1903131),-0.3729046442228636,-1.1365641320423432,0.24324324324324326,0.6568984904118498,1.0,9/26,23.29%,CSF2;TRPM2;IRF8;PPARG;BMP4;LY6D;IFI16;AXL;LYN
prerank,postreplication repair (GO:0006301),-0.3202925355825742,-1.1363117788448223,0.19480519480519481,0.6566910666755004,1.0,17/45,34.70%,RFC3;POLH;RPA3;ISG15;RFC5;RAD18;RFC2;POLD2;BRCA1;USP43;USP10;DTL;UBC;UBE2N;RFC4;SPRTN;POLD1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.3227133297862099,1.1359707935454038,0.22580645161290322,0.39100685889582093,1.0,12/37,15.12%,OPTN;PTX3;SIRT2;PLIN5;ITGB3;RIN3;DLG4;MT3;NFKB1;INS;EDNRB;ANKRD13A
prerank,positive regulation of protein localization to membrane (GO:1905477),0.25214585514920207,1.1357325252051245,0.26666666666666666,0.3907473476602898,1.0,30/100,16.85%,CLIP3;SORBS1;ATP2B4;PRNP;LGALS3;KCNB1;MAPK8;MYO1C;CNPY4;MTCL1;PIK3R1;GPER1;RAMP3;STAC;EGFR;YWHAZ;NECAB2;SLC51B;STAC2;BCL2;MIEF2;ITGB1BP1;BAD;ANK3;ITGA3;EPHA3;MFF;EFCAB7;SQSTM1;PPP3CC
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.3880620484563365,-1.1348809818765182,0.3013698630136986,0.6599646456753083,1.0,10/19,33.53%,POU4F1;PAX6;TGFB1;IFNG;POU4F2;GATA3;TWIST1;FOXC1;IGF1;TRAF6
prerank,positive regulation of phagocytosis (GO:0050766),-0.31024735457368774,-1.1347099030100438,0.2948717948717949,0.6595198907079242,1.0,18/51,26.22%,IL1B;IL15RA;C3;CALR;TULP1;SPACA3;FPR2;LYAR;C2;IFNG;CYBA;SIRPB1;PTPRJ;TNF;CLEC7A;LMAN2;IL2RB;CD300LF
prerank,positive regulation of dendritic spine development (GO:0060999),0.32207731721564725,1.1345398802547964,0.2564102564102564,0.39242576896407677,1.0,5/22,10.39%,PSEN1;DBN1;CAMK1;NLGN1;BHLHB9
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.3574735155345857,1.1339410287322846,0.34285714285714286,0.39320701897315086,1.0,16/16,64.28%,COX4I2;COX6A2;COX7C;COX6C;COX8A;NDUFA4;COX5A;COX7A2L;COX4I1;COX10;COX15;COX7B;COX5B;COX6A1;COX6B1;CYCS
prerank,mesenchyme development (GO:0060485),0.3807996841957971,1.1339244666815789,0.2608695652173913,0.39277232567374526,1.0,5/16,10.07%,FOXF1;CRELD1;PKD2;MEOX1;FGFR2
prerank,glucose homeostasis (GO:0042593),0.24436964427830227,1.1339131498536157,0.25,0.3922892108820186,1.0,24/84,17.23%,SLC2A4;NR1D1;CRY2;KCNB1;INPP5K;CARTPT;NGFR;CRTC2;PIK3R1;WFS1;OAS1;PRKAA2;USF1;HK2;LRRC8A;CRY1;PYGL;BAD;INS;HK1;LEPR;SLC30A8;PDK2;KLF7
prerank,mitotic cytokinetic process (GO:1902410),0.3527768044941163,1.1336002942963466,0.39285714285714285,0.39252401881448457,1.0,7/20,14.07%,CHMP3;RHOA;CNTROB;CHMP4A;CHMP7;KLHDC8B;VPS4A
prerank,RNA modification (GO:0009451),-0.318977110337523,-1.1331168733062211,0.25925925925925924,0.6632552775522313,1.0,21/53,31.86%,PUS7;WDR4;HENMT1;RBM15;TFB1M;APOBEC3F;NAT10;NSUN3;DTWD2;METTL1;CDKAL1;TRMT6;PUS7L;ANKRD16;TRUB1;AARS2;FTSJ1;NOP10;NSUN2;SSB;ADAT3
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.31328128303436953,-1.1321025253002417,0.3026315789473684,0.6654738097805081,1.0,11/39,20.15%,IL1A;IL1B;DHFR;CAV1;SCARB1;TERT;LYPLA1;DDAH1;PIK3CB;GLA;GCH1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.35294889905078386,-1.131087626820799,0.24,0.6676853545057037,1.0,8/33,14.28%,ABCA13;LIPG;CAV1;CETP;ABCA12;PON1;PTCH1;NFKBIA
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.29880617067411686,1.1308388068719304,0.17647058823529413,0.39688059531393843,1.0,10/35,10.72%,FAXDC2;MTURN;MAPK14;FES;HOXA5;NCKAP1L;MAPK11;ANKRD54;TAL1;ARNT
prerank,positive regulation of phospholipase C activity (GO:0010863),0.28486297001115646,1.1305915971510971,0.13636363636363635,0.3969859287979529,1.0,12/43,15.43%,FGFR1;LPAR1;KIT;ARHGAP6;FGF2;PDGFRA;P2RY12;EGFR;AVPR1A;GNAQ;NTF3;NTRK3
prerank,positive regulation of mitochondrial fission (GO:0090141),0.3257448986795365,1.1303577990449163,0.17857142857142858,0.39704175588438617,1.0,6/17,16.33%,DCN;MUL1;BNIP3;MIEF2;RALBP1;MFF
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.2998777548125962,-1.130342115749233,0.21686746987951808,0.6690404885386522,1.0,26/73,32.87%,RFC3;ERCC5;POLR2F;RPA3;LIG1;RFC5;ERCC8;CDK7;GTF2H2;HMGN1;POLR2J;RFC2;LIG3;POLD2;POLR2D;POLR2I;GTF2H3;ERCC6;CCNH;PRPF19;UBC;COPS5;USP7;AQR;RFC4;ERCC2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.4031784892012461,-1.130177775006575,0.22388059701492538,0.6685629476335389,1.0,8/16,27.29%,ISG15;NLRC5;USP18;OAS3;PTPN2;DCST1;SAMHD1;TTLL12
prerank,protein monoubiquitination (GO:0006513),-0.3498157241297439,-1.1301408945664155,0.2962962962962963,0.6676360137950668,1.0,14/36,29.83%,UBE2T;UHRF1;FANCL;RAG1;UBE3D;RAD18;RNF40;KBTBD8;DTX3L;LEO1;CUL3;CDC73;DTL;HUWE1
prerank,endoderm development (GO:0007492),-0.44684002264162087,-1.1299683917449799,0.3424657534246575,0.6671731455718117,1.0,7/15,19.06%,DUSP4;TBX20;DUSP1;APELA;HOXC11;DUSP2;LHX1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.29791525306167466,-1.1294496844324693,0.23529411764705882,0.6676874262440364,1.0,39/83,38.49%,KIF18A;CENPE;KIF15;KIF23;KIF2A;KDELR3;RACGAP1;KIF4B;KIF2C;KIF22;ATP9A;KDELR2;KIF3B;COPB2;ERGIC3;TMED3;RAB6C;TMED2;LMAN2;ZW10;NBAS;ERGIC2;KIF4A;COG3;RAB41;NSF;COPG1;COPA;TMED9;COPG2;COPZ1;TAPBP;RINT1;GOLPH3L;ATP9B;KDELR1;SURF4;SCFD1;KIF11
prerank,regulation of macrophage activation (GO:0043030),-0.3647734589467303,-1.129341832584791,0.3076923076923077,0.6669632217217386,1.0,6/29,12.58%,MIF;WNT5A;HSPD1;CEBPA;SPACA3;THBS1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.31263401534862295,1.128963944276059,0.2692307692307692,0.39933551581833343,1.0,6/19,18.57%,FES;CCL27;BAIAP2;NTF3;NTRK3;HCLS1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.2612830939936454,1.1282492853845696,0.2222222222222222,0.40017439017766016,1.0,29/73,23.91%,CLU;ZER1;BAG2;SIRT2;DNAJB2;RNF217;TRIB2;SMAD7;RNF144B;CSNK1E;RNF14;PIAS1;CSNK1A1;RNF180;ZYG11B;GABARAP;RNF19A;BBS7;CBFA2T3;SGTA;KLHL40;DVL1;HERPUD1;RNF144A;UBQLN2;NFE2L2;DDA1;ARIH2;DET1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.33211329626475694,1.1273790168028262,0.3548387096774194,0.401575504707259,1.0,8/17,20.57%,CALM1;MTOR;PPP1R12A;CALM2;MAGI2;PPP1R15A;AGTR2;CALM3
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.3089144367446317,-1.1273033917949637,0.2625,0.6723067551733224,1.0,26/59,32.59%,RIPK2;USP50;EGR1;GBP5;WNT5A;IL17A;CCL3;NLRP12;NLRP3;IFNG;MNDA;NOD2;IFI16;TYROBP;TNF;CLEC7A;HMGB1;NLRP10;TMEM106A;AIM2;NLRP2;TLR8;MYD88;NLRC4;AGER;LILRA5
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.24135838269142335,1.1272843397217787,0.0,0.40120889647940544,1.0,36/123,19.92%,PTEN;PIP5K1C;ITPKB;INPPL1;PI4KB;FGF2;INPP5K;PITPNM2;PIK3R1;TMEM150A;PIP4K2B;MTMR9;CDIPT;IP6K1;SOCS2;PIK3R3;SLC27A1;PI4K2A;INPP5E;BMX;IP6K3;PLEKHA4;FAM126A;PIP4K2A;PIGQ;RUFY1;ARF1;INPP5F;PIGH;TTC7B;CWH43;INPP5J;RAB14;MTMR12;OCRL;INPP4A
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.37131891469546063,-1.1272519748515746,0.3194444444444444,0.6714139422106093,1.0,10/21,28.65%,GRIN2B;USP50;PSMB9;NLRP12;FYN;TTBK1;MEFV;IFI16;LTF;AIM2
prerank,response to cadmium ion (GO:0046686),0.31496026426429,1.126903813940859,0.25,0.4013571445106051,1.0,12/29,20.43%,MAPK1;MAPK3;MAPK8;MT1X;MT1M;EGFR;MT3;MT1A;MT1E;AKR1C3;DAXX;JUN
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.3708341128401892,1.1267236886952168,0.3548387096774194,0.4011628057677427,1.0,4/18,6.58%,CLU;CASP3;IFNGR1;EPHA4
prerank,hexose biosynthetic process (GO:0019319),0.2662407739794743,1.125686418183698,0.22727272727272727,0.40294656059483913,1.0,10/42,12.93%,ENO2;ATF4;SLC25A12;CRTC2;ALDOA;AKR1B1;CHST15;MDH1;PGM1;CRY1
prerank,superoxide metabolic process (GO:0006801),-0.34112947714276404,-1.1254448508263277,0.3333333333333333,0.6759604350173329,1.0,9/30,17.31%,DUOX2;NOXO1;NOS2;NOX1;ALOX12;DUOX1;NCF2;CYBA;CYBB
prerank,nitrogen compound transport (GO:0071705),-0.27659998834417415,-1.1251294695913707,0.25287356321839083,0.6759240850487396,1.0,43/138,27.84%,SLC12A2;SLC6A14;SLC7A11;TCN1;SLC6A20;SLC7A5;AQP9;SLC38A5;ARRDC5;ABCC2;SLC6A6;LRP2;SLC16A10;SLC25A47;SLC1A5;SLC7A1;RHBG;SLC22A1;SLC1A4;LRRC8D;CENPF;SLC7A6;SLC52A3;SLC22A13;SLC6A4;ABCB6;SLC18A2;SLC6A18;CD3G;SLC38A3;ATP11B;SLC25A48;SLC52A2;SLC22A4;SLC7A7;CMTM6;SLC7A4;SLC44A1;SLC3A2;SLC7A10;SLC18A1;NDC1;SLC6A12
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.2113735727890548,1.1247739000263755,0.0,0.40436020880548373,1.0,36/163,13.01%,PALLD;MPZ;CDH19;PLXNB3;CADM3;CLDN5;IGSF11;TRO;ROBO3;NEXN;L1CAM;NPTN;CLDN11;PTPRS;MYOT;AMIGO2;OBSL1;SLITRK2;CDHR3;KIRREL3;PKD1;DCHS1;PTPRM;SLITRK3;ROBO4;CDH5;CEACAM1;NLGN1;PCDHB4;LRRC4C;NTNG1;TENM1;TENM3;SELP;GPC4;CADM1
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.33311078302722325,-1.1244419406707309,0.24675324675324675,0.6771368770655775,1.0,10/42,10.93%,THY1;TNFSF11;IL1B;SKAP1;CEACAM6;CD44;FOXA2;FUT7;BMP7;PLAUR
prerank,digestive tract development (GO:0048565),0.2712579001357022,1.1241395222570933,0.3157894736842105,0.4052833147703905,1.0,17/39,17.91%,FOXF1;CLMP;KIT;RARRES2;RARB;PKD1;NPY;GLI3;FGFR2;PKDCC;SMO;MEGF8;EDNRB;PYY;BBS7;GLI2;CCDC40
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.37335663309770895,-1.1239399130073884,0.3466666666666667,0.6776844154496541,1.0,12/23,30.52%,SOCS3;SOCS1;NLRC5;STAT1;ARG1;IFNGR2;IFNG;PTPN2;PPARG;PARP14;TXK;OTOP1
prerank,extracellular matrix organization (GO:0030198),-0.2602730966137979,-1.1234516514198103,0.1919191919191919,0.6780137118278077,1.0,64/288,16.01%,COL10A1;MMP7;MMP13;ACAN;COL1A1;COL11A1;ADAM12;LOXL2;COL1A2;TIMP1;VWF;TGFB2;LAMC2;TGFBI;ITGA5;KLK7;SPP1;MMP10;SERPINE1;MMP1;FN1;MMP24;MMP11;CTSV;IBSP;MMP20;ICAM1;CD44;BCAN;KIF9;MMP3;ADAMTS12;MMP2;CAPG;ADAMTS18;MMP25;PECAM1;NOXO1;FBN2;COL3A1;SMOC1;ITGAX;DMP1;MMP9;TMPRSS6;PPIB;AGRN;LAMA3;THBS1;COL2A1;TGFB1;ITGAD;ITGA11;LAMB3;P4HB;VCAN;KDR;SLC39A8;NF1;COL7A1;ADAM10;MMP12;ADAMTS20;ITGB6
prerank,miRNA metabolic process (GO:0010586),-0.37991047404922657,-1.123357810302778,0.3116883116883117,0.6772176577333585,1.0,8/17,29.39%,TRIM71;SND1;XPO5;LIN28A;RAN;LIN28B;KHSRP;DROSHA
prerank,keratan sulfate biosynthetic process (GO:0018146),0.2832401144964105,1.1233508201550373,0.32,0.40622851483203026,1.0,8/28,14.84%,PRELP;OGN;B4GAT1;ST3GAL3;KERA;ST3GAL6;OMD;FMOD
prerank,regulation of response to external stimulus (GO:0032101),-0.27520246104274215,-1.1229942745732688,0.26666666666666666,0.6770609160239014,1.0,44/125,31.85%,LRP8;CXCR4;EPHB2;WNT5A;PIK3AP1;CAV1;ADAMTS12;CAMKMT;GRK1;FOXA2;XIAP;USP18;RELA;GUCY2D;GATA6;CD55;BCL6;IL1RL2;SETD6;STK24;F2R;ZBP1;NOD2;NLRP6;IL20;TNFSF4;ERAP1;GP1BA;ACE2;XCL1;TKFC;ANXA1;SAMHD1;PPEF1;IL37;PTPN22;GNAT1;GRK7;SEMA7A;SPATA2;MYD88;SAG;CNGA1;GUCY2F
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.34681318370133163,1.1229307441836744,0.3076923076923077,0.40673408332504,1.0,9/19,22.16%,RGS10;CHRNA3;LY6H;CHRM2;GNAQ;CHRM3;RGS8;GNA11;GNB1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.2948878165081425,-1.122232015646045,0.27586206896551724,0.6783488685724882,1.0,14/82,7.73%,ENC1;IGF2BP1;GZMB;IGF2BP3;PUS7;TRIM71;CALR;DHFR;GRB7;NANOS3;NCL;IGF2BP2;SORL1;CAPRIN1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.22355426406990075,1.1221194761907438,0.09090909090909091,0.40774805651225965,1.0,35/146,14.04%,PLN;ATP2B4;SCGN;LPAR1;ADCY5;AGTR1;CAV2;HRC;P2RY1;NPTN;PTGER3;ACKR3;ATP1A2;TMEM178A;CACNA1C;PDGFRA;DLG4;GPER1;PRKACA;CD36;TRPC1;F2RL1;CALB2;SLC8A2;TRPC4;C1QTNF1;TBXA2R;SMAD3;TAC1;SLC8A1;CD24;TRPC6;PTGER4;ADCYAP1;CCR10
prerank,lipid homeostasis (GO:0055088),-0.3098946464517541,-1.1220339888952031,0.23255813953488372,0.6779003209112452,1.0,18/59,24.62%,DGAT2;ACOXL;TLCD1;PNPLA3;ANGPTL3;ZBTB20;LIPG;CETP;CEBPA;PNPLA1;MLXIPL;PPARG;ATP13A2;THADA;ABCB4;ABHD5;HNF4A;XBP1
prerank,regulation of JUN kinase activity (GO:0043506),0.28561046262908424,1.1217117104880867,0.20833333333333334,0.4081293830434552,1.0,11/33,17.37%,DVL3;SASH1;DVL2;DAB2IP;TLR9;DUSP19;MAPK8IP1;NPPA;HIPK3;PDCD4;MAP3K10
prerank,negative regulation of protein binding (GO:0032091),0.2480439782776889,1.1216068661657574,0.16,0.40797718453075626,1.0,14/67,10.92%,BAG2;CDKN1A;MAPK8;ADRB3;CAMK1;PRKCD;MAP2;DNAJB2;PDGFB;ACTB;B2M;CSNK1E;ATP2A2;PIN1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.2686428075744429,1.1215262594801196,0.2,0.40758354863554097,1.0,20/66,18.34%,TIMP4;WDR6;TIMP3;TIMP2;SIRT2;PLIN5;MTOR;RRAGA;DAB2IP;MTMR9;NUPR1;KLHL22;MT3;RASIP1;BCL2;INS;LEPR;GOLGA2;ZKSCAN3;STAT3
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.24352462408145686,1.1214792947733117,0.15,0.40719085784451586,1.0,17/72,12.69%,PHF1;DIRAS3;KAT2B;PHF2;MYO1C;WBP2;KAT2A;HDAC4;HDAC6;HDAC5;TAF1C;ACTB;CREBZF;CGGBP1;MECP2;SF3B1;MPHOSPH8
prerank,positive regulation of MAPK cascade (GO:0043410),0.21699617894319792,1.1211569707035882,0.3333333333333333,0.4072333108428005,1.0,63/259,14.49%,RAP1A;GLIPR2;FERMT2;FGFR1;LPAR1;CCL14;PLA2G5;CAV2;KIT;P2RY1;MAPK3;SEMA4C;ACKR3;FGF2;ROR2;MTURN;HAND2;ADRB3;TNFAIP8L3;TIRAP;PDGFRA;CCL21;GPER1;CD36;DAB2IP;RAMP3;PDGFB;GCNT2;F2RL1;CCL2;FGF1;ELANE;GH1;TLR9;EGFR;DUSP19;PDGFD;MID1;FLT4;FGFR2;NECAB2;ANGPT1;GPNMB;NDRG4;APP;ROR1;CX3CL1;TENM1;MT3;ARL6IP5;ADRA2B;CD24;CCL11;PRKCA;CCL13;NTRK1;ADCYAP1;CCL8;FGF10;INS;BCAR3;DIRAS2;LGALS9
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.35653894535355696,-1.120478755018046,0.265625,0.6813104932858759,1.0,11/22,37.95%,HKDC1;RPIA;RPE;RPEL1;PGD;G6PD;TALDO1;G6PC3;PGLS;TKT;PGM2L1
prerank,regulation of cellular response to heat (GO:1900034),0.25321870975677324,1.11939097657885,0.3,0.40978138085486426,1.0,10/76,4.96%,CRYAB;HSPB8;CAMK2G;CD34;MAPK1;BAG2;MAPK3;MAPT;BAG3;MTOR
prerank,cardiac muscle cell development (GO:0055013),0.3181273597878138,1.1190499146172124,0.2727272727272727,0.4097965689501168,1.0,10/24,16.92%,SORBS2;OBSL1;PDGFRA;ACTC1;MYL2;TCAP;SLC8A1;HEY2;FHOD3;ALPK3
prerank,cellular metal ion homeostasis (GO:0006875),0.23479429306402705,1.1187758416481057,0.11764705882352941,0.4097636489975243,1.0,24/101,13.78%,DMPK;ATP2B4;CCL14;ATP1B2;STIM1;NPTN;ATP1A2;KCNMA1;TPCN2;SLC24A3;ANK2;SLC41A1;PTH1R;ELANE;SLC8A2;CDH5;RGN;ATP2A2;ATP1A3;MT3;SLC8A1;CCL11;CCL13;CCL8
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.37635694505863865,-1.118506644189283,0.352112676056338,0.6861049118152533,1.0,10/26,29.31%,OLR1;ICAM1;SYK;PECAM1;SEMA4D;MSN;ITGB2;CCL5;EZR;ITGAL
prerank,glycerophospholipid metabolic process (GO:0006650),-0.31195652927404716,-1.118196190988199,0.2988505747126437,0.6860000696132563,1.0,18/75,16.53%,CPNE7;PDGFRB;PNPLA3;PLA2G7;PLA2G4D;SERINC5;PIGM;CETP;PLA2G4E;PIGW;PON1;PIGF;GDPD1;PLA2G3;PDXP;ACP6;PLEK;ABHD12
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.3194835290815497,1.1179087743151404,0.28125,0.4113152825236274,1.0,6/21,12.10%,ATF4;RBPJ;CREB3;SMAD4;SMAD9;MT3
prerank,nucleotide catabolic process (GO:0009166),-0.4040178411692211,-1.1178896543672623,0.25,0.6860345893280265,1.0,8/16,30.28%,PNP;ITPA;NUDT15;NT5C2;NT5C1B;SAMHD1;DNPH1;XDH
prerank,mammary gland epithelium development (GO:0061180),-0.415126758609212,-1.1174885934425094,0.35,0.6862398724446633,1.0,6/15,25.10%,WNT2;WNT7B;EPHA2;WNT3;WNT4;IRF6
prerank,transport across blood-brain barrier (GO:0150104),0.22089615899347428,1.1174628725909286,0.18181818181818182,0.4118081596923051,1.0,20/86,13.51%,SLC2A4;ATP2B4;ATP1B2;KCNJ8;ATP1A2;SLC29A1;SLC16A12;SLC24A3;CD36;SLC7A2;SLC16A2;SLC8A2;SLC27A1;ABCC5;AVPR1A;SLC6A17;ABCG2;ABCC9;SLC38A2;SLC6A9
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.26882186172192024,1.1167902374822316,0.2222222222222222,0.41239566348642825,1.0,7/41,8.82%,IL6R;FERMT2;WWTR1;DDR2;ZHX3;BMPR1A;PRKD1
prerank,phospholipid dephosphorylation (GO:0046839),0.313506733898948,1.116745677991255,0.16666666666666666,0.41197706470675793,1.0,11/26,20.01%,PTEN;INPP5K;MTMR9;INPP5B;MTMR10;INPP5F;INPP5J;EPHX2;MTMR12;OCRL;SGPP1
prerank,regulation of proteolysis (GO:0030162),-0.3148489793043826,-1.1164607463670186,0.30120481927710846,0.6883532176194179,1.0,18/51,27.34%,CST4;SHH;KNG1;CAV1;PLK1;PLAUR;PRSS37;PERP;CDK5;FGFR4;CSTB;TM4SF20;CLN6;HDAC2;ASPH;STUB1;ITCH;CSTA
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3473602384762693,1.1164295296080058,0.3076923076923077,0.4118461779896698,1.0,9/22,15.83%,TSG101;UBAP1;RNF115;VPS4A;VPS28;MVB12B;PTPN23;VPS37D;VPS37A
prerank,cellular response to drug (GO:0035690),-0.36228368178948445,-1.1162744768367407,0.3108108108108108,0.6880326627010839,1.0,4/26,3.70%,MYC;DPEP1;IL1B;KCNQ1
prerank,regulation of cell differentiation (GO:0045595),0.21540324696975316,1.1160748947843824,0.125,0.41193038503626533,1.0,43/152,18.10%,NR1D1;FGFR1;LGALS3;ATF4;HEY1;LTBP4;ZFP36L1;CDK9;SRF;NGF;CEBPD;FES;MEGF10;CAMK1;DDX17;PHLDB2;PRKACA;ID2;KLHL41;SMAD7;NLGN1;FGFR2;GNB3;GPS2;RAF1;NR1D2;PLEKHB1;CD24;HEY2;FLOT2;GDNF;PHLDB1;NOTCH4;NTF3;INS;TRIP4;EPHA3;CASZ1;PRKCB;KLF4;TIAM1;DLL1;AR
prerank,negative regulation of interleukin-2 production (GO:0032703),0.30801240663309615,1.1159640998046885,0.29411764705882354,0.4115853350297857,1.0,5/22,6.03%,CD34;PRNP;VSIG4;HDAC7;ZFP36
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.3666235237835547,-1.1158649704976478,0.3157894736842105,0.6882339853287465,1.0,13/27,33.53%,IRAK2;RIPK2;TNFAIP3;RELA;IRAK1;TAB3;NOD2;OTULIN;IKBKG;ITCH;UBC;UBE2N;TRAF6
prerank,spindle assembly (GO:0051225),-0.2952200753307387,-1.115562859541068,0.2716049382716049,0.6882648643259837,1.0,28/78,24.26%,KIF2A;NEK2;CHEK2;TPX2;HAUS7;NEK6;GOLGA8J;RCC1;GOLGA6C;GOLGA8H;GOLGA8T;GOLGA6D;HAUS6;GOLGA8S;GOLGA8O;MZT1;GOLGA8K;KIF3B;GOLGA8F;GOLGA6A;GOLGA6B;SMC1A;PIBF1;TUBGCP4;STAG1;GOLGA8M;HAUS8;HAUS2
prerank,regulation of nervous system development (GO:0051960),0.26435657218753067,1.1153709736850757,0.2692307692307692,0.41214581784848164,1.0,7/39,7.33%,LGI4;PTN;HEY1;PTPRZ1;SIRT2;ARNTL;NPHP3
prerank,glycolipid biosynthetic process (GO:0009247),-0.33857228392420885,-1.11527566376339,0.2876712328767123,0.6882214596856546,1.0,17/37,35.37%,ST8SIA6;PIGM;PIGU;PIGW;PYURF;PIGF;DPM1;B3GNT5;PIGN;B4GALT6;PIGA;PIGB;DPM2;PGAP2;ST8SIA5;ST3GAL2;PIGO
prerank,regulation of MAP kinase activity (GO:0043405),0.23359078918269577,1.114715432230666,0.16666666666666666,0.412942777420891,1.0,19/97,9.60%,RGS2;UCHL1;FGFR1;KIT;FGF2;SPRY1;INPP5K;TSG101;PRKCD;DAB2IP;PDGFB;TRIB2;SMPD1;FGF1;ELANE;GH1;EGFR;DUSP19;PDGFD
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.2268419957962894,1.1146220018154167,0.14285714285714285,0.41259775428292944,1.0,33/116,15.97%,LPAR1;RAMP1;CNR1;ADCY5;VIP;S1PR1;PTGER3;GNG2;ADRB3;ADCY4;ADGRD1;GPER1;ADGRB3;RAMP3;RAMP2;PTH1R;ADGRL4;GPR161;TBXA2R;ADRA2B;ADM;ADGRL2;PTGER4;GPR4;GNAQ;ADCYAP1;ADCY9;S1PR2;ADCY2;ADRB2;ADGRL1;PTGFR;ADCY6
prerank,positive regulation of telomere maintenance (GO:0032206),-0.3519587970626145,-1.114606140029294,0.3076923076923077,0.6892152842313326,1.0,10/31,23.54%,NEK2;PML;AURKB;MAPK15;NAF1;GNL3;SLX1A;PRKCQ;ATRX;MAPKAPK5
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.228995720766376,1.1138916045849998,0.15789473684210525,0.41367699039255074,1.0,24/87,15.52%,CLU;SYNPO2;LGALS3;EMILIN1;TSG101;TRABD2B;TIRAP;BCL2L11;SYNPO;DAB2IP;RHOC;CDH5;FLOT1;TAL1;BRK1;SMAD3;CX3CL1;PRKCA;VPS4A;PFN2;TFRC;RGCC;MPP7;SH3GLB1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.299447808780996,1.1135167545723867,0.2647058823529412,0.4138532304957177,1.0,9/31,10.07%,TPM1;S1PR1;HAND1;TGFBR3;ACTC1;SMAD7;MYL2;TCAP;FGFR2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.31612009893918575,-1.1130773644032093,0.3246753246753247,0.6929006231972646,1.0,17/44,28.13%,MIF;IL12RB2;IL12B;P4HB;IL10;MSN;IFNG;RALA;SNRPA1;IL12RB1;TALDO1;CAPZA1;HSPA9;PSME2;LCP1;CNN2;TYK2
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.2837080973238769,-1.1128226809739972,0.2976190476190476,0.6926921811851271,1.0,22/99,14.58%,CEBPB;TP73;IFI6;POU4F1;TRIB3;E2F1;PML;CHEK2;ERO1A;PRKDC;IKBKE;BCL2A1;EPHA2;PMAIP1;BCL2L1;STK24;MSH6;TNFRSF10B;CASP2;CHAC1;ATP2A1;TNFRSF1B
prerank,gonad development (GO:0008406),-0.3274289129264923,-1.1123465592878066,0.2948717948717949,0.6932323476893889,1.0,28/51,37.26%,INHBA;TGFB2;IRX5;WNT5A;SOX9;LRP2;ADAM20;CYP19A1;NUP107;GATA6;BIK;TEX19;LHB;ZFP42;GATA3;PRKACG;WNT4;SALL1;FGF8;SRD5A2;WT1;ADAM29;GATA4;NR5A1;FSHR;UTF1;SIX4;ADAM21
prerank,negative regulation of GTPase activity (GO:0034260),0.3150267111769136,1.1121960249490719,0.25,0.41620653680260344,1.0,6/22,9.34%,PLXNB3;ARL2;FICD;GPSM1;DAB2IP;RDX
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.40004261437575905,-1.1118934378293077,0.3333333333333333,0.6935184343965111,1.0,6/16,21.30%,PDX1;NOS2;AGT;MAFA;DDAH1;KCNC2
prerank,positive regulation of protein metabolic process (GO:0051247),-0.2847629697508665,-1.1117959016182033,0.26506024096385544,0.6927218118967113,1.0,24/113,14.28%,INHBA;CD80;IL1B;TFR2;CSNK2A3;TNFAIP3;IL23A;ASB9;WNT5A;IL23R;C4BPA;HECW1;UHRF1;HECW2;IL17F;RASGRP1;OAZ3;SORL1;IL12B;C4BPB;AGT;TGFB1;WNT7A;NFKBIA
prerank,negative regulation of innate immune response (GO:0045824),-0.3327949259798201,-1.1117141194164024,0.28378378378378377,0.691948546376443,1.0,16/37,27.29%,TNFAIP3;SERPING1;ISG15;NLRC5;USP18;LYAR;RPS19;OAS3;CR1;IRAK3;PTPN2;IFI16;DCST1;NMI;SAMHD1;TTLL12
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.37008213823607355,1.1109341043571141,0.28125,0.4183415483010699,1.0,8/17,18.13%,MYOC;FLCN;KCTD10;DLC1;RASIP1;ITGA3;KANK1;TNFAIP1
prerank,intracellular protein transport (GO:0006886),0.19792748157849568,1.1109024719211114,0.0,0.4179213752276927,1.0,89/322,20.48%,CLIP3;TBC1D1;ARL4D;RAB6B;SNX15;COPZ2;MAP1LC3C;SEC31B;RAB5B;WLS;SNX1;GPIHBP1;IPO13;DNAJC27;STX1B;MYO1C;VPS45;SGSM2;STX2;BAG3;NGFR;EVI5L;AKAP6;RAB23;STX12;TBC1D17;HDAC6;RABL2B;STX16;STRADA;PKD1;RAB28;RABGAP1;TECPR2;HAP1;TRIM23;FAM53C;RAB31;TBC1D25;ADPRH;TRAK2;TICAM2;USP6;GGA3;NAPB;OXA1L;NLGN1;EIF4ENIF1;SGSM1;TBC1D10A;RANBP3;RAB24;VPS26B;TBC1D26;SGSM3;GABARAP;VPS28;SNX27;SNX9;GGA2;HOMER3;STX7;SNX17;RABL2A;PTTG1IP;STX8;STXBP1;ARL6;AP2A1;ARF1;RAB5C;VIPAS39;TNPO2;RASSF9;RANBP3L;STAT3;RAB14;ANKLE1;VPS33A;FAM53B;EHD1;SAR1A;STXBP3;GGA1;EIF2D;AP4S1;IFT22;RAB29;STX4
prerank,blood vessel morphogenesis (GO:0048514),-0.31435950660604367,-1.110358847639823,0.3076923076923077,0.6946857326882045,1.0,14/56,15.30%,STRA6;TBX20;SHH;ANGPTL3;ENG;CAV1;PROX1;SYK;APELA;TNNI3;TGFB1;KDR;NF1;TGFBR2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.19466411137581208,1.1099992353254426,0.0,0.4195304998330337,1.0,106/455,15.75%,CRYAB;TCEAL7;PPARD;PER1;BEND5;CIPC;NR1D1;CRY2;CITED2;PBXIP1;ZNF219;TSHZ3;HEY1;SCMH1;EID1;NFIL3;ING4;ZMYND11;TWIST2;SOX13;NACC2;HAND1;ZBTB4;ZNF174;CDKN1C;EID2B;ZNF425;SMAD2;INPP5K;ZNF540;SIRT2;MBD1;SOX7;RING1;DMAP1;KLF10;ARNTL;IKZF4;ZHX3;ATOH8;HDAC4;NR2F2;PRDM11;PHC2;HDAC6;HDAC5;NR1H2;FOXP2;ARID5A;ID2;RBPJ;DAB2IP;ID3;DPF2;PDGFB;HHEX;TLE2;THRA;CBY1;SOX18;PRMT2;GLI3;TLE1;SMAD4;SFRP1;FOXN3;PCGF6;RBFOX2;BAP1;PFDN5;CREBZF;HINFP;CAPN3;MECP2;MDFIC;EIF4A2;CIART;MT3;RUNX1T1;NR1D2;PHF12;DKK3;NKX3-1;MPHOSPH8;CIC;CRY1;HEY2;ZGPAT;UIMC1;PIAS4;KAT8;USP47;PPM1F;SMARCE1;THAP7;BTRC;ZNF24;TSC22D4;GLIS2;BAHD1;HSPA8;L3MBTL2;ZNF568;DDIT3;TNP1;HEXIM1
prerank,mRNA modification (GO:0016556),-0.3793836671129379,-1.1095944654522396,0.3188405797101449,0.6959717684786466,1.0,9/21,29.53%,PUS7;DKC1;PUS1;TRMT6;TRUB1;TRMT10C;TRMT61B;TRUB2;NSUN2
prerank,protein depolymerization (GO:0051261),0.29995284785748977,1.109543548105877,0.29411764705882354,0.42017000210083977,1.0,5/28,2.24%,DSTN;GSN;CFL2;STMN2;STMN4
prerank,cholesterol efflux (GO:0033344),-0.37658841589490893,-1.1093700248473508,0.36764705882352944,0.6956878412562845,1.0,5/21,14.83%,ABCG5;APOC1;SCARB1;ABCG8;APOM
prerank,regulation of type I interferon production (GO:0032479),-0.2852896274722212,-1.1088929727788437,0.24719101123595505,0.6961241096773632,1.0,29/83,30.74%,POLR2F;TNFAIP3;POLR1C;PRKDC;IKBKE;ISG15;NLRC5;POLA1;POLR3B;NFKB2;RELA;POLR3K;IRAK1;IRF8;G3BP1;ZBP1;POLR3C;POLR3A;IFI16;GAPDH;POLR3G;CREBBP;ITCH;NLRP4;PTPN22;XRCC5;IRF7;MYD88;DHX9
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.34682125837427485,-1.1085624440139903,0.2876712328767123,0.6959969477673872,1.0,11/30,27.29%,WNT5A;ISG15;NLRC5;ABCE1;USP18;OAS3;ZBP1;PTPN2;DCST1;SAMHD1;TTLL12
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.302421500139014,-1.1084265146262575,0.25882352941176473,0.6954543826539749,1.0,20/64,30.10%,PSMB9;PSMD14;CAV1;OAZ3;NQO1;ODC1;PSMA3;FGFR4;PANK2;PSMB3;PSMC1;PSMB11;AZIN1;PSMA5;PSMB2;PSME2;PSMD12;PSMA7;PSME4;PSME3
prerank,regulation of centrosome cycle (GO:0046605),-0.375474752722337,-1.1079127795657315,0.2948717948717949,0.6960032306786444,1.0,7/22,25.19%,PKHD1;AURKA;CHMP4C;NAT10;NPM1;RAB6C;GEN1
prerank,endosome organization (GO:0007032),0.2553966467017279,1.1073134672147715,0.25,0.42419630823423976,1.0,12/37,16.73%,CORO1C;VPS11;AKTIP;PLEKHF1;PI4K2A;SNX3;SNX33;ANXA8L1;RILP;RAB27A;SQSTM1;VPS18
prerank,fluid transport (GO:0042044),-0.3966737531216617,-1.1072604398002872,0.3382352941176471,0.6967991882980471,1.0,5/18,14.94%,SLC4A11;UPK3A;AQP9;AQP2;AQP5
prerank,positive regulation of phosphatase activity (GO:0010922),0.31492753570413917,1.1066086718703634,0.35714285714285715,0.4249228751127641,1.0,9/20,18.08%,CALM1;MTOR;MTMR9;CALM2;MEF2C;CHP2;MAGI2;PPP1R15A;AGTR2
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.3762894747949556,-1.1064179019172187,0.3291139240506329,0.6985138150050928,1.0,7/19,20.50%,TNFSF9;IL12B;LST1;TNFRSF1B;TNFSF18;TNFSF8;IL27
prerank,response to ketone (GO:1901654),-0.3341161945417649,-1.106121501729353,0.2777777777777778,0.6982910706501108,1.0,13/28,26.85%,TGFB2;CAV1;CATSPERB;CATSPER1;THBS1;TGFB1;CATSPER3;ABHD2;ABCB4;CATSPER2;CATSPER4;CATSPERG;HSD3B1
prerank,Rac protein signal transduction (GO:0016601),0.30740474576558663,1.1059671391869645,0.2962962962962963,0.4258120710178208,1.0,6/18,19.52%,WASF1;RAC1;BRK1;TIAM1;ABI2;RHOG
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.30792314660267517,-1.105848760682534,0.30952380952380953,0.6981308898416445,1.0,27/50,39.97%,PNPO;BAAT;OSBPL3;PSAT1;SQLE;AKR1C4;CYP7B1;ALOX12;DHCR7;SC5D;CYP39A1;AKR1D1;TM7SF2;SLC27A5;SRD5A2;HSD3B7;MSMO1;HSD17B4;HSD17B10;EBP;OSBPL2;INSIG1;HMGCR;ACOT8;CYP7A1;CYP8B1;OSBP
prerank,potassium ion transport (GO:0006813),0.22127249175467892,1.1052945244050412,0.3333333333333333,0.42653506109385025,1.0,33/120,17.95%,KCNMB1;KCNQ4;KCNA5;KCNH2;KCNN3;AQP1;KCNJ8;KCNB1;ATP1A2;KCNMA1;PKD2;SLC9A9;SLC24A3;KCNA2;LRRC55;TMEM175;KCNS3;KCNE2;KCND3;KCND1;ABCC9;KCNF1;KCNMB4;ABCC8;KCNMB2;HCN3;KCNK4;KCNA1;KCNK3;KCNK7;KCNAB3;LRRC38;KCNK2
prerank,ceramide metabolic process (GO:0006672),-0.31741796555017326,-1.105196632735596,0.2804878048780488,0.6992281354565895,1.0,20/51,26.83%,CERS6;SPTLC1;ASAH2;FUT7;PNPLA1;ABCA12;ALOX12B;ASAH2B;ALOXE3;SPTLC2;SMPD2;ACER2;SPTSSB;FUT6;CLN6;FUT5;DEGS2;CERS2;GBA;CYP4F22
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.3349918390368064,1.1049192482663843,0.23529411764705882,0.4267177011483501,1.0,4/16,12.44%,AGTR1;ECE1;AVPR1A;AVPR2
prerank,regulation of telomerase activity (GO:0051972),-0.3274865659441326,-1.1047663573231725,0.3,0.6995197140785692,1.0,8/46,9.99%,MYC;NEK2;DKC1;AURKB;MAPK15;GRHL2;NAF1;PARP4
prerank,zymogen activation (GO:0031638),-0.32776306790749854,-1.1044713416222214,0.34615384615384615,0.6991838012311391,1.0,9/36,21.64%,PLAU;F12;RIPK2;CTSH;F11;PERP;PRSS3;IFI16;ASPH
prerank,respiratory system development (GO:0060541),-0.32759899436388934,-1.1043469987661365,0.3170731707317073,0.6985206232328074,1.0,9/35,14.74%,STRA6;SHH;WNT7B;CHD7;PROX1;CEBPA;RBP4;DNAAF1;CHI3L1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.31338939775379265,1.1037400299298772,0.34782608695652173,0.4287245749868821,1.0,15/44,13.07%,TPM1;FOXF1;HEY1;HAND1;TGFBR3;BMPR1A;RBPJ;SMAD7;MYL2;FGFR2;NPY2R;CPE;MEF2C;MYL3;HEY2
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.2788764201348807,1.1024494159523346,0.25,0.43049312821338614,1.0,12/39,14.38%,MAPK1;CADM4;CALM1;INPP5K;TRIM6;SIRT2;SMAD7;CALM2;APP;PARD3;PRKAG2;S1PR2
prerank,negative regulation of gene expression (GO:0010629),0.19321895527780097,1.1024170743454318,0.0,0.4300403937953378,1.0,65/308,13.83%,PHF1;TCEAL1;ATP2B4;PSEN1;CD34;CITED2;CLDN5;CILP;SYT11;MAPT;NPTN;PTBP2;EMILIN1;SAMD4A;FLCN;FGF2;ZNF540;TRIM6;HAND2;KAT2B;TARDBP;DAPK1;DAPK3;ATOH8;SLC24A3;OCLN;ZFP36;PGR;ASB1;BMPR1A;RBM4;GPER1;ID2;TWSG1;BTG2;PDGFB;NUDT16;PRKAA2;IGFBP5;SFRP1;DXO;CREBZF;EIF4ENIF1;GPNMB;RBMS3;MYADM;APP;MAP2K2;HINFP;MECP2;GATA2;NKX3-1;SMO;MPHOSPH8;MEF2C;TSC1;METTL3;OLFM1;HEY2;FLOT2;PTGER4;ZC3H10;NFKB1;RNH1;PCIF1
prerank,regulation of cell cycle phase transition (GO:1901987),-0.28606293362336194,-1.101425761567383,0.25882352941176473,0.7067091218134717,1.0,14/94,10.22%,DBF4;UBD;MAD2L1;CDK1;GTSE1;UBE2C;FBXO5;PSMB9;PSMD14;TFAP4;UBE2S;SIX3;ANAPC1;PLK1
prerank,DNA modification (GO:0006304),-0.3715669532557151,-1.0993118886119648,0.2923076923076923,0.7122656521415103,1.0,7/24,20.33%,NEIL3;PARP2;EXOSC3;EXOSC4;EXOSC5;UNG;NTHL1
prerank,protein complex oligomerization (GO:0051259),0.2334601880525766,1.0990035609238642,0.2727272727272727,0.43539333135977454,1.0,24/85,16.33%,RNF112;MPP2;BCL10;NACC2;SNCA;JMJD6;CPSF7;PKD2;ATL2;IKZF4;CUTC;MAT2A;ATL3;ALAD;OXA1L;HGSNAT;LRRC8A;BOK;ATL1;ARC;NINJ1;TMEM120A;MICU1;NOL3
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.37444110753423115,-1.0979548913338835,0.3472222222222222,0.7157940578263264,1.0,10/25,28.65%,IL23A;IL23R;STAT1;IL12B;APOBEC3F;IL12RB1;DTX3L;PTPN22;ZC3H12A;AIM2
prerank,synaptonemal complex organization (GO:0070193),-0.39892479112798684,-1.0968800554726985,0.375,0.7173313492977872,1.0,7/15,31.05%,HORMAD1;TRIP13;SYCE3;SYCP1;RAD21L1;SYCE2;P3H4
prerank,synaptonemal complex assembly (GO:0007130),-0.39892479112798684,-1.0968800554726985,0.375,0.7173313492977872,1.0,7/15,31.05%,HORMAD1;TRIP13;SYCE3;SYCP1;RAD21L1;SYCE2;P3H4
prerank,phosphatidylcholine metabolic process (GO:0046470),0.22462933279685904,1.0968046225921817,0.18181818181818182,0.43915051439848624,1.0,16/69,13.24%,PLA2G5;PLA2G4B;ABHD4;LCAT;ENPP2;NR1H2;TMEM86B;CHKB;SLC27A1;PLA2G4C;CSNK2B;PLA2G6;CSNK2A2;SLC44A2;LPIN1;PLA2G1B
prerank,positive regulation of cell population proliferation (GO:0008284),-0.2488082868504334,-1.0966857776262147,0.1919191919191919,0.7169933673619799,1.0,113/458,20.77%,MYC;IL11;IRS1;KIF14;OSM;WNT2;ESM1;TDGF1;CXCL5;TBX20;SHH;KIF20B;CSF2;AREG;PDGFRB;TIMP1;RASSF10;TGFB2;LAMC2;SOX4;IL1B;MIF;LEF1;EREG;SAPCD2;TIPIN;E2F1;FGF19;CIAO1;CSNK2A3;PAX2;FN1;MAZ;FBXO5;WNT5A;CTSH;CEACAM6;GDF9;RTKN2;SOX9;SPDYA;EPHA1;IL12RB2;CALR;HMGA2;BST2;MAPK15;PKHD1;PROX1;IL21;CD81;IGF1R;CXCR2;EPGN;STAT1;IL7R;PRAME;PRLR;CDK4;FGF20;BAMBI;RELA;ITGAX;TSHR;FOXM1;NOX1;WDR77;ZBED9;FGF3;MCTS1;CDC7;THBS1;AGT;TERT;TGFB1;PROK2;KDR;ADAM10;SSR1;ROMO1;MATK;TGFBR2;F2R;IFNG;CR1;FGF23;BIRC5;MLXIPL;NACC1;REG3A;LIF;ACER2;PHB;STOX1;CD86;FGFR4;MDM2;CHRNA7;NANOG;NOD2;CSNK2A1;SAAL1;CDCA7L;CRLF2;NME1;WNT3A;TNFSF4;INSL4;PRC1;EGR4;GHRHR;BMP4;NRG1
prerank,cell-substrate junction assembly (GO:0007044),0.276551892879996,1.0963142796746765,0.25925925925925924,0.43996852271235,1.0,7/32,10.20%,SORBS1;FERMT2;ACTN1;DST;LAMC1;DLC1;WHAMM
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.2255249213840378,1.096242141959218,0.125,0.43969278573378956,1.0,44/139,19.81%,TEAD3;PPARD;NR1D1;WWTR1;CDK9;KAT2B;THRB;HDAC7;TEAD2;PGR;RARB;TEAD1;HDAC5;NR1H2;RBPJ;THRA;RXRG;NRBP1;NPPA;ERCC3;MAML1;NR1D2;RXRA;RXRB;NOTCH4;TBL1X;GTF2H4;RARG;NR4A1;TAF9B;NR4A3;NR1H3;NR2C1;NR3C1;RARA;NR2C2;POLR2A;AR;TAF11;RORA;TAF13;SNW1;RORB;NR1H4
prerank,cellular response to interleukin-1 (GO:0071347),-0.2647330610719381,-1.0962382193808584,0.24468085106382978,0.7173265155506331,1.0,52/149,30.59%,IL1A;CXCL8;IRAK2;IL1B;IL1RN;CCL24;RIPK2;CCL20;EGR1;CCL22;PSMB9;SOX9;PSMD14;ADAMTS12;CCL4;CCL3;RELA;IRAK1;HYAL3;CCL17;NFKBIA;GBP1;PSMA3;CCL26;TAB3;IRAK3;CCL1;ST18;NOD2;XCL2;IKBKG;PSMB3;XCL1;PSMC1;PSMB11;PSMA5;GBP3;PSMB2;CCL5;PSME2;PSMD12;PSMA7;NLRP7;USP10;HAS2;ZC3H12A;PSME4;CCL7;MAPK13;PSME3;MYD88;UBC
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.30249370500422945,-1.0960264683157197,0.2948717948717949,0.716918543423416,1.0,9/41,9.28%,COL1A1;LOXL2;TGFB2;IL1B;LEF1;CRB2;BCL9L;AXIN2;BAMBI
prerank,peptidyl-arginine modification (GO:0018195),-0.3901820305612937,-1.0958017191763532,0.325,0.7166636163922403,1.0,6/15,34.32%,PADI1;PADI3;ART1;PRMT5;PRMT8;PADI4
prerank,regulation of Golgi organization (GO:1903358),0.35853768399657004,1.0958011239121248,0.3333333333333333,0.4401602188032685,1.0,10/16,26.68%,MAPK1;MAPK3;RBSN;MAP2K2;RAB33B;MYO5A;MAP2K1;EHD3;CAMSAP2;STX5
prerank,positive regulation of protein processing (GO:0010954),0.3265898631221525,1.095772801308931,0.2,0.4397226541384994,1.0,4/18,6.70%,GSN;BAG2;CCBE1;CLEC3B
prerank,sensory perception of chemical stimulus (GO:0007606),-0.2807477280806754,-1.0954101285537845,0.3448275862068966,0.7168542606705979,1.0,83/94,59.35%,OBP2B;OR6A2;OR10A5;OR2D2;DRD2;OBP2A;OR51B5;GFY;OMP;OR5B21;OR5M11;OR8D4;OR51I2;UGT2A1;OR51M1;OR8B12;OR52D1;OR4D1;OR51I1;OR51B6;OR1Q1;ADCY3;OR2S2;OR1D2;OR8B2;OR52A1;OR8B3;OR1D5;OR8A1;OR9Q2;OR1D4;OR8B8;OR1E2;OR8G1;OR5AK2;OR10A3;OR9I1;OR8D2;OR10J1;OR5AN1;OR3A2;OR2M4;OR5M1;OR5M10;OR8B4;OR1C1;OR9Q1;OR9G4;OR6C2;OR51B4;OR5B12;OR6C3;OR8D1;OR52A5;UBR3;OR5L1;OR8H2;OR5B3;OR5B17;OR51V1;OR5D18;OR8H3;OR5AP2;OR5D16;OR8K3;OR8H1;OR5M8;OR5D14;OR5M9;OR8U1;OR5I1;OR8K1;OR5AC2;OR5L2;OR5D13;OR8J3;OR8I2;OR8G5;OR5M3;OR5F1;OR8K5;OR5B2;OR8J1
prerank,positive regulation of proteolysis (GO:0045862),-0.3099418997906685,-1.0953813824216516,0.3333333333333333,0.7158934833316106,1.0,19/54,25.34%,PRSS22;IL1B;CTSH;PLK1;ASTL;TNFRSF1B;PERP;NKD2;IFNG;ADAM9;CTSC;ADAM8;FGFR4;CLN6;HDAC2;ASPH;TNF;STUB1;GBA
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3982331157787278,-1.0951473231309796,0.38235294117647056,0.7156915322730684,1.0,12/18,37.21%,CD81;PCSK9;RNF128;MSN;CTSC;VPS35;GBA;EZR;AMER1;FAF1;VGLL4;HSP90AA1
prerank,regulation of neuron differentiation (GO:0045664),0.25196475668157087,1.0947917373457998,0.3125,0.44099925442654336,1.0,25/75,19.66%,FGFR1;HEY1;NGF;ZC4H2;HOXD3;RHOA;PCP4;ID2;GPRC5B;NLGN1;NBL1;MMD;ADRA2B;MEF2C;NTF3;KCTD11;MMD2;CASZ1;SIN3A;TIAM1;DLL1;CNTN4;HEYL;SOX2;CDK5RAP3
prerank,regulation of presynapse organization (GO:0099174),0.32353899175574347,1.0943753719233755,0.19444444444444445,0.44072575092348926,1.0,8/18,18.90%,SNCA;SLITRK2;SLITRK3;APP;GPC4;LRFN5;MDGA1;GPC6
prerank,regulation of presynapse assembly (GO:1905606),0.32353899175574347,1.0943753719233755,0.19444444444444445,0.44072575092348926,1.0,8/18,18.90%,SNCA;SLITRK2;SLITRK3;APP;GPC4;LRFN5;MDGA1;GPC6
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.31059029961321916,1.0943307984479282,0.3333333333333333,0.4402895448900721,1.0,7/17,15.57%,VAMP2;AKAP6;NPPA;KCNE2;KCNE4;RNF207;ANK3
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.24995150648098924,-1.0943262018563897,0.24742268041237114,0.7171913838415805,1.0,91/330,23.90%,ETV4;IL1A;CEBPB;COL1A1;INHBA;SHH;LOXL2;TGFB2;IL1B;MIF;LEF1;EREG;CXCR4;FOXD1;SERPINE1;CYP27B1;PAX2;IL23A;HCAR2;FBXO5;WNT5A;SOX9;CLEC6A;ZBED2;CRB2;DIO2;BCL9L;CAV1;LCN2;IL17F;IL21;SIX1;IGF1R;SYK;FOXA2;AXIN2;SCD;SORL1;PIK3CG;OXTR;PRLR;IL12B;BAMBI;PAX8;TRPM8;APELA;ITGAX;TSHR;MED1;UCP1;PPIB;BATF;ALOX12B;AGT;PLA2G3;TERT;TGFB1;ITK;PAXIP1;IL10;RPS19;TGFBR2;HCRT;F2R;IFNG;CARD9;HLA-G;KSR2;IL26;IL20;ALMS1;LHX1;TNFSF4;RIF1;PIK3CD;GHRHR;BMP4;EGF;IFI16;GAPDH;CRTAM;MDK;TBX5;TRPV2;NFAM1;LBP;GHSR;NODAL;TNF;EZH2;GLMN
prerank,cellular response to fatty acid (GO:0071398),-0.3923327003189778,-1.0943152626099428,0.34615384615384615,0.7162342529336047,1.0,5/17,11.63%,IRS1;DGAT2;AKR1C4;FFAR2;UCP1
prerank,protein export from nucleus (GO:0006611),-0.3515927996480097,-1.0939506977450004,0.3888888888888889,0.7162735836708528,1.0,8/26,19.97%,CSE1L;CALR;XPO5;RANBP17;TGFB1;DUSP16;XPO4;RAN
prerank,protein targeting to lysosome (GO:0006622),0.3003183674862935,1.0936721566449379,0.36363636363636365,0.44135224419156976,1.0,6/20,18.17%,CLU;GGA3;VPS4A;HSPA8;NCOA4;SCARB2
prerank,regulation of chromosome organization (GO:0033044),-0.36345898307650054,-1.0936171102269618,0.3582089552238806,0.7162827322324794,1.0,10/21,33.93%,MYC;RMI2;BUB1;CDT1;SMG1;XRCC5;PIF1;HDAC8;CENPV;SHCBP1L
prerank,mitotic spindle assembly (GO:0090307),-0.3312462637789303,-1.093490867636213,0.2894736842105263,0.7156712986248628,1.0,23/40,39.28%,KIF23;KIF2A;CHEK2;RACGAP1;AURKB;KIF4B;TPX2;MZT1;KIF3B;SMC1A;PRC1;PIBF1;STAG1;KIFC1;KIF4A;KPNB1;STAG2;MISP;SMC3;OFD1;BCCIP;KIF11;SPICE1
prerank,eosinophil chemotaxis (GO:0048245),0.3449258299218746,1.0934204405298265,0.2857142857142857,0.44080327974605543,1.0,8/15,13.78%,LGALS3;CCL21;SCG2;CCL2;CX3CL1;CCL11;CCL13;CCL8
prerank,eosinophil migration (GO:0072677),0.3449258299218746,1.0934204405298265,0.2857142857142857,0.44080327974605543,1.0,8/15,13.78%,LGALS3;CCL21;SCG2;CCL2;CX3CL1;CCL11;CCL13;CCL8
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.3098635095274545,-1.0931877703460386,0.35135135135135137,0.7155113689903546,1.0,11/54,12.58%,DPEP1;IFI6;LAMP3;PAX2;NAIP;CD44;XIAP;BCL2L12;MMP9;PLAUR;THBS1
prerank,regulation of mitotic cell cycle (GO:0007346),-0.26544315371805244,-1.092891370075657,0.26595744680851063,0.7156313481745759,1.0,45/177,24.04%,TP73;UBD;KIF20B;MAD2L1;MCIDAS;CDK1;NEK2;DLGAP5;CDC25C;CKS2;UBE2C;FBXO5;PSMB9;PSMD14;TFAP4;PKMYT1;CKS1B;UBE2S;ASAH2;ANAPC1;NEK6;RCC1;PLK1;PTPN3;RFPL1;TGFB1;PDXP;IL10;EIF4E;RNF40;PSMA3;CDC20;MDM2;MKI67;BRINP2;FBXO43;CDK11B;BUB1B;PSMB3;EIF4EBP1;CDC26;BTG4;PSMC1;PSMB11;PSMA5
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.2977768761561368,-1.0928058672161234,0.2535211267605634,0.7148041863957999,1.0,19/53,27.31%,IL1RN;TRAIP;ISG15;NLRC5;ZNF675;USP18;PALM3;ARG1;OAS3;IRAK3;PTPN2;PPARG;IL36RN;DCST1;CARD16;SAMHD1;PARP14;TTLL12;RNF113A
prerank,transition metal ion transport (GO:0000041),-0.3360652235801126,-1.0922806626129093,0.4,0.715352772064881,1.0,18/34,37.33%,TFR2;HEPHL1;ATP7B;TRPC5;SLC11A2;SLC39A8;ATP2C1;SLC31A1;TRPC7;SLC39A2;SLC30A5;LTF;ATP2C2;SLC30A1;ATP7A;SLC30A9;FTH1;SLC31A2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.2731663713382324,-1.0920820280247936,0.35802469135802467,0.7149656237909505,1.0,23/111,16.22%,GNL3L;CSF2;ERCC5;FERMT1;USP50;MMP1;GBP5;SKAP1;RPA3;MMP3;ISG15;CAPG;SYK;AJUBA;IL5;CDT1;GTF2H2;BIK;TGFB1;ATR;TTBK1;PLEK;IFNG
prerank,polyol biosynthetic process (GO:0046173),0.35832564273629464,1.092063140070415,0.25,0.44284928207739277,1.0,6/16,13.74%,ITPKB;FGF2;IP6K1;IP6K3;ISYNA1;CYP27A1
prerank,DNA packaging (GO:0006323),-0.41316980241685053,-1.0913132401908643,0.3880597014925373,0.7163559715524127,1.0,2/15,1.65%,CHAF1B;CHAF1A
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.25659473422342155,1.0911243041608973,0.30434782608695654,0.44450064528280403,1.0,11/31,21.82%,LCAT;CHKB;SLC27A1;CSNK2B;CSNK2A2;SLC44A2;LPIN1;PCYT1A;ABHD3;LPIN3;ACHE
prerank,outflow tract septum morphogenesis (GO:0003148),-0.3496192484285517,-1.0910488766450972,0.3150684931506849,0.716275710282463,1.0,6/25,9.87%,TBX20;TGFB2;ROBO2;ENG;LRP2;GATA6
prerank,organonitrogen compound catabolic process (GO:1901565),0.24863179058570328,1.0894107063960263,0.3333333333333333,0.44750014179041986,1.0,14/61,11.41%,PLA2G5;CPQ;ENPP2;MTOR;LNPEP;GNPDA2;RENBP;ELANE;TPP1;PLA2G6;LRSAM1;LVRN;CAPN3;NAALADL1
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.3704877784893217,-1.0893039664595832,0.35,0.7206785782128958,1.0,9/22,27.63%,WNT5A;SLC7A5;FFAR2;IL10;TNFRSF1B;NOD2;TNF;SCIMP;CLC
prerank,negative regulation of multicellular organismal process (GO:0051241),0.20421772489616855,1.088779285180218,0.2,0.44818118549287794,1.0,61/207,17.31%,RGS2;ATP2B4;NR1D1;PTEN;ATF4;SYT11;HEY1;TFE3;NPTN;NOVA1;MYOCD;FLCN;SPRY1;CORO1C;ALDH1A1;SRF;MAP2K6;ARNTL;IFNGR1;PLCL1;LNPEP;ASB1;NR1H2;RBPJ;DAB2IP;IP6K1;TWSG1;SMAD7;ABHD6;PARP3;IL17RD;EGFR;SFRP1;LAMA4;GPNMB;NPR3;RAB11FIP3;EVL;WWC3;ADM;NKX3-1;MEF2C;HEY2;PTGER4;VASN;ADAMTS5;BBS2;IL15;INS;PFN2;RGCC;PTPN23;RHEB;DDIT3;TRPV3;NOVA2;NR1H3;GAS6;SFRP2;KLF7;WNT10B
prerank,regulation of defense response (GO:0031347),-0.27815185886042115,-1.087984101313102,0.2558139534883721,0.7236559041731736,1.0,26/81,30.41%,LRP8;WNT5A;PIK3AP1;ADAMTS12;XIAP;USP18;RELA;BCL6;IL1RL2;SETD6;ZBP1;NOD2;NLRP6;IL20;TNFSF4;ERAP1;ACE2;XCL1;TKFC;ANXA1;SAMHD1;IL37;PTPN22;SEMA7A;SPATA2;MYD88
prerank,skeletal system morphogenesis (GO:0048705),0.2832569357432823,1.087967487680764,0.4,0.4494322163098732,1.0,14/39,14.10%,FGFR1;HOXD3;HOXD9;PDGFRA;HOXC4;HOXA4;FGFR2;HOXD4;MEGF8;HOXB4;OSR2;CYP26B1;SKI;DSCAML1
prerank,regulation of neuron death (GO:1901214),-0.27843311122633463,-1.0878489148162083,0.3424657534246575,0.7229440180938276,1.0,31/84,27.50%,GRIN2B;KIF14;EGR1;FOS;WNT5A;SORL1;PCSK9;HLA-F;SULT1A3;FYN;TNFRSF1B;TRIM2;IFNG;CDK5;CHRNA7;TRAF2;ITGB2;ATP13A2;IKBKG;GRM4;GSK3B;TYROBP;PM20D1;KIR3DL2;VPS35;REST;GBA;CCL5;SIGMAR1;GPR75;DHCR24
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.2788875544150871,1.0877650996139658,0.28,0.44919610296461204,1.0,17/32,26.71%,TCF21;HDAC6;PKN1;PRMT2;RNF14;SFRP1;SAFB2;TRIM68;AR;HEYL;EP300;KLK3;SIRT1;DDX5;FOXP1;KDM5D;KLK2
prerank,regulation of immunoglobulin production (GO:0002637),-0.3477367440254719,-1.0876655099461991,0.3561643835616438,0.7226283051300693,1.0,8/28,19.94%,EPHB2;IL21;RBP4;IL10;CR1;PHB;CD86;TNFSF4
prerank,positive regulation of biomineral tissue development (GO:0070169),0.2680802439895475,1.0874874401807506,0.32142857142857145,0.44918862060117587,1.0,11/39,13.13%,PTN;GPM6B;OSR1;WNT6;P2RX7;BMPR1A;KL;PKDCC;SLC8A1;MEF2C;OSR2
prerank,cellular glucose homeostasis (GO:0001678),0.265847676075766,1.0862290373375751,0.2,0.45127725796378065,1.0,10/42,11.66%,NR1D1;KCNB1;CARTPT;NGFR;PIK3R1;GPER1;PRKACA;PRKAA2;HK2;LRRC8A
prerank,sulfur amino acid metabolic process (GO:0000096),-0.3713858546408889,-1.0860540416915168,0.32894736842105265,0.7264661750621039,1.0,4/23,7.67%,DPEP1;MAT1A;MTHFD1;AHCY
prerank,positive regulation of protein catabolic process (GO:0045732),-0.2866450943318564,-1.0858544466554465,0.275,0.7259891857321038,1.0,31/83,31.03%,IL1B;CSNK2A3;TNFAIP3;ASB9;WNT5A;C4BPA;HECW1;HECW2;OAZ3;SORL1;C4BPB;TNFRSF1B;MSN;IFNG;ADAM9;ADAM8;CSNK2A1;BARD1;GSK3B;TNF;VPS35;AXIN1;IDE;ITCH;APC2;EZR;DTL;HUWE1;GPLD1;NSF;NKD1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.28433775697595537,-1.0857677250627316,0.3411764705882353,0.7252682059123451,1.0,32/78,37.35%,PSMB9;CALR;PSMD14;FCGR1A;HLA-F;PDIA3;TAP1;NCF2;PSMA3;CYBA;CYBB;HLA-G;IKBKG;PSMB3;PSMC1;PSMB11;PSMA5;PSMB2;PSME2;PSMD12;PSMA7;VAMP8;PSME4;PSME3;NCF1;PSMD1;FCER1G;TAP2;TAPBP;MFSD6;PSMC4;CHUK
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.24565373939082552,1.085352072168506,0.2631578947368421,0.45254188361583136,1.0,20/60,18.19%,FLNA;LPAR1;ADCY5;PDE2A;AKAP12;GABBR1;ADCY4;GNAI2;CHRM2;P2RY12;CORT;GNAI1;RGS1;ADCY9;ADCY2;NPY1R;ADCY6;CHRM3;GNAL;HTR4
prerank,RNA export from nucleus (GO:0006405),-0.28609911164604696,-1.0845863177090322,0.35555555555555557,0.7280083871607732,1.0,53/103,38.22%,ZC3H11A;NUP62CL;U2AF1;NUP155;THOC3;NUP37;XPO5;NUP210;CPSF3;NUP107;RANBP2;MAGOHB;NUP35;NUP50;SEH1L;NCBP1;NUP205;EIF4E;NUP88;SRSF9;ALYREF;NUP93;POM121;RAN;RAE1;NXF3;MAGOH;CPSF2;GLE1;NUP43;NUP160;NUP153;NDC1;DDX39A;SMG1;CPSF4;NXT1;THOC2;NUP62;NUP98;SEC13;SLBP;AGFG1;RBM8A;EIF4A3;THOC6;NUP214;CDC40;FIP1L1;SMG7;POM121L2;SMG6;TPR
prerank,cellular response to oxidative stress (GO:0034599),0.23000931769947647,1.084170961312741,0.2727272727272727,0.4546220118962442,1.0,23/123,10.72%,TPM1;ATF4;MAPK1;MAPK3;MAPT;SNCA;MAPK8;SIRT2;DAPK1;STX2;ARNTL;PKD2;PRKCD;CCS;PDGFRA;PXN;HMOX1;PRKAA2;SOD1;PRKD1;EGFR;PRDX6;ARNT
prerank,protein K63-linked ubiquitination (GO:0070534),0.2547621283970151,1.083924551400502,0.23809523809523808,0.45458573268246294,1.0,13/43,19.10%,UBE2D4;UBE2G1;PELI3;TRAF1;TRIM21;ZFP91;RNF4;RNF115;UBE2B;UBE2V1;RNF135;RNF152;MAGEL2
prerank,gluconeogenesis (GO:0006094),0.2558149983932771,1.0821398482073172,0.17391304347826086,0.4576114676723961,1.0,8/39,12.93%,ENO2;ATF4;SLC25A12;CRTC2;ALDOA;MDH1;PGM1;CRY1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.23143294207319154,1.0821347924995621,0.30434782608695654,0.45709613944303523,1.0,13/66,11.32%,CAMK2G;IRF2;NCAM1;GBP2;IFNGR1;PRKCD;OAS1;B2M;TRIM21;MID1;JAK1;CAMK2D;TRIM34
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.3803886802023951,-1.081946561223663,0.3142857142857143,0.7348508839489073,1.0,7/20,22.76%,FOXP3;SOX4;IL1B;DIP2B;PAXIP1;BRCA1;RUVBL2
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.3087184435964053,1.081922818407444,0.3076923076923077,0.4570798295656122,1.0,4/19,6.79%,CLDN5;MYO1C;OCLN;PRKACA
prerank,vascular transport (GO:0010232),0.21280701547149936,1.0817906310146803,0.18181818181818182,0.45683751105951026,1.0,19/84,13.51%,SLC2A4;ATP2B4;ATP1B2;KCNJ8;ATP1A2;SLC29A1;SLC16A12;SLC24A3;SLC7A2;SLC16A2;SLC8A2;SLC27A1;ABCC5;AVPR1A;SLC6A17;ABCG2;ABCC9;SLC38A2;SLC6A9
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.30953805696331776,1.0811299989241803,0.3333333333333333,0.457927906810152,1.0,7/17,17.55%,CLIC4;MTCL1;DLG2;PARD3;SYNJ2BP;LRRC7;PARD3B
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.316552695073678,1.0809092684517665,0.2631578947368421,0.457775396240686,1.0,9/18,25.33%,HSPB1;MAPK7;INS;NME5;NOL3;SIRT1;NFE2L2;SOD2;PINK1
prerank,defense response to fungus (GO:0050832),-0.35554771935017054,-1.080651730006764,0.3888888888888889,0.7379902815024421,1.0,11/23,32.37%,CLEC6A;RNASE7;CARD9;IL36RN;GAPDH;CLEC7A;LTF;RNASE8;NLRP10;CLEC4D;CX3CR1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.24455029190390531,1.0805474241045616,0.24,0.4580512704302,1.0,19/55,17.99%,MAPK8;VPS11;ABLIM3;LEPROT;YWHAZ;SAE1;RHOU;BAP1;CSNK2A2;HSPA1L;BCL2;BAD;TOMM7;SH3GLB1;RNF31;UBE2D3;PPP3CC;ATG13;NMT1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.31971648327193936,1.0805433541864595,0.24,0.4575614122193473,1.0,5/20,9.01%,MFN2;SPRY1;LZTR1;DAB2IP;MAPKAP1
prerank,epithelium development (GO:0060429),-0.2690063090826507,-1.080532783386449,0.3614457831325301,0.7372761381191448,1.0,34/117,20.68%,WNT2;SHH;CDK1;WNT7B;TRIM71;PAX2;UPK3A;ACTL8;TIMELESS;SOX9;MTHFD1;PROX1;TAGLN;SIX1;GRHL2;STAT1;UPK2;PAX8;GATA6;APELA;EHF;ANXA4;RIPK4;TGFB1;PTCH1;KDR;KRT3;PTER;DLX3;LHX1;VDAC1;DMBT1;WNT3;PPARG
prerank,regulation of cell-cell adhesion (GO:0022407),0.27062318136759567,1.0804814711775417,0.3181818181818182,0.4572524746295504,1.0,10/41,13.11%,EPHA7;CITED2;FSTL3;MEGF10;EFNA5;SMAD7;CEACAM1;DPP4;TENM3;FLOT2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.37001480915059437,-1.080265860495447,0.34285714285714286,0.7370804551607107,1.0,12/24,33.53%,IRAK2;RIPK2;TNFAIP3;IRAK1;TAB3;NOD2;IKBKG;ITCH;RNF34;UBC;UBE2N;TRAF6
prerank,protein methylation (GO:0006479),-0.33476838013428545,-1.0799225510069037,0.34615384615384615,0.7372453741309813,1.0,16/34,34.04%,PRMT3;EEF2KMT;CAMKMT;NTMT1;METTL21C;CTCFL;CARM1;EZH2;NSD1;SNRPB;METTL21A;SNRPD3;GSPT1;PRMT6;PRMT5;PRMT8
prerank,cellular response to osmotic stress (GO:0071470),0.3182305565562733,1.0793445354277038,0.25925925925925924,0.4597059651159945,1.0,5/22,5.08%,MYLK;AQP1;ZFP36L1;YBX3;PKD2
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.3650949653805814,-1.0790829112112026,0.36764705882352944,0.7385371067741945,1.0,9/19,26.67%,AMELX;RUNX1;TGFB1;SUCO;F2R;BMP4;HDAC2;WNT4;CREB3L1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.2925197582309129,-1.0789112384384552,0.3614457831325301,0.7381658123516629,1.0,23/63,35.21%,POLR2F;CCNK;CDK7;CDK12;EAF1;GTF2H2;MLLT3;NCBP1;POLR2J;NELFCD;POLR2D;POLR2I;GTF2H3;EAF2;CCNH;LEO1;CDC73;ADRM1;GTF2F2;ERCC2;CDK13;CTR9;SSRP1
prerank,iron ion homeostasis (GO:0055072),0.2505921189733089,1.0782325590563513,0.34615384615384615,0.4616381382453431,1.0,13/58,11.81%,SLC22A17;ISCU;SCARA5;CYBRD1;SKP1;FBXL5;HMOX1;NEDD8;SOD1;B2M;SMAD4;BDH2;ABCG2
prerank,negative regulation of defense response (GO:0031348),0.22976703166237408,1.0776672457350147,0.3333333333333333,0.4623114316172069,1.0,17/79,10.81%,PPARD;NR1D1;TRAFD1;SIRT2;MAPK7;PTGIS;PRKCD;GPER1;C1QTNF3;MUL1;ELANE;CDH5;TRIM21;DHX58;GPS2;FNDC4;TNFRSF1A
prerank,endocardial cushion development (GO:0003197),-0.36639199047526216,-1.0776658024623595,0.3382352941176471,0.7408094459589387,1.0,4/21,5.28%,TBX20;TGFB2;SOX9;ENG
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.34293427189469333,-1.0768154555417293,0.40298507462686567,0.7425941546879777,1.0,12/24,34.27%,IL1A;IL1B;C3;NOX1;TGFB1;EIF2AK3;BRCA1;NODAL;HPSE;SULF2;HIF1A;GATA4
prerank,positive regulation of glycolytic process (GO:0045821),-0.370830503073141,-1.0766749335439034,0.38028169014084506,0.7409662482756313,1.0,7/20,18.13%,PFKFB3;GAPDHS;PFKFB4;ZBTB20;IFNG;MLXIPL;PFKFB1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.370830503073141,-1.0766749335439034,0.38028169014084506,0.7409662482756313,1.0,7/20,18.13%,PFKFB3;GAPDHS;PFKFB4;ZBTB20;IFNG;MLXIPL;PFKFB1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.33520447275314086,1.0765884571827633,0.3548387096774194,0.46446019038228303,1.0,6/22,9.58%,DVL3;SASH1;DVL2;DAB2IP;TLR9;DUSP19
prerank,positive regulation of organelle assembly (GO:1902117),-0.3167129632932778,-1.0761133144754358,0.3924050632911392,0.7417410603117214,1.0,16/44,30.81%,CSF2;SAXO1;SPAG5;GPSM2;CAPG;IL5;G3BP1;CNOT1;PLK4;SDC1;TNF;LCP1;NUP62;RAB3GAP2;DYNC1H1;CNOT6
prerank,protein targeting (GO:0006605),0.19906080644458296,1.0756466877750674,0.14285714285714285,0.46575474619759194,1.0,45/122,22.88%,NACAD;MFN2;MICALL1;MYO1C;AKAP6;ZDHHC7;ZDHHC15;HAP1;ZDHHC22;PEX19;ZFAND2B;TRAK2;NLGN1;ZDHHC18;MGARP;PARD3;AIP;GABARAP;GOLGA7;TOMM7;VPS37D;HOMER3;TAOK2;VPS37A;TIMM44;ARL6;MFF;RTP5;ZDHHC1;TIMM22;RASSF9;SRP14;PEX6;ZDHHC20;PITRM1;AP4S1;MAN1A1;ZDHHC11;NACA;FBXO7;SDCBP;ZFAND6;RTP1;PEX12;SPCS3
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.22583189723573865,1.0750082564564434,0.2,0.4668454714013785,1.0,23/109,13.78%,DMPK;ATP2B4;CCL14;SLC39A13;STIM1;NPTN;TPCN2;SLC24A3;MT1X;ANK2;SLC41A1;PTH1R;ELANE;SLC8A2;CDH5;RGN;MT1M;ATP2A2;MT3;SLC8A1;CCL11;CCL13;CCL8
prerank,negative regulation of response to external stimulus (GO:0032102),0.20770176391183473,1.07477876789285,0.2857142857142857,0.4667293728063684,1.0,22/111,10.81%,PPARD;NR1D1;PTEN;TRAFD1;FGF2;PTPRS;SIRT2;MAPK7;DUSP3;PTGIS;PRKCD;EPHA4;GPER1;C1QTNF3;MUL1;ELANE;CDH5;TRIM21;DHX58;GPS2;FNDC4;TNFRSF1A
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.2703598191652946,1.074224674615489,0.391304347826087,0.46746013726169106,1.0,10/40,13.37%,ATP2B4;CLU;CD34;RAC1;PKD2;PTGIS;CD36;KLF2;SMAD3;JAK2
prerank,regulation of intracellular signal transduction (GO:1902531),0.1804331652902252,1.0731920082431312,0.0,0.4693465167915052,1.0,74/426,11.30%,ARHGEF26;PTEN;PIP5K1C;RASD2;PPP2R5B;MAPK1;OPTN;SYDE1;PDE2A;PRKAB2;RHOB;ARHGAP10;AKAP12;RHOJ;MAPK3;ARHGAP6;MAPT;HSPB1;FBXO9;ARHGEF17;ARHGAP33;MYOC;RRAS;FLCN;PJA2;TRIM6;TRIP10;RAC1;STARD8;FAM83D;MAPK14;MAP2K6;MTOR;PRKAR2B;STARD13;AKAP6;USP2;PRDM11;JMY;ARHGEF18;RHOA;ARHGEF6;PIP4K2B;DAB2IP;RHOQ;MAPK11;F2RL1;PRKAA2;GNA12;DLC1;TRAF1;RHOT2;FGF1;ARHGAP20;RHOC;ANKRD54;ARHGAP23;MAPKAP1;CEACAM1;RGN;CHD3;ARHGAP1;ZNF385A;EGFR;NLGN1;RHOU;CSNK2B;PIDD1;ARHGAP19;CSNK2A2;PIN1;ARHGEF9;CAPN3;INPP5B
prerank,cellular senescence (GO:0090398),-0.34809067266644134,-1.0729900376302541,0.38571428571428573,0.7504636138631899,1.0,5/24,4.90%,HMGA1;PML;CDKN2A;CALR;HMGA2
prerank,sodium ion transmembrane transport (GO:0035725),0.23799254544302376,1.0722854992998092,0.2777777777777778,0.4705840613743925,1.0,26/86,15.40%,ASIC3;SCNN1D;ATP1B2;SCN7A;ATP1A2;SCNN1B;PKD2;SLC9A9;SCN3B;SLC24A3;SCN2B;SCN1B;SLC8A2;SCNN1G;SCN11A;ATP1A3;SLC6A16;SCN9A;SCN4B;SLC6A17;SLC8A1;SLC6A9;SCN4A;SLC6A8;HCN3;SLC6A15
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.3168145386287297,1.0720953670258413,0.21739130434782608,0.4704421435459157,1.0,8/21,18.30%,PLN;CASQ2;OSR1;SLN;CAMK2D;GOPC;ACTN2;CAB39
prerank,N-glycan processing (GO:0006491),-0.37865861180006216,-1.0718632980184892,0.34782608695652173,0.7525592710015753,1.0,3/19,4.64%,MAN2A1;ST8SIA6;FUT8
prerank,anion transmembrane transport (GO:0098656),-0.29230168978572013,-1.0716338312987468,0.375,0.7521152686012488,1.0,18/67,19.31%,LRRC8E;SLC6A20;SLC7A5;SLC13A4;SLC38A5;SLC7A1;SLC13A5;SLC5A6;LRRC8B;LRRC8D;MFSD12;SLC35A2;SLC39A8;SFXN2;SLC19A1;SLC25A13;SLC25A19;SLC13A3
prerank,macrophage activation (GO:0042116),0.2764708448570308,1.0714344500100177,0.30434782608695654,0.4714983044955688,1.0,9/36,13.37%,CLU;MAPT;SNCA;IFNGR1;CRTC3;APP;CX3CL1;DYSF;JAK2
prerank,monosaccharide transmembrane transport (GO:0015749),-0.3816187815376835,-1.0711171798739296,0.3835616438356164,0.7528897859731818,1.0,2/16,1.59%,SLC5A10;SLC5A2
prerank,endothelial cell migration (GO:0043542),-0.306195192087899,-1.0709098065725196,0.3875,0.7525996963754268,1.0,5/38,7.94%,FAP;LOXL2;S100P;S100A2;STAT1
prerank,lymphocyte migration (GO:0072676),-0.33516503740646203,-1.0705574993315792,0.32051282051282054,0.7525589305449555,1.0,15/36,22.54%,CCL24;CCL20;CCL22;CCL4;CCL3;ZAP70;CCL17;MSN;ADAM8;CCL26;CCL1;XCL2;CRTAM;XCL1;GATA3
prerank,protein localization to nucleus (GO:0034504),-0.2760999576730284,-1.0701380553546578,0.3793103448275862,0.7527760168026546,1.0,27/103,21.58%,COL1A1;NUP62CL;PML;NUP155;CSE1L;CALR;ARL2BP;SIX1;SYK;E2F3;NUP107;PLK1;BMP7;RANBP17;NXT2;WRN;NUP50;RRS1;MMP12;NUP88;MDM2;NUP93;GCKR;POM121;RAN;BMP4;TNPO3
prerank,regulation of cholesterol metabolic process (GO:0090181),0.3156346499672369,1.0700826286964846,0.35714285714285715,0.47385936791641914,1.0,12/21,26.61%,FMO5;ACADVL;GNB3;SREBF1;CES1;EPHX2;NR1H4;ARV1;ABCA2;ACADL;MBTPS1;APOE
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.2204751811801926,1.070045612313561,0.25,0.47342659866646886,1.0,16/78,14.27%,CIRBP;CLU;SAMD4A;CASP3;MTOR;LARP6;IFNGR1;PRKCD;EPHA4;POLDIP3;PLA2G6;TNFRSF1A;METTL3;VIM;PCIF1;SIRT3
prerank,regulation of vasoconstriction (GO:0019229),0.30461530013011645,1.0692704007889127,0.38461538461538464,0.4745644290466077,1.0,10/27,18.66%,AGTR1;ECE1;TBXA2R;AVPR1A;ADM;AVPR2;KCNMB4;KCNMB2;CHRM3;ADRA1A
prerank,positive regulation of developmental process (GO:0051094),0.21833657930675565,1.0692668707407664,0.4,0.47404350212119983,1.0,38/166,14.83%,PTN;PSEN1;FGFR1;DCN;SYDE1;FZD4;CORO1C;SRF;DVL3;PLD6;PRL;RAPGEF3;ENPP2;FST;CAMK1;DVL2;BMPR1A;DLG4;PHLDB2;NUMA1;DAB2IP;ZDHHC15;PDGFB;MUL1;RTN4;BMP1;BNIP3;CORO1B;NLGN1;PACSIN1;MIEF2;TAPT1;GDNF;PHLDB1;RALBP1;NRXN1;INS;TFRC
prerank,response to amyloid-beta (GO:1904645),-0.31545640451173973,-1.0690366045710027,0.36585365853658536,0.7556045548369038,1.0,13/44,17.81%,MMP13;ICAM1;CALCR;MMP3;IGF1R;MMP2;FPR2;MMP9;GRM5;FYN;MMP12;CDK5;CHRNA7
prerank,rRNA catabolic process (GO:0016075),-0.40408131490745713,-1.0689069500911408,0.352112676056338,0.7550077140866599,1.0,9/16,31.01%,EXOSC3;EXOSC8;DIS3;EXOSC4;EXOSC5;EXOSC7;XRN1;SLFN14;EXOSC2
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.334416135462273,-1.06879867601221,0.3466666666666667,0.7542888976568836,1.0,14/33,32.03%,CYP51A1;MOCOS;PRLR;CYP19A1;MOCS3;SRD5A1;GPHN;RDH8;GCH1;NOXRED1;HSD3B1;PYCR1;SRD5A2;FDXR
prerank,positive regulation of cellular protein localization (GO:1903829),0.2383113309103884,1.0686786637300933,0.23809523809523808,0.4749796276399723,1.0,16/67,11.08%,FERMT2;WWTR1;SYT11;RIC3;MAPT;NGFR;MAP1A;NUMA1;CROCC;PRKAA2;RTN4;TESK1;GPD1L;NECAB2;SNX33;MARK4
prerank,sphingolipid biosynthetic process (GO:0030148),0.24359336837492196,1.0685269569705251,0.2857142857142857,0.4748780536432475,1.0,20/68,15.03%,HACD1;ELOVL4;ABCA8;SPTLC3;DEGS1;CERS4;A4GALT;SMPD1;HACD4;PRKD1;ST8SIA1;KDSR;VAPA;PPM1L;CERS1;ST3GAL5;PRKD3;ST6GALNAC5;ST8SIA3;SAMD8
prerank,response to metal ion (GO:0010038),-0.2879349653708766,-1.0680248045503102,0.3375,0.7556702667396659,1.0,18/66,18.09%,IL1A;LOXL2;TFR2;SLC30A2;CAV1;AQP9;ATP7B;HOMER1;SLC34A1;KHK;HAMP;THBS1;SLC11A2;GPHN;ALG2;ADAM9;SLC25A13;TTN
prerank,bile acid and bile salt transport (GO:0015721),-0.33887316577297655,-1.0675199887119495,0.3194444444444444,0.7561092369489874,1.0,6/26,11.57%,ABCC11;SLCO1B3;SLC10A1;AKR1C4;ABCC2;SLCO1A2
prerank,positive regulation of cell junction assembly (GO:1901890),0.23532299454426012,1.0673557320497222,0.32,0.4765375798021309,1.0,16/56,14.56%,FERMT2;CLDN5;NLGN2;MYOC;RAC1;COL16A1;SLITRK2;FLOT1;SFRP1;NLGN1;NLGN3;BHLHB9;TSC1;PPM1F;NRXN1;NPHP1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.18083291572412147,1.0673310561224338,0.5,0.4760387606219405,1.0,34/160,15.71%,IGFBP6;WWTR1;DACT3;SOX13;TMEM88;LZTS2;FZD4;DVL3;IGFBP4;LMBR1L;JADE1;DVL2;DAB2IP;NPHP3;LATS2;PSMC5;TLE2;GLI3;TLE1;SFRP1;PFDN5;RBMS3;SFRP5;CSNK1A1;DKK3;ANKRD6;TMEM64;PSMD9;TLE4;TMEM170B;SOX17;FRZB;PSMB6;DDIT3
prerank,plasma membrane invagination (GO:0099024),0.294495646841171,1.0671934943467776,0.36363636363636365,0.4758265484585876,1.0,6/29,10.25%,GSN;RHOA;CD36;GULP1;SNX18;SNX33
prerank,hyaluronan metabolic process (GO:0030212),-0.35635301707152384,-1.0668589066877077,0.3108108108108108,0.7573045162431409,1.0,6/22,16.31%,CEMIP;IL1B;CD44;HYAL3;TGFB1;HEXB
prerank,negative regulation of translation (GO:0017148),-0.2853861217826923,-1.0666876204371056,0.35,0.7567377740155457,1.0,14/85,9.39%,ENC1;IGF2BP1;GZMB;IGF2BP3;PUS7;TRIM71;CALR;DHFR;GRB7;NANOS3;NCL;IGF2BP2;CAPRIN1;MEX3D
prerank,microtubule polymerization (GO:0046785),0.2783288843906906,1.0664585431602809,0.2903225806451613,0.4770627707549604,1.0,10/29,17.72%,MAPT;TUBG2;MAP7D3;TPPP3;TUBGCP6;SLAIN2;PIN1;GOLGA2;NDEL1;TUBGCP2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.1796545492153457,1.0656394363647859,0.3333333333333333,0.47823055456072694,1.0,72/347,16.04%,TGFB1I1;ASB2;UCHL1;RNF150;TRIM9;FBXO10;RNF11;FBXL22;UBE2D4;FBXO8;ZSWIM8;UBE2G1;SIRT2;TSG101;GID4;KCTD2;RNF122;TRIM3;KCTD10;ARNTL;FBXL7;KLHL42;WDR91;RNF130;UBE2E1;ANAPC16;NEDD8;RNF217;UBAP1;RNF185;PSMC5;MYLIP;RNF167;RNF146;UBE2G2;RNF144B;NTAN1;ZFAND2B;RNF216;RNF14;SPSB1;KLHL20;UBL7;ARMC8;UBXN1;HECTD3;KLHL22;FBXW4;RNF4;FBXW5;RNF115;RNF7;FEM1B;UBE3B;PSMD9;UBE2B;UBE2H;TBL1X;VPS4A;VPS28;MVB12B;BTRC;RNF215;PTPN23;UBE4B;PSMB6;VPS37D;DDIT3;APPBP2;VPS37A;KCTD6;KCTD21
prerank,regulation of steroid metabolic process (GO:0019218),0.26114318681453974,1.0654642794201306,0.40625,0.4781479974812899,1.0,11/23,26.61%,FMO5;ACADVL;GNB3;EPHX2;RORA;NR1H4;LAMTOR1;ARV1;ABCA2;ACADL;APOE
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.2753709309497817,1.0653702847802402,0.4,0.4777376085162445,1.0,11/38,16.33%,CLU;MOAP1;TNFSF10;MLLT11;BCL2L11;GPER1;BNIP3;BAD;FAM162A;NOL3;MFF
prerank,regulation of inflammatory response (GO:0050727),-0.254437774442916,-1.065127582945399,0.3548387096774194,0.7605730819871185,1.0,74/198,31.48%,OSM;IL1B;SERPINE1;TNFAIP3;IL23A;AOAH;WNT5A;ZP3;PLA2G7;PIK3AP1;MMP3;ADAMTS12;IL21;CEBPA;PROC;FFAR2;CCL3;FEM1A;FPR2;IL12B;XIAP;USP18;RELA;BCL6;IL1RL2;MMP9;MVK;SETD6;AGT;NLRP12;NFKBIA;IL10;TNFRSF1B;NLRP3;IFNG;ZBP1;CCL1;NOD2;PTPN2;NLRP6;IL20;MEFV;MGST2;MMP8;TNFSF4;PPARG;ACE2;OTULIN;MDK;XCL1;GATA3;NMI;GHSR;TNF;ANXA1;VPS35;GPR31;IL37;GBA;IL13;TLR7;CCL5;DNASE1;NLRP10;TEK;DAGLA;MAPK13;SEMA7A;SPATA2;MYD88;ETS1;DHX9;LPCAT3;IFI35
prerank,positive regulation of reproductive process (GO:2000243),0.26746614627523946,1.064722282318827,0.3333333333333333,0.4786824189360636,1.0,5/35,3.99%,TACR2;CACNA1H;SYDE1;VIP;SIRT2
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.2644900530903006,1.063843216186459,0.35714285714285715,0.48017067960247495,1.0,8/46,6.20%,FLNA;PSEN1;RAPGEF3;BAG3;DMAP1;CAMK1;PRKCD;PIK3R1
prerank,triglyceride catabolic process (GO:0019433),-0.38254672066802975,-1.063598054779095,0.40789473684210525,0.7648507436783477,1.0,4/22,8.14%,FABP6;PNPLA3;LIPG;PNPLA1
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.2542057874764691,-1.0635574847386415,0.37777777777777777,0.7638994410656625,1.0,47/160,22.69%,IRS1;OSM;AREG;PDGFRB;CD80;TRIB3;GDF15;EREG;FGF19;MAZ;PIK3AP1;CALCR;ENG;F7;IGF1R;EPGN;LRP2;PIK3CG;CCL3;MET;FGF20;SEMA5A;ICOS;FGF3;THBS1;TGFB1;FYN;CHI3L1;FGF23;ADAM8;STRN;PHB;CD86;FGFR4;LIN28A;IL26;PIK3CB;OSBPL8;NRG4;PIK3CD;PTPRJ;NRG1;CASS4;EGF;LCK;GATA3;AXL
prerank,microtubule bundle formation (GO:0001578),-0.30418933299344364,-1.0630664161581016,0.358974358974359,0.7643238496187079,1.0,13/41,22.33%,RP1;KIF20A;CFAP74;RP1L1;RSPH9;PLK1;SPAST;LRGUK;TTC26;NCKAP5;PSRC1;RSPH6A;CFAP46
prerank,endomembrane system organization (GO:0010256),0.1968580838105297,1.062852932523242,0.2857142857142857,0.4817211044817257,1.0,44/192,16.77%,DMPK;RNF112;SYNGR1;OPTN;CAV2;SEC31B;TJAP1;TBC1D20;VPS11;SUN2;ATL2;OBSL1;SYP;ATP8B2;SUN1;AKTIP;ATL3;A4GALT;PLEKHF1;PRKD1;VAPA;PI4K2A;GORASP1;TICAM2;RAB30;SNX33;LMAN2L;PLEKHM2;MYOF;GOLPH3;CSNK1A1;ATL1;DYSF;GOLGA8A;ANXA8L1;VPS4A;GBF1;LMAN1L;ANK3;CTDNEP1;REEP5;SQSTM1;VPS18;GOLGA2
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.2708872776684341,1.0623132916767382,0.4,0.4824843541151291,1.0,15/38,25.48%,WDR19;IFT81;CLUAP1;IFT46;KIFAP3;IFT80;DYNLRB2;IFT43;IFT172;IFT20;IFT22;DYNLL2;DYNLRB1;WDR35;IFT27
prerank,regulation of peptide hormone secretion (GO:0090276),-0.2868016333501761,-1.0622476564874812,0.37333333333333335,0.7657897026924111,1.0,24/69,26.45%,SSTR5;IL1B;TFR2;KCNG2;CACNA1D;CHD7;SYT7;FFAR2;PAX8;PASK;NOS2;CACNA1E;IFNG;SLC2A1;ITPR2;KCNC2;UQCC2;MTNR1B;HTR2C;HNF4A;TNF;GLP1R;CCL5;KCNJ11
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.3315386604537439,-1.0617859006719894,0.3972602739726027,0.766435570888439,1.0,5/34,2.11%,CEMIP;THY1;NPSR1;CXCL9;CXCL11
prerank,modulation by host of symbiont process (GO:0051851),-0.324511498955942,-1.0617234546250012,0.3424657534246575,0.7655902756748582,1.0,13/32,25.96%,LEF1;HMGA2;CCL4;TFAP4;CCL3;SMARCA4;CARD9;RRP1B;CHD1;HPN;SMARCB1;REST;CCL5
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.2586319218916354,1.0609001487864524,0.3684210526315789,0.4852903803041608,1.0,17/44,19.77%,NPR1;ADCY5;ADCY4;NPR2;NPPC;PANK4;ACAT1;NPPA;ADCY9;NPPB;AK5;ADCY2;ADCY6;AMPD1;SLC26A2;NUDT2;DCAKD
prerank,respiratory tube development (GO:0030323),-0.33243045461519993,-1.060879269343856,0.32,0.7671701924121854,1.0,8/30,14.74%,STRA6;SHH;WNT7B;PROX1;CEBPA;RBP4;DNAAF1;CHI3L1
prerank,hyaluronan catabolic process (GO:0030214),-0.3812400251308228,-1.0608086108339643,0.4225352112676056,0.7663168275338241,1.0,5/17,16.31%,CEMIP;CD44;HYAL3;TGFB1;HEXB
prerank,cellular amino acid catabolic process (GO:0009063),-0.26930592688504446,-1.060808536993706,0.35,0.7652977891993377,1.0,20/88,18.02%,GLS2;IL4I1;GAD1;ACMSD;MAT1A;KYNU;TDO2;IDO1;ALDH5A1;SHMT2;KMO;NOS2;GLDC;HAL;ARG1;UROC1;SDSL;GLUD2;MCCC2;DDAH1
prerank,cellular response to interleukin-12 (GO:0071349),-0.30186038452456465,-1.0599625962787502,0.4266666666666667,0.7668345287622289,1.0,17/46,28.13%,MIF;IL12RB2;IL12B;P4HB;IL10;MSN;IFNG;RALA;SNRPA1;IL12RB1;TALDO1;CAPZA1;HSPA9;PSME2;LCP1;CNN2;TYK2
prerank,lymphocyte proliferation (GO:0046651),-0.3160091121344066,-1.0597471007186643,0.4230769230769231,0.7663199995547039,1.0,24/38,41.66%,IFNK;RASGRP1;HSPD1;PIK3CG;CD70;IL10;MSN;IFNE;ELF4;IFNB1;CR2;TNFRSF4;HELLS;IFNA1;IFNA21;IFNA4;IFNA7;IFNA14;IFNA10;FLT3;IFNA17;CD40LG;IFNA2;IFNA16
prerank,calcium-mediated signaling (GO:0019722),-0.2604235125716458,-1.0595422214039951,0.3902439024390244,0.7659648159631055,1.0,28/101,21.09%,TNFSF11;CXCL8;CCR8;CXCR4;GPR143;CCL20;TRPM2;CXCR5;CXCR2;CCR4;CCL3;FPR2;NUDT4;TNNI3;SULT1A3;CXCR6;CCR3;GRM5;KDR;CXCR1;CCRL2;CXCR3;EIF2AK3;NMUR2;KSR2;PTPRJ;SAMD14;ATP1B1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.31283774263748176,-1.0594488304295655,0.3380281690140845,0.7652486206892279,1.0,15/34,23.36%,TGFB2;EGR1;FOS;SMARCA4;RELA;APLN;GNL3;TERT;TGFB1;IL10;PPARG;SPI1;KLF5;GATA3;TNF
prerank,mitochondrial translational elongation (GO:0070125),-0.27154961163125735,-1.0592219190544339,0.3902439024390244,0.76487725370495,1.0,34/88,34.81%,MRPL19;MRPL3;MRPS18C;GADD45GIP1;GFM2;MRPL17;MRPS16;MRPL13;MRPL48;GFM1;MRPL30;MRPS35;MRPL53;MRPS31;TUFM;MRPL47;MRPL9;MRPS23;MRPL50;MRPL14;MRPL37;MRPL42;DAP3;MRPS12;MRPS22;MRPL15;MRPL57;MRPS30;MRPS18A;MRPL4;MRPS11;MRPL52;MRPS33;MRPL44
prerank,regulation of interleukin-1 production (GO:0032652),-0.3968139631140778,-1.0591135868851753,0.3684210526315789,0.7642106644845994,1.0,6/15,24.18%,NLRP12;IL10;F2R;MEFV;ANXA1;HMGB1
prerank,ribosomal small subunit assembly (GO:0000028),-0.3768144874800531,-1.0590552070864576,0.37333333333333335,0.76337943759584,1.0,6/16,34.09%,PRKDC;RPS19;PWP2;RRP7A;XRCC5;MRPS11
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.2801018207433294,-1.058911884503377,0.40476190476190477,0.7627811970657844,1.0,25/76,24.36%,SLC12A2;SLC5A2;SLC12A8;SLC9C1;KCNJ13;TRPM2;SLC39A10;SLC9A7;TRPV4;SLC24A1;KCNJ15;ATP12A;SLC39A8;KCNJ4;SLC12A3;KCNJ14;SLC12A5;SLC12A1;ATP1B1;HCN4;TRPV2;KCNJ6;SLC5A1;KCNJ18;KCNJ3
prerank,regulation of protein modification process (GO:0031399),0.25128922168069945,1.0575304071198768,0.3333333333333333,0.4926527501567801,1.0,10/47,12.10%,CADM4;HSPB1;CDK9;FLCN;CORO1C;KAT2B;CDH5;ATG14;PIN1;MT3
prerank,base conversion or substitution editing (GO:0016553),0.3172549514423385,1.0574989555554166,0.39285714285714285,0.492143003964516,1.0,5/18,12.98%,ADARB1;NUDT16;APOBEC3C;ADARB2;METTL3
prerank,mRNA stabilization (GO:0048255),0.2919060952827654,1.0572923096117621,0.34615384615384615,0.4919812189481473,1.0,8/37,6.03%,CIRBP;VIP;RBM24;YBX3;TARDBP;MAPK14;TIRAP;ZFP36
prerank,positive regulation of cellular component organization (GO:0051130),0.23266332985703966,1.0571879009426937,0.2857142857142857,0.4916681932003872,1.0,34/108,18.10%,CLIP3;CLU;ADD1;LGALS3;SNCA;RAPGEF3;TRABD2B;TIRAP;CAMK1;BCL2L11;DAB2IP;DCTN1;SMPD1;BNIP3;RHOC;CDH5;FRMPD4;FLOT1;TAL1;PLEKHM2;BRK1;TMEM30A;GPC3;NRXN1;TFRC;PTPN23;MPP7;SH3GLB1;ADGRL1;TGFB3;PPP1R15A;CDC42EP2;DLL1;AR
prerank,inner mitochondrial membrane organization (GO:0007007),-0.3315073975788569,-1.0569653328290873,0.3116883116883117,0.7676426654397058,1.0,14/28,41.32%,TIMM8A;MTX1;ROMO1;UQCC3;APOO;CHCHD6;TIMM10;HSPA9;TIMM13;OPA1;AFG3L2;AGK;TIMM8B;CHCHD3
prerank,protein localization to cilium (GO:0061512),0.27060926154277215,1.0569378419875162,0.3448275862068966,0.49155053123848375,1.0,13/34,20.45%,TUB;TULP3;WDR19;ARL3;BBS1;RABEP1;ARL6;BBS4;IFT20;ATP6V1D;TTC21A;EHD1;RAB29
prerank,protein K11-linked ubiquitination (GO:0070979),-0.3601636893035119,-1.056747205498069,0.36619718309859156,0.7673350475371147,1.0,4/27,8.86%,UBE2T;UBE2C;UBE2S;ANAPC1
prerank,central nervous system development (GO:0007417),-0.24925393643107938,-1.0563261709333964,0.3958333333333333,0.7674604319045357,1.0,61/259,19.63%,GRIN2D;KLK6;GRIN2B;ACAN;POMK;CELSR1;ZIC2;SHH;ZIC5;DMBX1;SOX4;CXCR4;PAX6;POU6F2;C3;SOX9;CHD7;ROBO2;PAFAH1B3;ADGRG1;BCAN;MNX1;PROX1;SHROOM4;CAPG;FOXG1;GRHL2;SIX3;ALDH5A1;PAX8;SCT;SPATA5;MARCKSL1;VAX1;NHLH2;CYP26C1;TBR1;ASIC2;CNTNAP2;PTCH1;VCAN;AMIGO3;ABCB6;NF1;GSX1;SHROOM2;VCX3B;TGFBR2;VCX;PTS;UGT8;NKX2-2;B3GNT5;PBX4;CDK5;NPAS1;SLC2A1;NMUR2;LSR;MYRF;DHX37
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.33606211805110286,-1.0561618028163597,0.4084507042253521,0.7669701853714086,1.0,9/31,21.43%,THY1;SOCS3;SOCS1;CAV1;SEMA4D;PRKCZ;LILRB4;PTPN2;PIBF1
prerank,epithelial cell migration (GO:0010631),-0.2945910407764793,-1.0557441190540413,0.3888888888888889,0.7672699796072573,1.0,6/40,7.94%,FAP;LOXL2;S100P;FERMT1;S100A2;STAT1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.2745778183927765,1.055441964127213,0.22727272727272727,0.49480413457483713,1.0,6/27,9.17%,PRKAB2;WDTC1;ACADVL;NR1H2;PRKAA2;CEACAM1
prerank,regulation of dendrite development (GO:0050773),0.2703691429203736,1.0547080299048053,0.4,0.4957842396825394,1.0,9/39,11.20%,PTN;CHRNA3;SDC2;DBN1;DAB2IP;ADGRB3;ZDHHC15;MARK1;PACSIN1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.31869509926276196,-1.0545523568850614,0.38961038961038963,0.7700237756298732,1.0,8/37,13.80%,GRIN2B;GRM8;HOMER1;GRM7;TRPM1;GRM1;GRIN3B;GRM5
prerank,T cell receptor signaling pathway (GO:0050852),-0.26100613059990796,-1.0541742008713042,0.3763440860215054,0.7702639207110269,1.0,47/154,30.46%,THY1;CARD11;RIPK2;CD276;SKAP1;PSMB9;PSMD14;BTN1A1;VTCN1;RELA;ZAP70;INPP5D;ITK;FYN;LCP2;CD3D;CTLA4;BTNL10;CD3G;TEC;PSMA3;PIK3CB;PRKCQ;THEMIS;PIK3CD;PTPRJ;IKBKG;PSMB3;LCK;GATA3;PSMC1;PSMB11;PSMA5;PDE4B;DENND1B;PSMB2;PSME2;CD28;PSMD12;PTPN22;PSMA7;TRAT1;ZC3H12A;PSME4;PSME3;TXK;CD3E
prerank,positive regulation of DNA repair (GO:0045739),-0.3081176198566908,-1.0540564476770382,0.38461538461538464,0.7696903550541299,1.0,18/43,35.92%,HDAC10;TIMELESS;EYA1;PRKCG;BRCC3;ERCC8;FOXM1;BRCA1;NPAS2;HMGB1;ERCC6;SPIRE2;WRAP53;TIGAR;DHX9;UBE2N;DDX11;EYA3
prerank,muscle cell development (GO:0055001),-0.3263840919366837,-1.053813251153891,0.45569620253164556,0.7694102462505817,1.0,6/33,7.47%,NEBL;NEB;ENG;ALPK2;CXADR;FER1L5
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.3172139181264176,-1.05374336366421,0.38461538461538464,0.7686023654505464,1.0,4/29,4.05%,DDIAS;MIF;FBXO5;CD44
prerank,glucose metabolic process (GO:0006006),0.24045699984234176,1.0535807077188983,0.2916666666666667,0.4979697568649976,1.0,8/60,6.82%,PPARD;ENO2;ATF4;SLC25A12;APOD;CRTC2;ALDOA;OAS1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.3743578079280471,-1.0533505010723243,0.3835616438356164,0.768779406536603,1.0,9/17,31.12%,PLA2G4D;PLA2G4E;PLBD1;PLA2G2F;LCLAT1;PLA2G2E;LPGAT1;PLA2G2D;PLA2G10
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.22562898303562173,1.0533168886055264,0.2857142857142857,0.4980397087719744,1.0,13/82,7.53%,RGS2;FNTB;RGS11;GNG7;USP20;CALM1;RGS5;TULP3;SYP;ZDHHC7;GPER1;RAMP3;GRK5
prerank,organophosphate ester transport (GO:0015748),-0.3523107139248555,-1.053206228624739,0.39436619718309857,0.7683379740363782,1.0,8/23,24.45%,PRELID2;SCARB1;MTTP;PRELID1;LDLR;SLC25A19;OSBPL8;PITPNM1
prerank,"transcription, DNA-templated (GO:0006351)",-0.24994837022878316,-1.0531212894296664,0.4536082474226804,0.7675890759498425,1.0,78/215,35.21%,NFE2L3;POLR2F;EREG;CCNK;FOXE3;E2F1;ETV7;POLR1C;TRIM24;DDX21;TAF1A;HSF2BP;SMN1;NOCT;TAF4B;CBFB;CDK7;TAF1L;PAX8;TTF2;POLR3K;GTF3C4;TRIP13;EAF1;TAF1B;GTF2H2;TFDP1;GCM2;TFAM;NKX2-8;MLLT3;NCBP1;POLR2J;NELFCD;GCM1;TAF2;TFB2M;NFYA;POLR2D;GTF3A;LHX1;TEFM;POLR3A;ZNF141;POLR3G;POLR2I;BRF2;IVNS1ABP;TAF4;GTF2H3;PTMA;ERCC6;EAF2;XBP1;CCNH;PAX5;TRIP11;RNGTT;LEO1;SETX;NCOA6;CDC73;GTF2A1;GTF3C3;RREB1;GTF2E1;TAF1;IRF9;DEK;GTF2F2;ERCC2;PRMT5;CTR9;SCX;TBPL2;TCFL5;TAF5;SSRP1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.31889376640265155,-1.0526007938236586,0.4,0.768201858572863,1.0,8/33,14.58%,IL11;SERPINE1;TNFAIP3;ICAM1;PKHD1;SEMA5A;KDR;IL10
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.32977792699019437,-1.0524874730851368,0.3333333333333333,0.7675003351281389,1.0,11/29,23.36%,INHBA;PML;CAV1;PMAIP1;PPP2R1B;THBS1;AGT;TRAF2;WWOX;TNFRSF12A;TNF
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.34141783820708893,-1.0518825071810918,0.4603174603174603,0.7681568608070141,1.0,12/25,34.27%,IL1A;IL1B;C3;NOX1;TGFB1;EIF2AK3;BRCA1;NODAL;HPSE;SULF2;HIF1A;GATA4
prerank,response to glucocorticoid (GO:0051384),0.25989579249379013,1.051878785602224,0.4,0.5006484709759339,1.0,7/27,12.00%,FAM107A;ZFP36L1;SLIT3;BCL2L11;ZFP36;PDCD7;HSD3B2
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.3398544194202774,-1.0518456879262252,0.32,0.7672495116739052,1.0,12/28,29.76%,INHBA;FOXP3;CR1;LILRB4;TNFSF4;IL36RN;XCL1;AXL;HMGB1;ZC3H12A;C1QBP;PDCD1LG2
prerank,negative regulation of immune system process (GO:0002683),-0.3622434958525993,-1.0517012983607232,0.38666666666666666,0.7666240643403137,1.0,9/18,32.48%,FOXP3;SOX9;COL3A1;LILRB4;HLA-G;LYN;LILRB2;PDCD1;HOXA7
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3411695564630772,-1.0511641581820947,0.410958904109589,0.7672701797580819,1.0,12/27,29.24%,CEBPB;TRIB3;ERO1A;TNFRSF10B;CHAC1;ATP2A1;TRAF2;BBC3;BAX;TMEM117;DNAJC10;AIFM1
prerank,rRNA methylation (GO:0031167),-0.3778197164644584,-1.0509383713081017,0.3974358974358974,0.7670421001954345,1.0,5/19,16.53%,TFB1M;EMG1;NSUN3;FBL;TFB2M
prerank,ganglioside biosynthetic process (GO:0001574),0.3303969727475147,1.0507535726278947,0.3142857142857143,0.5027358119804516,1.0,6/15,16.09%,ST6GALNAC3;B3GALT4;ST3GAL5;ST6GALNAC5;ST8SIA3;ST6GALNAC6
prerank,peptide hormone secretion (GO:0030072),0.2694404007482829,1.0503232292997071,0.3333333333333333,0.5033157498078481,1.0,3/27,2.26%,CAMK2G;VIP;LTBP4
prerank,positive regulation of neuron death (GO:1901216),-0.2946609297947576,-1.0502959951601583,0.44155844155844154,0.7680543583873416,1.0,18/46,27.96%,GRIN2B;TGFB2;EGR1;FOS;WNT5A;CCL3;PCSK9;FYN;NF1;IFNG;CDK5;ITGB2;GSK3B;TYROBP;TNF;REST;CDK5R1;BAX
prerank,organelle fusion (GO:0048284),0.3209666920097132,1.0494456659961706,0.3333333333333333,0.5047309150249394,1.0,6/20,16.73%,MFN2;PLD6;VPS11;MIEF2;MFF;VPS18
prerank,male gonad development (GO:0008584),-0.3165747510169966,-1.0492196091243002,0.3561643835616438,0.7701406957890121,1.0,25/43,38.96%,INHBA;TGFB2;WNT5A;SOX9;LRP2;ADAM20;GATA6;BIK;TEX19;LHB;ZFP42;GATA3;PRKACG;WNT4;SRD5A2;WT1;ADAM29;GATA4;NR5A1;FSHR;UTF1;SIX4;ADAM21;ING2;MSH2
prerank,regulation of cellular protein catabolic process (GO:1903362),0.3099192640125442,1.0489503355256113,0.37037037037037035,0.5053289178696189,1.0,4/18,9.34%,VPS11;WDR91;DAB2IP;RDX
prerank,positive regulation of locomotion (GO:0040017),0.273986863253578,1.0486072115041558,0.4444444444444444,0.5054976051778649,1.0,8/30,10.12%,BVES;NTN1;RARRES2;CCL21;PDGFB;F2RL1;P2RY12;CCDC25
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.33346701737229684,-1.0485956954309106,0.4264705882352941,0.7701986033210414,1.0,7/30,13.96%,BAAT;ACSL6;THEM5;ACOT12;ACOT6;ACSM6;ACSM4
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.33346701737229684,-1.0485956954309106,0.4264705882352941,0.7701986033210414,1.0,7/30,13.96%,BAAT;ACSL6;THEM5;ACOT12;ACOT6;ACSM6;ACSM4
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.30730175761148404,1.0481874319592939,0.47058823529411764,0.5059224869436224,1.0,7/16,19.61%,PDGFRA;PDGFB;PDGFD;PLAT;NR4A3;PDGFA;FER
prerank,lymphocyte differentiation (GO:0030098),-0.26647736267990413,-1.0476998487099636,0.375,0.7716932694843481,1.0,44/83,41.66%,IL11;SOX4;CHD7;GPR89A;JAK3;GPR89B;IFNK;RAG1;LFNG;ZAP70;IL10;RAG2;PTPN2;IFNE;PIK3CD;PTPRJ;LY6D;LCK;GATA3;JAG2;AXL;NFAM1;IFNB1;RHOH;PTPN22;CR2;TPD52;ADGRG3;IFNA1;IKZF1;IFNA21;AICDA;TCF3;PBX1;IL2;IFNA4;IFNA7;MSH2;IFNA14;IFNA10;FLT3;IFNA17;IFNA2;IFNA16
prerank,regulation of defense response to virus by host (GO:0050691),-0.3334887689273902,-1.0473032157089888,0.44155844155844154,0.7720147512336168,1.0,13/32,30.74%,TNFAIP3;IL23A;IL23R;STAT1;IL12B;APOBEC3F;MICB;IL12RB1;DTX3L;PTPN22;ZC3H12A;AIM2;DHX9
prerank,mitochondrial fission (GO:0000266),-0.3474958231229096,-1.046885929816244,0.4126984126984127,0.7723175855396764,1.0,3/17,7.16%,MTFR2;MX1;MTFR1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.28271393277570045,1.0466331723215876,0.4,0.5089733431442004,1.0,13/35,18.08%,CRY2;CALM1;MTOR;HSP90B1;PPP1R12A;CALM2;CSNK2B;TSC1;MAGI2;PPP6R2;PPP1R15A;NUAK1;AGTR2
prerank,RNA biosynthetic process (GO:0032774),-0.32511807564493445,-1.0458958312534403,0.4155844155844156,0.7743470112659966,1.0,19/32,44.68%,PRIM1;PRIM2;SMN1;POLA1;TTF2;TERT;BRF2;TAF4;SETX;NCOA6;PRMT5;HELB;TBPL2;TAF5;TAF10;RSF1;SMARCA5;POLA2;MTERF1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3264306605389779,-1.0458293896758748,0.425,0.7725909107368805,1.0,5/26,12.50%,TP73;GZMB;E2F1;PMAIP1;TFDP1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3264306605389779,-1.0458293896758748,0.425,0.7725909107368805,1.0,5/26,12.50%,TP73;GZMB;E2F1;PMAIP1;TFDP1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.2988335773098506,-1.0458233233354195,0.43373493975903615,0.7716230540698976,1.0,14/46,23.94%,INHBA;BMP8A;TGFB2;GDF15;GDF9;ENG;BMP7;INHBC;TGFB1;BMP4;INHBE;NODAL;GDF2;TTK
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.3044415550191771,-1.0457243173017718,0.34615384615384615,0.7708879741444865,1.0,9/39,16.87%,MYC;RFWD3;FBXO5;POLH;HMGA2;NEK4;IER3;SMYD2;PARG
prerank,regulation of glucose transmembrane transport (GO:0010827),0.3454950062161739,1.0449810675419267,0.4166666666666667,0.5119323925238741,1.0,8/17,16.80%,CLIP3;INPP5K;OCLN;GH1;PLA2G1B;PRKAG2;NR4A3;PRKCB
prerank,cellular response to glucagon stimulus (GO:0071377),0.33156142784148646,1.0447304958559447,0.4411764705882353,0.5119441895425199,1.0,7/19,15.97%,ADCY5;ADCY4;PRKAR2B;PRKACA;ADCY9;ADCY2;ADCY6
prerank,contractile actin filament bundle assembly (GO:0030038),0.3524566785834304,1.0447187283309294,0.47058823529411764,0.510883121520155,1.0,3/15,6.27%,SORBS1;PDLIM1;RHOA
prerank,stress fiber assembly (GO:0043149),0.3524566785834304,1.0447187283309294,0.47058823529411764,0.510883121520155,1.0,3/15,6.27%,SORBS1;PDLIM1;RHOA
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.20320225063889677,1.0445714749863741,0.36,0.5105985737246056,1.0,27/92,17.12%,ATP2B4;SNCA;TRIM6;TERF2IP;NGF;RAPGEF3;CAMK1;NOS1;HDAC6;RAMP3;MTCP1;PRKD1;EGFR;APP;TENM1;RAF1;NTF3;BCAR3;PFN2;TFRC;NTRK3;SH2D3C;TXN;ARAF;CREBL2;GAS6;SFRP2
prerank,response to interleukin-1 (GO:0070555),-0.27165738023248737,-1.0441517745601676,0.3793103448275862,0.7744813110890725,1.0,33/80,30.41%,CXCL8;IRAK2;IL1B;CCL24;CCL20;CCL22;SOX9;ADAMTS12;CCL4;CCL3;RELA;IRAK1;HYAL3;CITED1;CCL17;GBP1;CHI3L1;CCL26;IRAK3;CCL1;XCL2;XCL1;ANXA1;GBP3;CCL5;NLRP7;USP10;HAS2;ZC3H12A;TNFRSF11A;CCL7;MAPK13;MYD88
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.33842045509845703,-1.043437596116862,0.4473684210526316,0.7756266859073956,1.0,14/32,27.77%,WNT5A;SLC7A5;FFAR2;CD55;HLA-F;HLA-G;TRAF2;NOD2;TNFSF4;XCL1;CLEC7A;SCIMP;CD160;RAET1G
prerank,neutrophil activation (GO:0042119),-0.38285370731555746,-1.0431887647388618,0.375,0.7752158880355917,1.0,4/16,8.82%,CXCL8;SYK;CXCR2;CXCL6
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.19473718859965972,1.043016206634058,0.3,0.5133280864199355,1.0,38/149,15.83%,HACD1;GSTM3;GSTM2;GSTM5;GSTA4;ELOVL4;LCAT;SPTLC3;DEGS1;MOCS1;CDO1;MOCS2;CERS4;PAM;CHKB;GSTM4;HPGDS;HACD4;PRKD1;KDSR;SLC27A1;PLA2G4C;VAPA;PPM1L;CERS1;CSNK2B;CSNK2A2;SLC44A2;GOLPH3;LPIN1;GSTT2B;DMD;PRKD3;ARG2;PLA2G4A;SAMD8;GAL3ST4;PCYT1A
prerank,establishment of protein localization to organelle (GO:0072594),-0.28239842795054304,-1.042886567633757,0.38823529411764707,0.7751498851320414,1.0,25/74,28.98%,LAMP3;NUP62CL;NUP155;CSE1L;SYK;E2F3;NUP107;RANBP17;NXT2;NUP50;MMP12;NUP88;RALA;NUP93;GCKR;POM121;RAN;TNPO3;HEATR3;IL10RA;NUP153;NXT1;KPNB1;NUP62;IPO11
prerank,glycerophospholipid catabolic process (GO:0046475),0.3208475101906948,1.0418462328674947,0.3684210526315789,0.5155854645696337,1.0,11/27,16.70%,PLA2G5;PLA2G4B;ENPP2;PLA2G4C;PRDX6;PLA2G6;GDPD3;ENPP6;ABHD16A;PLA2G4A;INPP5F
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.26909312867916,1.039914684613401,0.3793103448275862,0.5186639884150044,1.0,6/28,9.75%,PTEN;SPRY1;DAB2IP;SMAD7;IL17RD;SFRP1
prerank,nucleic acid-templated transcription (GO:0097659),-0.3110708280824166,-1.0396506200379205,0.4520547945205479,0.7837025486388728,1.0,11/42,23.51%,POLR2F;E2F1;PAX8;TAF1B;TERT;NKX2-8;POLR2J;POLR2D;POLR3A;POLR2I;PTMA
prerank,RNA transport (GO:0050658),0.2159612342746185,1.0395230440329244,0.1875,0.5190070938498699,1.0,14/74,9.71%,SRSF5;NXF1;ZFP36L1;DDX39B;SIDT2;CASC3;ZFP36;SRSF4;POLDIP3;U2AF1L4;THOC5;KIF5C;SRSF11;FLOT1
prerank,positive regulation of response to external stimulus (GO:0032103),-0.26028791046534355,-1.0394468990352514,0.4367816091954023,0.7833007596708171,1.0,53/132,32.59%,OSM;PDGFRB;IL1B;EREG;THBD;SERPINE1;IL23A;GBP5;WNT5A;ZP3;PLA2G7;IFNK;IL21;CEBPA;POLR3B;CCL3;FEM1A;FPR2;IL12B;THBS1;AGT;TGFB1;NLRP12;NFKBIA;IFNG;ZBP1;POLR3C;ANKRD17;ADAM8;CYBA;CCL26;CCL1;MGST2;TNFSF4;MDK;POLR3G;NMI;TNF;SCIMP;IFNB1;TLR7;CCL5;NLRP10;STX3;TLR8;MAPK13;PLSCR1;ETS1;DHX9;IFI35;TRIM15;OASL;LILRA5
prerank,determination of heart left/right asymmetry (GO:0061371),0.23538341497431178,1.0393147725218872,0.4,0.5189690955561932,1.0,20/47,20.27%,DAND5;HAND1;SRF;BBS5;PKD2;NPHP3;SOX18;NDRG4;SMO;MEGF8;MEF2C;SOX17;FOXN4;BBS7;BBS4;CCDC40;DLL1;VANGL2;CCDC39;MKKS
prerank,negative regulation of type I interferon production (GO:0032480),0.2433965798932748,1.0390574464926419,0.3333333333333333,0.519057838265827,1.0,14/40,19.66%,PTPRS;NLRX1;UBA7;TAX1BP1;RNF216;DHX58;PIN1;OTUD5;PPM1B;RNF135;PCBP2;GPATCH3;YY1;HERC5
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.34037466657440324,1.039041853750041,0.41379310344827586,0.5185559286448521,1.0,5/18,7.59%,THBS4;RAC1;TIRAP;CCL21;NCKAP1L
prerank,signal transduction by p53 class mediator (GO:0072331),-0.32647858975657834,-1.0387574290232366,0.39705882352941174,0.7843488968082207,1.0,10/32,24.10%,POU4F1;PMAIP1;MYO6;BATF;PAXIP1;ACER2;IFI16;POU4F2;ATRX;E2F7
prerank,regulation of fatty acid metabolic process (GO:0019217),0.30204862610604566,1.0385813762679825,0.4,0.5191926341394257,1.0,5/18,14.32%,PPARD;PRKAB2;PRKAA2;PRKAG2;INS
prerank,aspartate family amino acid catabolic process (GO:0009068),0.31089708456741405,1.0378726226750796,0.39285714285714285,0.5204803705092881,1.0,6/19,17.97%,DLD;ASPA;DLST;OGDH;AASS;HYKK
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.31281339108362166,-1.0375378064802778,0.4266666666666667,0.7870169300070256,1.0,9/37,23.48%,RFC3;ERCC5;RPA3;RFC5;GTF2H2;RFC2;POLD2;NTHL1;GTF2H3
prerank,zinc ion transport (GO:0006829),-0.3617379899414527,-1.0373002546354324,0.3972602739726027,0.7867263803879476,1.0,7/21,22.29%,SLC30A2;TRPM2;SLC39A11;SLC39A8;SLC30A6;SLC39A2;SLC30A5
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.36276758387278,-1.0372603700866858,0.3972602739726027,0.7858854006049899,1.0,7/22,20.21%,MMP7;HM13;RELA;TGFB1;ADAM10;ADAM9;MBTPS2
prerank,motor neuron axon guidance (GO:0008045),0.3309772032986777,1.0369549933098627,0.40476190476190477,0.5223750529556075,1.0,11/16,23.35%,NTN1;RAC1;EPHA4;SEMA3A;NTN5;CHN1;RHOG;RNF165;SLIT2;TMEFF1;SLIT1
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.37559072489281875,-1.0366187427903766,0.38961038961038963,0.7867765588244695,1.0,10/19,33.29%,DKC1;CEP295;CCT6A;CCT2;CENPJ;TNF;CEP135;WRAP53;CCT3;CCT8
prerank,development of primary male sexual characteristics (GO:0046546),-0.30889133108472644,-1.0364191695260196,0.4166666666666667,0.7863477647098494,1.0,23/43,37.26%,INHBA;TGFB2;WNT5A;SOX9;LRP2;ADAM20;GATA6;BIK;TEX19;LHB;ZFP42;GATA3;PRKACG;WNT4;SRD5A2;WT1;ADAM29;GATA4;NR5A1;FSHR;UTF1;SIX4;ADAM21
prerank,integrin-mediated signaling pathway (GO:0007229),-0.27533023606318613,-1.036092321884069,0.39325842696629215,0.7864517048866481,1.0,17/69,17.19%,THY1;ZYX;ITGA5;FN1;RCC2;ANGPTL3;ITGBL1;ISG15;SYK;COL3A1;LAMA3;ITGA11;ADAM10;PLEK;ITGB6;ADAM9;TEC
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.2504018308715579,1.0360159521520107,0.4090909090909091,0.5237827791876947,1.0,10/47,8.11%,AGTR1;MAPT;CDKN1A;MAPK14;PRKCD;CD36;PID1;PDGFB;F2RL1;SOD1
prerank,organelle organization (GO:0006996),0.18303411632131497,1.0359193284183776,0.0,0.5233834501264931,1.0,84/403,15.01%,RNF112;PALLD;TPM1;RAB34;OPTN;CAV2;ARHGAP10;DST;SEC31B;GEM;CNTNAP1;CHMP3;DES;CENPT;TJAP1;PLIN5;TBC1D20;ZNF135;VPS11;PKD2;ATL2;PACSIN3;OBSL1;CAPZB;PACSIN2;ATP8B2;MAST1;NUMA1;MCOLN1;MAST2;ATL3;PRM2;KIF5C;WASF3;ZMYM3;CCL2;PEX19;RHOT2;DPYSL2;PLEKHF1;RAB31;CHMP4A;PRKD1;VAPA;FGD6;PI4K2A;GORASP1;MARK1;TICAM2;KLHL20;SIPA1;MICAL3;PYROXD2;RAB30;RHOU;BSCL2;MTX3;LMAN2L;CHMP7;PLEKHM2;MARK4;PACSIN1;SLC25A36;GOLPH3;GABPB1;CSNK1A1;RANBP10;FITM1;ATL1;CCL11;CIDEC;ZMYM6;CCL13;MIEF2;GOLGA8A;ARC;PEX11A;VPS4A;SPRYD3;SIRT3;KIFAP3;GBF1;WTIP;LMAN1L
prerank,translation (GO:0006412),-0.25106917666039347,-1.0358316623538784,0.3617021276595745,0.7862071843109738,1.0,86/196,44.88%,IGF2BP3;DARS2;YARS2;ABCE1;RPL22L1;AIMP2;RPL39;MRPL3;MARS2;LARS2;RRBP1;MRPS18C;SRBD1;RPS19;FARSB;ASMT;FASTKD2;RPS21;GFM2;ZC3H15;MRPS16;MRPL13;RPL36;WARS2;FARS2;RARS2;RPL26L1;FARSA;ZAR1L;ABCF1;RPL23A;RPL37;FTSJ1;PPA1;TUFM;MRPL47;MRPL9;QRSL1;RPL8;MRPL37;EEF2;GSPT1;MRPL42;MRPS12;HBS1L;MRPL57;APEH;MRPS18A;COPS5;TMA7;NOA1;RPS18;EEF1D;RPS7;MRPS11;MRPL52;MRPS33;RPS2;RPL41;MRPS34;RPS24;RPS4Y2;RPL32;RPS29;RPL27A;MRPL28;RPL35;RPS3;PTCD3;RPS4X;RPL4;RPL30;RPS6KB2;RPL37A;MRPL36;RPL18;ZAR1;DRG1;MRPL11;RPL19;AGO2;EEF1B2;RPL38;RPLP2;RPL12;RPS14
prerank,sphingolipid metabolic process (GO:0006665),0.19179972588697078,1.0355461257166405,0.16666666666666666,0.5235717288737329,1.0,19/112,10.82%,HACD1;SERINC1;GBA2;ELOVL4;SPTLC3;ENPP2;ST6GALNAC3;DEGS1;ORMDL1;CERS4;SMPD1;HACD4;GLTP;PRKD1;KDSR;VAPA;PPM1L;CERS1;ESYT3
prerank,carbohydrate derivative transport (GO:1901264),-0.36096883646607847,-1.0355439417059453,0.4266666666666667,0.786006741154034,1.0,10/18,38.06%,SCARB1;SLC29A2;SLC28A1;SLC25A19;LBP;SLC10A7;PLA2G10;SLC15A2;SLC15A4;ABCG1
prerank,positive regulation of ossification (GO:0045778),0.2645565575322322,1.0353933930562607,0.4074074074074074,0.5234455986652878,1.0,10/39,13.13%,PTN;GPM6B;OSR1;P2RX7;BMPR1A;KL;PKDCC;SLC8A1;MEF2C;OSR2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.30436116103052324,-1.0348080879934545,0.4473684210526316,0.7870572215570159,1.0,17/42,31.90%,GBP5;IL17A;ADCY7;NOS2;PLD4;CARD9;LILRB4;NOD2;MEFV;CD6;TNF;CLEC7A;CHID1;NLRP7;ZC3H12A;MYD88;HIF1A
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.2983558568301115,-1.0344788541676948,0.42105263157894735,0.7871164069089421,1.0,18/52,28.36%,DPEP1;IFI6;LAMP3;PAX2;NAIP;CD44;XIAP;THBS1;CSNK2A1;IFI16;RPS6KA3;CARD16;TNF;ARL6IP1;LTF;CST7;DHCR24;SFN
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.3406764497052222,-1.0341702677045124,0.4507042253521127,0.7871667840412915,1.0,2/18,1.47%,LRP8;ADCY1
prerank,regulation of exocytosis (GO:0017157),0.24608419884663188,1.0338486458763128,0.4166666666666667,0.5260592960877913,1.0,10/44,12.59%,VAMP2;CHMP3;RAB3A;SNCA;HAP1;RAB2B;SYT1;RAB3C;RAB8B;LGI3
prerank,anterior/posterior pattern specification (GO:0009952),0.23796691476099127,1.0337887846691522,0.29411764705882354,0.5256383707331493,1.0,13/62,13.65%,HEY1;WLS;SMAD2;HOXD3;HOXA5;HOXD9;HHEX;HOXC4;HOXA4;HOXD4;HOXB4;HEY2;SKI
prerank,mitochondrial gene expression (GO:0140053),-0.3115987204716382,-1.033730236182516,0.4189189189189189,0.7875890472320073,1.0,18/40,37.95%,LARS2;TFAM;TFB2M;FASTKD2;GFM2;MRPS16;TEFM;RARS2;MRPL47;QRSL1;MRPS12;MRPL57;MRPS18A;NOA1;MRPS11;FASTKD5;SLC25A33;MRPS34
prerank,transition metal ion homeostasis (GO:0055076),0.2821548056288628,1.0335660028273963,0.41935483870967744,0.5255313585523951,1.0,7/26,12.10%,CYBRD1;CUTC;FBXL5;HMOX1;B2M;BDH2;MT3
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.29482706342011933,-1.033208878107543,0.47126436781609193,0.788139881581493,1.0,22/58,32.32%,MYC;PDGFRB;PML;EYA1;DNMT3L;BRCC3;ERCC8;GNL3;WRN;USP9X;FGFR4;BRCA1;ATRX;NPAS2;HMGB1;ERCC6;WRAP53;TIGAR;WT1;DHX9;UBE2N;USP7
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.34737100434845053,-1.0328193700545223,0.4266666666666667,0.7883355259654286,1.0,6/22,13.93%,MYC;CDK1;CTSH;SOX9;SULT1A3;KDR
prerank,positive regulation of glucose import (GO:0046326),0.2536948521951904,1.03269445635401,0.4074074074074074,0.5269881456140806,1.0,7/24,16.65%,SORBS1;OCLN;PIK3R1;RHOQ;ARPP19;INS;CREBL2
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.25458819927878856,1.032678006934806,0.35294117647058826,0.5264842614673328,1.0,9/35,14.82%,PPT2;HPGD;HMGCLL1;PAM;SCD5;ACAT1;BDH2;GGT5;GGT7
prerank,positive regulation of transferase activity (GO:0051347),-0.2516273930604258,-1.0322972275918305,0.38202247191011235,0.7890995777982127,1.0,41/145,24.58%,MYC;RFC3;PDGFRB;TRIB3;DSCC1;NEK2;DKC1;EPHB2;EPHA1;AURKB;DCUN1D5;MAPK15;SERINC5;EPHB3;IGF1R;RFC5;EPHA2;SORL1;GRHL2;MET;NAF1;PLK1;TGFB1;KDR;ROS1;RFC2;EPHA8;CCT2;FGFR4;CHRNA7;PRKCQ;EPHB4;HMBOX1;CHTF18;MAGEC2;DTX3L;AXL;DDR1;MAPKAPK5;AXIN1;LMTK2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.3033572028568453,1.0319696890914418,0.3611111111111111,0.527708199711805,1.0,6/21,14.35%,NAB2;MTOR;ZNF76;MAF1;TENM1;ZNF345
prerank,protein localization to chromosome (GO:0034502),0.2841211934942487,1.0314548948226394,0.3333333333333333,0.528493164294113,1.0,8/29,13.67%,IFFO1;TERF2IP;PARP3;TPP1;CHMP7;FAM47E;RPA1;TINF2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.29405666343095826,-1.031060006656673,0.4166666666666667,0.7917815485654295,1.0,12/50,14.58%,TP73;E2F1;PML;CHEK2;PRKDC;IKBKE;BCL2A1;EPHA2;BCL2L1;MSH6;CASP2;TNFRSF1B
prerank,stress granule assembly (GO:0034063),0.2994221719041412,1.030976712889098,0.5,0.5291727005185219,1.0,3/20,4.79%,CIRBP;MAPT;CSDE1
prerank,RNA processing (GO:0006396),0.19541419904479806,1.0307981480993293,0.2857142857142857,0.5290212261557505,1.0,45/171,19.60%,SRSF5;RBPMS;ADARB1;NOVA1;PABPN1;TARDBP;DDX39B;HNRNPH3;DDX17;RBMS1;ALKBH5;RBM6;SRSF4;SNRPN;MBNL1;RBM4;LUC7L3;PRKACA;AKAP8L;CELF2;SRSF11;PRPF18;TUT1;ADARB2;RBM5;RNPC3;PDCD7;SF3B1;METTL3;SRRM1;SRSF7;RRAGC;SCNM1;DHX16;CELF1;SF3B4;NOL3;WBP4;ZRSR2;RNASEL;SRSF2;RBMS2;PRPF4B;SRSF1;ZMAT5
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.2949601652078231,-1.0304013247075823,0.42168674698795183,0.7927458660421083,1.0,17/54,30.10%,PSMB9;PSMD14;OAZ3;NQO1;ODC1;PSMA3;PSMB3;PSMC1;PSMB11;AZIN1;PSMA5;PSMB2;PSME2;PSMD12;PSMA7;PSME4;PSME3
prerank,regulation of tissue remodeling (GO:0034103),-0.34689483912107694,-1.0302227436172777,0.4266666666666667,0.7923251763380462,1.0,7/20,13.99%,IL23A;SYT7;IL21;RUNX1;IL12B;TGFB1;SUCO
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.3375845649679939,-1.0300628579778726,0.4430379746835443,0.7917940094291097,1.0,11/29,28.11%,IL21;RASGRP1;RAET1E;HLA-F;NCR1;HLA-G;CRTAM;KLRC2;CD160;NCR3;SLAMF6
prerank,acylglycerol catabolic process (GO:0046464),-0.3335590123130397,-1.03005348822763,0.4473684210526316,0.7908443617671781,1.0,12/32,28.94%,FABP6;PNPLA3;LIPG;LIPE;PNPLA1;ABHD12B;ABHD12;ABHD2;LIPC;PNPLA4;DAGLA;FABP12
prerank,cellular response to light stimulus (GO:0071482),-0.2847126319801651,-1.0291719637976184,0.4177215189873418,0.7924211824047628,1.0,28/67,34.70%,MYC;GPR52;AURKB;GRK1;GNGT1;RRH;TRPM1;PTPRK;ATR;CDC25A;OPN3;NPM1;RUVBL2;FMR1;CREBBP;RHNO1;OPN5;GNAT1;MAPK13;SAG;CNGA1;TAF1;SDE2;KDM1A;NOC2L;PDE6G;EIF2AK4;POLD1
prerank,positive regulation of insulin secretion (GO:0032024),0.26727821654591305,1.029066877998456,0.42857142857142855,0.5319986142727311,1.0,10/37,16.78%,NLGN2;PPP3CB;NNAT;GPER1;PLA2G6;LRRC8A;BAD;PSMD9;DOC2B;SLC30A8
prerank,prostaglandin metabolic process (GO:0006693),-0.3242648089899359,-1.0288003293778334,0.4625,0.7927208039837053,1.0,5/30,6.33%,MIF;CYP2S1;TBXAS1;CYP4F8;AKR1C4
prerank,protein K48-linked ubiquitination (GO:0070936),0.24708576235517,1.0281852610291102,0.42857142857142855,0.5331898857744505,1.0,16/55,18.15%,UBE2D4;UBE2G1;UBE2Q2;UBE2E1;RNF146;UBE2G2;RNF216;NHLRC4;RNF4;RNF115;UBE3A;UBE2B;UBE2H;UBE2D3;KLHL3;RNF152
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3142850827625563,1.028156245834135,0.41935483870967744,0.5326625765700862,1.0,3/18,6.03%,SAMD4A;PAN2;ZFP36
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.26506247415788486,1.0281419052409964,0.4230769230769231,0.5321156950746343,1.0,9/25,20.02%,ABHD4;CHKB;SLC27A1;PLA2G6;LPIN1;ETNK2;PISD;NAAA;LPIN3
prerank,determination of bilateral symmetry (GO:0009855),-0.33890953024802756,-1.0277599802628001,0.4305555555555556,0.7945390385433818,1.0,13/26,32.25%,TDGF1;CCDC103;DNAH11;DNAH5;PITX2;DNAI1;KIF3B;DNAI2;NOTCH1;FOXJ1;CFC1B;MMP21;CFC1
prerank,negative regulation of programmed cell death (GO:0043069),-0.23644728577966767,-1.0276492237990795,0.3877551020408163,0.7939316813403481,1.0,112/373,28.16%,MYC;DPEP1;KIF14;TDGF1;SHH;IFI6;MAD2L1;DHRS2;CDK1;ERCC5;POU4F1;MIF;LEF1;CARD14;RIPK2;CDSN;FOXE3;CLEC5A;PAX2;NAIP;WNT5A;CTSH;CD44;SOX9;PRKDC;WDR73;HMGA2;PKHD1;BCL2A1;IFIT3;IGF1R;HSPD1;LRP2;PROC;FIGNL1;MET;PRAME;CEACAM5;PRLR;CBX4;XIAP;SEMA4D;VTCN1;DCPS;RELA;BCL2L1;GATA6;VHL;PLK1;MMP9;PLAUR;ANXA4;IRAK1;MED1;NAA15;THBS1;BIRC6;ATAD3A;CASP2;PROK2;PRELID1;KDR;NFKBIA;NAA35;IL10;TNFSF18;ADAM10;BIRC7;BIRC5;WNT11;PAX7;COMP;VDAC1;PRDX5;BARD1;BMP4;ANXA5;HPN;RPS6KA3;HDAC2;GSK3B;OPN3;SMAD6;NPM1;AXL;HYPK;PTMA;ARL6IP1;BAG4;PRKCI;PRDM9;ANXA1;FXN;XBP1;LTF;HSPA9;NUAK2;IL2RB;RASA1;TM7SF3;MIEN1;ITCH;CD28;DNAJC3;PA2G4;FANK1;DHCR24;TEK;AATF;TIGAR;SETX;MCL1
prerank,water transport (GO:0006833),-0.36388178617810485,-1.0275079312415387,0.40298507462686567,0.7934279772444115,1.0,8/18,28.86%,UPK3A;AQP9;AQP2;CFTR;AQP5;AQP3;SLC5A1;MIP
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.36901085335255357,-1.027378363303619,0.3939393939393939,0.7928914758873571,1.0,2/15,5.09%,BMP2K;SMAP1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.3133486331692932,1.0270660829626383,0.4411764705882353,0.5341904377472182,1.0,8/18,21.82%,PSEN1;TMCC2;APH1B;BACE1;NSG1;PSEN2;ADAM19;ACHE
prerank,hexose transmembrane transport (GO:0008645),0.2948577428578822,1.0268967839034981,0.4375,0.5341584298685814,1.0,3/21,2.66%,SLC2A4;PPARD;SLC45A1
prerank,cellular response to UV (GO:0034644),-0.27325350986582303,-1.0266989617975346,0.42857142857142855,0.7939532009075064,1.0,20/74,24.97%,MYC;CHEK1;TIMP1;MME;MMP1;AURKB;MMP3;MMP2;MMP9;HYAL3;PTPRK;ATR;CDC25A;CARD16;OPN3;NPM1;RUVBL2;FMR1;CREBBP;RHNO1
prerank,embryonic heart tube development (GO:0035050),0.3060747300227127,1.0266955230102157,0.4,0.5340647125999481,1.0,6/18,14.30%,CITED2;HAND1;SOX18;NDRG4;MEGF8;SOX17
prerank,regulation of telomere maintenance (GO:0032204),-0.334225046283666,-1.0265501862467004,0.4675324675324675,0.7935106861740788,1.0,9/25,32.32%,MYC;PML;GNL3;ATRX;SMG1;XRCC5;PIF1;HDAC8;USP7
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.263439240475133,-1.0263507141018524,0.37209302325581395,0.7932641371821937,1.0,16/75,14.79%,FOXP3;IRAK2;TNFAIP3;CDKN2A;PKHD1;NLRC5;ZNF675;NWD1;BMP7;ANXA4;IRAK1;SETD6;NLRP12;NFKBIA;IL10;NLRP3
prerank,regulation of transport (GO:0051049),0.2543027441047933,1.0263480653391384,0.38461538461538464,0.5340534693131644,1.0,12/34,16.78%,VAMP2;SNCA;FES;POFUT2;MUL1;ACTB;ICA1L;USP6;ARL6IP5;REEP5;LEPR;SLC30A8
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.27205879067703764,-1.0257955982515816,0.4157303370786517,0.7938137571775364,1.0,47/96,36.46%,ZC3H11A;U2AF1;NUP155;THOC3;NUP37;NUP210;CPSF3;NUP107;RANBP2;MAGOHB;NUP35;NUP50;SEH1L;NCBP1;NUP205;EIF4E;NUP88;SRSF9;ALYREF;NUP93;POM121;RAE1;NXF3;MAGOH;CPSF2;GLE1;NUP43;NUP160;NUP153;NDC1;DDX39A;SMG1;CPSF4;NXT1;THOC2;NUP62;NUP98;SEC13;SLBP;AGFG1;RBM8A;EIF4A3;THOC6;NUP214;CDC40;FIP1L1;SMG7
prerank,positive regulation of embryonic development (GO:0040019),-0.3585993789215674,-1.0253783016795521,0.42424242424242425,0.7941422654789256,1.0,9/18,34.03%,FOXA2;LHX1;WNT3A;TENM4;WNT4;NLRP5;OTX2;WNT1;SCX
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.26583375293456524,-1.0253399430061887,0.4823529411764706,0.7923344660977766,1.0,13/96,10.01%,SPTBN2;AP1S3;KIF18A;CENPE;KIF15;KIF23;KIF2A;CTSV;RACGAP1;KIF4B;AP1S1;KIF2C;KIF22
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.26583375293456524,-1.0253399430061887,0.4823529411764706,0.7923344660977766,1.0,13/96,10.01%,SPTBN2;AP1S3;KIF18A;CENPE;KIF15;KIF23;KIF2A;CTSV;RACGAP1;KIF4B;AP1S1;KIF2C;KIF22
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.22522882073927214,1.0250964351402534,0.38461538461538464,0.536549296647196,1.0,27/77,18.70%,FGFR1;DCN;KIT;MYOC;FGF2;ROR2;PIK3R1;PDGFRA;GPER1;PDGFB;F2RL1;GH1;PDGFD;ROR1;NKX3-1;SELP;JAK2;NTRK1;NTF3;INS;NTRK3;PDGFA;WNT16;PLXNB1;EPOR;HCLS1;ERBB3
prerank,heterochromatin assembly (GO:0031507),-0.34886296299551933,-1.0248890007148685,0.4444444444444444,0.7925877609319318,1.0,5/20,13.92%,HMGA1;CDKN2A;HMGA2;BEND3;SUV39H1
prerank,cholesterol homeostasis (GO:0042632),-0.27021495548509067,-1.024558199169935,0.42696629213483145,0.7926806048721009,1.0,16/66,18.12%,DGAT2;TMEM97;ANGPTL3;LIPG;ABCG5;CAV1;CETP;CYP7B1;SCARB1;MTTP;PCSK9;ABCG8;APOM;CYP39A1;FGFR4;LDLR
prerank,positive regulation of translational initiation (GO:0045948),-0.340441735942049,-1.0242872708214765,0.41935483870967744,0.7925967689103492,1.0,14/21,45.12%,BOLL;POLR2D;CDC123;CCL5;LARP1;UHMK1;YTHDF1;DAZ4;DAZL;DAZ2;DAZ3;RPS6KB2;EIF2B5;YTHDF3
prerank,glycerolipid catabolic process (GO:0046503),0.3262750589496062,1.0242140663853643,0.32,0.5378904287458899,1.0,8/19,15.16%,PLA2G4B;ABHD6;PLA2G4C;PRDX6;GDPD3;ENPP6;PLA2G4A;MGLL
prerank,positive regulation of MAP kinase activity (GO:0043406),0.2503180629501083,1.0241750561189173,0.47368421052631576,0.537444658838544,1.0,17/68,12.49%,FGFR1;KIT;FGF2;DVL3;SASH1;DVL2;DAB2IP;PDGFB;FGF1;ELANE;GH1;TLR9;EGFR;DUSP19;PDGFD;TENM1;CD24
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.34474689275668396,1.024146129657545,0.43902439024390244,0.5369383364363212,1.0,4/15,6.03%,RBM24;ZFP36L1;TARDBP;ZFP36
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.2255147242840389,1.023436270315086,0.3684210526315789,0.5379065926705314,1.0,14/64,14.06%,FGFR1;TNFSF10;LGALS3;BCL10;ZMYND11;FAS;PELI3;GPER1;SCG2;TRAF1;DEPTOR;CFLAR;FEM1B;RIPK1
prerank,RNA methylation (GO:0001510),-0.2962865401242637,-1.0229371685606743,0.4578313253012048,0.7956268207546604,1.0,19/56,29.98%,HENMT1;RBM15;METTL2A;TGS1;TFB1M;NSUN3;METTL1;TRMT6;FBL;TFB2M;METTL6;THUMPD3;THADA;METTL2B;FTSJ1;TRMT10C;TRMT61B;NSUN2;TARBP1
prerank,heart morphogenesis (GO:0003007),-0.28025480342828524,-1.0229207904692064,0.4567901234567901,0.7947181643807211,1.0,8/51,8.66%,TBX20;TGFB2;SOX9;CHD7;ENG;TH;ALPK2;ZFPM1
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.3160909919221489,-1.0229055895386538,0.43373493975903615,0.7937949313223437,1.0,15/40,26.80%,ENTPD7;RNASEH1;SND1;NUDT1;PNPT1;NUDT15;RNASEH2A;NCBP1;NUDT5;ENTPD1;RNASEH2B;XRN2;DNASE1L1;EXOSC7;DNASE1
prerank,positive regulation of B cell activation (GO:0050871),-0.29329896992744486,-1.0222140279879093,0.36585365853658536,0.7951736356100053,1.0,14/47,24.62%,MIF;EPHB2;IL21;CD81;SYK;CHRNB2;PAXIP1;SH3KBP1;NOD2;TNFSF4;RIF1;TNFSF13B;VAV3;XBP1
prerank,response to steroid hormone (GO:0048545),-0.29435750708608477,-1.0221487750054457,0.37662337662337664,0.7944358183995615,1.0,13/34,26.78%,TGFB2;CAV1;CATSPERB;CATSPER1;MED1;THBS1;TGFB1;CATSPER3;SOX30;ABHD2;CATSPER2;CATSPER4;CATSPERG
prerank,negative regulation of neuron death (GO:1901215),-0.2580386008142317,-1.0221169300624795,0.38202247191011235,0.7935412427806808,1.0,33/96,26.26%,FOXQ1;KIF14;POU4F1;NAIP;FOXB1;SIX1;SORL1;TOX3;PRKCG;FGF20;HLA-F;SULT1A3;PLA2G3;CITED1;NTF4;TNFRSF1B;F2R;SET;ADAM8;CDK5;TRAF2;ATP13A2;IKBKG;GSK3B;MDK;PM20D1;KIR3DL2;PRKCI;VPS35;REST;GBA;RASA1;BDNF
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.27769204557631033,1.0220754352618993,0.5,0.540692499464818,1.0,10/31,14.29%,IFNAR1;PKD2;PKD1;SOCS2;CCL2;STAT6;PIAS1;CLCF1;JAK2;IL15
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.3735824998673912,-1.0216850125995223,0.4142857142857143,0.7938153956092187,1.0,12/19,28.05%,THY1;GBP1;LILRB4;PTPN2;PVRIG;SLA2;PTPRJ;SH2D1A;CD160;UBASH3A;PTPN22;EZR
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.31643426772244243,-1.0211927140740098,0.4246575342465753,0.7943302649523404,1.0,14/41,22.53%,GRIN2D;GRIN2B;ERO1A;TRPM2;TRPV4;SLC24A1;DRD2;F2R;IBTK;ITPR2;XCL1;LCK;HTR2C;TRPV2
prerank,regulation of macrophage differentiation (GO:0045649),-0.38564843446080077,-1.0206725530760477,0.391304347826087,0.7950351163639977,1.0,4/15,18.80%,INHBA;PF4;LIF;PTPN2
prerank,regulation of ion transmembrane transport (GO:0034765),0.24950284790792515,1.0205357278307383,0.36,0.5435340227831607,1.0,7/35,10.46%,CASQ2;KCNH2;KCNJ8;AKAP6;P2RX7;AHCYL1;KCNE2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.35950428461742706,-1.0204353795125876,0.44285714285714284,0.7947252970826976,1.0,8/21,17.22%,TIMP1;IL1B;PTPN3;IL10;TNFRSF1B;IFNG;ADAM9;ADAM8
prerank,cellular transition metal ion homeostasis (GO:0046916),0.20785408384957452,1.0203785836632928,0.4,0.5434724595939989,1.0,17/93,12.10%,SLC22A17;ISCU;SCARA5;PRNP;SLC39A13;CYBRD1;SKP1;FBXL5;MT1X;HMOX1;NEDD8;SOD1;MT1M;SMAD4;APP;ABCG2;MT3
prerank,determination of left/right symmetry (GO:0007368),-0.310517588741247,-1.0202793508044175,0.4358974358974359,0.794250340562027,1.0,15/38,27.10%,TDGF1;SHH;CCDC103;DNAH11;ENKUR;PKD1L1;DNAAF1;DNAH5;PITX2;DNAI1;KIF3B;DNAI2;NOTCH1;FOXJ1;CFC1B
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.3636211176071771,-1.0200602220851844,0.4393939393939394,0.7940581510735407,1.0,2/18,1.69%,ERCC5;NEIL3
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.3811833237892387,-1.0193830308804104,0.44285714285714284,0.7949172031504674,1.0,7/18,23.06%,CEBPB;SOX9;CAV1;IFNG;GATA3;FOXN1;PRKX
prerank,female gamete generation (GO:0007292),-0.32772138620367103,-1.0185644693846583,0.3918918918918919,0.7960634777788881,1.0,13/29,29.59%,GDF9;NANOS3;HORMAD1;DIAPH2;TRIP13;USP9X;MDK;PRDM9;KMT2D;CGB7;MCM8;DMC1;STRA8
prerank,regulation of viral entry into host cell (GO:0046596),-0.3116683413470931,-1.018437605380342,0.45121951219512196,0.7956221998393948,1.0,4/37,0.67%,IFITM3;LY6E;IFITM1;IFITM2
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.32237983202751863,1.0176621842365947,0.34615384615384615,0.5488940505861795,1.0,3/17,6.41%,FZD7;HDAC4;HDAC5
prerank,protein processing (GO:0016485),-0.26095030822352905,-1.0176180168331237,0.4044943820224719,0.7970370290272976,1.0,21/98,20.16%,KLK6;CPZ;F12;MME;CTSH;CPN1;PCSK1;F7;MMEL1;HM13;CPD;PCSK9;MYRFL;CASP2;PTCH1;PCSK6;ADAM10;PCSK7;SRGN;MYRF;PRSS3
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.3277663404408058,1.017321508739013,0.4642857142857143,0.5489493611603202,1.0,3/16,7.06%,BCL10;KIT;GPRC5B
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.31238792173595237,-1.0171856849236491,0.43661971830985913,0.7972709207488566,1.0,4/25,9.71%,DDIAS;MIF;CD44;BCL2L1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.24840461677193348,1.0169268293310612,0.5,0.5494927628336737,1.0,12/36,21.68%,TRIM39;MAP1A;CAMLG;UBXN1;CSNK2A2;RYBP;SGTA;BAG6;KLHL40;WAC;HFE;SDCBP
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.3663299701250724,-1.0169147715934101,0.4864864864864865,0.7970354148723007,1.0,5/21,11.26%,IRAK2;WNT5A;RUNX1;CBFB;IRAK1
prerank,positive regulation of angiogenesis (GO:0045766),-0.2541862572365558,-1.0168839212502367,0.3855421686746988,0.7961760602698524,1.0,25/114,14.74%,IL1A;CXCL8;ADAM12;IL1B;ITGA5;SERPINE1;WNT5A;CTSH;EPHA1;ANGPTL3;HMGA2;FUT1;SMAD1;RLN2;RUNX1;SEMA5A;GATA6;APELA;ITGAX;CCR3;THBS1;ANXA3;KDR;ADM2;CHI3L1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.3353675865411416,-1.0164244690393927,0.44,0.7964265506673177,1.0,4/23,10.07%,GRIN2D;GRIN2B;GLRA1;DRD2
prerank,alpha-amino acid metabolic process (GO:1901605),-0.3016650229952947,-1.0159492014755347,0.4430379746835443,0.7966518660154192,1.0,12/42,18.02%,DPEP1;GLS2;MTHFD1;GPT2;KMO;ASS1;ALDH18A1;FOLH1B;IYD;SRR;SLC25A13;DDAH1
prerank,sterol homeostasis (GO:0055092),-0.26903182573199563,-1.0154564513846074,0.4431818181818182,0.7970403961970954,1.0,16/67,18.12%,DGAT2;TMEM97;ANGPTL3;LIPG;ABCG5;CAV1;CETP;CYP7B1;SCARB1;MTTP;PCSK9;ABCG8;APOM;CYP39A1;FGFR4;LDLR
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.2652344122217355,-1.015309162975702,0.4457831325301205,0.7964548993022812,1.0,21/77,21.83%,IL1A;IFI6;CSF2;IL1B;SERPINE1;TNFAIP3;ICAM1;PF4;EYA1;RELA;BCL2L1;THBS1;TERT;TNFRSF10B;BIRC6;FASLG;TRAF2;BRCA1;SCRT2;BMP4;GSK3B
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.3415520736416768,-1.0147634154468812,0.44285714285714284,0.7970714573613119,1.0,7/21,25.47%,SOX9;CCL3;TGFB1;FGF23;SRGN;NOTCH1;ROCK2
prerank,response to organonitrogen compound (GO:0010243),-0.3144140259702513,-1.0145818189032527,0.46835443037974683,0.7967565155928824,1.0,8/36,11.86%,KYNU;DHFR;TRPM2;GLRA1;HLCS;DRD2;GPRC6A;GLRA2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.3091803021795352,-1.0145051175862463,0.48,0.7960511534994461,1.0,11/32,20.72%,INHBA;SHH;TMEM190;PLD4;BATF;TGFB1;KDR;MLLT3;PLEK;PRRC2C;BMP4
prerank,receptor internalization (GO:0031623),0.24444110661975893,1.0138973194009628,0.43478260869565216,0.5561720819159975,1.0,10/47,9.17%,RAMP1;SNCA;SNX1;ACKR3;AP2M1;CD36;RAMP3;RAMP2;RAB31;CEACAM1
prerank,potassium ion homeostasis (GO:0055075),0.3089540940416072,1.0133723761152502,0.5416666666666666,0.5571131133314858,1.0,5/24,4.83%,ATP1B2;KCNH2;ATP1A2;KCNMA1;SLC12A4
prerank,growth hormone receptor signaling pathway (GO:0060396),0.30246104066238344,1.0131497106737677,0.4166666666666667,0.5569976733567706,1.0,7/20,13.37%,PRL;PIK3R1;PXN;SOCS2;GH1;STAT6;JAK2
prerank,mitochondrial fusion (GO:0008053),0.32563069973705694,1.013099699342582,0.4722222222222222,0.5565583083076373,1.0,4/16,16.33%,MFN2;PLD6;MIEF2;MFF
prerank,negative regulation of apoptotic process (GO:0043066),-0.23129538104688685,-1.0129393800972242,0.40816326530612246,0.7996532468913733,1.0,135/470,27.94%,MYC;FOXQ1;DPEP1;KIF14;TDGF1;SHH;IFI6;LAMP3;MAD2L1;DHRS2;CDK1;ERCC5;POU4F1;MIF;LEF1;CARD14;RIPK2;ITGA5;FOXE3;CLEC5A;PAX2;NAIP;MAZ;WNT5A;CTSH;MTRNR2L3;CEACAM6;CD44;SOX9;PRKDC;WDR73;HMGA2;FOXB1;PKHD1;BCL2A1;CAV1;IFIT3;SIX1;IGF1R;HSPD1;LRP2;PROC;ASAH2;TOX3;PRKCG;FIGNL1;PRAME;CEACAM5;PRLR;CBX4;FGF20;XIAP;SEMA4D;VTCN1;RELA;BCL2L1;GATA6;VHL;PLK1;MMP9;PLAUR;ANXA4;IRAK1;MED1;NAA15;RNF213;THBS1;ALOX12;PLA2G3;CITED1;BIRC6;ATAD3A;CASP2;PROK2;PRELID1;KDR;NTF4;NFKBIA;NAA35;IL10;TNFSF18;ADAM10;PTRH2;F2R;SET;BIRC7;BIRC5;WNT11;ADAM8;PAX7;MTRNR2L5;CSNK2A1;COMP;VDAC1;PRDX5;BARD1;BMP4;ANXA5;HPN;RPS6KA3;HDAC2;GSK3B;MDK;CARD16;OPN3;SMAD6;NPM1;AXL;HYPK;TNF;PTMA;ARL6IP1;BAG4;PRKCI;PRDM9;ANXA1;FXN;XBP1;NOTCH1;LTF;HSPA9;NUAK2;IL2RB;RASA1;BDNF;MIEN1;ITCH;CD28;DNAJC3;PA2G4;FANK1;DHCR24;TEK;AATF;SETX
prerank,activation of GTPase activity (GO:0090630),0.2112065531931259,1.0128687873283273,0.375,0.5565246166273736,1.0,23/98,14.09%,TBC1D1;ARHGEF26;SYDE1;CORO1C;SGSM2;ARHGEF15;EVI5L;TBC1D17;CCL21;RABGAP1;ARHGEF10;TAX1BP3;TBC1D25;ADPRH;SIPA1;USP6;SGSM1;TBC1D10A;TSC1;TBC1D26;SIPA1L2;SGSM3;NTF3
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.3026842786318474,-1.0124847989301367,0.47560975609756095,0.8000193377494423,1.0,14/33,31.60%,DCPS;LSM7;EXOSC3;EXOSC8;DIS3;EXOSC4;LSM5;EXOSC5;LSM4;EXOSC7;HBS1L;CNOT6;EXOSC2;PATL1
prerank,positive regulation of vasculature development (GO:1904018),-0.24634756077332037,-1.0122856795471675,0.38636363636363635,0.799694321443434,1.0,22/100,14.74%,IL1A;CXCL8;ADAM12;IL1B;SERPINE1;WNT5A;CTSH;EPHA1;ANGPTL3;HMGA2;RLN2;RUNX1;SEMA5A;GATA6;APELA;ITGAX;CCR3;THBS1;ANXA3;KDR;ADM2;CHI3L1
prerank,regulation of B cell activation (GO:0050864),-0.32177531432715406,-1.0109728865852259,0.4461538461538462,0.8024848014374864,1.0,16/27,42.49%,IL4I1;TNFAIP3;IL10;SH3KBP1;NOD2;TNFSF4;FOXJ1;SLAMF8;BANK1;SAMSN1;IKZF3;CD19;AHR;IGLL1;FCRL3;IL4
prerank,positive regulation of cellular metabolic process (GO:0031325),0.2154780794326045,1.010659643682609,0.45454545454545453,0.5609998576679978,1.0,26/101,15.25%,PPARD;BVES;AGPAT1;AGTR1;ACACB;SNCA;CDKN1A;IFNAR1;ECE1;MAPK14;CD63;NR1H2;PID1;RAMP3;PDGFB;GH1;ANGPT1;MT3;AKR1C1;RIPK1;NTF3;MAGI2;INS;VAMP3;RNF41;ANXA2
prerank,pigment granule transport (GO:0051904),0.32042625451336687,1.0105762666198874,0.52,0.5600359103501313,1.0,11/18,21.33%,BBS5;RAB11B;BBS2;ARL6;RAB27A;BBS7;BBS4;BLOC1S6;MKKS;MYO5A;BLOC1S5
prerank,melanosome transport (GO:0032402),0.32042625451336687,1.0105762666198874,0.52,0.5600359103501313,1.0,11/18,21.33%,BBS5;RAB11B;BBS2;ARL6;RAB27A;BBS7;BBS4;BLOC1S6;MKKS;MYO5A;BLOC1S5
prerank,positive regulation of biosynthetic process (GO:0009891),-0.29339618581605387,-1.01018185730899,0.45454545454545453,0.8039239135014375,1.0,15/42,26.67%,CXCL8;AMELX;ZBTB20;RUNX1;TGFB1;SUCO;F2R;MLXIPL;CYBA;MMP8;BMP4;HDAC2;WNT4;CCL5;CREB3L1
prerank,cellular response to hypoxia (GO:0071456),0.19646445362041054,1.0101112739092875,0.4444444444444444,0.5606439362273541,1.0,31/126,15.59%,HIF3A;AQP1;EGLN2;ZFP36L1;SIRT2;CPEB1;MTOR;PTGIS;HP1BP3;UBB;HMOX1;PSMC5;BNIP3;EGLN1;SFRP1;ARNT;MGARP;BNIP3L;MT3;NKX3-1;ANGPT4;FMN2;EPAS1;BAD;PSMD9;ACAA2;FAM162A;RGCC;AK4;HIGD1A;PSMB6
prerank,activation of protein kinase A activity (GO:0034199),0.3251356649652388,1.010064632187161,0.5185185185185185,0.5602035600945615,1.0,7/17,15.97%,ADCY5;ADCY4;PRKAR2B;PRKACA;ADCY9;ADCY2;ADCY6
prerank,activation of protein kinase activity (GO:0032147),0.20129356295563153,1.0097242326727787,0.5384615384615384,0.5604480777315831,1.0,33/113,17.11%,TLR3;ADCY5;CHRNA3;ITGB3;PILRB;ADCY4;MTOR;PRKAR2B;TIRAP;PRKCD;STRADA;PRKACA;PDGFB;FGF1;MAPKAP1;ZFP91;ANGPT1;MT3;ADRA2B;JAK2;ITGB1BP1;COPS8;ADCY9;NTF3;INS;ADCY2;ADRB2;NTRK3;TXN;TAOK2;ADCY6;NRK;GAS6
prerank,cellular protein catabolic process (GO:0044257),0.223915898262544,1.009694086421205,0.4666666666666667,0.559928385406033,1.0,19/57,18.63%,CTSF;UBE2G1;AP2M1;CTSO;CTSS;DAB2IP;DENND3;MYLIP;UBE2G2;BNIP3;AP2A2;BNIP3L;TCIRG1;CAPN2;RIPK1;AP2A1;VLDLR;PISD;ADAMTS7
prerank,mesoderm formation (GO:0001707),-0.35623735206129786,-1.0096875807830308,0.4647887323943662,0.8045585380771263,1.0,3/19,5.01%,TBX20;HMGA2;CRB2
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.23452948536258714,-1.0096700487226318,0.43010752688172044,0.8036882102798881,1.0,31/146,15.95%,CCR8;JPH1;CXCR4;GPR18;KISS1;ABL2;CALCR;TAC4;KNG1;CAV1;CXCR5;CXCR2;CCR4;TRPV4;FPR2;DRD2;CD55;CXCR6;TRPM1;CCR3;GRM1;PROK2;GPR157;GPR35;GNA15;CD52;CXCR1;CCRL2;GPR174;F2R;CXCR3
prerank,anterior/posterior axis specification (GO:0009948),-0.3396738194643959,-1.0095810300261738,0.47058823529411764,0.8030055870397557,1.0,2/19,0.86%,TDGF1;SHH
prerank,primary alcohol metabolic process (GO:0034308),0.2866416072896454,1.009360291551845,0.37037037037037035,0.5602128453576956,1.0,14/32,22.44%,ADH1B;LRAT;CYP1A1;CYP27C1;GDPD3;ALDH3A2;NAAA;CYP11A1;RETSAT;DHRS3;CYP11B1;ADH1C;DHRS9;CYP1B1
prerank,phospholipid catabolic process (GO:0009395),-0.34410056014566054,-1.0087784071680097,0.5068493150684932,0.804510066173274,1.0,6/23,10.89%,ANGPTL3;PLA2G4D;LIPG;PLA2G4E;PLBD1;GDPD1
prerank,neuron differentiation (GO:0030182),-0.24406448045763604,-1.0087312938678439,0.4835164835164835,0.8037152906603952,1.0,56/172,26.04%,ASCL2;WNT2;INHBA;SHH;TGFB2;WNT7B;SOX4;IRX5;PAX6;ANOS1;IRX2;WNT5A;EN2;DTNB;FOXA2;RUNX1;MET;PCSK9;LHX9;EN1;FZD10;VAX1;PTPRD;NEUROG2;NEUROD2;WNT8B;WNT7A;IRX3;GSX1;LHX2;USH2A;PITX2;WNT11;PTF1A;PBX4;CDK5;BHLHA15;NIF3L1;IRX4;LHX1;WNT3A;WNT3;LHX5;LHX3;BTG4;RUNX3;POU4F2;EMX1;TENM4;OLIG2;ERCC6;INSM1;XBP1;WNT4;MANF;OLIG3
prerank,cartilage development (GO:0051216),-0.292200017289278,-1.0085577037152904,0.4788732394366197,0.8033166018694737,1.0,12/50,14.74%,AMELX;CD44;SOX9;HMGA2;IL17F;TRPV4;RUNX1;HYAL3;COL2A1;TGFB1;WNT7A;CHI3L1
prerank,positive regulation of protein binding (GO:0032092),0.22122440592243478,1.008107326504259,0.3684210526315789,0.5625827551524278,1.0,11/55,11.52%,PSEN1;ADD1;CLDN5;AKTIP;PKD1;B2M;TRIM21;FLOT1;PIN1;APP;PPP2CB
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.3426685337387116,-1.0078070993883426,0.4626865671641791,0.8043172616951493,1.0,13/27,37.62%,IRAK2;RIPK2;TNFAIP3;IRAK1;TAB3;NOD2;IKBKG;ITCH;UBC;UBE2N;TRAF6;NOD1;TIFA
prerank,eye development (GO:0001654),-0.27578562696407055,-1.007541060431451,0.45121951219512196,0.8040552688861,1.0,15/57,17.13%,STRA6;TGFB2;PAX6;FOXE3;PAX2;SCO2;ADAMTS18;SIX3;FBN2;SMOC1;SIPA1L3;RBP4;SHROOM2;PITX2;PBX4
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.35528761736090364,-1.0072926146558818,0.5138888888888888,0.8037698190760884,1.0,11/20,34.74%,HPRT1;ADK;PNP;TERT;POLD2;AMPD3;DCK;AMPD2;APRT;POLD1;DGUOK
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.36347169544229907,-1.007068706975163,0.44285714285714284,0.8035410871995177,1.0,7/17,28.23%,IL4I1;JAK3;VTCN1;ASS1;TIGIT;PTPN22;LAX1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.29673781245858893,1.0069191471840293,0.46875,0.5645872621998576,1.0,9/20,17.60%,MAPK8;MAPK7;WFS1;PDGFB;KLF2;APP;NFKB1;MAP2K5;KLF4
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.25725802453248936,1.006728463902671,0.4230769230769231,0.5644058246938181,1.0,9/33,18.53%,HACD1;ELOVL4;HACD4;ACOT2;ACOX2;CYP4F12;ABCD4;ELOVL5;SLC27A2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.28690812830572315,-1.0064610697901382,0.45714285714285713,0.8046409312992668,1.0,8/42,10.64%,VWA2;IRS1;IL1B;SOCS1;GRB7;SORL1;FUT7;PRKCZ
prerank,protein homotetramerization (GO:0051289),-0.29277550799870844,-1.0061512326890656,0.475,0.8044916404512439,1.0,23/52,33.21%,MAT1A;GBP5;HPRT1;TRPM2;TK1;TDO2;HCN1;SHMT2;AQP2;AQP5;CTH;PKD2L1;SSBP1;ACOT13;ACACA;SYCP1;SAMHD1;KCNJ2;MIP;TRPV5;UPB1;KIF25;HSD17B10
prerank,cellular iron ion homeostasis (GO:0006879),0.2291669104939381,1.0055770776916824,0.4482758620689655,0.566484526608122,1.0,10/55,9.70%,SLC22A17;ISCU;SCARA5;CYBRD1;SKP1;FBXL5;HMOX1;NEDD8;SOD1;SMAD4
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.3221294151271841,1.00521796507097,0.4230769230769231,0.5667410853970356,1.0,8/17,19.13%,PLIN5;NR1H2;SLC27A1;PNPLA2;SREBF1;CTDNEP1;NR1H3;CNEP1R1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.3190636402296862,-1.0051637602791204,0.44594594594594594,0.8060748102334865,1.0,13/34,26.80%,DUSP4;DUSP1;DUSP18;PTPRO;DUSP9;DUSP16;DUSP2;PTPN2;PTPRJ;DUSP6;PGP;UBASH3B;PTPN22
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.22295199493845322,-1.004684108782362,0.5151515151515151,0.8064903160793949,1.0,130/458,26.99%,CEBPB;POU5F1B;TCF7;FOXP3;ZNF695;SOX14;HMGA1;SOX4;ZNF460;DSCC1;ESCO2;WWC1;MYBL2;E2F1;SPIN2A;HDAC10;PML;POU6F2;CHEK2;FBXO5;USP37;CHD7;ARNTL2;CALR;HMGA2;ZNF92;ZNF280A;ENG;SOX1;NANOS3;TOM1L1;IFNK;SIX1;CEBPA;AJUBA;ZNF648;NKX6-2;ZNF714;ZNF730;ZNF217;NFKB2;ZNF675;ELAVL2;NUP107;RELA;ZNF486;ZNF114;VGLL1;VHL;ZNF138;BRCA2;RNF6;TBX4;ZNF737;LIN54;PAK6;ZNF430;ONECUT1;NUP35;MYB;MAFA;ZNF205;ZNF708;GRM5;ZNF280B;ZNF680;NFXL1;SLC39A8;ZNF253;SKOR2;ZNF195;POFUT1;NOLC1;EIF4E;GCM1;MLXIPL;PTF1A;GTF2IRD1;NFYA;ANKRD17;PHB;ZNF488;MYBL1;TRRAP;SPTY2D1;FUS;KLF1;ACTR8;NANOG;ZNF716;CARM1;PKP3;PSPC1;ZNF492;PRKCQ;SCRT2;CRX;CDK11B;ZNF90;TRIM22;SCRT1;SPI1;ZNF141;ZNF280C;ZNF221;ZNF100;ZFHX3;MYCBP;RUNX3;ATRX;MAPKAPK5;EZH2;DLX4;CREBBP;HES6;REST;SBNO1;RHOH;NOTCH1;KMT2D;ZNF281;PLAG1;ESRRG;ZNF2;SP3;FOXN2;ZNF506;MYT1;SPIN2B;NSD1
prerank,negative regulation of cell adhesion (GO:0007162),0.2244659750041318,1.0046009158869136,0.3888888888888889,0.5677954696616817,1.0,19/68,16.58%,JAM3;CORO2B;PLXNB3;FZD7;FZD4;FBLN1;SPOCK1;RHOA;GCNT2;PDE3B;SIPA1;ANGPT1;CX3CL1;ADAMDEC1;ITGB1BP1;ARHGDIG;DMTN;SEMA6A;PLXNB1
prerank,regulation of stem cell differentiation (GO:2000736),-0.26034597029177164,-1.0039319796265598,0.5063291139240507,0.8077172070308246,1.0,27/90,30.72%,TACSTD2;OSM;TP73;SLC4A11;PUS7;PSMB9;PRKDC;PSMD14;RUNX1;CBFB;MYB;PSMA3;PSMB3;GATA3;PSMC1;PSMB11;PSMA5;NOTCH1;PSMB2;PSME2;ITCH;PSMD12;PSMA7;NSUN2;PSME4;PSME3;SP7
prerank,protein alkylation (GO:0008213),-0.3434764977766914,-1.0038611965043935,0.41025641025641024,0.8070003022369544,1.0,8/19,28.99%,PRMT3;EEF2KMT;CAMKMT;METTL21C;SNRPB;METTL21A;SNRPD3;GSPT1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.26495826791033317,-1.0036657848542725,0.45555555555555555,0.8067061573850124,1.0,23/94,19.38%,KIF24;CEP72;CDK1;NEK2;CEP250;RAB3IP;HAUS7;RPGRIP1L;SCLT1;PLK1;B9D1;HAUS6;CEP76;CEP152;CEP83;NDE1;PLK4;SDCCAG8;CENPJ;CKAP5;ALMS1;CEP78;CEP41
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.22230447917523324,1.0034439844357774,0.5263157894736842,0.5698446931016161,1.0,9/68,6.20%,FLNA;FERMT2;PSEN1;WWTR1;BAG3;NGFR;DMAP1;PRKCD;PIK3R1
prerank,regulation of insulin secretion (GO:0050796),0.21842083471684384,1.0034079155308098,0.5555555555555556,0.5694000034842555,1.0,24/100,15.29%,RAP1A;NR1D1;KCNA5;NLGN2;ADCY5;PPP3CB;KCNB1;RAPGEF3;ARNTL;CACNA1C;SNAP25;EFNA5;NNAT;GPER1;KCNS3;SFRP1;DPP4;LRRC8A;ITPR1;PRKCA;BAD;PSMD9;ABCC8;DOC2B
prerank,protein ADP-ribosylation (GO:0006471),0.2614813151245675,1.0021103884056108,0.45,0.5717818713634303,1.0,4/28,8.00%,PARP16;PARP6;SIRT2;PARP3
prerank,artery development (GO:0060840),-0.34352957060702444,-1.0018338381199228,0.48,0.8107145192377037,1.0,4/23,5.28%,STRA6;ANGPTL3;ROBO2;ENG
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.24292833822266713,-1.001533719365726,0.4574468085106383,0.8106626105150966,1.0,53/180,30.46%,THY1;CARD11;RIPK2;CD276;SKAP1;PSMB9;PSMD14;BTN1A1;SYK;VTCN1;RELA;ZAP70;INPP5D;ITK;FYN;LCP2;CD3D;CTLA4;BTNL10;CD3G;TEC;PSMA3;MNDA;PIK3CB;SLA2;PRKCQ;THEMIS;PIK3CD;PTPRJ;IKBKG;PSMB3;LCK;GATA3;NFAM1;PSMC1;PSMB11;PSMA5;VAV3;PDE4B;DENND1B;PSMB2;PSME2;CD28;PSMD12;PTPN22;PSMA7;TRAT1;LAX1;ZC3H12A;PSME4;PSME3;TXK;CD3E
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.22755325533580614,1.0,1.0,0.5733539620751272,1.0,119/402,19.22%,NFATC4;ATP6V1G2;SORBS1;EPHA7;PSEN1;EFS;FGFR1;NCK1;MAPK1;CHRNA3;NRP2;CAV2;DDR2;SDC2;ANGPTL1;VEGFB;KIT;MAPK3;SHC2;SHC4;FGF2;ROR2;FOXO4;FRS3;CASP3;SIRT2;NGF;RAC1;ITGB3;MAPK14;PILRB;NGFR;TIE1;FES;RARRES2;AP2M1;ARPC2;ATP6V1E1;PIK3R1;GFRA2;RHOA;PDGFRA;EFNA5;EPHA4;KL;PXN;FGF7;SOCS2;COL4A2;PDGFB;RHOQ;NCKAP1L;MAPK11;HAP1;ACTB;GRB14;FGF1;APH1B;PIK3R3;PRKD1;BAIAP2;GH1;GRB10;EGFR;PDGFD;TIAL1;PLAT;FLT4;FGFR2;RBFOX2;ANGPT1;EPHB6;AP2A2;BRK1;WASF2;ROR1;SH2D6;ELMO2;TCIRG1;BLNK;GIGYF1;JAK2;NTRK1;ZNF106;FGF5;FGF10;ATP6V0E2;NTF3;INS;BCAR3;TIA1;ADRB2;VEGFC;NTRK3;SOGA1;EPHA3;RET;NR4A3;PDGFA;TNK2;AP2A1;ATP6V1H;FGF17;PDK2;FGF16;EPHA10;TIAM1;PSEN2;POLR2A;STAT3;RAB14;ITSN1;SHC3;ERBB3;FGF9;ATP6V0A1;GRB2;ATP6V1D;CHN1
prerank,protein ubiquitination (GO:0016567),0.19543313072393703,1.0,1.0,0.5733539620751272,1.0,94/495,14.06%,DTX3;ASB2;RNF112;FBXO32;UBE2QL1;HIF3A;PDZRN3;ARRDC4;TRIM39;BCL10;FBXO10;RNF11;FBXL22;FBXO9;WSB1;UBE2D4;KLHL21;PJA2;ZSWIM8;FBXO17;UBE2G1;TRIM6;FBXO44;PELI3;SKP1;SASH1;RNF122;TRIM3;KCTD10;VPS11;LZTR1;FBXO31;CAND2;FBXL7;ASB5;KLHL42;FBXL5;LNPEP;ASB1;UBE2Q2;AKTIP;UBE2E1;FBXO30;UBB;RRAGA;RNF10;ANAPC16;NEDD8;KLHL41;RNF217;RNF185;PSMC5;MUL1;MYLIP;RNF167;TRIM23;RNF146;UBE2G2;RNF144B;TRIM47;RNF14;FBXO27;SPSB1;KLHL20;TRIM21;RNF25;TRIM63;TRIM69;KLHL22;LRSAM1;FBXW4;TRIM34;TRIM52;RNF4;UBOX5;RNF220;HECTD2;RNF38;LONRF1;FBXW5;RNF115;RUSC1;TMEM129;RNF7;RTF1;BCL2;EPAS1;UBE3B;UBE3A;PAF1;PSMD9;UBE2B;UBE2H;MIB2
prerank,protein polyubiquitination (GO:0000209),0.2092629686002981,1.0,1.0,0.5733539620751272,1.0,86/307,19.77%,FBXO32;UBE2QL1;FBXO10;FBXL22;FBXO9;WSB1;UBE2D4;FBXO17;UBE2G1;TRIM6;FBXO44;PELI3;SKP1;SASH1;TRIM3;FBXO31;FBXL7;KLHL42;FBXL5;LNPEP;UBE2Q2;AKTIP;UBE2E1;FBXO30;UBB;RNF217;PSMC5;MUL1;MYLIP;RNF167;TRAF1;RNF146;UBE2G2;RNF144B;RNF216;NHLRC4;RNF14;FBXO27;SPSB1;KLHL20;TRIM21;ZFP91;TRIM69;LRSAM1;FBXW4;TRIM34;RNF4;UBOX5;HECTD2;LONRF1;FBXW5;RNF115;RUSC1;TMEM129;BCL2;UBE3B;UBE3A;PSMD9;UBE2B;UBE2H;MIB2;BTRC;FBXL15;RNF41;UBE4B;PSMB6;RNF31;FBXL12;TRIM68;UBE2D3;UBE2V1;RNF19A;BLMH;KLHL3;RNF135;RNF152;RNF166;ANAPC4;CUL1;MAGEL2;FBXW2;DZIP3;HERC5;ZNRF1;DDB2;FBXW11
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.2027958333924253,1.0,1.0,0.5733539620751272,1.0,91/375,15.57%,CALCOCO1;BVES;GSN;PSEN1;CLU;ACTA2;CD34;CITED2;CLDN5;TLR3;ATF4;MAPK1;OSR1;HEY1;PDE2A;MITF;MAPK3;WNT6;SNCA;EMILIN1;FGF2;ECE1;MAPK8;MYOM1;MAPK7;NGF;HAND2;MAPK14;CD63;MTOR;ATF2;HOXD3;IFNGR1;SLC24A3;RHOXF1;OCLN;HOXA5;P2RX7;ANK2;WFS1;GPER1;ID2;FGF7;CD36;RBPJ;PID1;ACTC1;RAMP3;PDGFB;RAMP2;MAPK11;ZNF580;FGF1;PIK3R3;GH1;CDH5;TLR9;TLE1;RDX;C1QTNF1;ANGPT1;KLF2;RBMS3;APP;HINFP;SMAD3;GATA2;MT3;AVPR2;NKX3-1;SMO;MPHOSPH8;MEF2C;OLFM1;HEY2;OSR2;SLC38A2;FGF5;PPM1F;FGF10;NTF3;MAGI2;INS;VAMP3;LGALS9;TFRC;RNF207;ANXA2;RGCC;NTRK3;ANK3
prerank,protein phosphorylation (GO:0006468),0.19279328936898188,1.0,1.0,0.5733539620751272,1.0,132/480,17.83%,DMPK;PRRT1;NRBP2;FGFR1;MAP3K6;TLR3;MAP3K3;MAPK1;PPP3CB;NIM1K;DDR2;PNCK;KIT;ULK1;MAPK3;ILK;TNNI3K;CDK9;MAPK8;CDK3;ULK2;SMAD2;CDK20;DAPK1;RPS6KA2;MAPK14;MAP2K6;MTOR;FES;DAPK3;CAMK1;TGFBR3;EEF2K;PRKCD;STRADA;PDGFRA;BMPR1A;EPHA4;PKD1;NEK7;PRKACA;MAST1;DAB2IP;MKNK1;SIK3;PDGFB;GRK5;LATS2;PKN1;DCLK1;TRIB2;MAST2;EFEMP1;SMAD7;PRKAA2;FAM20C;CCL2;PRKG2;CLK2;CSNK1E;PRKD1;TLR9;SNRK;MAP4K2;MARK1;EGFR;YWHAZ;NRBP1;FLT4;FGFR2;JAK1;PIM1;CSNK2B;PRKG1;BRSK1;CREB1;STK32A;PPP4R1;BMX;HIPK4;MKNK2;CSNK2A2;MARK4;FAM20B;APP;CAMK2D;ERG;PKDCC;CSNK1A1;MAML1;IP6K3;TSSK3;STK33;MEX3B;CLK3;CCL11;CRY1;PRKCA;BCKDK;JAK2;NTRK1;STK36;COPS8;GTF2H4;RIPK1;PRKAG2;MAPK10;STK19;PXK;SGK1;GDF6;CTSG;MAP3K1;STK32B;TAOK2;AURKC;EPHA3;RET;CAMKK2;HIPK3;NRK;PRKCB;PDK2;GAS6;CDC42BPB;MAP3K10;STK38L;AATK;CDK14;NUAK1;BRD2;RARA
prerank,positive regulation of protein phosphorylation (GO:0001934),0.2509010366069449,1.0,1.0,0.5733539620751272,1.0,114/361,17.17%,IL6R;CLIP3;RAP1A;RBPMS;ATP2B4;CSPG4;PRNP;MAPK1;DDR2;FAXDC2;VEGFB;P2RY1;MAPK3;ILK;NPTN;SNCA;CDKN1A;BMP3;CDK9;FLCN;FAS;FGF2;CALM1;THBS4;DVL3;TRIM6;TERF2IP;NGF;RAC1;MAPRE3;ITGB3;RAPGEF3;ENPP2;RARRES2;RSPO1;CAMK1;NOS1;HDAC6;DVL2;BMPR1A;CCL21;EFNA5;AKTIP;GPER1;FGF7;RAMP3;TWSG1;MTCP1;PDGFB;MSTN;FGF1;TESK1;PIK3R3;PRKD1;GH1;CALM2;EGFR;DUSP19;PDGFD;SMAD4;FLOT1;FLT4;CSNK2B;ANGPT1;ATG14;GPNMB;MMD;PIN1;APP;CX3CL1;TENM1;RAF1;MT3;NKX3-1;ANGPT4;TNFRSF14;CAMKK1;JAK2;NTRK1;GDF5;ADCYAP1;FGF5;RALBP1;FGF10;RIPK1;PRKAG2;NTF3;IL15;INS;BCAR3;S1PR2;PFN2;RASSF2;TFRC;SNX9;GDF6;VEGFC;NTRK3;MMD2;SH2D3C;TXN;TAOK2;ARAF;PDGFA;TNK2;GDF10;CAMKK2;CREBL2;LEPR;FGF17;TGFB3;GAS6;SFRP2;FGF16
prerank,negative regulation of biosynthetic process (GO:0009890),0.30122831081644297,0.9998021555827268,0.4,0.5732057544782814,1.0,4/17,14.32%,EMILIN1;GPER1;CEACAM1;INS
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.24312874979354052,0.999750917529839,0.4,0.5727024653078254,1.0,10/42,19.66%,CLU;PTEN;TRIM39;GNA12;CSNK2A2;UBE3A;ARAF;FOXF2;SGTA;CDK5RAP3
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.27519538115212744,0.9992422091792602,0.5,0.5732060644752754,1.0,9/34,10.07%,TPM1;HAND1;TGFBR3;BMPR1A;RBPJ;SMAD7;MYL2;SMAD4;FGFR2
prerank,dicarboxylic acid transport (GO:0006835),-0.32764395745331454,-0.9991199053222002,0.4246575342465753,0.816399651822565,1.0,8/29,19.31%,FOLR1;SLC26A8;ABCC2;SLC13A5;SLC46A1;SLC19A1;SLC25A13;SLC13A3
prerank,cellular response to interferon-gamma (GO:0071346),-0.24708031208403292,-0.998928084026344,0.5287356321839081,0.8159775846735766,1.0,35/114,26.43%,TDGF1;CCL24;CCL20;PML;OAS2;GBP5;WNT5A;ICAM1;CCL22;CD44;CCL4;GBP7;CCL3;STAT1;FCGR1A;HLA-F;IRF8;CCL17;GBP1;OAS3;IFNGR2;IFNG;HLA-G;CCL26;CCL1;TRIM22;XCL2;GAPDH;IL12RB1;XCL1;GBP3;IRF6;TRIM31;CCL5;PDE12
prerank,fat cell differentiation (GO:0045444),0.22297512708651188,0.9988502831092537,0.44,0.5734722262700813,1.0,17/58,17.86%,CLIP3;STEAP4;WNT5B;PID1;C1QTNF3;CBY1;BSCL2;ZNF516;BBS2;GDF6;TMEM120A;NR4A1;NR4A3;BBS7;KLF4;OSBPL11;BBS4
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.29648263579697237,0.998840031106782,0.41379310344827586,0.572930783807907,1.0,22/22,70.38%,MAP1LC3C;HSP90B1;TECPR2;TMEM129;SEL1L;SYVN1;HERPUD1;DERL2;SEC16A;PREB;AUP1;FAF2;NPLOC4;VCP;OS9;RANGRF;SURF4;LMAN1;SEC61B;SEC13;TMED9;DERL1
prerank,B cell activation (GO:0042113),-0.25244094975713127,-0.9984560472756205,0.4470588235294118,0.8164177015719176,1.0,42/84,42.61%,IL11;EPHB2;JAK3;IFNK;RASGRP1;HSPD1;RAG1;CD70;CHRNB2;ZAP70;IL10;RAG2;PHB;CD86;PTPN2;IFNE;PIK3CD;PTPRJ;NFAM1;IFNB1;CR2;TPD52;LAX1;ADGRG3;IFNA1;BANK1;IFNA21;AICDA;TCF3;IFNA4;IFNA7;MSH2;IFNA14;IFNA10;FLT3;IFNA17;MALT1;CD40LG;IFNA2;IFNA16;IL4;LAT2
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.260732932587611,-0.9983503438292032,0.45348837209302323,0.8157913629027468,1.0,32/93,33.53%,IL1A;IRAK2;IL1B;IL1RN;RIPK2;EGR1;PSMB9;PSMD14;RELA;IRAK1;NFKBIA;PSMA3;TAB3;IRAK3;ST18;NOD2;IKBKG;PSMB3;PSMC1;PSMB11;PSMA5;PSMB2;PSME2;PSMD12;PSMA7;PSME4;PSME3;MYD88;UBC;UBE2N;PSMD1;TRAF6
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.27244167153434806,-0.9977471996583616,0.4675324675324675,0.8164435536675129,1.0,23/59,36.87%,DEFA6;GBP7;RPL39;LYG2;PGLYRP4;ROMO1;RNASE7;DEFB4A;PGLYRP3;PGLYRP1;DMBT1;PGLYRP2;DEFA1;LBP;RNASE8;ANG;DROSHA;GBP6;MYD88;MBL2;RNASE3;GBP4;HMGB2
prerank,cellular sodium ion homeostasis (GO:0006883),-0.36807262312775446,-0.9960965668684021,0.47761194029850745,0.8201181348760623,1.0,2/15,0.63%,TMPRSS3;SLC12A2
prerank,endocytic recycling (GO:0032456),0.24394525523956495,0.9958667507548133,0.47619047619047616,0.5792734013258803,1.0,13/45,20.82%,EHD2;VPS39;MICALL1;SNX3;RAB11FIP3;RAB11B;SNX27;PTPN23;SNX17;RAB13;RAB14;EHD1;VPS52
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.24223720659395254,-0.995525065207392,0.4943820224719101,0.8207876100667899,1.0,22/153,12.70%,CDH3;COL1A1;LGR5;SOX4;PTK7;ATP6V1C2;TNFAIP3;DEPDC1B;RUVBL1;PSMB9;PSMD14;CAV1;LGR6;LBX2;AXIN2;XIAP;BAMBI;SMARCA4;SEMA5A;SCEL;TERT;TGFB1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.3400700283292303,0.9941979408218873,0.42105263157894735,0.5826173608515905,1.0,3/16,2.79%,PSEN1;HEY1;HAND1
prerank,membrane lipid metabolic process (GO:0006643),-0.33386768448873344,-0.9941743240433917,0.4782608695652174,0.8236241135934435,1.0,6/22,19.52%,SPTLC1;ALOX12B;ALOXE3;FUT2;AGMO;MGST2
prerank,mesenchymal cell development (GO:0014031),-0.33459126530103556,-0.9940881810545207,0.5,0.822993217073405,1.0,8/19,33.39%,TBX20;CYP26C1;NOLC1;KBTBD8;NRG1;NOTCH1;FOXC1;TCOF1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.3125474200914212,-0.9936421819300127,0.47297297297297297,0.8233593376053593,1.0,4/21,10.07%,RASSF10;PROX1;LRP2;DRD2
prerank,chondrocyte differentiation (GO:0002062),-0.3079450069103967,-0.9935808884863816,0.5342465753424658,0.8226283460362505,1.0,9/31,22.34%,AMELX;SOX9;HMGA2;RUNX1;TGFB1;WNT7A;EIF2AK3;BMP4;RUNX3
prerank,negative regulation of neurogenesis (GO:0050768),-0.311979894710248,-0.9934845607452529,0.5074626865671642,0.8220163135423261,1.0,13/35,24.86%,THY1;IL1B;PAX6;LRP4;SORL1;RTN4R;WNT7A;NF1;OMG;WNT3A;TNF;REST;NOTCH1
prerank,response to alcohol (GO:0097305),-0.30524696614266067,-0.9933373968746801,0.425,0.8215150294728302,1.0,7/30,15.30%,GRIN2B;TH;CCL3;GLRA1;CHRNB2;TGFB1;TGFBR2
prerank,excitatory postsynaptic potential (GO:0060079),-0.35468476282726735,-0.9929469751965477,0.4857142857142857,0.8218187288793615,1.0,2/19,0.15%,GRIN2D;GRIN2B
prerank,regulation of protein catabolic process (GO:0042176),-0.25005986687095866,-0.9928491544352371,0.4945054945054945,0.821225227817599,1.0,34/100,31.03%,MAD2L1;CSNK2A3;CYP51A1;TNFAIP3;CHEK2;ASB9;WNT5A;C4BPA;HECW1;HECW2;OAZ3;SORL1;PRKCG;C4BPB;ODC1;SF3B3;PHB;MDM2;IRAK3;CSNK2A1;BARD1;ATP13A2;GSK3B;TNF;AZIN1;AXIN1;IDE;ITCH;APC2;DTL;HUWE1;CTSA;NSF;NKD1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.296096763299845,-0.9926287583228257,0.5061728395061729,0.8209211714026764,1.0,16/35,35.51%,DCPS;LSM7;EXOSC3;EXOSC8;DIS3;EXOSC4;LSM5;EXOSC5;LSM4;EXOSC7;HBS1L;CNOT6;EXOSC2;PATL1;DIS3L2;EXOSC1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.25504396480095887,-0.9920149125189913,0.5113636363636364,0.8218079132663721,1.0,13/101,10.01%,SPTBN2;AP1S3;KIF18A;CENPE;KIF15;KIF23;KIF2A;CTSV;RACGAP1;KIF4B;AP1S1;KIF2C;KIF22
prerank,potassium ion import across plasma membrane (GO:1990573),-0.2885951342655899,-0.9916429508880976,0.5064935064935064,0.8220167033403879,1.0,17/42,27.79%,SLC12A2;SLC12A8;KCNJ13;KCNJ15;ATP12A;KCNJ4;SLC12A3;KCNJ14;SLC12A5;SLC12A1;ATP1B1;HCN4;KCNJ6;KCNJ18;KCNJ3;KCNJ11;KCNJ2
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.31830807920500104,-0.9915994644556091,0.5061728395061729,0.8212315749013562,1.0,10/33,19.66%,NEK2;AURKB;MAPK15;NAF1;ATR;FBXO4;CCT6A;CCT2;PRKCQ;HMBOX1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.3311693905766427,-0.9915823112371255,0.52,0.8203396423040145,1.0,5/20,13.93%,GPR143;CCL20;TRPM2;GRM5;KDR
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.35328190072159016,-0.9915766910488082,0.49333333333333335,0.8194574228991099,1.0,7/15,37.48%,USP50;GBP5;MEFV;MYD88;EIF2AK2;PYDC1;PYDC2
prerank,regulation of neurogenesis (GO:0050767),-0.2665828379854612,-0.9906653684311902,0.5,0.8209829540383569,1.0,16/60,24.86%,ASCL2;RASSF10;IL1B;MME;PAX6;LRP2;SORL1;WNT7A;IFNG;OPRM1;WNT3A;WNT3;TNF;HES6;REST;NOTCH1
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.34653554312675433,-0.9898924044297842,0.5645161290322581,0.8221419471175898,1.0,3/17,4.08%,TACSTD2;TGFB2;SOX9
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.2965807513509439,-0.989852991372161,0.4939759036144578,0.821391874285854,1.0,18/50,31.25%,GNL3L;NEK2;AURKB;MAPK15;NAF1;NAT10;ATR;FBXO4;CCT6A;CCT2;PRKCQ;HMBOX1;MAPKAPK5;XRN1;XRCC5;PIF1;CCT3;HNRNPC
prerank,brain development (GO:0007420),-0.24550527296885236,-0.989700135851763,0.5294117647058824,0.820805364284763,1.0,32/146,17.13%,GRIN2D;GRIN2B;POMK;ZIC2;DMBX1;CXCR4;PAX2;ROBO2;PAFAH1B3;ADGRG1;PROX1;SHROOM4;FOXG1;GRHL2;SIX3;SCT;SPATA5;CENPF;TBR1;CNTNAP2;PTCH1;SLC6A4;AMIGO3;ABCB6;NF1;SHROOM2;VCX3B;TGFBR2;VCX;NKX2-2;B3GNT5;PBX4
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.33628799565729406,-0.9896623484263957,0.5555555555555556,0.8200121948620014,1.0,10/27,22.38%,ERO1A;TRPM2;DRD2;F2R;FASLG;IBTK;ITPR2;XCL1;LCK;HTR2C
prerank,adrenergic receptor signaling pathway (GO:0071875),0.29802904755297743,0.9896198383237567,0.4827586206896552,0.5926673480029517,1.0,6/20,18.66%,ADRB3;ADRA2B;PDE4D;ADCY9;ADRB2;ADRA1A
prerank,prostaglandin biosynthetic process (GO:0001516),0.31728899145023254,0.989618446407379,0.56,0.5920896995156194,1.0,5/18,14.96%,PTGS1;PTGIS;HPGDS;PTGDS;PLA2G4A
prerank,protein autophosphorylation (GO:0046777),-0.23755573397388924,-0.9892689809237474,0.5263157894736842,0.8202439733890861,1.0,45/156,24.58%,PDGFRB;SRMS;MAK;NEK2;VRK1;VRK2;CHEK2;EPHA1;AURKB;MAPK15;EPHB3;IGF1R;GRK1;AURKA;MAPKAPK2;EIF2AK1;NEK6;PASK;CDK12;MAP3K9;IRAK1;STK24;STK4;ITK;MYLK2;KDR;ATR;CAD;STK39;EPHA8;STK26;TEC;FGFR4;EIF2AK3;EPHB4;ATP13A2;MYO3A;GSK3B;PRKX;DDR1;STK17B;LYN;MAPKAPK5;MAPKAPK3;LMTK2
prerank,L-amino acid transport (GO:0015807),-0.3175491607085028,-0.9888512611055718,0.47058823529411764,0.8207442146689833,1.0,8/28,19.79%,SLC6A20;SLC7A5;SLC38A5;SLC7A1;SLC1A4;SLC25A13;SLC36A3;SLC38A3
prerank,regulation of cholesterol transport (GO:0032374),-0.3341846747805861,-0.9886457984587746,0.5135135135135135,0.8204450091802559,1.0,4/21,7.69%,ABCA13;LIPG;CETP;APOC1
prerank,regulation of p38MAPK cascade (GO:1900744),0.240795252025431,0.9880159207530362,0.3333333333333333,0.5956660701535944,1.0,6/37,7.09%,PER1;GADD45B;PJA2;HAND2;SASH1;DAB2IP
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.2690652829369997,-0.9872799450498932,0.4626865671641791,0.8231216701686125,1.0,9/42,14.13%,AREG;LRP8;EREG;DOK7;EPGN;FCGR1A;AGT;GRM5;FYN
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.3173970617156925,-0.9865777976180998,0.4875,0.8241379912583549,1.0,7/27,23.47%,MYC;PDGFRB;TOM1L1;PARP4;FGFR4;HMBOX1;GDF2
prerank,regulation of mitochondrial translation (GO:0070129),-0.329035544660481,-0.9852877919101887,0.5,0.8265675953156177,1.0,10/20,36.17%,SHMT2;NSUN3;FASTKD2;UQCC2;RMND1;TRMT10C;TRUB2;C1QBP;FASTKD3;MTG2
prerank,regulation of protein processing (GO:0070613),0.2685769080003618,0.985034765649412,0.5357142857142857,0.6021709930755283,1.0,3/22,3.67%,PRNP;BAG2;CCBE1
prerank,vesicle transport along actin filament (GO:0030050),-0.34268569960352513,-0.9849222448292972,0.5466666666666666,0.8267295738766413,1.0,9/19,32.72%,MYO1H;MYO6;MYO5B;MYO1E;FNBP1L;MYO1F;ACTN4;MYO19;MYO1G
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.325824284828818,-0.9847014116526197,0.4794520547945205,0.8264102139743437,1.0,9/25,24.57%,CEMIP;RIPK2;PLK1;BMP7;TGFB1;CHI3L1;STOX1;EGF;AXIN1
prerank,regulation of autophagosome assembly (GO:2000785),0.2702905808129478,0.9841247310907184,0.5,0.6034822446886782,1.0,19/33,28.08%,PIP4K2B;CHMP4A;ADPRH;NUPR1;FEZ2;LRSAM1;PIP4K2A;SH3GLB1;IFT20;NPRL2;UBQLN2;CHMP4B;RAB3GAP1;LRRK2;PINK1;PHF23;PIP4K2C;RALB;MTM1
prerank,cellular response to glucose starvation (GO:0042149),0.23652597720325216,0.984121963518048,0.5,0.6028963395967475,1.0,11/42,17.65%,ATF4;NIM1K;PRKAA2;KPTN;ATG14;BRSK1;ASNS;PRKAG2;SH3GLB1;RRP8;NUAK1
prerank,divalent inorganic cation homeostasis (GO:0072507),0.2813446269784404,0.9839575129755201,0.5384615384615384,0.6026042679278064,1.0,8/23,16.48%,JPH2;SNCA;WFS1;TMTC2;MT3;SLC8A1;ANK3;KCNA1
prerank,lipid biosynthetic process (GO:0008610),-0.25878047096725176,-0.9838847131004546,0.525,0.8277083449376382,1.0,16/79,17.89%,CYP51A1;IDI2;PDSS1;LIPG;ACSL6;SCD;PRLR;CYP19A1;MVK;SRD5A1;ACSM6;ACSM4;ACSF3;AGPAT5;ACSL5;RDH8
prerank,negative regulation of binding (GO:0051100),-0.2541032135268695,-0.9829410648510594,0.48148148148148145,0.8294074172225487,1.0,15/78,14.92%,GNL3L;LEF1;E2F1;MDFI;HMGA2;AURKB;CAV1;TFAP4;AURKA;SORL1;ZFPM1;CYP2D6;GTPBP4;NFKBIA;TTBK1
prerank,regulation of DNA repair (GO:0006282),-0.28671404502475,-0.9827760251690043,0.5454545454545454,0.829025313219528,1.0,21/41,41.04%,PML;POLH;EYA1;AXIN2;BRCC3;ERCC8;PARG;BRCA1;NPAS2;ERCC6;WRAP53;TIGAR;USP1;DHX9;UBE2N;DEK;EYA3;WRNIP1;UBR5;RPS3;RNF168
prerank,skeletal muscle contraction (GO:0003009),-0.3514680156811117,-0.9825150852681566,0.5142857142857142,0.8288340774579409,1.0,7/19,17.17%,TNNC2;CCDC78;MYH8;TNNI3;MYH14;JSRP1;STAC3
prerank,negative regulation of secretion by cell (GO:1903531),-0.2971900336909004,-0.9823656392289419,0.5609756097560976,0.8282180261021196,1.0,19/39,34.85%,IL11;OSM;CYP51A1;IL12B;RHBDF2;DRD2;GRM7;TNFRSF1B;FGF23;LIF;HRH3;ANXA1;NOTCH1;TRH;VAMP8;SLC30A1;IL1RAPL1;HTR1B;DRD3
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.29281190795833,-0.9823278269746196,0.527027027027027,0.827406092191402,1.0,15/39,38.18%,RFC3;ERCC5;RPA3;RFC5;GTF2H2;RFC2;POLD2;NTHL1;GTF2H3;UBC;RFC4;ERCC2;POLD1;FAN1;CUL4A
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.26673137967528554,-0.9823146691338508,0.44,0.8265201420779701,1.0,19/45,24.64%,TGFB2;EGR1;FOS;SOX9;SMARCA4;RELA;APLN;GNL3;TERT;TGFB1;IL10;LILRB4;PPARG;BMP4;SPI1;KLF5;GATA3;TNF;REST
prerank,negative regulation of neuron differentiation (GO:0045665),-0.3267880058085515,-0.9820185110157017,0.4520547945205479,0.8263551403785712,1.0,8/22,24.64%,SOX9;CALR;SIX3;BMP7;MED1;GSK3B;POU4F2;REST
prerank,regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.35179035656799224,-0.9816120192387604,0.5072463768115942,0.8266138909248557,1.0,4/16,16.28%,CXCL8;HMGA2;APOBEC3F;TOP2A
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.3222620660707625,-0.9809393623317473,0.5135135135135135,0.8275669158705249,1.0,8/26,19.59%,SLC12A2;SLC12A8;SLC9A7;ATP6V0A4;CLCN3;SLC12A3;SLC12A5;SLC12A1
prerank,fatty acid catabolic process (GO:0009062),0.22663764891230312,0.9804975702430494,0.55,0.6099739888024747,1.0,30/68,25.73%,PPARD;ACAD11;ECI2;ACADVL;CROT;ACAT1;BDH2;ACADS;HADHB;ECHDC2;LPIN1;ACAA2;PHYH;ABCD4;ACADM;SLC27A2;ALDH3A2;ABHD3;LPIN3;HADH;HADHA;MCEE;ECHDC1;ACAA1;ADIPOQ;SCP2;ACAD10;ECI1;ACADL;ADTRP
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.34107203164531025,-0.9802470318754212,0.5277777777777778,0.828548068879337,1.0,6/20,17.58%,CCND1;SPDYA;PROX1;TTBK1;PSRC1;STOX1
prerank,snRNA processing (GO:0016180),-0.34209538836155384,-0.979967024065343,0.48484848484848486,0.8283439164218593,1.0,11/20,44.28%,INTS7;INTS2;SAGE1;INTS6;CT45A1;CT45A5;CT45A3;INTS12;CT45A6;CT45A7;CT45A2
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.3176248138360392,-0.9798930722074299,0.5068493150684932,0.8276583969333641,1.0,13/32,25.96%,MGAT5;OCIAD2;IL7R;IL10;F2R;CRLF3;CENPJ;IL26;CRLF2;TNF;IL10RA;NOTCH1;CCL5
prerank,embryonic axis specification (GO:0000578),-0.3569472473601629,-0.9796500632501826,0.4603174603174603,0.8274481155259479,1.0,5/16,22.36%,TDGF1;WNT7A;PTCH1;RIPPLY1;SMAD6
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.2723931130316778,0.9796254370504229,0.48,0.6116231654267791,1.0,8/17,23.49%,GPIHBP1;NR1H2;ANGPTL4;LPL;NR1H3;HDAC9;PCSK5;SORT1
prerank,prostanoid metabolic process (GO:0006692),0.28555435354705316,0.979615411628331,0.41379310344827586,0.6110705666786448,1.0,5/18,12.73%,PTGS1;HPGD;HPGDS;AKR1C2;AKR1C1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.2905070174590184,0.9795144541409415,0.5,0.6106356620146299,1.0,5/21,10.43%,PPARD;SORBS1;MTOR;EEF1A2;CREB1
prerank,translational termination (GO:0006415),-0.25075224192554346,-0.9790102481079194,0.5119047619047619,0.8284026575356688,1.0,35/95,34.81%,MRPL19;ABCE1;MRPL3;MRPS18C;GADD45GIP1;GFM2;MRPL17;MRPS16;MRPL13;MRPL48;MRPL30;MRPS35;MRPL53;MRPS31;MRPL47;MRPL9;MRPS23;MRPL50;MRPL14;MRPL37;GSPT1;MRPL42;DAP3;MRPS12;MRPS22;MRPL15;MRPL57;APEH;MRPS30;MRPS18A;MRPL4;MRPS11;MRPL52;MRPS33;MRPL44
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.3330228310059645,0.9788002228389548,0.4444444444444444,0.6116774369682296,1.0,9/16,19.93%,ECSCR;GPER1;CCL2;RGCC;PDCD4;ITGA4;ANO6;CD40;AKR1C3
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.37120008980686703,-0.9787176898576712,0.47761194029850745,0.8282070380282733,1.0,8/16,32.28%,PAH;TH;AANAT;ASMT;SMOX;TPH2;DDC;DBH
prerank,protein localization to cell-cell junction (GO:0150105),0.3057687884264994,0.9781861050975386,0.5357142857142857,0.6123291982781792,1.0,5/15,15.37%,ARHGEF18;ACTB;CDH5;JAK1;MPP7
prerank,protein targeting to membrane (GO:0006612),0.20208493612108583,0.9776522424870097,0.5384615384615384,0.6129215591908229,1.0,30/84,22.47%,NACAD;MICALL1;MYO1C;ZDHHC7;ZDHHC15;ZDHHC22;PEX19;CHMP4A;ZDHHC18;RAB8B;PXMP2;PARD3;GOLGA7;VPS37D;TAOK2;VPS37A;ARL6;RTP5;ZDHHC1;SRP14;ZDHHC20;SGTA;SEC62;ALDH3A2;ZDHHC11;PEX11B;NACA;SDCBP;RTP1;PEX12
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.28695797990378213,0.9774404831337271,0.5185185185185185,0.612815716254352,1.0,8/23,17.68%,HDAC4;C1QTNF3;CLK2;NUPR1;CRY1;INS;SOGA1;CBFA2T3
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.2648690056532316,-0.9771880448332491,0.5060240963855421,0.8315274761213074,1.0,23/65,35.21%,POLR2F;CCNK;CDK7;CDK12;EAF1;GTF2H2;MLLT3;NCBP1;POLR2J;NELFCD;POLR2D;POLR2I;GTF2H3;EAF2;CCNH;LEO1;CDC73;ADRM1;GTF2F2;ERCC2;CDK13;CTR9;SSRP1
prerank,mRNA export from nucleus (GO:0006406),-0.25726118199813697,-0.9769953941714734,0.4772727272727273,0.8311042982423269,1.0,48/102,36.46%,ZC3H11A;U2AF1;NUP155;THOC3;NUP37;NUP210;CPSF3;NUP107;RANBP2;MAGOHB;NUP35;NUP50;SEH1L;NCBP1;NUP205;EIF4E;NUP88;SRSF9;ALYREF;POLR2D;NUP93;POM121;RAE1;NXF3;MAGOH;CPSF2;GLE1;NUP43;NUP160;NUP153;NDC1;DDX39A;SMG1;CPSF4;NXT1;THOC2;NUP62;NUP98;SEC13;SLBP;AGFG1;RBM8A;EIF4A3;THOC6;NUP214;CDC40;FIP1L1;SMG7
prerank,engulfment of apoptotic cell (GO:0043652),-0.35310737971417056,-0.9763699414750847,0.4925373134328358,0.8318489105037539,1.0,5/15,15.51%,XKR9;XKR5;XKR6;THBS1;XKR7
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.3163791952708909,-0.9763034051761923,0.4925373134328358,0.8310900478531741,1.0,11/28,22.38%,GPR18;DRD2;GRM1;GPR157;GPR35;GNA15;GPR174;F2R;P2RY10;GPR55;HTR2C
prerank,natural killer cell activation involved in immune response (GO:0002323),-0.3414605818777464,-0.9761374479761813,0.5138888888888888,0.8306985424321923,1.0,14/21,41.66%,IFNK;CORO1A;IFNE;IFNB1;CD244;IFNA1;IFNA21;IFNA4;IFNA7;IFNA14;IFNA10;IFNA17;IFNA2;IFNA16
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.23919663811370087,-0.9749117227127935,0.6111111111111112,0.833036839465004,1.0,33/119,23.47%,CDH3;CLDN1;MYC;AREG;CCL24;FOXE3;PAX2;WNT5A;SOX9;PKHD1;PROX1;EPGN;SEMA5A;AKT3;ZBED9;WNT7A;KDR;MMP12;REG3A;NRAS;CCL26;STAT5A;NOD2;NME1;PIK3CD;BMP4;HPN;EGF;MDK;NRARP;NODAL;VASH2;GDF2
prerank,regulation of multicellular organismal development (GO:2000026),-0.3315829455575589,-0.9748030627807324,0.4430379746835443,0.8323834085332557,1.0,5/27,5.89%,CDK1;OAS2;GBX2;RACGAP1;DUSP9
prerank,regulation of osteoblast differentiation (GO:0045667),0.2193625696921036,0.9746535631813605,0.5454545454545454,0.6193451578862893,1.0,17/79,13.65%,IL6R;FERMT2;WWTR1;ATF4;DDR2;TWIST2;CHRD;HDAC7;ZHX3;BMPR1A;PRKACA;PRKD1;FGFR2;SUFU;MEF2C;TMEM64;SKI
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.24967584870027434,-0.9745392789811519,0.5056179775280899,0.8322298695433394,1.0,26/87,24.64%,MYC;DPEP1;IFI6;LAMP3;PAX2;NAIP;CD44;SYK;PMAIP1;XIAP;THBS1;NLRP12;FOXL2;NLRP3;F2R;CARD9;CSNK2A1;BLID;RPS6KA3;CARD16;NODAL;TNF;CLEC7A;ARL6IP1;HMGB1;REST
prerank,maintenance of protein localization in organelle (GO:0072595),0.32253350828715754,0.9743296539405718,0.4074074074074074,0.6196778382692414,1.0,9/19,22.72%,SUPT7L;SKP1;ARL2;HK2;TAPT1;HK1;BBS4;MORC3;BCL3
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.25965079681081554,0.974196467371721,0.5483870967741935,0.6196044303707617,1.0,8/29,13.33%,MOAP1;NGF;BAG3;DAB2IP;TNFRSF1A;DEDD;BCL2;GABARAP
prerank,intermediate filament organization (GO:0045109),-0.3593936116616999,-0.9738947704610076,0.5555555555555556,0.833072611863325,1.0,5/17,9.87%,EPPK1;PKP1;DSP;BFSP2;TCHH
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.313993593092583,-0.9737506920435147,0.4857142857142857,0.8325919842383781,1.0,7/20,22.04%,IL4I1;PRKDC;PRDM1;PRELID1;ZNF683;CRTAM;CD2
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.21826948649051356,0.9737339899272786,0.5789473684210527,0.6198397811440399,1.0,11/62,10.81%,TLR3;DEFB124;BCL10;MAP3K14;TBKBP1;UBB;DAB2IP;TLR9;TICAM2;TAB1;TNFRSF1A
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.24592598440670857,0.9736995842363119,0.48148148148148145,0.6192846051657945,1.0,9/36,13.84%,MAPT;RNF122;UBB;PID1;SOD1;SLC25A36;ARL6IP5;BCL2;BAD
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.26112281691342687,0.9734452427733591,0.48148148148148145,0.6193465462302759,1.0,7/27,13.39%,PLN;CACNA1C;CTNNA3;ANK2;ATP2A2;CAMK2D;PDE4D
prerank,RNA metabolic process (GO:0016070),0.19023619148943466,0.9730545368952734,0.5,0.6197738015265939,1.0,23/130,13.12%,RBPMS;ADARB1;NOVA1;PABPN1;DDX24;DDX39B;PCBP3;HNRNPH3;SIDT2;DDX17;RBMS1;RBM6;RBM4;CELF2;RNASEH2C;HNRNPH2;ALKBH1;RBFOX2;ADARB2;RBM5;SKIV2L;METTL3;RNASE1
prerank,cation transport (GO:0006812),-0.23738156702700114,-0.9728404602273146,0.5217391304347826,0.8342632430085285,1.0,37/169,17.29%,SLC12A2;SLC4A11;SLC6A14;SLC6A20;SLC5A10;SLC5A2;KCNG2;KCNJ13;PKD1L3;TRPM2;SLC34A3;SLC38A5;SLC6A6;LRP2;SLC7A1;KCNJ15;TRPM8;KCNS1;RHBG;SLC5A6;SLC22A1;SLC5A8;KCNN4;TRPM1;SLC7A6;SLC11A2;CNGB3;KCNS2;KCNH4;SCN8A;KCNJ4;NDFIP2;SLC18A2;KCNA3;CATSPER3;KCNK1;SLC12A3
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.30428981106027353,-0.9727102228055939,0.5,0.833760146283945,1.0,7/27,19.85%,DUOX2;HBA1;NOX1;PRDX4;DUOX1;CYBA;PRDX5
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.35303889083187084,-0.9725498398663017,0.4927536231884058,0.8331544948898472,1.0,5/21,10.22%,MAD2L1;UBE2C;FBXO5;UBE2S;PLK1
prerank,response to copper ion (GO:0046688),0.2716294493232923,0.972378456581012,0.6129032258064516,0.6209304079467589,1.0,8/22,17.29%,PRNP;AQP1;SNCA;MT1X;MT1M;MT3;MT1A;MT1E
prerank,female gonad development (GO:0008585),-0.3390079159821239,-0.971760014157171,0.4794520547945205,0.8343023433462925,1.0,5/22,14.62%,CEBPB;INHBA;CYP19A1;NUP107;FOXL2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.3355590396956949,-0.971634278807728,0.4430379746835443,0.8338155653208069,1.0,5/17,18.56%,TRIB3;SOX9;APOC1;SLC22A13;BRCA1
prerank,regulation of phosphate metabolic process (GO:0019220),0.30541113240010315,0.9716285576363078,0.4838709677419355,0.6220656105093207,1.0,4/16,12.49%,PSEN1;SIRT2;GNB3;CD24
prerank,phagosome maturation (GO:0090382),0.2443522061108113,0.9713631102277642,0.5,0.6224315169782301,1.0,11/37,19.17%,ATP6V1G2;RAB34;ATP6V1E1;MCOLN1;RAB31;TCIRG1;ATP6V0E2;ATP6V1H;RAB14;ATP6V0A1;ATP6V1D
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.2917212668307112,-0.9712168961040888,0.48717948717948717,0.8341339911394658,1.0,8/32,18.13%,PFKFB3;GAPDHS;PFKFB4;ZBTB20;BEND3;IFNG;MLXIPL;PFKFB1
prerank,steroid biosynthetic process (GO:0006694),-0.269578295779482,-0.9711101186588412,0.47058823529411764,0.8335010116068247,1.0,33/65,40.44%,BAAT;OSBPL3;CYP51A1;SQLE;AKR1C4;CYP7B1;PRLR;CYP19A1;DHCR7;SRD5A1;SC5D;CYP39A1;RDH8;AKR1D1;TM7SF2;SLC27A5;SERPINA6;HSD3B1;SRD5A2;HSD3B7;MSMO1;FDXR;HSD17B4;HSD17B10;EBP;OSBPL2;INSIG1;HMGCR;ACOT8;CYP7A1;CYP8B1;OSBP;STAR
prerank,positive regulation of positive chemotaxis (GO:0050927),0.29223001340743215,0.9708268203187991,0.3870967741935484,0.6234481674515309,1.0,6/16,15.43%,VEGFB;F2RL1;SCG2;NTF3;VEGFC;NTRK3
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.33438612423876457,-0.9702709349833895,0.5125,0.8348719104213135,1.0,12/21,33.02%,IL4I1;TNFAIP3;JAK3;VTCN1;LST1;TIGIT;PIBF1;FOXJ1;PTPN22;LAX1;BANK1;SAMSN1
prerank,monocyte chemotaxis (GO:0002548),-0.28501790424377665,-0.9695801141334761,0.5180722891566265,0.8360413610693733,1.0,15/37,25.96%,TNFSF11;CCL24;CCL20;CCL22;PTPRO;CCL4;CCL3;CCL17;RPS19;CCL26;CCL1;XCL2;XCL1;ANXA1;CCL5
prerank,mitochondrial translational termination (GO:0070126),-0.2503868478054868,-0.9694974986615673,0.5189873417721519,0.8354598009909129,1.0,40/88,42.79%,MRPL19;MRPL3;MRPS18C;GADD45GIP1;GFM2;MRPL17;MRPS16;MRPL13;MRPL48;MRPL30;MRPS35;MRPL53;MRPS31;MRPL47;MRPL9;MRPS23;MRPL50;MRPL14;MRPL37;MRPL42;DAP3;MRPS12;MRPS22;MRPL15;MRPL57;MRPS30;MRPS18A;MRPL4;MRPS11;MRPL52;MRPS33;MRPL44;MRPS34;MRPL28;MRPL45;PTCD3;MTRF1L;MRPL36;MRPL11;MRPL22
prerank,tetrapyrrole metabolic process (GO:0033013),-0.34329149499568457,-0.969478341776883,0.5492957746478874,0.8346372635527156,1.0,6/20,25.76%,TCN1;MMACHC;ABCB6;MMAA;PRSS3;MMAB
prerank,regulation of response to biotic stimulus (GO:0002831),-0.30961199654152205,-0.9694535889210132,0.5375,0.833838439736605,1.0,8/29,26.80%,LRP8;XIAP;GATA6;CD55;ERAP1;TKFC;SAMHD1;PTPN22
prerank,peptidyl-lysine modification (GO:0018205),-0.25210932013895604,-0.9686371756425942,0.5806451612903226,0.8349747907181498,1.0,41/98,35.05%,LOXL2;HDAC10;NUP155;RNF212B;NUP37;LIPT2;EYA1;NUP210;NUP107;RANBP2;NUP35;METTL21C;NUP50;SEH1L;NUP205;NUP88;CTH;PLOD3;NUP93;POM121;RAE1;GCSH;NUP43;NUP160;NUP153;NSMCE2;RNF113A;NDC1;METTL21A;NUP62;SENP1;SUMO4;NUP98;P3H4;EGR2;RANGAP1;ESCO1;ATP7A;UBA2;ZNF451;NUP214
prerank,hepaticobiliary system development (GO:0061008),-0.3268805873763596,-0.9686062992722888,0.5571428571428572,0.8341919134033674,1.0,10/20,28.20%,PROX1;CEBPA;MET;PCSK9;NF1;NKX2-8;LSR;XBP1;WNT4;NIPBL
prerank,regulation of catabolic process (GO:0009894),-0.3367060083415204,-0.968582473073814,0.5875,0.8334545188777002,1.0,4/17,17.75%,FAP;CHEK2;ODC1;MDM2
prerank,ceramide biosynthetic process (GO:0046513),-0.2836372381199515,-0.9683775481182859,0.5308641975308642,0.8330399041894989,1.0,15/41,26.83%,CERS6;ST8SIA6;SPTLC1;ASAH2;PNPLA1;ALOX12B;ALOXE3;SPTLC2;SMPD2;SPTSSB;DEGS2;B4GALT6;CERS2;GBA;CYP4F22
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.303091230728315,-0.9682859186273131,0.5,0.831470099941314,1.0,12/31,32.87%,POLR2F;CDK7;GTF2H2;NCBP1;POLR2J;POLR2D;POLR2I;GTF2H3;CCNH;RNGTT;GTF2F2;ERCC2
prerank,7-methylguanosine RNA capping (GO:0009452),-0.303091230728315,-0.9682859186273131,0.5,0.831470099941314,1.0,12/31,32.87%,POLR2F;CDK7;GTF2H2;NCBP1;POLR2J;POLR2D;POLR2I;GTF2H3;CCNH;RNGTT;GTF2F2;ERCC2
prerank,negative regulation of cytokine production (GO:0001818),0.1795327628594983,0.9678701243249188,0.5714285714285714,0.6295163180199985,1.0,50/173,19.02%,CD34;PRNP;SYT11;APOD;NPTN;VSIG4;RAC1;HDAC7;ZFP36;NLRX1;ASB1;TWSG1;C1QTNF3;UBA7;NCKAP1L;TRIB2;F2RL1;CUEDC2;SSC5D;ELANE;TAX1BP1;RNF216;CEACAM1;TLR9;DHX58;GPNMB;PIN1;CX3CL1;OTUD5;TNFRSF21;PTGER4;LGALS9;RGCC;MAPKBP1;DDIT3;HOMER3;IL12A;HOMER2;SFTPD;MAP2K5;GAS6;PDCD4;RNF135;KLF4;RARA;DLL1;INHA;PCBP2;GPATCH3;RPS6KA5
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.31148303148942885,-0.9669443464514335,0.4875,0.8341666708107284,1.0,5/24,11.10%,RBP2;CYP27B1;CYP24A1;LRP2;TTPA
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.2806502202241705,-0.966585702471013,0.5185185185185185,0.834145658001396,1.0,16/41,27.80%,IL11;SERPINE1;TNFAIP3;ICAM1;SEMA5A;THBS1;KDR;IL10;HLA-G;FASLG;GATA3;TNF;PRKCI;IL13;CD160;TEK
prerank,protein modification by small protein conjugation (GO:0032446),0.16167760615924204,0.966434819581306,1.0,0.6325514029708368,1.0,65/383,14.06%,DTX3;ASB2;FBXO32;HIF3A;PDZRN3;ARRDC4;TRIM39;BCL10;PIAS3;FBXO10;FBXO9;UBE2D4;KLHL21;PJA2;ZSWIM8;UBE2G1;TRIM6;SKP1;KCTD10;VPS11;DCUN1D4;LZTR1;CAND2;FBXL7;ASB5;FBXL5;UBE2F;ASB1;UBE2Q2;UBE2E1;UBB;RRAGA;ANAPC16;NEDD8;KLHL41;UBA7;MUL1;MYLIP;TRIM23;UBE2G2;TRIM47;RNF14;SPSB1;KLHL20;TRIM21;RNF25;SAE1;TRIM63;TRIM69;PIAS1;TRIM34;TRIM52;RNF220;RNF38;FBXW5;AAAS;TMEM129;RNF7;RTF1;PIAS4;EPAS1;PAF1;UBE2B;UBE2H;MIB2
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.3179007718818968,-0.9663118393131261,0.4647887323943662,0.8339576342408093,1.0,4/25,5.28%,TBX20;FOXD1;CRB2;ENG
prerank,cellular response to peptide (GO:1901653),0.2325395998537816,0.9661628293858137,0.47368421052631576,0.6326575907242667,1.0,13/57,13.65%,PSEN1;LDOC1;PRNP;ZFP36L1;NGFR;EPHA4;GPER1;CACNA2D1;CD36;ATP1A3;APP;NTRK1;VIM
prerank,protein-containing complex subunit organization (GO:0043933),0.2066149667214391,0.9661616622040903,0.5,0.6320573463307901,1.0,27/108,16.24%,SH3BGR;VAMP2;WASF1;MITF;FAS;LAMC1;SKAP2;WDR19;OCLN;TEAD2;TSPAN4;TEAD1;DLG4;NCKAP1L;WASF3;TRAF1;ST13;TCAP;CAPN3;PARD3;WIPF1;SLC9A3R2;VAMP3;KIFAP3;SNX9;DMTN;LIN7A
prerank,cell chemotaxis (GO:0060326),-0.25557344064097964,-0.9657717275969278,0.5194805194805194,0.8343867360806028,1.0,15/64,15.95%,CCR8;PDGFRB;LEF1;CXCR4;CCL20;CXCR5;EPHA2;CXCR2;CCR4;SEMA5A;CXCR6;CCR3;CXCR1;CCRL2;CXCR3
prerank,ncRNA metabolic process (GO:0034660),-0.2960995847509382,-0.965694386488082,0.5263157894736842,0.8337277167667778,1.0,12/34,29.39%,PIWIL1;TRIM71;HENMT1;XPO5;NIFK;FKBP6;TDRD1;RAN;EXD1;KHSRP;ASZ1;DROSHA
prerank,regulation of cholesterol efflux (GO:0010874),-0.3010172978748803,-0.9647939745200015,0.47297297297297297,0.8351264307761918,1.0,7/32,14.28%,SHH;CAV1;CETP;ABCA12;PON1;PTCH1;NFKBIA
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.27582228220558536,-0.9641113324875481,0.48717948717948717,0.8360593305527787,1.0,15/48,25.34%,INHBA;NANOS3;UHRF1;AGT;TGFB1;WNT7A;GRM5;NFKBIA;NOLC1;EIF4E;PKP3;CNDP1;MAPKAPK5;VPS35;GBA
prerank,negative regulation of blood pressure (GO:0045776),0.29631231370716904,0.9638948449624164,0.47058823529411764,0.6366641376331478,1.0,4/15,13.93%,SCPEP1;NOS1;NPPA;NPPB
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.26641139243573686,-0.9631957633118036,0.55,0.837727344119379,1.0,13/54,17.54%,MTHFD1L;DHFR;MTHFD1;ALDH5A1;GPT2;SHMT2;ASS1;ALDH18A1;NAGS;MTHFD2;SLC46A1;SLC19A1;GLUD2
prerank,fatty acid biosynthetic process (GO:0006633),0.20008662443342912,0.9630845547207678,0.5,0.6376996361522451,1.0,13/68,13.24%,HACD1;ELOVL4;FADS3;DEGS1;HPGD;CYP1A1;GSTM4;SCD5;ACSM5;HACD4;LPL;LIAS;PLA2G1B
prerank,integrated stress response signaling (GO:0140467),-0.3480703940121067,-0.9630468384020577,0.5396825396825397,0.8371903128208068,1.0,3/15,8.19%,CXCL8;IGFBP1;EIF2AK1
prerank,negative regulation of interleukin-8 production (GO:0032717),0.29170127402793666,0.9623876441913886,0.4,0.6389996393278726,1.0,11/18,27.14%,SSC5D;ELANE;TLR9;MAPKBP1;MAP2K5;KLF4;BCL3;OTUD7B;ARRB1;TLR6;CACTIN
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.34428511196492306,-0.961995745688486,0.4857142857142857,0.8391782296890574,1.0,13/18,44.24%,HSD17B12;ACSL6;ACSF3;ACSL5;ELOVL7;TECR;ACSL3;HACD2;ACSL4;ACSBG2;ACSBG1;ELOVL3;ELOVL6
prerank,lung development (GO:0030324),-0.2824624577445365,-0.9611385659594488,0.5064935064935064,0.8404705208894728,1.0,9/35,16.84%,STRA6;SHH;WNT7B;PROX1;CEBPA;RBP4;DNAAF1;CHI3L1;WNT11
prerank,regulation of protein-containing complex assembly (GO:0043254),0.20581567192596867,0.9609775441504449,0.6923076923076923,0.6416472607629803,1.0,25/107,16.14%,CRYAB;GSN;CLU;LGALS3;ULK1;STX1B;TRABD2B;TIRAP;BCL2L11;HDAC6;CD36;DAB2IP;RHOC;CDH5;NAPB;TAL1;BRK1;RAF1;SELP;FBLIM1;TFRC;HSPA8;MPP7;SH3GLB1;STXBP1
prerank,protein deacylation (GO:0035601),0.27811507797899104,0.9609518136145101,0.5416666666666666,0.6410603587508603,1.0,5/23,6.41%,SIRT2;HDAC7;HDAC4;HDAC6;HDAC5
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.31074511314959835,-0.9609283825822496,0.5625,0.840241764734209,1.0,14/31,35.99%,TOMM20L;HSPD1;PEX7;ROMO1;TIMM23;TOMM40;DNAJC15;GRPEL2;PEX10;AIFM1;PEX16;TIMM50;PEX1;GRPEL1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.2160490379652379,0.9602315285010533,0.625,0.6422396365380982,1.0,8/52,10.32%,PTGS1;GSTM2;PLA2G4B;FADS3;DEGS1;SCD5;PLA2G4C;EPHX1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.23229815358989403,0.9595249061193664,0.5,0.6432650002866955,1.0,12/46,14.61%,NLGN2;TSHZ3;ATP1A2;GRIK3;CCL2;NLGN1;NLGN3;SYT1;MEF2C;TPRG1L;NRXN1;CDH2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.2935313068523993,0.959247580847579,0.45161290322580644,0.6432654823558163,1.0,5/19,12.90%,PSEN1;WFS1;ATP2A2;CAMK2D;BCL2
prerank,positive regulation of chemokine production (GO:0032722),0.22857834626769302,0.9591352998827757,0.5625,0.6429442264447748,1.0,14/53,14.49%,IL6R;TLR3;DEFB124;TIRAP;OAS1;HMOX1;F2RL1;TLR9;TSLP;APP;LPL;ADCYAP1;IL7;LGALS9
prerank,regulation of intracellular transport (GO:0032386),0.22766264679509826,0.9588833232440785,0.5172413793103449,0.643001732855519,1.0,11/36,16.90%,CRYAB;RBM4;MAP2;NUMA1;HAP1;RAB11B;AAAS;GRIPAP1;REEP5;INPP5F;NDEL1
prerank,diol metabolic process (GO:0034311),-0.34707719457400477,-0.9588001033637757,0.5362318840579711,0.8447796642091445,1.0,6/16,23.55%,ASAH2;GCHFR;SGPP2;PTS;GCH1;DEGS2
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.23393776075672315,-0.9587657797721926,0.5384615384615384,0.8439580859683171,1.0,44/120,32.59%,IL1A;MIF;EPHB2;TNFAIP3;IL23A;OAS2;WNT5A;PF4;IL17A;RASGRP1;SYK;MAPKAPK2;CCL3;IL12B;ARFGEF2;THBS1;IL10;OAS3;IFNG;CYBA;CHRNA7;IRAK3;NOD2;MMP8;PTPRJ;CD2;TYROBP;LBP;GHSR;CLEC7A;HMGB1;IL37;LTF;LILRA4;TWIST1;PTPN22;TMEM106A;ZC3H12A;PTPN11;DHX9;IGF1;AGER;CX3CR1;LILRA5
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.2612086509832043,0.9581677683861435,0.5925925925925926,0.644286992254519,1.0,4/29,5.16%,KANK2;UFSP2;VPS11;WBP2
prerank,presynapse assembly (GO:0099054),-0.34216032215824177,-0.9574655948423341,0.5584415584415584,0.8462661031829128,1.0,6/17,13.55%,WNT5A;LRP4;CEL;PCLO;PTPRD;WNT7A
prerank,histone deubiquitination (GO:0016578),0.28149267753952145,0.9574255550298022,0.5,0.6454188606983396,1.0,4/17,13.22%,KAT2A;USP21;USP51;UIMC1
prerank,protein secretion (GO:0009306),-0.26059437377529715,-0.957224256801648,0.5517241379310345,0.8460251949900333,1.0,17/63,20.84%,PDX1;CTAGE4;CTAGE9;CTAGE8;CTAGE15;CTAGE6;PDIA4;RAB15;MTTP;RAB8A;RAB3D;MAFA;CANX;FAM3B;TVP23C;CTAGE1;MIA2
prerank,heart trabecula morphogenesis (GO:0061384),0.31825783602907537,0.9570667039177778,0.5882352941176471,0.645662433787428,1.0,5/19,6.99%,HEY1;S1PR1;TGFBR3;BMPR1A;RBPJ
prerank,melanosome localization (GO:0032400),0.28351601273772936,0.9569955225012802,0.5,0.6451709035868475,1.0,12/21,21.33%,BBS5;RAB11B;BBS2;ARL6;RAB27A;BBS7;BBS4;BLOC1S6;VPS33A;MKKS;MYO5A;BLOC1S5
prerank,positive regulation of peptidase activity (GO:0010952),-0.3393307542986549,-0.9569324549274795,0.582089552238806,0.8458348947833373,1.0,6/20,30.10%,PRSS22;CTSH;PRELID1;PSME2;CLDN4;PSME3
prerank,telomere capping (GO:0016233),-0.3709984064261569,-0.9565038713138608,0.5342465753424658,0.846038352368543,1.0,3/15,11.07%,DCLRE1C;PRKDC;DCLRE1B
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.3000910785007857,-0.9560823905423748,0.5625,0.8461913813129697,1.0,10/36,19.66%,NEK2;AURKB;MAPK15;NAF1;ATR;FBXO4;CCT6A;CCT2;PRKCQ;HMBOX1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.2589631086384506,-0.9550781589469569,0.5647058823529412,0.8479001015509591,1.0,10/72,8.16%,FAP;GZMB;TNFAIP3;CTSV;CTSH;ADAMTS12;ISG15;HM13;PMAIP1;CHMP4C
prerank,sodium ion transport (GO:0006814),-0.2576840102249081,-0.9545049614257274,0.5609756097560976,0.8485500535580618,1.0,33/88,28.64%,SLC12A2;SLC4A11;SLC6A14;SLC6A20;SLC5A10;SLC5A2;SLC34A3;SLC6A6;SLC24A1;HCN1;SLC5A6;SLC5A8;ASIC2;SLC6A4;SCN8A;SLC6A18;CATSPER3;KCNK1;SLC12A3;SLC4A8;SLC12A1;ASIC5;PKD2L1;ATP1B1;HCN4;SCN10A;SLC5A1;CATSPER4;SLC5A4;SCN1A;SLC17A3;SLC6A12;SLC6A5
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.2540265187230488,-0.9542852580932297,0.5595238095238095,0.8481872008140885,1.0,15/69,17.22%,FOXQ1;KIF14;POU4F1;NAIP;FOXB1;SIX1;TOX3;PRKCG;FGF20;PLA2G3;CITED1;NTF4;F2R;SET;ADAM8
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2048323420919967,0.9539991526459544,0.6470588235294118,0.6515682246622394,1.0,6/62,4.07%,BCL2L2;CLU;HSPB1;ACKR3;YBX3;MAPK7
prerank,negative regulation of immune response (GO:0050777),0.16945242831859708,0.9537378795664248,1.0,0.6516925563842263,1.0,38/174,16.71%,GLP2R;POMC;RAMP1;LGALS3;ADCY5;VIP;ADCYAP1R1;TRAFD1;GNG2;SIRT2;ADRB3;MAPK14;ADCY4;PRKAR2B;VIPR2;PRKACA;RAMP3;RAMP2;MUL1;PTH1R;TRIM21;DHX58;CREB1;ADM;AVPR2;P2RY11;SPINK5;PTGER4;ADCYAP1;GPBAR1;ADCY9;GGT5;ADCY2;ADRB2;MAPKBP1;ADCY6;GPR20;PPM1B
prerank,leukotriene metabolic process (GO:0006691),-0.3145755841596164,-0.9536717708526378,0.5263157894736842,0.8488924705635346,1.0,4/21,12.62%,DPEP1;MAPKAPK2;CYP4F3;ALOX12
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.3555019866899224,-0.9534668910570185,0.5138888888888888,0.8485157887559092,1.0,6/15,23.09%,SRMS;IGF1R;ITK;KDR;TEC;DDR1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.2131838390152502,-0.9533016570441725,0.6224489795918368,0.8481753769881448,1.0,120/422,26.99%,CEBPB;POU5F1B;TCF7;FOXP3;ZNF695;SOX14;HMGA1;SOX4;ZNF460;WWC1;MYBL2;E2F1;SPIN2A;HDAC10;PML;POU6F2;CHEK2;CHD7;ARNTL2;CALR;HMGA2;ZNF92;ZNF280A;ENG;SOX1;IFNK;SIX1;CEBPA;AJUBA;ZNF648;NKX6-2;ZNF714;ZNF730;ZNF217;NFKB2;ZNF675;ELAVL2;NUP107;RELA;ZNF486;ZNF114;VGLL1;VHL;ZNF138;BRCA2;RNF6;TBX4;ZNF737;LIN54;PAK6;ZNF430;ONECUT1;NUP35;MYB;MAFA;ZNF205;ZNF708;ZNF280B;ZNF680;NFXL1;SLC39A8;ZNF253;SKOR2;ZNF195;POFUT1;GCM1;MLXIPL;PTF1A;GTF2IRD1;NFYA;PHB;ZNF488;MYBL1;TRRAP;SPTY2D1;FUS;KLF1;ACTR8;NANOG;NIF3L1;ZNF716;CARM1;PSPC1;ZNF492;PRKCQ;SCRT2;CRX;CDK11B;ZNF90;TRIM22;SCRT1;SPI1;ZNF141;ZNF280C;ZNF221;ZNF100;ZFHX3;MYCBP;RUNX3;ATRX;EZH2;DLX4;CREBBP;HES6;REST;SBNO1;RHOH;NOTCH1;KMT2D;ZNF281;PLAG1;ESRRG;ZNF2;SP3;FOXN2;ZNF506;MYT1;ACTN4;SPIN2B;NSD1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.353925848265768,-0.9530863257269202,0.5230769230769231,0.8478995025388003,1.0,7/15,36.91%,KIF20B;SHTN1;ARFGEF1;ROCK2;TEK;RAP1B;LLGL2
prerank,positive regulation of neutrophil migration (GO:1902624),0.28805819896363904,0.9528738506960291,0.46875,0.6530564224776398,1.0,5/21,7.59%,THBS4;RAC1;TIRAP;CCL21;NCKAP1L
prerank,purine ribonucleotide transport (GO:0015868),0.3017921663409079,0.9528515819043505,0.5675675675675675,0.652484761691612,1.0,5/17,11.66%,SLC25A4;SLC25A42;SLC25A41;ABCC5;LRRC8A
prerank,negative regulation of inflammatory response (GO:0050728),0.17650051630612087,0.952206122493693,0.5,0.6533016167827855,1.0,40/205,14.58%,GLP2R;PPARD;NR1D1;POMC;RAMP1;ADCY5;VIP;ADCYAP1R1;GNG2;MAPK7;ADRB3;MAPK14;ADCY4;PRKAR2B;PTGIS;PRKCD;VIPR2;GPER1;PRKACA;RAMP3;C1QTNF3;RAMP2;PTH1R;ELANE;CDH5;CREB1;GPS2;FNDC4;TNFRSF1A;ADM;AVPR2;P2RY11;PTGER4;ADCYAP1;GPBAR1;ADCY9;GGT5;INS;LRFN5;ADCY2
prerank,cellular response to amyloid-beta (GO:1904646),0.287157837369583,0.951749657612279,0.5882352941176471,0.6538547045283603,1.0,10/35,15.25%,PSEN1;PRNP;NGFR;EPHA4;CACNA2D1;CD36;ATP1A3;APP;NTRK1;ADRB2
prerank,regulation of monocyte differentiation (GO:0045655),-0.36958794136448325,-0.9511654831203171,0.4868421052631579,0.8519898751959695,1.0,2/15,4.29%,MYC;DCSTAMP
prerank,chordate embryonic development (GO:0043009),-0.2674775212280807,-0.9505553976989375,0.5903614457831325,0.8527727094486575,1.0,15/58,18.56%,COL1A1;WNT7B;TRIM71;WNT5A;CHD7;FUT8;PROX1;GRHL2;BMP7;TGFB1;RBP4;PTCH1;ADAM10;WNT11;BRCA1
prerank,monocarboxylic acid transport (GO:0015718),-0.25856301194224607,-0.9504442069371086,0.5119047619047619,0.8522737759157738,1.0,17/55,24.08%,ABCC11;SLCO1B3;SLC16A13;SLC10A1;AKR1C4;ABCC2;SLC5A6;SLCO1A2;SLC22A13;SLC16A3;SLCO3A1;SLC16A6;SLC16A11;SLC10A5;ABCB4;SLCO1C1;SLC27A5
prerank,mitochondrion organization (GO:0007005),0.1702567767643457,0.9502367863906347,0.5,0.6567647835254933,1.0,33/163,16.33%,MTFR1L;SLC25A4;COX7A1;CAV2;WASF1;MFN2;PLD6;ATCAY;PID1;MUL1;HAP1;RHOT2;BNIP3;TRAK2;MEF2A;PYROXD2;OXA1L;MTX3;HK2;SLC25A36;MGARP;BNIP3L;GABPB1;ATPAF1;AIP;MIEF2;SIRT3;HIGD1B;CHCHD4;TOMM7;HIGD1A;TIMM44;MFF
prerank,membrane lipid biosynthetic process (GO:0046467),0.21721995621055856,0.9495921931779976,0.5714285714285714,0.6580241127162599,1.0,11/54,10.21%,HACD1;ELOVL4;SPTLC3;DEGS1;CERS4;HACD4;PRKD1;KDSR;VAPA;PPM1L;CERS1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.28719762709110225,0.9494117827407641,0.46875,0.6579922044665374,1.0,6/20,13.07%,HEY1;SPRY1;TGFBR3;RBPJ;OLFM1;HEY2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.27407648610360846,-0.9485981395361007,0.5571428571428572,0.8563968460741775,1.0,10/39,21.30%,THY1;LRP8;DOK7;CAV1;FCGR1A;AGT;GRM5;LILRB4;RAP2B;CASS4
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.2554382234158645,0.9481961781209027,0.53125,0.6600692027087932,1.0,11/36,15.71%,NCK1;NACC2;BCL2L11;UBB;SOD1;NUPR1;BOK;NKX3-1;BCL2;BAD;DDIT3
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.338858565430424,-0.9479858850256255,0.5972222222222222,0.8571446495197729,1.0,3/17,5.96%,CCND1;SPDYA;PROX1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.2636161585963066,-0.9474833911208194,0.5949367088607594,0.8576229911375048,1.0,21/69,23.29%,PDGFRB;SRMS;EPHB2;EPHA1;JAK3;ABL2;IL21;IGF1R;SYK;PRLR;ZAP70;ITK;KDR;FYN;TTBK1;TEC;FGFR4;PIBF1;LCK;DDR1;LYN
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.30252677671647704,-0.9474783897525673,0.5733333333333334,0.8567901017373809,1.0,10/27,34.30%,WDR43;BTBD18;CDK12;EAF1;NELFCD;EAF2;LEO1;CDC73;CDK13;LDB1
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.2675087194468265,-0.9474199347881394,0.475,0.8560433319206491,1.0,14/44,28.48%,WDR43;IL1B;HEATR1;RELA;TGFB1;PNPT1;MYCN;LIN28A;UTP15;BMP4;ZPR1;LIN28B;SETX;NMD3
prerank,neurogenesis (GO:0022008),-0.27456698012256053,-0.9470861597207662,0.6266666666666667,0.8561346700306697,1.0,10/43,16.40%,WNT2;TGFB2;WDR62;CXCR4;SIX1;PRDM12;PCSK9;GCM2;CHAC1;GCM1
prerank,positive regulation of interferon-beta production (GO:0032728),-0.29732582413307446,-0.9465678158149745,0.5294117647058824,0.8564927110792415,1.0,13/34,30.74%,RIPK2;OAS2;ISG15;POLR3B;OAS3;POLR3C;POLR3A;POLR3G;TLR7;TLR8;IRF7;PTPN11;DHX9
prerank,RNA 3'-end processing (GO:0031123),0.20751972413848796,0.9462186491573461,0.7,0.6643797594263634,1.0,12/64,10.15%,SRSF5;PABPN1;DDX39B;CPSF7;CASC3;SRSF4;RPRD1A;POLDIP3;U2AF1L4;THOC5;SRSF11;TUT1
prerank,potassium ion transmembrane transport (GO:0071805),-0.22762727513617104,-0.9458247922164731,0.5666666666666667,0.8575867461968327,1.0,38/136,24.41%,SLC12A2;KCNG2;SLC12A8;KCNE3;SLC9C1;KCNJ13;KCNQ1;KCNC3;SLC9A7;KCNA7;SLC24A1;HCN1;KCNK12;KCNJ15;KCNS1;KCNV2;KCNN4;KCNH7;ATP12A;KCNS2;KCNH4;KCNJ4;KCNA3;KCNK1;SLC12A3;KCNJ14;KCNK13;SLC12A5;SLC12A1;PKD2L1;ATP1B1;KCNC2;HPN;HCN4;KCNJ6;KCNJ18;KCNJ3;KCNB2
prerank,positive regulation of histone methylation (GO:0031062),-0.31634641217744663,-0.9458160316062743,0.5903614457831325,0.8567510440142788,1.0,9/25,22.14%,DNMT1;DNMT3B;PRDM12;MYB;PAXIP1;AUTS2;BRCA1;RIF1;JARID2
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.27855359272390906,0.9454454021516473,0.5151515151515151,0.6655714901148637,1.0,7/26,9.53%,DUSP22;ZFP36L1;INPP5K;DUSP3;ZFP36;DAB2IP;EGFR
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.2823416280817389,-0.9447899239194821,0.55,0.8586689069571609,1.0,6/34,13.07%,TP73;GZMB;E2F1;PMAIP1;TFDP1;ZNF205
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.23207926282136257,-0.9444750323867445,0.6555555555555556,0.8584983458744939,1.0,20/126,14.76%,MYC;IRS1;PDGFRB;TGFB2;SOX4;IL1B;EREG;EIF3C;ATAD5;PRKDC;DNA2;NLRC5;PASK;CDT1;NAT10;NOX1;THBS1;NLRP12;KDR;HSPH1
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.20896062436409701,-0.9441345096890287,0.6262626262626263,0.8585168095680313,1.0,81/311,23.29%,IL1A;CXCL1;DPEP1;CXCL3;CXCL8;CXCL2;IRS1;WNT2;TESC;CXCL5;CD80;WNT7B;POU4F1;IL1B;CXCL9;PTK7;CXCL11;FOLR1;SERPINE1;TNFAIP3;CARD17;PAX2;EGR1;FOS;WNT5A;KCNQ1;SOX9;TNIP3;ABL2;PF4;MMP3;AQP9;DEFA6;FFAR2;HCN1;GLRA1;CXCL6;RELA;TSHR;MMP9;IRAK1;SH3BP4;CXCL10;FZD10;UCP1;GLRA2;PDXP;WNT8B;CFTR;PTPRK;IL10;TNFRSF1B;NLRP3;AANAT;ROMO1;ADAM9;WNT11;PF4V1;P2RY2;IL36B;PLAA;CD86;NOD2;BRINP2;WNT3A;PRDX5;TNFSF4;WNT3;DEFA1;KCNC2;IL36RN;ERCC6L2;CARD16;AKAP9;HCN4;POU4F2;AXL;RUVBL2;ABCB4;LBP;LYN
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.35256774493923165,-0.9439076816094271,0.5294117647058824,0.8583327764905858,1.0,3/15,12.61%,MAD2L1;FBXO5;LIMK1
prerank,cellular response to hexose stimulus (GO:0071331),-0.31775488108784444,-0.9431979444459888,0.5342465753424658,0.8591115820745084,1.0,4/24,6.69%,SOX4;PAX2;ZBTB20;IGF1R
prerank,transferrin transport (GO:0033572),0.23816509052942864,0.9430405564460433,0.5555555555555556,0.6709856161153507,1.0,14/35,22.09%,ATP6V1G2;ATP6V1E1;MCOLN1;ARHGAP1;RAB11B;TCIRG1;ATP6V0E2;TFRC;ATP6V1H;ATP6V0A1;ATP6V1D;ATP6V0D1;HFE;ATP6V0E1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.2956316523449585,0.9429851461207456,0.5,0.6704584484014174,1.0,4/17,9.72%,FLCN;HDAC4;PID1;NUPR1
prerank,positive regulation of DNA binding (GO:0043388),-0.291610011513299,-0.9429823303799866,0.5189873417721519,0.8588437136920047,1.0,19/31,39.16%,POU4F1;MMP9;PLAUR;TGFB1;NME1;MMP8;PPARG;EGF;POU4F2;GATA3;HMGB1;TWIST1;FOXC1;SUMO4;IGF1;TRAF6;HMGB2;HES1;PYHIN1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.18336066850261085,0.9424398500098595,0.7,0.6712140123591862,1.0,13/123,6.37%,GNAO1;PPP3CB;FZD7;GNG2;CALM1;FZD4;ROR2;DVL3;RAC1;PRICKLE2;AP2M1;RHOA;DVL2
prerank,organic substance transport (GO:0071702),-0.23011298459120427,-0.9416517840994527,0.5909090909090909,0.8615346327866819,1.0,25/129,17.39%,TCN1;ABCA13;SLC22A11;ABCC11;SLCO1B3;MFSD2B;ABCG5;CETP;AQP9;ARRDC5;LRP2;ABCA12;SLC22A1;ABCG8;SLCO1A2;CENPF;MFSD12;SLC6A4;ABCB6;TAP1;SLC18A2;SLC22A25;CD3G;SLC22A9;SLC19A1
prerank,Golgi to endosome transport (GO:0006895),0.29445022994653725,0.9415377656819538,0.5454545454545454,0.6728218994246745,1.0,7/15,23.49%,CORO7;KLHL20;GBF1;AP2A1;RAB14;SYS1;SORT1
prerank,proteasomal protein catabolic process (GO:0010498),0.17403671393904435,0.9413185213229015,0.75,0.6726467941885871,1.0,38/202,15.75%,UCHL1;NR1D1;TRIM9;FBXL22;ZSWIM8;UBE2G1;SIRT2;GID4;FBXO44;KCTD2;RNF122;TRIM3;KCTD10;ARNTL;KLHL42;RNF185;PSMC5;UBXN6;ZFAND2B;RNF216;SPSB1;KLHL20;ARMC8;UBXN1;HECTD3;KLHL22;RNF4;FBXW5;FEM1B;PSMD9;UBE2B;TBL1X;BTRC;RNF41;UBE4B;PSMB6;DDIT3;APPBP2
prerank,negative regulation of proteolysis (GO:0045861),0.24593593920091053,0.9405775290299605,0.5,0.6738058034693332,1.0,8/39,9.81%,TIMP4;PRNP;TIMP3;TIMP2;HDAC6;EPHA4;TRIM21;PLAT
prerank,translational elongation (GO:0006414),-0.236770165792587,-0.9405422444816023,0.5517241379310345,0.8633788198855595,1.0,37/101,34.81%,MRPL19;MRPL3;MRPS18C;GADD45GIP1;GFM2;MRPL17;MRPS16;MRPL13;MRPL48;GFM1;MRPL30;MRPS35;MRPL53;MRPS31;TUFM;MRPL47;MRPL9;MRPS23;NEMF;MRPL50;MRPL14;MRPL37;EEF2;MRPL42;DAP3;MRPS12;MRPS22;MRPL15;MRPL57;MRPS30;MRPS18A;MRPL4;EEF1D;MRPS11;MRPL52;MRPS33;MRPL44
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.3209691804539336,-0.9400428241015635,0.5675675675675675,0.8639550340773751,1.0,7/22,26.08%,PRKDC;HMGA2;ACTR2;RIF1;DTX3L;ERCC6;WRAP53
prerank,regulation of cellular component biogenesis (GO:0044087),0.2172742179738617,0.9390017237522026,0.6,0.6767949571330611,1.0,6/38,9.34%,RAP1A;VPS11;TIE1;CD36;DAB2IP;RDX
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.26660189529160827,0.9384585667542313,0.5238095238095238,0.6776336790146525,1.0,7/23,14.96%,PLA2G5;PLA2G4B;ABHD4;PLA2G4C;PLA2G6;PLA2G1B;PLA2G4A
prerank,DNA conformation change (GO:0071103),-0.3230457454219805,-0.9379256255336758,0.5866666666666667,0.8681458211461289,1.0,5/18,16.28%,TOP3B;TOP1MT;HMGB3;TOP1;TOP2A
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.3305771878358438,-0.9377591348360562,0.5625,0.867738620398926,1.0,10/27,29.49%,POP1;RNASEH1;CPSF3;LACTB2;PDE12;XRN1;SLFN14;ZC3H12A;CSTF3;ZC3H12D
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.3302521705530433,-0.9376344668513078,0.6133333333333333,0.8672144774206126,1.0,7/24,31.25%,GNL3L;NAT10;SLX1A;XRN1;PIF1;SLX4;HNRNPC
prerank,protein tetramerization (GO:0051262),-0.2620307310773965,-0.9374366439762106,0.5542168674698795,0.8668366759769934,1.0,22/70,25.01%,GRIN2B;MAT1A;GBP5;HPRT1;TRPM2;KCNC3;HOMER1;TK1;TDO2;HCN1;SHMT2;AQP2;AQP5;FARSB;CTH;PKD2L1;FARSA;SSBP1;ACOT13;ACACA;SYCP1;SAMHD1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.23801248888954335,0.9372690593349612,0.5909090909090909,0.6798748736517606,1.0,9/36,10.72%,ZFP36L1;MAPK14;HOXA5;ZFP36;NCKAP1L;MAPK11;ANKRD54;TAL1;ARNT
prerank,regulation of protein secretion (GO:0050708),-0.22489657329680274,-0.9368180476660234,0.5888888888888889,0.8677246244367992,1.0,36/119,28.05%,IL1A;SLC12A2;SSTR5;TGFB2;IL1B;KCNG2;CACNA1D;CYP51A1;MYH10;SYT7;IL12B;RHBDF2;DRD2;NOS2;TGFB1;CD2AP;CACNA1E;IFNG;ADAM9;EXPH5;ADAM8;SLC2A1;TTN;ITPR2;ATP13A2;KCNC2;UQCC2;MTNR1B;HNF4A;TNF;GLP1R;CCL5;KCNJ11;ANG;CACNA1A;EZR
prerank,negative regulation of actin filament polymerization (GO:0030837),0.2674458780765094,0.9366850730978666,0.4166666666666667,0.6804692911761551,1.0,10/24,22.05%,GSN;KANK3;PRKCD;MYADM;PFN2;KANK1;SSH3;TWF2;PFN1;SLIT2
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.3117392848695506,-0.9366111488033855,0.5342465753424658,0.8674230283224709,1.0,8/23,21.44%,PFKFB3;GAPDHS;PFKFB4;ZBTB20;IFNG;MLXIPL;PFKFB1;EGF
prerank,negative regulation of RNA splicing (GO:0033119),0.28408801069814404,0.9362165234123921,0.5333333333333333,0.6808044591551422,1.0,4/19,14.08%,PTBP2;SRSF4;PCBP4;SRSF7
prerank,adenine nucleotide transport (GO:0051503),0.298838353105002,0.9361661516941042,0.6060606060606061,0.6802547042655418,1.0,5/18,11.66%,SLC25A4;SLC25A42;SLC25A41;ABCC5;LRRC8A
prerank,erythrocyte differentiation (GO:0030218),-0.2804791466776938,-0.9355921524431348,0.5584415584415584,0.8690606454651331,1.0,13/43,25.28%,INHBA;TSPO2;JAK3;ZFPM1;LYAR;MED1;DYRK3;RPS19;KLF1;PTPN2;LYN;HIPK2;HSPA9
prerank,oligodendrocyte differentiation (GO:0048709),-0.33020470807677216,-0.9347257415674515,0.5135135135135135,0.8702746194342708,1.0,5/18,19.23%,SHH;SOX9;ZNF488;CDK5;MYRF
prerank,cilium organization (GO:0044782),0.17349974275518243,0.9344617599926834,0.5,0.6836264863241786,1.0,50/211,17.95%,FLNA;GSN;EHD2;RFX2;TTLL3;PARVA;DZIP1;BBS5;WDR19;PKD2;RAB23;ARL3;CYS1;HDAC6;RABL2B;BBS1;IFT81;PKD1;ABLIM3;NPHP3;INTU;TXNDC15;FBF1;UBXN10;CLUAP1;INPP5E;MARK4;RAB11FIP3;IFT46;CC2D2A;RAB8B;CEP126;TMEM138;STK36;CEP89;BBS2;KIFAP3;GBF1;IFT80;EXOC7;RILP;PTPN23;ARL6;RILPL2;CEP19;BBS7;IFT43;FAM161B;BBS4;IFT172
prerank,phospholipid metabolic process (GO:0006644),-0.2615018573903155,-0.9343386073751161,0.525,0.8704533912238577,1.0,16/64,17.43%,CYP2W1;PNPLA3;IDI2;ANGPTL3;PLA2G4D;LIPG;PLA2G4E;PLBD1;PLA2G2F;PLA2G3;PDXP;ACP6;AGPAT5;ABHD12;SMPD2;PLAA
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.2821649497779412,-0.9339437104675483,0.5526315789473685,0.8704529659452391,1.0,8/28,23.37%,GPR143;CCL4;CCL3;NEUROD2;GBP1;PLEK;SLA2;CLEC7A
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.2928268531758745,-0.9334352634133389,0.5641025641025641,0.8710229154798399,1.0,5/28,9.09%,MYC;INHBA;CCL3;ZFPM1;ZNF675
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.2223118886290418,0.9333028312005517,0.7619047619047619,0.6854657820499693,1.0,9/54,7.39%,AGTR1;SNCA;CDKN1A;SIRT2;RAC1;PLIN5;MAPK14;PID1;PDGFB
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.18370670214396143,0.9332246286755553,0.6,0.6850235122026899,1.0,26/134,14.58%,GLP2R;POMC;RAMP1;ADCY5;VIP;ADCYAP1R1;GNG2;ADRB3;MAPK14;ADCY4;PRKAR2B;VIPR2;PRKACA;RAMP3;RAMP2;PTH1R;CREB1;ADM;AVPR2;P2RY11;PTGER4;ADCYAP1;GPBAR1;ADCY9;GGT5;ADCY2
prerank,carbohydrate biosynthetic process (GO:0016051),-0.31494782282656875,-0.9329974840083245,0.6438356164383562,0.8711935650594781,1.0,12/24,35.75%,ST8SIA6;FUT8;FUT1;FUT7;FUT2;FUT6;FUT5;MPDU1;B4GALT1;B3GALT2;ST3GAL2;FUT3
prerank,cation transmembrane transport (GO:0098655),-0.27909850861556934,-0.9328303586563318,0.5301204819277109,0.8707809050524046,1.0,14/44,21.09%,SLC6A20;SLC7A5;TRPM2;SLC38A5;SLC7A1;TRPM8;TRPM1;MFSD12;ASIC2;SFXN2;SLC25A19;ATP13A2;PKD2L1;ATP1B1
prerank,lipid droplet organization (GO:0034389),0.27771740328027433,0.9327873036202611,0.5517241379310345,0.6854631310198577,1.0,7/22,14.54%,ZFYVE1;PLIN5;PLA2G4C;BSCL2;FITM1;CIDEC;CDS2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.32984702682014233,-0.9327848124343033,0.5507246376811594,0.8700196070328177,1.0,8/21,30.02%,HS6ST2;NDST3;GLCE;HS3ST4;EXT1;HS2ST1;HPSE;SULF2
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.287733950026012,0.9326437691371944,0.5806451612903226,0.6850766873170708,1.0,8/16,27.14%,PRPF39;PSIP1;WBP4;SRSF1;SFSWAP;SART1;SRSF12;CACTIN
prerank,sterol metabolic process (GO:0016125),-0.2437651295182063,-0.9326080828968512,0.5125,0.869581516908112,1.0,14/64,17.49%,SULT2B1;CYP51A1;ANGPTL3;SQLE;CETP;NR0B2;CYP7B1;CYP19A1;CYP26C1;DHCR7;SC5D;CYP26A1;CYP39A1;NSDHL
prerank,acidic amino acid transport (GO:0015800),-0.3200114564587102,-0.9325067412438478,0.5844155844155844,0.8690553804357005,1.0,9/18,39.38%,LRRC8E;SLC6A6;LRRC8D;SLC25A13;SLC25A22;SLC6A13;SLC1A1;SLC9A3R1;SLC1A6
prerank,cellular response to nitrogen compound (GO:1901699),-0.3381312893794505,-0.932436876524561,0.5753424657534246,0.8683799683601422,1.0,7/18,26.43%,BLM;TIMELESS;DDI1;ATRX;FMR1;ROCK2;PDE12
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.28547989912528215,0.9322627253628735,0.43478260869565216,0.6853322326260165,1.0,6/20,12.60%,TMBIM1;AP2M1;PID1;RHOQ;PKDCC;NUMB
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.26312879958326496,0.9318994105089669,0.6190476190476191,0.6855507013649225,1.0,4/24,4.80%,GADD45B;PJA2;HAND2;SASH1
prerank,regulation of integrin activation (GO:0033623),-0.3329778510076812,-0.9312650650840515,0.5571428571428572,0.8703676913176698,1.0,3/15,3.69%,KIF14;FERMT1;SKAP1
prerank,mitochondrial membrane organization (GO:0007006),0.2451097325793591,0.9310460180919019,0.5454545454545454,0.6867380961481023,1.0,6/28,13.84%,SLC25A4;MFN2;BNIP3;MTX3;BCL2;BAD
prerank,regulation of translational initiation (GO:0006446),0.22036220370559587,0.9307280317381175,0.4666666666666667,0.6870827986821901,1.0,14/66,15.39%,NCK1;ATF4;CTIF;HSPB1;EIF1B;EIF4EBP3;CSDE1;RBM4;EIF1;ALKBH1;EIF4A2;EIF5;EIF4H;PAIP2B
prerank,positive regulation of translation (GO:0045727),-0.23134796272613187,-0.9306902452344791,0.6590909090909091,0.8708923813337377,1.0,38/95,36.93%,SOX4;EIF3C;PRKDC;PASK;BOLL;EIF2S3;NAT10;THBS1;EIF5AL1;FASTKD2;JMJD4;POLR2D;EIF5A;LIN28A;UQCC2;CDC123;LARP4;RMND1;NPM1;FMR1;LARP4B;TRMT10C;EIF6;CCL5;CD28;TRUB2;EEF2;PKM;C1QBP;LARP1;DHX9;UHMK1;PLD1;FASTKD3;EIF4A3;YTHDF1;DAZ4;DAZL
prerank,positive regulation of histone modification (GO:0031058),0.23753454550509506,0.9301806817215775,0.5185185185185185,0.6880110652386238,1.0,13/33,19.02%,MAPK3;CDK9;NOS1;AKAP8L;SAP30BP;GLYR1;FAM47E;PAF1;TADA2B;CHTOP;ZBTB7B;AKAP8;RPS6KA5
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.24775561191591927,-0.9297714513020247,0.5851063829787234,0.8723560987742228,1.0,9/66,7.59%,MCIDAS;MYO10;USP6NL;TRPM2;MAPK15;CAV1;TBC1D14;EPHA2;DCDC2
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3075986366734507,0.9297176606032068,0.5,0.6882263130277851,1.0,2/15,3.49%,PYGM;CALM1
prerank,phospholipid transport (GO:0015914),-0.25824480993640003,-0.9278981972011177,0.6024096385542169,0.8760082905391918,1.0,15/53,26.44%,ATP11A;PRELID2;APOC1;SCARB1;MTTP;ABCA12;PRELID1;ATP9A;ATP10B;LDLR;OSBPL8;ATP11B;ABCB4;PITPNM1;ABCB1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.2550951737683502,0.9277287104696863,0.6923076923076923,0.6922497471931729,1.0,7/21,14.40%,GNB5;STAC;NPPA;STAC2;CACNB2;DMD;AHNAK
prerank,activin receptor signaling pathway (GO:0032924),-0.350654581650009,-0.9272666659200453,0.5866666666666667,0.8768863221733461,1.0,2/18,0.76%,TDGF1;INHBA
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.29671114781885927,0.927185697738478,0.53125,0.6928613094446701,1.0,4/15,14.32%,SORBS1;EPM2AIP1;PPP1R3E;INS
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.32020724019447994,-0.927149549963305,0.5,0.8762480052126345,1.0,7/20,24.00%,TNIP3;PIK3AP1;IRAK1;ITGB2;NMI;LBP;SCIMP
prerank,muscle tissue morphogenesis (GO:0060415),0.3043934017277267,0.9269500493430874,0.5806451612903226,0.692871499081227,1.0,6/16,13.07%,MYLK;EFEMP2;TGFBR3;ACTC1;TCAP;HEY2
prerank,positive regulation of response to wounding (GO:1903036),-0.28858893790870516,-0.926713344727221,0.5492957746478874,0.8764930479848775,1.0,9/27,24.05%,CLDN1;DUOX2;INSL3;DUOX1;REG3A;ARFGEF1;MDK;CLEC7A;ANXA1
prerank,regulation of primary metabolic process (GO:0080090),-0.23080361850861447,-0.9261422106741773,0.6521739130434783,0.8769477669080517,1.0,40/126,26.84%,CYP51A1;PSMB9;SQLE;PSMD14;TGS1;OAZ3;SCD;HELZ2;NQO1;MVK;MED1;ODC1;DHCR7;SC5D;FDPS;NFYA;PSMA3;SERPINA3;FGFR4;LDLR;CARM1;PPARG;FASN;TM7SF2;PSMB3;PSMC1;HNF4A;ACACA;PSMB11;AZIN1;CERS2;PSMA5;CREBBP;ROCK2;PSMB2;PSAPL1;PSME2;HMGCS1;PSMD12;PSMA7
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.3304957573790903,-0.9253366893126511,0.5384615384615384,0.8779434062312577,1.0,6/15,28.41%,NAA15;NAA35;AANAT;NAA20;CREBBP;NAA11
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.29886287418037705,0.9252052293855318,0.6428571428571429,0.6961892416243834,1.0,5/21,7.59%,THBS4;RAC1;TIRAP;CCL21;NCKAP1L
prerank,stabilization of membrane potential (GO:0030322),-0.3149534263477851,-0.9249742567050527,0.5147058823529411,0.8780710840942002,1.0,4/17,18.57%,KCNK12;KCNN4;KCNK1;KCNK13
prerank,histone ubiquitination (GO:0016574),-0.32167404301409197,-0.924965736453363,0.6,0.877231917623159,1.0,9/21,33.89%,UHRF1;RAG1;RNF40;DTX3L;LEO1;CDC73;HUWE1;UBE2N;CTR9
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.22089488159160686,0.9248222416105027,0.5769230769230769,0.6961600951857521,1.0,9/41,15.25%,CLU;CD63;CCL21;B2M;GH1;ANGPT1;NTF3;MAGI2;ANXA2
prerank,regulation of translation (GO:0006417),-0.22207450109425908,-0.9246946696008679,0.5957446808510638,0.8770358941863081,1.0,58/169,34.22%,ENC1;IGF2BP1;GZMB;IGF2BP3;SOX4;PUS7;EIF3C;TRIM71;PRKDC;CALR;DHFR;GRB7;NANOS3;NCL;IGF2BP2;CAPRIN1;SHMT2;PASK;MTIF2;NAT10;THBS1;TRAP1;CNOT1;NSUN3;GRM5;NCBP1;NOLC1;EIF4E;EIF2AK3;LIN28A;PKP3;MRPL13;CNOT10;RPS6KA3;LARP4;GAPDH;NPM1;FMR1;MAPKAPK5;LARP4B;GLE1;EIF6;CD28;NEMF;EEF2;GSPT1;RPS6KA1;SYNCRIP;OGFOD1;LARP1;DHX9;GEMIN5;PLD1;GIGYF2;TCOF1;EIF2AK4;PATL2;EIF4A3
prerank,regulation of interferon-beta production (GO:0032648),0.21400136278208803,0.9237114883517397,0.5714285714285714,0.6983078846210845,1.0,8/47,9.71%,TLR3;PTPRS;TIRAP;OAS1;RNF216;TLR9;DHX58;FLOT1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.29424273610638196,-0.9227988687771214,0.6142857142857143,0.8808948521207278,1.0,10/30,22.04%,GPR18;ADGRG1;RTN4R;COL3A1;GPR35;GPR174;F2R;SYNPO2L;P2RY10;GPR55
prerank,regulation of transferase activity (GO:0051338),-0.33969504787244637,-0.9227937806213937,0.6176470588235294,0.8800621313927608,1.0,10/17,41.43%,NLRC5;FEM1A;PARP4;SPTSSB;HMBOX1;JMJD8;SLAMF8;LDB1;SMG6;NABP2
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.2970336040882874,-0.9226526841805965,0.5833333333333334,0.8796148173914778,1.0,8/25,28.54%,CCNK;BTBD18;CDK12;HMGN1;ALYREF;ERCC6;LEO1;CDC73
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.28361525651141545,0.9221948798823966,0.5,0.7013217730272898,1.0,5/17,18.66%,ADRB3;ADRA2B;ADCY9;ADRB2;ADRA1A
prerank,ventricular septum development (GO:0003281),-0.28680129435384993,-0.9221247250194914,0.5405405405405406,0.880177414896452,1.0,7/38,8.66%,STRA6;TGFB2;SOX4;MATR3;ROBO2;PROX1;ZFPM1
prerank,dendritic spine organization (GO:0097061),-0.2996270183145544,-0.92177117016157,0.5833333333333334,0.8801475234507392,1.0,8/27,20.94%,EPHB2;EPHB3;IGF1R;WNT7A;FYN;SHANK1;CHRNA7;DOCK10
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.23120051305903846,-0.9214052459306629,0.651685393258427,0.8802251156197128,1.0,30/129,19.38%,CEP72;CDK1;SKP2;NEK2;PHLDA1;CEP250;CDC25C;CHEK2;MASTL;PKMYT1;HAUS7;AJUBA;AURKA;CDK7;PLK1;FOXM1;HAUS6;CEP76;USH1C;CEP152;CDC25A;NDE1;PLK4;TAF2;SDCCAG8;CENPJ;CKAP5;ALMS1;CEP78;CEP41
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.2870639545185302,-0.9213599179153317,0.5882352941176471,0.8794506775278537,1.0,4/27,7.78%,AREG;EREG;EPGN;GPRC5A
prerank,limb development (GO:0060173),-0.30578166887462965,-0.9212788381846106,0.625,0.8788452519049733,1.0,12/26,29.96%,KREMEN2;CHD7;LRP4;SMOC1;TBX4;PTCH1;ZNRF3;COMP;ZNF141;SALL1;FGF8;KDF1
prerank,triglyceride homeostasis (GO:0070328),-0.3074375038165852,-0.9210362044619202,0.6172839506172839,0.8785623383380217,1.0,11/27,30.62%,DGAT2;ANGPTL3;CETP;SCARB1;MLXIPL;GCKR;HNF4A;XBP1;LIPC;PLA2G12B;FITM2
prerank,mitochondrial transport (GO:0006839),0.2086111255062484,0.9200633646873005,0.55,0.7053986101184042,1.0,12/53,16.87%,SLC25A4;MFN2;BNIP3;OXA1L;MGARP;BCL2;AIP;BAD;TOMM7;TIMM44;MFF;TIMM22
prerank,ion homeostasis (GO:0050801),-0.2988069908131402,-0.9190412164831017,0.6027397260273972,0.8825004381371201,1.0,8/30,22.09%,SLC4A11;SLC30A2;SLC4A9;WNK4;P2RY2;SLC4A8;SLC12A5;HCN4
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.1866557999486111,0.9188043835773263,0.8333333333333334,0.707821765197269,1.0,43/163,18.20%,TEAD3;PPARD;NR1D1;WWTR1;MAPK3;CDK9;KAT2B;THRB;HDAC7;TEAD2;PGR;RARB;TEAD1;HDAC5;NR1H2;TAF1C;RBPJ;THRA;NAT14;RXRG;NRBP1;NPPA;ERCC3;MAML1;NR1D2;RXRA;RXRB;NOTCH4;TBL1X;GTF2H4;RARG;NR4A1;TAF9B;NR4A3;NR1H3;NR2C1;NR3C1;RARA;NR2C2;POLR2A;AR;TAF11;RORA
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.3216217703008794,-0.918673742652435,0.5833333333333334,0.8824952338095479,1.0,4/19,14.33%,PMM2;GNPNAT1;GFPT1;PGM3
prerank,acute inflammatory response (GO:0002526),-0.31664994991969436,-0.9185216369975198,0.5443037974683544,0.8819893528617505,1.0,9/21,30.42%,CEBPB;C2CD4A;VNN1;TNFSF4;CD6;LBP;IL22;C2CD4B;PLSCR1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.30675372411651386,-0.9184240541056915,0.5915492957746479,0.8814043999710384,1.0,10/22,29.06%,MASTL;MGAT5;STYXL1;PPP1R1B;GSK3B;TNF;BOD1L2;PPP4R4;ROCK2;FKBP1B
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.2342326518873705,-0.9183476895479866,0.6451612903225806,0.880713947850816,1.0,16/108,9.51%,NOTUM;FOXP3;DKK4;PTK7;FOLR1;SHISA2;ATP6V1C2;RNF43;TNFAIP3;DEPDC1B;MDFI;LGR6;RUNX1;DCDC2;CBFB;SMARCA4
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.27651533574780945,0.9182411948344491,0.625,0.7085776201292111,1.0,4/22,6.58%,CLU;CASP3;IFNGR1;EPHA4
prerank,mRNA 3'-end processing (GO:0031124),0.2019782590351084,0.918138027321945,0.8,0.7081402060440025,1.0,18/77,14.08%,SRSF5;PABPN1;DDX39B;CPSF7;LSM11;CASC3;SRSF4;RPRD1A;POLDIP3;U2AF1L4;THOC5;AHCYL1;SRSF11;TUT1;APP;PAF1;SRRM1;SRSF7
prerank,regulation of B cell differentiation (GO:0045577),-0.30905799388899646,-0.916694159070084,0.6233766233766234,0.8836860562985823,1.0,3/18,7.05%,INHBA;IL4I1;SYK
prerank,canonical Wnt signaling pathway (GO:0060070),-0.24696492860143873,-0.9166783470965281,0.5822784810126582,0.8828883422385086,1.0,8/67,5.95%,CDH3;TCF7;WNT2;WNT7B;LEF1;WNT5A;BCL9L;CAV1
prerank,detection of mechanical stimulus (GO:0050982),-0.3322003257928114,-0.916561052164899,0.6133333333333333,0.8822781769174673,1.0,7/19,20.72%,PKD1L3;LHFPL5;PKD2L2;PKD1L1;JUP;TTN;PKD2L1
prerank,regulation of lipid storage (GO:0010883),-0.3243225169767421,-0.9160817997788798,0.5925925925925926,0.8827245962587219,1.0,9/20,31.12%,MEST;C3;IKBKE;NFKBIA;PTPN2;TNF;FBXW7;ZC3H12A;PLA2G10
prerank,acyl-CoA metabolic process (GO:0006637),-0.27571644514236116,-0.914723933413345,0.589041095890411,0.8851795620733461,1.0,17/36,39.29%,BAAT;ACSL6;THEM5;ACOT12;ACOT6;ACSM6;ACSM4;ACOT13;ACACA;HMGCS1;DBI;GLYAT;ACOT4;ACOT11;ACOT7;HMGCS2;ACOT8
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.24169274402364968,0.9146287740588328,0.5172413793103449,0.7149027639492914,1.0,7/22,22.04%,UBB;ERCC3;XPA;GTF2H4;CETN2;DDB2;GTF2H5
prerank,peptide biosynthetic process (GO:0043043),-0.22845047722675837,-0.9139880823845475,0.6630434782608695,0.8859602934268668,1.0,64/155,45.88%,IGF2BP3;PCSK1;RHCE;YARS2;RPL39;MRPL3;RRBP1;MRPS18C;GGTLC2;SRBD1;RHD;RPS19;FARSB;ASMT;RPS21;MRPS16;MRPL13;RPL36;ZAR1L;ABCF1;RPL23A;GGTLC1;RPL37;MRPL9;RPL8;MRPL37;GSPT1;MRPL42;MRPS12;HBS1L;MRPS18A;COPS5;RPS18;RPS7;MRPS11;MRPL52;MRPS33;RPS2;RPL41;RPS24;RPS4Y2;RPL32;RPS29;RPL27A;MRPL28;RPL35;RPS3;RPS4X;RPL4;RPL30;RPS6KB2;RPL37A;MRPL36;RPL18;ZAR1;MRPL11;RPL19;AGO2;RPL38;RPLP2;RPL12;RPS14;MRPS18B;RPS3A
prerank,sensory perception (GO:0007600),-0.26635028023531604,-0.9138513704408241,0.6588235294117647,0.8854091047987283,1.0,13/49,17.81%,MME;PRDM12;CHRNB2;ADGRV1;PROK2;NIPSNAP1;OBP2A;USH1C;ALOXE3;USH2A;CLRN1;OPRM1;CHRNA7
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.32215145563085557,-0.913139210338002,0.582089552238806,0.8862079868176855,1.0,3/21,9.71%,FAP;MTRNR2L3;BCL2L1
prerank,BMP signaling pathway (GO:0030509),0.2127079496459222,0.9129564041958452,0.8333333333333334,0.7178495248737572,1.0,13/62,13.49%,TMEM100;RGMA;MAPK3;SMAD2;CHRD;TGFBR3;BMPR1A;SMAD7;SMAD4;SMAD3;SMAD9;MEGF8;GDF5
prerank,actin filament-based transport (GO:0099515),-0.30836035553198027,-0.9124382893414085,0.5774647887323944,0.8868600175358754,1.0,10/21,32.72%,MYO1H;MYO6;MYO5B;MYO1E;FNBP1L;SYNE2;MYO1F;ACTN4;MYO19;MYO1G
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.2549122043590714,-0.9122887211237588,0.6235294117647059,0.8864151454046618,1.0,20/65,30.10%,CHEK1;PSMB9;AURKB;PSMD14;AURKA;CHMP4C;RFPL1;PSMA3;NABP1;PSMB3;PSMC1;GPR132;PSMB11;PSMA5;PSMB2;PSME2;PSMD12;PSMA7;PSME4;PSME3
prerank,regulation of programmed cell death (GO:0043067),-0.22058235347907534,-0.9114403801349947,0.6483516483516484,0.8874086570551432,1.0,66/180,32.88%,TP73;LRP8;GLS2;POU4F1;SKP2;PAX2;SOX9;JAK3;CALR;TRIM24;ALPK2;PMAIP1;STAT1;TOX3;TNFSF9;LGALS1;DCPS;PAX8;TNFRSF10C;BCL6;CXCL10;AGT;WRN;TNFRSF10B;CITED1;CASP2;PRELID1;IGFBP3;PERP;BIRC5;STK26;ACER2;PHB;CDK5;RTKN;TRAF2;USP17L1;NME1;ANP32A;FBXO11;USP17L4;POU4F2;OLFM4;TNF;USP42;BCL2L14;CREBBP;TM7SF3;ACTN4;RSL1D1;FANK1;USP17L18;TIGAR;BAX;USP17L22;NUP62;USP17L10;CD3E;NLRC4;USP17L13;USP17L20;STEAP3;NAE1;BID;TNFRSF10A;ANP32B
prerank,glycolytic process (GO:0006096),-0.2854024503001903,-0.9113794739520119,0.6582278481012658,0.8866874065617669,1.0,9/28,21.72%,GAPDHS;HKDC1;ENO4;PKLR;PGAM4;ALDOB;PFKFB1;LDHA;GAPDH
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.22790587969447326,-0.9110739764360504,0.6823529411764706,0.8865664606011808,1.0,32/130,26.84%,CDH3;COL1A1;LGR5;SOX4;PTK7;RUVBL1;PSMB9;PSMD14;CAV1;LGR6;AXIN2;XIAP;BAMBI;SEMA5A;SCEL;TGFB1;PSMA3;JUP;WNT3A;SFRP4;EGF;PSMB3;PSMC1;NRARP;PSMB11;PSMA5;AXIN1;PSMB2;PSME2;USP34;PSMD12;PSMA7
prerank,regulation of interleukin-8 production (GO:0032677),-0.23891242939479534,-0.9110194692465152,0.6436781609195402,0.8858539270568149,1.0,26/79,30.41%,IL1B;SERPINE1;IL17F;SYK;FFAR2;RELA;NOS2;ANXA4;IL10;CHI3L1;F2R;NOD2;CD2;LBP;TNF;CLEC7A;GDF2;ANXA1;HMGB1;TLR7;PTPN22;NLRP10;CD58;CD244;TLR8;MYD88
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.3104462293374536,-0.9097246262319377,0.5945945945945946,0.8880596112682905,1.0,8/20,30.42%,CHAC1;CHAC2;PTDSS1;GSS;GGCT;MGST2;GCLM;PLSCR1
prerank,positive regulation of ATPase activity (GO:0032781),0.23110678673641052,0.9095106548348716,0.7142857142857143,0.7249875189686376,1.0,12/42,17.02%,TPM1;ATP1B2;TOR1AIP1;GABARAPL2;DNAJB2;RGN;MYL3;FGF10;TNNT3;PFN2;MYL4;CHTOP
prerank,regulation of cell development (GO:0060284),-0.2611174820049988,-0.9090925881129925,0.5853658536585366,0.8884890476782078,1.0,3/39,1.66%,ASCL2;SIGLEC15;IL1B
prerank,mRNA metabolic process (GO:0016071),0.1961570082567931,0.9087889805364836,0.5625,0.7259945594287436,1.0,25/92,19.30%,SRSF5;PCBP3;LSM11;ALKBH5;ZFP36;SRSF4;PRKACA;NUDT16;AKAP8L;SRSF11;PRPF18;DXO;LSM10;METTL3;RNH1;SRSF7;RNASE4;CELF1;SF3B4;HIPK3;SRSF2;PCBP2;AGO4;SRSF1;ZFP36L2
prerank,regulation of transmembrane transport (GO:0034762),-0.279538336660743,-0.90846520858811,0.6125,0.8891603006786482,1.0,13/33,27.79%,TRIB3;KCNJ13;KCNJ15;KCNJ4;KCNJ14;SLC2A1;ACE2;SCN10A;KCNJ6;KCNJ18;KCNJ3;KCNJ11;KCNJ2
prerank,lipid transport (GO:0006869),-0.23260457115983774,-0.9079951486210774,0.6744186046511628,0.8894634354843206,1.0,18/102,13.82%,ABCA13;ABCC11;SLCO1B3;MFSD2B;SLC10A1;ABCG5;PRELID2;CETP;AKR1C4;ABCC2;SCARB1;MTTP;ABCA12;TTPA;ABCG8;SLCO1A2;GLTPD2;PRELID1
prerank,positive regulation of cellular component movement (GO:0051272),-0.29232098973230947,-0.9078759015780048,0.6282051282051282,0.8889151490217421,1.0,10/26,30.94%,DUOXA2;DUOX2;C1QTNF8;DUOX1;RPS19;LYN;TWIST1;ACTN4;ETS1;TGFBR1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.30324066785137094,-0.9076752736178951,0.6081081081081081,0.8885313581339654,1.0,5/23,15.05%,HNF1A;MED1;MED14;PAXIP1;MED13
prerank,regulation of neuroinflammatory response (GO:0150077),-0.32973665596678964,-0.9075321539533697,0.6438356164383562,0.8879914934008366,1.0,8/19,31.94%,IL1B;MMP3;MMP9;TNFRSF1B;MMP8;TNF;DAGLA;IGF1
prerank,negative regulation of lipid storage (GO:0010888),0.2917083388929902,0.9073427031553216,0.6296296296296297,0.7288875507927907,1.0,6/19,16.81%,PPARD;ITGB3;NR1H2;PNPLA2;CES1;NR1H3
prerank,protein import (GO:0017038),-0.24137622798040403,-0.907012509845659,0.6593406593406593,0.8884055427643364,1.0,39/88,40.61%,NUP62CL;NUP155;CSE1L;SYK;E2F3;NUP107;ACBD5;RANBP17;NXT2;NUP50;MMP12;NUP88;PEX13;NUP93;GCKR;POM121;RAN;TNPO3;HEATR3;NUP153;GDAP1;HSPA4;NXT1;KPNB1;NUP62;IPO11;PEX16;PEX3;LAMP2;SEC13;NUP214;IPO7;POM121L2;HSP90AA1;RPAIN;TPR;IPO5;POM121C;AKT1
prerank,mRNA transport (GO:0051028),-0.240357766668244,-0.9068425219389513,0.6363636363636364,0.8879515676946195,1.0,48/101,36.46%,ZC3H11A;U2AF1;NUP155;THOC3;NUP37;NUP210;CPSF3;NUP107;RANBP2;MAGOHB;NUP35;NUP50;SEH1L;NCBP1;NUP205;EIF4E;NUP88;SRSF9;ALYREF;NUP93;POM121;RAE1;NXF3;MAGOH;FMR1;CPSF2;GLE1;NUP43;NUP160;NUP153;NDC1;DDX39A;SMG1;CPSF4;NXT1;THOC2;NUP62;NUP98;SEC13;SLBP;AGFG1;RBM8A;EIF4A3;THOC6;NUP214;CDC40;FIP1L1;SMG7
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.341441017017837,-0.9063970837132234,0.6,0.8880847549219811,1.0,3/15,7.03%,ITGA5;FUT1;SMAD1
prerank,toll-like receptor signaling pathway (GO:0002224),0.19071603699454076,0.9063789678007639,0.7142857142857143,0.7304281865967296,1.0,19/85,16.50%,TLR3;BCL10;SCARA3;TIRAP;CTSS;COLEC12;OAS1;UBB;CD36;HSP90B1;TLR9;TICAM2;TAB1;RIPK1;LGALS9;MAP3K1;TLR1;UBE2D3;SFTPD
prerank,reverse cholesterol transport (GO:0043691),-0.33232672857255874,-0.9063220433252824,0.5972222222222222,0.8874366612283099,1.0,4/15,14.83%,LIPG;CETP;SCARB1;APOM
prerank,regulation of cell migration (GO:0030334),-0.203050586664213,-0.9055685836333136,0.7346938775510204,0.8884024094266245,1.0,61/390,14.44%,MMP7;CLDN1;CEMIP;THY1;DPEP1;COL1A1;KIF14;IFITM1;TDGF1;SHH;PLAU;PDGFRB;EPPK1;LAMC2;IL1B;GTSE1;MIF;LEF1;CCL24;KIF2A;EPHB2;FGF19;SERPINE1;MAZ;PARD6B;RCC2;CTSH;CEACAM6;EPHA1;FAM83H;ANGPTL3;BST2;GRB7;ENG;MAPK15;MGAT5;F7;CAV1;LGR6;IGF1R;PLET1;SORL1;CCL3;PECAM1;FGF20;SEMA4D;SEMA5A;DRD2;ITGAX;MMP9;GTPBP4;FGF3;STK24;THBS1;TGFB1;TMSB10;CXCL16;KDR;PTPRK;NF1;PLXNC1
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.2328282997222828,0.9052397817626567,0.6956521739130435,0.7320019667255998,1.0,8/37,11.29%,DYNC1I1;MYO1C;HAP1;KIF1A;PAFAH1B1;TRAK2;SYT4;MYO5C
prerank,response to tumor necrosis factor (GO:0034612),-0.22593667807267248,-0.9052215955204522,0.7078651685393258,0.8883464089402219,1.0,36/102,30.74%,CXCL8;TDGF1;UBD;CCL24;CCL20;CCL22;DCSTAMP;ADAMTS12;CCL4;CCL3;RELA;HYAL3;CXCL16;CCL17;GBP1;CHI3L1;ADAM10;ADAM9;CCL26;CCL1;BRCA1;GCH1;XCL2;XCL1;GATA3;OCSTAMP;BAG4;GBP3;GBA;CCL5;HAS2;ZC3H12A;TNFRSF11A;CD58;CCL7;DHX9
prerank,keratan sulfate metabolic process (GO:0042339),0.2244880630549568,0.9044981029657972,0.6,0.7333219144308974,1.0,8/33,14.84%,PRELP;OGN;B4GAT1;ST3GAL3;KERA;ST3GAL6;OMD;FMOD
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.26415964048555357,-0.9043528526322299,0.6172839506172839,0.889465302048412,1.0,6/33,12.61%,AREG;EREG;EPGN;MMP9;PLAUR;AGT
prerank,positive regulation of cilium assembly (GO:0045724),0.2948095130624435,0.90342981846412,0.5714285714285714,0.7348544858794936,1.0,5/16,17.86%,CROCC;HAP1;MARK4;TAPT1;BBS4
prerank,regulation of cellular metabolic process (GO:0031323),0.21464715679859311,0.9032561546876358,0.7142857142857143,0.7345049770030655,1.0,20/44,25.33%,AGPAT1;ACACB;RSPO1;PID1;FLOT1;GNB3;RNF41;ARF1;PDK2;PARL;LAMTOR1;COQ7;PDK3;CYP1B1;BTN2A2;PM20D2;PDK4;BCO2;ABCA2;PINK1
prerank,response to peptide hormone (GO:0043434),0.2048141317133678,0.9032137985111264,0.7777777777777778,0.7339772625430587,1.0,18/50,20.37%,ZFP36L1;TGFBR3;GPER1;SLC27A1;IGFBP5;STAT6;CREB1;EIF2B1;EPM2AIP1;TSC1;CRY1;GNAI1;EIF2B4;ZBTB7B;STAT3;CYP11A1;CELA2A;CYP11B1
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.24423950032543207,-0.9025087664295349,0.6625,0.8927285142523405,1.0,21/60,30.41%,IL1B;SERPINE1;SYK;FFAR2;RELA;NOS2;CHI3L1;F2R;NOD2;CD2;LBP;TNF;CLEC7A;GDF2;HMGB1;TLR7;NLRP10;CD58;CD244;TLR8;MYD88
prerank,protein-containing complex assembly (GO:0065003),0.1671288315126867,0.9023665144454197,1.0,0.7354337015030497,1.0,60/257,16.33%,SH3BGR;VAMP2;FERMT2;F8;WASF1;MITF;FAS;LAMC1;TBC1D20;COL16A1;SKP1;SKAP2;WDR19;CAND2;FBXL7;AP2M1;OCLN;TEAD2;P2RX7;TSPAN4;PYGO1;TEAD1;DLG4;NCKAP1L;WASF3;TLE2;TRAF1;ST13;TLE1;GORASP1;TCAP;HGSNAT;CSNK2B;TNFRSF1A;CAPN3;TRAPPC6B;CX3CL1;BOK;TRAPPC3;CSNK1A1;PARD3;TCF7L1;WIPF1;PEF1;DMD;ITGB1BP1;BAD;RIPK1;TLE4;GRIA1;CD59;SLC9A3R2;VAMP3;KIFAP3;SNX9;DMTN;LIN7A;PYGO2;MCFD2;NOL3
prerank,peptide catabolic process (GO:0043171),0.26172082708425265,0.9019735529162707,0.5833333333333334,0.7355665849239235,1.0,8/24,14.82%,CPQ;ECE1;LNPEP;TPP1;LVRN;NAALADL1;GGT5;GGT7
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.3005098278150523,-0.9013944153220836,0.5352112676056338,0.8945409799561431,1.0,6/28,12.61%,TRIB3;FBXO5;DCUN1D5;FEM1A;PLK1;LIMK1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.26451570521644296,-0.9011513815361689,0.6875,0.8942724003576598,1.0,5/35,7.69%,BMP2K;SERPINE1;C3;SMAP1;APOC1
prerank,filopodium assembly (GO:0046847),0.28064630997952467,0.9003970128802308,0.6296296296296297,0.7381783162110537,1.0,16/16,71.96%,FGD6;S1PR2;SRGAP2;FGD1;FGD5;FGD2;VSTM5;ARHGEF4;PPP1R9B;FGD3;DNM3;SPEF1;SPATA13;RAB17;FGD4;EZR
prerank,regulation of embryonic development (GO:0045995),-0.27714713929108203,-0.8998861279800907,0.5753424657534246,0.896461632996525,1.0,4/34,7.29%,CDK1;RACGAP1;CRB2;FOXA2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.24767115242060112,-0.8997534574893981,0.6172839506172839,0.8959204313406843,1.0,15/56,23.94%,INHBA;BMP8A;TGFB2;GDF15;GDF9;ENG;BMP7;INHBC;TGFB1;BMP4;INHBE;SMAD6;NODAL;GDF2;TTK
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.2949507378376187,-0.8995508970113901,0.625,0.8955867766878092,1.0,5/27,11.44%,SLC6A20;SLC7A5;SLC38A5;SLC7A1;SLC1A4
prerank,cell cycle G2/M phase transition (GO:0044839),-0.2268159164650352,-0.8986894075319513,0.7272727272727273,0.8965434940386139,1.0,30/130,19.38%,CEP72;CDK1;SKP2;NEK2;PHLDA1;CEP250;CDC25C;CHEK2;MASTL;PKMYT1;HAUS7;AJUBA;AURKA;CDK7;PLK1;FOXM1;HAUS6;CEP76;USH1C;CEP152;CDC25A;NDE1;PLK4;TAF2;SDCCAG8;CENPJ;CKAP5;ALMS1;CEP78;CEP41
prerank,body fluid secretion (GO:0007589),-0.33713658083346365,-0.8986680509237792,0.6338028169014085,0.8957910933633612,1.0,4/15,10.00%,FOXB1;OXTR;PRLR;APLN
prerank,ERBB signaling pathway (GO:0038127),-0.24078816741253947,-0.8985004030296617,0.6052631578947368,0.8953554843136786,1.0,15/64,24.18%,TDGF1;AREG;EREG;FAM83A;SOX9;GRB7;EPGN;REPS2;TGFB1;MATK;NRG4;NRG1;EGF;STUB1;KIF16B
prerank,regulation of synapse assembly (GO:0051963),0.21839241566745293,0.8982886022940191,0.6923076923076923,0.7421753290498243,1.0,14/47,17.38%,NLGN2;SNCA;SLITRK2;SLITRK3;NLGN1;NLGN3;BHLHB9;APP;GPC4;MEF2C;NRXN1;LRFN5;MDGA1;CLSTN2
prerank,cellular response to interferon-beta (GO:0035458),-0.3206740879531792,-0.8982328300435484,0.6447368421052632,0.8951328988150177,1.0,7/18,28.65%,IFITM2;STAT1;PNPT1;MNDA;IFI16;IFNB1;AIM2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.3417958606553075,-0.8980953070179486,0.6111111111111112,0.8946472889552801,1.0,6/16,18.26%,CARD14;TNFSF15;IRAK1;TNFRSF10B;CHI3L1;TRAF2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.30336231670708663,-0.8980260562855894,0.676056338028169,0.89398924676853,1.0,12/25,28.05%,THY1;GBP1;LILRB4;PTPN2;PVRIG;SLA2;PTPRJ;SH2D1A;CD160;UBASH3A;PTPN22;EZR
prerank,response to glucose (GO:0009749),-0.27303103710161963,-0.897938434002666,0.6493506493506493,0.8933195807335772,1.0,8/44,13.01%,PDX1;SOX4;PAX2;ZBTB20;IGF1R;KHK;THBS1;MAFA
prerank,protein homotrimerization (GO:0070207),0.295775333093237,0.8977705625486605,0.696969696969697,0.7420013266247901,1.0,3/15,4.68%,SCARA5;DISP1;STEAP4
prerank,protein trimerization (GO:0070206),0.295775333093237,0.8977705625486605,0.696969696969697,0.7420013266247901,1.0,3/15,4.68%,SCARA5;DISP1;STEAP4
prerank,carbohydrate homeostasis (GO:0033500),-0.23774668403363186,-0.897687159391802,0.6623376623376623,0.8931124827416576,1.0,17/67,23.17%,IRS1;SOX4;PAX6;HNF1A;IGF1R;CEBPA;FFAR2;BACE2;VGF;RBP4;MLXIPL;FGFR4;PTPN2;GCKR;PPARG;MTNR1B;HNF4A
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.2543054768725543,-0.8975147101593206,0.6785714285714286,0.8926432920697112,1.0,14/50,27.93%,MYC;HMGA2;EYA1;PMAIP1;BRCC3;ERCC8;ATR;BRCA1;FMR1;SPRED1;NPAS2;ERCC6;WRAP53;TIGAR
prerank,cholesterol transport (GO:0030301),-0.26598962319419167,-0.8969162267024537,0.6282051282051282,0.8930959644164035,1.0,9/46,11.24%,TSPO2;LIPG;ABCG5;CAV1;CETP;CEL;APOC1;SCARB1;ABCG8
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.27784671321986276,-0.8963588233579557,0.6025641025641025,0.8934519613059048,1.0,12/33,25.96%,OCIAD2;PRLR;IL10;F2R;CRLF3;CENPJ;IL26;PIBF1;TNF;IL10RA;NOTCH1;CCL5
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.29595779085017193,0.8950233597528904,0.696969696969697,0.7468729750178588,1.0,7/18,12.55%,IGFBP6;CILP;IGFBP4;ZFAND2B;GH1;IGFBP5;NKX3-1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.2787677585327866,0.8948093660487986,0.5238095238095238,0.7465866605019437,1.0,7/18,21.78%,CIRBP;CELF4;PRDX6;SF3B4;SNW1;TRA2A;THRAP3
prerank,metal ion transport (GO:0030001),-0.23732119794041948,-0.8943169889060834,0.6790123456790124,0.8973122617927556,1.0,22/86,18.70%,CACNA1D;CYP27B1;TRPM2;CAV1;LRP2;TRPV4;CCL3;SLC24A1;CHRNB2;CATSPER1;KCNN4;TRPC5;FYN;SLC39A8;MAGT1;ATP2A1;NDFIP2;ATP2C1;CACNA1E;CHRNA7;NMUR2;NIPA2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.28079959083058564,-0.8931124313990266,0.6351351351351351,0.89944336397741,1.0,10/31,21.83%,SERPINE1;TNFAIP3;ICAM1;BCL2L1;TNFRSF10B;FASLG;TRAF2;BRCA1;SCRT2;GSK3B
prerank,chromatin remodeling (GO:0006338),-0.2341716263515474,-0.8923016784434907,0.6744186046511628,0.9005445983727081,1.0,33/103,29.17%,MYC;FOXP3;SUV39H2;RUVBL1;SOX9;HMGA2;SMARCA4;NPM3;TOP1;BAZ1A;MYB;ACTL6A;CBX3;ACTR8;NUDT5;ARID1B;SMARCC1;KDM5A;HDAC2;JARID2;SMARCB1;NPM1;ATRX;RUVBL2;SATB2;CHD4;ERCC6;SMARCAD1;ARID1A;BAZ2B;KDM6A;BPTF;TAF6L
prerank,regulation of cellular response to stress (GO:0080135),-0.22866657936542809,-0.8921061506657008,0.6774193548387096,0.9001348867388158,1.0,46/114,30.18%,CEBPB;NUP155;NUP37;RPA3;AJUBA;NUP210;MAPKAPK2;NEK6;DNAJC2;NUP107;NEK4;RANBP2;IER3;NUP35;PNPT1;NUP50;SEH1L;DYRK3;ATR;HSPH1;NUP205;NUP88;OPRM1;NUP93;POM121;RAE1;MBTPS2;GSK3B;NPM1;BAG4;NPAS2;CREBBP;ROCK2;MANF;NUP43;NUP160;NUP153;RSL1D1;NDC1;MCL1;SMG1;DNAJC7;NUP62;ADCY8;NUP98;FKBP4
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.3304471326804213,-0.891885427004494,0.5974025974025974,0.8998467788031865,1.0,7/16,25.53%,FOXE3;CAV1;ZEB1;MMP9;IFNG;SPRED1;IL13
prerank,ephrin receptor signaling pathway (GO:0048013),-0.2337570699995221,-0.8918408718736162,0.6875,0.8991016088574304,1.0,26/82,27.90%,GRIN2B;EFNA3;EPHB2;EPHA1;ARHGEF28;EPHB3;MMP2;EPHA2;MMP9;EFNA2;EFNA4;FYN;EPHA8;ACTR2;EPHB4;KALRN;LYN;ACTR3;VAV3;ROCK2;YES1;RASA1;EFNA1;VAV2;CDK5R1;EFNB1
prerank,regulation of neuron migration (GO:2001222),-0.27645230267552023,-0.8915976793999882,0.6716417910447762,0.8989102011942489,1.0,7/27,21.96%,KIF20B;ADGRG1;COL3A1;SHTN1;PLAA;ULK4;MDK
prerank,B cell receptor signaling pathway (GO:0050853),-0.2596997203469851,-0.8915604563159351,0.6533333333333333,0.8982433516493449,1.0,10/33,27.96%,SYK;ITK;CTLA4;TEC;MNDA;PIK3CD;LCK;NFAM1;VAV3;BAX
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.1766311329104061,0.8910269821776138,1.0,0.7542132330908587,1.0,26/135,14.58%,GLP2R;POMC;RAMP1;ADCY5;VIP;ADCYAP1R1;GNG2;ADRB3;MAPK14;ADCY4;PRKAR2B;VIPR2;PRKACA;RAMP3;RAMP2;PTH1R;CREB1;ADM;AVPR2;P2RY11;PTGER4;ADCYAP1;GPBAR1;ADCY9;GGT5;ADCY2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.3083305094338815,-0.8907220505264627,0.647887323943662,0.899225615346534,1.0,9/18,33.85%,TGFB2;SKAP1;SYK;ADAM9;LIF;CCL5;CXCL13;CD3E;FOXC2
prerank,epithelial tube morphogenesis (GO:0060562),0.22904445764119033,0.8906817543023722,0.7692307692307693,0.7542222832266909,1.0,10/34,14.30%,RHOB;PKD2;PKD1;CSNK2B;NKX3-1;MEGF8;MEF2C;RASIP1;FGF10;SOX17
prerank,regulation of multicellular organism growth (GO:0040014),-0.3059850815956819,-0.8903827365819762,0.6533333333333333,0.8990916055180838,1.0,10/18,33.58%,GDF15;PPIB;PTCH1;STAT5A;STAT5B;GHRHR;GHSR;GHRH;IGF1;GHRL
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.28283931038862764,-0.88962465277392,0.6212121212121212,0.8999005125566548,1.0,9/25,26.99%,POU4F1;MSX2;ZNF675;TGFB1;POU4F2;GATA3;ANKRD33;TWIST1;NSD1
prerank,regulation of cellular pH (GO:0030641),-0.2791285861490874,-0.8895633965360557,0.6818181818181818,0.8991846060654348,1.0,6/30,19.16%,SLC9C1;SLC9A7;SLC9B1;SLC4A9;SLC4A8;TM9SF4
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.2352796407879159,0.8886048513910112,0.55,0.7578263527067952,1.0,9/29,16.81%,PLA2G5;PLA2G4B;NR1H2;TMEM86B;PLA2G4C;PLA2G6;PLA2G1B;PLA2G4A;NR1H3
prerank,histone lysine methylation (GO:0034968),-0.27522271861981246,-0.8882845022547354,0.6329113924050633,0.9012108241805129,1.0,13/34,27.60%,SUV39H2;SMYD3;SETD6;SUV39H1;PAXIP1;SMYD2;RBBP5;WDR5B;EZH2;PRDM9;KMT2D;DYDC2;KDM6A
prerank,chromatin organization (GO:0006325),-0.22668543026321422,-0.8873990483674971,0.7415730337078652,0.9024446966747128,1.0,34/138,23.81%,MYC;LOXL2;FOXP3;SUV39H2;PADI1;HDAC10;RUVBL1;PADI3;SOX9;HMGA2;SOX1;SMARCA4;NPM3;TOP1;BAZ1A;MYB;HMGN1;SUV39H1;ACTL6A;VCX;CBX3;NUDT5;SMARCC1;KDM5A;CHD1;SPI1;HDAC2;JARID2;SMARCB1;NPM1;ATRX;RUVBL2;SATB2;EZH2
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.28874521405118686,-0.8870980703879224,0.6164383561643836,0.9023462202611189,1.0,12/29,28.58%,TNFAIP3;NLRP12;IL10;LILRB4;IRAK3;GHSR;TNF;IL37;GBA;FOXJ1;PTPN22;ZC3H12A
prerank,pore complex assembly (GO:0046931),-0.31295983353161744,-0.8868526041511118,0.6794871794871795,0.9020211824609013,1.0,11/18,38.30%,NUP107;ADAM10;NUP205;NUP93;TSPAN33;NUP153;NDC1;NUP98;PDZD11;TPR;PLEKHA7
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.2556849990749609,-0.8868319945625456,0.6486486486486487,0.9012436580244048,1.0,18/49,32.74%,RTKN2;CAV1;PMAIP1;BCL2L1;PTPMT1;MMP9;PLAUR;P4HB;STYXL1;EIF2AK3;BBC3;LCK;SIAH1;BAX;MCL1;URI1;BID;NOC2L
prerank,establishment of melanosome localization (GO:0032401),0.27589812319029794,0.8866812017017514,0.6153846153846154,0.7617425738137615,1.0,11/19,21.33%,BBS5;RAB11B;BBS2;ARL6;RAB27A;BBS7;BBS4;BLOC1S6;MKKS;MYO5A;BLOC1S5
prerank,peptidyl-tyrosine modification (GO:0018212),-0.2551464168932644,-0.8866036462695025,0.7368421052631579,0.9009893476404288,1.0,13/56,17.71%,PDGFRB;SRMS;EPHB2;EPHA1;JAK3;ABL2;SYK;ZAP70;KDR;FYN;TTBK1;TEC;FGFR4
prerank,regulation of phosphorylation (GO:0042325),-0.22433271125052268,-0.8858821780634355,0.6781609195402298,0.9016839790478091,1.0,44/122,29.67%,INHBA;MIF;EREG;PML;FN1;NUP155;SOCS1;NUP37;CDKN2A;NLRC5;NUP210;MCM7;NUP107;RANBP2;BMP7;NUP35;THBS1;NUP50;SEH1L;GRM5;NUP205;NUP88;CCDC88C;NUP93;GCKR;POM121;RAE1;BARD1;BMP4;EGF;LYN;GLMN;EIF6;CCL5;NUP43;NUP160;NUP153;JMJD8;SRPX2;ANG;NDC1;DSCAM;NUP62;NUP98
prerank,modification-dependent protein catabolic process (GO:0019941),0.1603301102494002,0.8858628402575153,1.0,0.7627172963176996,1.0,27/196,9.66%,ASB2;RNF150;FBXO10;RNF11;UBE2D4;FBXO8;UBE2G1;KCTD10;FBXL7;WDR91;RNF130;UBE2E1;UBB;ANAPC16;NEDD8;RNF217;RNF185;MYLIP;RNF167;RNF146;UBE2G2;RNF144B;NTAN1;PCYOX1;RNF14;SPSB1;UBL7
prerank,peptide metabolic process (GO:0006518),-0.23557150426344076,-0.8857910424373425,0.6790123456790124,0.901141045310241,1.0,12/78,10.15%,DPEP1;CPZ;MME;MMACHC;NLN;CPN1;PCSK1;MIPEP;HM13;RHCE;BACE2;CPD
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.21581378563493492,0.8852478527545754,0.6875,0.7629661288549545,1.0,13/56,14.06%,TNFSF10;TRIM39;BCL10;FAS;BCL2L11;GPER1;DAB2IP;NUPR1;BOK;NKX3-1;BCL2;BAD;RIPK1
prerank,negative regulation of B cell activation (GO:0050869),-0.31719487957207787,-0.8851467584136209,0.5915492957746479,0.9015458731702173,1.0,11/22,35.59%,INHBA;TNFAIP3;IL10;CTLA4;MNDA;TYROBP;LYN;FOXJ1;BANK1;SAMSN1;CD300A
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.3260037376353756,-0.8846554529909296,0.5737704918032787,0.9017745709444633,1.0,6/15,22.16%,OAS2;MX1;STAT1;CANX;IL27;IL27RA
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.2807266634391433,0.884516323505605,0.6285714285714286,0.7640439523935577,1.0,3/18,7.04%,FLNA;ATF4;MAF1
prerank,positive regulation of glial cell differentiation (GO:0045687),0.2594325716070654,0.8843678409961125,0.6216216216216216,0.7637093324253162,1.0,4/18,10.37%,PTN;PTPRZ1;ID2;CLCF1
prerank,bile acid biosynthetic process (GO:0006699),-0.28708798829847193,-0.8836468008616327,0.6621621621621622,0.9033735715653339,1.0,15/27,39.97%,BAAT;OSBPL3;AKR1C4;CYP7B1;CYP39A1;AKR1D1;SLC27A5;HSD3B7;HSD17B4;HSD17B10;OSBPL2;ACOT8;CYP7A1;CYP8B1;OSBP
prerank,regulation of vasculature development (GO:1901342),0.2367768107676122,0.8825659334456256,0.7142857142857143,0.7665110334440309,1.0,8/26,18.97%,FGF2;HMOX1;EGLN1;SFRP1;GPNMB;RNH1;KRT1;ADGRA2
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.3167822718317078,-0.8814852874204286,0.6190476190476191,0.9074648186862052,1.0,6/17,19.20%,TDGF1;TGFB2;MFRP;SCEL;BRCA1;FOXI1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.24010361376365416,-0.8812848994797144,0.6875,0.907050358554401,1.0,18/68,23.36%,OSM;CSF2;SOCS3;IL23A;SOCS1;IL23R;ARL2BP;IL21;IL12B;IL22RA2;TNFSF18;IFNG;LIF;PTPN2;IL20;PIBF1;LYN;TNF
prerank,positive regulation of secretion by cell (GO:1903532),-0.23456882340426966,-0.8812355079246841,0.691358024691358,0.9063494924717096,1.0,14/67,18.09%,IL1A;SLC12A2;TGFB2;IL1B;CADPS;MYH10;TGFB1;CFTR;CD2AP;ADAM9;EXPH5;ADAM8;CADPS2;TTN
prerank,RNA stabilization (GO:0043489),-0.2948191791849701,-0.8812141170639523,0.6447368421052632,0.9056124521750133,1.0,6/26,12.41%,DKC1;E2F1;NOCT;AXIN2;NAF1;PABPC1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.23225785273102692,-0.8808283052502482,0.6976744186046512,0.9056743096014432,1.0,14/67,14.26%,EPPK1;TGFB2;CASK;EREG;SOX9;CAV1;STAT1;BRCA2;MED1;WDR77;THBS1;TGFB1;PTPRK;NF1
prerank,connective tissue development (GO:0061448),-0.2676222987033148,-0.8803994817452064,0.6933333333333334,0.9058792467880129,1.0,16/37,34.03%,CD44;SOX9;IL17F;HYAL3;COL2A1;CHI3L1;SPTLC2;GDF2;XBP1;TRIP11;SULF2;NAMPT;LRP5;ATP7A;GHRL;SCX
prerank,negative regulation of cell population proliferation (GO:0008285),-0.2016477696475128,-0.8803526290385579,0.7878787878787878,0.9051508037020678,1.0,95/362,25.51%,FAP;MYC;IL1A;SULT2B1;CXCL1;CXCL8;OSM;IFITM1;TESC;CDKN3;INHBA;TP73;CGREF1;FOXP3;DHRS2;EPPK1;SSTR5;TGFB2;HMGA1;SOX4;IL1B;EREG;FABP6;AZGP1;E2F1;CYP27B1;TNFAIP3;PML;WNT5A;SOX9;CDKN2A;ADGRG1;PROX1;IFNK;IFIT3;TFAP4;CEBPA;AXIN2;E2F3;IL12B;GATA6;DRD2;VHL;UTP20;SH3BP4;S100A11;GTPBP4;RFPL1;TFDP1;TGFB1;FRK;RBP4;PTPRK;NF1;IL10;TRIB1;IGFBP3;F2R;IFNG;CDC6;SMYD2;OPRM1;STRN;PHB;DDAH1;ST18;IL26;PTPN2;NME1;PTPRJ;SFRP4;PPARG;BMP4;HPN;ITGA1;TBX5;BTG4;RUNX3;SMAD6;GATA3;NPM1;NMI;TPTE;HNF4A;NODAL;LYN;GLMN;E2F7;INSM1;REST;NOTCH1;IRF6;DLG3;SSTR3;ARID2
prerank,positive regulation of viral process (GO:0048524),-0.2404494415534759,-0.8801716288398941,0.7,0.90469709358417,1.0,19/62,30.74%,POLR2F;SRPK1;PPIH;PABPC1;HACD3;FKBP6;POLR2J;NELFCD;POLR2D;TMEM39A;POLR2I;AXL;KPNA2;CCL5;PDE12;CD28;STAU1;LARP1;DHX9
prerank,modulation by symbiont of entry into host (GO:0052372),-0.2967976557136671,-0.8800511128073945,0.581081081081081,0.904182095456273,1.0,5/19,20.21%,CXCL8;CAV1;FUCA2;TRIM14;TRIM22
prerank,regulation of spindle assembly (GO:0090169),-0.2972544321595007,-0.8793433195731403,0.6363636363636364,0.905113450027774,1.0,4/25,10.22%,SPAG5;GPSM2;CHMP4C;PLK1
prerank,negative regulation of protein transport (GO:0051224),-0.28757432681605155,-0.8793088309674141,0.6933333333333334,0.9043758611775152,1.0,5/25,14.95%,CYP51A1;IL12B;RHBDF2;DRD2;NDFIP2
prerank,odontogenesis (GO:0042476),-0.2641081256189773,-0.8789738809414448,0.6216216216216216,0.9042402626463995,1.0,4/37,1.52%,INHBA;COL1A2;AMELX;TGFB2
prerank,regulation of monooxygenase activity (GO:0032768),-0.27600664285279586,-0.8788184008476615,0.6470588235294118,0.9037955431623631,1.0,3/24,5.95%,IL1A;IL1B;CAV1
prerank,negative regulation of developmental process (GO:0051093),-0.23166057704901954,-0.8787878858572966,0.6428571428571429,0.9030672467883772,1.0,13/73,12.72%,THY1;SHH;LOXL2;MIF;SOX9;ALPK2;PRAME;FOXM1;SFMBT1;WDR77;HYAL3;TGFB1;NEUROD2
prerank,cardiac muscle tissue development (GO:0048738),-0.24164585362357474,-0.8787641269497916,0.6705882352941176,0.9023155273898613,1.0,14/52,22.09%,TBX20;MSX2;SMAD1;ZFPM1;GATA6;BMP7;RBP4;MYLK2;TTN;GJB6;SHOX2;BMP4;NRG1;HCN4
prerank,xenobiotic transport (GO:0042908),-0.3182282041829307,-0.8782820932237131,0.6911764705882353,0.9026326919986902,1.0,4/20,11.00%,ABCC11;SLC7A5;ABCC2;SLC22A1
prerank,cholesterol metabolic process (GO:0008203),-0.22988288872012122,-0.8770537117509142,0.6623376623376623,0.9044413391751175,1.0,21/70,28.67%,SULT2B1;CYP51A1;IDI2;ANGPTL3;SQLE;CETP;NR0B2;CEL;MVK;DHCR7;FDPS;NSDHL;AKR1D1;G6PD;TM7SF2;CLN6;ACAT2;GBA;HMGCS1;DHCR24;SULT2A1
prerank,iron ion transport (GO:0006826),0.17464939303910046,0.8768508070135818,0.6923076923076923,0.778002763668649,1.0,16/48,22.94%,ATP6V1G2;SCARA5;ATP6V1E1;MCOLN1;ARHGAP1;RAB11B;TCIRG1;ATP6V0E2;TFRC;ATP6V1H;ATP6V0A1;ATP6V1D;ATP6V0D1;HFE;ATP6V0E1;TTYH1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.30150938472416067,-0.8768252935891488,0.6176470588235294,0.9041092761350269,1.0,2/20,0.63%,TMPRSS3;SLC12A2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.28638421229712424,-0.8768226494056348,0.618421052631579,0.9033223524604818,1.0,3/24,7.78%,THY1;CAV1;GPRC5A
prerank,lipid translocation (GO:0034204),-0.29178564410652524,-0.876639758637332,0.6666666666666666,0.9029488074771134,1.0,14/23,46.07%,ATP11A;RFT1;ATP9A;ATP10B;ATP11B;ABCB4;ABCB1;ABCC1;ATP8B1;ATP9B;ABCA4;ATP8B4;TMEM30B;ABCA7
prerank,positive regulation of transport (GO:0051050),-0.22013555303816193,-0.8766319448160591,0.6976744186046512,0.9021581342656623,1.0,32/89,33.84%,CDH3;IL1B;TFR2;IL15RA;SPAG5;CALR;TULP1;SPACA3;FPR2;LYAR;PON1;ZNF205;IFNG;CYBA;PLAA;SIRPB1;GSK3B;FMR1;TNF;CLEC7A;ANXA1;LMAN2;IL2RB;BAX;DOCK2;GPLD1;DYNC1H1;ACSL3;SIRPG;BID;MLC1;FCER1G
prerank,positive regulation of gene expression (GO:0010628),-0.19794833917594887,-0.8765237580147438,0.81,0.9015714145297038,1.0,106/468,21.84%,CDH3;MYC;IL1A;CXCL8;TESC;INHBA;CSF2;LAMP3;POU4F1;SOX4;IL1B;TFR2;MIF;LEF1;POLR2F;EREG;FOXD1;PAX6;EPHB2;E2F1;EIF3C;FGF19;FN1;EGR1;MAZ;POLR1C;WNT5A;CTSH;SOX9;CLEC6A;DNMT1;PRKDC;CALCR;HMGA2;PF4;DNMT3B;DDX21;NR0B2;IL17F;IL21;TAF1A;PKP1;SMAD1;ACTG2;RLN2;PIK3CG;CCL3;SLC26A9;POLR1B;FGF20;NWD1;PASK;ITGAX;BMP7;MED1;TAF1B;NAT10;RHOXF2;FGF3;BATF;ALOX12B;THBS1;AGT;TGFB1;CITED1;ITK;MYLK2;POLR1A;ADM2;IL10;TTBK1;MYCN;MSN;IFNG;FGF23;CARD9;WNT11;PHB;CTCFL;IL36B;STOX1;FGFR4;EIF2AK3;TTN;CD46;LIN28A;BRCA1;IL26;PIK3CB;PKP3;WNT3A;MMP8;TNFSF4;WNT3;PIK3CD;RHOXF2B;SFRP4;ATP13A2;BMP4;HPN;EGF;IFI16;LARP4;GAPDH;GSK3B;CRTAM
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.30266142581840655,-0.8765023278404683,0.6486486486486487,0.9008262594558795,1.0,9/20,37.35%,RIPK2;HSPD1;STAT1;TLR7;TLR8;IRF7;DHX9;IRF3;CHUK
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.22485159659497203,0.8763170394140335,0.8181818181818182,0.7784833468955485,1.0,9/37,12.90%,TRIM39;FAS;DAB2IP;TRAF1;DEPTOR;CSNK2A2;CX3CL1;NKX3-1;BCL2
prerank,carbohydrate derivative catabolic process (GO:1901136),0.27359687799151,0.8761739802548727,0.6333333333333333,0.7781899960759139,1.0,4/18,9.95%,FBXO17;FBXO44;FBXO27;BPGM
prerank,regulation of cell communication (GO:0010646),0.2334867298728833,0.875955072685691,0.5263157894736842,0.7782482572110763,1.0,10/36,16.17%,TSPYL2;CASQ2;ANK2;SOCS2;GRK5;MTCH1;CAMK2D;SLC8A1;MGLL;IGFBP7
prerank,arachidonic acid metabolic process (GO:0019369),-0.2499144411581923,-0.8755011937847516,0.6623376623376623,0.9020003953769808,1.0,12/54,15.39%,CYP2S1;CYP2F1;FAAH2;TBXAS1;CYP2A7;CYP4F3;CYP2B6;CYP2D6;ALOX12B;ALOX12;AWAT1;ALOXE3
prerank,insulin secretion (GO:0030073),0.257749282987889,0.875465599595506,0.6086956521739131,0.778709829737757,1.0,8/18,19.50%,CAMK2G;RAB11B;ADCYAP1;PTPRN;SNX19;RAB11FIP2;SLC30A8;RAB11FIP5
prerank,cellular response to chemical stress (GO:0062197),-0.2196428311680539,-0.8751845533187288,0.6941176470588235,0.901788816491336,1.0,28/99,29.30%,LRRC8E;SLC4A11;DHRS2;VRK2;ERO1A;CAV1;ERMP1;TRPV4;NOX1;LRRC8D;PNPT1;GPX2;FANCC;NCF2;CYBA;CYBB;STOX1;G6PD;PRDX5;ATP13A2;BRF2;VKORC1L1;GSR;SETX;PYROXD1;ZC3H12A;PYCR1;SUMO4
prerank,tRNA methylation (GO:0030488),-0.28441834992258386,-0.874828590339893,0.6301369863013698,0.901791704221335,1.0,15/32,36.50%,METTL2A;METTL1;METTL6;THUMPD3;THADA;METTL2B;FTSJ1;TRMT10C;TRMT61B;NSUN2;TARBP1;DALRD3;HSD17B10;NSUN6;TRMT12
prerank,aortic valve development (GO:0003176),-0.2537036273918509,-0.8736972600185199,0.6714285714285714,0.9034080884958128,1.0,12/36,26.73%,TBX20;SOX9;ROBO2;TGFB1;TNFRSF1B;BMP4;SMAD6;GATA3;NOTCH1;ROCK2;EFNA1;TWIST1
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.23900015777560876,-0.8735884188839478,0.7272727272727273,0.9028172382785943,1.0,18/67,26.95%,PRB3;SERPINE1;IL23A;IL23R;DEFA6;IL12B;NOS2;RPS19;ROMO1;RNASE7;DEFB4A;DMBT1;DEFA1;LBP;S100A7;LTF;RNASE8;NLRP10
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.15844729557407616,0.8734203095320068,1.0,0.7822373709859795,1.0,58/312,15.75%,UCHL1;TRIM9;FBXL22;FBXO9;DNAJC18;ZSWIM8;FBXO17;UBE2G1;SIRT2;GID4;FBXO44;SKP1;KCTD2;RNF122;TRIM3;KCTD10;ARNTL;FBXO31;FBXL7;KLHL42;FBXL5;UBE2E1;WFS1;USP19;UBB;DNAJB2;HSP90B1;ANAPC16;RNF185;TMUB2;PSMC5;FAM8A1;UBE2G2;ZFAND2B;RNF216;FBXO27;SPSB1;KLHL20;ARMC8;UBXN1;HECTD3;KLHL22;FBXW4;RNF4;FBXW5;ANKZF1;TMEM129;FEM1B;PSMD9;UBE2B;TBL1X;BTRC;FBXL15;UBE4B;PSMB6;DDIT3;FBXL12;APPBP2
prerank,regulation of dephosphorylation (GO:0035303),0.2910311356289971,0.8728002002556713,0.5333333333333333,0.7829047782387757,1.0,2/15,7.11%,INPP5K;MTMR9
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.29835568081828556,0.8726957723368978,0.5416666666666666,0.7823814369266995,1.0,9/16,24.95%,FLOT1;PPM1F;NOTCH4;RGCC;EPCAM;DENND6A;ADAM19;TJP1;PTPRU
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.26875621668526645,-0.8718146478374615,0.6081081081081081,0.9059063905431054,1.0,11/30,26.73%,SOX9;NOCT;SEMA4D;BAMBI;CITED1;PTCH1;FGF23;PPARG;SMAD6;NOTCH1;TWIST1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.303338679605098,-0.8717705188032965,0.6764705882352942,0.9044493564066731,1.0,3/21,12.36%,ERCC5;RPA3;GTF2H2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.303338679605098,-0.8717705188032965,0.6764705882352942,0.9044493564066731,1.0,3/21,12.36%,ERCC5;RPA3;GTF2H2
prerank,positive regulation of receptor internalization (GO:0002092),-0.28280801101814146,-0.8716602159624652,0.6029411764705882,0.9039265905707611,1.0,7/23,23.04%,APLN;APELA;PCSK9;WNT3A;SFRP4;EGF;FMR1
prerank,positive regulation of developmental growth (GO:0048639),0.1953887519724809,0.8714323378058391,0.7647058823529411,0.7843235073456909,1.0,8/52,10.79%,NTN1;L1CAM;MAPT;DBN1;NGF;GH1;SYT4;SYT1
prerank,organelle fission (GO:0048285),0.2610955093640839,0.8713370850053759,0.7297297297297297,0.7838173066442442,1.0,4/24,8.15%,MTFR1L;CORO1C;MUL1;PEX19
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.2381360002310021,-0.8704411906305494,0.7435897435897436,0.9056482402385838,1.0,20/63,25.97%,THY1;PLAU;CASK;SKAP1;EPHA1;CDKN2A;PKHD1;FUT1;PLET1;THBS1;NF1;ACER2;JUP;PIK3CB;GSK3B;UTRN;ADAM15;ROCK2;RASA1;CAMSAP3
prerank,positive regulation of telomere capping (GO:1904355),-0.31088314041403,-0.8694833396364863,0.6075949367088608,0.9069113056329455,1.0,3/17,5.50%,NEK2;AURKB;MAPK15
prerank,positive regulation of binding (GO:0051099),-0.23269096381812573,-0.8689114147569799,0.7317073170731707,0.9072496290047126,1.0,35/87,31.94%,TRIB3;RIPK2;CAV1;MET;BAMBI;PON1;CDT1;MMP9;PLAUR;TERT;STK4;NCBP1;NME1;WNT3A;HMBOX1;MMP8;RAN;PPARG;BMP4;EPB41;EGF;GSK3B;DTX3L;STMN1;HIPK2;HMGB1;ZNF618;IDE;NMD3;FOXC1;SUMO4;DERL1;DHX9;TAF1;IGF1
prerank,cobalamin metabolic process (GO:0009235),-0.30529923093451483,-0.8685351138795383,0.6621621621621622,0.9073811845199868,1.0,5/19,25.76%,TCN1;MMACHC;MMAA;PRSS3;MMAB
prerank,apoptotic mitochondrial changes (GO:0008637),-0.2580779018878187,-0.8678351276207098,0.6052631578947368,0.9080699380552011,1.0,16/33,38.66%,IFI6;HSPD1;BCL2L1;BIK;ATP2A1;GGCT;ATG3;BBC3;VPS35;BAX;SFN;TIMM50;BID;IFIT2;FZD9;NDUFS1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.30073607509962974,-0.8674803206388978,0.6081081081081081,0.9079160329006783,1.0,3/19,10.72%,HS6ST2;NDST3;GLCE
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.295744784669179,-0.8667405043089232,0.6438356164383562,0.9087241083217706,1.0,8/18,32.95%,TERT;TGFB1;MYCN;LIN28A;BMP4;TNF;ZC3H12A;NCOR1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.2591051346674575,-0.8666917087911385,0.72,0.9080320499229598,1.0,11/38,23.68%,CEACAM6;ICAM1;CRB2;CXADR;CEACAM5;PTPRD;AMIGO3;REG3A;CRTAM;CD6;TENM4
prerank,lipid modification (GO:0030258),-0.26543842733855505,-0.8665891743270583,0.6891891891891891,0.9074860973834272,1.0,6/29,16.58%,CYP3A7;PLA2G7;SGPP2;ALOX12B;ALOX12;DGKK
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.209428837147984,-0.8665846767970773,0.7628865979381443,0.9067057997932437,1.0,43/175,26.62%,CDH3;MYC;CXCL8;IRS1;PDGFRB;SOX4;IL1B;EREG;DUOXA2;EIF3C;ATAD5;EGR1;PRKDC;DNA2;SCARB1;DUOXA1;PASK;CDT1;NAT10;THBS1;ASS1;ZNF205;AGXT2;IFNG;MLXIPL;FGFR4;DDAH1;LDLR;PTPN2;MMP8;EGF;LARP4;OPN3;NPM1;FMR1;TNF;CLEC7A;LARP4B;EIF6;CCL5;ASIP;LPGAT1;CD28
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.2958663292883807,-0.8657850628765799,0.6666666666666666,0.9076748869708372,1.0,5/20,14.54%,SAPCD2;MRAP;BCL2L1;TGFB1;GBP1
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.206196280782118,-0.8651850255157222,0.7263157894736842,0.9081845956093577,1.0,43/195,18.99%,DUSP4;PFKFB3;CYP2W1;XYLB;EPHB2;GK;ALPP;PFKFB4;ANGPTL3;MIOX;DUSP18;PLCH1;PLA2G4D;HKDC1;IPPK;PLA2G4E;PSPH;PLCB4;GFPT1;PIK3CG;PLBD1;PRKCG;PLA2G2F;NUDT4;TOP1;PTPRD;PLD4;PLA2G3;TGFB1;INPP5D;PDXP;DUSP16;ACP6;GPD2;NUDT14;THTPA;PLAA;CDK5;ALDOB;PFKFB1;PANK2;NUDT5;PIK3CB
prerank,regulation of centriole replication (GO:0046599),-0.3045021706153909,-0.8649841911863227,0.6875,0.9078088723191986,1.0,8/18,22.55%,CEP295NL;CEP76;CEP295;PLK4;CENPJ;BRCA1;ALMS1;NPM1
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.3003618333468635,-0.8648253206392803,0.6567164179104478,0.9073315848173608,1.0,6/16,28.54%,ATAD5;DYRK3;NPM1;EZH2;CUL3;CDC73
prerank,stem cell differentiation (GO:0048863),-0.27152579161782237,-0.8644450684773105,0.6805555555555556,0.9073056467260671,1.0,9/38,14.97%,SHH;TGFB2;PAX2;HMGA2;DNMT3L;SETD6;BATF;WNT7A;MLLT3
prerank,peptidyl-threonine modification (GO:0018210),-0.23997433824336312,-0.8636363979183553,0.6818181818181818,0.908204054312977,1.0,21/67,27.64%,CHEK1;CDK1;CSNK2A3;PRKDC;SBK1;GALNT3;MYLK2;DYRK3;TTBK1;TGFBR2;CAD;STK39;CDK5;CSNK2A1;GALNTL6;GSK3B;HIPK2;LMTK2;ROCK2;CIT;CDK5R1
prerank,organelle disassembly (GO:1903008),-0.27071273383866257,-0.8625348435470984,0.6282051282051282,0.9096286469035908,1.0,7/32,18.07%,CDK1;VRK1;KIF9;MTIF2;MCTS1;DYRK3;GFM2
prerank,blood vessel endothelial cell migration (GO:0043534),0.2832078475844102,0.8620387246789336,0.72,0.8014059970413582,1.0,5/23,9.16%,FGF2;SRF;SOX18;PIK3R3;CDH5
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.22571714147534716,-0.8620234193212133,0.7674418604651163,0.9099003989146559,1.0,55/93,56.99%,RPL39;SSR1;RPS19;SRP72;RPS21;RPL36;TRAM1;ARL6IP1;RPL23A;RPL37;SIL1;RPL8;RPS18;RPS7;RPS2;RPL41;SEC61A1;RPS24;RPL32;RPS29;RPL27A;RPL35;RPS3;RPS4X;RPL4;RPL30;RPL37A;RPL18;RPL19;RPL38;RPLP2;RPL12;RPS14;RPS3A;SRP9;SRP54;RPL28;RPL31;RPS28;RPLP0;RPL18A;UBA52;RPS11;RPS17;RPL11;RPS15;RPL35A;RPL23;RPL29;RPS9;RPL5;SEC63;RPL7A;RPS5;RPL27
prerank,generation of neurons (GO:0048699),-0.2093761109031112,-0.8618214181021994,0.7252747252747253,0.9095670412785157,1.0,61/196,27.85%,CELSR1;ASCL2;WNT2;SHH;TGFB2;WNT7B;IL1B;IRX5;ANOS1;IRX2;WNT5A;EN2;RACGAP1;DTNB;SIX1;RUNX1;DCDC2;SIX3;MET;PCSK9;LHX9;EN1;FZD10;VAX1;PTPRD;NEUROG2;NEUROD2;WNT8B;WNT7A;IRX3;GSX1;LHX2;USP9X;AUTS2;WNT11;CDK5;SDCCAG8;BHLHA15;NIF3L1;PEX13;IRX4;LHX1;WNT3A;WNT3;LHX5;LHX3;BTG4;RUNX3;POU4F2;EMX1;OLIG2;ERCC6;INSM1;HES6;WNT4;OLIG3;INSM2;CIT;CDK5R1;FGF8;KIAA0319
prerank,pyruvate metabolic process (GO:0006090),0.20207831029660198,0.8603837380006125,0.7222222222222222,0.8042853645787752,1.0,14/54,16.11%,DLD;ENO2;DLAT;PDHB;PDHA1;ALDOA;PDHX;PFKM;HK2;HAGH;PGM1;HK1;ME3;NR4A3
prerank,regulation of neuroblast proliferation (GO:1902692),0.2676568757686782,0.8600387950334809,0.6774193548387096,0.8041638144688549,1.0,2/15,4.59%,PTN;SMARCD3
prerank,regulation of neuron apoptotic process (GO:0043523),-0.2197081735243631,-0.8595020481210093,0.7674418604651163,0.9137084061539553,1.0,21/96,17.70%,FOXQ1;KIF14;TGFB2;POU4F1;NAIP;FOXB1;SIX1;CCL3;TOX3;PRKCG;FGF20;PCSK9;PLA2G3;CITED1;NTF4;NF1;F2R;SET;TRIM2;ADAM8;CDK5
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.2417832822118896,-0.8591776558990684,0.6847826086956522,0.9137309564711731,1.0,19/60,27.64%,CHEK1;CDK1;CSNK2A3;PRKDC;SBK1;MYLK2;DYRK3;TTBK1;TGFBR2;CAD;STK39;CDK5;CSNK2A1;GSK3B;HIPK2;LMTK2;ROCK2;CIT;CDK5R1
prerank,receptor catabolic process (GO:0032801),0.2387418947611388,0.8568394036670989,0.6923076923076923,0.8100639611195531,1.0,7/25,16.85%,GPRASP1;AP2M1;MYLIP;AP2A2;SH3GLB1;AP2A1;VLDLR
prerank,positive regulation of B cell proliferation (GO:0030890),-0.2770963445840437,-0.8566816431147255,0.7088607594936709,0.9177841014504945,1.0,5/30,9.64%,MIF;EPHB2;IL21;CD81;CHRNB2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.25870921346348885,-0.8558893412471669,0.7,0.9186980822754441,1.0,14/34,31.94%,IRS1;IGF1R;PIK3CG;NF1;PIK3CB;PIK3CD;GATA3;TPTE;CD160;MYO16;PIK3C2B;TPTE2;C1QBP;IGF1
prerank,regulation of protein kinase B signaling (GO:0051896),-0.20017786318031025,-0.8557262534214154,0.7894736842105263,0.9182215593889127,1.0,52/204,22.76%,IRS1;OSM;AREG;PDGFRB;CD80;TRIB3;GDF15;EREG;FGF19;MAZ;PIK3AP1;CALCR;ENG;PKHD1;F7;IGF1R;EPHA2;EPGN;LRP2;PIK3CG;CCL3;MET;FGF20;SEMA5A;ICOS;DRD2;FGF3;THBS1;TGFB1;FYN;CHI3L1;FGF23;ADAM8;STRN;PHB;HLA-G;CD86;FGFR4;LIN28A;IL26;PIK3CB;OSBPL8;NRG4;PIK3CD;PTPRJ;NRG1;CASS4;EGF;LCK;GATA3;AXL;TPTE
prerank,dephosphorylation (GO:0016311),0.17616678688449447,0.8553424446789561,1.0,0.8123893485407596,1.0,43/138,21.44%,PTEN;PPP2R5B;PPP3CB;DUSP26;PPM1M;PTPRZ1;INPP5K;PTPRS;DUSP3;CTDSP2;PPP2R5D;PTPN21;PPP1CB;PPP1R12A;PTPRM;FRA10AC1;PPM1L;TAB1;PPP4R1;PPP2R3A;PPP2CB;PPM1A;THNSL2;PPM1F;PTPN5;BTRC;PTPN14;CTDSP1;LHPP;CTDNEP1;PPM1B;PPP3CC;ILKAP;EPHX2;ACP2;SDHAF2;FBXW11;DUSP8;SGPP1;ALPL;FAM220A;SBF1;PPP6C
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.252503918477038,-0.8547894194538952,0.7272727272727273,0.9193242123440181,1.0,12/39,21.83%,SERPINE1;TNFAIP3;ICAM1;PMAIP1;BCL2L1;THBS1;TNFRSF10B;FASLG;TRAF2;BRCA1;SCRT2;GSK3B
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.21158633244601072,0.8541630110035364,0.85,0.8137899463583208,1.0,10/27,22.21%,NME4;NME3;CTPS1;AK1;AK5;AK4;NME2;DUT;TXNRD1;AK6
prerank,phosphorylation (GO:0016310),-0.19381245962078508,-0.8535170973866203,0.8865979381443299,0.9211986312228243,1.0,78/385,18.99%,POMK;CHEK1;CDK1;TGFB2;MAK;XYLB;NEK2;EPHB2;BMP2K;VRK1;GK;CSNK2A3;VRK2;LMTK3;CHEK2;SRPK1;PRKDC;FGGY;JAK3;IKBKE;AURKB;CCNE1;SYK;GRK1;AURKA;MAPKAPK2;PIK3CG;LIPE;PRKCG;HUNK;NEK6;CDK4;CDK7;NEK4;PLK1;PASK;CDK12;AKT3;MAP3K9;PRKCZ;IRAK1;ZAP70;PAK6;FAM20A;TOP1;STK24;LIMK1;TGFB1;FRK;BIRC6;STK4;DYRK3;FYN;ADM2;TRIB1;IGFBP3;ADAM10;TTBK1;TP53RK;ROS1;MATK;TGFBR2;CDKL4;WNK4;BIRC5;STK39;PLK4;DGKK;WNT11;STK26;TEC;CDK5;EIF2AK3;IRAK3;PANK2;CSNK2A1;GLYCTK;PIK3CB
prerank,regulation of bone mineralization (GO:0030500),-0.23187288363671715,-0.8534618874457479,0.7142857142857143,0.9205249825258246,1.0,10/55,12.70%,NOTUM;BMP2K;CYP27B1;ISG15;CCL3;FBN2;BMP7;ADGRV1;ANKH;TGFB1
prerank,RNA catabolic process (GO:0006401),-0.24437536015768146,-0.8532336885054148,0.76,0.9201435822351878,1.0,15/47,29.49%,RNASEH1;SND1;FEN1;DNA2;PNPT1;RNASEH2A;NCBP1;LSM5;RNASEH2B;CNOT10;XRN2;ZPR1;EXOSC7;SLFN14;ZC3H12D
prerank,positive regulation of catalytic activity (GO:0043085),0.19539554587046484,0.8523715222666866,0.8333333333333334,0.8165767747182437,1.0,13/40,20.48%,PSEN1;MAPK3;MAPK8;MAPK14;SOD1;MT3;NHEJ1;AZIN2;CHTOP;B3GAT3;PSEN2;MID1IP1;STX4
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.28059382246075204,0.8522061389004987,0.6666666666666666,0.8162023486785126,1.0,3/15,9.67%,ECI2;CROT;ACOX2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.24135067980838693,-0.8511712403139713,0.75,0.9234668570582222,1.0,17/63,25.79%,ACMSD;BAAT;OSBPL3;LIPG;AKR1C4;CYP7B1;ACSM6;ACSM4;ACSF3;CYP39A1;SRR;AKR1D1;SDS;ACACA;SLC27A5;XBP1;LIPC
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.23661937429165295,0.8511344151087615,0.7391304347826086,0.8174400894220499,1.0,6/24,14.37%,GPER1;RBPJ;HAP1;RTN4;AFAP1L2;BCAR3
prerank,phosphatidylserine metabolic process (GO:0006658),-0.2687609797248668,-0.8502714314383332,0.7051282051282052,0.924352833248478,1.0,15/32,31.12%,PLA2G4D;SERINC5;PLA2G4E;PLA2G2F;PLA2G3;ABHD12B;PTDSS1;ABHD12;OSBPL8;PLA2G2E;PLA2G2D;PLSCR1;OSBPL10;LPCAT3;PLA2G10
prerank,autonomic nervous system development (GO:0048483),-0.296393484539725,-0.849758816570636,0.6986301369863014,0.9245676841002836,1.0,4/20,15.01%,SOX4;FN1;NF1;ARX
prerank,B cell differentiation (GO:0030183),-0.2253434481856068,-0.8495706860489559,0.7926829268292683,0.9240716622431253,1.0,30/60,42.74%,IL11;JAK3;IFNK;RAG1;IL10;RAG2;PTPN2;IFNE;PTPRJ;NFAM1;IFNB1;CR2;TPD52;ADGRG3;IFNA1;IFNA21;AICDA;TCF3;IFNA4;IRF2BP2;IFNA7;MSH2;IFNA14;IFNA10;FLT3;IFNA17;IFNA2;IFNA16;IL4;FNIP1
prerank,regulation of protein localization to nucleus (GO:1900180),-0.2311458288825755,-0.8490663524059431,0.7407407407407407,0.9242508923077309,1.0,13/46,22.66%,SHH;CDK1;GTSE1;PLK1;BYSL;TGFB1;LILRB4;LIF;EIF2AK3;ATP13A2;BMP4;GSK3B;DTX3L
prerank,cell-cell junction organization (GO:0045216),-0.23310571853397713,-0.8486740745872169,0.8117647058823529,0.9243175125020371,1.0,26/77,24.74%,CDH3;CLDN1;TGFB2;PARD6B;PKHD1;PKP1;CXADR;TRPV4;MARVELD2;DSP;DSG1;TGFB1;DSG2;CDH7;F2R;JUP;CDH11;PKP3;PKP2;CDH18;PKP4;CDH20;PRKCI;CDH15;CDH6;CDH22
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.2918922846172824,-0.8485952210857326,0.6933333333333334,0.9237048344951311,1.0,8/19,33.25%,ABL2;PDP1;AGT;NOD2;TNF;FXN;PDP2;ATP7A
prerank,regulation of extracellular matrix organization (GO:1903053),-0.32611730588653176,-0.8482520605830851,0.6142857142857143,0.9235770689378465,1.0,6/15,24.86%,FAP;RUNX1;AGT;FGFR4;DDR1;NOTCH1
prerank,mesonephric tubule development (GO:0072164),0.26482636237493146,0.8475667859878917,0.7333333333333333,0.824302515402319,1.0,5/17,10.07%,OSR1;PKD2;TCF21;PKD1;FGFR2
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.21222973536708498,-0.8474308015633519,0.7586206896551724,0.9244872210865529,1.0,40/131,29.03%,SRPK1;PRKDC;BRIX1;BOP1;TGS1;SMN1;SNRPD1;NAF1;SNRPG;SNRPF;EIF2S3;WDR77;MCTS1;NLE1;RPS19;NCBP1;EIF2S2;RRS1;PWP2;SHQ1;SRSF9;CLNS1A;POLR2D;PRPF6;CRNKL1;LSM4;MDN1;CELF5;RPF2;RPL23A;EIF6;RRP7A;SNRPB;SETX;SNRPE;SNRPD3;PRPF19;CDC73;XRCC5;DENR
prerank,regulation of secretion (GO:0051046),-0.3375106237190425,-0.8473227287894483,0.7419354838709677,0.9239702012827469,1.0,5/15,21.44%,OAS2;KCNQ1;MYO6;NRG1;EGF
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.2196209695145762,0.8470661192116026,0.7727272727272727,0.8248219286520859,1.0,4/31,7.11%,RAB6B;COPZ2;GABARAPL2;VTI1B
prerank,morphogenesis of an epithelium (GO:0002009),-0.29063734991623424,-0.846854334969483,0.7916666666666666,0.924113297419208,1.0,16/27,38.54%,TIMELESS;SOX9;LAMA3;RIPK4;LHX1;PRKX;TBX18;KDM2B;AIRE;KDF1;AHI1;LIN7C;ACTG1;WNT10A;TRAF3IP1;SLC9A3R1
prerank,ureteric bud development (GO:0001657),-0.2881635868806701,-0.8467459238415054,0.6142857142857143,0.923573932950407,1.0,10/19,30.33%,ROBO2;SIX1;BMP7;WNT11;LHX1;BMP4;FOXJ1;SALL1;FOXC1;WT1
prerank,sulfur compound catabolic process (GO:0044273),-0.2658861450761464,-0.845970397733448,0.6904761904761905,0.9242401108563156,1.0,9/39,16.69%,ACAN;DPEP1;BCAN;VCAN;CHAC1;CHAC2;GLB1;HEXB;CTH
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.24940436744319935,-0.845904320335051,0.7228915662650602,0.9236310865294882,1.0,19/50,28.58%,TRIB3;ACMSD;FGF19;PRMT3;CAV1;PROX1;APOC1;FYN;PLEK;BRCA1;GLA;OPN3;PGP;WNT4;ROCK2;ERLIN1;KHSRP;FBXW7;ZC3H12A
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.18993134183577604,0.8456793091979422,0.6923076923076923,0.8267231319084961,1.0,17/85,15.84%,HIF3A;ATF4;EGLN2;MAPK7;BAG3;UBB;HMOX1;PSMC5;EGLN1;KLF2;ARNT;EPAS1;PSMD9;HIGD1A;PSMB6;DDIT3;ANKRD2
prerank,neuromuscular process (GO:0050905),-0.30808714846795804,-0.8456206790263062,0.71875,0.9233633353661695,1.0,8/19,25.61%,STRA6;CHRND;SHANK1;MYCBP2;DCANP1;GCH1;TIFAB;AGTPBP1
prerank,protein heterooligomerization (GO:0051291),0.2653306492969856,0.8446846985562998,0.5517241379310345,0.8279130547927546,1.0,4/17,7.31%,CPSF7;PKD2;PKD1;MAT2A
prerank,cellular response to pH (GO:0071467),0.24445828407317438,0.844469531387689,0.65,0.8275825947615548,1.0,6/18,19.85%,MCOLN1;TRPV1;RAB11B;KCNK4;RAB11FIP5;SLC9A1
prerank,nucleosome organization (GO:0034728),-0.24132264136000459,-0.8442912795791715,0.8292682926829268,0.9252413624823027,1.0,21/56,34.32%,CHAF1B;HMGA1;CHAF1A;SOX9;SMARCA4;LIN54;SET;SPTY2D1;SMARCC1;SMARCB1;NPM1;ATRX;NFE2;PRDM9;ARID2;ARID1A;BPTF;GRWD1;ANP32B;BRDT;PADI4
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.29088214329115647,-0.8440221613841012,0.7222222222222222,0.9244060730916503,1.0,5/20,22.72%,POLR2F;POLR2J;POLR2D;POLR2I;ATRX
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.29088214329115647,-0.8440221613841012,0.7222222222222222,0.9244060730916503,1.0,5/20,22.72%,POLR2F;POLR2J;POLR2D;POLR2I;ATRX
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.23212843174061662,-0.8433737490039138,0.7195121951219512,0.924957135444648,1.0,18/61,24.86%,GPR18;ADGRG1;RASGRP1;PIK3CG;RTN4R;COL3A1;GPR35;GPR174;F2R;AUTS2;LRRC59;RASGRF1;SYNPO2L;PIK3CB;P2RY10;GPR55;LYN;NOTCH1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.26589100785998315,0.8432664934850465,0.59375,0.8290972847923503,1.0,4/18,12.78%,FGFR1;FGF2;CCL2;MEF2C
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.25082146679886874,-0.8431571168632713,0.7123287671232876,0.9246017642976482,1.0,13/37,29.65%,CHEK1;E2F1;RBBP8;TFDP1;CDC7;CBX3;HLA-G;BRCA1;RNF2;EZH2;PHC3;RRM2;SUZ12
prerank,protein localization to microtubule organizing center (GO:1905508),-0.3149906455241043,-0.8426606690563312,0.6986301369863014,0.9246205637996645,1.0,4/16,21.43%,SPAG5;SNX10;CEP83;PIBF1
prerank,regulation of mRNA catabolic process (GO:0061013),-0.21625580267437708,-0.8421917659447118,0.8045977011494253,0.9248026371514676,1.0,44/122,35.51%,IGF2BP1;IGF2BP3;PSMB9;PSMD14;IGF2BP2;PKP1;MAPKAPK2;EXOSC3;PABPC1;PNPT1;CNOT1;EXOSC8;DIS3;EXOSC4;SET;EXOSC5;PSMA3;ANP32A;PKP3;CARHSP1;PSMB3;PSMC1;FMR1;PSMB11;PSMA5;PSMB2;EXOSC7;PSME2;PSMD12;PSMA7;XRN1;KHSRP;ZC3H12A;PSME4;PSME3;UBC;EXOSC2;XPO1;PSMD1;YWHAB;NUP214;SERBP1;YTHDF1;EXOSC1
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.28513132387235873,-0.8418866139215075,0.7733333333333333,0.9246522416374464,1.0,10/19,48.09%,HBA1;PRDX4;PRDX5;HBQ1;PXDNL;HBG1;MPO;GPX1;HBG2;PRDX1
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.27728088933865125,-0.841655142590733,0.6533333333333333,0.9243215937493754,1.0,5/23,14.28%,CAV1;ABCA12;PON1;PTCH1;NFKBIA
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.26455320702807134,-0.8411879058656553,0.6944444444444444,0.9244045591976842,1.0,9/33,24.79%,GRIN2D;GRIN2B;GLRA1;DRD2;GABRE;GSK3B;GABRA1;GABRA3;GABRG3
prerank,regulation of exosomal secretion (GO:1903541),0.2571817395883375,0.8408226663106773,0.7777777777777778,0.8327624237622951,1.0,2/18,4.04%,CHMP3;TSG101
prerank,protein deubiquitination (GO:0016579),-0.19814290373721147,-0.8399887052366083,0.845360824742268,0.9260045793404124,1.0,74/250,32.32%,MYC;OTUB2;CDK1;SKP2;USP50;TNFAIP3;RUVBL1;USP37;PSMB9;TNIP3;POLB;PSMD14;KDM1B;SMAD1;BRCC3;SHMT2;USP18;USP26;RNF128;CFTR;CLSPN;NFKBIA;NLRP3;ACTL6A;USP9X;CDC25A;PSMA3;CDC20;TRRAP;MDM2;ACTR8;TRAF2;BRCA1;USP17L1;BARD1;UCHL5;OTULIN;VCPIP1;USP17L4;IKBKG;ASXL2;PSMB3;GATA3;PSMC1;USP42;USP38;STAMBPL1;PSMB11;USP32;PSMA5;PSMB2;PSME2;USP34;PSMD12;PSMA7;USP17L18;USP10;ZC3H12A;USP17L22;UCHL3;ADRM1;PSME4;USP1;PSME3;USP17L10;SPATA2;UBC;USP17L13;TGFBR1;USP17L20;STAM;HIF1A;COPS5;USP7
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.2598008267536862,0.8386400164826011,0.6363636363636364,0.8365589690294883,1.0,4/17,8.74%,HDAC6;BNIP3;SLN;TBC1D25
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.2684366241089936,-0.8380591298966776,0.7285714285714285,0.9291236948423532,1.0,12/24,30.55%,TGFB2;CCL3;PCSK9;NF1;CDK5;TYROBP;TNF;CDK5R1;BAX;MCL1;FBXW7;TFAP2A
prerank,positive regulation of histone acetylation (GO:0035066),-0.2921702414116292,-0.8378141788030206,0.717948717948718,0.9289471337131668,1.0,7/23,22.76%,FOXP3;IL1B;PAXIP1;LIF;BRCA1;SMARCB1;RUVBL2
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.24355340082228522,0.8375685700506312,0.8076923076923077,0.8375634511010789,1.0,6/25,14.96%,PLA2G5;PLA2G4B;SLC27A1;PLA2G1B;CDS2;PLA2G4A
prerank,aortic valve morphogenesis (GO:0003180),-0.2541104078657022,-0.8374901147527827,0.6956521739130435,0.9287476700828602,1.0,11/32,26.73%,TBX20;SOX9;ROBO2;TGFB1;BMP4;SMAD6;GATA3;NOTCH1;ROCK2;EFNA1;TWIST1
prerank,regulation of Notch signaling pathway (GO:0008593),0.18651627062859902,0.8370301842155207,0.8,0.837913369465237,1.0,21/74,18.34%,YJEFN3;HEY1;KAT2B;RBPJ;EGFL7;RFNG;EGFR;EPN2;TM2D3;ZMIZ1;MAML1;GATA2;ENHO;METTL3;ITGB1BP1;NOTCH4;SYNJ2BP;HIF1AN;LLGL1;DLL1;STAT3
prerank,cellular response to alcohol (GO:0097306),0.1966768506479462,0.8370249123702161,0.8695652173913043,0.8372327574263211,1.0,14/47,16.10%,KLF9;ADCY5;GNG2;SFRP1;GOLPH3;AKR1C2;SMO;OSBPL7;GNAI1;PTGER4;ADCY2;PTGFR;ADCY6;CES1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.2068042666629247,0.8366186654411489,0.7272727272727273,0.8371878899154617,1.0,13/29,25.36%,NGF;JAK2;NTRK1;FGF10;STK19;MMD2;EPOR;GRB2;SHC1;RAPGEF1;RASGRP4;RELN;EPO
prerank,regulation of ERBB signaling pathway (GO:1901184),0.24774126431431803,0.8355067955398957,0.7142857142857143,0.838325504346721,1.0,5/16,14.60%,RBPJ;CEACAM1;EGFR;RHBDF1;MVB12B
prerank,sphingolipid catabolic process (GO:0030149),-0.31997464468141074,-0.834965787573955,0.7236842105263158,0.9327895946636316,1.0,5/16,19.31%,ASAH2;ASAH2B;SMPD2;ACER2;GLA
prerank,cellular response to virus (GO:0098586),-0.25863207373287883,-0.8347435285489374,0.7105263157894737,0.9324946655810595,1.0,14/32,37.35%,IFI6;IL21;CXCL10;EIF5A;RRP1B;FMR1;IFNB1;CCL5;BAX;ZC3H12A;HIF1A;IRF3;HSP90AA1;CHUK
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.24795163887460092,-0.8344666309584795,0.7605633802816901,0.9322812021854734,1.0,12/39,29.23%,TNFSF11;SOX4;TFR2;DRD2;SCT;RBP4;GHRHR;TRH;TM7SF3;GHRH;MCU;AACS
prerank,cardiac ventricle development (GO:0003231),-0.3029086190406347,-0.8339590274774792,0.676056338028169,0.9324899924052051,1.0,3/20,5.28%,STRA6;MATR3;ENG
prerank,histone H2A ubiquitination (GO:0033522),0.2650520854247057,0.8338811816568241,0.7333333333333333,0.8406425816172678,1.0,4/17,14.41%,RING1;SKP1;UBE2B;RYBP
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.2581027283677449,-0.8336780106717364,0.6901408450704225,0.9322826589578663,1.0,4/29,12.36%,ERCC5;RPA3;CDK7;GTF2H2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.2832551412767663,-0.8331790721878228,0.6986301369863014,0.93248533460164,1.0,13/25,39.36%,PPIH;PPIB;PPIL1;PPIL6;PPIAL4C;FKBP1B;PPIAL4A;FKBP4;PPIAL4G;PPIF;PPIAL4F;PPIAL4D;PPIL3
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.27469173392607654,-0.8329866590618673,0.6986301369863014,0.9320592669002877,1.0,5/26,17.17%,CCND1;MTBP;TFDP1;CDC6;ANKRD17
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.2619916091878163,-0.8325277343333379,0.7105263157894737,0.9322099486658908,1.0,6/27,15.39%,ASAH2;CYP2D6;ALOX12B;ALOX12;ASAH2B;ALOXE3
prerank,mRNA processing (GO:0006397),0.1471919979878659,0.8323453758199161,1.0,0.8427162179239271,1.0,81/292,22.04%,SRSF5;NOVA1;PABPN1;DHX35;SNRNP70;DDX39B;CPSF7;HNRNPH3;CASC3;ALKBH5;RBM6;SRSF4;SNRPN;RPRD1A;RBM4;POLDIP3;PRKACA;U2AF1L4;ISY1;SF1;THOC5;AKAP8L;CMTR1;SRSF11;PRPF18;HNRNPH2;SRRM2;ERCC3;RBM5;RNPC3;PDCD7;SF3B1;METTL3;DDX42;CWC25;SRRM1;GTF2H4;SRSF7;SYF2;PNN;HSPA8;DHX16;CELF1;SF3B4;IK;NOVA2;PLRG1;RBM17;DNAJC8;WBP4;CD2BP2;CHTOP;RNMT;SNIP1;POLR2A;XAB2;ZRSR2;SUPT5H;SRSF2;ZMAT2;PCBP2;PRPF4B;SRSF1;SNW1;RAVER1;ZMAT5;USP49;RBM4B;MFAP1;RBM14;SMNDC1;SARNP;SF3A1;SUGP1;DHX38;SRRT;TRA2A;POLR2E;HNRNPA3;THOC1;GTF2H5
prerank,protein targeting to mitochondrion (GO:0006626),-0.23609049136578383,-0.8318387516585304,0.7160493827160493,0.9325503237149508,1.0,18/53,31.36%,TIMM8A;TOMM20L;TOMM34;HSPD1;MIPEP;ROMO1;TIMM23;TOMM40;DNAJC15;GRPEL2;TIMM10;IMMP2L;TIMM13;GDAP1;HSPA4;AIFM1;IMMP1L;TIMM50
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.19871631146354404,0.8316169687094195,0.9411764705882353,0.8431454377941444,1.0,10/42,17.83%,CD34;POMC;SYT11;CX3CL1;ARG2;LGALS9;NFKBIL1;GAS6;MC1R;RARA
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.22624248408323322,0.831088084449694,0.8260869565217391,0.8434885383185382,1.0,7/39,12.21%,BTC;SPRY1;TSG101;DUSP3;DAB2IP;EGFR;RNF115
prerank,regulation of establishment of planar polarity (GO:0090175),0.17335548347109078,0.8303486805134703,0.8421052631578947,0.8441893932343122,1.0,11/88,7.74%,FZD7;FZD4;ROR2;DVL3;RAC1;PRICKLE2;AP2M1;RHOA;DVL2;NPHP3;PSMC5
prerank,peptidyl-serine modification (GO:0018209),-0.19760408662465034,-0.8297233858714781,0.8817204301075269,0.935639145083085,1.0,43/164,24.58%,TDGF1;CDK1;VRK1;CSNK2A3;VRK2;MASTL;PRKDC;IKBKE;SBK1;AURKA;MAPKAPK2;PRKCG;NEK6;PLK1;GALNT3;PARP2;AKT3;NTMT1;PRKCZ;CAMKV;TOP1;CDC7;STK4;DYRK3;ATR;CLSPN;TTBK1;TGFBR2;STK39;CDK5;EIF2AK3;CSNK2A1;PRKCQ;RPS6KA3;GSK3B;PRKX;CSNK1A1L;MAPKAPK5;HIPK2;TTK;PRKCI;MAPKAPK3;LMTK2
prerank,gene expression (GO:0010467),-0.19616406387997246,-0.8294654529342551,0.8854166666666666,0.9353900269002277,1.0,132/349,39.33%,TESC;ZC3H11A;IGF2BP3;POLR2F;U2AF1;DUOXA2;DKC1;E2F1;NUP155;THOC3;NUP37;HSPD1;NUP210;SORL1;CPSF3;YARS2;RPL39;NUP107;PAX8;MRPL3;NUFIP1;RANBP2;MAGOHB;RRBP1;MRPS18C;TAF1B;SRBD1;NUP35;PRSS37;NUP50;SEH1L;NKX2-8;RPS19;NCBP1;POLR2J;FARSB;NUP205;EIF4E;NUP88;ASMT;APOBEC1;SRSF9;FASTKD2;RPS21;ALYREF;POLR2D;NUP93;MRPS16;PRPF4;MRPL13;RPL36;POM121;RAE1;POLR3A;NXF3;MAGOH;TSPAN33;ZAR1L;ABCF1;POLR2I;PTMA;STUB1;XRN2;TASP1;RPL23A;CPSF2;RPL37;GLE1;MRPL9;NUP43;NUP160;RNGTT;NUP153;NDC1;DDX39A;SETX;SMG1;RPL8;DHX8;CPSF4;NXT1;MRPL37;THOC2;NUP62;GSPT1;MRPL42;DROSHA;NUP98;MRPS12;DNAJB11;SYNCRIP;HBS1L;BICD1;TFIP11;MRPS18A;COPS5;SEC13;SLBP;SNRNP40;AGFG1;RBM8A;RPS18;DDX54;SCX;RPS7;MRPS11;DUSP11;EIF4A3;THOC6;MRPL52;MRPS33;MRPL44;NUP214;HNRNPF;CDC40;FIP1L1;ANGPT2;RPS2;NOX4;SMG7;RPL41;RPS24;SMG6;TPR;HNRNPU;TOPORS;RPS4Y2;RPL32;RPS29;RPL27A;MRPL28;RPL35
prerank,regulation of T cell migration (GO:2000404),0.2551484606680947,0.8292308204438175,0.6296296296296297,0.8454346339533586,1.0,5/19,12.78%,APOD;RHOA;CCL21;APP;TNFRSF14
prerank,nuclear export (GO:0051168),-0.2159389549058097,-0.8289797776494118,0.8181818181818182,0.9354972982753752,1.0,20/82,21.51%,ZC3H11A;NUP62CL;U2AF1;NUP155;THOC3;CSE1L;CALR;XPO5;MAGOHB;RANBP17;TGFB1;NCBP1;XPO4;EIF4E;SRSF9;ALYREF;POM121;RAN;RAE1;MAGOH
prerank,T cell mediated immunity (GO:0002456),-0.29090017244177085,-0.8286989729745612,0.6818181818181818,0.935254440411673,1.0,5/16,21.84%,CTSH;CD70;CD55;CD46;CRTAM
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.31024646344833495,-0.8286630964746544,0.7222222222222222,0.9345476662540939,1.0,1/18,0.07%,GNL3L
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.2941045692820352,-0.8284364701940128,0.726027397260274,0.9341456078250456,1.0,4/17,12.63%,CSF2;PF4;AGT;PLA2G3
prerank,ventricular septum morphogenesis (GO:0060412),-0.2604073123333923,-0.8282791828587289,0.7567567567567568,0.9336354700003544,1.0,5/28,8.66%,TGFB2;SOX4;ROBO2;PROX1;ZFPM1
prerank,positive regulation of synapse assembly (GO:0051965),-0.2635598025168452,-0.8281043648660513,0.6764705882352942,0.9332062191323041,1.0,10/28,27.42%,EPHB2;EPHB3;SEMA4D;AGRN;PTPRD;WNT7A;SYNDIG1;BDNF;SEMA4A;SRPX2
prerank,positive regulation of protein transport (GO:0051222),-0.21458294204387043,-0.827982594006154,0.7816091954022989,0.9327148178921425,1.0,12/63,18.09%,IL1A;KIF20B;TGFB2;MYH10;ARHGEF5;TGFB1;ATP2C1;CD2AP;ADAM9;EXPH5;ADAM8;TTN
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.2622836742764116,-0.8276835983825416,0.7222222222222222,0.9325952974228982,1.0,14/30,29.27%,ITGA5;CXADR;DSP;ITGAX;ITGAD;DSG2;IZUMO1;JUP;PKP2;ITGB2;CD2;DSC2;LILRB2;CD58
prerank,cellular response to misfolded protein (GO:0071218),0.2563523868615344,0.8274002758181452,0.7931034482758621,0.8477339198663864,1.0,9/19,23.62%,DNAJC18;RNF185;POMT2;DNAJB12;BAG6;ATXN3;KLHL15;RNF5;DNAJB14
prerank,protein localization to Golgi apparatus (GO:0034067),0.21871791440415647,0.8272594841556674,0.7142857142857143,0.8472720218368197,1.0,7/27,18.79%,OPTN;OBSL1;ZDHHC15;GOLPH3;GBF1;RAB33B;IFT20
prerank,neuropeptide signaling pathway (GO:0007218),-0.2317854989686744,-0.8267305123447111,0.7777777777777778,0.9337023954731165,1.0,14/62,19.67%,SSTR5;NXPH4;NMU;HCRTR1;SORL1;GLRA1;GLRA2;AGRP;RXFP3;OPRM1;KISS1R;NMUR2;GPR84;NPBWR1
prerank,regulation of interleukin-13 production (GO:0032656),-0.3048458789317239,-0.826443973121565,0.7297297297297297,0.9336107652549891,1.0,9/16,42.49%,LEF1;PRKCZ;TNFSF4;GATA3;IFNL1;LILRA5;IL18;IFNA2;IL4
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.24905205094282185,0.8262607386449662,0.6538461538461539,0.8484604811183823,1.0,7/21,12.78%,FGF2;TGFBR3;BMPR1A;RBPJ;FGFR2;PIM1;MEF2C
prerank,regulation of B cell proliferation (GO:0030888),-0.24448251325255,-0.8258977129248739,0.7564102564102564,0.9337869505860911,1.0,12/46,24.32%,MIF;EPHB2;IL21;CD81;CHRNB2;IL10;CTLA4;MNDA;TNFSF13B;TYROBP;LYN;VAV3
prerank,dendritic spine morphogenesis (GO:0060997),-0.29989138287116945,-0.8248922112134611,0.7536231884057971,0.9349245310171748,1.0,5/16,20.94%,EPHB2;EPHB3;WNT7A;SHANK1;DOCK10
prerank,dopamine metabolic process (GO:0042417),-0.28717274570043166,-0.8246020069721092,0.7162162162162162,0.9347354744404582,1.0,10/18,35.34%,TGFB2;TH;DRD2;SULT1A3;GCH1;SNCAIP;DBH;ATP7A;DRD3;LRTOMT
prerank,regulation of viral release from host cell (GO:1902186),0.23628787211183044,0.8235810320247408,0.7619047619047619,0.85228062766368,1.0,5/22,17.10%,CHMP3;TSG101;TRIM21;VPS4A;TRIM8
prerank,regulation of ruffle assembly (GO:1900027),-0.2866166896433558,-0.8229155818879362,0.7236842105263158,0.9371089471102014,1.0,3/22,9.40%,TACSTD2;CAV1;EPS8L1
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.3118860220147135,-0.8226094747102793,0.7384615384615385,0.9369013993001515,1.0,7/19,19.26%,CHRNE;CHRNA5;CHRNB2;NQO1;CHRNA7;CHRNB3;CHRNA2
prerank,response to gamma radiation (GO:0010332),0.2502160902187469,0.8223704909537057,0.7368421052631579,0.8540061261294644,1.0,3/23,6.87%,CRYAB;TSPYL5;TMEM109
prerank,acylglycerol homeostasis (GO:0055090),-0.29268434709719593,-0.8216349739927713,0.7564102564102564,0.9379760632866329,1.0,7/21,25.79%,ANGPTL3;CETP;SCARB1;MLXIPL;GCKR;HNF4A;LIPC
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.25826587925098676,-0.8213594684852412,0.7375,0.9376151295527536,1.0,6/32,12.20%,HECW1;HECW2;CAPRIN1;SEMA4D;CHRNB2;PTPRD
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.2748322099922168,-0.8210540248841659,0.7076923076923077,0.9374982815453217,1.0,12/20,33.79%,SULT2B1;SOX9;IL20;SFRP4;BMP4;FOXN1;IL13;FOXJ1;SFN;KDF1;NKX6-1;AHI1
prerank,retinoic acid metabolic process (GO:0042573),-0.26059361020218885,-0.8206885934781153,0.6621621621621622,0.9373985968906922,1.0,3/24,3.25%,CYP2W1;CYP2S1;CYP3A7
prerank,receptor metabolic process (GO:0043112),0.2134486012286939,0.8206154298353471,0.7777777777777778,0.8560679733318649,1.0,11/54,12.35%,RAMP1;SNCA;SNX1;ACKR3;AP2M1;CD36;RAMP3;RAMP2;RAB31;RAB11B;ADM
prerank,protein import into mitochondrial matrix (GO:0030150),-0.28221078869803917,-0.8205530068991628,0.75,0.9369655024272419,1.0,6/18,25.09%,TOMM20L;ROMO1;TIMM23;TOMM40;DNAJC15;GRPEL2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.21360652127333343,-0.8201438100255334,0.7777777777777778,0.9369059515556254,1.0,21/81,22.38%,GPR18;CXCR2;HOMER1;FPR2;DRD2;AGT;GRM1;GRM5;GPR157;GPR35;GRPR;GNA15;GPR174;F2R;TRHR;OPRM1;NMUR2;P2RY10;FPR3;GPR55;HTR2C
prerank,protein acetylation (GO:0006473),-0.24915646658457352,-0.8195549501599165,0.7534246575342466,0.9371682409651769,1.0,6/30,14.90%,DSCC1;ESCO2;NAA15;NAT10;NAA35;AANAT
prerank,response to UV (GO:0009411),-0.21381319970759366,-0.8194709693619757,0.7857142857142857,0.936538972537855,1.0,15/94,14.21%,MYC;CCND1;ERCC5;ZRANB3;POLH;AURKB;FEN1;ERCC8;IL12B;RELA;GTF2H2;MSH6;WRN;PTPRK;ATR
prerank,negative regulation of cellular component movement (GO:0051271),0.2685111307878191,0.8189030453823426,0.7,0.8580246546758222,1.0,4/15,10.92%,ACTN1;FBLN1;TGFBR3;PIN1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.328153871958796,-0.8180269018623696,0.7205882352941176,0.9386777808408292,1.0,5/15,18.72%,ENTPD7;NUDT1;NUDT15;NUDT5;ENTPD1
prerank,regulation of cilium assembly (GO:1902017),-0.22541658504978426,-0.81747885915666,0.8414634146341463,0.938892968328437,1.0,7/61,7.59%,MCIDAS;SAXO1;USP6NL;MAPK15;TBC1D14;TBC1D30;DCDC2
prerank,regulation of viral life cycle (GO:1903900),0.22044733423386098,0.8172838228760615,0.8461538461538461,0.8598933701003119,1.0,7/25,17.16%,TRIM6;TSG101;TRIM21;TRIM34;VPS4A;TRIM68;KPNA6
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.285030573347948,-0.8169197273492544,0.6619718309859155,0.9391303168213689,1.0,6/18,28.58%,ADCY7;LILRB4;MEFV;CHID1;NLRP7;ZC3H12A
prerank,positive regulation of cartilage development (GO:0061036),-0.28038332461191257,-0.8166862480828723,0.7014925373134329,0.9388163265017783,1.0,2/18,4.08%,LOXL2;SOX9
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.20808599121616356,-0.8158408399984246,0.8235294117647058,0.9394915231474827,1.0,30/100,28.72%,INHBA;SOX4;EIF3C;PRKDC;UHRF1;PLK1;PASK;NAT10;THBS1;AGT;TGFB1;WNT7A;NFKBIA;PERP;MSN;FGFR4;CLN6;HDAC2;ASPH;LARP4;NPM1;FMR1;STUB1;VPS35;LARP4B;ASPSCR1;EIF6;CD28;EZR;EEF2
prerank,cellular response to interleukin-6 (GO:0071354),-0.26520328016174316,-0.8154396423843253,0.6883116883116883,0.9393685892579173,1.0,8/28,20.95%,TDGF1;SOCS3;CEBPA;STAT1;RELA;PHB;ST18;SPI1
prerank,"wound healing, spreading of cells (GO:0044319)",-0.27074710906111027,-0.8146021232048977,0.7580645161290323,0.940132001681726,1.0,5/21,15.54%,ITGA5;CD44;PLET1;WNT7A;MMP12
prerank,positive regulation of exocytosis (GO:0045921),-0.2519882784821351,-0.8143411773590012,0.8115942028985508,0.9398854632169756,1.0,9/34,21.75%,CADPS;RAB15;RAB3D;CFTR;IFNG;EXPH5;CADPS2;ATP13A2;SDC1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.27850719868552243,-0.8138147801087221,0.7014925373134329,0.9400928851164407,1.0,9/25,22.38%,ERO1A;TRPM2;DRD2;F2R;IBTK;ITPR2;XCL1;LCK;HTR2C
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.2943107030552852,-0.8133883693488323,0.7246376811594203,0.9401824785677224,1.0,2/15,1.74%,IL1B;GTSE1
prerank,ERBB2 signaling pathway (GO:0038128),0.2156276903094883,0.8131905086760405,0.7857142857142857,0.866648858626833,1.0,6/31,13.05%,BTC;MYOC;PIK3R1;EGFR;NRG2;PRKCA
prerank,response to hydrogen peroxide (GO:0042542),-0.21845047833163306,-0.8127046464509231,0.8048780487804879,0.9406129599309245,1.0,17/48,31.31%,TNFAIP3;PAX2;TRPM2;RELA;ECT2;HBA1;STK24;FYN;ADAM9;STK26;APTX;ANXA1;FXN;SETX;GLRX2;MAPK13;PDCD10
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.23610870600982142,0.8114827129513125,0.8125,0.8684057506779047,1.0,6/23,13.43%,EPHA4;PKD1;PRKACA;UBB;RHBDF1;UBE3A
prerank,negative regulation of leukocyte activation (GO:0002695),0.2606044420705923,0.8112120512554161,0.6956521739130435,0.8681157952013703,1.0,15/15,73.96%,GPER1;LRFN5;NR1H3;BPI;CD200;IL31RA;FCGR2B;GRN;HAVCR2;IL4;CD300A;MILR1;ZC3H12A;CD300LF;CD84
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.30862739027224484,-0.8098806773995009,0.8028169014084507,0.9451151071955345,1.0,4/15,18.47%,MIF;CD44;MDM2;ARMC10
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.20975014321349708,0.8095470359277144,0.7777777777777778,0.8703073248845299,1.0,9/32,18.10%,UFSP2;HDAC6;PKN1;PRMT2;RNF14;SAFB2;KCTD6;TRIM68;AR
prerank,diacylglycerol metabolic process (GO:0046339),-0.26477047878922977,-0.8086314163576789,0.7285714285714285,0.9465401166487293,1.0,4/22,16.58%,DGAT2;LIPE;MOGAT1;DGKK
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.1861406534396691,0.8083630605553808,0.75,0.8717026010337601,1.0,8/54,10.28%,TLR3;BCL10;CTSS;UBB;CD36;HSP90B1;TLR9;TAB1
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.27523374279504736,-0.8079952368966846,0.8055555555555556,0.9467971976170385,1.0,11/23,35.75%,FUT8;FUT1;FUT7;FUT2;FUT6;FUT5;MPDU1;B4GALT1;B3GALT2;ST3GAL2;FUT3
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.25450427259149755,-0.8073589413417948,0.7361111111111112,0.9471207450538984,1.0,12/34,37.21%,DKC1;DCLRE1B;TERT;SLX1A;GAR1;SHQ1;WRAP53;NOP10;PIF1;NHP2;CDK2;HSP90AA1
prerank,negative regulation of lyase activity (GO:0051350),0.2512187630621609,0.8070916683790994,0.75,0.8729270473240475,1.0,2/16,5.62%,PALM;GNAI2
prerank,Notch signaling pathway (GO:0007219),-0.21736455982022965,-0.8060373170722396,0.76,0.9485073589601574,1.0,16/60,24.86%,MYC;NOTCH3;DLGAP5;WWC1;DTX2;STAT1;GMDS;NLE1;ADAM10;POFUT1;MDK;JAG2;DTX3L;NRARP;CREBBP;NOTCH1
prerank,vesicle organization (GO:0016050),-0.23701956490105752,-0.8056263899893015,0.7407407407407407,0.9484228602285624,1.0,10/42,19.78%,USP50;CAV1;SNX10;ARFGEF2;CORO1A;LAPTM4B;PI4K2B;HOOK1;SRGN;FNBP1L
prerank,cardiac muscle cell differentiation (GO:0055007),-0.2658136626850365,-0.8050694229253739,0.7375,0.9486498362022436,1.0,7/24,20.77%,ALPK2;CXADR;IRX3;MYH11;TTN;SHOX2;NRG1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.20999301164685857,-0.8048776079306118,0.8202247191011236,0.9482264879091746,1.0,14/88,12.78%,INHBA;TBX20;BMP8A;TGFB2;GDF15;FOXD1;GDF9;CRB2;ENG;BMP7;INHBC;THBS1;TGFB1;CITED1
prerank,calcium ion transmembrane transport (GO:0070588),0.1860531511088242,0.8046501278956997,1.0,0.8760686538814485,1.0,26/84,18.77%,ATP2B4;CACNA1C;PKD2;SLC24A3;P2RX7;PKD1;CACNA2D1;MCOLN1;TRPC1;SLC8A2;TRPC4;TRPV1;ATP2A2;RYR3;MCOLN3;SLC25A23;SLC8A1;TRPC6;SMDT1;MICU3;MICU1;TRPV3;GAS6;PARL;ANO6;ATP2B3
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.23132673993219074,-0.8044541646948774,0.7733333333333333,0.9482145731176438,1.0,14/37,33.08%,AREG;EREG;EPHB2;EPGN;IL10;IFNG;EGF;HDAC2;FBXW7;TAF1;HIF1A;NRP1;BUD31;NCF1
prerank,regulation of leukocyte activation (GO:0002694),-0.2920150161952999,-0.8034349032237058,0.7076923076923077,0.9490568338606746,1.0,7/16,34.10%,MIF;LILRB4;LCK;LYN;PLSCR1;PLA2G10;CD74
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.21734465582749693,-0.8028906112523687,0.8444444444444444,0.9492105447391567,1.0,24/74,33.53%,CARD14;PSMB9;PSMD14;TNFSF15;NFKB2;RELA;IRAK1;TNFRSF10B;CHI3L1;PSMA3;TRAF2;PSMB3;PSMC1;PSMB11;PSMA5;PSMB2;PSME2;PSMD12;PSMA7;PSME4;PSME3;TNFRSF10A;PSMD1;TRAF6
prerank,inorganic cation transmembrane transport (GO:0098662),-0.18921033112045024,-0.8028347500139222,0.8958333333333334,0.9486108834987502,1.0,67/267,23.06%,SLC12A2;SLC4A11;SLC6A14;SLC6A20;KCNG2;CACNA1D;SLC30A2;SLC9C1;KCNQ1;TRPM2;KCNC3;SLC39A11;SLC9A7;KCNA7;SLC6A6;TRPV4;ATP6V0A4;RHCE;SLC24A1;HCN1;KCNK12;TRPM8;KCNS1;RHBG;KCNV2;KCNN4;UCP1;SLC40A1;SLC24A5;TRPM1;TRPC5;KCNH7;ATP12A;RHD;ASIC2;SLC11A2;SLC6A4;SLC39A8;ATP2A1;KCNS2;KCNH4;SCN8A;KCNJ4;ATP2C1;KCNA3;SLC6A18;KCNK1;SLC46A1;SLC12A3;KCNJ14;TRPC7;KCNK13;SLC36A3;SLC4A8;SLC12A1;SLC30A6;ASIC5;PKD2L1;SLC39A2;ATP1B1;KCNC2;HPN;HCN4;SLC30A5;TRPV2;SCN10A;TMCO1
prerank,sterol transport (GO:0015918),-0.28434422348379096,-0.8026337824340911,0.7866666666666666,0.9481726352314765,1.0,4/19,11.24%,ABCG5;CAV1;CETP;ABCG8
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.18410435100643893,0.8019492528858617,0.8947368421052632,0.8796423553928717,1.0,14/54,19.58%,CLIP3;PELI3;F2RL1;TRAF1;TAX1BP1;GPS2;TNFRSF1A;CFLAR;RIPK1;RNF31;CCDC3;GAS6;SPPL2B;CASP1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.2827376717275926,-0.8018099873606579,0.7236842105263158,0.9488132305350971,1.0,13/23,39.42%,RELA;BMP7;NLRP12;NLRP3;SPI1;NMI;TSPAN6;ADGRG3;ZC3H12A;IFI35;CPNE1;PYDC2;TMSB4X
prerank,positive regulation of mRNA processing (GO:0050685),0.22568374280691386,0.8016256724595914,0.7083333333333334,0.8794453082769988,1.0,8/23,21.78%,CIRBP;CELF4;PRDX6;PAF1;SF3B4;SNW1;TRA2A;THRAP3
prerank,cellular response to BMP stimulus (GO:0071773),-0.2164988170076745,-0.8015093144380291,0.8222222222222222,0.9485357275252637,1.0,8/68,7.03%,BMP8A;TGFB2;GDF15;GDF9;SOX9;ENG;ADAMTS12;SMAD1
prerank,early endosome to late endosome transport (GO:0045022),0.24174907818273728,0.801340213632838,0.7777777777777778,0.8792317971079572,1.0,9/20,25.89%,WDR91;AKTIP;RILP;PTPN23;STX8;WDR81;SNX16;PIK3C3;RAB7A
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.2334838645927691,0.8012740980360724,0.7307692307692307,0.8785991669015014,1.0,2/18,1.99%,PLA2G5;PLA2G4B
prerank,regulation of lymphocyte activation (GO:0051249),-0.3023499422641206,-0.8011583185663836,0.6944444444444444,0.9483580263838666,1.0,10/15,45.93%,SIT1;CRTAM;LCK;CLEC7A;CCL5;IKZF3;CD19;FCRL3;CD4;LAT
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.17551253521979288,0.801031179214211,0.95,0.8780849462533025,1.0,13/73,15.59%,HIF3A;CITED2;EGLN2;SIRT2;UBB;RBPJ;PSMC5;EGLN1;ARNT;EPAS1;PSMD9;HIGD1A;PSMB6
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.1879850067607925,-0.8002494758894481,0.8947368421052632,0.9491293478782266,1.0,56/242,24.01%,TNFSF11;ZIC2;WNT2;SHH;LRP8;IRAK2;CARD11;ADCY1;IL1B;CARD14;RIPK2;WNT5A;RTKN2;IKBKE;CAV1;ARHGEF5;NFKB2;SMARCA4;RELA;PRKCZ;IRAK1;NHLH2;RIPK4;NEUROG2;TFDP1;AGT;NEUROD2;ANXA3;NFKBIA;IL10;TNFSF18;NLRP3;RHEBL1;CARD9;SLCO3A1;ADAM8;JUP;TAB3;IRAK3;TRAF2;NOD2;PRKCQ;TRIM14;TRIM22;MBTPS2;PPARG;IKBKG;CARD16;SMARCB1;NPM1;NFAM1;NODAL;TNF;CLEC7A;HIPK2;PRKCI
prerank,protein kinase B signaling (GO:0043491),-0.2689767012329454,-0.8001379349503077,0.76,0.9485656464863861,1.0,6/24,13.93%,IL1B;PAX2;EPHA2;CCL3;TGFB1;KDR
prerank,histone H3-K4 methylation (GO:0051568),-0.2566165887469512,-0.7989215525727635,0.7972972972972973,0.9498973377033245,1.0,11/30,27.60%,BEND3;TET3;PAXIP1;PRDM7;RBBP5;WDR5B;PRDM9;KMT2D;TET2;DYDC2;KDM6A
prerank,canonical glycolysis (GO:0061621),0.2271966769369107,0.7978345452017029,0.8,0.8814609368994405,1.0,8/23,21.19%,ENO2;ALDOA;PFKM;HK2;HK1;ENO3;PGK1;ENO1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.2271966769369107,0.7978345452017029,0.8,0.8814609368994405,1.0,8/23,21.19%,ENO2;ALDOA;PFKM;HK2;HK1;ENO3;PGK1;ENO1
prerank,negative regulation of mRNA processing (GO:0050686),0.25133212805168476,0.7977428347305132,0.6388888888888888,0.880845280434433,1.0,3/15,14.08%,SRSF4;PCBP4;SRSF7
prerank,aminoglycan biosynthetic process (GO:0006023),0.1751486050030304,0.7975623995425345,0.7916666666666666,0.8803643212720443,1.0,17/49,21.04%,SDC2;SDC3;B4GAT1;GPC1;GCNT2;NDST2;GPC4;GPC3;NDST1;B3GAT3;HSPG2;B3GNT9;GPC6;HS6ST1;B3GALT1;HS3ST5;UGDH
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.18809993451354828,0.7973767502763678,0.8823529411764706,0.8798340740005612,1.0,3/44,1.60%,CD34;POMC;SYT11
prerank,response to hexose (GO:0009746),0.24223908492663562,0.7971497634082227,0.7586206896551724,0.8793213876946426,1.0,6/21,16.78%,VAMP2;EIF2B1;LPL;SLC2A5;EIF2B4;SLC30A8
prerank,protein hydroxylation (GO:0018126),0.27370870495023014,0.7970792781809405,0.6285714285714286,0.8786928763374536,1.0,5/15,17.65%,P3H2;JMJD7;P3H3;HIF1AN;VIPAS39
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.25545963904914654,-0.7970382689079433,0.75,0.952239486531093,1.0,9/22,28.41%,TTLL10;TTLL4;TTLL9;CEP41;AGBL4;TTLL5;VKORC1L1;AGTPBP1;NAA11
prerank,regulation of interferon-alpha production (GO:0032647),-0.25929365736310483,-0.7970140744631456,0.6756756756756757,0.951537206602172,1.0,9/25,30.74%,RIPK2;HSPD1;STAT1;IL10;TLR7;LILRA4;TLR8;IRF7;DHX9
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.23646669649469895,0.7970056605703231,0.75,0.8781653295516898,1.0,8/17,28.08%,HDAC6;CSNK2A2;SREBF1;CAMKK2;FBXO7;PINK1;GSK3A;DNM1L
prerank,regulation of mRNA stability (GO:0043488),-0.20019315508933616,-0.7965040738057733,0.8791208791208791,0.951671168025787,1.0,51/139,35.51%,IGF2BP1;IGF2BP3;E2F1;PSMB9;PSMD14;IGF2BP2;NOCT;AXIN2;MAPKAPK2;MEX3D;EXOSC3;PABPC1;EXOSC8;DIS3;EXOSC4;SET;EXOSC5;PSMA3;FUS;ANP32A;CARHSP1;PSMB3;NPM1;PSMC1;FMR1;PSMB11;PSMA5;ROCK2;PSMB2;EXOSC7;PSME2;PDE12;PSMD12;PSMA7;XRN1;KHSRP;PSME4;PSME3;TBRG4;UBC;LARP1;EXOSC2;XPO1;GIGYF2;PSMD1;FASTKD3;YWHAB;NUP214;SERBP1;YTHDF1;EXOSC1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.27154952196277804,-0.7963662665212097,0.7323943661971831,0.9511845438694398,1.0,3/20,12.20%,LRP8;CAPRIN1;PTPRD
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.26198557975551184,-0.7962908140350387,0.7761194029850746,0.9505505651354291,1.0,7/19,24.86%,CXCR4;SOX1;NF1;TNFRSF1B;MDK;TENM4;NOTCH1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.2538608949341812,-0.7960812690471003,0.7391304347826086,0.950153280389753,1.0,4/23,13.43%,IL1B;HCAR2;APOC1;SLC22A13
prerank,protein modification process (GO:0036211),-0.2094064661953639,-0.7952427090566135,0.8160919540229885,0.9509506444879114,1.0,8/77,10.96%,LOXL2;ERO1A;PRKDC;ABL2;RPN2;UBE2S;PARP4;RPN1
prerank,protein localization to centrosome (GO:0071539),-0.2857607345871105,-0.7948183142313126,0.8311688311688312,0.9509586637512033,1.0,4/18,21.43%,SPAG5;SNX10;CEP83;PIBF1
prerank,regulation of lipid metabolic process (GO:0019216),-0.20812077968698695,-0.794522043248674,0.8488372093023255,0.9507588615411054,1.0,27/87,26.50%,IL1B;CYP51A1;SQLE;CAV1;TGS1;SCD;APOC1;HELZ2;MVK;MED1;DHCR7;SC5D;FDPS;NFYA;SERPINA3;FGFR4;PANK2;CARM1;PPARG;FASN;TM7SF2;HNF4A;ACACA;CERS2;CREBBP;PSAPL1;HMGCS1
prerank,positive regulation of cell growth (GO:0030307),0.16987172987151397,0.7944132972263068,0.9166666666666666,0.8808834990020824,1.0,16/95,14.32%,NTN1;L1CAM;MAPT;DBN1;NGF;AKAP6;LGI1;SYT4;EGFR;SFRP1;KLHL22;SYT1;N6AMT1;BCL2;USP47;INS
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.1731523478641494,0.7940272553229022,1.0,0.8806875431828187,1.0,10/85,7.74%,FZD7;FZD4;ROR2;DVL3;RAC1;PRICKLE2;AP2M1;RHOA;DVL2;PSMC5
prerank,embryonic digit morphogenesis (GO:0042733),0.2629935802131791,0.7932471003004088,0.7096774193548387,0.8810899696831611,1.0,5/17,13.13%,OSR1;ECE1;INTU;GLI3;OSR2
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.2351808998735314,-0.793114837857587,0.7567567567567568,0.9524937674748983,1.0,6/38,14.58%,FXYD5;IL1RN;GTPBP4;ASS1;TGFB1;IL10
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.25597418083685847,-0.7929644100804977,0.7567567567567568,0.9519327119952021,1.0,7/27,24.60%,WDR43;CCNK;EAF1;HMGN1;ALYREF;ERCC6;EAF2
prerank,ganglioside metabolic process (GO:0001573),0.21544134789077019,0.7927724806664065,0.8461538461538461,0.8809605630063637,1.0,6/20,16.09%,ST6GALNAC3;B3GALT4;ST3GAL5;ST6GALNAC5;ST8SIA3;ST6GALNAC6
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.2216673921532591,0.7910204091544525,0.8205128205128205,0.8828381970835893,1.0,5/24,12.10%,ATF4;MAPK7;RBPJ;KLF2;MT3
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.2626980774130692,-0.7909669840808623,0.7777777777777778,0.9543078031714446,1.0,5/22,15.05%,HNF1A;MED1;MED14;PAXIP1;MED13
prerank,regulation of protein ubiquitination (GO:0031396),-0.20057954387201582,-0.790843217796784,0.8505747126436781,0.9537625650473995,1.0,34/101,33.55%,GNL3L;PRR7;SOX4;RIPK2;TNFAIP3;PRMT3;CAV1;ISG15;PRKCG;XIAP;GTPBP4;PAXIP1;NDFIP2;FBXO4;MYCBP2;BIRC7;BRCA1;IVNS1ABP;STUB1;AXIN1;FANCI;TBC1D7;CUL3;FBXW7;COMMD1;DERL1;HUWE1;TGFBR1;HDAC8;UBE2N;SH3RF2;SPRTN;TRAF6;AMER1
prerank,intracellular protein transmembrane transport (GO:0065002),-0.23573356466801898,-0.7895594847211835,0.7701149425287356,0.955184695043431,1.0,17/43,37.59%,TOMM20L;HSPD1;PEX7;ROMO1;TIMM23;TOMM40;DNAJC15;GRPEL2;PEX10;AIFM1;PEX16;TIMM50;PEX1;SEC61G;SEC61B;GRPEL1;SEC61A1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.19097784364702078,-0.788536081334534,0.9032258064516129,0.9561582759265234,1.0,35/153,24.01%,TNFSF11;IRAK2;CARD11;IL1B;CARD14;RIPK2;WNT5A;RTKN2;CAV1;NFKB2;RELA;PRKCZ;IRAK1;RIPK4;AGT;NFKBIA;TNFSF18;NLRP3;RHEBL1;CARD9;SLCO3A1;ADAM8;TAB3;IRAK3;TRAF2;NOD2;PRKCQ;TRIM14;TRIM22;IKBKG;CARD16;NPM1;TNF;CLEC7A;PRKCI
prerank,heart looping (GO:0001947),-0.23151891917814282,-0.7880288508005835,0.7875,0.9562165983572495,1.0,5/43,5.28%,TBX20;SHH;FOLR1;CCDC103;ENG
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.21945758835912876,-0.787792962704004,0.8170731707317073,0.9558454836617265,1.0,22/64,34.72%,HTR1D;SSTR5;MTNR1A;TSHR;AGT;OPRM1;HTR6;OR10H1;MTNR1B;HTR2C;HRH3;XCR1;ANXA1;SSTR3;MC3R;OR6T1;OR10H5;HTR1F;PTGIR;HTR1B;MC2R;GALR3
prerank,eye morphogenesis (GO:0048592),0.22299786589096798,0.787277425401132,0.7941176470588235,0.8871322043908972,1.0,6/19,18.34%,MFAP5;EFEMP1;TENM3;SKI;RARG;STAT3
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.27159104122357847,-0.7858561101291668,0.8292682926829268,0.9583205583608013,1.0,4/21,8.35%,CXCL8;MRAP;RPGRIP1L;MET
prerank,response to zinc ion (GO:0010043),-0.25415456736444647,-0.7856629399585263,0.75,0.9578615687038955,1.0,9/29,28.53%,SLC30A2;GLRA1;KHK;GLRA2;ATP13A2;SLC30A5;HAAO;MT4;ZNF658
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.23928352066173536,-0.7854767138497827,0.8378378378378378,0.9575063096769976,1.0,5/34,11.52%,MYC;DUSP1;ZNF675;FOXM1;KLHL31
prerank,regulation of telomere capping (GO:1904353),-0.26264741262206825,-0.7853539174007708,0.7105263157894737,0.9569132080889413,1.0,3/23,5.50%,NEK2;AURKB;MAPK15
prerank,cellular response to glucose stimulus (GO:0071333),-0.2506989817142815,-0.7852830610590422,0.8082191780821918,0.9563210217811136,1.0,4/29,6.69%,SOX4;PAX2;ZBTB20;IGF1R
prerank,regulation of vacuole organization (GO:0044088),0.21999610451078885,0.7838428884397146,0.8125,0.8910879823869517,1.0,9/20,22.44%,ENO2;ADPRH;ANXA2;ENO3;SCARB2;IFT20;ENO1;NPRL2;UBQLN2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.2233050059721752,0.7836631465773362,0.8333333333333334,0.8905702573924418,1.0,5/21,14.59%,SASH1;CD36;CX3CL1;PRKCA;NFKBIL1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.2587451258453737,-0.7833068601454118,0.7605633802816901,0.958548164678825,1.0,7/19,32.37%,SELL;GCNT1;SLC39A8;TNF;SELPLG;PODXL2;CX3CR1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.25644489325389114,-0.7828763818219866,0.8028169014084507,0.9584691499392617,1.0,12/25,32.64%,CAV1;CXADR;DSP;DSG2;JUP;PKP2;AKAP9;HCN4;DSC2;TBX18;NOS1AP;DLG1
prerank,Fc receptor signaling pathway (GO:0038093),0.16697061705274532,0.7827887862674581,1.0,0.890962579313317,1.0,11/112,6.20%,MAPK1;PPP3CB;BCL10;KIT;MAPK3;MAP2K4;CALM1;MAPK8;RAC1;SKP1;PIK3R1
prerank,secondary alcohol metabolic process (GO:1902652),-0.22508633499669337,-0.78245978836397,0.8082191780821918,0.958379454256798,1.0,5/44,6.30%,SULT2B1;ANGPTL3;SQLE;CETP;NR0B2
prerank,sympathetic nervous system development (GO:0048485),0.21394242450759235,0.7820903066375721,0.8275862068965517,0.8912386361657708,1.0,4/16,13.57%,NRP2;SEMA3A;NTRK1;GDNF
prerank,macromolecule catabolic process (GO:0009057),0.20852360973633247,0.7819444332674805,0.8181818181818182,0.8907880765862866,1.0,5/28,11.27%,MTOR;ELANE;TPP1;LRSAM1;CAPN3
prerank,negative regulation of phagocytosis (GO:0050765),0.2533735229340724,0.7819418894623492,0.8,0.8900579224251502,1.0,4/15,15.97%,SYT11;SNX3;DYSF;PRTN3
prerank,protein homooligomerization (GO:0051260),-0.2029277661930328,-0.7812011744457823,0.8658536585365854,0.9597039482863186,1.0,25/120,17.77%,BLM;CARD11;MIF;MAT1A;GBP5;HPRT1;TRPM2;TRIM72;PRF1;TK1;TDO2;HCN1;SHMT2;SLC1A5;BEND3;ECT2;RNF213;AQP2;PNPT1;SPAST;AQP5;CARD9;CTH;HLA-G;FUS
prerank,cytoplasmic translation (GO:0002181),-0.203162533528635,-0.7808203556518474,0.8571428571428571,0.9596188343718574,1.0,55/93,56.99%,RPL22L1;RPL39;RPS19;RPS21;ZC3H15;RPL36;RPL26L1;RPL23A;RPL37;FTSJ1;RPL8;GSPT1;TMA7;EIF3M;RPS18;RPS7;RPS2;RPL41;RPS24;RPL32;RPS29;RPL27A;RPL35;RPS3;RPS4X;RPL4;RPL30;RPL37A;RPL18;DRG1;RPL19;RPL38;RPL12;RPS14;RPS3A;EIF3I;RPL28;RPL31;RPS28;RPLP0;RPL18A;UBA52;RPS11;RPS17;RPL11;RPS15;RPL35A;RPL23;GSPT2;RPL29;RPS9;RPL5;RPL7A;RPS5;RPL27
prerank,positive regulation of nervous system development (GO:0051962),-0.22513207998321078,-0.7796249469561223,0.8309859154929577,0.9607193989532462,1.0,9/45,17.29%,RASSF10;MME;EPHB2;EPHB3;LRP2;PTPRD;WNT7A;IFNG;OPRM1
prerank,nucleosome assembly (GO:0006334),-0.2507319583655516,-0.7791479724113664,0.7808219178082192,0.9607736390243206,1.0,12/30,36.87%,CHAF1B;CHAF1A;SOX9;HIRA;SPTY2D1;NPM1;ATRX;GRWD1;ANP32B;ASF1B;PADI4;HMGB2
prerank,regulation of organelle assembly (GO:1902115),-0.2013026299145261,-0.7790026172151215,0.8705882352941177,0.9602466923678495,1.0,16/73,20.73%,MCIDAS;USP6NL;KIF9;MAPK15;TBC1D14;DCDC2;CEP295NL;TBC1D2;CEP76;CEP295;MSN;SDCCAG8;CENPJ;ATG3;ALMS1;CDKL1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.26245471349357485,-0.7787574435517729,0.7971014492753623,0.9599141060415232,1.0,7/21,29.06%,MASTL;STYXL1;PPP1R1B;GSK3B;BOD1L2;PPP4R4;FKBP1B
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.2689864021846749,-0.7787369193546939,0.7611940298507462,0.9592167093371072,1.0,6/17,24.00%,TGFB2;CARD9;NOD2;IL26;LYN;SCIMP
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.18060107399377825,-0.778665456943181,0.8829787234042553,0.9585955351373262,1.0,40/184,24.55%,SPTBN2;AREG;F5;CTAGE4;CTAGE9;KDELR3;FOLR1;CTAGE8;CTAGE15;CTAGE6;F7;COG5;PROC;SPTB;HYOU1;GOLT1A;COG6;CD55;ANK1;PROZ;SPAST;STX17;CNIH3;COL7A1;SPTBN5;CTSC;VTI1A;PGAP1;KDELR2;SPTA1;CTAGE1;COPB2;SEC24A;MIA2;ERGIC3;TMED3;TMED2;LMAN2;CAPZA1;YIF1B
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.18549945813481708,-0.7785868055779722,0.9595959595959596,0.958002131414737,1.0,48/185,27.09%,NOTUM;DKK4;KREMEN2;SHISA2;RNF43;WNT5A;MDFI;PSMB9;SOX9;HECW1;LRP4;PTPRO;PSMD14;CAV1;ALPK2;AXIN2;IGFBP1;RNF213;CITED1;STK4;MLLT3;NKD2;WNT11;WIF1;PSMA3;ZNRF3;UBAC2;CCDC88C;WWOX;SFRP4;SOX30;GSK3B;MDK;PSMB3;RUVBL2;PSMC1;CSNK1A1L;DRAXIN;PSMB11;PSMA5;AXIN1;IGFBP2;PSMB2;PSME2;INVS;PSMD12;PSMA7;APC2
prerank,response to acidic pH (GO:0010447),0.24399051117342718,0.7785158789623698,0.7272727272727273,0.8937776686643879,1.0,6/15,19.85%,CTSS;TRPV1;RAB11B;GPR4;RAB11FIP5;SLC9A1
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.18715756968222935,-0.7779677300001447,0.9139784946236559,0.9583798008642084,1.0,40/154,24.58%,TDGF1;CDK1;VRK1;CSNK2A3;VRK2;MASTL;PRKDC;IKBKE;SBK1;AURKA;MAPKAPK2;PRKCG;NEK6;PLK1;AKT3;PRKCZ;CAMKV;TOP1;CDC7;STK4;DYRK3;ATR;CLSPN;TTBK1;TGFBR2;STK39;CDK5;EIF2AK3;CSNK2A1;PRKCQ;RPS6KA3;GSK3B;PRKX;CSNK1A1L;MAPKAPK5;HIPK2;TTK;PRKCI;MAPKAPK3;LMTK2
prerank,negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.24227421706257513,0.7775952364358809,0.8888888888888888,0.894330392613416,1.0,3/15,14.49%,MICA;CEACAM1;LGALS9
prerank,necroptotic process (GO:0070266),0.23862021284670556,0.7772228549100629,0.7714285714285715,0.8942406728869849,1.0,3/16,14.06%,TLR3;TICAM2;RIPK1
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.2759494555442797,-0.776708623312195,0.8059701492537313,0.959512081878369,1.0,5/17,18.29%,HMGA2;CCNE1;TERT;CITED1;NANOG
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.2751827774548918,-0.7758657808008752,0.8055555555555556,0.9601128014964778,1.0,9/21,32.72%,DGAT2;THEM5;SCD;FASN;ACACA;FITM2;ACSL3;FAR2;HSD17B4
prerank,protein localization to lysosome (GO:0061462),-0.24967586915466222,-0.7758157970458406,0.8192771084337349,0.9594558771204507,1.0,6/28,22.04%,CD81;SORL1;SH3BP4;RNF128;ATP13A2;GCC2
prerank,cognition (GO:0050890),-0.2290929348497274,-0.7757978294693935,0.85,0.9587518600287881,1.0,12/45,23.61%,STRA6;CHD7;SHROOM4;CHRNB2;SLC1A4;GRM5;MAGT1;NF1;CHRNA7;HRH3;TNF;TMPRSS11E
prerank,T cell proliferation (GO:0042098),-0.3043416555608402,-0.775320258886367,0.7808219178082192,0.9587911244808992,1.0,6/15,21.84%,RASGRP1;PIK3CG;TNFSF18;MSN;DOCK8;CRTAM
prerank,endothelial cell proliferation (GO:0001935),-0.28268258001226715,-0.7743243144262525,0.8,0.9595613036182755,1.0,9/18,33.84%,LOXL2;SEMA5A;PROK2;BMP4;PRKX;NRARP;TEK;DLG1;NOX5
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.22673684033494962,-0.7742372892535387,0.8987341772151899,0.9589654418213294,1.0,16/51,26.79%,IL1B;IL23A;RTKN2;IL12B;RELA;IRAK1;NLRP12;PHB;CD86;NFAT5;NOD2;MMP8;NMI;TNF;TLR7;ACTN4
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.22396177288728597,0.7729968198371464,0.7931034482758621,0.899213479841312,1.0,5/18,16.12%,ANXA6;SLC25A23;SMDT1;MICU3;MICU1
prerank,cellular response to ionizing radiation (GO:0071479),-0.22191069479057446,-0.7727456121342672,0.8795180722891566,0.960469510823221,1.0,11/47,21.47%,BLM;RAD51AP1;INTS7;FIGNL1;RAD9B;ECT2;WRN;ATR;MDM2;HUS1;IFI16
prerank,snRNA metabolic process (GO:0016073),-0.29991344933743813,-0.7726404940848969,0.7777777777777778,0.9598898344419421,1.0,3/15,25.40%,INTS7;INTS2;INTS6
prerank,bone development (GO:0060348),0.21369320774152117,0.7717695123602768,0.8333333333333334,0.9000396017705443,1.0,11/40,13.65%,BGLAP;MYOC;SBDS;GH1;FGFR2;VKORC1;OSR2;LRRC17;PTGER4;CYP26B1;SKI
prerank,nucleic acid metabolic process (GO:0090304),-0.20400677163982772,-0.7687447675912841,0.8313253012048193,0.9651251400254304,1.0,29/71,41.10%,POLR2F;WDR74;FEN1;DNA2;TOPBP1;WRN;NCBP1;POLR2J;LSM8;POLR2D;RAN;POLR2I;KPNA2;XRN2;DNASE1L1;PDE12;DNTT;HNRNPC;GTF2F2;DDX54;DUSP11;HNRNPF;PTBP1;HNRNPR;LSM1;HNRNPU;ENPP1;POLR2B;DNASE1L2
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.15815467846162093,0.7683831741993923,1.0,0.9038344930089874,1.0,17/88,15.72%,FBXL22;FBXO9;FBXO17;FBXO44;SKP1;FBXO31;FBXL7;FBXL5;PSMC5;FBXO27;FBXW4;FBXW5;PSMD9;BTRC;FBXL15;PSMB6;FBXL12
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.2369815837155594,0.7683105451620199,0.8,0.9032454365919884,1.0,5/18,19.28%,DDX17;CELF4;SCNM1;RBM17;SRSF1
prerank,cellular protein metabolic process (GO:0044267),-0.1774313450115765,-0.7680783903030559,0.9696969696969697,0.9653932739987869,1.0,42/388,11.21%,NOTUM;SERPIND1;LOXL2;TIMP1;AMELX;IGF2BP3;F5;EVA1A;SPP1;MMP1;FN1;CHEK2;SERPINA10;CTSH;ERO1A;MSLN;C3;PRKDC;ABL2;RPN2;KNG1;TMEM132A;MMP2;UBE2S;PROC;SLC34A1;HM13;IGFBP1;PDIA6;YARS2;LGALS1;RPL39;VGF;GATA6;PARP4;MRPL3;PCSK9;DMP1;AFP;RRBP1;RPN1;MRPS18C
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.23901678170399032,0.7677063177908222,0.7931034482758621,0.9036075396608627,1.0,7/17,22.16%,RGS10;CHRM2;GNAQ;CHRM3;RGS8;GNA11;GNB1
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.24089153781497558,-0.7671991254941458,0.8333333333333334,0.9658947012096961,1.0,13/30,32.06%,SERPINE1;PLA2G7;CALR;FPR2;CXCL10;CCL1;TNF;S100A7;HMGB1;CCL5;C1QBP;CCR6;AGER
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.2013701239425398,-0.7670415918383137,0.9195402298850575,0.965402899561207,1.0,13/97,11.63%,CEBPB;CXCR4;DIO2;CAV1;LCN2;IGF1R;SYK;SCD;OXTR;PRLR;TRPM8;TSHR;UCP1
prerank,bile acid metabolic process (GO:0008206),-0.24066161698932423,-0.7665359105838088,0.7866666666666666,0.9653467132943377,1.0,18/33,39.97%,BAAT;OSBPL3;AKR1C4;CYP7B1;CYP39A1;AKR1D1;SLC27A5;UGT2A1;NPC1;HSD3B7;HSD17B4;HSD17B10;OSBPL2;UGT2A2;ACOT8;CYP7A1;CYP8B1;OSBP
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.21053197714311958,-0.7662168600477484,0.8481012658227848,0.9650203470635002,1.0,13/49,25.91%,TESC;RBM15;PF4;RUNX1;CBFB;ZFPM1;THBS1;RBBP5;PRKCQ;GP1BA;NFE2;KMT2D;EIF6
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.21431713179449247,0.7651454402839224,0.8,0.9060479711225005,1.0,8/24,21.19%,ENO2;ALDOA;PFKM;HK2;HK1;ENO3;PGK1;ENO1
prerank,phospholipid biosynthetic process (GO:0008654),-0.23216963491222803,-0.7643328574429618,0.7974683544303798,0.9668284838178084,1.0,5/36,15.97%,CPNE7;IDI2;SRD5A3;FDPS;AGPAT5
prerank,apoptotic cell clearance (GO:0043277),-0.24424595465092303,-0.7628869306790662,0.7848101265822784,0.9681682574175045,1.0,10/33,24.72%,XKR9;SCARB1;XKR5;XKR6;THBS1;XKR7;TYROBP;ANXA1;HMGB1;RHOH
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.24030598177819606,-0.7614321354257582,0.863013698630137,0.9695535977370061,1.0,6/29,14.28%,CSF2;PF4;CETP;AGT;PLA2G3;NFKBIA
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.258253610273749,-0.7612536735177652,0.8208955223880597,0.9690665462395087,1.0,1/18,0.08%,MYC
prerank,neutrophil activation involved in immune response (GO:0002283),-0.17307920361884435,-0.759993510150076,0.98989898989899,0.9702009953132051,1.0,169/467,36.40%,CXCL1;PLAU;TCN1;S100P;ABCA13;MME;MIF;OLR1;CLEC5A;SELL;ADGRE3;CTSH;DSN1;DIAPH1;CEACAM6;C3;CD44;FCGR3B;ATP11A;BST2;TRPM2;PSMD14;LCN2;GGH;PKP1;PNP;SYK;CXCR2;MMP25;CHIT1;PECAM1;FPR2;DSP;DSG1;CLEC4C;ITGAX;CD55;RHOF;MMP9;PLAUR;S100A11;PRDX4;RAB3D;FRK;ARG1;VNN1;ANXA3;MAGT1;GLB1;TNFRSF1B;CHI3L1;ADAM10;CXCR1;MLEC;TMC6;CR1;HEXB;TMEM63A;ACTR2;CTSC;CRACR2A;CCT2;PDXK;SLPI;ADAM8;CYBA;CYBB;NRAS;JUP;SERPINA3;AMPD3;NEU1;MNDA;SIRPB1;FUCA2;GPR84;GLA;PGLYRP1;MMP8;CSTB;SERPINB1;ITGB2;PRSS3;ATP11B;PTPRJ;RAP2B;ILF2;FCAR;DEFA1;GCA;MGAM;OLFM4;CEACAM3;NFAM1;TYROBP;CANT1;S100A7;PSMA5;HMGB1;CMTM6;MANBA;LTF;DNASE1L1;FRMPD3;DDOST;PSMD12;HPSE;DNASE1;DNAJC3;PA2G4;CNN2;TUBB4B;VAMP8;NBEAL2;ADGRG3;PTPRN2;EEF2;KPNB1;XRCC5;DOCK2;CKAP4;LILRB2;CD58;ITGAL;OSTF1;PKM;ATAD3B;HUWE1;CTSA;GDI2;DYNC1H1;PIGR;APEH;APRT;LAMP2;SVIP;CLEC4D;SERPINA1;ERP44;CPNE3;IQGAP1;B4GALT1;PLD1;ADGRE5;CDK13;LAMTOR2;OSCAR;TUBB;NAPRT;CCT8;PSMD1;AGPAT2;TARM1;FCER1G;IMPDH2;EPX;SERPINB10;MCEMP1;FCGR2A;GLIPR1;CD300A;RAP1B;DSC1;SIGLEC5;CPNE1;PTAFR;CD47;SLC15A4;RNASE3
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.21929964401239918,-0.7594853223185599,0.88,0.9702681068657345,1.0,22/53,35.51%,DCPS;LSM7;EXOSC3;CNOT1;EXOSC8;DIS3;EXOSC4;LSM5;EXOSC5;POLR2D;CNOT10;LSM4;CNOT11;EXOSC7;PDE12;HBS1L;CNOT6;EXOSC2;PATL1;PATL2;PAN3;EXOSC1
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.26286382158778565,-0.7590795774377277,0.8157894736842105,0.9700768169955544,1.0,11/23,32.18%,E2F1;PKP1;NOCT;AXIN2;PABPC1;FUS;PKP3;FMR1;NBAS;LARP1;DHX34
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.24524525986505877,0.757734178631302,0.75,0.9143562821623452,1.0,7/15,19.13%,PLIN5;NR1H2;SLC27A1;SREBF1;CTDNEP1;NR1H3;CNEP1R1
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.20695076614748212,-0.7568745066317586,0.8823529411764706,0.9725985680141039,1.0,29/75,33.55%,TRIB3;RIPK2;DCUN1D5;CAV1;XIAP;PLK1;FANCM;PAXIP1;NDFIP2;FBXO4;MYCBP2;BIRC7;BRCA1;MAGEC2;SPSB4;STUB1;AXIN1;FANCI;TBC1D7;CUL3;FBXW7;COMMD1;DERL1;HUWE1;UBE2N;KDM1A;SPRTN;TRAF6;AMER1
prerank,cellular response to dsRNA (GO:0071359),0.22502183294046102,0.7560619630484542,0.90625,0.915509275817483,1.0,3/16,9.71%,COLEC12;MUL1;FLOT1
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.21800764332089234,-0.7553978666403728,0.8072289156626506,0.9738374973669857,1.0,5/47,5.28%,TBX20;SHH;FOLR1;CCDC103;ENG
prerank,cardiac conduction system development (GO:0003161),-0.25148602418920785,-0.7549606568774792,0.8857142857142857,0.9736807790779027,1.0,9/25,28.39%,MSX2;SMAD1;GATA6;GJB6;SHOX2;BMP4;HCN4;TBX18;MSC
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.22507332980512937,-0.7547547131091549,0.7702702702702703,0.9732720245739964,1.0,4/36,7.71%,TP73;POU4F1;PML;PMAIP1
prerank,"phagocytosis, engulfment (GO:0006911)",-0.22257800366653446,-0.7546227855614952,0.8860759493670886,0.9727588477392054,1.0,7/36,15.51%,XKR9;HAVCR1;XKR5;XKR6;FCGR1A;THBS1;XKR7
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.21596049501248782,-0.7545229347322164,0.9487179487179487,0.972167721799229,1.0,8/59,8.97%,OSM;CSF2;SOCS3;IL23A;IL23R;ARL2BP;IL21;IL12B
prerank,spermatid development (GO:0007286),-0.22757295034794273,-0.7542005466298506,0.8461538461538461,0.9719025988901916,1.0,11/40,21.48%,SYCP3;PIWIL1;RIMBP3;RIMBP3C;RIMBP3B;TDRD5;ZMYND15;TSSK1B;CCDC42;FAM9A;SOX30
prerank,neutrophil degranulation (GO:0043312),-0.17147512057480344,-0.754158489445785,0.98989898989899,0.9712396361171904,1.0,167/463,36.40%,CXCL1;PLAU;TCN1;S100P;ABCA13;MME;MIF;OLR1;CLEC5A;SELL;ADGRE3;CTSH;DSN1;DIAPH1;CEACAM6;C3;CD44;FCGR3B;ATP11A;BST2;TRPM2;PSMD14;LCN2;GGH;PKP1;PNP;CXCR2;MMP25;CHIT1;PECAM1;FPR2;DSP;DSG1;CLEC4C;ITGAX;CD55;RHOF;MMP9;PLAUR;S100A11;PRDX4;RAB3D;FRK;ARG1;VNN1;ANXA3;MAGT1;GLB1;TNFRSF1B;CHI3L1;ADAM10;CXCR1;MLEC;TMC6;CR1;HEXB;TMEM63A;ACTR2;CTSC;CRACR2A;CCT2;PDXK;SLPI;ADAM8;CYBA;CYBB;NRAS;JUP;SERPINA3;AMPD3;NEU1;MNDA;SIRPB1;FUCA2;GPR84;GLA;PGLYRP1;MMP8;CSTB;SERPINB1;ITGB2;PRSS3;ATP11B;PTPRJ;RAP2B;ILF2;FCAR;DEFA1;GCA;MGAM;OLFM4;CEACAM3;NFAM1;TYROBP;CANT1;S100A7;PSMA5;HMGB1;CMTM6;MANBA;LTF;DNASE1L1;FRMPD3;DDOST;PSMD12;HPSE;DNAJC3;PA2G4;CNN2;TUBB4B;VAMP8;NBEAL2;ADGRG3;PTPRN2;EEF2;KPNB1;XRCC5;DOCK2;CKAP4;LILRB2;CD58;ITGAL;OSTF1;PKM;ATAD3B;HUWE1;CTSA;GDI2;DYNC1H1;PIGR;APEH;APRT;LAMP2;SVIP;CLEC4D;SERPINA1;ERP44;CPNE3;IQGAP1;B4GALT1;PLD1;ADGRE5;CDK13;LAMTOR2;OSCAR;TUBB;NAPRT;CCT8;PSMD1;AGPAT2;TARM1;FCER1G;IMPDH2;EPX;SERPINB10;MCEMP1;FCGR2A;GLIPR1;CD300A;RAP1B;DSC1;SIGLEC5;CPNE1;PTAFR;CD47;SLC15A4;RNASE3
prerank,transcription by RNA polymerase II (GO:0006366),-0.17535933266210618,-0.7539473935590026,0.9393939393939394,0.9708237564947568,1.0,94/312,33.03%,NFE2L3;NOTCH3;POLR2F;CCNK;FOXE3;HDAC10;ETV7;INTS7;CSTF2;MAZ;TEAD4;GTF2I;TRIM24;DDX21;NR0B2;TAF1A;HSF2BP;NOCT;E2F3;TAF4B;CPSF3;CBFB;CDK7;SNRPG;TAF1L;TTF2;SNRPF;CDK12;TRIP13;EAF1;MED1;NR1I3;GTF2H2;TFDP1;GCM2;NKX2-8;CSTF1;MLLT3;NCBP1;POLR2J;NR2C2AP;NELFCD;GCM1;TAF2;NFYA;POLR2D;LHX1;PPARG;ZNF141;NABP1;ZNF473;TBX5;INTS2;POLR2I;HNF4A;TAF4;GTF2H3;ERCC6;CREBBP;EAF2;XBP1;CPSF2;NOTCH1;CCNH;INTS6;ESRRG;PAX5;TRIP11;RNGTT;SNRPB;LEO1;NR2E1;SETX;SNRPE;SNRPD3;CPSF4;HNF4G;CDC73;CSTF3;GTF2A1;MAML2;ADRM1;MAML3;RREB1;ESR2;GTF2E1;TAF1;IRF9;DEK;GTF2F2;ERCC2;SLBP;NCOR1;CDK13
prerank,response to estrogen (GO:0043627),-0.2314746044592974,-0.7517049303645134,0.8072289156626506,0.9732547761793654,1.0,12/34,26.06%,CYP27B1;CAV1;TRIM24;CITED1;BRCA1;RBBP5;GHRHR;SLC34A2;GATA3;OCSTAMP;KMT2D;SFR1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.22362271900850872,0.7513347860360181,0.8571428571428571,0.9203345509226764,1.0,9/24,21.91%,ZER1;HDAC6;RNF185;POMT2;ZYG11B;BAG6;ATXN3;KLHL15;RNF5
prerank,histone H2A acetylation (GO:0043968),0.25198468748050235,0.7506864942067322,0.7407407407407407,0.9203060503273034,1.0,6/16,18.98%,MORF4L1;DMAP1;BRD8;ING3;MSL3;MEAF6
prerank,RNA interference (GO:0016246),-0.2792316580495504,-0.7505618957610053,0.7922077922077922,0.9739777692980967,1.0,12/17,49.91%,HENMT1;TERT;TSN;DROSHA;DHX9;MRPL44;NRDE2;TARBP2;AGO2;CLP1;DICER1;AGO3
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.24600695248732957,-0.7504165303411626,0.88,0.973498087784259,1.0,9/26,29.61%,EPHB2;CALCR;GPRC5A;LILRB4;PPARG;ACE2;TNF;VPS25;CBLC
prerank,cellular zinc ion homeostasis (GO:0006882),0.20863578848139752,0.7500584221331044,0.8709677419354839,0.9205221424791827,1.0,7/28,17.29%,SLC39A13;MT1X;MT1M;MT3;MT1A;SLC30A8;MT1E
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.2512176856553709,-0.7486117109614754,0.8285714285714286,0.9752743552386769,1.0,8/18,32.61%,IFI6;BCL2L1;GGCT;BBC3;BAX;SFN;TIMM50;BID
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.2662896086369216,-0.748339995964565,0.8028169014084507,0.9749300538312168,1.0,7/19,26.65%,TGFB2;SOX4;ZFPM1;TGFBR2;SMAD6;NOTCH1;EFNA1
prerank,gastrulation (GO:0007369),0.21431400774193649,0.7480263324877545,0.75,0.9219596273924296,1.0,7/19,21.04%,SMAD2;NPHP3;MEGF8;GPC3;NR4A3;MKKS;UGDH
prerank,phosphate ion transport (GO:0006817),-0.277401791405675,-0.7479565233458911,0.855072463768116,0.9746175401843331,1.0,6/17,27.39%,SLC34A3;SLC34A1;SLC34A2;SLC37A1;SLC17A3;SLC17A1
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.2664465167503512,-0.7476670987359253,0.8026315789473685,0.9742690287774043,1.0,6/17,40.44%,EGR1;FGFR4;WNT4;NR5A1;CYP7A1;STAR
prerank,RNA splicing (GO:0008380),-0.19141185323857754,-0.7473337251729177,0.9397590361445783,0.9739678790968815,1.0,35/97,35.98%,DDX47;U2AF1;SRPK1;RNF113B;SNRPD1;SNRPG;SNRPF;CDK12;MAGOHB;RSRC1;SF3B3;NCBP1;FUS;PRPF4;WDR83;SNRPA1;PRPF6;MAGOH;LSM4;IVNS1ABP;SNRPB;RNF113A;KHSRP;DHX8;SNRPD3;SYNCRIP;WT1;HNRNPC;SNRNP40;RBM8A;SNRPD2;SRPK2;RP9;NRDE2;PTBP1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.22200923811353135,-0.7455303609272563,0.8888888888888888,0.9756383937088228,1.0,10/44,21.63%,AREG;EREG;EPGN;GPRC5A;PTPN3;SH3KBP1;PTPN2;PTPRJ;EGF;ITGA1
prerank,neutrophil mediated immunity (GO:0002446),-0.16982655476856748,-0.7454317022602002,1.0,0.9750248408469817,1.0,168/469,36.40%,CXCL1;PLAU;TCN1;S100P;ABCA13;MME;MIF;OLR1;CLEC5A;SELL;ADGRE3;CTSH;DSN1;DIAPH1;CEACAM6;C3;CD44;FCGR3B;ATP11A;BST2;TRPM2;PSMD14;LCN2;GGH;PKP1;PNP;CXCR2;MMP25;CHIT1;PECAM1;FPR2;DSP;DSG1;CLEC4C;ITGAX;CD55;RHOF;MMP9;PLAUR;S100A11;PRDX4;RAB3D;FRK;ARG1;VNN1;ANXA3;MAGT1;GLB1;TNFRSF1B;CHI3L1;ADAM10;CXCR1;MLEC;TMC6;CR1;HEXB;TMEM63A;ACTR2;CTSC;CRACR2A;CARD9;CCT2;PDXK;SLPI;ADAM8;CYBA;CYBB;NRAS;JUP;SERPINA3;AMPD3;NEU1;MNDA;SIRPB1;FUCA2;GPR84;GLA;PGLYRP1;MMP8;CSTB;SERPINB1;ITGB2;PRSS3;ATP11B;PTPRJ;RAP2B;ILF2;FCAR;DEFA1;GCA;MGAM;OLFM4;CEACAM3;NFAM1;TYROBP;CANT1;S100A7;PSMA5;HMGB1;CMTM6;MANBA;LTF;DNASE1L1;FRMPD3;DDOST;PSMD12;HPSE;DNAJC3;PA2G4;CNN2;TUBB4B;VAMP8;NBEAL2;ADGRG3;PTPRN2;EEF2;KPNB1;XRCC5;DOCK2;CKAP4;LILRB2;CD58;ITGAL;OSTF1;PKM;ATAD3B;HUWE1;CTSA;GDI2;DYNC1H1;PIGR;APEH;APRT;LAMP2;SVIP;CLEC4D;SERPINA1;ERP44;CPNE3;IQGAP1;B4GALT1;PLD1;ADGRE5;CDK13;LAMTOR2;OSCAR;TUBB;NAPRT;CCT8;PSMD1;AGPAT2;TARM1;FCER1G;IMPDH2;EPX;SERPINB10;MCEMP1;FCGR2A;GLIPR1;CD300A;RAP1B;DSC1;SIGLEC5;CPNE1;PTAFR;CD47;SLC15A4;RNASE3
prerank,cellular macromolecule catabolic process (GO:0044265),-0.21897743770366634,-0.7452402030577941,0.8552631578947368,0.9745160643350987,1.0,16/49,26.80%,CHEK2;RNASEH1;SND1;STT3B;PNPT1;RNASEH2A;NCBP1;RNASEH2B;MAGEC2;XRN2;NGLY1;MANBA;DNASE1L1;EXOSC7;IDE;DNASE1
prerank,limb morphogenesis (GO:0035108),-0.24912681404202264,-0.7450917503744127,0.8648648648648649,0.9739457657131431,1.0,8/22,28.20%,SHH;TGFB2;TBX4;PTCH1;ZNF141;TBX5;FGF8;NIPBL
prerank,membrane fusion (GO:0061025),0.19069949208548914,0.7446223841748031,0.9714285714285714,0.9250712887723012,1.0,7/34,15.81%,VAMP2;VTI1B;VAPA;MYOF;DYSF;VAMP3;RABEP1
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.1902222684918023,-0.743008928438378,0.9042553191489362,0.9758291584591439,1.0,30/104,29.63%,CEBPB;CXCL8;TRIB3;ERO1A;TMEM33;RNF183;PDIA4;ERP27;HYOU1;THBS1;TNFRSF10B;P4HB;CFTR;CHAC1;PDIA3;ATP2A1;EIF2AK3;TRAF2;RASGRF1;MBTPS2;BBC3;GSK3B;TMCO1;CREB3L1;BAX;TMEM117;DNAJC10;AIFM1;AGR2;DERL1
prerank,chromatin assembly (GO:0031497),-0.23212292802950815,-0.7424811562408437,0.8831168831168831,0.9757458306610791,1.0,4/36,4.90%,CHAF1B;CHAF1A;SOX9;HMGA2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.2269494109081713,0.742459701863361,0.96,0.9266654076250467,1.0,3/15,14.49%,MICA;CEACAM1;LGALS9
prerank,negative regulation of dephosphorylation (GO:0035305),-0.2629760579920626,-0.7422772521644203,0.8648648648648649,0.9752587362634746,1.0,8/19,35.00%,SH2D4A;PPP1R35;TMEM225;GPATCH2;URI1;PPP1R27;SH3RF2;YWHAB
prerank,negative regulation of immune effector process (GO:0002698),-0.2678771667482271,-0.7420260571906955,0.8048780487804879,0.9748241028248158,1.0,11/16,43.82%,CD55;RPS19;CR1;IFNL1;SLAMF8;ENPP3;CD300A;CD47;RC3H1;LILRB1;HAVCR2
prerank,global genome nucleotide-excision repair (GO:0070911),0.18491461741018103,0.7418476687070341,0.875,0.9265506562192011,1.0,7/26,22.04%,UBB;ERCC3;XPA;GTF2H4;CETN2;DDB2;GTF2H5
prerank,cilium assembly (GO:0060271),-0.17240484817202884,-0.7414897635837454,0.9896907216494846,0.9747985747303006,1.0,57/293,20.64%,KIF24;CEP72;RP1;MCIDAS;CDK1;MAK;NEK2;CEP250;CCNO;CCDC113;CFAP74;ARL13A;PKHD1;RAB3IP;RP1L1;SNX10;HAUS7;RSPH9;RPGRIP1L;DCDC2;POC1B;SCLT1;DNAAF3;CDC14C;KIF27;PLK1;RAB8A;B9D1;PLA2G3;DNAAF1;HAUS6;CEP76;LRGUK;TTC26;CEP152;CEP83;TBC1D32;TMEM107;NDE1;RP2;PLK4;ACTR2;DNAH5;TEKT5;CFAP52;SDCCAG8;CENPJ;CKAP5;KIF3B;ALMS1;CEP78;EXOC4;CEP41;FNBP1L;FHDC1;DNAI2;RSPH6A
prerank,Golgi organization (GO:0007030),-0.1815915781704543,-0.7402275409683128,0.9347826086956522,0.9757960774992465,1.0,37/129,31.31%,ZFP69B;CDK1;VRK1;USP6NL;GOLGA8J;VMP1;GOLGA6C;GOLGA8H;GOLGA8T;GOLGA6D;STX17;GOLGA8S;GOLGA8O;PI4K2B;SPTBN5;VTI1A;GOLGA8K;ARFGEF1;GOLGA8F;GOLGA6A;GOLGA6B;FHDC1;VCPIP1;GCC2;GOLGA8M;TMED3;TMED2;LMAN2;ZW10;STX6;TRIP11;GOLGA8R;COG3;HUWE1;TMED6;TMED9;PDCD10
prerank,organophosphate biosynthetic process (GO:0090407),-0.23144649941115522,-0.7401404455907707,0.9,0.9751761462103701,1.0,13/39,30.62%,PNPO;GK;MOCOS;IPPK;MOCS3;GPHN;AGPAT5;G6PD;IPMK;PPIP5K1;TPK1;TPI1;FITM2
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.18926771604749743,-0.7397332030466144,0.8829787234042553,0.9749750083935602,1.0,55/112,51.91%,HELZ2;RPL39;MAGOHB;PABPC1;RPS19;NCBP1;RPS21;RPL36;MAGOH;RPL23A;RPL37;SMG1;RPL8;GSPT1;DHX34;RBM8A;RPS18;RPS7;EIF4A3;RPS2;SMG7;RPL41;RPS24;SMG6;RPL32;RPS29;RPL27A;RPL35;RPS3;RPS4X;RPL4;RPL30;RPL37A;RPL18;RPL19;EIF3E;RPL38;RPLP2;RPL12;RPS14;NCBP2;RPS3A;UPF3B;RPL28;PPP2R2A;RPL31;SMG8;RPS28;RPLP0;RPL18A;UBA52;RPS11;RPS17;RPL11;EIF4G1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.21924568027176872,0.7387322213862727,0.9428571428571428,0.929034060012126,1.0,2/16,6.10%,WNT6;ROGDI
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.23184933457007606,-0.7379557855795741,0.8421052631578947,0.9764908624193266,1.0,18/29,44.48%,HSD17B12;ACSL6;SCD;ACSF3;ACSL5;FASN;ACACA;ELOVL7;TECR;ACSL3;HACD2;ACSL4;ACSBG2;ACSBG1;ACLY;ELOVL3;ELOVL6;CBR4
prerank,regulation of G0 to G1 transition (GO:0070316),-0.22028378989954034,-0.7364968847978972,0.8428571428571429,0.9777881292435523,1.0,14/40,29.65%,CHEK1;E2F1;RBBP8;TFDP1;CDC7;CBX3;HLA-G;BRCA1;RNF2;EZH2;RHNO1;PHC3;RRM2;SUZ12
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.20711919003578555,-0.7348399837707501,0.8823529411764706,0.9793305811372711,1.0,16/56,30.10%,PSMB9;PSMD14;AURKA;RFPL1;PSMA3;PSMB3;PSMC1;GPR132;PSMB11;PSMA5;PSMB2;PSME2;PSMD12;PSMA7;PSME4;PSME3
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.19304133417362582,-0.7345459544234695,0.9318181818181818,0.9789778141334299,1.0,52/90,56.99%,RPL39;RPS19;SRP72;RPS21;RPL36;RPL23A;RPL37;RPL8;RPS18;RPS7;SEC61B;RPS2;RPL41;SEC61A1;RPS24;RPL32;RPS29;RPL27A;RPL35;RPS3;RPS4X;RPL4;RPL30;RPL37A;RPL18;RPL19;RPL38;RPLP2;RPL12;RPS14;RPS3A;SRP9;SRP54;RPL28;RPL31;RPS28;RPLP0;RPL18A;UBA52;RPS11;RPS17;RPL11;RPS15;RPL35A;RPL23;RPL29;RPS9;RPL5;SEC63;RPL7A;RPS5;RPL27
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.23237509034605452,-0.7333765209279397,0.8311688311688312,0.9797409737569257,1.0,5/30,10.22%,TRIB3;UBE2C;DCUN1D5;UBE2S;PLK1
prerank,positive regulation of intracellular transport (GO:0032388),-0.22288702424200502,-0.732153679741573,0.8607594936708861,0.9803643339130781,1.0,7/36,17.35%,KIF20B;SPAG5;PLA2G4E;SORL1;ABCA12;ATP2A1;PGAP1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.24904865969329015,-0.731991597137773,0.84,0.9798730042136198,1.0,5/21,19.41%,IL1B;C3;NLRP3;ENTPD1;MEFV
prerank,programmed necrotic cell death (GO:0097300),0.20801817292801955,0.7318945158555136,0.9117647058823529,0.9355370643006433,1.0,3/18,14.06%,TLR3;TICAM2;RIPK1
prerank,negative regulation of catabolic process (GO:0009895),-0.2141579113455985,-0.731633444940892,0.8421052631578947,0.9796388360763496,1.0,10/48,18.18%,MAD2L1;IL1B;CYP51A1;HCAR2;APOC1;PRKCG;SF3B3;PHB;PFKFB1;IRAK3
prerank,positive regulation of lipid storage (GO:0010884),-0.26032999878018653,-0.7313812054939636,0.8493150684931506,0.9792461313682368,1.0,3/20,7.86%,C3;IKBKE;SCARB1
prerank,response to growth factor (GO:0070848),-0.21906653413246036,-0.7300904206057273,0.927710843373494,0.9801036160578378,1.0,5/40,9.87%,MYC;IBSP;EPHA2;LRP2;GATA6
prerank,regulation of platelet aggregation (GO:0090330),0.23297329222467036,0.7291903784813344,0.8888888888888888,0.9374742568096938,1.0,6/18,16.16%,PRKCD;CEACAM1;C1QTNF1;PRKG1;PRKCA;DMTN
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.19726136605382574,-0.7291812513637903,0.8837209302325582,0.980407144524276,1.0,25/77,28.58%,IL1B;IL23A;RTKN2;IL12B;RELA;BMP7;IRAK1;NLRP12;NFKBIA;NLRP3;PHB;CD86;NFAT5;NOD2;MMP8;SPI1;NMI;TSPAN6;TNF;TLR7;ACTN4;PTPN22;EZR;ADGRG3;ZC3H12A
prerank,JNK cascade (GO:0007254),-0.21882423604970913,-0.7289064563198204,0.9,0.9799942828606694,1.0,10/41,21.93%,IRAK2;RIPK2;DUSP9;IRAK1;ADORA2B;TRIB1;TAB3;NOD2;IKBKG;SH2D3A
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.18826929532014364,0.7282908096989015,0.9473684210526315,0.9378371149483538,1.0,7/35,14.07%,AGPAT1;C1QTNF4;TRIM6;TICAM2;TSLP;RIPK1;IL7
prerank,regulation of platelet activation (GO:0010543),-0.24034285184893472,-0.7280968051298675,0.8382352941176471,0.9803025590062173,1.0,6/21,23.29%,THBD;SYK;PLEK;TEC;PRKCQ;LYN
prerank,response to light stimulus (GO:0009416),-0.20177364428542566,-0.7276800379882772,0.8795180722891566,0.9799976102531409,1.0,11/58,14.90%,ERCC5;GPR52;ZRANB3;SLC24A1;ERCC8;DRD2;RRH;TRPM1;GTF2H2;MSH6;AANAT
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.17899480177092464,-0.7275861075529403,0.945054945054945,0.9793971453128671,1.0,48/138,32.55%,FOXP3;IRAK2;TNFAIP3;MDFI;CDKN2A;PKHD1;PROX1;NR0B2;NLRC5;FOXA2;ZNF675;NWD1;NFKBIE;BMP7;ANXA4;IRAK1;SETD6;FOXH1;NLRP12;PTCH1;NFKBIA;PAXIP1;TRIB1;NLRP3;IRAK3;TNFSF4;RNF2;SFRP4;SPI1;OTULIN;HDAC2;XCL1;POU4F2;HES6;FOXJ1;ITCH;ADGRG3;ZC3H12A;AIM2;COMMD1;EOMES;NLRP2;TNFRSF4;PLA2G10;TAF1;ID1;USP7;KDM1A
prerank,positive regulation of metabolic process (GO:0009893),-0.18695473485992023,-0.7274077239522314,0.9302325581395349,0.9788842369216414,1.0,37/112,33.58%,CEBPB;CXCR4;DIO2;CAV1;LCN2;IGF1R;SYK;SCD;OXTR;PRLR;BEND3;PYURF;TRPM8;TSHR;UCP1;HCRT;IFNG;KSR2;ALMS1;FASN;TRPV2;TNF;CLEC7A;ACACA;IL13;ESRRG;PIGA;PDGFC;PTH2R;CPT2;FGF21;DYNC1H1;G0S2;DBH;KDM1A;UCP2;GHRL
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.23192966384972746,-0.7260863822063193,0.7536231884057971,0.9797376253887438,1.0,10/25,33.09%,CAMKMT;GRK1;GUCY2D;PPEF1;GNAT1;GRK7;SAG;CNGA1;GUCY2F;PDE6G
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.19279566208750723,-0.7255697190584961,0.9036144578313253,0.9797343788640315,1.0,20/64,28.54%,CSF2;RBM15;PF4;HOXB8;RUNX1;CBFB;ZFPM1;THBS1;RBBP5;PRKCQ;GP1BA;SPI1;NFE2;LYN;CREBBP;KMT2D;HSPA9;EIF6;LEO1;CDC73
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.24037941797145074,-0.7252278042254963,0.8695652173913043,0.97948182735203,1.0,2/21,3.17%,TP73;PML
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.23795156453679805,-0.7246456420135247,0.8205128205128205,0.9794228439667363,1.0,3/22,7.69%,TRIB3;PRMT3;APOC1
prerank,RNA destabilization (GO:0050779),0.22785247255169286,0.7246237326041104,0.8620689655172413,0.9406757034672972,1.0,4/17,15.82%,RBM24;DXO;METTL3;CELF1
prerank,cellular response to estradiol stimulus (GO:0071392),0.20425543361051113,0.7241921647688244,0.8571428571428571,0.9404693829802243,1.0,4/20,9.75%,GPER1;RAMP3;EGFR;SFRP1
prerank,regulation of protein transport (GO:0051223),0.2085944359910521,0.7231536366175456,0.9,0.9407643247973597,1.0,9/28,19.70%,DISP1;SNX3;RHBDF1;PPM1F;INS;HSPA8;NDEL1;LLGL1;STXBP5L
prerank,fatty acid metabolic process (GO:0006631),-0.18591829138669777,-0.7230195729987113,0.9176470588235294,0.9805121580929992,1.0,29/122,25.79%,BAAT;AOAH;PNPLA3;ANGPTL3;LIPG;ACSL6;NUDT19;CEL;PON1;ACBD5;ALOX12B;ALOX12;ACOT12;ACOT6;ACSM6;ACSM4;ACSF3;PON3;ALOXE3;HAO2;ACSL5;CYP4F11;PPARG;FASN;ACACA;SLC27A5;XBP1;CYP4F2;LIPC
prerank,melanosome organization (GO:0032438),-0.22580406786768267,-0.7202290478567096,0.8472222222222222,0.9830417377209544,1.0,5/27,16.44%,GPR143;ABCB6;AP3B1;SHROOM2;PMEL
prerank,carbohydrate catabolic process (GO:0016052),-0.213701439809085,-0.7198462869368076,0.891566265060241,0.9827266463690029,1.0,10/39,21.72%,GAPDHS;HKDC1;ENO4;PKLR;PGAM4;ALDOB;PFKFB1;NEU1;LDHA;GAPDH
prerank,regulation of spindle organization (GO:0090224),-0.26476190280884904,-0.7196684269833112,0.8571428571428571,0.9822092274856673,1.0,8/18,30.65%,TACC3;GPSM2;TPX2;PSRC1;RAE1;CLTC;NUP62;DYNC1H1
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.22522790446323868,-0.7191551835050755,0.8382352941176471,0.9819711808992334,1.0,13/21,45.34%,CAV1;WNT8B;WNT3A;GSK3B;AXIN1;PPP1CA;AMER1;WNT1;FZD2;LRP6;APC;FRAT2;WNT8A
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.20686581954417585,0.7168337475530092,0.9375,0.946031789354592,1.0,10/27,21.69%,MORF4L1;KAT2B;KAT2A;BRD8;KAT8;MSL3;BAG6;KAT5;KAT7;EP300
prerank,metal ion homeostasis (GO:0055065),-0.22152780820509593,-0.7166426636474358,0.8674698795180723,0.9838393764116629,1.0,5/41,5.95%,CLDN16;SLC12A2;SLC12A8;CYP27B1;CAV1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.1730317879291852,0.7162887689991366,0.782608695652174,0.9459346020552251,1.0,10/31,19.39%,MTCL1;RHOA;WDR1;DLG2;PARD3;SYNJ2BP;LIN7A;LRRC7;PARD3B;LIN7B
prerank,regulation of sequestering of triglyceride (GO:0010889),0.2508130651447709,0.7160920147891013,0.7878787878787878,0.9453378437997955,1.0,5/15,17.74%,PLIN5;LPL;FITM1;PNPLA2;OSBPL11
prerank,regulation of mast cell degranulation (GO:0043304),-0.28493188559946975,-0.7159400138597445,0.855072463768116,0.9838938969479034,1.0,2/15,7.05%,ADGRE2;SYK
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.2563504718883328,-0.7159156174354985,0.76,0.9832204244069283,1.0,4/16,18.99%,PIK3CG;AUTS2;RASGRF1;PIK3CB
prerank,glycolipid metabolic process (GO:0006664),-0.21130019533869088,-0.7145712737766178,0.9186046511627907,0.9840380617690212,1.0,11/52,19.31%,ST8SIA6;PIGW;GLB1;UGT8;HEXB;B3GNT5;SMPD2;PGAP1;NEU1;FUT2;GLA
prerank,non-motile cilium assembly (GO:1905515),-0.23178660636528625,-0.714313869585675,0.9078947368421053,0.9836026959017691,1.0,5/29,16.16%,CEP250;ARL13A;RPGRIP1L;TBC1D32;TMEM107
prerank,mRNA destabilization (GO:0061157),-0.2150761614715603,-0.7135905641351326,0.9411764705882353,0.9836824501074072,1.0,14/34,35.33%,PLEKHN1;TRIM71;DCPS;MEX3D;CNOT1;POLR2D;ROCK2;PDE12;KHSRP;ZC3H12A;ZC3H12D;GIGYF2;DIS3L2;YTHDF1
prerank,sodium ion homeostasis (GO:0055078),-0.24824534430582307,-0.7134433794482004,0.8382352941176471,0.9831320352019841,1.0,2/24,0.63%,TMPRSS3;SLC12A2
prerank,protein modification by small protein removal (GO:0070646),-0.16728049246080967,-0.7127814545121093,1.0,0.9830609082430019,1.0,69/261,31.10%,MYC;OTUB2;CDK1;SKP2;USP50;TNFAIP3;RUVBL1;USP37;PSMB9;TNIP3;POLB;PSMD14;KDM1B;SMAD1;BRCC3;USP18;USP26;RNF128;CFTR;CLSPN;NFKBIA;NLRP3;ACTL6A;USP9X;CDC25A;PSMA3;CDC20;TRRAP;MDM2;ACTR8;TRAF2;BRCA1;USP17L1;BARD1;UCHL5;VCPIP1;USP17L4;IKBKG;ASXL2;PSMB3;GATA3;PSMC1;USP42;USP38;STAMBPL1;PSMB11;USP32;PSMA5;PSMB2;PSME2;USP34;PSMD12;PSMA7;USP17L18;USP10;ZC3H12A;USP17L22;SENP1;UCHL3;ADRM1;PSME4;USP1;PSME3;USP17L10;UBC;USP17L13;TGFBR1;USP17L20;STAM
prerank,ion transport (GO:0006811),-0.1780472076882708,-0.7125501548887945,0.9425287356321839,0.9826123929894759,1.0,22/114,20.72%,SLC12A2;PKD1L3;GABRB1;SLC26A8;SLC9A7;SLC26A9;SLC24A1;GLRA1;CHRNB2;SLC5A8;KCNN4;SLC24A5;CNGB3;WNK4;SLC12A3;CHRNA7;CHRNA2;SLC12A5;VDAC1;SLC12A1;ATP11B;PKD2L1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.21234065871133573,0.7124267339576501,0.9642857142857143,0.9480923615583893,1.0,4/20,11.66%,NCK1;BCL2L11;CREB3;BOK
prerank,zinc ion homeostasis (GO:0055069),0.20282530915254193,0.711043055973013,0.9230769230769231,0.9486214415845284,1.0,7/29,17.29%,SLC39A13;MT1X;MT1M;MT3;MT1A;SLC30A8;MT1E
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.17408732881071448,-0.7110196237346541,0.9659090909090909,0.9835325710235893,1.0,31/139,20.99%,MTHFD1L;CYP2S1;BAAT;CYP3A7;AOAH;KYNU;ANGPTL3;CKMT2;HLCS;VNN3;SLC5A6;ALOX12;ACOT12;VNN1;SLC16A3;ACOT6;AGXT;ACSF3;AGXT2;CYP26A1;LDHAL6B;MCCC2;PANK2;PCCA;CYP4F11;UGT1A7;VDAC1;PCCB;LDHA;PPARG;FASN
prerank,regulation of mitotic spindle organization (GO:0060236),-0.22284107750517962,-0.7110106296112829,0.8918918918918919,0.9828280347979276,1.0,5/35,10.22%,TACC3;GPSM2;TPX2;CHMP4C;PLK1
prerank,protein autoubiquitination (GO:0051865),-0.2019525895020805,-0.70961359538528,0.8674698795180723,0.9834855765186133,1.0,16/61,23.88%,UBE2T;TRIM71;RNF183;UHRF1;RAG1;ERCC8;UBE3D;RAD18;RNF213;TRIM17;MDM2;TRAF2;BRCA1;ASB4;DTX3L;STUB1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.15112552544212698,0.7094752380547155,1.0,0.9493104913462606,1.0,28/111,20.79%,MAPK1;PPP3CB;BCL10;MAPK3;MAP2K4;CALM1;MAPK8;RAC1;SKP1;PIK3R1;PSMC5;TAB1;NFKB1;PSMD9;NFATC1;MAPK10;BTRC;MAP3K1;PSMB6;NR4A3;FCER1A;NFATC3;GRB2;CUL1;FER;FBXW11;JUN;SHC1
prerank,activation of phospholipase C activity (GO:0007202),0.19808808215897875,0.7092194908993728,1.0,0.9487290119835295,1.0,6/32,13.40%,LPAR1;ARHGAP6;P2RY12;EGFR;AVPR1A;GNAQ
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.23442405651126066,-0.7091647891421966,0.8732394366197183,0.9831635108871016,1.0,5/21,18.56%,PAX2;MMP3;TRAP1;SLC18A2;BRCA1
prerank,steroid hormone biosynthetic process (GO:0120178),-0.23602770358325592,-0.7091455384525623,0.8860759493670886,0.9824908405597492,1.0,5/29,12.87%,SRD5A3;CYP19A1;MED1;DHCR7;SRD5A1
prerank,proteoglycan metabolic process (GO:0006029),-0.2288960071013099,-0.7088799954246605,0.8309859154929577,0.9820647012403793,1.0,10/25,31.94%,ADAMTS12;HS3ST4;CANT1;FOXL1;B4GALT7;HPSE;CHST13;SULF2;B3GALT6;IGF1
prerank,regulation of establishment of protein localization (GO:0070201),0.24223143356125454,0.7085088299394019,0.90625,0.9485980256748342,1.0,1/15,0.54%,CORO2B
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.22427414382020183,0.7083334473628248,0.8275862068965517,0.947969912607648,1.0,4/15,17.11%,AGPAT1;TSLP;IL7;GAS6
prerank,regulation of protein metabolic process (GO:0051246),-0.20962653510769547,-0.7074804541406025,0.9615384615384616,0.9830063696808536,1.0,12/44,25.47%,SHH;CHEK2;IL17F;PLAUR;ODC1;MDM2;CHRNA7;LDLR;CNDP1;VPS35;GBA;ROCK2
prerank,response to exogenous dsRNA (GO:0043330),-0.2187328036232462,-0.7067758596040308,0.9142857142857143,0.9830709100266477,1.0,16/33,41.66%,CAV1;IFNK;IRAK3;IFNE;IFNB1;SLC3A2;DHX9;IFNA1;IFNA21;IFNA4;IFNA7;IFNA14;IFNA10;IFNA17;IFNA2;IFNA16
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.25905268441850693,-0.7063734679398427,0.8571428571428571,0.9827602895618904,1.0,3/19,12.65%,TRIM71;HENMT1;TERT
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.19701840645848118,-0.7059622342676326,0.9411764705882353,0.9824850930650848,1.0,14/66,21.63%,IFI6;AREG;EREG;EPGN;RHBDF2;MMP9;PTPN3;PLAUR;AGT;SH3KBP1;PTPN2;PTPRJ;EGF;ITGA1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.2543988030545871,-0.7048264456681886,0.8648648648648649,0.982330103957751,1.0,3/15,13.13%,NANOS3;PABPC1;CNOT1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.2543988030545871,-0.7048264456681886,0.8648648648648649,0.982330103957751,1.0,3/15,13.13%,NANOS3;PABPC1;CNOT1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.1862323494634403,-0.7038841257294415,0.9340659340659341,0.9826492173019973,1.0,17/92,18.65%,CXCL8;TDGF1;POLR2F;FGF19;TRIM71;ANOS1;CD44;SHCBP1;FGF20;GALNT3;FGF3;NCBP1;POLR2J;FGF23;FGFR4;POLR2D;FGFRL1
prerank,mRNA polyadenylation (GO:0006378),-0.23372542751514444,-0.7028769636779677,0.8571428571428571,0.982215466404921,1.0,8/24,28.94%,CPSF3;PABPC1;PNPT1;MTPAP;CPSF2;LEO1;CDC73;CSTF3
prerank,RNA polyadenylation (GO:0043631),-0.23372542751514444,-0.7028769636779677,0.8571428571428571,0.982215466404921,1.0,8/24,28.94%,CPSF3;PABPC1;PNPT1;MTPAP;CPSF2;LEO1;CDC73;CSTF3
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.13048528721071,0.7025765250309125,1.0,0.9524724973915087,1.0,64/246,21.71%,SRSF5;NOVA1;PABPN1;DHX35;SNRNP70;DDX39B;CPSF7;HNRNPH3;CASC3;RBM6;SRSF4;SNRPN;RBM4;U2AF1L4;ISY1;SF1;SRSF11;HNRNPH2;SRRM2;RBM5;RNPC3;PDCD7;SF3B1;METTL3;DDX42;CWC25;SRRM1;SRSF7;SYF2;PNN;HSPA8;DHX16;SF3B4;IK;NOVA2;PLRG1;RBM17;DNAJC8;WBP4;CD2BP2;SNIP1;POLR2A;XAB2;ZRSR2;SRSF2;ZMAT2;PCBP2;PRPF4B;SRSF1;SNW1;RAVER1;ZMAT5;USP49;RBM4B;MFAP1;RBM14;SMNDC1;SF3A1;SUGP1;DHX38;SRRT;TRA2A;POLR2E;HNRNPA3
prerank,intracellular pH reduction (GO:0051452),-0.21642263907453932,-0.7021891804148696,0.8875,0.9822204884065078,1.0,7/35,20.40%,ATP6V1C2;GPR89A;GPR89B;ATP6V0A4;CLCN3;RAB39A;DMXL2
prerank,TOR signaling (GO:0031929),-0.22606169492041944,-0.7006558591454918,0.8888888888888888,0.9831106195996735,1.0,13/25,42.74%,CARD11;SYAP1;RHEBL1;EIF4EBP1;GATA3;SMG1;LARP1;PRR5;NPRL3;AKT1;RPS6KB2;PRR5L;FNIP1
prerank,oligosaccharide metabolic process (GO:0009311),-0.2048848002771507,-0.7005681180204844,0.9230769230769231,0.9824839322062948,1.0,19/49,35.75%,ST8SIA6;FUT8;FUT1;FUT7;NEU1;FUT2;GLA;FUT6;FUT5;MANBA;AMY1B;ST8SIA5;MPDU1;B4GALT1;B3GALT2;ST3GAL2;MAN1B1;ST8SIA4;FUT3
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.21807842718081152,0.6997598884190165,0.75,0.9542449306966181,1.0,3/18,8.77%,FGF2;SRF;PIK3R3
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.24898748194659803,-0.6996456495421352,0.8783783783783784,0.9827419953352855,1.0,2/18,5.40%,EGR1;DCUN1D5
prerank,cellular response to heat (GO:0034605),-0.21440537493445794,-0.6996351612312576,0.9125,0.982066834906204,1.0,2/34,0.97%,IL1A;CLPB
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.17895410040750376,0.6995721998309685,0.9166666666666666,0.9535177955567289,1.0,3/23,7.67%,UBB;RNF185;MAN1C1
prerank,aspartate family amino acid metabolic process (GO:0009066),0.21326284391094194,0.6981825327705317,0.88,0.9539112616610631,1.0,6/19,18.32%,SLC25A12;ASPA;NAALAD2;ASNS;MSRA;MTHFR
prerank,regulation of cartilage development (GO:0061035),-0.2323722296139433,-0.6981047317731114,0.8695652173913043,0.982900014841447,1.0,4/18,21.96%,SOX9;WNT11;BMP4;MDK
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.23192980703688537,-0.6961829686364279,0.8857142857142857,0.9841135533578681,1.0,8/27,23.37%,IL1B;ASS1;AGXT2;IFNG;DDAH1;MMP8;TNF;CLEC7A
prerank,peptidyl-proline modification (GO:0018208),-0.2290740062218958,-0.6947310019767996,0.9285714285714286,0.984651973927989,1.0,15/30,39.36%,PPIH;NTMT1;PPIB;PPIL1;PPIL6;PPIAL4C;FKBP1B;PPIAL4A;FKBP4;OGFOD1;PPIAL4G;PPIF;PPIAL4F;PPIAL4D;PPIL3
prerank,phagosome acidification (GO:0090383),0.19135518330335402,0.6923367380158594,0.9444444444444444,0.9577396677989882,1.0,9/28,22.09%,ATP6V1G2;ATP6V1E1;TCIRG1;ATP6V0E2;ATP6V1H;ATP6V0A1;ATP6V1D;ATP6V0D1;ATP6V0E1
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.2423748393065745,-0.690529961489593,0.8918918918918919,0.9879308361355524,1.0,2/16,7.71%,IRS1;PMAIP1
prerank,nucleus organization (GO:0006997),-0.20801155622041492,-0.6899730497151226,0.8904109589041096,0.9877488509543173,1.0,10/46,20.16%,CEP55;NUP155;WDR73;CHMP4C;NUP35;SEH1L;RPS19;NUP205;NUP93;SUN3
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.23049202695853482,-0.6890959340430096,0.9253731343283582,0.9878932312114574,1.0,9/19,35.98%,PTBP3;TERT;TGFB1;SHQ1;TNF;ZC3H12A;NCOR1;NRDE2;PTBP1
prerank,mesoderm development (GO:0007498),0.20638682736808292,0.688668409030165,0.9354838709677419,0.9598375945365247,1.0,4/17,15.17%,TIE1;BMX;JAK2;SECTM1
prerank,microtubule nucleation (GO:0007020),0.20394514642006434,0.688490354506257,0.8709677419354839,0.9591881009718609,1.0,6/20,17.72%,TUBG2;TUBGCP6;SLAIN2;GOLGA2;NDEL1;TUBGCP2
prerank,metallo-sulfur cluster assembly (GO:0031163),0.21239106683839815,0.688097852348059,0.875,0.958746874741739,1.0,3/19,11.74%,ISCU;ISCA1;HSCB
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.23534527508840675,-0.6879869177344309,0.9041095890410958,0.9882497237747805,1.0,8/25,28.43%,B3GNT4;NDST3;B3GNT2;B3GNT3;HAS3;EXT1;HS2ST1;HAS2
prerank,regulation of stem cell proliferation (GO:0072091),0.2074182191349303,0.6878726364833582,0.9583333333333334,0.9580833445001126,1.0,2/17,3.69%,ZFP36L1;FBLN1
prerank,linoleic acid metabolic process (GO:0043651),-0.22869140670700633,-0.6875215682424289,0.8513513513513513,0.9878853366548853,1.0,3/19,15.39%,ALOX12B;ALOX12;ALOXE3
prerank,telomere maintenance via telomerase (GO:0007004),-0.23861603364128287,-0.6861827393333426,0.9047619047619048,0.9883103625489033,1.0,10/28,37.21%,DKC1;TERT;GAR1;SHQ1;WRAP53;NOP10;PIF1;NHP2;CDK2;HSP90AA1
prerank,response to estradiol (GO:0032355),-0.21375807644021988,-0.6860048263394364,0.8666666666666667,0.9877296492356878,1.0,11/35,28.55%,POU4F1;CYP19A1;TGFB1;WNT8B;STAT5B;POU4F2;RUVBL2;LCOR;ANXA1;CCDC62;NRIP1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.24582945005416545,-0.6857715514969884,0.8428571428571429,0.987228530323232,1.0,7/20,36.01%,AJUBA;CNOT1;EIF6;CNOT6;TNRC6B;NRDE2;HELZ
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.2541361528285381,-0.6857666671620486,0.8769230769230769,0.9865411444584566,1.0,4/17,16.41%,CAV1;MMP9;HAMP;STK39
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.22962268203764957,-0.6844950848559687,0.9014084507042254,0.9869659209401552,1.0,5/28,18.18%,IRAK2;HSPD1;IRAK1;TAB3;IRAK3
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.2344429893684058,-0.6825672765841578,0.90625,0.9880288401228275,1.0,10/29,37.21%,DKC1;TERT;GAR1;SHQ1;WRAP53;NOP10;PIF1;NHP2;CDK2;HSP90AA1
prerank,regulation of protein export from nucleus (GO:0046825),-0.2297589520220786,-0.6818803802379619,0.8571428571428571,0.9878922492258517,1.0,2/23,1.74%,IL1B;GTSE1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.23107765928176,-0.6805357129623465,0.9493670886075949,0.9883446287066471,1.0,4/26,11.39%,INHBA;PRKDC;STAT1;MED1
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.2154203138595857,0.6782419061268239,0.8888888888888888,0.9636759161747439,1.0,4/16,13.93%,NPPA;SLC2A5;ADM;NPPB
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.2194621916389967,-0.6771471888158879,0.9054054054054054,0.9905958010779872,1.0,10/28,30.01%,IL1B;ASS1;AGXT2;IFNG;DDAH1;MMP8;TNF;CLEC7A;TMEM106A;NOS1AP
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.21240168815098626,-0.6750106090220132,0.8493150684931506,0.9915258256916235,1.0,6/27,23.10%,NOTCH3;LFNG;DLK2;CHAC1;EGF;NRARP
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.26216552115477343,-0.6749325134812344,0.8732394366197183,0.9909073459160553,1.0,4/15,23.21%,SMARCA4;FOXH1;PHB;NODAL
prerank,regulation of leukocyte migration (GO:0002685),-0.243145571052588,-0.6731295762324736,0.859375,0.9917380000017035,1.0,7/17,32.48%,ZP3;CD81;TNFSF18;ANXA1;RHOH;RAC2;HOXA7
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.22905388868369364,-0.6725061657984999,0.9605263157894737,0.9915456120502432,1.0,9/21,31.12%,PLA2G4D;PLA2G4E;PLA2G2F;OSBPL8;PLA2G2E;PLA2G2D;OSBPL10;LPCAT3;PLA2G10
prerank,cytoplasmic translational initiation (GO:0002183),0.19528955842791498,0.6718501323885427,0.9047619047619048,0.9671921803126347,1.0,7/18,21.93%,RBM4;EIF4A1;EIF4A2;EIF5;EIF4H;EIF2D;DHX29
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.2542863484502296,-0.67172945742467,0.8985507246376812,0.9914951858699206,1.0,3/18,7.94%,SOCS3;CEBPA;STAT1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.25559546584273046,-0.6704561546430418,0.8571428571428571,0.9919526196174504,1.0,5/15,28.87%,BRCA2;TERT;ATR;ATRX;XRCC5
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.235316051955604,-0.6689330645621806,0.8767123287671232,0.9923899003635137,1.0,5/17,24.97%,SUV39H2;SUV39H1;SMYD2;PRDM9;KMT2D
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.19442983964605137,-0.6670344121521162,0.9230769230769231,0.9933287815371776,1.0,10/44,23.54%,MATR3;TRIM71;NANOS3;MEX3D;GRM5;NOLC1;EIF4E;PKP3;LARP4;MAPKAPK5
prerank,response to cholesterol (GO:0070723),-0.2343643342174984,-0.6660494235051717,0.8732394366197183,0.9932870019607033,1.0,8/19,33.40%,CCL3;TGFB1;PTCH1;TGFBR2;GRAMD1B;GPLD1;TGFBR1;MLC1
prerank,positive regulation of nervous system process (GO:0031646),-0.24275533016983916,-0.6625317206355575,0.9142857142857143,0.9953097534822394,1.0,7/17,25.58%,ITGAX;TNFRSF1B;HCRT;MYRF;NCMAP;TENM4;CST7
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.17736404040530768,-0.6613075238987424,0.9878048780487805,0.9955196726014581,1.0,10/67,22.46%,POLR2F;CCNK;INTS7;CDK7;NCBP1;POLR2J;POLR2D;NABP1;INTS2;POLR2I
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.1897559685328843,0.6611819600022932,1.0,0.9734361447817449,1.0,5/18,17.88%,SLC25A23;SMDT1;MICU3;MICU1;PARL
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.22218312433954593,-0.6606657970518941,0.92,0.9952771076295384,1.0,3/24,8.26%,LAMP3;PML;PRKCG
prerank,regulation of fatty acid oxidation (GO:0046320),-0.24153282721519673,-0.660582952756577,0.9473684210526315,0.994646164650461,1.0,1/16,4.08%,SOX9
prerank,lipid catabolic process (GO:0016042),-0.2129336910698995,-0.6589033737772713,0.9210526315789473,0.995142585343057,1.0,7/25,25.79%,LIPG;CEL;LIPE;CYP4F3;CYP4F11;CYP4F2;LIPC
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.18312372475192296,0.6586611666910143,0.96,0.9743827202256533,1.0,6/30,19.00%,TLR3;UBB;TICAM2;RIPK1;UBE2D3;CD40
prerank,organic cation transport (GO:0015695),0.20287591561954338,0.657503966867661,0.9285714285714286,0.9742806496710369,1.0,4/20,13.81%,SLC5A7;SLC25A42;SLC44A2;RALBP1
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.221164793723786,-0.6572860986794355,0.9594594594594594,0.9957256590974632,1.0,11/21,40.24%,TIMM8A;PMAIP1;ROMO1;TIMM10;TIMM13;BAX;HSPA4;COX18;HSP90AA1;AGK;TIMM8B
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.20432496355366675,0.656998742516109,0.8888888888888888,0.9738458175030423,1.0,6/20,15.79%,C1QTNF3;CLK2;CRY1;BCKDK;INS;SOGA1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.2210735280503886,-0.6555827008148329,0.9625,0.9963176246464778,1.0,3/26,7.03%,TRIM71;PUS10;SMAD1
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.17051766918525182,-0.6551861755811546,0.9767441860465116,0.9959105991148867,1.0,32/78,40.29%,FAAH2;PNPLA3;ACSL6;ASAH2;CYP4F3;CYP2D6;ALOX12B;ALOX12;ASAH2B;AWAT1;ALOXE3;ACSL5;CYP4F11;CYP4F2;CYP2D7;DAGLA;CPT2;PLA2G10;ACSL3;HSD17B4;AIG1;ACOT4;GLYATL2;ACSL4;CYP2J2;ACSBG2;CYP2C9;ACSBG1;ACOX1;ACOT8;FAAH;HACL1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.1790380966220428,-0.6543580918599264,0.9574468085106383,0.995775296241445,1.0,29/75,35.98%,POLR2F;FGF19;TRIM71;ANOS1;SHCBP1;FGF20;GALNT3;FGF3;NCBP1;POLR2J;FGF23;FGFR4;POLR2D;FGFRL1;POLR2I;ESRP1;SPRED1;KIF16B;FGF8;SETX;ESRP2;FGF21;PTPN11;GTF2F2;FGF18;KLB;FGF6;HNRNPF;PTBP1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.14402414123750754,0.6541066789240918,1.0,0.9749640850179382,1.0,33/86,26.88%,TIMM21;NDUFA11;OXA1L;COA5;COX16;ECSIT;NDUFC2;NDUFA5;NDUFS2;NDUFB8;CHCHD4;SURF1;COX14;NDUFB10;UQCRFS1;NDUFS4;SDHAF2;UQCC1;NDUFV2;BCS1L;TIMMDC1;NDUFAF1;NDUFA8;NDUFS8;NDUFV1;SDHAF1;NDUFA13;NDUFC1;NDUFS5;TMEM126B;NDUFA6;LYRM7;SMIM20
prerank,snRNA transcription (GO:0009301),-0.17512538992560062,-0.6533467230480592,0.9634146341463414,0.9958143774668119,1.0,10/68,22.46%,POLR2F;CCNK;INTS7;CDK7;NCBP1;POLR2J;POLR2D;NABP1;INTS2;POLR2I
prerank,positive regulation of viral transcription (GO:0050434),-0.21098210669244633,-0.652371124212204,0.9305555555555556,0.9957421886942595,1.0,5/26,22.46%,POLR2F;POLR2J;NELFCD;POLR2D;POLR2I
prerank,amyloid-beta metabolic process (GO:0050435),-0.21592353259237423,-0.6513252502255672,0.9253731343283582,0.9957135887384608,1.0,2/17,8.26%,MME;BACE2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.16913149100231037,-0.6509475937792542,1.0,0.9953035507336504,1.0,6/72,6.80%,RFC3;ERCC5;RPA3;FEN1;DNA2;RFC5
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.196438348954381,-0.6503405405343384,0.975609756097561,0.9950484929660626,1.0,15/36,36.12%,SELL;DSG1;CDH7;ATP2C1;CDH11;CDH18;CDH20;CDH6;CDH22;CDH12;PCDHB9;PCDHB13;PCDHGB4;CDH9;CDH17
prerank,protein lipidation (GO:0006497),-0.18000573103124226,-0.6485777446815878,0.9425287356321839,0.9954737146515173,1.0,9/58,14.03%,ZDHHC9;PIGM;PIGU;PIGW;PYURF;PIGF;ALOX12B;DPM1;ZDHHC13
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.22628257834958676,-0.6472902740791873,0.8955223880597015,0.9955706685005653,1.0,4/19,19.18%,COX20;SCO2;PET117;COA1
prerank,histone monoubiquitination (GO:0010390),-0.21588737321658777,-0.6458349732488385,0.9315068493150684,0.9958215875391903,1.0,11/24,35.78%,UHRF1;RAG1;RNF40;RNF2;DTX3L;LEO1;CDC73;KDM2B;BCOR;CTR9;TRIM37
prerank,positive regulation of viral life cycle (GO:1903902),-0.21498160738663713,-0.6455408495401042,0.9367088607594937,0.9953455098711936,1.0,7/24,25.60%,LGALS1;P4HB;AXL;FMR1;VPS37B;KPNA2;TMPRSS4
prerank,cortical actin cytoskeleton organization (GO:0030866),0.20268039403668983,0.64429685373035,0.896551724137931,0.9795786924848696,1.0,8/20,23.86%,RHOQ;NCKAP1L;FHOD3;RAB13;LLGL1;FHOD1;STRIP1;NCKAP1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.23902662353180798,-0.6442663005241333,0.9230769230769231,0.9955048688444559,1.0,1/15,1.39%,GET4
prerank,regulation of phosphatase activity (GO:0010921),0.1848772929390064,0.6439838604225255,1.0,0.9789351119400098,1.0,5/25,14.22%,MTMR9;HSP90B1;TSC1;CHP2;PPP6R2
prerank,protein import into peroxisome membrane (GO:0045046),0.180427975490082,0.643052014836165,0.8461538461538461,0.9786402225338018,1.0,10/22,26.94%,PEX19;RAB8B;PXMP2;ALDH3A2;PEX11B;PEX12;PEX14;PEX5;FIS1;ATAD1
prerank,regulation of microtubule depolymerization (GO:0031114),0.1631536380508618,0.6423293810293583,1.0,0.978203674971755,1.0,2/24,5.37%,STMN2;MAP1A
prerank,positive regulation of cell development (GO:0010720),-0.18684204955807598,-0.6418746227302274,0.9583333333333334,0.9963512212047063,1.0,8/37,23.37%,RASSF10;MME;LRP2;IFNG;OPRM1;BMP4;TYROBP;CLEC7A
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.23104622606919317,-0.6417794779058307,0.92,0.9957653036974271,1.0,5/18,22.30%,TGFB2;FN1;ITGB6;CD46;XCL1
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.18795161476538538,-0.6408737835362526,0.9428571428571428,0.9956840934310036,1.0,12/40,31.31%,TGFB2;BMP2K;ROBO2;NOD2;JAG2;PRKCI;CREBBP;NOTCH1;ELF3;MAML2;MAML3;PDCD10
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.20497085385819008,-0.6407936081408435,0.9722222222222222,0.9950610663308059,1.0,10/29,29.74%,TNFAIP3;LYAR;TRIB1;IRAK3;IFI16;CARD16;NMI;LTF;ITCH;C1QBP
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.15556052563603615,-0.640190621358189,1.0,0.994726443112719,1.0,58/191,32.68%,MYC;RNF39;TP73;SHH;IGF2BP1;PRDM13;IGF2BP3;PROX1;IGF2BP2;FEZF2;ALPK2;ZFP64;CDK4;PRDM12;PRDM1;TRIM17;IL10;NPAT;PRDM7;UBAP2;STOX1;LDLR;NANOG;ZNF683;LHX1;MEFV;TRIM14;TRIM22;MKLN1;UNCX;ATP1B1;PRDM9;KIF16B;INSM1;REST;ROCK2;TMPRSS4;IHH;RASA1;TRIM31;MTMR3;MTMR1;KDM6A;KHSRP;ADNP;AFF2;ZC3H12A;ZNF462;TBC1D16;PRDM14;HNRNPAB;TXK;HIF1A;IGF1;TRIM15;TRIML2;ZNF711;CDK6
prerank,positive regulation of growth (GO:0045927),0.14381289026957647,0.6395847596377106,1.0,0.9785251968463068,1.0,14/69,17.12%,AKAP6;LGI1;WFS1;GH1;EGFR;SFRP1;KLHL22;N6AMT1;BCL2;USP47;PPM1F;INS;TAF9B;SFRP2
prerank,regulation of viral transcription (GO:0046782),-0.18463203837215408,-0.6357066478591445,0.961038961038961,0.9968156496189338,1.0,18/41,45.71%,IFITM3;POLR2F;POLR2J;NELFCD;POLR2D;TRIM14;POLR2I;TRIM31;DHX9;GTF2F2;TRIM11;TRIM27;TARBP2;POLR2B;TRIM13;RSF1;POLR2H;POLR2K
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.20646663199543722,0.6354778330955978,1.0,0.9797922036361606,1.0,6/15,23.84%,HSP90B1;TMEM129;SEL1L;SYVN1;HERPUD1;DERL2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.23844076300432088,-0.6348721050734605,0.9594594594594594,0.9966286522977813,1.0,2/18,12.85%,NAF1;SLX1A
prerank,leukocyte tethering or rolling (GO:0050901),-0.21741382760478065,-0.63309248126092,0.9393939393939394,0.996958446392593,1.0,6/18,32.37%,SELL;GCNT1;TNF;SELPLG;PODXL2;CX3CR1
prerank,regulation of postsynapse organization (GO:0099175),-0.2023533766009989,-0.6302669907386962,0.9722222222222222,0.9978135347644443,1.0,9/28,33.16%,WNT5A;HOMER1;CDK5;VPS35;ABHD17C;CDK5R1;PPFIA2;IL1RAPL1;LZTS3
prerank,hexose metabolic process (GO:0019318),-0.19337249818156668,-0.6293006832225878,0.9583333333333334,0.997683554837887,1.0,8/41,18.86%,PMM2;SORD;GALK2;KHK;SLC35A2;FUOM;ALDOB;FUCA2
prerank,NAD biosynthetic process (GO:0009435),-0.21132156338893043,-0.6276761487411002,0.9710144927536232,0.9979928663249173,1.0,7/19,33.16%,KYNU;SLC5A8;SLC22A13;QPRT;HAAO;NAMPT;NAPRT
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.1544702902770915,-0.6271408164893295,0.9893617021276596,0.9975958357849655,1.0,70/164,45.95%,HELZ2;RPL39;DCPS;MAGOHB;MRTO4;PABPC1;CNOT1;EXOSC8;RPS19;EXOSC4;NCBP1;EXOSC5;RPS21;POLR2D;RPL36;CNOT10;MAGOH;MTPAP;CNOT11;XRN2;RPL23A;RPL37;EXOSC7;PDE12;XRN1;NBAS;SMG1;RPL8;ZC3H12A;GSPT1;CNOT6;PATL1;DHX34;RBM8A;RPS18;RPS7;PATL2;ERI1;EIF4A3;PAN3;DIS3L2;RPS2;SMG7;RPL41;RPS24;SMG6;LSM1;RPL32;RPS29;RPL27A;RPL35;RPS3;RPS4X;RPL4;RPL30;RC3H1;RC3H2;RPL37A;RPL18;RPL19;EIF3E;DCP2;PARN;RPL38;RPLP2;RPL12;RPS14;NCBP2;RPS3A;UPF3B
prerank,iron-sulfur cluster assembly (GO:0016226),0.18760868751226983,0.6267418085090329,0.9032258064516129,0.9827586726175838,1.0,3/21,11.74%,ISCU;ISCA1;HSCB
prerank,neuromuscular junction development (GO:0007528),-0.21644382792361977,-0.6265941325025299,0.9135802469135802,0.9971850451904075,1.0,6/24,21.04%,DOK7;LRP4;AGRN;F2R;GPHN;PPFIBP2
prerank,regulation of synapse organization (GO:0050807),-0.20859188834499093,-0.6239647000253398,0.9382716049382716,0.9979132323357498,1.0,3/26,9.64%,KLK8;WNT5A;CHRNB2
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.20471432916208343,-0.6234248040525803,0.9333333333333333,0.9976551048168701,1.0,1/28,0.07%,GNL3L
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.21057516969719847,-0.6207376147413993,0.9210526315789473,0.9982583089792241,1.0,5/21,24.90%,PMAIP1;ATR;EIF5A;SPRED1;RPL37
prerank,cellular response to zinc ion (GO:0071294),0.1971383606528118,0.6191114687722427,0.9142857142857143,0.9851065687467759,1.0,5/18,17.29%,MT1X;MT1M;MT3;MT1A;MT1E
prerank,COPII-coated vesicle budding (GO:0090114),-0.15835219678958953,-0.6182621123356313,0.9871794871794872,0.9988892172842584,1.0,4/70,4.14%,AREG;F5;FOLR1;SEC23B
prerank,proton transmembrane transport (GO:1902600),-0.2031006097938136,-0.6169374774738624,0.9615384615384616,0.9988399692727327,1.0,11/33,33.84%,SLC4A11;ATP6V0A4;UCP1;ATP12A;SLC46A1;SLC36A3;ATP6V1A;OTOP1;SLC36A2;UCP2;NOX5
prerank,establishment of epithelial cell polarity (GO:0090162),-0.2161529436189721,-0.6162484180885394,0.9701492537313433,0.9985296946729668,1.0,6/20,28.05%,FERMT1;SIPA1L3;MSN;SYNE4;CAMSAP3;EZR
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.15988688547987157,-0.6156733010036992,1.0,0.9980964972085686,1.0,36/76,43.26%,MAZ;RTKN2;ASAH2;RELA;BCL2L1;MMP9;PLAUR;THBS1;BIRC6;PRELID1;CSNK2A1;BMP4;TNF;FXN;BDNF;MCL1;URI1;PSME3;TGFBR1;IGF1;CX3CR1;NOC2L;OPA1;GATA4;PPIF;SH3RF1;FZD9;CAAP1;HTT;AKT1;ITGA6;TRIAP1;PHIP;IL4;ITGAV;GSTP1
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.18706469191845726,-0.6098367269123777,0.9857142857142858,1.0,1.0,6/32,17.71%,CXCL8;C3;MED1;MFSD12;TNFRSF1B;FGFR4
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.22231623135651044,-0.6097266054359464,0.9264705882352942,0.9995390361275347,1.0,6/15,32.04%,PDGFRB;S100A11;MDK;CCL5;IGF1;NRP1
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.20654669542120307,-0.6082366084326328,0.9701492537313433,0.9994563754379657,1.0,3/20,7.80%,HSPD1;PSMG1;THEG
prerank,COPII vesicle coating (GO:0048208),-0.162533449019899,-0.6071335536329702,0.9864864864864865,0.9978199782212107,1.0,16/63,34.65%,AREG;F5;FOLR1;TRAPPC9;CNIH3;COL7A1;CTSC;TRAPPC10;SEC24A;TMED2;CUL3;NSF;SERPINA1;SEC13;SEC24D;SEC24C
prerank,vesicle coating (GO:0006901),-0.162533449019899,-0.6071335536329702,0.9864864864864865,0.9978199782212107,1.0,16/63,34.65%,AREG;F5;FOLR1;TRAPPC9;CNIH3;COL7A1;CTSC;TRAPPC10;SEC24A;TMED2;CUL3;NSF;SERPINA1;SEC13;SEC24D;SEC24C
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.162533449019899,-0.6071335536329702,0.9864864864864865,0.9978199782212107,1.0,16/63,34.65%,AREG;F5;FOLR1;TRAPPC9;CNIH3;COL7A1;CTSC;TRAPPC10;SEC24A;TMED2;CUL3;NSF;SERPINA1;SEC13;SEC24D;SEC24C
prerank,microvillus assembly (GO:0030033),-0.2336109641542753,-0.6029020340933715,0.8840579710144928,0.9987727257330408,1.0,10/15,47.86%,FXYD5;STK26;RAP2B;EZR;RAP1B;RAP2A;SLC9A3R1;RAPGEF2;TNIK;RAPGEF6
prerank,proteoglycan biosynthetic process (GO:0030166),-0.18320702248979764,-0.6024647388577642,0.9452054794520548,0.9982284533910174,1.0,11/31,34.78%,NDST3;GLCE;CANT1;EXT1;B3GAT2;FOXL1;B4GALT7;CHST13;B3GALT6;IGF1;PXYLP1
prerank,respiratory chain complex IV assembly (GO:0008535),-0.2037393836033966,-0.6014506571136322,0.9701492537313433,0.9979725426491599,1.0,8/22,35.81%,COX20;SCO2;PET117;COA1;COA6;FASTKD3;COX18;COX19
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.20636501954669176,0.6001267596995965,0.9512195121951219,0.9905809638309289,1.0,5/16,17.11%,PELI3;F2RL1;GPS2;CCDC3;GAS6
prerank,regulation of developmental growth (GO:0048638),0.15913987793844056,0.5991870259870968,1.0,0.9902157199358465,1.0,9/30,20.54%,PRL;LATS2;SOD1;APP;OLFM1;SIN3A;DLL1;FGFR3;GHR
prerank,histone modification (GO:0016570),-0.15180322756080913,-0.598671550722554,1.0,0.9984426359658124,1.0,46/110,42.99%,INCENP;PADI1;HDAC10;RUVBL1;PADI3;AURKB;UHRF1;EYA1;HLCS;PARP2;NTMT1;CPA4;PHB;CTCFL;TRRAP;CARM1;RCOR2;HDAC2;RUVBL2;PHF20L1;EZH2;CREBBP;MRGBP;NSD1;TAF6L;HUWE1;PRMT6;UBE2N;TBL1Y;PRMT8;PADI4;PADI6;KAT6A;EYA3;CDK2;BAZ1B;NEK11;MTA2;BRMS1;TAF10;UBE2U;PRMT1;CCNA2;KAT6B;TBL1XR1;HDAC1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.15853806956328861,0.596619782043007,1.0,0.9901651451167581,1.0,11/43,20.82%,RBM24;ZFP36L1;ZFP36;BTG2;EIF4ENIF1;METTL3;CELF1;CPEB3;NANOS1;ZFP36L2;CNOT8
prerank,nucleotide metabolic process (GO:0009117),-0.1987091733584838,-0.5959949261914951,0.971830985915493,0.998832046686329,1.0,11/23,43.68%,PNP;NUDT5;RNASEH2B;CTPS2;DCK;CMPK2;ENPP3;ME1;AK7;CMPK1;FHIT
prerank,smoothened signaling pathway (GO:0007224),-0.18436236234892894,-0.5942549986959239,0.95,0.9988397685531407,1.0,8/32,25.66%,SHH;B9D1;PTCH1;TTC26;PKD2L1;HIPK2;KIAA0586;IHH
prerank,regulation of hippo signaling (GO:0035330),-0.20842777299154824,-0.5912754429413215,0.9411764705882353,0.9992189858900543,1.0,9/20,41.17%,WWC1;AJUBA;NEK8;SCHIP1;CIT;SHANK2;VGLL4;NF2;MAP2K3
prerank,regulation of glucose metabolic process (GO:0010906),-0.18580973750021607,-0.5897927071368829,0.9726027397260274,0.9990525583880673,1.0,3/31,11.16%,IRS1;PMAIP1;KHK
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.22590362342638753,-0.5888139874802877,0.9594594594594594,0.9987078939002512,1.0,1/16,0.73%,ENTPD7
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.1699149776676184,-0.5831214628513394,1.0,0.9999405951733371,1.0,12/42,27.14%,SMARCA4;ACTL6A;SPTY2D1;ACTR8;ARID1B;SMARCC1;HDAC2;SMARCB1;CHD4;ERCC6;SMARCAD1;ARID1A
prerank,glycoprotein catabolic process (GO:0006516),-0.20248232983408987,-0.5830157846270988,0.9701492537313433,0.9993143959682622,1.0,5/17,24.78%,ADAMTS12;STT3B;MMP12;NGLY1;MANBA
prerank,glial cell development (GO:0021782),-0.1939208499174594,-0.5818564638528009,0.9452054794520548,0.9989936817754701,1.0,5/25,21.96%,SOX4;NF1;ZNF488;MYRF;MDK
prerank,copper ion homeostasis (GO:0055070),-0.2074317357157789,-0.5813109166440955,0.9705882352941176,0.9984954125202965,1.0,4/17,17.42%,ATP7B;XIAP;ABCB6;SLC31A1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.16547154621487858,0.5809033608868137,1.0,0.9933316508630822,1.0,2/21,5.44%,CASP3;MUS81
prerank,gene silencing by miRNA (GO:0035195),-0.18229533292315542,-0.5734890202352331,1.0,1.0,1.0,4/31,13.13%,TRIM71;XPO5;AJUBA;CNOT1
prerank,mRNA catabolic process (GO:0006402),-0.16646721260448502,-0.5733556459300628,1.0,0.9997694665999324,1.0,12/40,32.18%,MRTO4;PNPT1;EXOSC4;LSM5;CNOT10;XRN2;PDE12;XRN1;NBAS;SLFN14;ZC3H12D;DHX34
prerank,regulation of oxidative phosphorylation (GO:0002082),0.17755880147603817,0.572963393067688,0.9655172413793104,0.9946115653367318,1.0,1/16,0.92%,COX7A1
prerank,negative regulation of telomere maintenance (GO:0032205),0.18869526253620555,0.5700784177778341,0.9655172413793104,0.9944950121370709,1.0,1/16,4.03%,TERF2IP
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.1904612702462451,-0.5695749140286291,1.0,1.0,1.0,5/26,19.70%,UCP1;TRAP1;SLC18A2;CYBA;MMP8
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.1807815166200567,-0.5681721220888499,0.9868421052631579,0.9999844147454753,1.0,9/31,33.39%,NANOS3;GRM5;NOLC1;EIF4E;PKP3;MAPKAPK5;TIGAR;GEMIN5;TCOF1
prerank,peroxisomal membrane transport (GO:0015919),-0.18659103396957405,-0.5658078018963649,0.9493670886075949,1.0,1.0,8/27,33.32%,PEX7;ACBD5;PEX13;GDAP1;PEX10;PEX16;PEX3;PEX1
prerank,glycoprotein metabolic process (GO:0009100),-0.15766170430752177,-0.5657746045685911,0.9861111111111112,0.999373071256211,1.0,17/52,34.99%,MAN2A1;ST8SIA6;FUT8;GCNT1;STT3B;PCSK6;GAL3ST2;NGLY1;MANBA;B4GALT7;HPSE;HIF1A;ST8SIA5;ERP44;ST3GAL2;MAN1B1;ST8SIA4
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.17172616398112706,0.5633729508786813,0.9333333333333333,0.9952240672817727,1.0,16/16,82.84%,DHX58;GPATCH3;BIRC2;SEC14L1;RNF125;USP15;BIRC3;ZCCHC3;PUM2;NPLOC4;PUM1;DDX60;OASL;TRIM15;C1QBP;ANKRD17
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.158111671683561,0.5589928559726594,1.0,0.9949977119008979,1.0,1/20,1.38%,STMN2
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.1588126308113129,-0.5584385496824426,0.9873417721518988,1.0,1.0,14/47,31.36%,TOMM20L;TOMM34;HSPD1;ROMO1;RALA;TIMM23;TOMM40;DNAJC15;GRPEL2;TIMM10;TIMM13;GDAP1;AIFM1;TIMM50
prerank,protein targeting to ER (GO:0045047),-0.14199751701056004,-0.5540625909170583,0.9888888888888889,1.0,1.0,56/101,56.99%,RPL39;SRPRB;RPS19;SRP72;RPS21;RPL36;RPL23A;RPL37;RPL8;RPS18;RPS7;SEC61G;RPS2;RPL41;SEC61A1;RPS24;RPL32;RPS29;RPL27A;RPL35;RPS3;EDEM1;RPS4X;RPL4;RPL30;RPL37A;RPL18;RPL19;SPCS2;RPL38;RPLP2;RPL12;SPCS1;RPS14;RPS3A;SRP9;SRP54;RPL28;RPL31;RPS28;RPLP0;RPL18A;UBA52;RPS11;RPS17;RPL11;RPS15;RPL35A;RPL23;RPL29;RPS9;RPL5;SEC63;RPL7A;RPS5;RPL27
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.19670848929109838,-0.5537519567838513,0.9333333333333333,1.0,1.0,7/18,38.42%,ZNF205;GSK3B;TMEM102;BAX;BID;HIP1R;FZD9
prerank,neural crest cell differentiation (GO:0014033),-0.20484588223378447,-0.5530777234561157,0.9841269841269841,0.9997604341383095,1.0,4/19,20.77%,CYP26C1;NOLC1;KBTBD8;NRG1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.20478009493162194,-0.5505495304660729,0.9705882352941176,0.9996512079866375,1.0,8/15,41.45%,BCL2L1;PRELID1;FXN;IGF1;OPA1;PPIF;AKT1;TRIAP1
prerank,apoptotic nuclear changes (GO:0030262),0.16651267914593632,0.549490760590238,1.0,0.9958659290186361,1.0,3/22,12.07%,CASP3;GPER1;DNASE1L3
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.17829767226144297,-0.5485122500930649,0.9857142857142858,0.9994538420974737,1.0,5/23,23.81%,DNMT1;DNMT3B;SPI1;JARID2;EZH2
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.20907534958620072,-0.5467972232887018,0.9714285714285714,0.9991127897953513,1.0,8/17,40.19%,RAN;MBTPS2;ERLIN1;KPNB1;LPCAT3;SEC14L2;ABCG1;ERLIN2
prerank,peroxisome organization (GO:0007031),0.1636414208096792,0.5446095859991443,1.0,0.9958424814313075,1.0,8/24,22.47%,PEX19;PEX11A;MFF;ABCD4;PEX6;SEC16B;PEX11B;PEX12
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.12670982282013057,-0.5431015425832787,1.0,0.9992083863669278,1.0,77/269,36.20%,POLR2F;U2AF1;CSTF2;SRPK1;RBM15;TGS1;SMN1;SNRPD1;CPSF3;PPIH;ELAVL2;RBMXL2;SNRPG;DCPS;SNRPF;MAGOHB;RSRC1;SF3B3;WDR77;LSM7;PABPC1;PRPF40A;CSTF1;NCBP1;POLR2J;RBM41;LSM5;LSM8;SRSF9;FUS;CLNS1A;ALYREF;POLR2D;PPIL1;EFTUD2;PSPC1;PRPF4;WDR83;SNRPA1;PRPF6;MAGOH;CRNKL1;LSM4;POLR2I;CPSF2;RBMXL3;SNRPB;RNF113A;DDX39A;SNRPE;DHX8;SNRPD3;CPSF4;PRPF19;CSTF3;SYNCRIP;CDC5L;DHX9;HNRNPC;GEMIN5;TFIP11;BUD31;AQR;GTF2F2;SNRNP40;CDK13;RBM8A;PRMT5;SNRPD2;EIF4A3;SNRPB2;SRPK2;RALY;HNRNPF;CDC40;PTBP1;FIP1L1
prerank,positive regulation of dendrite extension (GO:1903861),0.15486312040952582,0.5428689776046215,1.0,0.9952884162160704,1.0,17/17,84.53%,SYT4;SYT1;RIMS1;CPNE5;ITSN2;RNF157;CPNE9;SMURF1;CPNE6;NEDD4L;SYT3;SYT17;SYT2;RIMS2;UNC13A;PLAA;RASAL1
prerank,regulation of dendrite extension (GO:1903859),0.15487001424501415,0.5416048475078544,1.0,0.9946572331564852,1.0,18/18,84.53%,SYT4;SYT1;OSTN;RIMS1;CPNE5;ITSN2;RNF157;CPNE9;SMURF1;CPNE6;NEDD4L;SYT3;SYT17;SYT2;RIMS2;UNC13A;PLAA;RASAL1
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.20209412383308928,-0.5407039428337779,1.0,0.9990441658375535,1.0,2/19,10.22%,CHMP4C;PLK1
prerank,apoptotic DNA fragmentation (GO:0006309),-0.20020747119965598,-0.5391805973087865,1.0,0.9987040599245767,1.0,6/15,39.31%,FOXL2;ENDOG;HMGB1;KPNB1;HMGB2;DNASE2B
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.1929239532182933,-0.5350532079572429,0.9859154929577465,0.998832155473203,1.0,2/22,6.33%,DHRS2;AKR1C4
prerank,acetyl-CoA metabolic process (GO:0006084),0.17875680991768866,0.5318156962641221,1.0,0.9950711084789983,1.0,4/15,18.69%,ACACB;ACAT1;PMVK;ACSS1
prerank,phospholipid translocation (GO:0045332),-0.16466769839246378,-0.5307206332439666,0.9868421052631579,0.9989600820303404,1.0,16/29,46.07%,ATP11A;PLSCR2;ATP9A;ATP10B;ATP11B;ABCB4;ABCB1;PLSCR1;ABCC1;ATP8B1;ATP9B;ABCA4;ATP8B4;MFSD2A;TMEM30B;ABCA7
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.19698698846533297,-0.5209903584884539,1.0,0.9997769808569278,1.0,9/15,50.10%,GSTO2;ZC3H12A;MAPK13;ATF3;PPIF;ZFAND1;DHX36;VCP;HNRNPA1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.18016873217642593,-0.5176538157740274,1.0,0.9995667060697285,1.0,9/16,47.32%,SRPRB;RAB3GAP2;SEC61G;SEC61A1;EDEM1;RAB10;SPCS2;SPCS1;SRP54
prerank,protein targeting to peroxisome (GO:0006625),-0.16620735879927495,-0.5152284180898392,0.9629629629629629,0.999199661556628,1.0,8/29,33.32%,PEX7;ACBD5;PEX13;GDAP1;PEX10;PEX16;PEX3;PEX1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.1465379175209039,0.5062780339786678,0.96,0.9968390401893462,1.0,2/18,7.57%,UBB;RNF185
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.1608703387718191,-0.5049367047998717,1.0,0.999848615242734,1.0,6/27,23.04%,AJUBA;TGFB1;MYCN;LIN28A;BMP4;FMR1
prerank,positive regulation of exosomal secretion (GO:1903543),-0.17477749765328085,-0.5017791821356085,1.0,0.9994864809643518,1.0,3/15,21.75%,IFNG;ATP13A2;SDC1
prerank,cellular response to sterol (GO:0036315),-0.18096898913556522,-0.5016159592634847,0.9846153846153847,0.9988436178766358,1.0,9/16,44.89%,PTCH1;GRAMD1B;GPLD1;MLC1;INSIG1;CYP7A1;LRP6;RORC;DYNAP
prerank,regulation of intracellular protein transport (GO:0033157),-0.14974567618571655,-0.4929491895562407,1.0,0.9990124109052622,1.0,8/31,31.54%,KIF20B;TGFB1;ATP13A2;BMP4;GCC2;LCP1;PDCD10;UHMK1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.14965266341977657,-0.47881876426094133,1.0,0.9995446875946947,1.0,2/31,5.19%,TNIP3;IKBKE
prerank,transcription by RNA polymerase III (GO:0006383),-0.15455643043226647,-0.4676356750097469,1.0,0.9995563708403744,1.0,5/27,23.41%,POLR3K;GTF3C4;GTF3A;POLR3G;IVNS1ABP
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.1421060111789968,-0.455658945222108,1.0,0.9994209082437192,1.0,8/25,39.86%,SF3B3;PRPF4;WDR83;PRPF6;KHSRP;SNRNP40;LSM1;SCAF11
prerank,histone lysine demethylation (GO:0070076),-0.1341857876075895,-0.38331327005106103,1.0,1.0,1.0,8/24,39.58%,KDM1B;KDM5A;KDM7A;KDM6A;KDM2B;KDM1A;JMJD1C;KDM4E
prerank,vacuolar acidification (GO:0007035),-0.12265704999777392,-0.3424976917287302,1.0,0.9999770409451784,1.0,21/21,87.75%,ATP6V0A4;DMXL2;CLN6;ATP6V0A2;ATP6V0D2;DMXL1;PPT1;GRN;CLN5;TMEM199;TMEM9;ATP6AP2;SLC11A1;CLN3;CCDC115;ATP6V0E1;ATP6V0D1;ATP6V0A1;ATP6V1H;ATP6V0E2;TCIRG1
